PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Knowles, TP; Fitzpatrick, AW; Meehan, S; Mott, HR; Vendruscolo, M; Dobson, CM; Welland, ME				Knowles, Tuomas P.; Fitzpatrick, Anthony W.; Meehan, Sarah; Mott, Helen R.; Vendruscolo, Michele; Dobson, Christopher M.; Welland, Mark E.			Role of intermolecular forces in defining material properties of protein nanofibrils	SCIENCE			English	Article							CROSS-BETA-SPINE; DYNAMICS; FIBRILS; FIBERS	Protein molecules have the ability to form a rich variety of natural and artificial structures and materials. We show that amyloid fibrils, ordered supramolecular nanostructures that are self- assembled from a wide range of polypeptide molecules, have rigidities varying over four orders of magnitude, and constitute a class of high- performance biomaterials. We elucidate the molecular origin of fibril material properties and show that the major contribution to their rigidity stems from a generic interbackbone hydrogen- bonding network that is modulated by variable side- chain interactions.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Nanosci Ctr, Cambridge, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; mew10@cam.ac.uk	Knowles, Tuomas/C-6663-2009; Mott, Helen/AAV-3873-2020; Vendruscolo, Michele/F-5901-2012	Knowles, Tuomas/0000-0002-7879-0140; Mott, Helen/0000-0002-7890-7097; Vendruscolo, Michele/0000-0002-3616-1610	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashby MF., 1980, ENG MAT INTRO THEIR; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n; Wang JC, 2002, J MOL BIOL, V315, P601, DOI 10.1006/jmbi.2001.5130; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	28	588	596	7	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1900	1903		10.1126/science.1150057	http://dx.doi.org/10.1126/science.1150057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096801				2022-12-24	WOS:000251786600052
J	Mori, T; Vale, RD; Tomishige, M				Mori, Teppei; Vale, Ronald D.; Tomishige, Michio			How kinesin waits between steps	NATURE			English	Article							HAND-OVER-HAND; PROCESSIVE MOTOR; ATP HYDROLYSIS; BINDING; HEAD; COORDINATION; TRANSPORT; MOLECULE; PROTEIN; DOMAINS	Kinesin-1 ( conventional kinesin) is a dimeric motor protein that carries cellular cargoes along microtubules(1,2) by hydrolysing ATP(3) and moving processively in 8-nm steps(4). The mechanism of processive motility involves the hand-over-hand motion of the two motor domains ('heads')(5-7), a process driven by a conformational change in the neck-linker domain of kinesin(8-12.) However, the 'waiting conformation' of kinesin between steps remains controversial(13-16)-some models propose that kinesin adopts a one-head-bound intermediate(17-21), whereas others suggest that both the kinesin heads are bound to adjacent tubulin subunits(7,22,23). Addressing this question has proved challenging, in part because of a lack of tools to measure structural states of the kinesin dimer as it moves along a microtubule. Here we develop two different single-molecule fluorescence resonance energy transfer (smFRET) sensors to detect whether kinesin is bound to its microtubule track by one or two heads. Our FRET results indicate that, while moving in the presence of saturating ATP, kinesin spends most of its time bound to the microtubule with both heads. However, when nucleotide binding becomes rate-limiting at low ATP concentrations, kinesin waits for ATP in a one-head-bound state and makes brief transitions to a two-head-bound intermediate as it walks along the microtubule. On the basis of these results, we suggest a model for how transitions in the ATPase cycle position the two kinesin heads and drive their hand-over-hand motion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Tokyo; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu						Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2002, P NATL ACAD SCI USA, V99, P5977, DOI 10.1073/pnas.092546199; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	28	123	127	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					750	U15		10.1038/nature06346	http://dx.doi.org/10.1038/nature06346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18004302				2022-12-24	WOS:000251209700060
J	Czechowicz, A; Kraft, D; Weissman, IL; Bhattacharya, D				Czechowicz, Agnieszka; Kraft, Daniel; Weissman, Irving L.; Bhattacharya, Deepta			Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; MONOCLONAL-ANTIBODIES; PROGENITOR CELLS; MURINE MARROW; MICE; RECONSTITUTION; ENGRAFTMENT; IRRADIATION; RECIPIENTS	Upon intravenous transplantation, hematopoietic stem cells (HSCs) can home to specialized niches, yet most HSCs fail to engraft unless recipients are subjected to toxic preconditioning. We provide evidence that, aside from immune barriers, donor HSC engraftment is restricted by occupancy of appropriate niches by host HSCs. Administration of ACK2, an antibody that blocks c-kit function, led to the transient removal of > 98% of endogenous HSCs in immunodeficient mice. Subsequent transplantation of these mice with donor HSCs led to chimerism levels of up to 90%. Extrapolation of these methods to humans may enable mild but effective conditioning regimens for transplantation.	Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	irv@stanford.edu			NCI NIH HHS [R01 CA086065-08, R01 CA086065-06, 5R01CA086065, R01 CA086065-07, R01 CA086065] Funding Source: Medline; NHLBI NIH HHS [K08 HL076335-02, R01 HL058770, K08 HL076335-01A2, R01 HL058770-06, 5K08HL076335, 5R01HL058770, R01 HL058770-07, K08 HL076335-03, R01 HL058770-08] Funding Source: Medline; NIAID NIH HHS [T32 AI007290, T32AI0729022] Funding Source: Medline; NIDDK NIH HHS [5K01DK078318, K01 DK078318, K01 DK078318-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL076335, R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078318] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACH FH, 1968, LANCET, V2, P1364; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; BRECHER G, 1982, P NATL ACAD SCI-BIOL, V79, P5085, DOI 10.1073/pnas.79.16.5085; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; Ferry C, 2003, EXP HEMATOL, V31, P1182, DOI 10.1016/j.exphem.2003.09.008; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; GAMBEL P, 1984, TRANSPLANTATION, V38, P152, DOI 10.1097/00007890-198408000-00012; GATTI RA, 1968, LANCET, V2, P1366; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; MICKLEM HS, 1968, TRANSPLANTATION, V6, P299; Miller CL, 1996, EXP HEMATOL, V24, P185; Muller SM, 2000, BLOOD, V96, P4344, DOI 10.1182/blood.V96.13.4344.h8004344_4344_4349; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; STEWART FM, 1993, BLOOD, V81, P2566; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; TJONNFJORD GE, 1994, BLOOD, V84, P3584; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	30	278	299	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1296	1299		10.1126/science.1149726	http://dx.doi.org/10.1126/science.1149726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033883	Green Accepted			2022-12-24	WOS:000251086600042
J	Liou, TG; Adler, FR; Cox, DR; Cahill, BC				Liou, Theodore G.; Adler, Frederick R.; Cox, David R.; Cahill, Barbara C.			Lung transplantation and survival in children with cystic fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; DONT DEPRIVE CHILDREN; OPTION; MODELS; HEART	Background The effects of lung transplantation on the survival and quality of life in children with cystic fibrosis are uncertain. Methods We used data from the U.S. Cystic Fibrosis Foundation Patient Registry and from the Organ Procurement and Transplantation Network to identify children with cystic fibrosis who were on the waiting list for lung transplantation during the period from 1992 through 2002. We performed proportional-hazards survival modeling, using multiple clinically relevant covariates that were available before the children were on the waiting list and the interactions of these covariates with lung transplantation as a time-dependent covariate. The data were insufficient in quality and quantity for a retrospective quality-of-life analysis. Results A total of 248 of the 514 children on the waiting list underwent lung transplantation in the United States during the period from 1992 through 2002. Proportional-hazards modeling identified four variables besides transplantation that were associated with changes in survival. Burkholderia cepacia infection decreased survival, regardless of whether the patient underwent transplantation. A diagnosis of diabetes before the patient was placed on the waiting list decreased survival while the patient was on the waiting list but did not decrease survival after transplantation, whereas older age did not affect waiting-list survival but decreased post-transplantation survival. Staphylococcus aureus infection increased waiting-list survival but decreased post-transplantation survival. Using age, diabetes status, and S. aureus infection status as covariates, we estimated the effect of transplantation on survival for each patient group, expressed as a hazard factor of less than 1 for a benefit and more than 1 for a risk of harm. Five patients had a significant estimated benefit, 315 patients had a significant risk of harm, 76 patients had an insignificant benefit, and 118 patients had an insignificant risk of harm associated with lung transplantation. Conclusions Our analyses estimated clearly improved survival for only 5 of 514 patients on the waiting list for lung transplantation. Prolongation of life by means of lung transplantation should not be expected in children with cystic fibrosis. A prospective, randomized trial is needed to clarify whether and when patients derive a survival and quality-of-life benefit from lung transplantation.	Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Lung Transplant Program, Salt Lake City, UT 84112 USA; Univ Oxford Nuffield Coll, Oxford OX1 1NF, England	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Oxford	Liou, TG (corresponding author), Div Resp Crit Care & Occupat Pulm Med, 26 N Med Dr, Salt Lake City, UT 84132 USA.	ted.liou@utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NHLBI NIH HHS [R21 HL084341-01A1, R21 HL084341] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084341] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1998, Am J Respir Crit Care Med, V158, P335; Aurora P, 1999, LANCET, V354, P1591, DOI 10.1016/S0140-6736(99)03031-7; BRITTON A, 1995, LANCET, V345, P1511, DOI 10.1016/S0140-6736(95)91071-9; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1992, J ROY STAT SOC A STA, V155, P353, DOI 10.2307/2982889; COX DR, 1972, J R STAT SOC B, V34, P187; CROWLEY J, 1977, J AM STAT ASSOC, V72, P27, DOI 10.2307/2286902; *CYST FIBR FDN PAT, 2003, 2002 ANN DAT REP CEN; Davison AC, 1997, BOOTSTRAP METHODS TH; *DEP HLTH HUM SERV, 2005, ANN REP US ORG PROC; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Geertsma A, 1998, J HEART LUNG TRANSPL, V17, P511; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kugler C, 2005, J HEART LUNG TRANSPL, V24, P2262, DOI 10.1016/j.healun.2005.07.005; Liou TG, 2006, AM J RESP CRIT CARE, V173, P247, DOI 10.1164/ajrccm.173.2.247; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; SHARPLES L, 1993, J HEART LUNG TRANSPL, V12, P669; Smeritschnig B, 2005, J HEART LUNG TRANSPL, V24, P474, DOI 10.1016/j.healun.2003.12.013; Sweet SC, 2006, AM J RESP CRIT CARE, V173, P246; Therneau TM, 2000, MODELING SURVIVAL DA; Yankaskas JR, 1998, CHEST, V113, P217, DOI 10.1378/chest.113.1.217	26	136	137	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2143	2152		10.1056/NEJMoa066359	http://dx.doi.org/10.1056/NEJMoa066359			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032764	Green Accepted			2022-12-24	WOS:000251076500006
J	Psaty, BM; Korn, D				Psaty, Bruce M.; Korn, David			Congress responds to the IOM drug safety report - In full	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Assoc Amer Med Coll, Div Biomed & Hlth Sci Res, Washington, DC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Association of American Medical Colleges	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL068639, R01HL074745] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL74745, HL68639, HL085251] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACIU A, 2006, FUTURE DRUG SAFETY P; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; *FOOD DRUG ADM, 2007, FUT DRUG SAF PROM PR; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; *OFF INSP GEN, 2007, FOOD DRUG ADM OV CLI; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2007, JAMA-J AM MED ASSOC, V297, P1917, DOI 10.1001/jama.297.17.1917; Steenburg C, 2006, FOOD DRUG LAW J, V61, P295; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; 2007, FED REG, V72, P5069	13	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2185	2187		10.1001/jama.298.18.2185	http://dx.doi.org/10.1001/jama.298.18.2185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000202				2022-12-24	WOS:000250869800025
J	Liu, JG; Diamond, J				Liu, Jianguo; Diamond, Jared			Science and government - Revolutionizing China's environmental protection	SCIENCE			English	Editorial Material									[Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA; [Liu, Jianguo] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Shanghai, Peoples R China; [Liu, Jianguo] Fudan Univ, Shanghai 200433, Peoples R China; [Diamond, Jared] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	Michigan State University; Chinese Academy of Sciences; Fudan University; University of California System; University of California Los Angeles	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				[Anonymous], 2005, EC HUM WELL BEING SY; CHEN Q, 2007, YUE PAN ENV EC POLIC; Chinese Academy for Environmental Planning, 2006, CHIN GREEN NAT ACC S; *INT EN AG, 2006, CO2 EM FUEL COMB; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; National Bureau of Statistics of China, 2004, CHIN STAT YB 2004; NDRC of China, 2006, OUTL 11 5 YEAR PLAN; *NETH ENV ASS AG M, 2007, GLOB CO2 EM; SEPA, 2006, CHIN 11 5 YEAR PLAN; World Bank, 2007, COST POLL CHIN; *YAL CTR ENV LAW P, 2006, ENV PERF MEAS PROJ	12	152	170	5	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					37	38		10.1126/science.1150416	http://dx.doi.org/10.1126/science.1150416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174421				2022-12-24	WOS:000252084000015
J	Thewissen, JGM; Cooper, LN; Clementz, MT; Bajpai, S; Tiwari, BN				Thewissen, J. G. M.; Cooper, Lisa Noelle; Clementz, Mark T.; Bajpai, Sunil; Tiwari, B. N.			Whales originated from aquatic artiodactyls in the Eocene epoch of India	NATURE			English	Article							BONE-DENSITY; PHYLOGENETIC-RELATIONSHIPS; STABLE CARBON; TERRESTRIAL; MAMMALIA; CETACEANS; PAKISTAN; ANTHRACOTHERIIDAE; CETARTIODACTYLA; HIPPOPOTAMIDAE	Although the first ten million years of whale evolution are documented by a remarkable series of fossil skeletons, the link to the ancestor of cetaceans has been missing. It was known that whales are related to even- toed ungulates ( artiodactyls), but until now no artiodactyls were morphologically close to early whales. Here we show that the Eocene south Asian raoellid artiodactyls are the sister group to whales. The raoellid Indohyus is similar to whales, and unlike other artiodactyls, in the structure of its ears and premolars, in the density of its limb bones and in the stable- oxygen- isotope composition of its teeth. We also show that a major dietary change occurred during the transition from artiodactyls to whales and that raoellids were aquatic waders. This indicates that aquatic life in this lineage occurred before the origin of the order Cetacea.	Northeastern Ohio Univ Coll Med & Pharm, Dept Anat, Rootstown, OH 44272 USA; Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Wyoming; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG)	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu	Bajpai, Sunil/E-8416-2010	Thewissen, J. G. M./0000-0002-0973-4137				Bajpai Sunil, 2005, Journal of the Palaeontological Society of India, V50, P101; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Boisserie JR, 2005, ZOOL SCR, V34, P119, DOI 10.1111/j.1463-6409.2005.00183.x; Boisserie JR, 2005, P NATL ACAD SCI USA, V102, P1537, DOI 10.1073/pnas.0409518102; BRUNET M, 1968, CR ACAD SCI D NAT, V267, P835; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; COLBERT EH, 1938, AM MUS NAT HIST BULL, V74, P419; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; DOMNING DP, 1991, MAR MAMMAL SCI, V7, P331, DOI 10.1111/j.1748-7692.1991.tb00111.x; DUBOST G, 1978, MAMMALIA, V42, P1, DOI 10.1515/mamm.1978.42.1.1; Ducrocq Stephane, 1999, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V252, P93; Ducrocq Stephane, 1999, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V4, P199; FISH FE, 1991, ZOOMORPHOLOGY, V110, P339, DOI 10.1007/BF01668024; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Geisler JH, 2003, J VERTEBR PALEONTOL, V23, P991, DOI 10.1671/32; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; KAISER H.E., 1960, PALAEONTOGR ABT A, V114, P113; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Kumar K., 1985, Journal of Vertebrate Paleontology, V5, P153; Lihoreau F, 2004, ZOOL SCR, V33, P97, DOI 10.1111/j.1463-6409.2004.00139.x; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Madar SI, 2007, J PALEONTOL, V81, P176, DOI 10.1666/0022-3360(2007)81[176:TPSOEE]2.0.CO;2; Milinkovitch MC, 1998, ADV VERT PALEOBIOL, P113; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nummela S, 2006, J VERTEBR PALEONTOL, V26, P746, DOI 10.1671/0272-4634(2006)26[746:CAOPCM]2.0.CO;2; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; Ranga Rao A., 1981, HIMAL GEOL, V11, P422; RAO AR, 1971, J GEOL SOC INDIA, V12, P125; Roe LJ, 1998, ADV VERT PALEOBIOL, P399; Suteethorn V., 1988, N JB GEOL PALAONT MH, V9, P563; Taylor Michael A., 2000, Historical Biology, V14, P15; Theodor Jessica M., 2005, Journal of Mammalian Evolution, V12, P161, DOI 10.1007/s10914-005-5706-6; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; WALL WP, 1983, J PALEONTOL, V57, P197; WEST RM, 1980, J PALEONTOL, V54, P508	48	217	241	13	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1190	U1		10.1038/nature06343	http://dx.doi.org/10.1038/nature06343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097400				2022-12-24	WOS:000251786200041
J	Kayagaki, N; Phung, Q; Chan, S; Chaudhari, R; Quan, C; O'Rourke, KM; Eby, M; Pietras, E; Cheng, GH; Bazan, JF; Zhang, ZM; Arnott, D; Dixit, VM				Kayagaki, Nobuhiko; Phung, Qui; Chan, Salina; Chaudhari, Ruchir; Quan, Casey; O'Rourke, Karen M.; Eby, Michael; Pietras, Eric; Cheng, Genhong; Bazan, J. Fernando; Zhang, Zemin; Arnott, David; Dixit, Vishva M.			DUBA: A deubiquitinase that regulates type I interferon production	SCIENCE			English	Article							UBIQUITIN-BINDING DOMAINS; TOLL-LIKE RECEPTORS; ANTIVIRAL RESPONSES; RIG-I; RNA; INNATE; ACTIVATION; INDUCTION; TRAF3; RECOGNITION	Production of type I interferon (IFN-I) is a critical host defense triggered by pattern-recognition receptors (PRRs) of the innate immune system. Deubiquitinating enzyme A ( DUBA), an ovarian tumor domain-containing deubiquitinating enzyme, was discovered in a small interfering RNA-based screen as a regulator of IFN-I production. Reduction of DUBA augmented the PRR-induced IFN-I response, whereas ectopic expression of DUBA had the converse effect. DUBA bound tumor necrosis factor receptor-associated factor 3 ( TRAF3), an adaptor protein essential for the IFN-I response. TRAF3 is an E3 ubiquitin ligase that preferentially assembled lysine-63-linked polyubiquitin chains. DUBA selectively cleaved the lysine-63-linked polyubiquitin chains on TRAF3, resulting in its dissociation from the downstream signaling complex containing TANKbinding kinase 1. A discrete ubiquitin interaction motif within DUBA was required for efficient deubiquitination of TRAF3 and optimal suppression of IFN-I. Our data identify DUBA as a negative regulator of innate immune responses.	Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California Los Angeles; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	dixit@gene.com	Bazan, J. Fernando/B-4562-2010; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bowie AG, 2007, TRENDS IMMUNOL, V28, P147, DOI 10.1016/j.it.2007.02.002; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	26	355	380	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1628	1632		10.1126/science.1145918	http://dx.doi.org/10.1126/science.1145918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17991829				2022-12-24	WOS:000251421700047
J	O'Farrell, N; Moodley, P; Sturm, AW				O'Farrell, Nigel; Moodley, Prashini; Sturm, A. Wim			Genital herpes in Africa: time to rethink treatment	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLEX-VIRUS; WOMEN; ACYCLOVIR; INFECTION; REACTIVATION; PREVALENCE; THERAPY; IMPACT; SPREAD		[O'Farrell, Nigel] Ealing Gen Hosp, London UB1 3HW, England; [Moodley, Prashini; Sturm, A. Wim] Univ KwaZulu Natal, Nelson Mandela Sch Med, Dept Med Microbiol, Durban, South Africa	Imperial College London; University of Kwazulu Natal	O'Farrell, N (corresponding author), Ealing Gen Hosp, Pasteur Suite,Uxbridge Rd, London UB1 3HW, England.	nigel.ofarrell@lshtm.ac.uk						Aoki FY, 2006, CLIN INFECT DIS, V42, P8, DOI 10.1086/498521; Blower S, 2004, J INFECT DIS, V190, P1610, DOI 10.1086/424850; BROCK BV, 1990, JAMA-J AM MED ASSOC, V263, P418, DOI 10.1001/jama.263.3.418; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; COREY L, 1986, NEW ENGL J MED, V314, P686, DOI 10.1056/NEJM198603133141105; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; KOELLE DM, 1992, ANN INTERN MED, V116, P433, DOI 10.7326/0003-4819-116-6-433; KOUTSKY LA, 1992, NEW ENGL J MED, V326, P1533, DOI 10.1056/NEJM199206043262305; KREISS JK, 1986, NEW ENGL J MED, V314, P414, DOI 10.1056/NEJM198602133140704; LANGENBERG A, 1989, ANN INTERN MED, V110, P882, DOI 10.7326/0003-4819-110-11-882; Levin MJ, 2004, CLIN INFECT DIS, V39, pS248, DOI 10.1086/422364; MAYAUD P, 2006, ANRS SAT S TOR 15 AU; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; O'Farrell N, 1999, SEX TRANSM INFECT, V75, P377, DOI 10.1136/sti.75.6.377; O'Farrell N, 2006, SEX TRANSM DIS, V33, P558, DOI 10.1097/01.olq.0000216033.00860.1b; OFARRELL N, 2005, 16 BIENN M INT SOC S; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; REICHMAN RC, 1984, JAMA-J AM MED ASSOC, V251, P2103, DOI 10.1001/jama.251.16.2103; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Spruance SL, 1996, ARCH INTERN MED, V156, P1729, DOI 10.1001/archinte.156.15.1729; STIGMA, 2019, GUID MAN SEX TRANSM; Trollope-Kumar K, 2006, LANCET, V367, P1380, DOI 10.1016/S0140-6736(06)68593-0; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, CLIN INFECT DIS, V34, P944, DOI 10.1086/339325; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; White PJ, 1999, SEX TRANSM INFECT, V75, P49, DOI 10.1136/sti.75.1.49; Williams JR, 2007, SEX TRANSM DIS, V34, P123, DOI 10.1097/01.olq.0000258486.81492.a2	29	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2164	2166		10.1016/S0140-6736(07)61910-2	http://dx.doi.org/10.1016/S0140-6736(07)61910-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156037				2022-12-24	WOS:000252058600038
J	Ghavidel, A; Kislinger, T; Pogoutse, O; Sopko, R; Jurisica, I; Emili, A				Ghavidel, Ata; Kislinger, Thomas; Pogoutse, Oxana; Sopko, Richelle; Jurisica, Igor; Emili, Andrew			Impaired tRNA nuclear export links DNA damage and cell-cycle checkpoint	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; MASTER REGULATOR; GENE-EXPRESSION; GLOBAL ANALYSIS; PROTEIN-KINASE; IN-VIVO; YEAST; PHOSPHORYLATION	In response to genotoxic stress, cells evoke a plethora of physiological responses collectively aimed at enhancing viability and maintaining the integrity of the genome. Here, we report that unspliced tRNA rapidly accumulates in the nuclei of yeast Saccharomyces cerevisiae after DNA damage. This response requires an intact MEC1- and RAD53-dependent signaling pathway that impedes the nuclear export of intron-containing tRNA via differential relocalization of the karyopherin Los1 to the cytoplasm. The accumulation of unspliced tRNA in the nucleus signals the activation of Gcn4 transcription factor, which, in turn, contributes to cell-cycle arrest in G1 in part by delaying accumulation of the cyclin Cln2. The regulated nucleocytoplasmic tRNA trafficking thus constitutes an integral physiological adaptation to DNA damage. These data further illustrate how signal-mediated crosstalk between distinct functional modules, namely, tRNA nucleocytoplasmic trafficking, protein synthesis, and checkpoint execution, allows for functional coupling of tRNA biogenesis and cell-cycle progression.	[Ghavidel, Ata; Jurisica, Igor] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Kislinger, Thomas; Pogoutse, Oxana] Ontario Canc Inst, Div Canc Genom & Prot, Toronto, ON, Canada; [Pogoutse, Oxana; Sopko, Richelle; Emili, Andrew] Univ Toronto, Donnely Ctr Cellular & Biomed Res, Toronto, ON, Canada; [Kislinger, Thomas; Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Pogoutse, Oxana; Sopko, Richelle; Emili, Andrew] Univ Toronto, Dept Med Genet, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Ghavidel, A (corresponding author), Ontario Canc Inst, Div Signaling Biol, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	aghavide@uhnres.utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; COLBY D, 1981, P NATL ACAD SCI-BIOL, V78, P415, DOI 10.1073/pnas.78.1.415; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerald JNF, 2002, J CELL SCI, V115, P1749; Germain D, 1997, J CELL SCI, V110, P1813; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; HOPPER AK, 1980, CELL, V19, P741, DOI 10.1016/S0092-8674(80)80050-X; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Majka J, 2005, DNA REPAIR, V4, P1189, DOI 10.1016/j.dnarep.2005.07.008; MANN C, 1992, MOL CELL BIOL, V12, P4314, DOI 10.1128/MCB.12.10.4314; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Niwa M, 2000, P NATL ACAD SCI USA, V97, P12396, DOI 10.1073/pnas.250476097; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Paulovich AG, 1997, GENETICS, V145, P45; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; SIEDE W, 1994, GENETICS, V138, P271; Simos G, 1999, CURR BIOL, V9, pR238, DOI 10.1016/S0960-9822(99)80152-3; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; STUART D, 1994, MOL CELL BIOL, V14, P4788, DOI 10.1128/MCB.14.7.4788; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TYERS M, 1991, COLD SH Q B, V56, P21; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	49	67	73	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					915	926		10.1016/j.cell.2007.09.042	http://dx.doi.org/10.1016/j.cell.2007.09.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045534	Bronze			2022-12-24	WOS:000251800900014
J	Byrne, JA; Pedersen, DA; Clepper, LL; Nelson, M; Sanger, WG; Gokhale, S; Wolf, DP; Mitalipov, SM				Byrne, J. A.; Pedersen, D. A.; Clepper, L. L.; Nelson, M.; Sanger, W. G.; Gokhale, S.; Wolf, D. P.; Mitalipov, S. M.			Producing primate embryonic stem cells by somatic cell nuclear transfer	NATURE			English	Article							RHESUS-MONKEY EMBRYOS; IN-VITRO; THERAPEUTIC CLONING; MICROSATELLITE LOCI; NONHUMAN PRIMATE; MACACA-MULATTA; MOUSE; LINES; DIFFERENTIATION; TRANSPLANTATION	Derivation of embryonic stem (ES) cells genetically identical to a patient by somatic cell nuclear transfer ( SCNT) holds the potential to cure or alleviate the symptoms of many degenerative diseases while circumventing concerns regarding rejection by the host immune system. However, the concept has only been achieved in the mouse, whereas inefficient reprogramming and poor embryonic development characterizes the results obtained in primates. Here, we used a modified SCNT approach to produce rhesus macaque blastocysts from adult skin fibroblasts, and successfully isolated two ES cell lines from these embryos. DNA analysis confirmed that nuclear DNA was identical to donor somatic cells and that mitochondrial DNA originated from oocytes. Both cell lines exhibited normal ES cell morphology, expressed key stem-cell markers, were transcriptionally similar to control ES cells and differentiated into multiple cell types in vitro and in vivo. Our results represent successful nuclear reprogramming of adult somatic cells into pluripotent ES cells and demonstrate proof-of-concept for therapeutic cloning in primates.	Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; Munroe Meyer Inst, Omaha, NE 68198 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Mitalipov, SM (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu		Byrne, James/0000-0002-2232-292X				Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BAVISTER BD, 1977, BIOL REPROD, V16, P228, DOI 10.1095/biolreprod16.2.228; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bowles EJ, 2007, CURR TOP DEV BIOL, V77, P251, DOI 10.1016/S0070-2153(06)77010-7; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BYRNE JA, 2007, INT SOC STEM CELL RE, P52; Byrne James A, 2006, Curr Stem Cell Res Ther, V1, P127, DOI 10.2174/157488806776956913; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; DomingoRoura X, 1997, AM J PRIMATOL, V43, P357, DOI 10.1002/(SICI)1098-2345(1997)43:4<357::AID-AJP7>3.0.CO;2-W; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kuo HC, 2003, BIOL REPROD, V68, P1727, DOI 10.1095/biolreprod.102.012195; Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703; Martin MJ, 2003, CLONING STEM CELLS, V5, P117, DOI 10.1089/153623003322234713; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; McKiernan SH, 2000, HUM REPROD, V15, P157, DOI 10.1093/humrep/15.1.157; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov S, 2006, STEM CELLS, V24, P2177, DOI 10.1634/stemcells.2006-0125; Mitalipov SM, 2002, BIOL REPROD, V66, P1367, DOI 10.1095/biolreprod66.5.1367; Mombaerts P, 2003, P NATL ACAD SCI USA, V100, P11924, DOI 10.1073/pnas.1934141100; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Ng SC, 2004, DEVELOPMENT, V131, P2475, DOI 10.1242/dev.01118; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PEARSON PL, 1979, CYTOGENET CELL GENET, V25, P82, DOI 10.1159/000131403; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Simerly C, 2004, DEV BIOL, V276, P237, DOI 10.1016/j.ydbio.2004.10.006; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; St John JC, 2004, GENETICS, V167, P897, DOI 10.1534/genetics.103.025049; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Yang JF, 2007, BIOL REPROD, V76, P36, DOI 10.1095/biolreprod.106.051383; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; ZELINSKIWOOTEN MB, 1995, HUM REPROD, V10, P1658, DOI 10.1093/oxfordjournals.humrep.a136151; Zhou Q, 2006, HUM REPROD, V21, P2564, DOI 10.1093/humrep/del216	43	392	434	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					497	U3		10.1038/nature06357	http://dx.doi.org/10.1038/nature06357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18004281				2022-12-24	WOS:000251158500036
J	Wong, SL; Ji, H; Hollenbeck, BK; Morris, AM; Baser, O; Birkmeyer, JD				Wong, Sandra L.; Ji, Hong; Hollenbeck, Brent K.; Morris, Arden M.; Baser, Onur; Birkmeyer, John D.			Hospital lymph node examination rates and survival after resection for colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEER-MEDICARE DATA; PROCEDURE VOLUME; RECTAL-CANCER; POPULATION; SURGERY; NUMBER	Context Several studies suggest improved survival among patients in whom a higher number of nodes are examined after colectomy for colon cancer. The National Quality Forum and other organizations recently endorsed a 12-node minimum as a measure of hospital quality. Objective To assess whether hospitals that examine more lymph nodes after resection for colon cancer have superior late survival rates. Design, Setting, and Patients Retrospective cohort study, using the national Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database (19952005), of US patients undergoing colectomy for nonmetastatic colon cancer (n=30 625). Hospitals were ranked according to the proportion of their patients in whom 12 or more lymph nodes were examined and then were sorted into 4 evenly sized groups. Late survival rates were assessed for each hospital group, adjusting for potentially confounding patient and clinician characteristics. Main Outcome Measures Hospitals' lymph node examination rates in association with cancer staging, use of adjuvant chemotherapy ( indicated for patients with node-positive disease), and 5-year survival rate. Results Hospitals with the highest proportions of patients with examination of 12 or more lymph nodes tended to treat lower-risk patients and had substantially higher procedure volumes. After adjusting for these and other factors, there remained no statistically significant relationship between hospital lymph node examination rates and survival after surgery (adjusted hazard ratio, highest vs lowest hospital quartile, 0.95; 95% confidence interval, 0.88-1.03). Although the 4 hospital groups varied widely in the number of lymph nodes examined, they were equally likely to find node-positive tumors and had very similar overall unadjusted rates of adjuvant chemotherapy (26% vs 25%, highest vs lowest hospital quartile). Conclusions The number of lymph nodes hospitals examine following colectomy for colon cancer is not associated with staging, use of adjuvant chemotherapy, or patient survival. Efforts by payers and professional organizations to increase node examination rates may have limited value as a public health intervention.	Univ Michigan, Michigan Surg Collaborat Outcomes Res & Evaluat, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wong, SL (corresponding author), 1500 E Med Ctr Dr,3310 CCC, Ann Arbor, MI 48109 USA.	wongsl@umich.edu		Wong, Sandra/0000-0002-8594-6086; Morris, Arden/0000-0001-5795-2940	NCI NIH HHS [1 R01 CA098481-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098481] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Canessa CE, 2001, DIS COLON RECTUM, V44, P1333, DOI 10.1007/BF02234794; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; KELDER W, EUR J SURG ONCOL; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; *NAT QUAL FOR, SPEC NAT VOL CONS ST; National Cancer Institute, CANC COL RECT; OSTADI MA, SURG ENDOSC; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001; Rieger NA, 2007, J CLIN ONCOL, V25, P463, DOI 10.1200/JCO.2006.09.2304; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Schrag D, 2002, ANN SURG, V236, P583, DOI 10.1097/00000658-200211000-00008; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; World Health Organization, 1977, INT CLASS DIS	21	254	258	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2149	2154		10.1001/jama.298.18.2149	http://dx.doi.org/10.1001/jama.298.18.2149			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000198	Bronze			2022-12-24	WOS:000250869800020
J	Nelson, EC; Braun, PV				Nelson, Erik C.; Braun, Paul V.			Enhancing colloids through the surface	SCIENCE			English	Editorial Material							PARTICLES; NANOPARTICLES; BIDISPERSE; CRYSTALS		Univ Illinois, Beckman Inst, Dept Mat Sci & Engn, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nelson, EC (corresponding author), Univ Illinois, Beckman Inst, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	pbraun@uiuc.edu						Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Cho YS, 2005, J AM CHEM SOC, V127, P15968, DOI 10.1021/ja0550632; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Hermanson KD, 2001, SCIENCE, V294, P1082, DOI 10.1126/science.1063821; Hong L, 2006, NANO LETT, V6, P2510, DOI 10.1021/nl061857i; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Milam VT, 2003, LANGMUIR, V19, P10317, DOI 10.1021/la034376c; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Piech M, 2006, LANGMUIR, V22, P1379, DOI 10.1021/la051636c; Plunkett KN, 2005, J AM CHEM SOC, V127, P14574, DOI 10.1021/ja054666a; Zhang G, 2005, NANO LETT, V5, P143, DOI 10.1012/nl048121a; Zhang ZL, 2005, LANGMUIR, V21, P11547, DOI 10.1021/la0513611	15	34	35	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					924	925		10.1126/science.1148009	http://dx.doi.org/10.1126/science.1148009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991849				2022-12-24	WOS:000250788500027
J	Pardal, R; Ortega-Saenz, P; Duran, R; Lopez-Barneo, J				Pardal, Ricardo; Ortega-Saenz, Patricia; Duran, Rocio; Lopez-Barneo, Jose			Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body	CELL			English	Article							CARDIAC NEURAL CREST; SELF-RENEWAL; INTRASTRIATAL TRANSPLANTATION; PARKINSONIAN RATS; BASIC FGF; NEURONS; OXYGEN; PROLIFERATION; HYPOXIA; DIFFERENTIATION	Neurogenesis is known to occur in the specific niches of the adult mammalian brain, but whether germinal centers exist in the neural-crest-derived peripheral nervous system is unknown. We have discovered stem cells in the adult carotid body (CB), an oxygen-sensing organ of the sympathoadrenal lineage that grows in chronic hypoxemia. Production of new neuron like CB glomus cells depends on a population of stem cells, which form multipotent and self-renewing colonies in vitro. Cell fate mapping experiments indicate that, unexpectedly, CB stem cells are the glia-like sustentacular cells and can be identified using glial markers. Remarkably, stem cell-derived glomus cells have the same complex chemosensory properties as mature in situ glomus cells. They are highly dopaminergic and produce glial cell line-derived neurotrophic factor. Thus, the mammalian CB is a neurogenic center with a recognizable physiological function in adult life. CB stem cells could be potentially useful for antiparkinsonian cell therapy.	Univ Seville, Hosp Univ Virgen Rocio, Lab Invest Biomed, Seville 41013, Spain	University of Sevilla; Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Lab Invest Biomed, Avenida Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es	IBIS, NEUROBIOLOGIA/O-9922-2015; Sáenz, Patricia Ortega/E-8623-2016; Pardal, Ricardo/C-4370-2015; IBIS, FISIOPATOLOGIA/O-9510-2015	Pardal, Ricardo/0000-0003-1085-0714; 				ACHILLES E, 1991, HISTOPATHOLOGY, V18, P453, DOI 10.1111/j.1365-2559.1991.tb00877.x; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ARIASSTELLA J, 1976, HUM PATHOL, V7, P361, DOI 10.1016/S0046-8177(76)80052-4; Arjona V, 2003, NEUROSURGERY, V53, P321, DOI 10.1227/01.NEU.0000073315.88827.72; Astrom K, 2003, HUM GENET, V113, P228, DOI 10.1007/s00439-003-0969-6; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dinger B, 2003, OXYGEN SENSING RESPO, P439; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EDWARDS C, 1971, J PATHOL, V104, P1, DOI 10.1002/path.1711040102; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; HEATH D, 1982, J PATHOL, V138, P115, DOI 10.1002/path.1711380203; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kameda Y, 2005, DEV BIOL, V283, P128, DOI 10.1016/j.ydbio.2005.04.004; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; KLIEWER KE, 1989, HUM PATHOL, V20, P29, DOI 10.1016/0046-8177(89)90199-8; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; MCGREGOR KH, 1984, J APPL PHYSIOL, V57, P1430, DOI 10.1152/jappl.1984.57.5.1430; Mejias R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nurse CA, 1997, DEV BIOL, V184, P197, DOI 10.1006/dbio.1997.8539; Paciga M, 2001, NEUROREPORT, V12, P3287, DOI 10.1097/00001756-200110290-00028; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pardal R, 2002, NAT NEUROSCI, V5, P197, DOI 10.1038/nn812; ROBERTSON DI, 1980, CANCER-AM CANCER SOC, V46, P2623, DOI 10.1002/1097-0142(19801215)46:12<2623::AID-CNCR2820461215>3.0.CO;2-U; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Villadiego J, 2005, J NEUROSCI, V25, P4091, DOI 10.1523/JNEUROSCI.4312-04.2005; Young HM, 1998, DEV BIOL, V202, P67, DOI 10.1006/dbio.1998.8987	50	249	262	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					364	377		10.1016/j.cell.2007.07.043	http://dx.doi.org/10.1016/j.cell.2007.07.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956736	Bronze			2022-12-24	WOS:000250507700025
J	Nelson, JA				Nelson, Jay A.			Small RNAs and large DNA viruses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CYTOMEGALOVIRUS; APOPTOSIS; INHIBITOR		Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Oregon Health & Science University	Nelson, JA (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.							Calin GA, 2007, J CLIN INVEST, V117, P2059, DOI 10.1172/JCI32577; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956	7	6	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2630	2632		10.1056/NEJMcibr0706718	http://dx.doi.org/10.1056/NEJMcibr0706718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	242MJ	18094385				2022-12-24	WOS:000251728900016
J	Wang, GY; Innes, JL; Lei, JF; Dai, SY; Wu, SW				Wang, Guangyu; Innes, John L.; Lei, Jiafu; Dai, Shuanyou; Wu, Sara W.			Ecology - China's forestry reforms	SCIENCE			English	Editorial Material									Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1Z4, Canada; State Forestry Adm, Beijing 100714, Peoples R China; World Forest Inst, Portland, OR 97221 USA	University of British Columbia	Innes, JL (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1Z4, Canada.	john.innes@ubc.ca	Innes, John L/E-4355-2013	Innes, John L/0000-0002-7076-1222				*CENTR COMM COMM P, 2003, DIR ENH FOR DEV; MA J, 2006, PATH ENV HARMONY CHI; *STAT FOR ADM, 2003, REP MON ASS SOC EC I; *STAT FOR ADM, 2005, CHIN FOR DEV REP; *STAT FOR ADM, 2005, 6 NAT SURV FOR RES P; *STAT FOR ADM, 2006, ENH FOR EC IMPR ACC; *STAT FOR ADM TASK, 2007, INV REP JIANGX FOR O; Sun X., 2007, CHINANEWS       0706, V15; *UNECE TIMB COMM, 2006, STAT FOR PROD MARK 2; Zhang PC, 2000, SCIENCE, V288, P2135, DOI 10.1126/science.288.5474.2135	10	224	245	17	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1556	1557		10.1126/science.1147247	http://dx.doi.org/10.1126/science.1147247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063773				2022-12-24	WOS:000251421700019
J	Klompas, M; Platt, R				Klompas, Michael; Platt, Richard			Ventilator-associated pneumonia-the wrong quality measure for Benchmarking	ANNALS OF INTERNAL MEDICINE			English	Article							DIAGNOSTIC-ACCURACY	Legislators, payers, and quality-of-care advocates across the United States are considering requiring hospitals to report ventilator-associated pneumonia rates as a way to benchmark and reward quality of care. Accurate diagnosis of ventilator-associated pneumonia, however, is notoriously difficult because several common complications of critical care can mimic the clinical appearance of ventilator-associated pneumonia. The challenge is compounded by substantial subjectivity inherent in the current surveillance definition. These sources of variability make ventilator-associated pneumonia rates difficult to acquire, interpret, and compare both within and among institutions. Ventilator-associated pneumonia should be excluded from compulsory reporting initiatives until we develop and validate more objective outcome measures that meaningfully reflect quality of care for ventilated patients.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Pilgrim Hlth Care, Boston, MA 02115 USA	Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Harvard Pilgrim Hlth Care, 133 Brookline Ave, 6th Fl, Boston, MA 02215 USA.		Klompas, Michael/Z-2415-2019					[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bregeon F, 2000, EUR RESPIR J, V16, P969, DOI 10.1183/09031936.00.16596900; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; *HEALTHC INF CONTR, 2005, INFECT CONT HOSP EP, V26, P580; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; Klompas M, 2007, JAMA-J AM MED ASSOC, V297, P1583, DOI 10.1001/jama.297.14.1583; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Louthan F B, 1996, Semin Respir Infect, V11, P77; MARQUETTE CH, 1995, AM J RESP CRIT CARE, V151, P1878, DOI 10.1164/ajrccm.151.6.7767535; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221	14	92	92	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					803	235		10.7326/0003-4819-147-11-200712040-00013	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056666				2022-12-24	WOS:000251539100009
J	Juhasz, AL; Smith, E; Weber, J				Juhasz, Albert L.; Smith, Euan; Weber, John			Brominated flame retardants-safety at what cost?	LANCET			English	Editorial Material							POLYBROMINATED DIPHENYL ETHERS; HUMAN EXPOSURE; MARKET-BASKET; HOUSE-DUST; PBDES; FOOD		Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia	University of South Australia	Juhasz, AL (corresponding author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes Campus, Mawson Lakes, SA 5095, Australia.	Albert.Juhasz@unisa.edu.au	Juhasz, Albert/F-6600-2011	Juhasz, Albert/0000-0002-1164-4085				Alaee M, 2002, CHEMOSPHERE, V46, P579, DOI 10.1016/S0045-6535(01)00224-7; Alm H, 2006, ENVIRON HEALTH PERSP, V114, P254, DOI 10.1289/ehp.8419; Birnbaum LS, 2006, ENVIRON HEALTH PERSP, V114, P1770, DOI 10.1289/ehp.9061; Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Fischer D, 2006, ENVIRON HEALTH PERSP, V114, P1581, DOI 10.1289/ehp.8554; FOWLES JR, 1994, TOXICOLOGY, V86, P49, DOI 10.1016/0300-483X(94)90052-3; Jones-Otazo HA, 2005, ENVIRON SCI TECHNOL, V39, P5121, DOI 10.1021/es048267b; LORBER M, 2007, J EXP SCI ENV E 0411; Meironyte D, 1999, J TOXICOL ENV HEAL A, V58, P329, DOI 10.1080/009841099157197; Schecter A, 2006, ENVIRON HEALTH PERSP, V114, P1515, DOI 10.1289/ehp.9121; Voorspoels S, 2007, ENVIRON INT, V33, P93, DOI 10.1016/j.envint.2006.08.003; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282	12	5	6	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 1	2007	370	9602					1813	1814		10.1016/S0140-6736(07)61757-7	http://dx.doi.org/10.1016/S0140-6736(07)61757-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061044				2022-12-24	WOS:000251588700010
J	Oldham, ML; Khare, D; Quiocho, FA; Davidson, AL; Chen, J				Oldham, Michael L.; Khare, Dheeraj; Quiocho, Florante A.; Davidson, Amy L.; Chen, Jue			Crystal structure of a catalytic intermediate of the maltose transporter	NATURE			English	Article							BINDING CASSETTE TRANSPORTER; ATP-BINDING; ABC TRANSPORTER; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; CYTOPLASMIC MEMBRANE; MACROMOLECULAR STRUCTURES; MUTATIONAL ANALYSIS; TRANSITION-STATE; P-GLYCOPROTEIN	The maltose uptake system of Escherichia coli is a well-characterized member of the ATP-binding cassette transporter superfamily. Here we present the 2.8-angstrom crystal structure of the intact maltose transporter in complex with the maltose-binding protein, maltose and ATP. This structure, stabilized by a mutation that prevents ATP hydrolysis, captures the ATP-binding cassette dimer in a closed, ATP-bound conformation. Maltose is occluded within a solvent-filled cavity at the interface of the two transmembrane subunits, about halfway into the lipid bilayer. The binding protein docks onto the entrance of the cavity in an open conformation and serves as a cap to ensure unidirectional translocation of the sugar molecule. These results provide direct evidence for a concerted mechanism of transport in which solute is transferred from the binding protein to the transmembrane subunits when the cassette dimer closes to hydrolyse ATP.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu						[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; BOOS W, 1996, ESCHERICHIA COLI SAL, P1175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DASSA E, 1993, MOL MICROBIOL, V7, P29, DOI 10.1111/j.1365-2958.1993.tb01094.x; DAVIDSON AL, 1991, J BIOL CHEM, V266, P8946; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEAN DA, 1989, J BACTERIOL, V171, P503, DOI 10.1128/jb.171.1.503-510.1989; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; EHRMANN M, 1991, J BIOL CHEM, V266, P16530; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERENCI T, 1980, EUR J BIOCHEM, V108, P613; Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nelson BD, 1998, J BACTERIOL, V180, P2507, DOI 10.1128/JB.180.9.2507-2514.1998; Neuhard J, 1987, ESCHERICHIA COLI SAL, P445; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAIBAUD O, 1979, MOL GEN GENET, V174, P241, DOI 10.1007/BF00267796; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SILHAVY TJ, 1979, MOL GEN GENET, V174, P249, DOI 10.1007/BF00267797; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Steinke A, 2001, J BACTERIOL, V183, P375, DOI 10.1128/JB.183.1.375-381.2001; Sun H, 2001, J BIOENERG BIOMEMBR, V33, P523, DOI 10.1023/A:1012883306823; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	61	412	417	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					515	U7		10.1038/nature06264	http://dx.doi.org/10.1038/nature06264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033289				2022-12-24	WOS:000251158500039
J	Shapiro, D				Shapiro, Daniel			The last gift	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												shapiro@u.arizona.edu		Shapiro, Daniel/0000-0002-7166-7705					0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2116	2116		10.1001/jama.298.18.2116	http://dx.doi.org/10.1001/jama.298.18.2116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230II	18000188				2022-12-24	WOS:000250869800001
J	Yu, D; Tan, AHM; Hu, X; Athanasopoulos, V; Simpson, N; Silva, DG; Hutloff, A; Giles, KM; Leedman, PJ; Lam, KP; Goodnow, CC; Vinuesa, CG				Yu, Di; Tan, Andy Hee-Meng; Hu, Xin; Athanasopoulos, Vicki; Simpson, Nicholas; Silva, Diego G.; Hutloff, Andreas; Giles, Keith M.; Leedman, Peter J.; Lam, Kong Peng; Goodnow, Christopher C.; Vinuesa, Carola G.			Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA	NATURE			English	Article							IMMUNE-RESPONSES; ICOS; HELPER; ACTIVATION; TOLERANCE; RECEPTOR; SIGNALS; STRESS; FAMILY; LIGAND	Immune responses are normally targeted against microbial pathogens and not self-antigens by mechanisms that are only partly understood. Here we define a newly discovered pathway that prevents autoimmunity by limiting the levels on T lymphocytes of a co-stimulatory receptor, the inducible T-cell co-stimulator (ICOS). In sanroque mice homozygous for an M199R mutation in the ROQ domain of Roquin (also known as Rc3h1)(1), increased Icos expression on T cells causes the accumulation of lymphocytes that is associated with a lupus-like autoimmune syndrome. Roquin normally limits Icos expression by promoting the degradation of Icos messenger RNA. A conserved segment in the unusually long ICOS 39 untranslated mRNA is essential for regulation by Roquin. This segment comprises a 47-base-pair minimal region complementary to T-cell-expressed microRNAs including miR-101, the repressive activity of which is disrupted by base-pair inversions predicted to abrogate miR-101 binding. These findings illuminate a critical post-transcriptional pathway within T cells that regulates lymphocyte accumulation and autoimmunity, and highlights the therapeutic potential of partially antagonising the ICOS pathway.	Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia; ASTAR, Inst Biomed Sci, Cellular & Mol Immunol Lab, Singapore 138673, Singapore; Australian Natl Univ, ARC Ctr Mol Genet Dev, Canberra, ACT 2601, Australia; Robert Koch Inst, D-13353 Berlin, Germany; Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Lab Canc Med, Perth, WA 6000, Australia; Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia; Australian Phenom Facil, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Agency for Science Technology & Research (A*STAR); Australian National University; Robert Koch Institute; University of Western Australia; University of Western Australia	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Canberra, ACT 2601, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010; Yu, Di/C-2163-2009; Goodnow, Christopher C/V-8108-2018; Lam, Kong-Peng/G-5374-2012; Hutloff, Andreas/D-1781-2014; Leedman, Peter J/O-4044-2014; Silva, Diego/GRF-5446-2022	Vinuesa, Carola G/0000-0001-9799-0298; Yu, Di/0000-0003-1721-8922; Goodnow, Christopher C/0000-0001-5296-6155; Hutloff, Andreas/0000-0002-0572-8151; Lam, Kong-Peng/0000-0002-1316-4333; Athanasopoulos, Vicki/0000-0002-5764-5948				Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; LAFFERTY KJ, 1980, IMMUNOL REV, V51, P279, DOI 10.1111/j.1600-065X.1980.tb00325.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Newbury SF, 2006, EMBO REP, V7, P143, DOI 10.1038/sj.embor.7400628; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	30	325	348	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					299	U15		10.1038/nature06253	http://dx.doi.org/10.1038/nature06253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	18172933				2022-12-24	WOS:000250746200061
J	Singh, AP; Buscaglia, CA; Wang, Q; Levay, A; Nussenzweig, DR; Walker, JR; Winzeler, EA; Fujii, H; Fontoura, BMA; Nussenzweig, V				Singh, Agam Prasad; Buscaglia, Carlos A.; Wang, Qian; Levay, Agata; Nussenzweig, Daniel R.; Walker, John R.; Winzeler, Elizabeth A.; Fujii, Hodaka; Fontoura, Beatriz M. A.; Nussenzweig, Victor			Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite	CELL			English	Article							NF-KAPPA-B; NUCLEAR-LOCALIZATION SIGNALS; MALARIA PARASITES; TOXOPLASMA-GONDII; HOST ERYTHROCYTE; MAMMALIAN-CELLS; GENE-EXPRESSION; SPOROZOITES; VIRULENCE; INNATE	The liver stages of malaria are clinically silent but have a central role in the Plasmodium life cycle. Liver stages of the parasite containing thousands of merozoites grow inside hepatocytes for several days without triggering an inflammatory response. We show here that Plasmodium uses a PEXEL/VTS motif to introduce the circumsporozoite (CS) protein into the hepatocyte cytoplasm and a nuclear localization signal (NLS) to enter its nucleus. CS outcompetes NFkB nuclear import, thus downregulating the expression of many genes controlled by NFkB, including those involved in inflammation. CS also influences the expression of over one thousand host genes involved in diverse metabolic processes to create a favorable niche for the parasite growth. The presence of CS in the hepatocyte enhances parasite growth of the liver stages in vitro and in vivo. These findings have far reaching implications for drug and vaccine development against the liver stages of the malaria parasite.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Inst Canc, New York, NY 10016 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Novartis Res Fdn, Genom Inst, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, ICND202, La Jolla, CA 92037 USA	New York University; New York University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Novartis; Scripps Research Institute	Singh, AP (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	singha05@med.nyu.edu	Fujii, Hodaka/N-9792-2019; Winzeler, Elizabeth/AAP-6752-2020; singh, Agam prasad/F-2532-2012; Singh, Agam/AAH-2031-2020; Fujii, Hodaka/A-2420-2008; Levay, Agata/R-5392-2019	Fujii, Hodaka/0000-0003-1296-4256; Winzeler, Elizabeth/0000-0002-4049-2113; singh, Agam prasad/0000-0003-4262-2556; Singh, Agam/0000-0003-4262-2556; Fujii, Hodaka/0000-0003-1296-4256; Levay, Agata/0000-0001-9404-4503; Buscaglia, Carlos/0000-0001-6466-4138	NIAID NIH HHS [AI059315] Funding Source: Medline; NIGMS NIH HHS [GM067159] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067159] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1992, METHOD ENZYMOL, V219, P97; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chabicovsky M, 2003, ENDOCRINOLOGY, V144, P3497, DOI 10.1210/en.2003-0388; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Denkers EY, 2003, FEMS IMMUNOL MED MIC, V39, P193, DOI 10.1016/S0928-8244(03)00279-7; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; GILBERT LA, 2006, CELL, V6, P73; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P24, DOI 10.4269/ajtmh.1983.32.24; Hoshino A, 2004, MOL CELL, V15, P153, DOI 10.1016/j.molcel.2004.06.017; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002; PIED S, 1992, J IMMUNOL, V148, P197; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Shapira S, 2004, INT J PARASITOL, V34, P393, DOI 10.1016/j.ijpara.2003.12.005; SHORTT HE, 1954, T ROY SOC TROP MED H, V48, P122, DOI 10.1016/0035-9203(54)90004-8; STEWART MJ, 1991, J PROTOZOOL, V38, P411, DOI 10.1111/j.1550-7408.1991.tb01379.x; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209	49	159	168	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					492	504		10.1016/j.cell.2007.09.013	http://dx.doi.org/10.1016/j.cell.2007.09.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981117	Bronze			2022-12-24	WOS:000250618500017
J	Chabot, JR; Pedraza, JM; Luitel, P; van Oudenaarden, A				Chabot, Jeffrey R.; Pedraza, Juan M.; Luitel, Prashant; van Oudenaarden, Alexander			Stochastic gene expression out-of-steady-state in the cyanobacterial circadian clock	NATURE			English	Article							PROTEIN EXPRESSION; NOISE; RHYTHMS; VARIABILITY; LUCIFERASE; REPORTER; ORIGINS; CELLS	Recent advances in measuring gene expression at the single- cell level have highlighted the stochastic nature of messenger RNA and protein synthesis(1-3). Stochastic gene expression creates a source of variability in the abundance of cellular components, even among isogenic cells exposed to an identical environment. Recent integrated experimental and modelling studies(4-13) have shed light on the molecular sources of this variability. However, many of these studies focus on systems that have reached a steady state and therefore do not address a large class of dynamic phenomena including oscillatory gene expression. Here we develop a general protocol for analysing and predicting stochastic gene expression in systems that never reach steady states. We use this framework to analyse experimentally stochastic expression of genes driven by the Synechococcus elongatus circadian clock. We find that, although the average expression at two points in the circadian cycle separated by 12 hours is identical, the variability at these two time points can be different. We show that this is a general feature of out- of- steady- state systems. We demonstrate how intrinsic noise sources, owing to random births and deaths of mRNAs and proteins, or extrinsic noise sources, which introduce fluctuations in rate constants, affect the cell- to- cell variability. To distinguish experimentally between these sources, we measured how the correlation between expression fluctuations of two identical genes is modulated during the circadian cycle. This quantitative framework is generally applicable to any out- of steady state system and will be necessary for understanding the fidelity of dynamic cellular systems.	MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, George R Harrison Spect Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Pedraza, Juan/0000-0002-1802-3337				Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Johnson CH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-217; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168	30	86	87	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1249	1252		10.1038/nature06395	http://dx.doi.org/10.1038/nature06395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097413				2022-12-24	WOS:000251786200054
J	Schumacher, MA; Glover, TC; Brzoska, AJ; Jensen, SO; Dunham, TD; Skurray, RA; Firth, N				Schumacher, Maria A.; Glover, Tiffany C.; Brzoska, Anthony J.; Jensen, Slade O.; Dunham, Thomas D.; Skurray, Ronald A.; Firth, Neville			Segrosome structure revealed by a complex of ParR with centromere DNA	NATURE			English	Article							CRYSTAL-STRUCTURE; PLASMID R1; ANGSTROM RESOLUTION; BETA-SHEETS; PROTEIN; SEGREGATION; ACTIN; RECOGNITION; HELIX; PARTITION	The stable inheritance of genetic material depends on accurate DNA partition. Plasmids serve as tractable model systems to study DNA segregation because they require only a DNA centromere, a centromere- binding protein and a force- generating ATPase. The centromeres of partition ( par) systems typically consist of a tandem arrangement of direct repeats(1-7). The best- characterized par system contains a centromere- binding protein called ParR and an ATPase called ParM. In the first step of segregation, multiple ParR proteins interact with the centromere repeats to form a large nucleoprotein complex of unknown structure called the segrosome, which binds ParM filaments(4,8-10). pSK41 ParR binds a centromere consisting of multiple 20- base- pair ( bp) tandem repeats to mediate both transcription autoregulation and segregation. Here we report the structure of the pSK41 segrosome revealed in the crystal structure of a ParR - DNA complex. In the crystals, the 20- mer tandem repeats stack pseudo- continuously to generate the full- length centromere with the ribbon - helix - helix ( RHH) fold of ParR binding successive DNA repeats as dimer- of- dimers. Remarkably, the dimer- of- dimers assemble in a continuous protein super- helical array, wrapping the DNA about its positive convex surface to form a large segrosome with an open, solenoid-shaped structure, suggesting a mechanism for ParM capture and subsequent plasmid segregation.	Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, Houston, TX 77030 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Sydney	Schumacher, MA (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000, 1515 Holcombe Blvd, Houston, TX 77030 USA.	maschuma@mdanderson.org		Firth, Neville/0000-0002-5791-7691; Jensen, Slade/0000-0003-4489-589X				BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DELANO WL, 2002, PYMOL MOL GRAPHCIS S, P33202; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2004, CELL, V116, P359, DOI 10.1016/S0092-8674(04)00116-3; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HE YY, 1992, NATURE, V359, P431, DOI 10.1038/359431a0; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Khare D, 2004, NAT STRUCT MOL BIOL, V11, P656, DOI 10.1038/nsmb773; Kwong SM, 2004, MOL MICROBIOL, V51, P497, DOI 10.1046/j.1365-2958.2003.03843.x; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Larson JD, 2006, PROTEIN SCI, V15, P2630, DOI 10.1110/ps.062425706; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; RAUMANN BE, 1994, CURR OPIN STRUC BIOL, V4, P36, DOI 10.1016/S0959-440X(94)90057-4; RAVISHANKER G, 1989, J BIOMOL STRUCT DYN, V6, P669, DOI 10.1080/07391102.1989.10507729; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101	34	79	80	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1268	U15		10.1038/nature06392	http://dx.doi.org/10.1038/nature06392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097417				2022-12-24	WOS:000251786200058
J	Dixon-Mueller, R; Germain, A				Dixon-Mueller, Ruth; Germain, Adrienne			HIV testing: the mutual rights and responsibilities of partners	LANCET			English	Editorial Material									Int Womens Hlth Coalit, New York, NY 10001 USA		Germain, A (corresponding author), Int Womens Hlth Coalit, New York, NY 10001 USA.	agermain@iwhc.org						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2004, GEND DIM HIV STAT DI; Csete J, 2004, LANCET, V363, P493, DOI 10.1016/S0140-6736(04)15509-8; McGrath JW, 2007, AIDS CARE, V19, P418, DOI 10.1080/09540120600717668; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Tarantola D, 2007, LANCET, V370, P202, DOI 10.1016/S0140-6736(07)61102-7; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; *UN, 1996, 4 WORLD C WOM BEIJ S; *WHO, 2003, GEND HIV AIDS GEND H	9	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1808	1809		10.1016/S0140-6736(07)61754-1	http://dx.doi.org/10.1016/S0140-6736(07)61754-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061041				2022-12-24	WOS:000251588700007
J	Mateen, FJ				Mateen, Farrah Jasmine			Smoking the pipe of peace	LANCET			English	Editorial Material									Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic	Mateen, FJ (corresponding author), Mayo Clin, Coll Med, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	mateen.farrah@mayo.edu		Mateen, Farrah/0000-0002-4293-8115				CATLIN G, 1973, LETT NOTES MANNERS C, V2, P258	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2007	370	9605					2170	2171		10.1016/S0140-6736(07)61912-6	http://dx.doi.org/10.1016/S0140-6736(07)61912-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156039				2022-12-24	WOS:000252058600040
J	Till, S; Ladurner, AG				Till, Susanne; Ladurner, Andreas G.			RNA Pol IV plays catch with argonaute 4	CELL			English	Editorial Material							PROCESSING CENTER; HETEROCHROMATIN; BODIES; DNA	Small-interfering RNAs regulate gene expression by affecting chromatin structure, transcription, translation, and RNA stability. In a recent report in Genes & Development, El-Shami et al. (2007) show that in plants, Argonaute 4 - which is involved in RNA-directed DNA methylation-directly associates with RNA polymerase IVb through a repeat motif, establishing an intimate molecular link between RNAi and transcription.	European Mol Biol Lab, Struct & Computat Biol Unit, Gene Express Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, EMBL Int PhD Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Ladurner, AG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Gene Express Unit, D-69117 Heidelberg, Germany.	ladurner@embl.de		Ladurner, Andreas/0000-0003-3835-232X				Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Partridge JF, 2007, MOL CELL, V26, P593, DOI 10.1016/j.molcel.2007.05.004; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302	10	15	20	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					643	645		10.1016/j.cell.2007.10.044	http://dx.doi.org/10.1016/j.cell.2007.10.044			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022355	Bronze			2022-12-24	WOS:000250966300008
J	Bai, XC; Ma, DZ; Liu, AL; Shen, XY; Wang, QJM; Liu, YJ; Jiang, Y				Bai, Xiaochun; Ma, Dongzhu; Liu, Anling; Shen, Xiaoyun; Wang, Qiming J.; Liu, Yongjian; Jiang, Yu			Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38	SCIENCE			English	Article							SMALL GTPASE RHEB; TSC2 GAP ACTIVITY; DIRECT TARGET; TOR; BINDING; GROWTH; PROTEINS; RAPTOR; BCL-2	The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase ( GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein ( FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.	Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China	Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol, E1357 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15213 USA.	jiang@server.pharm.pitt.edu	Liu, Yongjian/J-7852-2018; Wang, Qiming Jane/B-6064-2012	Wang, Qiming Jane/0000-0002-9502-4851; Bai, Xiaochun/0000-0001-9631-4781	NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129821] Funding Source: Medline; NIGMS NIH HHS [GM068832, R01 GM068832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	20	295	301	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					977	980		10.1126/science.1147379	http://dx.doi.org/10.1126/science.1147379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991864				2022-12-24	WOS:000250788500044
J	Pfennig, KS				Pfennig, Karin S.			Facultative mate choice drives adaptive hybridization	SCIENCE			English	Article							SPADEFOOT TOADS; TREE FROGS; SPECIATION; REINFORCEMENT; WOODHOUSII; SELECTION	Mating with another species ( hybridization) is often maladaptive. Consequently, females typically avoid heterospecifics as mates. Contrary to these expectations, female spadefoot toads were more likely to choose heterospecific males when exposed to environmental conditions that favor hybridization. Indeed, those females with phenotypic characteristics for which hybridization is most favorable were most likely to switch from choosing conspecifics to heterospecifics. Moreover, environmentally dependent mate choice has evolved only in populations and species that risk engaging in, and can potentially benefit from, hybridization. Thus, when the benefits of mate choice vary, females may radically alter their mate selection in response to their own phenotype and their environment, even to the point of choosing males of other species.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Pfennig, KS (corresponding author), Univ N Carolina, Dept Biol, Campus Box 3280,Coker Hall, Chapel Hill, NC 27599 USA.	kpfennig@email.unc.edu						Andersson Malte, 1994; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Britch SC, 2001, MOL ECOL, V10, P627, DOI 10.1046/j.1365-294x.2001.01215.x; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; FORESTER D C, 1975, Herpetologica, V31, P282; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; JONES JM, 1973, EVOLUTION, V27, P435, DOI 10.1111/j.1558-5646.1973.tb00690.x; LAMB T, 1986, P NATL ACAD SCI USA, V83, P2526, DOI 10.1073/pnas.83.8.2526; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; LEVINS RICHARD, 1968; Malmos KB, 2001, EVOLUTION, V55, P626, DOI 10.1554/0014-3820(2001)055[0626:CBADHB]2.0.CO;2; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig KS, 2003, EVOLUTION, V57, P2842; PFENNIG KS, 2002, EVOL INT J ORG EVOL, V56, P1810; Saetre GP, 1997, NATURE, V387, P589; SATTLER PW, 1985, COPEIA, P324; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SIMOVICH M A, 1991, Proceedings of the San Diego Society of Natural History, P1; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Welch AM, 2003, EVOLUTION, V57, P883; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144	27	170	175	1	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					965	967		10.1126/science.1146035	http://dx.doi.org/10.1126/science.1146035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991861				2022-12-24	WOS:000250788500040
J	Prasad, GVR; Verma, O; Sahni, A; Parmar, V; Khosla, A				Prasad, G. V. R.; Verma, O.; Sahni, A.; Parmar, V.; Khosla, A.			A cretaceous hoofed mammal from India	SCIENCE			English	Article							ORIGIN		Univ Jammu, Dept Geol, Jammu 180006, India; Panjab Univ, Ctr Adv Study Geol, Chandigarh 160014, India	University of Jammu; Panjab University	Prasad, GVR (corresponding author), Univ Jammu, Dept Geol, Jammu 180006, India.	guntupalli.vrprasad@gmail.com	PARMAR, VARUN/T-6965-2017	PARMAR, VARUN/0000-0001-6896-5341; Prasad, Guntupalli/0000-0002-0620-4712; Khosla, Ashu/0000-0002-6237-7765; Verma, Omkar/0000-0003-4655-9216				ARCHIBALD J D, 1982, University of California Publications in Geological Sciences, V122, P1; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; de Muizon Christian, 2000, Geodiversitas, V22, P47; Eberle Jaelyn J., 1998, Rocky Mountain Geology, V33, P49; van Valen L., 1978, Evolutionary Theory, V4, P45; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854	6	45	47	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					937	937		10.1126/science.1149267	http://dx.doi.org/10.1126/science.1149267			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991854				2022-12-24	WOS:000250788500032
J	Joshi, R; Passner, JM; Rohs, R; Jain, R; Sosinsky, A; Crickmore, MA; Jacob, V; Aggarwal, AK; Honig, B; Mann, RS				Joshi, Rohit; Passner, Jonathan M.; Rohs, Remo; Jain, Rinku; Sosinsky, Alona; Crickmore, Michael A.; Jacob, Vinitha; Aggarwal, Aneel K.; Honig, Barry; Mann, Richard S.			Functional specificity of a Hox protein mediated by the recognition of minor groove structure	CELL			English	Article							HOMEODOMAIN-DNA COMPLEX; MONTE-CARLO SIMULATIONS; HOMEOTIC GENE-FUNCTION; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; BINDING MECHANISM; TARGET GENE; DROSOPHILA; EXTRADENTICLE; TRACT	The recognition of specific DNA-binding sites by transcription factors is a critical yet poorly understood step in the control of gene expression. Members of the Hox family of transcription factors bind DNA by making nearly identical major groove contacts via the recognition helices of their homeodomains. In vivo specificity, however, often depends on extended and unstructured regions that link Hox homeodomains to a DNA-bound cofactor, Extradenticle (Exd). Using a combination of structure determination, computational analysis, and in vitro and in vivo assays, we show that Hox proteins recognize specific Hox-Exd binding sites via residues located in these extended regions that insert into the minor groove but only when presented with the correct DNA sequence. Our results suggest that these residues, which are conserved in a paralog-specific manner, confer specificity by recognizing a sequence-dependent DNA structure instead of directly reading a specific DNA sequence.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Icahn School of Medicine at Mount Sinai	Aggarwal, AK (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.	aneel.aggarwal@mssm.edu; bh6@columbia.edu; rsm10@columbia.edu	Rohs, Remo/F-5752-2011; Joshi, Rohit/AAH-3941-2019	Joshi, Rohit/0000-0001-9151-1372	NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R24GM074105, R01GM062947] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA121852] Funding Source: Medline; NIAID NIH HHS [R01 AI041706, AI41706] Funding Source: Medline; NIGMS NIH HHS [R01 GM054510, GM54510, R24 GM074105-04, GM62947, R24 GM074105, R01 GM054510-14, GM074105, R01 GM062947, R24 GM074105-03, R01 GM054510-13, R01 GM054510-15, R01 GM054510-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chauvet S, 2000, P NATL ACAD SCI USA, V97, P4064, DOI 10.1073/pnas.070046997; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Faiger H, 2007, NUCLEIC ACIDS RES, V35, P4409, DOI 10.1093/nar/gkm451; Fraenkel E, 1998, J MOL BIOL, V284, P351, DOI 10.1006/jmbi.1998.2147; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Galant R, 2002, DEVELOPMENT, V129, P3115; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gearhart MD, 2003, J MOL BIOL, V327, P819, DOI 10.1016/S0022-2836(03)00183-9; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hirsch JA, 1995, EMBO J, V14, P6280, DOI 10.1002/j.1460-2075.1995.tb00318.x; Hizver J, 2001, P NATL ACAD SCI USA, V98, P8490, DOI 10.1073/pnas.151247298; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lavery R, 2005, Q REV BIOPHYS, V38, P339, DOI 10.1017/S0033583505004105; LI T, 1995, SCIENCE, V270, P262, DOI 10.1126/science.270.5234.262; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; PANZER S, 1992, DEVELOPMENT, V114, P49; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rohs R, 2005, NUCLEIC ACIDS RES, V33, P7048, DOI 10.1093/nar/gki1008; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Shakked Z., 1999, OXFORD HDB NUCL ACID, P455; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Sklenar H, 2006, J COMPUT CHEM, V27, P309, DOI 10.1002/jcc.20345; Stefl R, 2004, P NATL ACAD SCI USA, V101, P1177, DOI 10.1073/pnas.0308143100; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309; Zhao YX, 2002, DEV BIOL, V244, P21, DOI 10.1006/dbio.2002.0595; ZHURKIN VB, 2005, DNA CONFORMATION TRA	60	261	264	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					530	543		10.1016/j.cell.2007.09.024	http://dx.doi.org/10.1016/j.cell.2007.09.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981120	Green Accepted, Bronze			2022-12-24	WOS:000250618500020
J	Edwards, AM; Phillips, RA; Watkins, NW; Freeman, MP; Murphy, EJ; Afanasyev, V; Buldyrev, SV; da Luz, MGE; Raposo, EP; Stanley, HE; Viswanathan, GM				Edwards, Andrew M.; Phillips, Richard A.; Watkins, Nicholas W.; Freeman, Mervyn P.; Murphy, Eugene J.; Afanasyev, Vsevolod; Buldyrev, Sergey V.; da Luz, M. G. E.; Raposo, E. P.; Stanley, H. Eugene; Viswanathan, Gandhimohan M.			Revisiting Levy flight search patterns of wandering albatrosses, bumblebees and deer	NATURE			English	Article							ANOMALOUS DIFFUSION; MOVEMENT; BEHAVIOR; SUCCESS; WALKS	The study of animal foraging behaviour is of practical ecological importance(1), and exemplifies the wider scientific problem of optimizing search strategies(2). Levy flights are random walks, the step lengths of which come from probability distributions with heavy power-law tails(3,4), such that clusters of short steps are connected by rare long steps. Levy flights display fractal properties, have no typical scale, and occur in physical(3-5) and chemical(6) systems. An attempt to demonstrate their existence in a natural biological system presented evidence that wandering albatrosses perform Levy flights when searching for prey on the ocean surface(7). This well known finding(2,4,8,9) was followed by similar inferences about the search strategies of deer(10) and bumblebees(10). These pioneering studies have triggered much theoretical work in physics (for example, refs 11, 12), as well as empirical ecological analyses regarding reindeer(13), microzooplankton(14), grey seals(15), spider monkeys(16) and fishing boats(17). Here we analyse a new, high-resolution data set of wandering albatross flights, and find no evidence for Levy flight behaviour. Instead we find that flight times are gamma distributed, with an exponential decay for the longest flights. We re-analyse the original albatross data(7) using additional information, and conclude that the extremely long flights, essential for demonstrating Levy flight behaviour, were spurious. Furthermore, we propose a widely applicable method to test for power-law distributions using likelihood(18) and Akaike weights(19,20). We apply this to the four original deer and bumblebee data sets(10), finding that none exhibits evidence of Levy flights, and that the original graphical approach(10) is insufficient. Such a graphical approach has been adopted to conclude Levy flight movement for other organisms(13-17), and to propose Levy flight analysis as a potential real-time ecosystem monitoring tool(17). Our results question the strength of the empirical evidence for biological Levy flights.	British Antarctic Survey, Cambridge CB3 0ET, England; Boston Univ, Dept Phys, Boston, MA 02215 USA; Yeshiva Univ, Dept Phys, New York, NY 10033 USA; Univ Fed Parana, Dept Fis, BR-81531990 Curitiba, Parana, Brazil; Univ Fed Pernambuco, Dept Fis, Lab Fis Teor & Computac, BR-50670901 Recife, PE, Brazil; Univ Fed Alagoas, Inst Fis, BR-57072970 Maceio, AL, Brazil	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Boston University; Yeshiva University; Universidade Federal do Parana; Universidade Federal de Pernambuco; Universidade Federal de Alagoas	Edwards, AM (corresponding author), British Antarctic Survey, High Cross, Cambridge CB3 0ET, England.	EdwardsAnd@pac.dfo-mpo.gc.ca	Watkins, Nick/GPX-7439-2022; murphy, eugene/GZL-1620-2022; Viswanathan, Gandhimohan M/J-8558-2012; Raposo, Ernesto P./ABA-7215-2020; Watkins, Nicholas Wynn/C-5140-2008; Raposo, Ernesto P/N-2786-2017; Freeman, Mervyn/E-5687-2019; da luz, marcos g e gomes eleuterio/H-7835-2012; Buldyrev, Sergey V/I-3933-2015; edwards, andrew m/E-6900-2010; Viswanathan, Gandhimohan/AAF-3937-2020	Watkins, Nick/0000-0003-4484-6588; Viswanathan, Gandhimohan M/0000-0002-2301-5593; Raposo, Ernesto P./0000-0002-4178-8266; Watkins, Nicholas Wynn/0000-0003-4484-6588; Raposo, Ernesto P/0000-0002-3595-4352; Freeman, Mervyn/0000-0002-8653-8279; da luz, marcos g e gomes eleuterio/0000-0003-3865-2621; Stanley, H./0000-0003-2800-4495; Buldyrev, Sergey/0000-0002-3008-1070	Natural Environment Research Council [bas010021] Funding Source: researchfish; NERC [bas010021] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AFANASYEV V, 1993, NERC TECH, V1, P4; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; BARDOU F, 2002, LEVY STATISTICS LASE; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; ben Avraham D., 2000, DIFFUSION REACTIONS; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Focardi S, 1996, J ANIM ECOL, V65, P606, DOI 10.2307/5740; HEINRICH B, 1979, OECOLOGIA, V40, P235, DOI 10.1007/BF00345321; Hilborn R., 1997, MONOGRAPHS POPULATIO, V28; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Klafter J, 2005, PHYS WORLD, V18, P29; Marell A, 2002, CAN J ZOOL, V80, P854, DOI 10.1139/Z02-061; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OTT A, 1990, PHYS REV LETT, V65, P2201, DOI 10.1103/PhysRevLett.65.2201; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; Pueyo S, 2006, SCIENCE, V313, DOI 10.1126/science.1129595; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041928; Shlesinger M., 1995, LEVY FLIGHTS RELATED, Ved, DOI [10.1007/3-540-59222-9, DOI 10.1007/3-540-59222-9]; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sokal R. R., 2012, BIOMETRY; Turchin Peter, 1998; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866	30	628	635	6	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1044	U5		10.1038/nature06199	http://dx.doi.org/10.1038/nature06199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960243	Green Accepted			2022-12-24	WOS:000250395000051
J	Halevy, I; Zuber, MT; Schrag, DP				Halevy, Itay; Zuber, Maria T.; Schrag, Daniel P.			A sulfur dioxide climate feedback on early Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; MARTIAN SURFACE; ATMOSPHERE; EVOLUTION; RADIATION; LIFE; SO2; CO2; CONDENSATION; ASSEMBLAGES	Ancient Mars had liquid water on its surface and a CO(2)-rich atmosphere. Despite the implication that massive carbonate deposits should have formed, these have not been detected. On the basis of fundamental chemical and physical principles, we propose that climatic conditions enabling the existence of liquid water were maintained by appreciable atmospheric concentrations of volcanically degassed SO(2) and H(2)S. The geochemistry resulting from equilibration of this atmosphere with the hydrological cycle is shown to inhibit the formation of carbonates. We propose an early martian climate feedback involving SO2, much like that maintained by CO(2) on Earth.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Halevy, I (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ihalevy@fas.harvard.edu	HALEVY, ITAY/K-1364-2012; Halevy, Itay/W-9850-2019	HALEVY, ITAY/0000-0002-7325-8139; Halevy, Itay/0000-0002-7325-8139				Andrews-Hanna JC, 2007, NATURE, V446, P163, DOI 10.1038/nature05594; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BLUTH GJS, 1993, NATURE, V366, P327, DOI 10.1038/366327a0; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CLARK BC, 1976, SCIENCE, V194, P1283, DOI 10.1126/science.194.4271.1283; Coombs ML, 2006, J VOLCANOL GEOTH RES, V151, P19, DOI 10.1016/j.jvolgeores.2005.07.037; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; FANALE FP, 1995, LUN PLAN SCI C 26, P391; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; HAFF LV, 1970, CHEM ANAL, V29, P183; Hanna JC, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002330; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Jakosky B. M., 1992, MARS, P969; JOHNSON SS, 2006, WORKSH MART SULF REC; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; Knoll AH, 2005, EARTH PLANET SC LETT, V240, P179, DOI 10.1016/j.epsl.2005.09.045; Krasnopolsky VA, 2005, ICARUS, V178, P487, DOI 10.1016/j.icarus.2005.05.006; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Molina-Cuberos GJ, 2001, ICARUS, V154, P216, DOI 10.1006/icar.2001.6658; Morner NA, 2002, GLOBAL PLANET CHANGE, V33, P185, DOI 10.1016/S0921-8181(02)00070-X; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Neukum G, 2001, SPACE SCI REV, V96, P55, DOI 10.1023/A:1011989004263; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; RONOV AB, 1967, GEOCHEM INT, V4, P1041; Ryabinina AF, 1972, T URAL LESOTEKH I, V28, P182; SCHRAG DP, 2003, 6 INT C MARS PAS CA; Shuster DL, 2005, SCIENCE, V309, P594, DOI 10.1126/science.1113077; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Tosca NJ, 2006, EARTH PLANET SC LETT, V241, P21, DOI 10.1016/j.epsl.2005.10.021; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALLACE PJ, 1994, AM MINERAL, V79, P161; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003; Yen AS, 2005, NATURE, V436, P881, DOI 10.1038/nature04042; Yung YL, 1997, ICARUS, V130, P222, DOI 10.1006/icar.1997.5808; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; ZAHNLE KJ, 2006, WORKSH MART SULF REC	48	151	152	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1903	1907		10.1126/science.1147039	http://dx.doi.org/10.1126/science.1147039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096802				2022-12-24	WOS:000251786600053
J	Lutz, S; Shankaranarayanan, A; Coco, C; Ridilla, M; Nance, MR; Vettel, C; Baltus, D; Evelyn, CR; Neubig, RR; Wieland, T; Tesmer, JJG				Lutz, Susanne; Shankaranarayanan, Aruna; Coco, Cassandra; Ridilla, Marc; Nance, Mark R.; Vettel, Christiane; Baltus, Doris; Evelyn, Chris R.; Neubig, Richard R.; Wieland, Thomas; Tesmer, John J. G.			Structure of G alpha(q)-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs	SCIENCE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PLURIPOTENT STEM-CELLS; PLECKSTRIN HOMOLOGY; G-PROTEINS; GTPASES; TRIO; FIBROBLASTS; P63RHOGEF; DOMAINS; DISEASE	The guanine nucleotide exchange factor p63RhoGEF is an effector of the heterotrimeric guanine nucleotide- binding protein ( G protein) G alpha(q) and thereby links G alpha(q)- coupled receptors ( GPCRs) to the activation of the small- molecular- weight G protein RhoA. We determined the crystal structure of the G alpha(q)-p63RhoGEF- RhoA complex, detailing the interactions of G alpha(q) with the Dbl and pleckstrin homology ( DH and PH) domains of p63RhoGEF. These interactions involve the effector- binding site and the C- terminal region of G alpha(q) and appear to relieve autoinhibition of the catalytic DH domain by the PH domain. Trio, Duet, and p63RhoGEF are shown to constitute a family of G alpha(q) effectors that appear to activate RhoA both in vitro and in intact cells. We propose that this structure represents the crux of an ancient signal transduction pathway that is expected to be important in an array of physiological processes.	Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, D-68169 Mannheim, Germany; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	Ruprecht Karls University Heidelberg; University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan	Wieland, T (corresponding author), Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Maybachstr 14, D-68169 Mannheim, Germany.	thomas.wieland@urz.uni-heidelberg.de; tesmerjj@umich.edu	Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Ridilla, Marc/0000-0002-0306-7097; Tesmer, John/0000-0003-1125-3727; Neubig, Richard/0000-0003-0501-0008	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NHLBI NIH HHS [HL071818, HL086865] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2004, N-S ARCH PHARMACOL, V369, P540, DOI 10.1007/s00210-004-0926-5; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McPherson CE, 2002, GENE, V284, P41, DOI 10.1016/S0378-1119(02)00386-4; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Skowronek KR, 2004, J BIOL CHEM, V279, P37895, DOI 10.1074/jbc.M312677200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Souchet M, 2002, J CELL SCI, V115, P629; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Worthylake DK, 2004, STRUCTURE, V12, P1079, DOI 10.1016/j.str.2004.03.021; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	160	168	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1923	1927		10.1126/science.1147554	http://dx.doi.org/10.1126/science.1147554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096806				2022-12-24	WOS:000251786600059
J	Wan, FY; Anderson, DE; Barnitz, RA; Snow, A; Bidere, N; Zheng, LX; Hegde, V; Lam, LT; Staudt, LM; Levens, D; Deutsch, WA; Lenardo, MJ				Wan, Fengyi; Anderson, D. Eric; Barnitz, Robert A.; Snow, Andrew; Bidere, Nicolas; Zheng, Lixin; Hegde, Vijay; Lam, Lloyd T.; Staudt, Louis M.; Levens, David; Deutsch, Walter A.; Lenardo, Michael J.			Ribosomal protein S3: A KH domain subunit in NF-kappa B complexes that mediates selective gene regulation	CELL			English	Article							RIBOSOMAL-PROTEIN S3; NUCLEAR RIBONUCLEOPROTEIN-K; BINDING SITES; DNA-BINDING; HUMAN-CELLS; TRANSCRIPTION; INDUCTION; ACTIVATION; COACTIVATORS; HETERODIMER	NF-kappa B is a DNA-binding protein complex that transduces a variety of activating signals from the cytoplasm to specific sets of target genes. To understand the preferential recruitment of NF-kappa B to specific gene regulatory sites, we used NF-kappa B p65 in a tandem affinity purification and mass spectrometry proteomic screen. We identified ribosomal protein S3 (RPS3), a KH domain protein, as a non-Rel subunit of p65 homodimer and p65-p50 heterodimer DNA-binding complexes that synergistically enhances DNA binding. RPS3 knockdown impaired NF-kappa B-mediated transcription of selected p65 target genes but not nuclear shuttling or global protein translation. Rather, lymphocyte-activating stimuli caused nuclear translocation of RPS3, parallel to p65, to form part of NF-kappa B bound to specific regulatory sites in chromatin. Thus, RPS3 is an essential but previously unknown subunit of NF-kappa B involved in the regulation of key genes in rapid cellular activation responses. Our observations provide insight into how NF-kappa B selectively controls gene expression.	[Wan, Fengyi; Barnitz, Robert A.; Snow, Andrew; Bidere, Nicolas; Zheng, Lixin; Lenardo, Michael J.] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Anderson, D. Eric] Natl Inst Diabet & Digesti & Kidney Dis, Prot & Mass Spectrometry Facil, Bethesda, MD 20892 USA; [Lam, Lloyd T.; Staudt, Louis M.] Ctr Canc Res, Natl Canc Inst, Metabolism Branch, Bethesda, MD 20892 USA; [Levens, David] Ctr Canc Res, Natl Canc Inst, Pathol Lab, Bethesda, MD 20892 USA; [Hegde, Vijay; Deutsch, Walter A.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, Bethesda, MD 20892 USA.	lenardo@nih.gov	Staudt, Louis/AAC-5324-2019; Levens, David/C-9216-2009; Bidère, Nicolas/K-8887-2015	Levens, David/0000-0002-7616-922X; Bidère, Nicolas/0000-0001-9177-0008; Barnitz, Tony/0000-0002-9634-4558; Snow, Andrew/0000-0002-8728-6691	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 109798] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000565] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; BRISKIN M, 1988, SCIENCE, V242, P1036, DOI 10.1126/science.3143155; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen WJ, 2004, J BIOL CHEM, V279, P13496, DOI 10.1074/jbc.M212390200; Furumoto Y, 2006, J IMMUNOL, V176, P5167, DOI 10.4049/jimmunol.176.9.5167; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hegde V, 2004, DNA REPAIR, V3, P121, DOI 10.1016/j.dnarep.2003.10.004; Hegde V, 2007, DNA REPAIR, V6, P94, DOI 10.1016/j.dnarep.2006.09.004; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Lam LT, 2005, CLIN CANCER RES, V11, P28; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P5056, DOI 10.1073/pnas.91.11.5056; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Phelps CB, 2000, J BIOL CHEM, V275, P24392, DOI 10.1074/jbc.M003784200; Sathe SS, 2004, P NATL ACAD SCI USA, V101, P192, DOI 10.1073/pnas.0306812101; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009	34	256	275	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					927	939		10.1016/j.cell.2007.10.009	http://dx.doi.org/10.1016/j.cell.2007.10.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045535	Bronze			2022-12-24	WOS:000251800900015
J	Handke, M; Harloff, A; Olschewski, M; Hetzel, A; Geibel, A				Handke, Michael; Harloff, Andreas; Olschewski, Manfred; Hetzel, Andreas; Geibel, Annette			Patent foramen ovale and cryptogenic stroke in older patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL SEPTAL ANEURYSM; ISCHEMIC-STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PULMONARY-EMBOLISM; RISK FACTOR; ATHEROSCLEROTIC DISEASE; PERCUTANEOUS CLOSURE; AORTIC-ARCH; POPULATION; EVENTS	Background Studies to date have shown an association between the presence of patent foramen ovale and cryptogenic stroke in patients younger than 55 years of age. This association has not been established in patients 55 years of age or older. Methods We prospectively examined 503 consecutive patients who had had a stroke, and we compared the 227 patients with cryptogenic stroke and the 276 control patients with stroke of known cause. We examined the prevalences of patent foramen ovale and of patent foramen ovale with concomitant atrial septal aneurysm in all patients, using transesophageal echocardiography. We also compared data for the 131 younger patients (<55 years of age) and those for the 372 older patients (>= 55 years of age). Results The prevalence of patent foramen ovale was significantly greater among patients with cryptogenic stroke than among those with stroke of known cause, for both younger patients (43.9% vs. 14.3%; odds ratio, 4.70; 95% confidence interval [CI], 1.89 to 11.68; P<0.001) and older patients (28.3% vs. 11.9%; odds ratio, 2.92; 95% CI, 1.70 to 5.01; P<0.001). Even stronger was the association between the presence of patent foramen ovale with concomitant atrial septal aneurysm and cryptogenic stroke, as compared with stroke of known cause, among both younger patients (13.4% vs. 2.0%; odds ratio, 7.36; 95% CI, 1.01 to 326.60; P=0.049) and older patients (15.2% vs. 4.4%; odds ratio, 3.88; 95% CI, 1.78 to 8.46; P<0.001). Multivariate analysis adjusted for age, plaque thickness, and presence or absence of coronary artery disease and hypertension showed that the presence of patent foramen ovale was independently associated with cryptogenic stroke in both the younger group (odds ratio, 3.70; 95% CI, 1.42 to 9.65; P=0.008) and the older group (odds ratio, 3.00; 95% CI, 1.73 to 5.23; P<0.001). Conclusions There is an association between the presence of patent foramen ovale and cryptogenic stroke in both older patients and younger patients. These data suggest that paradoxical embolism is a cause of stroke in both age groups.	Univ Hosp Freiburg, Dept Cardiol & Angiol, Freiburg, Germany; Univ Hosp Freiburg, Dept Neurol & Neurophysiol, Freiburg, Germany; Univ Hosp Freiburg, Dept Med Biometry & Stat, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Handke, M (corresponding author), Univ Basel Hosp, Dept Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.	handkem@uhbs.ch						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Amarenco P, 1996, NEW ENGL J MED, V334, P1216; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; De Castro S, 2006, J CARDIOVASC MED, V7, P191, DOI 10.2459/01.JCM.0000215272.32273.b9; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; Fraticelli A, 1998, ARCH GERONTOL GERIAT, V27, P41, DOI 10.1016/S0167-4943(98)00016-8; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Homma S, 2004, STROKE, V35, P2145, DOI 10.1161/01.STR.0000135773.24116.18; Iwanaga T, 2007, J NEUROL SCI, V254, P102, DOI 10.1016/j.jns.2007.01.006; JOB FP, 1994, AM J CARDIOL, V74, P381, DOI 10.1016/0002-9149(94)90407-3; JONES EF, 1994, AM J CARDIOL, V74, P596, DOI 10.1016/0002-9149(94)90750-1; KASPER W, 1992, LANCET, V340, P561, DOI 10.1016/0140-6736(92)92102-L; Kessel-Schaefer A, 2001, CIRCULATION, V103, P1928; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Meier B, 2006, J AM COLL CARDIOL, V47, P446, DOI 10.1016/j.jacc.2005.11.024; Nomura E, 2005, INTERNAL MED, V44, P401, DOI 10.2169/internalmedicine.44.401; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Petty GW, 1999, STROKE, V30, P2513, DOI 10.1161/01.STR.30.12.2513; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Stone DA, 1996, AM HEART J, V131, P158, DOI 10.1016/S0002-8703(96)90065-4; Wahl A, 2001, NEUROLOGY, V57, P1330, DOI 10.1212/WNL.57.7.1330; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WEBSTER MWI, 1988, LANCET, V2, P11; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; Yeung M, 1996, J NEUROL NEUROSUR PS, V61, P445, DOI 10.1136/jnnp.61.5.445	30	396	422	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2262	2268		10.1056/NEJMoa071422	http://dx.doi.org/10.1056/NEJMoa071422			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046029				2022-12-24	WOS:000251176400007
J	McCartney, M				McCartney, Margaret			Medicine and the media - Mixed messages over breast milk and brainy babies	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				DER G, 2006, BRIT MED J, V333, P945; 2007, PNAS	2	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 24	2007	335	7629					1074	1074		10.1136/bmj.39401.651146.0F	http://dx.doi.org/10.1136/bmj.39401.651146.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	18033929	Green Published			2022-12-24	WOS:000251403000033
J	Strander, B; Andersson-Ellstrom, A; Milsom, I; Sparen, P				Strander, Bjorn; Andersson-Ellstrom, Agneta; Milsom, Ian; Sparen, Par			Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA; DIAGNOSIS; HPV; ADENOCARCINOMA; TRENDS; WOMEN	Objective To study the long term risk of invasive cancer of the cervix or vagina after treatment for cervical intraepithelial neoplasia grade 3. Design Prospective cohort study. Setting Swedish cancer registry. Participants All women in Sweden with severe dysplasia or cervical carcinoma in situ (equivalent to cervical intraepithelial neoplasia grade 3) treated during 1958-2002 (n=132 493) contributing 2 315 724 woman years. Main outcome measures Standardised incidence ratios with risk of cancer in the Swedish general female population as reference and relative risks in multivariable log-linear regression model with internal references. Results Women with previous cervical intraelpithelial neoplasia grade 3 had an increased risk of invasive cervical cancer compared with the general female population (standardised incidence ratio 2.34 95% confidence interval 2.18 to 2.50). The increased risk showed a decreasing trend with time since diagnosis for women treated later than 1970 but the risk was still increased after 25 years. An effect of age was found with an accentuated increase in risk for women aged more than 50. The excess risk for cervical cancer associated with previous cervical intraepithelial neoplasia grade 3 has steadily increased since 1958. For vaginal cancer the standardised incidence ratio was 6.82 (5.61 to 8.21) but this decreased to 2.65 after 25 years. Adjustments in the multivariable log-linear regression model did not substantially alter these results. Conclusions Women previously treated for cervical intraepithelial neoplasia grade 3 are at an increased risk of developing invasive cervical cancer and vaginal cancer. This risk has increased since the 1960s and is accentuated in women aged more than 50. The risk is still increased 25 years after treatment.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Gothenburg Univ, Dept Obstet & Gynecol, Sahlgrens Acad, SU, SE-41685 Ostra Sjukhuset, Sweden	Karolinska Institutet; University of Gothenburg	Strander, B (corresponding author), Sahlgrens Univ Hosp, Ctr Oncol, SE-41345 Gothenburg, Sweden.	bjorn.strander@oc.gu.se	Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955; Sparen, Par/0000-0002-5184-8971				Andersson-Ellstrom A, 2000, ACTA OBSTET GYN SCAN, V79, P221, DOI 10.1034/j.1600-0412.2000.079003221.x; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8; *HARG, 1997, ATT FOR CERV SAMT VA; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; KOLSTAD P, 1976, OBSTET GYNECOL, V48, P125; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; *NAT BOARD HLTH WE, 1998, GYN CELLPR FORSL SCR; National Board of Health and Welfare, 1998, SWED HOSP DISCH REG; PETTERSSON F, 1985, INT J EPIDEMIOL, V14, P521, DOI 10.1093/ije/14.4.521; PETTERSSON F, 1989, RADIOTHER ONCOL, V16, P115, DOI 10.1016/0167-8140(89)90028-5; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; STRANDER B, 2004, SVENSK GYNEKOLOGI UN; Strander B, 2007, EUR J CANCER, V43, P1849, DOI 10.1016/j.ejca.2007.05.016; The National Board of Health and Welfare; Centre for Epidemiology, 2005, CANC INC SWED 2003; Zielinski GD, 2004, OBSTET GYNECOL SURV, V59, P543, DOI 10.1097/00006254-200407000-00024	21	105	118	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2007	335	7629					1077	+		10.1136/bmj.39363.471806.BE	http://dx.doi.org/10.1136/bmj.39363.471806.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UX	17959735	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000251403000035
J	Jorgensen, C; Enberg, K; Dunlop, ES; Arlinghaus, R; Boukal, DS; Brander, K; Ernande, B; Gardmark, A; Johnston, F; Matsumura, S; Pardoe, H; Raab, K; Silva, A; Vainikka, A; Dieckmann, U; Heino, M; Rijnsdorp, AD				Jorgensen, Christian; Enberg, Katja; Dunlop, Erin S.; Arlinghaus, Robert; Boukal, David S.; Brander, Keith; Ernande, Bruno; Gaerdmark, Anna; Johnston, Fiona; Matsumura, Shuichi; Pardoe, Heidi; Raab, Kristina; Silva, Alexandra; Vainikka, Anssi; Dieckmann, Ulf; Heino, Mikko; Rijnsdorp, Adriaan D.			Ecology - Managing evolving fish stocks	SCIENCE			English	Editorial Material							FISHERIES; MANAGEMENT; EVOLUTION; MATURATION; HISTORY; TRAITS; YIELDS		Univ Bergen, Dept Biol, N-5020 Bergen, Norway; Inst Marine Res, N-5024 Bergen, Norway; Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; Humboldt Univ, Inst Anim Sci, Berlin, Germany; Int Council Explorat Sea, Copenhagen, Denmark; IFREMER, F-14520 Port En Bessin, France; Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; Swedish Board Fisheries, Inst Coastal Res, Oregrund, Sweden; Marine Res Inst, IS-121 Reykjavik, Iceland; Univ Iceland, Inst Biol, Reykjavik, Iceland; Holaskoli, Saudarkrokur, Iceland; INRB IPIMAR, Natl Inst Agr & Fisheries, Lisbon, Portugal; Wageningen Inst Marine Resources & Ecosyst Studie, Ijmuiden, Netherlands	University of Bergen; Institute of Marine Research - Norway; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Ifremer; International Institute for Applied Systems Analysis (IIASA); Marine & Freshwater Research Institute (MFRI); University of Iceland; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Wageningen University & Research	Jorgensen, C (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	christian.jorgensen@bio.uib.no	Dunlop, Erin/HGA-8508-2022; SILVA, MARIA ALEXANDRA/I-4326-2017; Pardoe, Heidi/B-6581-2008; Arlinghaus, Robert/J-6171-2019; Matsumura, Shuichi/C-7986-2013; Arlinghaus, Robert/E-3340-2010; Rijnsdorp, Adriaan/A-4217-2008; Boukal, David/H-4762-2014; Heino, Mikko P/C-7241-2009; Brander, Keith/AAN-6278-2021; Ernande, Bruno/C-1182-2008; Enberg, Katja/C-8630-2009; Jørgensen, Christian/B-4453-2009; Dieckmann, Ulf/E-1424-2011; Gårdmark, Anna/AAC-3909-2021	SILVA, MARIA ALEXANDRA/0000-0002-2950-1429; Matsumura, Shuichi/0000-0002-0368-006X; Arlinghaus, Robert/0000-0003-2861-527X; Rijnsdorp, Adriaan/0000-0003-0785-9662; Boukal, David/0000-0001-8181-7458; Heino, Mikko P/0000-0003-2928-3940; Ernande, Bruno/0000-0002-0727-5774; Enberg, Katja/0000-0002-0045-7604; Jørgensen, Christian/0000-0001-7087-4625; Dieckmann, Ulf/0000-0001-7089-0393; Brander, Keith/0000-0001-9927-9600; Vainikka, Anssi/0000-0002-0172-5615				Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; CLARK CW, 2006, WORLDWIDE CRISIS FIS; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; FAO, 1996, 2 FAO; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; Heino M, 2002, B MAR SCI, V70, P639; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Law R, 2007, MAR ECOL PROG SER, V335, P271, DOI 10.3354/meps335271; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Mertz G, 1998, CAN J FISH AQUAT SCI, V55, P478, DOI 10.1139/cjfas-55-2-478; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; *US FAO, 2003, 4 FAO S, V2; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x	20	489	502	1	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1247	1248		10.1126/science.1148089	http://dx.doi.org/10.1126/science.1148089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033868	Green Submitted, Green Published			2022-12-24	WOS:000251086600025
J	Hayashi, Y; Lo, N; Miyata, H; Kitade, O				Hayashi, Yoshinobu; Lo, Nathan; Miyata, Hitoshi; Kitade, Osamu			Sex-linked genetic influence on caste determination in a termite	SCIENCE			English	Article							RETICULITERMES-SPERATUS ISOPTERA; RHINOTERMITIDAE; PARTHENOGENESIS; WORKER; ANT; HYMENOPTERA; EVOLUTION; ORIGIN	The most ecologically successful and destructive termite species are those with both a nymph caste and an irreversibly wingless worker caste. The early developmental bifurcation separating these castes is widely accepted to be strictly environmentally determined. We present evidence that genotype also influences this process. Offspring from four different crosses of nymph-and worker-derived secondary reproductive individuals had strongly differentiated caste and sex ratios, despite uniform rearing conditions. These data fit an X-linked, one-locus-two-allele model. Of five possible genotypes, one was lethal, two resulted in workers, and two resulted in either nymphs or environmentally determined workers. Caste is thus controlled both by environment and by a complex genetic inheritance pattern.	Ibaraki Univ, Coll Sci, Nat Hist Lab, Ibaraki 3108512, Japan; Univ Sydney, Sch Biol Sci, Behav & Genet Social Insects Lab, Sydney, NSW 2006, Australia	Ibaraki University; University of Sydney	Kitade, O (corresponding author), Ibaraki Univ, Coll Sci, Nat Hist Lab, Ibaraki 3108512, Japan.	kitade@mx.ibaraki.ac.jp	Lo, Nathan/E-6115-2010	Lo, Nathan/0000-0003-2176-2840				Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Hayashi Y, 2006, SOCIOBIOLOGY, V48, P849; Hayashi Yoshinobu, 2003, Entomological Science, V6, P253, DOI 10.1046/j.1343-8786.2003.00030.x; HIGASHI M, 1996, BIODIVERSITY ECOLOGI, P83; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Korb J, 2004, EVOL DEV, V6, P342, DOI 10.1111/j.1525-142X.2004.04042.x; Lo N, 2007, BIOL LETTERS, V3, P562, DOI 10.1098/rsbl.2007.0264; Long CE, 2003, B ENTOMOL RES, V93, P439, DOI 10.1079/BER2003258; LUYKX P, 1990, GENOME, V33, P80, DOI 10.1139/g90-013; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Miyata H, 2004, ENTOMOL SCI, V7, P309, DOI 10.1111/j.1479-8298.2004.00078.x; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve HK, 1997, EVOL ECOL, V11, P357, DOI 10.1023/A:1018472521277; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; SEGER J, 1981, J THEOR BIOL, V91, P191, DOI 10.1016/0022-5193(81)90380-5; Thompson GJ, 2000, J EVOLUTION BIOL, V13, P869, DOI 10.1046/j.1420-9101.2000.00237.x; Thorne BL, 1997, ANNU REV ECOL SYST, V28, P27, DOI 10.1146/annurev.ecolsys.28.1.27; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Wilson E.O., 1971, INSECT SOC; WINTER U, 1986, ENTOMOL GEN, V11, P125	24	66	70	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					985	987		10.1126/science.1146711	http://dx.doi.org/10.1126/science.1146711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991866				2022-12-24	WOS:000250788500046
J	Wisse, BE; Kim, F; Schwartz, MW				Wisse, Brent E.; Kim, Francis; Schwartz, Michael W.			An integrative view of obesity	SCIENCE			English	Editorial Material							INSULIN; HYPOTHALAMUS; RESISTANCE; LEPTIN; BETA		Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; Univ Washington, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle	Wisse, BE (corresponding author), Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK061384, R01DK073878, R01DK012829, P01DK068384, R01DK074758] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK61384, DK073878, R01 DK074758, P01-DK 068384, DK12829] Funding Source: Medline; NINDS NIH HHS [NS3227] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345	10	99	103	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					928	929		10.1126/science.1148032	http://dx.doi.org/10.1126/science.1148032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991852				2022-12-24	WOS:000250788500030
J	Yashiro, K; Shiratori, H; Hamada, H				Yashiro, Kenta; Shiratori, Hidetaka; Hamada, Hiroshi			Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch	NATURE			English	Article							PHARYNGEAL ARCH; PITX2; EXPRESSION; ALPHA; HEART	Laterality of the internal organs of vertebrates is determined by asymmetric Nodal signalling in the lateral plate mesoderm(1). A deficiency of such signalling results in heterotaxia syndrome, characterized by anomalous laterality of visceral organs and complex congenital heart conditions(1). Pitx2, the transcription factor induced by the Nodal signal, regulates left-right asymmetric morphogenesis(1-4). The cellular and molecular bases of asymmetric morphogenesis remain largely unknown, however. Here we show that ablation of unilateral Pitx2 expression in mice impairs asymmetric remodelling of the branchial arch artery (BAA) system, resulting in randomized laterality of the aortic arch. Pitx2-positive cells were found not to contribute to asymmetrically remodelled arteries. Instead, Pitx2 functions in the secondary heart field(5) and induces a dynamic morphological change in the outflow tract of the heart, which results in the provision of an asymmetric blood supply to the sixth BAA. This uneven distribution of blood flow results in differential signalling by both the platelet-derived growth factor receptor and vascular endothelial growth factor receptor 2. The consequent stabilization of the left sixth BAA and regression of its right counterpart underlie left-sided formation of the aortic arch. Our results therefore indicate that haemodynamics, generated by a Pitx2-induced morphological change in the outflow tract, is responsible for the asymmetric remodelling of the great arteries.	Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yashiro, K (corresponding author), Univ London, Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	k.yashiro@qmul.ac.uk; hamada@fbs.osaka-u.ac.jp	Hamada, Hiroshi/N-6374-2015	Hamada, Hiroshi/0000-0002-7196-5948				Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Bajolle F, 2006, CIRC RES, V98, P421, DOI 10.1161/01.RES.0000202800.85341.6e; BECKER AE, 1981, PATHOLOGY CONGENITAL, P321; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Groot ACGD, 2006, TRENDS CARDIOVAS MED, V16, P1; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Phoon CKL, 2000, ULTRASOUND MED BIOL, V26, P1275, DOI 10.1016/S0301-5629(00)00278-7; RYCHTER Z., 1962, ADVANCES MORPHOGENESIS, V2, P333; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Shiratori H, 2006, DEVELOPMENT, V133, P3015, DOI 10.1242/dev.02470; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Waldo K, 1998, CARDIOVAS MOL MORPH, P187; Yanagisawa H, 1998, J CLIN INVEST, V102, P22, DOI 10.1172/JCI2698; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	27	164	171	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					285	U11		10.1038/nature06254	http://dx.doi.org/10.1038/nature06254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994097				2022-12-24	WOS:000250746200058
J	Chen, KY; Cong, B; Wing, R; Vrebalov, J; Tanksley, SD				Chen, Kai-Yi; Cong, Bin; Wing, Rod; Vrebalov, Julia; Tanksley, Steven D.			Changes in regulation of a transcription factor lead to autogamy in cultivated tomatoes	SCIENCE			English	Article							LYCOPERSICON; BACKCROSS; PLANTS; QTL	We report the cloning of Style2.1, the major quantitative trait locus responsible for a key floral attribute (style length) associated with the evolution of self-pollination in cultivated tomatoes. The gene encodes a putative transcription factor that regulates cell elongation in developing styles. The transition from cross-pollination to self-pollination was accompanied, not by a change in the STYLE2.1 protein, but rather by a mutation in the Style2.1 promoter that results in a down-regulation of Style2.1 expression during flower development.	Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Univ Arizona, Dept Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; Cornell Univ, USDA ARS, Plant Soil Nutr Lab, Ithaca, NY 14853 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Arizona; Cornell University; United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research	Tanksley, SD (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	sdt4@cornell.edu	Wing, Rod A/Z-2885-2019	Wing, Rod A/0000-0001-6633-6226; CHEN, KAI-YI/0000-0002-6211-0198				Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; Bernacchi D, 1997, GENETICS, V147, P861; Brown A. H. D., 1989, Isozymes in plant biology., P73; Chen KY, 2004, GENETICS, V168, P1563, DOI 10.1534/genetics.103.022558; Fulton TM, 1997, THEOR APPL GENET, V95, P881, DOI 10.1007/s001220050639; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; Rick C. M., 1979, The biology and taxonomy of the Solanaceae, P667; Rick C.M., 1988, PLANT EVOLUTIONARY B, P133, DOI DOI 10.1007/978-94-009-1207-6_6; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; Smyth DR, 2005, PLANT CELL, V17, P330, DOI 10.1105/tpc.104.030353; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249	14	104	110	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					643	645		10.1126/science.1148428	http://dx.doi.org/10.1126/science.1148428			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962563				2022-12-24	WOS:000250409200046
J	Fryxell, JM; Mosser, A; Sinclair, ARE; Packer, C				Fryxell, John M.; Mosser, Anna; Sinclair, Anthony R. E.; Packer, Craig			Group formation stabilizes predator-prey dynamics	NATURE			English	Article							FUNCTIONAL-RESPONSES; POPULATION-DYNAMICS; SPATIAL SCALE; LIONS; FOOD	Theoretical ecology is largely founded on the principle of mass action, in which uncoordinated populations of predators and prey move in a random and well-mixed fashion across a featureless landscape. The conceptual core of this body of theory is the functional response, predicting the rate of prey consumption by individual predators as a function of predator and/or prey densities(1-5). This assumption is seriously violated in many ecosystems in which predators and/or prey form social groups. Here we develop a new set of group-dependent functional responses to consider the ecological implications of sociality and apply the model to the Serengeti ecosystem. All of the prey species typically captured by Serengeti lions (Panthera leo) are gregarious, exhibiting nonlinear relationships between prey-group density and population density. The observed patterns of group formation profoundly reduce food intake rates below the levels expected under random mixing, having as strong an impact on intake rates as the seasonal migratory behaviour of the herbivores. A dynamical system model parameterized for the Serengeti ecosystem (using wildebeest (Connochaetes taurinus) as a well-studied example) shows that grouping strongly stabilizes interactions between lions and wildebeest. Our results suggest that social groups rather than individuals are the basic building blocks around which predator-prey interactions should be modelled and that group formation may provide the underlying stability of many ecosystems.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of Guelph; University of Minnesota System; University of Minnesota Twin Cities; University of British Columbia	Fryxell, JM (corresponding author), Univ Guelph, Dept Integrat Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jfryxell@uoguelph.ca						Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; CANTRELL RS, 1991, J MATH BIOL, V29, P315, DOI 10.1007/BF00167155; Cosner C, 1999, THEOR POPUL BIOL, V56, P65, DOI 10.1006/tpbi.1999.1414; Donalson DD, 1999, ECOLOGY, V80, P2492, DOI 10.1890/0012-9658(1999)080[2492:PDASSE]2.0.CO;2; ELLIOTT JP, 1977, CAN J ZOOL, V55, P1811, DOI 10.1139/z77-235; FRYXELL JM, 1988, AM NAT, V131, P781, DOI 10.1086/284822; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Hastings A., 1997, POPULATION BIOL CONC; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hosseini PR, 2003, AM NAT, V161, P567, DOI 10.1086/368293; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Keeling MJ, 2000, SCIENCE, V290, P1758, DOI 10.1126/science.290.5497.1758; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Nachman G, 2006, J ANIM ECOL, V75, P948, DOI 10.1111/j.1365-2656.2006.01114.x; Nisbet RM, 1998, ECOL LETT, V1, P34, DOI 10.1046/j.1461-0248.1998.00011.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pascual M, 2001, ECOLOGY, V82, P2357, DOI 10.1890/0012-9658(2001)082[2357:ODASST]2.0.CO;2; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Yodzis P., 1989, INTRO THEORETICAL EC	29	154	156	0	143	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1041	U4		10.1038/nature06177	http://dx.doi.org/10.1038/nature06177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960242				2022-12-24	WOS:000250395000050
J	Towbin, JA				Towbin, Jeffrey A.			Scarring in the heart - A reversible phenomenon?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FIBROSIS		Baylor Coll Med, Dept Pediat, Pediat Cardiol Sect, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat, Pediat Cardiol Sect, Houston, TX 77030 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X				Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	4	26	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2007	357	17					1767	1768		10.1056/NEJMcibr075397	http://dx.doi.org/10.1056/NEJMcibr075397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223FN	17960018				2022-12-24	WOS:000250355100016
J	Callaway, E				Callaway, Ewen			Dogs help sniff out genes	NATURE			English	News Item																		HILLBERTZ N, 2007, NATURE GENET; KARLSSON E, 2007, NATURE GENET; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338	3	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					514	514		10.1038/449514b	http://dx.doi.org/10.1038/449514b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972361	Bronze			2022-12-24	WOS:000249893500005
J	Cam, HP; Noma, K; Ebina, H; Levin, HL; Grewal, SIS				Cam, Hugh P.; Noma, Ken-ichi; Ebina, Hirotaka; Levin, Henry L.; Grewal, Shiv I. S.			Host genome surveillance for retrotransposons by transposon-derived proteins	NATURE			English	Article							HUMAN CENTROMERE PROTEIN; FISSION YEAST; CENP-B; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; MOLECULAR-CLONING; DNA METHYLATION; HETEROCHROMATIN; SEQUENCE; ELEMENTS	Transposable elements and their remnants constitute a substantial fraction of eukaryotic genomes. Host genomes have evolved defence mechanisms, including chromatin modifications and RNA interference, to regulate transposable elements. Here we describe a genome surveillance mechanism for retrotransposons by transposase- derived centromeric protein CENP- B homologues of the fission yeast Schizosaccharomyces pombe. CENP- B homologues of S. pombe localize at and recruit histone deacetylases to silence Tf2 retrotransposons. CENP- Bs also repress solo long terminal repeats ( LTRs) and LTR- associated genes. Tf2 elements are clustered into 'Tf' bodies, the organization of which depends on CENP- Bs that display discrete nuclear structures. Furthermore, CENP- Bs prevent an 'extinct' Tf1 retrotransposon from re- entering the host genome by blocking its recombination with extant Tf2, and silence and immobilize a Tf1 integrant that becomes sequestered into Tf bodies. Our results reveal a probable ancient retrotransposon surveillance pathway important for host genome integrity, and highlight potential conflicts between DNA transposons and retrotransposons, major transposable elements believed to have greatly moulded the evolution of genomes.	[Cam, Hugh P.; Noma, Ken-ichi; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Ebina, Hirotaka; Levin, Henry L.] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Levin, Henry/0000-0003-1728-118X; Grewal, Shiv/0000-0002-4552-9261	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001009] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001009] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523, ZIABC011208] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atwood A, 1998, J VIROL, V72, P1324, DOI 10.1128/JVI.72.2.1324-1333.1998; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Gao X, 2005, TRENDS GENET, V21, P133, DOI 10.1016/j.tig.2005.01.006; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Halverson D, 1997, J CELL BIOL, V136, P487, DOI 10.1083/jcb.136.3.487; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Irelan JT, 2001, GENETICS, V157, P1191; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; JONES ME, 1994, GENETICS, V136, P1209; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; LEVIN HL, 1995, MOL CELL BIOL, V15, P3310; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Murakami Y, 1996, P NATL ACAD SCI USA, V93, P502, DOI 10.1073/pnas.93.1.502; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Sehgal A, 2007, PLOS GENET, V3, P1389, DOI 10.1371/journal.pgen.0030131; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tawaramoto MS, 2003, J BIOL CHEM, V278, P51454, DOI 10.1074/jbc.M310388200; THON G, 1994, GENETICS, V138, P29; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoda K, 1998, GENES CELLS, V3, P533, DOI 10.1046/j.1365-2443.1998.00210.x; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	50	129	133	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					431	U2		10.1038/nature06499	http://dx.doi.org/10.1038/nature06499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18094683	Bronze			2022-12-24	WOS:000252554100037
J	Steinbrook, R				Steinbrook, Robert			HIV in india - A downsized epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; *UNAIDS, 2007, AIDS EP UPD; 2007, 2005 06 NAT FAM HLTH	5	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					107	109		10.1056/NEJMp0708474	http://dx.doi.org/10.1056/NEJMp0708474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	249CJ	18184956				2022-12-24	WOS:000252204200002
J	Vadas, P; Gold, M; Perelman, B; Liss, GM; Lack, G; Blyth, T; Simons, FER; Simons, KJ; Cass, D; Yeung, J				Vadas, Peter; Gold, Milton; Perelman, Boris; Liss, Gary M.; Lack, Gideon; Blyth, Thomas; Simons, F. Estelle R.; Simons, Keith J.; Cass, Dan; Yeung, Jupiter			Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN	Background: Platelet-activating factor (PAF) is an important mediator of anaphylaxis in animals, and interventions that block PAF prevent fatal anaphylaxis. The roles of PAF and PAF acetylhydrolase, the enzyme that inactivates PAF, in anaphylaxis in humans have not been reported. Methods: We measured serum PAF levels and PAF acetylhydrolase activity in 41 patients with anaphylaxis and in 23 control patients. Serum PAF acetylhydrolase activity was also measured in 9 patients with peanut allergy who had fatal anaphylaxis and compared with that in 26 nonallergic pediatric control patients, 49 nonallergic adult control patients, 63 children with mild peanut allergy, 24 patients with nonfatal anaphylaxis, 10 children who died of nonanaphylactic causes, 15 children with life-threatening asthma, and 19 children with non-life-threatening asthma. Results: Mean (+/-SD) serum PAF levels were significantly higher in patients with anaphylaxis (805+/-595 pg per milliliter) than in patients in the control groups (127+/-104 pg per milliliter, P<0.001 after log transformation) and were correlated with the severity of anaphylaxis. The proportion of subjects with elevated PAF levels increased from 4% in the control groups to 20% in the group with grade 1 anaphylaxis, 71% in the group with grade 2 anaphylaxis, and 100% in the group with grade 3 anaphylaxis (P<0.001). There was an inverse correlation between PAF levels and PAF acetylhydrolase activity (P<0.001). The proportion of patients with low PAF acetylhydrolase values increased with the severity of anaphylaxis (P<0.001 for all comparisons). Serum PAF acetylhydrolase activity was significantly lower in patients with fatal peanut anaphylaxis than in control patients (P values <0.001 for all comparisons). Conclusions: Serum PAF levels were directly correlated and serum PAF acetylhydrolase activity was inversely correlated with the severity of anaphylaxis. PAF acetylhydrolase activity was significantly lower in patients with fatal anaphylactic reactions to peanuts than in patients in any of the control groups. Failure of PAF acetylhydrolase to inactivate PAF may contribute to the severity of anaphylaxis.	St Michaels Hosp, Dept Med, Div Clin Immunol & Allergy, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Dept Emergency Med, Toronto, ON M5B 1W8, Canada; Hosp Sick Children, Dept Pediat, Div Immunol & Allergy, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Publ Hlth Sci, Gage Occupat & Environm Hlth Unit, Toronto, ON, Canada; St Marys Hosp, Imperial Coll, Dept Pediat Allergy, London, England; Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; Univ Manitoba, Fac Pharm, Div Pharmaceut Sci, Winnipeg, MB R3T 2N2, Canada; Food Prod Assoc, Washington, DC USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Imperial College London; University of Manitoba; University of Manitoba	Vadas, P (corresponding author), St Michaels Hosp, Dept Med, Div Clin Immunol & Allergy, Carter Wing 8-161,30 Bond St, Toronto, ON M5B 1W8, Canada.	vadasp@smh.toronto.on.ca		Lack, Gideon/0000-0001-7350-4021	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ansley DM, 1997, J INVEST SURG, V10, P87, DOI 10.3109/08941939709032138; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Brown AFT, 2001, J ALLERGY CLIN IMMUN, V108, P861, DOI 10.1067/mai.2001.119028; Devenney I, 2000, ANN ALLERG ASTHMA IM, V85, P455, DOI 10.1016/S1081-1206(10)62571-9; Estelle F, 2006, J ALLERGY CLIN IMMUN, V117, P367, DOI 10.1016/j.jaci.2005.12.002; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Pumphrey R, 2004, CURR OPIN ALLERGY CL, V4, P285, DOI 10.1097/01.all.0000136762.89313.0b; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sarchielli P, 2004, CEPHALALGIA, V24, P623, DOI 10.1111/j.1468-2982.2003.00717.x; Schwartz Lawrence B, 2004, Novartis Found Symp, V257, P65; Simons FER, 2002, J ALLERGY CLIN IMMUN, V109, P171, DOI 10.1067/mai.2002.120758; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; Strait Richard, 2004, Novartis Found Symp, V257, P80; Vadas P., 2003, Journal of Allergy and Clinical Immunology, V111, pS206, DOI 10.1016/S0091-6749(03)80712-1	20	371	384	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					28	35		10.1056/NEJMoa070030	http://dx.doi.org/10.1056/NEJMoa070030			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172172				2022-12-24	WOS:000252031200005
J	Davidson, AG; Chan, V; O'Dell, R; Schieber, MH				Davidson, Adam G.; Chan, Vanessa; O'Dell, Ryan; Schieber, Marc H.			Rapid changes in throughput from single motor cortex neurons to muscle activity	SCIENCE			English	Article							SPIKE-TRIGGERED AVERAGES; PRIMATE CORTICOMOTONEURONAL CELLS; HAND MUSCLES; CORTICOSPINAL NEURONS; CONSCIOUS MONKEY; RECTIFIED EMG; FACILITATION; MOVEMENT; MOTONEURONS; PLASTICITY	Motor cortex output is capable of considerable reorganization, which involves modulation of excitability within the cortex. Does such reorganization also involve changes beyond the cortex, at the level of throughput from single motor cortex neurons to muscle activity? We examined such throughput during a paradigm that provided incentive for enhancing functional connectivity from motor cortex neurons to muscles. Short- latency throughput from a recorded neuron to muscle activity not present during some behavioral epochs often appeared during others. Such changes in throughput could not always be attributed to a higher neuron firing rate, to more ongoing muscle activity, or to neuronal synchronization, indicating that reorganization of motor cortex output may involve rapid changes in functional connectivity from single motor cortex neurons to alpha-motoneuron pools.	Univ Rochester, Sch Med & Dent, Dept Neurol & Neurobiol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Schieber, MH (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol & Neurobiol, 601 Elmwood Ave, Rochester, NY 14642 USA.	mhs@cvs.rochester.edu		O'Dell, Ryan/0000-0001-7673-6661	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027686] Funding Source: NIH RePORTER; NINDS NIH HHS [R01/R37-NS27686] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baker SN, 1998, J NEUROPHYSIOL, V80, P1391, DOI 10.1152/jn.1998.80.3.1391; BENNETT KMB, 1994, J PHYSIOL-LONDON, V477, P291, DOI 10.1113/jphysiol.1994.sp020191; BUYS EJ, 1986, J PHYSIOL-LONDON, V381, P529, DOI 10.1113/jphysiol.1986.sp016342; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Davidson AG, 2007, J NEUROSCI, V27, P8053, DOI 10.1523/JNEUROSCI.0040-07.2007; Davidson AG, 2007, J NEUROSCI METH, V163, P283, DOI 10.1016/j.jneumeth.2007.03.010; FETZ EE, 1978, J PHYSIOL-PARIS, V74, P239; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fetz EE, 2002, BRAIN RES REV, V40, P53, DOI 10.1016/S0165-0173(02)00188-1; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Jackson A, 2006, J PHYSIOL-LONDON, V573, P107, DOI 10.1113/jphysiol.2005.100537; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; LAWRENCE DG, 1985, J COMP NEUROL, V232, P499, DOI 10.1002/cne.902320407; LEMON RN, 1986, J PHYSIOL-LONDON, V381, P497, DOI 10.1113/jphysiol.1986.sp016341; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; MEWES K, 1991, J NEUROPHYSIOL, V66, P1965, DOI 10.1152/jn.1991.66.6.1965; MUIR RB, 1973, J PHYSIOL-LONDON, V228, P749, DOI 10.1113/jphysiol.1973.sp010110; NIELSEN J, 1994, J PHYSIOL-LONDON, V477, P47, DOI 10.1113/jphysiol.1994.sp020170; Nudo RJ, 1996, J NEUROSCI, V16, P785; PALMER SS, 1985, J NEUROPHYSIOL, V54, P1194, DOI 10.1152/jn.1985.54.5.1194; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PORTER R, 1969, J NEUROPHYSIOL, V32, P443, DOI 10.1152/jn.1969.32.3.443; Schieber MH, 2005, J NEUROPHYSIOL, V94, P3325, DOI 10.1152/jn.00007.2005; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807	26	38	38	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1934	1937		10.1126/science.1149774	http://dx.doi.org/10.1126/science.1149774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096808				2022-12-24	WOS:000251786600062
J	Chu, TF; Rupnick, MA; Kerkela, R; Dallabrida, SM; Zurakowski, D; Nguyen, L; Woulfe, K; Pravda, E; Cassiola, F; Desai, J; George, S; Morgan, JA; Harris, DM; Ismail, NS; Chen, JH; Schoen, FJ; Van den Abbeele, AD; Demetri, GD; Force, T; Chen, MH				Chu, Tammy F.; Rupnick, Maria A.; Kerkela, Risto; Dallabrida, Susan M.; Zurakowski, David; Nguyen, Lisa; Woulfe, Kathleen; Pravda, Elke; Cassiola, Flavia; Desai, Jayesh; George, Suzanne; Morgan, Jeffrey A.; Harris, David M.; Ismail, Nesreen S.; Chen, Jey-Hsin; Schoen, Frederick J.; Van den Abbeele, Annick D.; Demetri, George D.; Force, Thomas; Chen, Ming Hui			Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib	LANCET			English	Article							RENAL-CELL CARCINOMA; METASTATIC BREAST-CANCER; GASTROINTESTINAL STROMAL TUMORS; ENDOTHELIAL GROWTH-FACTOR; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; FACTOR RECEPTORS; THERAPY; SU11248; HYPOTHYROIDISM	Background Sunitinib, a multitargeted tyrosine-kinase inhibitor, which is approved by both US and European Commission regulatory agencies for clinical use, extends survival of patients with metastatic renal-cell carcinoma and gastrointestinal stromal tumours, but concerns have arisen about its cardiac safety We therefore assessed the cardiovascular risk associated with sunitinib in patients with metastatic gastrointestinal stromal. tumours. Methods We retrospectively reviewed all cardiovascular events in 75 patients with imatinib-resistant, metastatic, gastrointestinal stromal. tumours who had been enrolled in a phase I/II trial investigating the efficacy of sunitinib. The composite cardiovascular endpoint was cardiac death, myocardial infarction, and congestive heart failure. We also examined sunitinib's effects on left ventricular ejection fraction (LVEF) and blood pressure. We investigated potential mechanisms of sunitinib-associated cardiac effects by studies in isolated rat cardiomyocytes and in mice. Findings Eight of 75 (11%) patients given repeating cycles of sunitinib in the phase I/II trial had a cardiovascular event, with congestive heart failure recorded in six of 75 (8%). Ten of 36 (28%) patients treated at the approved sunitinib dose had absolute LVEF reductions in ejection fraction (EF) of at least 10%, and seven of 36 (19%) had LVEF reductions of 15 EF% or more. Sunitinib induced increases in mean systolic and diastolic blood pressure, and 35 of 75 (47%) individuals developed hypertension (>150/100 mm Hg). Congestive heart failure and left ventricular dysfunction generally responded to sunitinib being withheld and institution of medical management. Sunitinib caused mitochondrial injury and cardiomyocyte apoptosis in mice and in cultured rat cardiomyocytes. Interpretation Left ventricular dysfunction might be due, in part, to direct cardiomyocyte toxicity, exacerbated by hypertension. Patients treated with sunitinib should be closely monitored for hypertension and LVEF reduction, especially those with a history of coronary artery disease or cardiac risk factors.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Vasc Biol Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Womens Hlth & Gender Biol Div, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA; Thomas Jefferson Univ, Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Cardiol, Philadelphia, PA 19107 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Jefferson University; Jefferson University	Chen, MH (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	minghui.chen@cardio.chboston.org	Desai, Jayesh/AAV-1237-2021; Van den Abbeele, Annick/AAK-9792-2020	Woulfe, Kathleen/0000-0001-9885-7026; Force, Thomas/0000-0002-0450-8659; Desai, Jayesh/0000-0003-4246-9344	NHLBI NIH HHS [R01 HL061688-09, R01 HL061688, R01 HL061688-11, HL61688, R01 HL067371, R01 HL061688-10, HL67371] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067371, R01HL061688] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACC/ AHA, 2005, ACC AHA 2005 GUID UP; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Baselga J, 1999, SEMIN ONCOL, V26, P78; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desai J, 2006, ANN INTERN MED, V145, P660, DOI 10.7326/0003-4819-145-9-200611070-00008; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Fiedler W, 2005, BLOOD, V105, P986, DOI 10.1182/blood-2004-05-1846; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim DW, 2006, J CLIN ENDOCR METAB, V91, P4070, DOI 10.1210/jc.2005-2845; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Mann DL, 2006, NAT MED, V12, P881, DOI 10.1038/nm0806-881; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Pietras RJ, 1998, ONCOGENE, V17, P2235, DOI 10.1038/sj.onc.1202132; Rini BI, 2007, JNCI-J NATL CANCER I, V99, P81, DOI 10.1093/jnci/djk008; Sica DA, 2006, J CLIN ONCOL, V24, P1329, DOI 10.1200/JCO.2005.04.5740; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Urbanova D, 2006, NEOPLASMA, V53, P183; *US NAT LIB MED, SUN PAG; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503	30	779	816	3	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2011	2019		10.1016/S0140-6736(07)61865-0	http://dx.doi.org/10.1016/S0140-6736(07)61865-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083403	Green Accepted			2022-12-24	WOS:000251698600028
J	Dey, A; Francis, EJ; Adams, MWW; Babini, E; Takahashi, Y; Fukuyama, K; Hodgson, KO; Hedman, B; Solomon, EI				Dey, Abhishek; Jenney, Francis E., Jr.; Adams, Michael W. W.; Babini, Elena; Takahashi, Yasuhiro; Fukuyama, Keiichi; Hodgson, Keith O.; Hedman, Britt; Solomon, Edward I.			Solvent tuning of electrochemical potentials in the active sites of HiPIP versus ferredoxin	SCIENCE			English	Article							IRON-SULFUR PROTEINS; RAY-ABSORPTION SPECTROSCOPY; K-EDGE XAS; REDOX POTENTIALS; FE4S4 CLUSTERS; ELECTRONIC-STRUCTURE; AZOTOBACTER-VINELANDII; CHEMICAL-PROCESSES; SYNTHETIC ANALOGS; DFT CALCULATIONS	A persistent puzzle in the field of biological electron transfer is the conserved iron-sulfur cluster motif in both high potential iron-sulfur protein (HiPIP) and ferredoxin (Fd) active sites. Despite this structural similarity, HiPIPs react oxidatively at physiological potentials, whereas Fds are reduced. Sulfur K-edge x-ray absorption spectroscopy uncovers the substantial influence of hydration on this variation in reactivity. Fe-S covalency is much lower in natively hydrated Fd active sites than in HiPIPs but increases upon water removal; similarly, HiPIP covalency decreases when unfolding exposes an otherwise hydrophobically shielded active site to water. Studies on model compounds and accompanying density functional theory calculations support a correlation of Fe-S covalency with ease of oxidation and therefore suggest that hydration accounts for most of the difference between Fd and HiPIP reduction potentials.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Bologna, I-47023 Cesena, Italy; Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	Stanford University; University System of Georgia; University of Georgia; University of Bologna; Osaka University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Hodgson, KO (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hodgson@ssrl.slac.stanford.edu; hedman@ssrl.slac.stanford.edu; edward.solomon@stanford.edu	Babini, Elena/H-1744-2018; Takahashi, Yasuhiro/F-1119-2011; Dey, Abhishek/D-2825-2013; Dey, Abhishek/AAS-3103-2020	Babini, Elena/0000-0001-9906-4909; Takahashi, Yasuhiro/0000-0002-0588-6045; Dey, Abhishek/0000-0002-9166-3349; Dey, Abhishek/0000-0002-9166-3349; Adams, Michael/0000-0002-9796-5014; Jenney, Francis/0000-0002-1667-6924; Solomon, Edward/0000-0003-0291-3199	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060329] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-001209, RR-01209] Funding Source: Medline; NIGMS NIH HHS [GM 60329] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG FA, 1982, FEBS LETT, V150, P214, DOI 10.1016/0014-5793(82)81337-9; AVERILL BA, 1973, J AM CHEM SOC, V95, P3523, DOI 10.1021/ja00792a013; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentrop D, 1999, BIOCHEMISTRY-US, V38, P4669, DOI 10.1021/bi982647q; BLONK HL, 1991, INORG CHEM, V30, P3231, DOI 10.1021/ic00016a022; Boon EM, 2003, P NATL ACAD SCI USA, V100, P12543, DOI 10.1073/pnas.2035257100; CARTER CW, 1977, J BIOL CHEM, V252, P7802; CARTER CW, 1972, P NATL ACAD SCI USA, V69, P3526, DOI 10.1073/pnas.69.12.3526; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Dey A, 2005, J AM CHEM SOC, V127, P12046, DOI 10.1021/ja0519031; Dey A, 2006, J AM CHEM SOC, V128, P533, DOI 10.1021/ja0549695; Florian J, 1997, J PHYS CHEM B, V101, P5583, DOI 10.1021/jp9705075; Fukuta K., 2004, LAB MOUSE, P543; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P5514, DOI 10.1074/jbc.273.10.5514; Glaser T, 2000, ACCOUNTS CHEM RES, V33, P859, DOI 10.1021/ar990125c; Glaser T, 2001, J AM CHEM SOC, V123, P4859, DOI 10.1021/ja0155940; GLOUX J, 1995, J AM CHEM SOC, V117, P7513, DOI 10.1021/ja00133a024; GLOUX J, 1994, J AM CHEM SOC, V116, P1953, DOI 10.1021/ja00084a040; HEERING HA, 1995, EUR J BIOCHEM, V232, P811, DOI 10.1111/j.1432-1033.1995.811zz.x; JENSEN GM, 1994, BIOCHEMISTRY-US, V33, P10911, DOI 10.1021/bi00202a010; JOHNSON RE, 1983, J AM CHEM SOC, V105, P7280, DOI 10.1021/ja00363a013; LANGEN R, 1992, J BIOL CHEM, V267, P25625; Lee SC, 2004, CHEM REV, V104, P1135, DOI 10.1021/cr0206216; LePape L, 1997, J AM CHEM SOC, V119, P9757, DOI 10.1021/ja963349o; LUZHKOV V, 1992, J COMPUT CHEM, V13, P199, DOI 10.1002/jcc.540130212; Morelli X, 2000, BIOCHEMISTRY-US, V39, P2530, DOI 10.1021/bi992306s; Neese F, 1999, INORG CHEM, V38, P4854, DOI 10.1021/ic990461p; ORMEJOHNSON NR, 1983, BIOCHIM BIOPHYS ACTA, V748, P68, DOI 10.1016/0167-4838(83)90028-6; OSULLIVAN T, 1985, J AM CHEM SOC, V107, P4096, DOI 10.1021/ja00299a066; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; SHERIDAN RP, 1981, J BIOL CHEM, V256, P5052; Solomon EI, 2005, COORDIN CHEM REV, V249, P97, DOI 10.1016/j.ccr.2004.03.020; SPIRO TG, 1982, METAL IONS BIOL, V4; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; Zhou CY, 2000, INORG CHIM ACTA, V300, P892, DOI 10.1016/S0020-1693(99)00593-9	41	145	146	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1464	1468		10.1126/science.1147753	http://dx.doi.org/10.1126/science.1147753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048692				2022-12-24	WOS:000251246100050
J	Sharek, PJ; Parast, LM; Leong, K; Coombs, J; Earnest, K; Sullivan, J; Frankel, LR; Roth, SJ				Sharek, Paul J.; Parast, Layla M.; Leong, Kit; Coombs, Jodi; Earnest, Karla; Sullivan, Jill; Frankel, Lorry R.; Roth, Stephen J.			Effect of a rapid response team on hospital-wide mortality and code rates outside the ICU in a children's hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; PEDIATRIC CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; CARE; IMPACT; TRIAL; ANTECEDENTS; DISPARITIES; REDUCTION; EDUCATION	Context Introduction of a rapid response team (RRT) has been shown to decrease mortality and cardiopulmonary arrests outside of the intensive care unit (ICU) in adult inpatients. No published studies to date show significant reductions in mortality or cardiopulmonary arrests in pediatric inpatients. Objective To determine the effect on hospital-wide mortality rates and code rates outside of the ICU setting after RRT implementation at an academic children's hospital. Design, Setting, and Participants A cohort study design with historical controls at a 264-bed, free-standing, quaternary care academic children's hospital. Pediatric inpatients who spent at least 1 day on a medical or surgical ward between January 1, 2001, and March 31, 2007, were included. A total of 22 037 patient admissions and 102 537 patient-days were evaluated preintervention ( before September 1, 2005), and 7257 patient admissions and 34 420 patient-days were evaluated postintervention ( on or after September 1, 2005). Intervention The RRT included a pediatric ICU-trained fellow or attending physician, ICU nurse, ICU respiratory therapist, and nursing supervisor. This team was activated using standard criteria and was available at all times to assess, treat, and triage decompensating pediatric inpatients. Main Outcome Measures Hospital-wide mortality rates and code ( respiratory and cardiopulmonary arrests) rates outside of the ICU setting. All outcomes were adjusted for case mix index values. Results After RRT implementation, the mean monthly mortality rate decreased by 18% (1.01 to 0.83 deaths per 100 discharges; 95% confidence interval [CI], 5%30%; P=.007), the mean monthly code rate per 1000 admissions decreased by 71.7% (2.45 to 0.69 codes per 1000 admissions), and the mean monthly code rate per 1000 patient-days decreased by 71.2% (0.52 to 0.15 codes per 1000 patient-days). The estimated code rate per 1000 admissions for the postintervention group was 0.29 times that for the preintervention group ( 95% likelihood ratio CI, 0.10-0.65; P=. 008), and the estimated code rate per 1000 patient-days for the postintervention group was 0.28 times that for the preintervention group ( 95% likelihood ratio CI, 0.10-0.64; P=. 007). Conclusion Implementation of an RRT was associated with a statistically significant reduction in hospital-wide mortality rate and code rate outside of the pediatric ICU setting.	Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; Lucile Packard Childrens Hosp, Dept Qual Management, Palo Alto, CA 94304 USA; Lucile Packard Childrens Hosp, Dept Nursing, Palo Alto, CA 94304 USA; Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Lucile Packard Children's Hospital (LPCH); Stanford University	Sharek, PJ (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 700 Welch Rd,Ste 227, Palo Alto, CA 94304 USA.	psharek@lpch.org		Parast, Layla/0000-0002-7288-1009				*AG HEALTHC RES QU, PARTN IMPL PAT SAF G; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; *AM HEART ASS, 2005, CIRCULATION, V12, P167, DOI DOI 10.1161/CIRCXULATIONAHA.105.166573; ASPDEN P, 2003, COMMITTEE DATA STAND; Averill Richard F, 2002, J AHIMA, V73, P46; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Box G.E.P., 1976, TIME SERIES ANAL FOR; Buist M, 2004, Crit Care Resusc, V6, P88; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; Catalano Kathleen, 2006, J Perianesth Nurs, V21, P6, DOI 10.1016/j.jopan.2005.11.005; Coffey RM, 2005, MED CARE, V43, P48; Cook T.D., 1979, QUASIEXPERIMENTATIO; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; Flores G, 2006, PEDIATR CLIN N AM, V53, P1197, DOI 10.1016/j.pcl.2006.09.003; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Friedman LS, 2007, INJURY PREV, V13, P156, DOI 10.1136/ip.2006.014027; GIBBS N, 2006, TIME MAGAZINE   0501; Grimshaw Jeremy M, 2002, J Contin Educ Health Prof, V22, P237, DOI 10.1002/chp.1340220408; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; *I HEALTHC IMPR, GETT START KIT RAP R; *JOINT COMM ACCR H, FACTS PAT SAF; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; LEMONICK MD, 1999, TIME MAGAZINE   1213; Luk R, 2006, ADDICTION, V101, P738, DOI 10.1111/j.1360-0443.2006.01434.x; Luria JW, 2006, PEDIATR CLIN N AM, V53, P1121, DOI 10.1016/j.pcl.2006.09.007; Milstein A, 2000, Eff Clin Pract, V3, P313; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Polk HC, 2006, MAYO CLIN PROC, V81, P345, DOI 10.4065/81.3.345; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; *SAS I INC, PROM AN FOR DEM PLAN; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; SCHMIDT K, 2006, DRG EXPERT COMPREHEN; Tamura T, 2000, CIRCULATION, V102, P253, DOI 10.1161/01.CIR.102.2.253; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; TIBBALLS J, 2007, PEDIATR CRIT CARE ME, V8, P236; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X	47	257	264	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2267	2274		10.1001/jama.298.19.2267	http://dx.doi.org/10.1001/jama.298.19.2267			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029830	Bronze			2022-12-24	WOS:000251055900026
J	Kolodkin-Gal, I; Hazan, R; Gaathon, A; Carmeli, S; Engelberg-Kulka, H				Kolodkin-Gal, Ilana; Hazan, Ronen; Gaathon, Ariel; Carmeli, Shmuel; Engelberg-Kulka, Hanna			A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli	SCIENCE			English	Article							STAPHYLOCOCCUS-AUREUS; STRESSFUL CONDITIONS; BACTERIA; TOXIN; COMMUNICATION; CANNIBALISM; PROKARYOTES; MODULE	mazEF is a toxin-antitoxin module located on many bacterial chromosomes, including those of pathogens. Here, we report that Escherichia coli mazEF-mediated cell death is a population phenomenon requiring a quorum-sensing molecule that we call the extracellular death factor (EDF). Structural analysis revealed that EDF is a linear pentapeptide, Asn-Asn-Trp-Asn-Asn. Each of the five amino acids of EDF is important for its activity.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Core Res Facil, IL-91120 Jerusalem, Israel; Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.	hanita@cc.huji.ac.il	Hazan, Ronen/ABI-1067-2020; Carmeli, shmuel/N-1273-2018; Hazan, Ronen/R-8384-2016; Gal, Ilana Kolodkin/AFE-8494-2022	Hazan, Ronen/0000-0001-9967-730X; Carmeli, shmuel/0000-0002-9641-9943; Hazan, Ronen/0000-0001-9967-730X; Gal, Ilana Kolodkin/0000-0002-8464-5660	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ellermeier CD, 2006, CELL, V124, P549, DOI 10.1016/j.cell.2005.11.041; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hochman A, 1997, CRIT REV MICROBIOL, V23, P207, DOI 10.3109/10408419709115136; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Okada M, 2005, NAT CHEM BIOL, V1, P23, DOI 10.1038/nchembio709; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PUCHER GEORGE W., 1940, INDUST AND ENGINEER CHEM ANALYT ED, V12, P27, DOI 10.1021/ac50141a008; Reitzer L.J., 1996, ESCHERICHIA COLI SAL, P391; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	27	193	212	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					652	655		10.1126/science.1147248	http://dx.doi.org/10.1126/science.1147248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962566				2022-12-24	WOS:000250409200049
J	Ledford, H				Ledford, Heidi			Minimum telomere length defined for healthy cells	NATURE			English	News Item																			0	1	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					515	515		10.1038/449515a	http://dx.doi.org/10.1038/449515a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17972362	Bronze			2022-12-24	WOS:000249893500006
J	Al-Amoudi, A; Diez, DC; Betts, MJ; Frangakis, AS				Al-Amoudi, Ashraf; Diez, Daniel Castano; Betts, Matthew J.; Frangakis, Achilleas S.			The molecular architecture of cadherins in native epidermal desmosomes	NATURE			English	Article							CELL-CELL ADHESION; CRYOELECTRON MICROSCOPY; VITREOUS SECTIONS; STRUCTURAL BASIS; HOMOPHILIC BINDING; IDENTIFICATION; ECTODOMAIN; DIMERIZATION; SPECIFICITY; DEPENDENCE	Desmosomes are cadherin- based adhesive intercellular junctions, which are present in tissues such as heart and skin. Despite considerable efforts, the molecular interfaces that mediate adhesion remain obscure. Here we apply cryo- electron tomography of vitreous sections from human epidermis to visualize the three- dimensional molecular architecture of desmosomal cadherins at close- to- native conditions. The three- dimensional reconstructions show a regular array of densities at similar to 70 angstrom intervals along the midline, with a curved shape resembling the X- ray structure of C- cadherin, a representative 'classical' cadherin. Model- independent three- dimensional image processing of extracted sub- tomograms reveals the cadherin organization. After fitting the C- cadherin atomic structure into the averaged sub- tomograms, we see a periodic arrangement of a trans W- like and a cis V- like interaction corresponding to molecules from opposing membranes and the same cell membrane, respectively. The resulting model of cadherin organization explains existing two- dimensional data and yields insights into a possible mechanism of cadherin- based cell adhesion.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Frangakis, AS (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	frangak@embl.de		Betts, Matthew/0000-0003-4583-9814; Castano-Diez, Daniel/0000-0002-0197-163X; Frangakis, Achilleas/0000-0002-8067-6611				Al-Amoudi A, 2005, J STRUCT BIOL, V150, P109, DOI 10.1016/j.jsb.2005.01.003; Al-Amoudi A, 2005, J INVEST DERMATOL, V124, P764, DOI 10.1111/j.0022-202X.2005.23630.x; Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; FORSTER F, IN PRESS J STRUCT BI; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Franzen A, 2006, EUR SOCIOL REV, V22, P353, DOI 10.1093/esr/jcl001; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Hsieh CE, 2006, J STRUCT BIOL, V153, P1, DOI 10.1016/j.jsb.2005.10.004; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Masich S, 2006, J STRUCT BIOL, V156, P461, DOI 10.1016/j.jsb.2006.05.010; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Shaikh TR, 2003, J STRUCT BIOL, V142, P301, DOI 10.1016/S1047-8477(03)00029-7; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	38	211	212	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					832	U8		10.1038/nature05994	http://dx.doi.org/10.1038/nature05994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064004				2022-12-24	WOS:000251394900046
J	Robbins, J; Aragaki, AK; Kooperberg, C; Watts, N; Wactawski-Wende, J; Jackson, RD; LeBoff, MS; Lewis, CE; Chen, Z; Stefanick, ML; Cauley, J				Robbins, John; Aragaki, Aaron K.; Kooperberg, Charles; Watts, Nelson; Wactawski-Wende, Jean; Jackson, Rebecca D.; LeBoff, Meryl S.; Lewis, Cora E.; Chen, Zhao; Stefanick, Marcia L.; Cauley, Jane			Factors associated with 5-year risk of hip fracture in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASE-LINE CHARACTERISTICS; PHYSICAL-ACTIVITY; TRIAL; PARTICIPANTS; QUESTIONNAIRE; PREDICTION; ESTROGEN; VALIDITY; DISEASE; DESIGN	Context The 329 000 hip fractures that annually occur in the United States are associated with high morbidity, mortality, and cost. Identification of those at high risk is a step toward prevention. Objective To develop an algorithm to predict the 5-year risk of hip fracture in postmenopausal women. Design, Setting, and Participants A total of 93 676 women who participated in the observational component of the Women's Health Initiative (WHI), a multiethnic longitudinal study, were used to develop a predictive algorithm based on commonly available clinical features. Selected factors that predicted hip fracture were then validated by 68 132 women who participated in the clinical trial. The model was tested in a subset of 10 750 women who had undergone dual-energy x-ray absorptiometry (DXA) scans for bone mass density assessment. Main Outcome Measure The prediction of centrally adjudicated hip fracture, measured by the area under the receiver operator characteristic (ROC) curves. Results During a mean (SD) follow-up of 7.6 ( 1.7) years, 1132 hip fractures were identified among women participating in the observational study (annualized rate, 0.16%), whereas during a mean follow-up of 8.0 ( 1.7) years, 791 hip fractures occurred among women participating in the clinical trial ( annualized rate, 0.14%). Eleven factors predicted hip fracture within 5 years: age, self-reported health, weight, height, race/ethnicity, self-reported physical activity, history of fracture after age 54 years, parental hip fracture, current smoking, current corticosteroid use, and treated diabetes. Receiver operating characteristic curves showed that the algorithm had an area under the curve of 80% (95% confidence interval [Cl], 0.77%-0.82%) when tested in the cohort of different women who were in the clinical trial. A simplified point score was developed for the probability of hip fracture. Receiver operating characteristic curves comparing DXA-scan prediction based on a 10% subset of the cohort and the algorithm among those who participated the clinical trial were similar, with an area under the curve of 79% ( 95% Cl, 73%-85%) vs 71% ( 95% Cl, 66%-76%). Conclusion This algorithm, based on 11 clinical factors, may be useful to predict the 5-year risk of hip fracture among postmenopausal women of various ethnic backgrounds. Further studies are needed to assess the clinical implication of the algorithm in general and specifically to identify treatment benefits.	Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Univ Buffalo, Div Endocrinol Diabet & Metab, Buffalo, NY USA; Ohio State Univ, Dept Internal Med & Phys Med, Columbus, OH 43210 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Alabama, Div Prevent Med, Birmingham, AL USA; Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; Stanford Prevent Res Ctr, Stanford, CA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of California System; University of California Davis; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Arizona; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Robbins, J (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, 4150 V St,Ste 2400, Sacramento, CA 95817 USA.	jarobbins@ucdavis.edu	Wactawski-Wende, Jean/AGH-5457-2022; Cauley, Jane A/N-4836-2015	Wactawski-Wende, Jean/0000-0003-3096-9595; Cauley, Jane A/0000-0003-0752-4408				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Buist DSM, 2002, J AM GERIATR SOC, V50, P1031, DOI 10.1046/j.1532-5415.2002.50257.x; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Fang J, 2004, ETHNIC DIS, V14, P280; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hsia J, 2005, AM J PREV MED, V28, P19, DOI 10.1016/j.amepre.2004.09.012; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jackson RD, 2003, ANN EPIDEMIOL, V13, pS98, DOI 10.1016/S1047-2797(03)00046-2; KOOPERBERG C, 2007, POLSPLINE POLYNOMIAL; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; McGrother CW, 2002, OSTEOPOROSIS INT, V13, P89, DOI 10.1007/s198-002-8343-6; National Center for Health Statistics, NAT HOSP DISCH AMB S; Neuhouser ML, 2003, PUBLIC HEALTH NUTR, V6, P703, DOI 10.1079/PHN2003486; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; R Development Core Team, 2007, R LANG ENV STAT COMP; Ritenbaugh C, 2003, ANN EPIDEMIOL, V13, pS87, DOI 10.1016/S1047-2797(03)00044-9; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; van Staa TP, 2002, BONE, V31, P508, DOI 10.1016/S8756-3282(02)00848-7; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	33	185	188	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2389	2398		10.1001/jama.298.20.2389	http://dx.doi.org/10.1001/jama.298.20.2389			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042916				2022-12-24	WOS:000251163400019
J	Volkov, I; Banavar, JR; Hubbell, SP; Maritan, A				Volkov, Igor; Banavar, Jayanth R.; Hubbell, Stephen P.; Maritan, Amos			Patterns of relative species abundance in rainforests and coral reefs	NATURE			English	Article							NEUTRAL BIODIVERSITY THEORY; DENSITY-DEPENDENCE; POPULATION; DIVERSITY	A formidable many-body problem in ecology is to understand the complex of factors controlling patterns of relative species abundance (RSA) in communities of interacting species. Unlike many problems in physics, the nature of the interactions in ecological communities is not completely known. Although most contemporary theories in ecology start with the basic premise that species interact, here we show that a theory in which all interspecific interactions are turned off leads to analytical results that are in agreement with RSA data from tropical forests and coral reefs. The assumption of non-interacting species leads to a sampling theory for the RSA that yields a simple approximation at large scales to the exact theory. Our results show that one can make significant theoretical progress in ecology by assuming that the effective interactions among species are weak in the stationary states in species-rich communities such as tropical forests and coral reefs.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Smithsonian Trop Res Inst, APO, AA 34002 USA; Univ Padua, Dipartimento Fis G Galilei, CNISM, I-35131 Padua, Italy; Ist Nazl Fis Nucl, I-35131 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Padua; Istituto Nazionale di Fisica Nucleare (INFN)	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Volkov, Igor/GVT-6571-2022	Maritan, Amos/0000-0002-3535-7873				Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, SCIENCE, V313, DOI 10.1126/science.1129115; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dewdney AK, 1998, THEOR POPUL BIOL, V54, P294, DOI 10.1006/tpbi.1997.1370; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Etienne RS, 2007, J THEOR BIOL, V248, P522, DOI 10.1016/j.jtbi.2007.06.010; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2006, ECOL LETT, V9, P500, DOI 10.1111/j.1461-0248.2006.00907.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Etienne RS, 2004, ECOL LETT, V7, P170, DOI 10.1111/j.1461-0248.2004.00572.x; Feller W., 1968, INTRO PROBABILITY TH, VI; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hubbell Stephen P., 2001, V32, pi; KENDALL DG, 1949, J R STAT SOC B, V11, P230; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Maxwell J.C., 2003, SCI PAPERS JC MAXWEL, V1; PIELOU E C, 1969, P286; PRESS WH, 1993, NUMERICAL RECIPES C; Rannala B, 1996, THEOR POPUL BIOL, V50, P91, DOI 10.1006/tpbi.1996.0024; Rao C. R., 1971, STATISTICAL ECOLOGY, V1, P131; Van der Waals J.D., 2004, CONTINUITY GASEOUS L; van Kampen N.G., 2001, STOCHASTIC PROCESSES; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883	29	205	209	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					45	49		10.1038/nature06197	http://dx.doi.org/10.1038/nature06197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972874				2022-12-24	WOS:000250585800033
J	Granville-Chapman, J; Dunne, RL				Granville-Chapman, J.; Dunne, R. L.			Excuse me!	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Granville-Chapman, J.; Dunne, R. L.] Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England	Salisbury District Hospital	Granville-Chapman, J (corresponding author), Salisbury Dist Hosp, Dept Plast Surg, Salisbury, Wilts, England.	jgchapman@doctors.org.uk						Romney MG, 2001, J HOSP INFECT, V47, P251, DOI 10.1053/jhin.2000.0912	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1293	1293		10.1136/bmj.39422.578970.DE	http://dx.doi.org/10.1136/bmj.39422.578970.DE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156233	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000252182700014
J	Horton, R				Horton, Richard			Managing risk: identifying environmental causes of disease	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							*AC MED SCI, 2007, ID ENV CAUS DIS REP; *DEP BUS ENT REG R, 2007, FUND FOR INTR; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1986	1987		10.1016/S0140-6736(07)61725-5	http://dx.doi.org/10.1016/S0140-6736(07)61725-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18045682				2022-12-24	WOS:000251698600010
J	Hart, DO; Raha, T; Lawson, ND; Green, MR				Hart, Daniel O.; Raha, Tamal; Lawson, Nathan D.; Green, Michael R.			Initiation of zebrafish haematopoiesis by the TATA-box-binding protein-related factor Trf3	NATURE			English	Article							EMBRYONIC-DEVELOPMENT; VERTEBRATE; TBP; EXPRESSION; XENOPUS; GENES; CELLS	TATA- box- binding protein ( TBP)- related factor 3, TRF3 ( also called TBP2), is a vertebrate- specific member of the TBP family that has a conserved carboxy- terminal region and DNA- binding domain virtually identical to that of TBP ( ref. 1). TRF3 is highly expressed during embryonic development, and studies in zebrafish and Xenopus have shown that it is required for normal embryogenesis(2,3). Here we show that zebrafish embryos depleted of Trf3 exhibit multiple developmental defects and, in particular, fail to undergo haematopoiesis. Expression profiling for Trf3-dependent genes identified mespa, which encodes a transcription factor whose murine orthologue is required for mesoderm specification(4), and chromatin immunoprecipitation verified that Trf3 binds to the mespa promoter. Depletion of Mespa resulted in developmental and haematopoietic defects markedly similar to those induced by Trf3 depletion. Injection of mespa messenger RNA ( mRNA) restored normal development to a Trf3- depleted embryo, indicating mespa is the single Trf3 target gene required for zebrafish embryogenesis. Zebrafish embryos depleted of Trf3 or Mespa also failed to express cdx4, a caudal- related gene required for haematopoiesis. Mespa binds to the cdx4 promoter, and epistasis analysis revealed an ordered trf3 - mespa - cdx4 pathway. Thus, in zebrafish, commitment of mesoderm to the haematopoietic lineage occurs through a transcription factor pathway initiated by a TBP- related factor.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu; michael.green@umassmed.edu		Lawson, Nathan/0000-0001-7788-9619	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P40 RR012546] Funding Source: Medline; NIGMS NIH HHS [R01 GM033977-23, R01 GM033977] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEVERLEY SM, 2001, CURRENT PROTOCOLS MO; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Langeland James A., 1997, P383; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Persengiev SP, 2003, P NATL ACAD SCI USA, V100, P14887, DOI 10.1073/pnas.2036440100; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Thisse B, 2001, ZFIN DIRECT DATA SUB; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	17	65	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1082	U12		10.1038/nature06349	http://dx.doi.org/10.1038/nature06349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18046332	Green Accepted			2022-12-24	WOS:000251579900087
J	Boyce, W				Boyce, Walter			Earth monitoring: Vigilance is not enough	NATURE			English	Editorial Material									Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, NIH Ctr Rapid Influenza Surveillance & Res, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Boyce, W (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.							Gaidet N, 2007, J WILDLIFE DIS, V43, pS22	1	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					791	792		10.1038/450791a	http://dx.doi.org/10.1038/450791a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063984				2022-12-24	WOS:000251394900024
J	Lalueza-Fox, C; Rompler, H; Caramelli, D; Staubert, C; Catalano, G; Hughes, D; Rohland, N; Pilli, E; Longo, L; Condemi, S; de la Rasilla, M; Fortea, J; Rosas, A; Stoneking, M; Schoneberg, T; Bertranpetit, J; Hofreiter, M				Lalueza-Fox, Carles; Roempler, Holger; Caramelli, David; Staubert, Claudia; Catalano, Giulio; Hughes, David; Rohland, Nadin; Pilli, Elena; Longo, Laura; Condemi, Silvana; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Stoneking, Mark; Schoeneberg, Torsten; Bertranpetit, Jaume; Hofreiter, Michael			A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals	SCIENCE			English	Article							MC1R; SKIN; VARIANTS; HAIR; DNA	The melanocortin 1 receptor (MC1R) regulates pigmentation in humans and other vertebrates. Variants of MC1R with reduced function are associated with pale skin color and red hair in humans of primarily European origin. We amplified and sequenced a fragment of the MC1R gene (mc1r) from two Neanderthal remains. Both specimens have a mutation that was not found in similar to 3700 modern humans analyzed. Functional analyses show that this variant reduces MC1R activity to a level that alters hair and/or skin pigmentation in humans. The impaired activity of this variant suggests that Neanderthals varied in pigmentation levels, potentially on the scale observed in modern humans. Our data suggest that inactive MC1R variants evolved independently in both modern humans and Neanderthals.	Univ Barcelona, Dept Biol Anim, E-08007 Barcelona, Spain; Univ Leipzig, Fac Med, Dept Mol Biochem, D-7010 Leipzig, Germany; Univ Florence, Dept Anim Biol & Genet, Lab Anthropol, I-50121 Florence, Italy; Univ Pompeu Fabra, Unitat Biol Evolut, Barcelona, Spain; Univ Siena, Dipartimento Sci Ambientali, I-53100 Siena, Italy; CNRS, UMR 6578, Unite Anthropol, Marseille, France; Univ Oviedo, Area Prehist, Oviedo, Spain; CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Barcelona; Leipzig University; University of Florence; Pompeu Fabra University; University of Siena; Centre National de la Recherche Scientifique (CNRS); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Max Planck Society; Harvard University	Lalueza-Fox, C (corresponding author), Univ Barcelona, Dept Biol Anim, E-08007 Barcelona, Spain.	clalueza@ub.edu; hofreite@eva.mpg.de	Stäubert, Claudia/I-7397-2015; Longo, Laura/G-2797-2011; Catalano, Giulio/AAT-2749-2020; LALUEZA-FOX, CARLES/AAG-5341-2020; Condemi, Silvana/ABE-2701-2021; Hughes, David/E-7190-2015; Bertranpetit, Jaume/F-8550-2012; Rosas, Antonio/D-9742-2016; Hofreiter, Michael/A-3996-2017	Stäubert, Claudia/0000-0003-0721-8507; Longo, Laura/0000-0001-6562-3047; Catalano, Giulio/0000-0002-2564-5775; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Condemi, Silvana/0000-0002-6516-0879; Hughes, David/0000-0002-9644-8998; Bertranpetit, Jaume/0000-0003-0100-0590; Rosas, Antonio/0000-0002-5829-9952; Pilli, Elena/0000-0002-3150-5082; Hofreiter, Michael/0000-0003-0441-4705; de la RASILLA, Marco/0000-0002-5505-0625; Caramelli, David/0000-0001-6468-1675				Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Cann HM, 2002, SCIENCE, V296, P261; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rana BK, 1999, GENETICS, V151, P1547; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Sanchez-Laorden L, 2006, CELL MOL BIOL, V52, P39, DOI 10.1170/T706; Santos N. M. D., 2006, J BIOL CHEM, V281, P12896; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021	27	203	213	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1453	1455		10.1126/science.1147417	http://dx.doi.org/10.1126/science.1147417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17962522				2022-12-24	WOS:000251246100046
J	Hu, WW; Feng, ZH; Teresky, AK; Levine, AJ				Hu, Wenwei; Feng, Zhaohui; Teresky, Angelika K.; Levine, Arnold J.			p53 regulates maternal reproduction through LIF	NATURE			English	Article							LEUKEMIA INHIBITORY FACTOR; IMPLANTATION FAILURE; POLYMORPHISM; BLASTOCYST; EXPRESSION; APOPTOSIS; PATHWAY; HUMANS; UTERUS; CELLS	Extensive studies have shown that p53 is important in tumour prevention(1). However, little is known about its normal physiological function. Here we show that p53 is important in reproduction, in a gender-specific manner. Significant decreases in embryonic implantation, pregnancy rate and litter size were observed in matings with p53(-/-) female mice but not with p53(-/-) male mice. The gene encoding leukaemia inhibitory factor (LIF), a cytokine critical for implantation(2), was identified as a p53-regulated gene that functions as the downstream mediator of this effect. p53 can regulate both basal and inducible transcription of LIF. Loss of p53 decreased both the level and function of LIF in uteri. Lower LIF levels were observed in the uteri of p53(-/-) mice than in those of p53(+/+) mice, particularly at day 4 of pregnancy, when transiently induced high levels of LIF were crucial for embryonic implantation. This observation probably accounts for the impaired implantation of embryos in p53(-/-) female mice. Administration of LIF to pregnant p53(-/-) mice restored maternal reproduction by improving implantation. These results demonstrate a function for p53 in maternal reproduction through the regulation of LIF. Evidence is accumulating that p53 may have a similar function in humans.	Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA; Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Institute for Advanced Study - USA	Levine, AJ (corresponding author), Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	alevine@ias.edu						ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Kay C, 2006, REPROD BIOMED ONLINE, V13, P492, DOI 10.1016/S1472-6483(10)60635-9; Murphy ME, 2006, CELL DEATH DIFFER, V13, P916, DOI 10.1038/sj.cdd.4401907; Nagy A., 2003, MANIPULATING MOUSE E; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602	19	328	344	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					721	U8		10.1038/nature05993	http://dx.doi.org/10.1038/nature05993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046411				2022-12-24	WOS:000251209700054
J	Martinez-Pomares, L; Gordon, S				Martinez-Pomares, Luisa; Gordon, Siamon			Antigen presentation the macrophage way	CELL			English	Editorial Material							NODE B-CELLS; LYMPH-NODE; DENDRITIC CELLS; RECOGNITION; FOLLICLES; RECEPTOR	Multiphoton intravital microscopy of lymph nodes has revolutionized the study of the early events leading to induction of acquired immunity. Using this technique, Junt et al. (2007) report in a recent issue of Nature that macrophages of the mouse lymph node subcapsular sinus facilitate B cell activation in vivo by collecting and displaying native antigen.	Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2UH, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Nottingham; University of Oxford	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Inst Infect Immun & Inflammat, Floor A,W Block,Room 1323, Nottingham NG7 2UH, England.	luisa.martinez-pomares@nottingham.ac.uk; siamon.gordon@path.ox.ac.uk	Eckhardt, Erik/G-1567-2010	Martinez-Pomares, Luisa/0000-0002-2331-127X				Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; JUNT T, 2007, NATURE          1014; Kumamoto Y, 2004, J BIOL CHEM, V279, P49274, DOI 10.1074/jbc.M409300200; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117	9	55	58	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					641	643		10.1016/j.cell.2007.10.046	http://dx.doi.org/10.1016/j.cell.2007.10.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022354	Bronze			2022-12-24	WOS:000250966300007
J	Wands, J				Wands, Jack			Hepatocellular carcinoma and sex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Wands, J (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							BRUIX J, 2006, ZAKIM BOYERS HEPATOL, V2, P1109; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Tennant BC, 2004, GASTROENTEROLOGY, V127, pS283, DOI 10.1053/j.gastro.2004.09.043	4	81	86	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1974	1976		10.1056/NEJMcibr075652	http://dx.doi.org/10.1056/NEJMcibr075652			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989393				2022-12-24	WOS:000250732500017
J	Menuz, K; Stroud, RM; Nicoll, RA; Hays, FA				Menuz, Karen; Stroud, Robert M.; Nicoll, Roger A.; Hays, Franklin A.			TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists	SCIENCE			English	Article							GLUTAMATE-RECEPTOR; DESENSITIZATION; CNQX; ACTIVATION; STARGAZIN; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; CYCLOTHIAZIDE; INTERNEURONS; TRAFFICKING; NEURONS	Quinoxalinedione compounds such as 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) are the most commonly used alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. However, we find that in the presence of transmembrane AMPA receptor regulatory proteins (TARPs), which are AMPA receptor auxiliary subunits, CNQX acts as a partial agonist. CNQX induced small depolarizing currents in neurons of the central nervous system, and reconstitution of this agonist activity required coexpression of TARPs. A crystal structure of CNQX bound to the TARP-less AMPA receptor ligand-binding domain showed that, although CNQX induces partial domain closure, this movement is not transduced into linker separation, suggesting that TARPs may increase agonist efficacy by strengthening the coupling between domain closure and channel opening. Our results demonstrate that the presence of an auxiliary subunit can determine whether a compound functions as an agonist or antagonist.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu; nicoll@cmp.ucsf.edu		Menuz, Karen/0000-0001-8163-0941	NIGMS NIH HHS [P50 GM73210, GM078754] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078754, P50GM073210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BERTOLINO M, 1993, RECEPTOR CHANNEL, V1, P267; Bialer M, 2007, EPILEPSY RES, V73, P1, DOI 10.1016/j.eplepsyres.2006.10.008; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Catarzi D, 2007, MED RES REV, V27, P239, DOI 10.1002/med.20084; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hashimoto Y, 2004, NEUROSCI LETT, V358, P33, DOI 10.1016/j.neulet.2003.12.083; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Maccaferri G, 2002, NEUROPHARMACOLOGY, V43, P523, DOI 10.1016/S0028-3908(02)00161-2; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Palay S. L., 1974, CEREBELLAR CORTEX CY; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rogawski MA, 2006, EPILEPSY RES, V68, P22, DOI 10.1016/j.eplepsyres.2005.09.012; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; TARNAWA I, 1993, BIOORG MED CHEM LETT, V3, P99, DOI 10.1016/S0960-894X(00)80100-6; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	32	117	118	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					815	817		10.1126/science.1146317	http://dx.doi.org/10.1126/science.1146317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975069				2022-12-24	WOS:000250583900046
J	Patterson, PH				Patterson, Paul H.			Maternal effects on schizophrenia risk	SCIENCE			English	Editorial Material							TWINS; INFECTION; PREGNANCY; AUTISM; LEADS		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Patterson, PH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	php@caltech.edu						Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; DAVIS JO, 1995, SCHIZOPHRENIA BULL, V21, P357, DOI 10.1093/schbul/21.3.357; Derom CA, 2006, TWIN RES HUM GENET, V9, P733, DOI 10.1375/183242706779462723; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P25, DOI 10.1023/A:1015337611258; Hyman SL, 2006, INT REV RES MENT RET, V30, P171; Jacobs N, 2001, BEHAV GENET, V31, P209, DOI 10.1023/A:1010257512183; Meyer U., 2007, MOL PSYCHIAT; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Monteiro J, 1998, AM J HUM GENET, V63, P339, DOI 10.1086/301978; Phung DT, 2002, AM J OBSTET GYNECOL, V186, P1041, DOI 10.1067/mob.2002.122449; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rosa A, 2002, SCHIZOPHRENIA BULL, V28, P697, DOI 10.1093/oxfordjournals.schbul.a006973; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; TORREY EF, 1992, SCHIZOPHRENIA BULL, V18, P159, DOI 10.1093/schbul/18.2.159; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	17	131	140	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					576	577		10.1126/science.1150196	http://dx.doi.org/10.1126/science.1150196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962542				2022-12-24	WOS:000250409200024
J	Schlegel, T; Schuster, S				Schlegel, Thomas; Schuster, Stefan			Small circuits for large tasks: High-speed decision-making in archerfish	SCIENCE			English	Article							NEURAL BASIS; FISH LEARN; REPRESENTATION; OBJECT; MOTION	The enormous progress made in functional magnetic resonance imaging technology allows us to watch our brains engage in complex cognitive and social tasks. However, our understanding of what actually is computed in the underlying cellular networks is hindered by the vast numbers of neurons involved. Here, we describe a vertebrate system, shaped for top speed, in which a complex and plastic decision is performed by surprisingly small circuitry that can be studied at cellular resolution.	[Schlegel, Thomas; Schuster, Stefan] Univ Erlangen Nurnberg, Inst Zool 2, D-91058 Erlangen, Germany	University of Erlangen Nuremberg	Schuster, S (corresponding author), Univ Erlangen Nurnberg, Inst Zool 2, Staudtstr 5, D-91058 Erlangen, Germany.	sschuste@biologie.uni-erlangen.de		Schuster, Stefan/0000-0002-0873-8996				Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Canfield JG, 2007, J COMP PHYSIOL A, V193, P1055, DOI 10.1007/s00359-007-0258-2; Canfield JG, 2006, BRAIN BEHAV EVOLUT, V67, P188, DOI 10.1159/000091652; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DILL LM, 1977, BEHAV ECOL SOCIOBIOL, V2, P169, DOI 10.1007/BF00361900; Fetcho JR, 2004, CURR OPIN NEUROBIOL, V14, P707, DOI 10.1016/j.conb.2004.10.008; Fetcho JR, 1997, CURR OPIN NEUROBIOL, V7, P832, DOI 10.1016/S0959-4388(97)80143-2; GUTHRIE DM, 1990, VISUAL NEUROSCI, V4, P367, DOI 10.1017/S0952523800004570; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; LENNIE P, 1981, VISION RES, V21, P815, DOI 10.1016/0042-6989(81)90180-2; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; Rossel S, 2002, J EXP BIOL, V205, P3321; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; Schuster S, 2006, CURR BIOL, V16, P378, DOI 10.1016/j.cub.2005.12.037; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; Wohl S, 2006, J EXP BIOL, V209, P141, DOI 10.1242/jeb.01981; ZOTTOLI SJ, 1987, BRAIN RES, V401, P113, DOI 10.1016/0006-8993(87)91170-X	23	59	59	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					104	106		10.1126/science.1149265	http://dx.doi.org/10.1126/science.1149265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174445				2022-12-24	WOS:000252084000042
J	Burton, BM; Marquis, KA; Sullivan, NL; Rapoport, TA; Rudner, DZ				Burton, Briana M.; Marquis, Kathleen A.; Sullivan, Nora L.; Rapoport, Tom A.; Rudner, David Z.			The ATPase SpoIIIE transports DNA across fused septal membranes during sporulation in Bacillus subtilis	CELL			English	Article							ASYMMETRIC CELL-DIVISION; ESCHERICHIA-COLI; GENE-EXPRESSION; CHROMOSOME SEGREGATION; BACTERIAL CONJUGATION; MOTHER CELL; SUBCELLULAR-LOCALIZATION; PROTEIN; FTSK; TRANSLOCASE	The FtsK/SpoIIIE family of ATP-dependent DNA transporters mediates proper chromosome segregation in dividing bacteria. In sporulating Bacillus subtilis cells, SpoIIIE translocates much of the circular chromosome from the mother cell into the forespore, but the molecular mechanism remains unclear. Using a new assay to monitor DNA transport, we demonstrate that the two arms of the chromosome are simultaneously pumped into the forespore. Up to 70 molecules of SpoIIIE are recruited to the site of DNA translocation and assemble into complexes that could contain 12 subunits. The fusion of the septal membranes during cytokinesis precedes DNA translocation and does not require SpoIIIE, as suggested by analysis of lipid dynamics, serial thin-section electron microscopy, and cell separation by protoplasting. These data support a model for DNA transport in which the transmembrane segments of FtsK/SpoIIIE form linked DNA-conducting channels across the two lipid bilayers of the septum.	[Burton, Briana M.; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Marquis, Kathleen A.; Sullivan, Nora L.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu; rudner@hms.harvard.edu			NIGMS NIH HHS [R01 GM073831, R01 GM073831-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Bartosik AA, 2005, ACTA BIOCHIM POL, V52, P1; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2003, CURR BIOL, V13, P2196, DOI 10.1016/S0960-9822(03)00912-6; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Chary VK, 2003, J BACTERIOL, V185, P879, DOI 10.1128/JB.185.3.879-886.2003; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Corre J, 2005, MOL MICROBIOL, V56, P1539, DOI 10.1111/j.1365-2958.2005.04633.x; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Errington J, 2001, CURR OPIN MICROBIOL, V4, P660, DOI 10.1016/S1369-5274(01)00266-1; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gomis-Ruth FX, 2001, INT J BIOCHEM CELL B, V33, P839, DOI 10.1016/S1357-2725(01)00060-7; Gunton JE, 2007, MICROBIOL-SGM, V153, P428, DOI 10.1099/mic.0.2006/001297-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hilbert DW, 2004, J BACTERIOL, V186, P1983, DOI 10.1128/JB.186.7.1983-1990.2004; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Khvorova A, 2000, J BACTERIOL, V182, P4425, DOI 10.1128/JB.182.16.4425-4429.2000; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Li ZH, 2001, P NATL ACAD SCI USA, V98, P12538, DOI 10.1073/pnas.221454798; Liu NJL, 2006, MOL MICROBIOL, V59, P1097, DOI 10.1111/j.1365-2958.2005.05004.x; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; NESMEYANOVA MA, 1982, FEBS LETT, V142, P189, DOI 10.1016/0014-5793(82)80131-2; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Pogliano K, 1997, J BACTERIOL, V179, P3331, DOI 10.1128/jb.179.10.3331-3341.1997; Preble AM, 2001, GENETICS, V157, P163; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sharp MD, 1999, P NATL ACAD SCI USA, V96, P14553, DOI 10.1073/pnas.96.25.14553; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sharp MD, 2003, J BACTERIOL, V185, P2005, DOI 10.1128/JB.185.6.2005-2008.2003; SHARPE ME, 1995, P NATL ACAD SCI USA, V92, P8630, DOI 10.1073/pnas.92.19.8630; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 1997, EMBO J, V16, P2161, DOI 10.1093/emboj/16.8.2161; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998; Zupancic ML, 2001, MOL MICROBIOL, V39, P1471, DOI 10.1046/j.1365-2958.2001.02331.x	51	98	99	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1301	1312		10.1016/j.cell.2007.11.009	http://dx.doi.org/10.1016/j.cell.2007.11.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160039	Bronze, Green Accepted			2022-12-24	WOS:000252217200019
J	Okada, T; Ohzeki, JI; Nakano, M; Yoda, K; Brinkley, WR; Larionov, V; Masumoto, H				Okada, Teruaki; Ohzeki, Jun-Ichirou; Nakano, Megumi; Yoda, Kinya; Brinkley, William R.; Larionov, Vladimir; Masumoto, Hiroshi			CENP-B controls centromere formation depending on the chromatin context	CELL			English	Article							ARTIFICIAL CHROMOSOME FORMATION; HISTONE H3 METHYLTRANSFERASE; ALPHA-SATELLITE ARRAY; DNA METHYLATION; NULL MICE; PROTEIN; COMPLEX; HETEROCHROMATIN; KINETOCHORE; IDENTIFICATION	The centromere is a chromatin region that serves as the spindle attachment point and directs accurate inheritance of eukaryotic chromosomes during cell divisions. However, the mechanism by which the centromere assembles and stabilizes at a specific genomic region is not clear. The de novo formation of a human/mammalian artificial chromosome (HAC/MAC) with a functional centromere assembly requires the presence of alpha-satellite DNA containing binding motifs for the centromeric CENP-B protein. We demonstrate here that de novo centromere assembly on HAC/MAC is dependent on CENP-B. In contrast, centromere formation is suppressed in cells expressing CENP-B when alpha-satellite DNA was integrated into a chromosomal site. Remarkably, on those integration sites CENP-B enhances histone H3-K9 trimethylation and DNA methylation, thereby stimulating heterochromatin formation. Thus, we propose that CENP-B plays a dual role in centromere formation, ensuring de novo formation on DNA lacking a functional centromere but preventing the formation of excess centromeres on chromosomes.	[Okada, Teruaki; Masumoto, Hiroshi] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Ohzeki, Jun-Ichirou; Nakano, Megumi; Larionov, Vladimir; Masumoto, Hiroshi] NCI, Mol Pharmacol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; [Yoda, Kinya] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Brinkley, William R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Nagoya University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nagoya University; Baylor College of Medicine	Masumoto, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	g44478a@nucc.cc.nagoya-u.ac.jp			Intramural NIH HHS [NIH0011582802] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; Edwards NS, 2005, MOL BIOL CELL, V16, P1800, DOI 10.1091/mbc.e04-09-0788; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Grimes BR, 2002, MOL THER, V5, P798, DOI 10.1006/mthe.2002.0612; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kapoor M, 1998, CHROMOSOMA, V107, P570, DOI 10.1007/s004120050343; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Mejia JE, 2001, AM J HUM GENET, V69, P315, DOI 10.1086/321977; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MURO Y, 1992, J CELL BIOL, V116, P585, DOI 10.1083/jcb.116.3.585; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakashima H, 2005, J CELL SCI, V118, P5885, DOI 10.1242/jcs.02702; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Okamoto Y, 2007, EMBO J, V26, P1279, DOI 10.1038/sj.emboj.7601584; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Spence JM, 2002, EMBO J, V21, P5269, DOI 10.1093/emboj/cdf511; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Suzuki N, 2004, J BIOL CHEM, V279, P5934, DOI 10.1074/jbc.M306477200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tanaka Y, 2005, J BIOL CHEM, V280, P41609, DOI 10.1074/jbc.M509666200; Tanaka Y, 2005, FEBS J, V272, P282, DOI 10.1111/j.1432-1033.2004.04406.x; Vafa O, 1999, CHROMOSOMA, V108, P367, DOI 10.1007/s004120050388; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	45	173	179	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1287	1300		10.1016/j.cell.2007.10.045	http://dx.doi.org/10.1016/j.cell.2007.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160038	Bronze			2022-12-24	WOS:000252217200018
J	Patocs, A; Zhang, L; Xu, YM; Weber, F; Caldes, T; Mutter, GL; Platzer, P; Eng, C				Patocs, Attila; Zhang, Li; Xu, Yaomin; Weber, Frank; Caldes, Trinidad; Mutter, George L.; Platzer, Petra; Eng, Charis			Breast-cancer stromal cells with TP53 mutations and nodal metastases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOMATIC MUTATIONS; P53; BRCA1; CARCINOMAS; GENE; HETEROZYGOSITY; TRANSFORMATION; PROGRESSION; EPITHELIUM; PROGNOSIS	Background: The importance of cross-talk between a cancer and its microenvironment has been increasingly recognized. We hypothesized that mutational inactivation of the tumor-suppressor gene TP53 and genomic alterations in stromal cells of a tumor's microenvironment contribute to the clinical outcome. Methods: We performed TP53 mutation analysis and genomewide analysis of loss of heterozygosity and allelic imbalance on DNA from isolated neoplastic epithelial and stromal cells from 43 patients with hereditary breast cancer and 175 patients with sporadic breast cancer. Compartment-specific patterns and TP53 mutations were analyzed. Associations between compartment-specific TP53 status, loss of heterozygosity or allelic imbalance, and clinical and pathological characteristics were computed. Results: TP53 mutations were associated with an increased loss of heterozygosity and allelic imbalance in both hereditary and sporadic breast cancers, but samples from patients with hereditary disease had more frequent mutations than did those from patients with sporadic tumors (74.4% vs. 42.3%, P=0.001). Only 1 microsatellite locus (2p25.1) in stromal cells from hereditary breast cancers was associated with mutated TP53, whereas there were 66 such loci in cells from sporadic breast cancers. Somatic TP53 mutations in stroma, but not epithelium, of sporadic breast cancers were associated with regional nodal metastases (P=0.003). A specific set of five loci linked to an increased loss of heterozygosity and allelic imbalance in the stroma of sporadic tumors was associated with nodal metastases in the absence of TP53 mutations. No associations were found between any of the clinical or pathological features of hereditary breast cancer with somatic TP53 mutations. Conclusions: Stroma-specific loss of heterozygosity or allelic imbalance are associated with somatic TP53 mutations and regional lymph-node metastases in sporadic breast cancer but not in hereditary breast cancer.	Cleveland Clin Fdn, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; San Carlos Univ Hosp, Mol Oncol Lab, Madrid, Spain; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Hospital Clinico San Carlos; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Eng, C (corresponding author), Cleveland Clin, Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	Haviv, Izhak/E-3782-2015; Mutter, George L/C-5819-2009; Weber, Frank/A-1883-2012	Haviv, Izhak/0000-0002-0837-5005; Weber, Frank/0000-0002-0995-667X; Patocs, Attila/0000-0001-7506-674X; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [1P01CA97189-01A2, 1P50/U54CA113001-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Barclay WW, 2005, ENDOCRINOLOGY, V146, P13, DOI 10.1210/en.2004-1123; BISSELL MJ, 1987, J CELL SCI, P327; Chen SL, 2003, MOL CARCINOGEN, V36, P204, DOI 10.1002/mc.10110; Dacic S, 2005, AM J SURG PATHOL, V29, P897, DOI 10.1097/01.pas.0000164367.96379.66; Eissa S, 1997, ANTICANCER RES, V17, P3091; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Gasco M, 2003, HUM MUTAT, V21, P301, DOI 10.1002/humu.10173; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hayward SW, 2001, CANCER RES, V61, P8135; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Hothorn LA, 2006, J BIOPHARM STAT, V16, P711, DOI 10.1080/10543400600860576; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Kurose K, 2002, NAT GENET, V32, P681, DOI 10.1038/ng1202-681b; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Maffini MV, 2005, AM J PATHOL, V167, P1405, DOI 10.1016/S0002-9440(10)61227-8; Marsh DJ, 1997, CANCER RES, V57, P500; Martin AM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e34; Matrisian LM, 2001, CANCER RES, V61, P3844; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; *NCCN, 2007, GEN FAM HIGH RISK AS; Nelson HH, 2005, CARCINOGENESIS, V26, P1770, DOI 10.1093/carcin/bgi125; Overgaard J, 2000, ACTA ONCOL, V39, P327, DOI 10.1080/028418600750013096; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Rines RD, 1998, CARCINOGENESIS, V19, P979, DOI 10.1093/carcin/19.6.979; Shekhar MPV, 2001, CANCER RES, V61, P1320; Smith PD, 1999, ONCOGENE, V18, P2451, DOI 10.1038/sj.onc.1202565; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang Xiaojuan, 2002, Breast Cancer, V9, P216, DOI 10.1007/BF02967592; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Weber F, 2007, JAMA-J AM MED ASSOC, V297, P187, DOI 10.1001/jama.297.2.187; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062	38	238	253	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2007	357	25					2543	2551		10.1056/NEJMoa071825	http://dx.doi.org/10.1056/NEJMoa071825			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242MJ	18094375				2022-12-24	WOS:000251728900005
J	Rancz, EA; Ishikawa, T; Duguid, I; Chadderton, P; Mahon, S; Hausser, M				Rancz, Ede A.; Ishikawa, Taro; Duguid, Ian; Chadderton, Paul; Mahon, Severine; Haeusser, Michael			High-fidelity transmission of sensory information by single cerebellar mossy fibre boutons	NATURE			English	Article							GRANULE CELL LAYER; IN-VIVO; PURKINJE-CELLS; RAT; RESPONSES; SYNAPSE; CORTEX; BRAIN; INTEGRATION; MORPHOLOGY	Understanding the transmission of sensory information at individual synaptic connections requires knowledge of the properties of presynaptic terminals and their patterns of firing evoked by sensory stimuli. Such information has been difficult to obtain because of the small size and inaccessibility of nerve terminals in the central nervous system. Here we show, by making direct patch- clamp recordings in vivo from cerebellar mossy fibre boutons - the primary source of synaptic input to the cerebellar cortex(1,2) - that sensory stimulation can produce bursts of spikes in single boutons at very high instantaneous firing frequencies ( more than 700 Hz). We show that the mossy fibre - granule cell synapse exhibits high- fidelity transmission at these frequencies, indicating that the rapid burst of excitatory postsynaptic currents underlying the sensory- evoked response of granule cells(3) can be driven by such a presynaptic spike burst. We also demonstrate that a single mossy fibre can trigger action potential bursts in granule cells in vitro when driven with in vivo firing patterns. These findings suggest that the relay from mossy fibre to granule cell can act in a 'detonator' fashion, such that a single presynaptic afferent may be sufficient to transmit the sensory message. This endows the cerebellar mossy fibre system with remarkable sensitivity and high fidelity in the transmission of sensory information.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Mahon, Severine/E-7195-2017; mahon, severine/AAG-9225-2021; Ishikawa, Taro/AAX-9928-2020; Rancz, Ede Attila/AAS-6867-2020; Hausser, Michael/AAW-6827-2020	mahon, severine/0000-0001-8339-9034; Ishikawa, Taro/0000-0003-2335-439X; Hausser, Michael/0000-0002-2673-8957; Rancz, Ede Attila/0000-0002-7951-1385; Chadderton, Paul/0000-0002-6276-1011; Duguid, Ian/0000-0001-6966-2641	Wellcome Trust [068699] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; CAJAL SR, 2004, TEXTURA SISTEMA NERV; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; ECCLES JC, 1971, EXP BRAIN RES, V13, P15, DOI 10.1007/BF00236428; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; LEUSEN I, 1972, PHYSIOL REV, V52, P1, DOI 10.1152/physrev.1972.52.1.1; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Morissette J, 1996, EXP BRAIN RES, V109, P240; Palay S. L., 1974, CEREBELLAR CORTEX CY; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Simpson JI, 2005, PROG BRAIN RES, V148, P329, DOI 10.1016/S0079-6123(04)48026-1; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74	33	209	210	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1245	U12		10.1038/nature05995	http://dx.doi.org/10.1038/nature05995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097412	Green Accepted			2022-12-24	WOS:000251786200053
J	Cauley, JA; Hochberg, MC; Lui, LY; Palermo, L; Ensrud, KE; Hillier, TA; Nevitt, MC; Cummings, SR				Cauley, Jane A.; Hochberg, Marc C.; Lui, Li-Yung; Palermo, Lisa; Ensrud, Kristine E.; Hillier, Teresa A.; Nevitt, Michael C.; Cummings, Steven R.			Long-term risk of incident vertebral fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN PROSPECTIVE OSTEOPOROSIS; POSTMENOPAUSAL WOMEN; NONVERTEBRAL FRACTURES; OLDER WOMEN; EPIDEMIOLOGY; MORTALITY; TRIAL; MEN; POPULATION; PREDICTION	Context Vertebral fractures are the most common osteoporotic fracture. Women with low bone mineral density ( BMD) and prevalent vertebral fractures have a greater risk of incident vertebral fractures over the short- term, but their absolute risk of vertebral fracture over the long- term is uncertain. Objective To examine the absolute risk of incident vertebral fracture by BMD and prevalent vertebral fracture status over 15 years. Design, Setting, and Participants A total of 9704 white women were recruited at 4 US clinical centers and enrolled in the Study of Osteoporotic Fractures, a longitudinal cohort study. Of these, 2680 attended a clinic visit an average of 14.9 years after baseline; mean age of 68.8 years at entry and 83.8 years at follow- up. Mean Outcome Measure Incident vertebral fractures identified from lateral spinal radiographs defined as a decrease of at least 20% and 4 mm at any vertebral level. Prevalent vertebral fractures were identified on the baseline radiographs using vertebral morphometry. Bone mineral density was measured at the total hip and lumbar spine using dual- energy x- ray absorptiometry. Results Of the 2680 women, 487 ( 18.2%) had an incident vertebral fracture including 163 of the 394 ( 41.4%) with a prevalent vertebral fracture at baseline and 324 of the 2286 ( 14.2%) without a prevalent vertebral fracture at baseline ( odds ratio, 4.21; 95% confidence interval, 3.33- 5.34). Low BMD was associated with an increased risk of incident vertebral fracture ( odds ratio per 1 SD decrease in total hip BMD, 1.78 [ 95% confidence interval, 1.58- 2.00]). The absolute risk of vertebral fracture ranged from 56% among women with total hip BMD T score of - 2.5 or less and a prevalent vertebral fracture to 9% in women with normal BMD and no prevalent vertebral fracture. Conclusions Low BMD and prevalent vertebral fractures are independently related to new vertebral fractures over 15 years of follow- up. Women with a prevalent vertebral fracture have a substantially increased absolute risk of an incident fracture, especially if they have osteoporosis diagnosed by BMD.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA; Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Minneapolis VA Med Ctr, Dept Med, Minneapolis, MN USA; Kaiser Permanente Ctr Hlth Res NW Hawaii, Portland, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Kaiser Permanente	Cauley, JA (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 DeSoto St,Crabtree A524, Pittsburgh, PA 15261 USA.	jcauley@edc.pitt.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Ensrud, Kristine/0000-0002-9069-3036	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035584, R01AR035583, R01AR035582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027576, R01AG005394, R01AG005407, R01AG027574] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35583, AR35584, AR35582] Funding Source: Medline; NIA NIH HHS [R01 AG005407, 2 R01 AG005394-22A1, AG05407, AG05394, 2 R01 AG027574-22A1, R01 AG027576-22] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1999, J BONE MINER RES, V14, P90, DOI 10.1359/jbmr.1999.14.1.90; BLACK DM, 1995, J BONE MINER RES, V10, P890; Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; BLACK DM, 1991, J BONE MINER RES, V6, P883; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; COOPER C, 1993, BONE, V14, pS89; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUMMINGS SR, 1995, J BONE MINER RES, V10, P518; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Genant HK, 2007, OSTEOPOROSIS INT, V18, P69, DOI 10.1007/s00198-006-0199-6; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Jalava T, 2003, J BONE MINER RES, V18, P1254, DOI 10.1359/jbmr.2003.18.7.1254; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kado DM, 2003, OSTEOPOROSIS INT, V14, P589, DOI 10.1007/s00198-003-1412-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kaptoge S, 2006, OSTEOPOROSIS INT, V17, P1369, DOI 10.1007/s00198-005-0067-9; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Lewiecki EM, 2006, J CLIN ENDOCR METAB, V91, P4215, DOI 10.1210/jc.2006-1178; Lindsay R, 2005, OSTEOPOROSIS INT, V16, P306, DOI 10.1007/s00198-004-1691-5; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; Melton LJ, 1997, SPINE, V22, p2S, DOI 10.1097/00007632-199712151-00002; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; Nevitt MC, 2005, J BONE MINER RES, V20, P131, DOI 10.1359/JBMR.041003; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Samelson EJ, 2006, J BONE MINER RES, V21, P1207, DOI 10.1359/JBMR.060513; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; Wasnich RD, 1996, BONE, V18, pS179, DOI 10.1016/8756-3282(95)00499-8	39	163	172	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2761	2767		10.1001/jama.298.23.2761	http://dx.doi.org/10.1001/jama.298.23.2761			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165669	Bronze			2022-12-24	WOS:000251716000021
J	Miller, CT; Beleza, S; Pollen, AA; Schluter, D; Kittles, RA; Shriver, MD; Kingsley, DM				Miller, Craig T.; Beleza, Sandra; Pollen, Alex A.; Schluter, Dolph; Kittles, Rick A.; Shriver, Mark D.; Kingsley, David M.			cis-regulatory changes in kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans	CELL			English	Article							MORPHOLOGICAL EVOLUTION; MELANOCYTE DEVELOPMENT; GENETIC ARCHITECTURE; SKIN PIGMENTATION; PELVIC REDUCTION; MICE; MUTATIONS; PATTERNS; COLOR; POPULATIONS	Dramatic pigmentation changes have evolved within most vertebrate groups, including fish and humans. Here we use genetic crosses in sticklebacks to investigate the parallel origin of pigmentation changes in natural populations. High-resolution mapping and expression experiments show that light gills and light ventrums map to a divergent regulatory allele of the Kit ligand (Kitlg) gene. The divergent allele reduces expression in gill and skin tissue and is shared by multiple derived freshwater populations with reduced pigmentation. In humans, Europeans and East Asians also share derived alleles at the KITLG locus. Strong signatures of selection map to regulatory regions surrounding the gene, and admixture mapping shows that the KITLG genomic region has a significant effect on human skin color. These experiments suggest that regulatory changes in Kitlg contribute to natural variation in vertebrate pigmentation, and that similar genetic mechanisms may underlie rapid evolutionary change in fish and humans.	[Miller, Craig T.; Pollen, Alex A.; Kingsley, David M.] Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; [Miller, Craig T.; Pollen, Alex A.; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Beleza, Sandra] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4250400 Oporto, Portugal; [Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Kittles, Rick A.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Universidade do Porto; University of British Columbia; University of British Columbia; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kingsley, DM (corresponding author), Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu	Miller, Craig/GWQ-5012-2022	Shriver, Mark/0000-0003-0006-0479; Beleza, Sandra/0000-0002-7004-3431; Schluter, Dolph/0000-0003-1683-7836	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002154, P50HG002568] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG002154-06, P50 HG002568-06, P50 HG002568] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Bedell MA, 1996, GENETICS, V142, P935; BELL MA, 1994, EVOLUTION THREESPINE; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Boughman JW, 2005, EVOLUTION, V59, P361; *BROAD I, 2006, DRAFT STICKL GEN; Charlier C, 1996, MAMM GENOME, V7, P138, DOI 10.1007/s003359900034; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cott H. B., 1940, ADAPTIVE COLOURATION; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Fay JC, 2000, GENETICS, V155, P1405; Girvan JR, 1998, P ROY SOC B-BIOL SCI, V265, P913, DOI 10.1098/rspb.1998.0378; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Jablonski NG, 2004, ANNU REV ANTHROPOL, V33, P585, DOI 10.1146/annurev.anthro.33.070203.143955; Johnsen S, 2002, P ROY SOC B-BIOL SCI, V269, P243, DOI 10.1098/rspb.2001.1855; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kingsley David M., 2007, P41; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; MCPHAIL JD, 1969, J FISH RES BOARD CAN, V26, P3183, DOI 10.1139/f69-301; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; MOODIE GEE, 1972, HEREDITY, V28, P155, DOI 10.1038/hdy.1972.21; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; MOTRO B, 1991, DEVELOPMENT, V113, P1207; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parichy DM, 2006, HEREDITY, V97, P200, DOI 10.1038/sj.hdy.6800867; Parra EJ, 2004, NAT GENET, V36, pS54, DOI 10.1038/ng1440; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rajaraman S, 2002, GENETICS, V162, P341; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Yoshida Y, 2007, FASEB J, V21, P2829, DOI 10.1096/fj.06-6845com	58	267	269	4	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1179	1189		10.1016/j.cell.2007.10.055	http://dx.doi.org/10.1016/j.cell.2007.10.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083106	Green Accepted, Bronze			2022-12-24	WOS:000252217100024
J	Grafton, RQ; Kompas, T; Hilborn, RW				Grafton, R. Q.; Kompas, T.; Hilborn, R. W.			Economics of overexploitation revisited	SCIENCE			English	Article									Australian Natl Univ, Crawford Sch, Canberra, ACT 0200, Australia; Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Australian National University; University of Washington; University of Washington Seattle	Grafton, RQ (corresponding author), Australian Natl Univ, Crawford Sch, Ellery Crescent, Canberra, ACT 0200, Australia.	quentin.grafton@anu.edu.au	Grafton, Quentin/AAS-2316-2021; Grafton, Quentin/A-5277-2008; Hilborn, Ray W/D-6332-2013; Kompas, Tom/M-8851-2019; Kompas, T/F-5930-2010	Grafton, Quentin/0000-0002-0048-9083; Grafton, Quentin/0000-0002-0048-9083; Kompas, Tom/0000-0002-0665-0966; Kompas, T/0000-0002-0665-0966				CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; CLARK CW, 1975, J ENVIRON ECON MANAG, V2, P92, DOI 10.1016/0095-0696(75)90002-9; FAO, 2007, STAT WORLD FISH AQ 2; GRAFTON RQ, 1995, J ENVIRON ECON MANAG, V28, P48, DOI 10.1006/jeem.1995.1004; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Hannesson R, 2007, MAR RESOUR ECON, V22, P69, DOI 10.1086/mre.22.1.42629536; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Judd Kenneth, 1999, NUMERICAL METHODS EC; [No title captured]	9	160	164	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1601	1601		10.1126/science.1146017	http://dx.doi.org/10.1126/science.1146017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063793				2022-12-24	WOS:000251421700039
J	Weir, BA; Woo, MS; Getz, G; Perner, S; Ding, L; Beroukhim, R; Lin, WM; Province, MA; Kraja, A; Johnson, LA; Shah, K; Sato, M; Thomas, RK; Barletta, JA; Borecki, IB; Broderick, S; Chang, AC; Chiang, DY; Chirieac, LR; Cho, J; Fujii, Y; Gazdar, AF; Giordano, T; Greulich, H; Hanna, M; Johnson, BE; Kris, MG; Lash, A; Lin, L; Lindeman, N; Mardis, ER; McPherson, JD; Minna, JD; Morgan, MB; Nadel, M; Orringer, MB; Osborne, JR; Ozenberger, B; Ramos, AH; Robinson, J; Roth, JA; Rusch, V; Sasaki, H; Shepherd, F; Sougnez, C; Spitz, MR; Tsao, MS; Twomey, D; Verhaak, RGW; Weinstock, GM; Wheeler, DA; Winckler, W; Yoshizawa, A; Yu, SY; Zakowski, MF; Zhang, QY; Beer, DG; Wistuba, II; Watson, MA; Garraway, LA; Ladanyi, M; Travis, WD; Pao, W; Rubin, MA; Gabriel, SB; Gibbs, RA; Varmus, HE; Wilson, RK; Lander, ES; Meyerson, M				Weir, Barbara A.; Woo, Michele S.; Getz, Gad; Perner, Sven; Ding, Li; Beroukhim, Rameen; Lin, William M.; Province, Michael A.; Kraja, Aldi; Johnson, Laura A.; Shah, Kinjal; Sato, Mitsuo; Thomas, Roman K.; Barletta, Justine A.; Borecki, Ingrid B.; Broderick, Stephen; Chang, Andrew C.; Chiang, Derek Y.; Chirieac, Lucian R.; Cho, Jeonghee; Fujii, Yoshitaka; Gazdar, Adi F.; Giordano, Thomas; Greulich, Heidi; Hanna, Megan; Johnson, Bruce E.; Kris, Mark G.; Lash, Alex; Lin, Ling; Lindeman, Neal; Mardis, Elaine R.; McPherson, John D.; Minna, John D.; Morgan, Margaret B.; Nadel, Mark; Orringer, Mark B.; Osborne, John R.; Ozenberger, Brad; Ramos, Alex H.; Robinson, James; Roth, Jack A.; Rusch, Valerie; Sasaki, Hidefumi; Shepherd, Frances; Sougnez, Carrie; Spitz, Margaret R.; Tsao, Ming-Sound; Twomey, David; Verhaak, Roel G. W.; Weinstock, George M.; Wheeler, David A.; Winckler, Wendy; Yoshizawa, Akihiko; Yu, Soyoung; Zakowski, Maureen F.; Zhang, Qunyuan; Beer, David G.; Wistuba, Ignacio I.; Watson, Mark A.; Garraway, Levi A.; Ladanyi, Marc; Travis, William D.; Pao, William; Rubin, Mark A.; Gabriel, Stacey B.; Gibbs, Richard A.; Varmus, Harold E.; Wilson, Richard K.; Lander, Eric S.; Meyerson, Matthew			Characterizing the cancer genome in lung adenocarcinoma	NATURE			English	Article							HIGH-RESOLUTION ANALYSIS; COPY-NUMBER; HOMOZYGOUS DELETIONS; SOMATIC MUTATIONS; FREQUENT TARGET; GENE DELIVERY; WIDE ANALYSIS; AMPLIFICATION; BEVACIZUMAB; CARBOPLATIN	Somatic alterations in cellular DNA underlie almost all human cancers(1). The prospect of targeted therapies(2) and the development of high-resolution, genome-wide approaches(3-8) are now spurring systematic efforts to characterize cancer genomes. Here we report a large-scale project to characterize copy-number alterations in primary lung adenocarcinomas. By analysis of a large collection of tumours ( n = 371) using dense single nucleotide polymorphism arrays, we identify a total of 57 significantly recurrent events. We find that 26 of 39 autosomal chromosome arms show consistent large-scale copy-number gain or loss, of which only a handful have been linked to a specific gene. We also identify 31 recurrent focal events, including 24 amplifications and 7 homozygous deletions. Only six of these focal events are currently associated with known mutations in lung carcinomas. The most common event, amplification of chromosome 14q13.3, is found in similar to 12% of samples. On the basis of genomic and functional analyses, we identify NKX2-1 ( NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung adenocarcinomas. More generally, our results indicate that many of the genes that are involved in lung adenocarcinoma remain to be discovered.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Harvard Univ, Canc Program, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Genome Biol Program, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Ulm, Inst Pathol, D-89081 Ulm, Germany; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63130 USA; Washington Univ, Div Stat Genom, St Louis, MO 63130 USA; Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; Univ Cologne, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, Max Planck Soc, D-50931 Cologne, Germany; Univ Cologne, Fac Med, D-50931 Cologne, Germany; Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Computat Biol, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; Univ Michigan, Thorac Surg Sect, Dept Surg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Nagoya City Univ, Sch Med, Dept Surg, Nagoya, Aichi 4678602, Japan; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; Univ Hlth Network, Toronto, ON M5G 2C4, Canada; Princess Margaret Hosp, Toronto, ON M5G 2C4, Canada; MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Ulm University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Nagoya City University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Massachusetts Institute of Technology (MIT)	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	McPherson, John D/D-2633-2017; Sato, MITSUO/I-7280-2014; Meyerson, Matthew L/E-7123-2012; Verhaak, Roel/ABE-7058-2020; Chirieac, Lucian R./AAD-2030-2019; Wheeler, David A/M-9740-2018; Tsao, Ming Sound/AFQ-7332-2022; Chiang, Derek/L-6452-2019; Yoshizawa, Akihiko/AAM-9519-2020; Wilson, Richard K./AAF-4139-2019; Ladanyi, Marc/AAG-8585-2019; Mardis, Elaine/W-2202-2019; Weinstock, George M/C-6314-2013; Tsao, Ming-Sound/M-3503-2017	McPherson, John D/0000-0001-8049-9347; Sato, MITSUO/0000-0001-5458-9576; Wheeler, David A/0000-0002-9056-6299; Tsao, Ming Sound/0000-0002-9160-5405; Wilson, Richard K./0000-0002-1992-1358; Weinstock, George M/0000-0002-2997-4592; Giordano, Thomas/0000-0003-0641-8873; Lash, Alex/0000-0003-3787-1590; Chang, Andrew/0000-0001-9506-0425; Rubin, Mark/0000-0002-8321-9950; Rusch, Valerie/0000-0003-2345-6900; Kris, Mark/0000-0002-7317-5341	NCI NIH HHS [P50 CA070907, K08 CA122833-01A1, F32 CA113126-02, F32 CA113126-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA113126, P50CA070907, K08CA122833] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; BEROUKHIM R, IN PRESS P NATL ACAD; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bingle CD, 1997, INT J BIOCHEM CELL B, V29, P1471, DOI 10.1016/S1357-2725(97)00007-1; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Phelps RM, 1996, J CELL BIOCHEM, P32; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang AJ, 2000, CANCER RES, V60, P6230; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zhu CQ, 2006, BRIT J CANCER, V94, P1452, DOI 10.1038/sj.bjc.6603110; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	40	844	873	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					893	U22		10.1038/nature06358	http://dx.doi.org/10.1038/nature06358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	17982442	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000251394900059
J	Yermiyahu, U; Tal, A; Ben-Gal, A; Bar-Tal, A; Tarchitzky, J; Lahav, O				Yermiyahu, U.; Tal, A.; Ben-Gal, A.; Bar-Tal, A.; Tarchitzky, J.; Lahav, O.			Environmental science - Rethinking desalinated water quality and agriculture	SCIENCE			English	Editorial Material							BORON		Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84990 Sede Boqer, Israel; Agr Res Org, Gilat Res Ctr, IL-85280 Negev 2, Israel; Agr Res Org, Inst Soil Water & Environm Sci, Volcani Ctr, IL-50250 Bet Dagan, Israel; Minist Agr, Extens Serv, IL-50250 Bet Dagan, Israel; Fac Civil & Environm Engn, IL-32000 Haifa, Israel	Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Tal, A (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Sede Boqer Campus, IL-84990 Sede Boqer, Israel.	alontal@bgu.ac.il	Bar-Tal, Asher/A-8144-2012; Ben-Gal, Alon/F-5190-2013; Lahav, Ori/N-2932-2019; Lahav, Ori/E-4801-2011	Ben-Gal, Alon/0000-0003-4105-7807; Lahav, Ori/0000-0002-0654-352X				BELTRAN JM, 2006, WATER DESALINATION A; Ben-Gal A, 2002, PLANT SOIL, V247, P211, DOI 10.1023/A:1021556808595; Birnhack L, 2007, WATER RES, V41, P3989, DOI 10.1016/j.watres.2007.06.007; de Kreij C., 1992, GUIDE VALUES NUTR EL, V3rd; DOLNICAR S, 2006, P AWWA AM WAST WAT A; *EUR COMM, 2006, ENV TECHN ACT PLAN W; Gleick PH, 2002, WORLDS WATER 2002 20; *IDA, 2004, 18 IDA WANGN CONS; *ISR MIN AGR RUR D, 2007, QUAL DES WAT AGR; Lahav O, 2007, DESALINATION, V207, P286, DOI 10.1016/j.desal.2006.05.022; Murray FJ, 1995, REGUL TOXICOL PHARM, V22, P221, DOI 10.1006/rtph.1995.0004; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Postel S., 1999, PILLAR SAND CAN IRRI; Service RF, 2006, SCIENCE, V313, P1088, DOI 10.1126/science.313.5790.1088; Tal A, 2006, SCIENCE, V313, P1081, DOI 10.1126/science.1126011; von Medeazza GM, 2004, DESALINATION, V169, P287, DOI 10.1016/j.desal.2004.04.001; WHO, 2005, NUTR DRINK WAT; WHO, 2004, GUID DRINK WAT QUAL; Yermiyahu U, 2006, PLANT PATHOL, V55, P544, DOI 10.1111/j.1365-3059.2006.01388.x; YERMIYAHU U., 2006, WORLD C SOIL SCI PHI; YERMIYAHU U, 2007, UNPUB IRRIGATION CRO	21	162	167	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					920	921		10.1126/science.1146339	http://dx.doi.org/10.1126/science.1146339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991846				2022-12-24	WOS:000250788500024
J	Fauci, AS				Fauci, Anthony S.			25 years of HIV/AIDS science: Reaching the poor with research advances	CELL			English	Editorial Material							GLOBAL HEALTH; HIV; AIDS; COUNTRIES	Last year marked the 25th anniversary of the recognition of what we now call AIDS. The AIDS pandemic has claimed more than 25 million lives, the majority of them in the developing world, and has exacerbated poverty and slowed human development. Although much has been accomplished in HIV/AIDS research, much remains to be done, especially regarding delivery of HIV/AIDS therapies and care and prevention interventions to the poorest countries that need them most.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Alnwick D., 2007, BRINGING HIV PREVENT; BERTOZZI S, 2006, DIS CONTROL PRIORITE, pCH18; Fauci AS, 2006, SCIENCE, V313, P409, DOI 10.1126/science.1131993; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Folkers GK, 2001, JAMA-J AM MED ASSOC, V286, P458, DOI 10.1001/jama.286.4.458; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kim JY, 2006, NEW ENGL J MED, V355, P645, DOI 10.1056/NEJMp068166; Koenig SP, 2006, BMJ-BRIT MED J, V332, P602, DOI 10.1136/bmj.332.7541.602; Kumar P, 2007, NEW ENGL J MED, V356, P2564, DOI 10.1056/NEJMp078091; Mukherjee JS, 2003, BMJ-BRIT MED J, V327, P1104, DOI 10.1136/bmj.327.7423.1104; Siegel Lawrence, 2007, Curr Infect Dis Rep, V9, P243, DOI 10.1007/s11908-007-0038-8; UNAIDS, 2006, REP GLOB AIDS EP; United Nations Population Division, 2006, WORLD POP PROSP 2006; *WHO UNAIDS, 2006, AIDS EP UPD SPEC REP; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI	15	14	15	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					429	432		10.1016/j.cell.2007.10.019	http://dx.doi.org/10.1016/j.cell.2007.10.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981106	Bronze			2022-12-24	WOS:000250618500006
J	Nachman, I; Regev, A; Ramanathan, S				Nachman, Iftach; Regev, Aviv; Ramanathan, Sharad			Dissecting timing variability in yeast meiosis	CELL			English	Article							MEIOTIC GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; POSITIVE REGULATOR; PROTEIN-KINASE; BUDDING YEAST; FLUCTUATING ENVIRONMENTS; FILAMENTOUS GROWTH; SIGNAL PATHWAY; MESSENGER-RNA	Cell-to-cell variability in the timing of cell-fate changes can be advantageous for a population of single-celled organisms growing in a fluctuating environment. We study timing variability during meiosis in Saccharomyces cerevisiae, initiated upon nutritional starvation. We use time-lapse fluorescence microscopy to measure the timing of meiotic events in single cells and find that the duration of meiosis is highly variable between cells. This variability is concentrated between the beginning of starvation and the onset of early meiosis genes. Cell-cycle variability and nutritional history have little effect on this timing variability. Rather, variation in the production rate of the meiotic master regulator Ime1 and its gradual increase over time govern this variability, and cell size effects are channeled through Ime1. These results tie phenotypic variability with expression dynamics of a transcriptional regulator and provide a general framework for the study of temporal developmental processes.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Bell Labs, Murray Hill, NJ 07974 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); AT&T	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	sharad@cmt.harvard.edu	Nachman, Iftach/E-6750-2010; Nachman, Iftach/AAK-2051-2020	Nachman, Iftach/0000-0002-4667-0398; 	NIGMS NIH HHS [P50 GM068763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Colomina N, 2003, MOL CELL BIOL, V23, P7415, DOI 10.1128/MCB.23.20.7415-7424.2003; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Day A, 2004, CELL CYCLE, V3, P1433, DOI 10.4161/cc.3.11.1205; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Gilbert SF, 2006, DEV BIOL; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GRANOT D, 1989, MOL GEN GENET, V218, P308, DOI 10.1007/BF00331283; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; HORESH O, 1979, CHROMOSOMA, V75, P101, DOI 10.1007/BF00330628; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; MANDEL S, 1994, DEV GENET, V15, P139, DOI 10.1002/dvg.1020150204; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pedraza JM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100121; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; SHEFERVAIDA M, 1995, DEV GENET, V16, P219, DOI 10.1002/dvg.1020160302; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; SHERMAN A, 1993, MOL GEN GENET, V237, P375, DOI 10.1007/BF00279441; SIMCHEN G, 1972, EXP CELL RES, V75, P207, DOI 10.1016/0014-4827(72)90538-1; SIMCHEN G, 1989, GENOME, V31, P95, DOI 10.1139/g89-018; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Vidan S, 1997, MOL CELL BIOL, V17, P2688, DOI 10.1128/MCB.17.5.2688; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299; WILLIAMSON DH, 1983, EXP CELL RES, V145, P209, DOI 10.1016/S0014-4827(83)80022-6; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000	46	101	101	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					544	556		10.1016/j.cell.2007.09.044	http://dx.doi.org/10.1016/j.cell.2007.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981121	Bronze			2022-12-24	WOS:000250618500021
J	Ahuja, R; Pinyol, R; Reichenbach, N; Custer, L; Klingensmith, J; Kessels, MM; Qualmann, B				Ahuja, Rashmi; Pinyol, Roser; Reichenbach, Nicole; Custer, Laura; Klingensmith, John; Kessels, Michael M.; Qualmann, Britta			Cordon-bleu is an actin nucleation factor and controls neuronal morphology	CELL			English	Article							ARP2/3 COMPLEX; N-WASP; CYTOSKELETAL DYNAMICS; STRUCTURAL BASIS; MECHANISM; DOMAIN; CYTOCHALASIN; ENDOCYTOSIS; REGULATOR; NETWORKS	Despite the wealth of different actin structures formed, only two actin nucleation factors are well established in vertebrates: the Arp2/3 complex and formins. Here, we describe a further nucleator, cordon-bleu (Cobl). Cobl is a brainenriched protein using three Wiskott-Aldrich syndrome protein homology 2 (WH2) domains for actin binding. Cobl promotes nonbundled, unbranched filaments. Filament formation relies on barbed-end growth and requires all three Cobl WH2 domains and the extended linker L2. We suggest that the nucleation power of Cobl is based on the assembly of three actin monomers in cross-filament orientation. Cobl localizes to sites of high actin dynamics and modulates cell morphology. In neurons, induction of both neurites and neurite branching is dramatically increased by Cobl expression effects that critically depend on Cobl's actin nucleation ability. Correspondingly, Cobl depletion results in decreased dendritic arborization. Thus, Cobl is an actin nucleator controlling neuronal morphology and development.	Leibniz Inst Neurobiol, Res Grp Membrane Trafficking & Cytoskeleton, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; Leibniz Inst Neurobiol, Res Grp Cell Biol, D-39118 Magdeburg, Germany; Univ Jena, Inst Biochem 1, D-07740 Jena, Germany; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Friedrich Schiller University of Jena; Duke University	Kessels, MM (corresponding author), Leibniz Inst Neurobiol, Res Grp Membrane Trafficking & Cytoskeleton, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany.	kessels@ifn-magdeburg.de; qualmann@ifn-magdeburg.de	Pinyol, Roser/AAA-4404-2019	Pinyol, Roser/0000-0002-0288-6314	NICHD NIH HHS [P01 HD039948-020001, P01 HD039948] Funding Source: Medline; NIDCR NIH HHS [R01 DE013674, R01 DE013674-06] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013674] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Carroll EA, 2003, DEV BIOL, V262, P16, DOI 10.1016/S0012-1606(03)00323-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Kessels MM, 2000, MOL BIOL CELL, V11, P393, DOI 10.1091/mbc.11.1.393; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2002, INT REV CYTOL, V220, P93; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Strasser GA, 2004, NEURON, V43, P81, DOI 10.1016/j.neuron.2004.05.015; VARTIAINEN MK, 2004, CURR OPIN CELL BIOL, V43, P81; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	34	183	186	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					337	350		10.1016/j.cell.2007.08.030	http://dx.doi.org/10.1016/j.cell.2007.08.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956734	Bronze, Green Accepted			2022-12-24	WOS:000250507700023
J	Idnurm, A; Walton, FJ; Floyd, A; Heitman, J				Idnurm, Alexander; Walton, Felicia J.; Floyd, Anna; Heitman, Joseph			Identification of the sex genes in an early diverged fungus	NATURE			English	Article							MATING-TYPE REGION; PHYCOMYCES-BLAKESLEEANUS; NEUROSPORA-CRASSA; EVOLUTION; LOCUS; RECOMBINATION; CHROMOSOMES; PHYLOGENY	Sex determination in fungi is controlled by a small, specialized region of the genome in contrast to the large sex- specific chromosomes of animals and some plants. Different gene combinations reside at these mating- type ( MAT) loci and confer sexual identity; invariably they encode homeodomain, alpha-box, or high mobility group ( HMG)- domain transcription factors(1). So far, MAT loci have been characterized from a single monophyletic clade of fungi, the Dikarya ( the ascomycetes and basidiomycetes)(2), and the ancestral state and evolutionary history of these loci have remained a mystery. Mating in the basal members of the kingdom has been less well studied, and even their precise taxonomic interrelationships are still obscure(3,4). Here we apply bioinformatic and genetic mapping to identify the sex- determining ( sex) region in Phycomyces blakesleeanus ( Zygomycota), which represents an early branch within the fungi. Each sex allele contains a single gene that encodes an HMG- domain protein, implicating the HMG- domain proteins as an earlier form of fungal MAT loci. Additionally, one allele also contains a copy of a unique, chromosome- specific repetitive element, suggesting a generalized mechanism for the earliest steps in the evolution of sex determination and sex chromosome structure in eukaryotes.	[Idnurm, Alexander; Walton, Felicia J.; Floyd, Anna; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA	Duke University; University of Missouri System; University of Missouri Kansas City	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@mc.duke.edu	Idnurm, Alexander/K-8558-2013; Heitman, Joseph/ABC-6006-2021; Idnurm, Alexander/GPX-9055-2022; Idnurm, Alexander/AAC-9614-2019	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040; Pagliuca, Felicia/0000-0003-4589-1807				ALVAREZ MI, 1983, GENETICS, V105, P873; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Arnaise S, 2001, GENETICS, V159, P545; Bakkeren G, 2006, FUNGAL GENET BIOL, V43, P655, DOI 10.1016/j.fgb.2006.04.002; Blakeslee AF, 1904, SCIENCE, V19, P0864, DOI 10.1126/science.19.492.864; Blakeslee AF, 1904, P AM ACAD ARTS SCI, V40, P205, DOI DOI 10.2307/20021962; Burgeff H., 1914, FLORA, V107, P259, DOI [DOI 10.1016/S0367-1615(17)32823-9, 10.1016/S0367-1615(17)32823-9]; Burglin TR, 2003, DEV GENES EVOL, V213, P50, DOI 10.1007/s00427-002-0287-3; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; CERDAOLMEDO E, 1975, GENET RES, V25, P285, DOI 10.1017/S0016672300015718; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Ferreira AVB, 1998, GENETICS, V148, P1069; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; GOVIND NS, 1986, J GEN MICROBIOL, V132, P2775; Heitman J., 2007, SEX FUNGI MOL DETERM; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lee N, 1999, P NATL ACAD SCI USA, V96, P15026, DOI 10.1073/pnas.96.26.15026; Mehta BJ, 2001, GENETICS, V158, P635; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872	29	114	118	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					193	U8		10.1038/nature06453	http://dx.doi.org/10.1038/nature06453			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185588				2022-12-24	WOS:000252214400043
J	Brand, S				Brand, Stewart			Whole Earth comes into focus	NATURE			English	Editorial Material																		Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; *NASA, NASA DEEP SPAC CLIM; VALERO F, DSCOVR MISSION SUMMA; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	5	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					797	797		10.1038/450797a	http://dx.doi.org/10.1038/450797a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18063991	Bronze			2022-12-24	WOS:000251394900031
J	Budnitz, DS; Shehab, N; Kegler, SR; Richards, CL				Budnitz, Daniel S.; Shehab, Nadine; Kegler, Scott R.; Richards, Chesley L.			Medication use leading to emergency department visits for adverse drug events in older adults	ANNALS OF INTERNAL MEDICINE			English	Article							BEERS CRITERIA; ELDERLY OUTPATIENTS; BLEEDING COMPLICATIONS; NATIONAL SURVEILLANCE; ORAL ANTICOAGULATION; EXPLICIT CRITERIA; INAPPROPRIATE; POPULATION; OUTCOMES; WARFARIN	Background: The Beers criteria identify inappropriate use of medications in older adults. The number of and risk for adverse events from these medications are unknown. Objective: To estimate the number of and risk for emergency department visits for adverse events involving Beers criteria medications compared with other medications. Design: Nationally representative, public health surveillance of adverse drug events and a cross-sectional survey of outpatient medical visits. Setting: National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance System, 2004 - 2005; National Ambulatory Medical Care Survey, 2004; and National Hospital Ambulatory Medical Care Survey, 2004. Participants: Persons 65 years of age or older seeking emergency department and outpatient care. Measurements: Estimated number of and risks for emergency department visits for adverse drug events involving Beers criteria medications and other medications. Results: Among U. S. patients 65 years of age or older, an estimated 177 504 emergency department visits (95% Cl, 100 155 to 254 854 visits) for adverse drug events occurred both years. An estimated 3.6% (Cl, 2.8% to 4.5%) of these visits were for adverse events medications considered to be always potentially inappropriate, according to the Beers criteria, and 33.3% (Cl, 27.8% to 38.7%) of visits were for adverse events from 3 other medications ( warfarin [17.3%], insulin [13.0%], and digoxin [3.2%]). Accounting for outpatient prescription frequency, the risk for emergency department visits for adverse events due to these 3 medications was 35 times (Cl, 9.6 to 61) greater than that for medications considered to be always potentially inappropriate. Limitation: Adverse events were identified only in emergency departments. Conclusion: Compared with other medications, Beers criteria medications caused low numbers of and few risks for emergency department visits for adverse events. Performance measures and interventions targeting warfarin, insulin, and digoxin use could prevent more emergency department visits for adverse events.	CDCP, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; CDCP, Coordinating Ctr Environm Hlth & Injury Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Budnitz, DS (corresponding author), CDCP, Div Healthcare Qual Promot, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.			Budnitz, Daniel/0000-0002-0136-2623; Shehab, Nadine/0000-0001-8700-8539				AVOM J, 2001, JAMA-J AM MED ASSOC, V286, P2866; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, PHARMACOEPIDEM DR S, V16, P160, DOI 10.1002/pds.1242; Budnitz DS, 2005, ANN EMERG MED, V45, P197, DOI 10.1016/j.annemergmed.2004.09.020; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS43; Chang CM, 2005, PHARMACOTHERAPY, V25, P831, DOI 10.1592/phco.2005.25.6.831; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Copland M, 2001, ARCH INTERN MED, V161, P2125, DOI 10.1001/archinte.161.17.2125; Crownover Brian K, 2005, J Manag Care Pharm, V11, P416; Curtis LH, 2004, ARCH INTERN MED, V164, P1621, DOI 10.1001/archinte.164.15.1621; De Wilde S, 2007, PHARMACOEPIDEM DR S, V16, P658, DOI 10.1002/pds.1306; Eaton L, 2007, BRIT MED J, V334, P714, DOI 10.1136/bmj.39170.698356.DB; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Field TS, 2005, MED CARE, V43, P1171, DOI 10.1097/01.mlr.0000185690.10336.70; Fillenbaum Gerda G, 2004, Am J Geriatr Pharmacother, V2, P92, DOI 10.1016/S1543-5946(04)90014-1; Food and Drug Administration (FDA), 2007, FUT DRUG SAF PROM PR; Fu AZ, 2007, MED CARE, V45, P472, DOI 10.1097/01.mlr.0000254571.05722.34; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; GANDHI TK, 2007, AHRQ PUBLICATION; Goldstein DJ, 2004, J AM GERIATR SOC, V52, P1580, DOI 10.1111/j.1532-5415.2004.52430_2.x; Goulding MR, 2004, ARCH INTERN MED, V164, P305, DOI 10.1001/archinte.164.3.305; Gupta S, 1996, CLIN THER, V18, P183, DOI 10.1016/S0149-2918(96)80189-5; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Hanlon JT, 2006, J GERONTOL A-BIOL, V61, P511, DOI 10.1093/gerona/61.5.511; Hanlon JT, 2002, MED CARE, V40, P166, DOI 10.1097/00005650-200202000-00011; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; *HEDIS, 2006, FIN NDC LISTS DRUGS; Hing Esther, 2006, Adv Data, P1; Huang BJ, 2002, PHARMACOEPIDEM DR S, V11, P127, DOI 10.1002/pds.688; Jackson SL, 2004, J INTERN MED, V256, P137, DOI 10.1111/j.1365-2796.2004.01352.x; Jano E, 2007, ANN PHARMACOTHER, V41, P438, DOI 10.1345/aph.1H473; KISH L, 1995, SURVEY SAMPLING, P206; Lapane KL, 2007, J AM GERIATR SOC, V55, P666, DOI 10.1111/j.1532-5415.2007.01153.x; Lau DT, 2005, ARCH INTERN MED, V165, P68, DOI 10.1001/archinte.165.1.68; Maio V, 2006, DRUG AGING, V23, P915, DOI 10.2165/00002512-200623110-00006; Martins SDO, 2006, PHARM WORLD SCI, V28, P296, DOI 10.1007/s11096-006-9046-2; McCaig Linda F, 2006, Adv Data, P1; McDonnell PJ, 2006, AM J MANAG CARE, V12, P256; Middleton Kimberly R, 2006, Adv Data, P1; *NAT CTR HLTH STAT, 2006, PUBL US DAT FIL DOC; *NAT HEALTHC QUAL, 2006, AHRQ PUBL; Page Robert L 2nd, 2006, Am J Geriatr Pharmacother, V4, P297; Perri M, 2005, ANN PHARMACOTHER, V39, P405, DOI 10.1345/aph.1E230; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Poon IO, 2007, J CLIN PHARM THER, V32, P21, DOI 10.1111/j.1365-2710.2007.00792.x; Pugh MJV, 2006, J MANAGE CARE PHARM, V12, P537, DOI 10.18553/jmcp.2006.12.7.537; Raebel MA, 2006, AM J MANAG CARE, V12, P268; Rask KJ, 2005, AM J MANAG CARE, V11, P145; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Schroeder T, 2001, NATL ELECT INJURY SU; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; STAFANACCI RD, 2006, ANN LONG TERM CARE, V14, P15; Steinman MA, 2007, MED CARE, V45, P95, DOI 10.1097/01.mlr.0000241111.11991.62; STUCK AE, 1994, ARCH INTERN MED, V154, P2195; Swagerty Daniel, 2005, J Am Med Dir Assoc, V6, P80, DOI 10.1016/j.jamda.2004.12.019; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vervloet D, 1998, BRIT MED J, V316, P1511, DOI 10.1136/bmj.316.7143.1511; Viswanathan H, 2005, CLIN THER, V27, P88, DOI 10.1016/j.clinthera.2005.01.009; Wagner AK, 2007, ANN INTERN MED, V146, P96, DOI 10.7326/0003-4819-146-2-200701160-00004; White TJ, 1999, PHARMACOECONOMICS, V15, P445, DOI 10.2165/00019053-199915050-00003; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823; Zhan CL, 2005, J AM GERIATR SOC, V53, P262, DOI 10.1111/j.1532-5415.2005.53112.x; 2005, MMWR MORB MORTAL WKL, V54, P380	69	425	437	2	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					755	U26		10.7326/0003-4819-147-11-200712040-00006	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056659				2022-12-24	WOS:000251539100002
J	Fischer, C; Jonckx, B; Mazzone, M; Zacchigna, S; Loges, S; Pattarini, L; Chorianopoulos, E; Liesenborghs, L; Koch, M; De Mol, M; Autiero, M; Wyns, S; Plaisance, S; Moons, L; van Rooijen, N; Giacca, M; Stassen, JM; Dewerchin, M; Collen, D; Carmeliet, P				Fischer, Christian; Jonckx, Bart; Mazzone, Massimiliano; Zacchigna, Serena; Loges, Sonja; Pattarini, Lucia; Chorianopoulos, Emmanuel; Liesenborghs, Laurens; Koch, Marta; De Mol, Maria; Autiero, Monica; Wyns, Sabine; Plaisance, Stephane; Moons, Lieve; van Rooijen, Nico; Giacca, Mauro; Stassen, Jean-Marie; Dewerchin, Mieke; Collen, Desire; Carmeliet, Peter			Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels	CELL			English	Article							HUMAN BREAST-CANCER; COLORECTAL-CANCER; FACTOR-RECEPTOR; PATHOLOGICAL CONDITIONS; ANTIANGIOGENIC THERAPY; TARGETED INACTIVATION; FACTOR-A; ANGIOGENESIS; MICE; METASTASIS	Novel antiangiogenic strategies with complementary mechanisms are needed to maximize efficacy and minimize resistance to current angiogenesis inhibitors. We explored the therapeutic potential and mechanisms of alpha PIGF, an antibody against placental growth factor (PIGF), a VEGF homolog, which regulates the angiogenic switch in disease, but not in health. alpha PIGF inhibited growth and metastasis of various tumors, including those resistant to VEGF(R) inhibitors (VEGF(R)Is), and enhanced the efficacy of chemotherapy and VEGF(R)Is. alpha PIGF inhibited angiogenesis, lymphangiogenesis, and tumor cell motility. Distinct from VEGF(R)Is, alpha PIGF prevented infiltration of angiogenic macrophages and severe tumor hypoxia, and thus, did not switch on the angiogenic rescue program responsible for resistance to VEGF(R)Is. Moreover, it did not cause or enhance VEGF(R)I-related side effects. The efficacy and safety of alpha PIGF, its pleiotropic and complementary mechanism to VEGF(R)Is, and the negligible induction of an angiogenic rescue program suggest that alpha PIGF may constitute a novel approach for cancer treatment.	Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; VUMC, Dept Mol Cell Biol, NL-1007 Amsterdam, Netherlands; ThromboGenics NV, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; International Center for Genetic Engineering & Biotechnology (ICGEB)	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	carmeliet@med.kuleuven.be	Van Rooijen, Nico/Z-1578-2019; Carmeliet, Peter/AAQ-5140-2020; Loges, Sonja/ABE-9868-2021; Giacca, Mauro/J-9287-2016; Plaisance, Stephane/ABI-6307-2020; Plaisance, Stephane/B-3488-2009; ZACCHIGNA, SERENA/E-9496-2017	Carmeliet, Peter/0000-0001-7961-1821; Loges, Sonja/0000-0002-7650-8527; Giacca, Mauro/0000-0003-2927-7225; Plaisance, Stephane/0000-0002-1651-241X; Plaisance, Stephane/0000-0002-1651-241X; Mazzone, Massimiliano/0000-0001-8824-4015; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Liesenborghs, Laurens/0000-0001-5616-8548; ZACCHIGNA, SERENA/0000-0001-6705-3076				Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Carmeliet P, 1997, ANN NY ACAD SCI, V811, P191, DOI 10.1111/j.1749-6632.1997.tb52002.x; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen CN, 2004, CANCER LETT, V213, P73, DOI 10.1016/j.canlet.2004.05.020; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Davidoff AM, 2002, CANCER RES, V62, P3077; DECLERCK PJ, 1995, THROMB HAEMOSTASIS, V74, P1305; Errico M, 2004, J BIOL CHEM, V279, P43929, DOI 10.1074/jbc.M401418200; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2001, CANCER RES, V61, P1207; Ho MC, 2007, CANCER LETT, V250, P237, DOI 10.1016/j.canlet.2006.10.005; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kramer I, 2007, J CLIN PHARM THER, V32, P1, DOI 10.1111/j.1365-2710.2007.00800.x; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; Malik AK, 2006, BLOOD, V107, P550, DOI 10.1182/blood-2005-05-2047; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Matsumoto K, 2003, ANTICANCER RES, V23, P4953; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; PARK JE, 1994, J BIOL CHEM, V269, P25646; Parr C, 2005, EUR J CANCER, V41, P2819, DOI 10.1016/j.ejca.2005.07.022; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170; Roy H, 2005, HUM GENE THER, V16, P1422, DOI 10.1089/hum.2005.16.1422; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sweeney CJ, 2003, TRENDS MOL MED, V9, P24, DOI 10.1016/S1471-4914(02)00007-2; Taylor AP, 2007, MOL CANCER THER, V6, P524, DOI 10.1158/1535-7163.MCT-06-0461; Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059; Wei SC, 2005, GUT, V54, P666, DOI 10.1136/gut.2004.050831; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	40	640	678	1	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					463	475		10.1016/j.cell.2007.08.038	http://dx.doi.org/10.1016/j.cell.2007.08.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981115	Green Submitted, Bronze			2022-12-24	WOS:000250618500015
J	Masse, K; Bhamra, S; Eason, R; Dale, N; Jones, EA				Masse, Karine; Bhamra, Surinder; Eason, Robert; Dale, Nicholas; Jones, Elizabeth A.			Purine-mediated signalling triggers eye development	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; VERTEBRATE EYE; GROWTH-FACTOR; HOMEOBOX GENE; PINEAL-GLAND; XENOPUS; ATP; EXPRESSION; TISSUE; PROLIFERATION	A conserved network of eye field transcription factors (EFTFs) underlies the development of the eye in vertebrates and invertebrates(1). To direct eye development, Pax6, a key gene in this network(2,3), interacts with genes encoding other EFTFs such as Rx1 and Six3 (refs 4-6). However, the mechanisms that control expression of the EFTFs remain unclear(7). Here we show that purine-mediated signalling triggers both EFTF expression and eye development in Xenopus laevis. Overexpression of ectonucleoside triphosphate diphosphohydrolase 2 (E-NTPDase2)(8), an ectoenzyme that converts ATP to ADP(9), caused ectopic eye-like structures, with occasional complete duplication of the eye, and increased expression of Pax6, Rx1 and Six3. In contrast, down-regulation of endogenous E-NTPDase2 decreased Rx1 and Pax6 expression. E-NTPDase2 therefore acts upstream of these EFTFs. To test whether ADP (the product of E-NTPDase2) might act to trigger eye development through P2Y1 receptors, selective in Xenopus for ADP(10,11), we simultaneously knocked down expression of the genes encoding E-NTPDase2 and the P2Y1 receptor. This could prevent the expression of Rx1 and Pax6 and eye formation completely. We next measured ATP release(12-14) in the presumptive eye field, demonstrating a transient release of ATP at a time that could plausibly trigger (once converted to ADP) expression of the EFTFs. This surprising role for transient purine-mediated signalling in eye development may be widely conserved, because alterations to the locus of E-NTPDase2 on human chromosome 9 cause severe head and eye defects, including microphthalmia(15-18). Our results suggest a new mechanism for the initiation of eye development.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Dale, N (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	n.e.dale@warwick.ac.uk; elizabeth.jones@warwick.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLDERDICE PW, 1983, AM J HUM GENET, V35, P1005; Barnett MW, 1998, DEV GROWTH DIFFER, V40, P47; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Braun N, 2003, EUR J NEUROSCI, V17, P1355, DOI 10.1046/j.1460-9568.2003.02567.x; Brown P, 2002, J PHYSIOL-LONDON, V540, P843; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Cheng AWM, 2003, NEUROREPORT, V14, P351, DOI 10.1097/01.wnr.0000058033.29600.a3; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Chow RL, 1999, DEVELOPMENT, V126, P4213; Collignon J, 1996, DEVELOPMENT, V122, P509; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Haldin CE, 2003, INT J DEV BIOL, V47, P253; Hampshire DJ, 2006, EUR J HUM GENET, V14, P543, DOI 10.1038/sj.ejhg.5201577; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Li HS, 1997, DEVELOPMENT, V124, P603; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Masse K, 2006, GENOMICS, V87, P366, DOI 10.1016/j.ygeno.2005.11.003; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Neas KR, 2005, AM J MED GENET A, V132A, P425, DOI 10.1002/ajmg.a.30496; Pearson RA, 2005, NEURON, V46, P731, DOI 10.1016/j.neuron.2005.04.024; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Yatsenko SA, 2005, J MED GENET, V42, P328, DOI 10.1136/jmg.2004.028258; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	33	96	97	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1058	U6		10.1038/nature06189	http://dx.doi.org/10.1038/nature06189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960245	Bronze			2022-12-24	WOS:000250395000054
J	Malone, JH; Michalak, P				Malone, John H.; Michalak, P.			Physiological sex predicts hybrid sterility regardless of genotype	SCIENCE			English	Article							RULE		[Malone, John H.; Michalak, P.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Michalak, P (corresponding author), Univ Texas Arlington, Dept Biol, Box 19498, Arlington, TX 76019 USA.	michalak@uta.edu						Coyne J. A., 2004, SPECIATION, P283; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; KOBEL HR, 1996, BIOL XENOPUS, P391; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; Malone JH, 2006, J MOL EVOL, V63, P427, DOI 10.1007/s00239-005-0263-4; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Zhang Y, 2007, CURR OPIN GENET DEV, V17, P113, DOI 10.1016/j.gde.2007.02.002	8	27	27	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					59	59		10.1126/science.1148231	http://dx.doi.org/10.1126/science.1148231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174434				2022-12-24	WOS:000252084000028
J	Sussan, TE; Yang, AN; Li, F; Ostrowski, MC; Reeves, RH				Sussan, Thomas E.; Yang, Annan; Li, Fu; Ostrowski, Michael C.; Reeves, Roger H.			Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome	NATURE			English	Article							INTESTINAL NEOPLASIA; CANCER INCIDENCE; MAJOR MODIFIER; MORTALITY; GROWTH; GENE; ANGIOGENESIS; LOCUS	Epidemiological studies spanning more than 50 yr reach conflicting conclusions as to whether there is a lower incidence of solid tumours in people with trisomy 21 ( Down's syndrome)(1,2). We used mouse models of Down's syndrome and of cancer in a biological approach to investigate the relationship between trisomy and the incidence of intestinal tumours. Apc(Min)-mediated tumour number was determined in aneuploid mouse models Ts65Dn, Ts1Rhr and Ms1Rhr. Trisomy for orthologues of about half of the genes on chromosome 21 ( Hsa21) in Ts65Dn mice or just 33 of these genes in Ts1Rhr mice resulted in a significant reduction in the number of intestinal tumours. In Ms1Rhr, segmental monosomy for the same 33 genes that are triplicated in Ts1Rhr resulted in an increased number of tumours. Further studies demonstrated that the Ets2 gene contributed most of the dosage- sensitive effect on intestinal tumour number. The action of Ets2 as a repressor when it is overexpressed differs from tumour suppression, which requires normal gene function to prevent cellular transformation. Upregulation of Ets2 and, potentially, other genes involved in this kind of protective effect may provide a prophylactic effect in all individuals, regardless of ploidy.	[Sussan, Thomas E.; Yang, Annan; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Sussan, Thomas E.; Yang, Annan; Reeves, Roger H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Li, Fu; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Johns Hopkins University; Johns Hopkins University; University System of Ohio; Ohio State University	Reeves, RH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rreeves@jhmi.edu	Li, Fu/E-7072-2011; Ostrowski, Michael/H-3108-2011	Sussan, Thomas/0000-0002-5240-4299; Ostrowski, Michael/0000-0003-2948-6297	NCI NIH HHS [P01 CA097189, R01 CA053271] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053271, P01CA097189] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Goldacre MJ, 2004, ARCH DIS CHILD, V89, P1014, DOI 10.1136/adc.2003.046219; Hill DA, 2003, ARCH INTERN MED, V163, P705, DOI 10.1001/archinte.163.6.705; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; *JACKS LAB, GEN PROT APC; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Moore DS, 2005, AM STAT, V59, P1, DOI 10.1198/000313005X20745; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Patja K, 2006, INT J CANCER, V118, P1769, DOI 10.1002/ijc.21518; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; Smith JL, 2000, MOL CELL BIOL, V20, P8026, DOI 10.1128/MCB.20.21.8026-8034.2000; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Wolvetang EJ, 2003, NEUROBIOL DIS, V14, P349, DOI 10.1016/S0969-9961(03)00107-4; Yamada Y, 2007, CANCER SCI, V98, P6, DOI 10.1111/j.1349-7006.2006.00348.x; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	21	125	131	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					73	U10		10.1038/nature06446	http://dx.doi.org/10.1038/nature06446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172498				2022-12-24	WOS:000252079300036
J	Pletcher, MJ; Kertesz, SG; Kohn, MA; Gonzales, R				Pletcher, Mark J.; Kertesz, Stefan G.; Kohn, Michael A.; Gonzales, Ralph			Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-CARE; CANCER PAIN; NONMEDICAL USE; DISPARITIES; ETHNICITY; ANALGESIA; PRESCRIPTION; PHYSICIAN; RACE; FRACTURES	Context National quality improvement initiatives implemented in the late 1990s were followed by substantial increases in opioid prescribing in the United States, but it is unknown whether opioid prescribing for treatment of pain in the emergency department has increased and whether differences in opioid prescribing by race/ethnicity have decreased. Objectives To determine Whether opioid prescribing in emergency departments has increased, whether non-Hispanic white patients are more likely to receive an opioid than other racial/ethnic groups, and whether differential prescribing by race/ethnicity has diminished since 2000. Design and Setting Pain-related visits to US emergency departments were identified using reason-for-visit and physician diagnosis codes from 13 years (1993-2005) of the National Hospital Ambulatory Medical Care Survey. Main Outcome Measure Prescription of an opioid analgesic. Results Pain-related visits accounted for 156729 of 374891 (42%) emergency department visits. Opioid prescribing for pain- related visits increased from 23 % (95 % confidence interval [Cl], 21%-24%) in 1993 to 37% (95% Cl, 34%-39%) in 2005 (P<.001 for trend), and this trend was more pronounced in 2001-2005 (P=.02). Overall years, white patients with pain were more likely to receive an opioid (31 %)than black (23%), Hispanic (24%), or Asian/other patients (28%) (P<.001 for trend), and differences did not diminish over time (P=.44), with opioid prescribing rates of 40% for white patients and 32 % for all other patients in 2005. Differential prescribing by race/ethnicity was evident for all types of pain visits, was more pronounced with increasing pain severity, and was detectable for long-bone fracture and nephrolithiasis as well as among children. Statistical adjustment for pain severity and other factors did not substantially attenuate these differences, with white patients remaining significantly more likely to receive an opioid prescription than black patients (adjusted odds ratio, 0.66; 95% Cl, 0.62-0.70), Hispanic patients (0.67; 95% Cl, 0.63-0.72), and Asian/other patients (0.79; 95% Cl, 0.67-0.93). Conclusion Opioid prescribing for patients making a pain-related visit to the emergency department increased after national quality improvement initiatives in the late 1990s, but differences in opioid prescribing by race/ethnicity have not diminished.	[Pletcher, Mark J.; Kohn, Michael A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Pletcher, Mark J.; Gonzales, Ralph] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94107 USA; [Kertesz, Stefan G.] Univ Alabama, Div Prevent Med, Birmingham, AL USA; [Kertesz, Stefan G.] Vet Affairs Med Ctr, Deep S Ctr Effectiveness, Birmingham, AL USA; [Kohn, Michael A.] Mills Peninsula Med Ctr, Emergency Dept, Burlingame, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu		Kertesz, Stefan/0000-0001-6101-8421	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA015487] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS016238] Funding Source: Medline; NIDA NIH HHS [K23DA015487] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Betancourt JR, 2004, NEW ENGL J MED, V351, P953, DOI 10.1056/NEJMp048033; Campana D, 2004, INT J MULTIPHAS FLOW, V30, P431, DOI 10.1016/j.ijmultiphaseflow.2004.03.007; Choi DMA, 2000, BRIT MED J, V320, P980, DOI 10.1136/bmj.320.7240.980; Cooper LA, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00305.x; Epstein AM, 2001, NEW ENGL J MED, V344, P1471, DOI 10.1056/NEJM200105103441911; FRIEDLAND LR, 1994, ANN EMERG MED, V23, P203, DOI 10.1016/S0196-0644(94)70031-1; Fry Margaret, 2002, Emerg Med (Fremantle), V14, P249, DOI 10.1046/j.1442-2026.2002.00339.x; Fry Margaret, 2004, Accid Emerg Nurs, V12, P136, DOI 10.1016/j.aaen.2004.02.006; Fuentes EF, 2002, ACAD EMERG MED, V9, P910, DOI 10.1197/aemj.9.9.910; Heins Alan, 2006, J Opioid Manag, V2, P335; Heins JK, 2006, J EMERG NURS, V32, P219, DOI 10.1016/j.jen.2006.01.010; Hostetler MA, 2002, AM J EMERG MED, V20, P139, DOI 10.1053/ajem.2002.33002; Kalauokalani D, 2007, PAIN MED, V8, P17, DOI 10.1111/j.1526-4637.2007.00170.x; Karpman RR, 1997, CLIN ORTHOP RELAT R, P270; Lanser P, 2001, Healthc Benchmarks, V8, P68; Lanser P, 2001, HEALTHC BENCHMARKS, V8, P62; Lee WW, 2001, AM J EMERG MED, V19, P549, DOI 10.1053/ajem.2001.28038; MAX MB, 1995, JAMA-J AM MED ASSOC, V274, P1874, DOI 10.1001/jama.1995.03530230060032; Miner J, 2006, ACAD EMERG MED, V13, P140, DOI 10.1197/j.aem.2005.08.008; Rupp T, 2004, ANN EMERG MED, V43, P494, DOI 10.1016/j.annemergmed.2003.11.019; Schneider D, 1979, VITAL HLTH STAT, V2, pi; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Singer AJ, 2002, J BURN CARE REHABIL, V23, P361, DOI 10.1097/00004630-200211000-00001; Tamayo-Sarver JH, 2003, AM J PUBLIC HEALTH, V93, P2067, DOI 10.2105/AJPH.93.12.2067; Tamayo-Sarver JH, 2004, ANN EMERG MED, V43, P483, DOI 10.1016/j.annemergmed.2003.10.043; Tamayo-Sarver JH, 2003, ACAD EMERG MED, V10, P1239, DOI 10.1197/S1069-6563903)00494-9; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; TODD KH, 1994, JAMA-J AM MED ASSOC, V271, P925, DOI 10.1001/jama.271.12.925; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; Vallerand AH, 2005, PAIN MED, V6, P242, DOI 10.1111/j.1526-4637.2005.05038.x; Walls CA, 2002, ACAD EMERG MED, V9, P1140, DOI 10.1111/j.1553-2712.2002.tb01568.x; Yen K, 2003, ANN EMERG MED, V42, P41, DOI 10.1067/mem.2003.230; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6; Zechnich AD, 1996, ACAD EMERG MED, V3, P312, DOI 10.1111/j.1553-2712.1996.tb03443.x	35	555	556	0	32	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					70	78		10.1001/jama.2007.64	http://dx.doi.org/10.1001/jama.2007.64			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167408	Bronze			2022-12-24	WOS:000252052000018
J	John, EM; Miron, A; Gong, G; Phipps, AI; Felberg, A; Li, FP; West, DW; Whittemore, AS				John, Esther M.; Miron, Alexander; Gong, Gail; Phipps, Amanda I.; Felberg, Anna; Li, Frederick P.; West, Dee W.; Whittemore, Alice S.			Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER PATIENTS; POPULATION-BASED SERIES; SENSITIVE GEL-ELECTROPHORESIS; AFRICAN-AMERICAN FAMILIES; SAN-LUIS VALLEY; BREAST/OVARIAN CANCER; OVARIAN-CANCER; GENETIC EPIDEMIOLOGY; HIGH PROPORTION; GERMLINE MUTATIONS	Context Information on the prevalence of pathogenic BRCA1 mutation carriers in racial/ ethnic minority populations is limited. Objective To estimate BRCA1 carrier prevalence in Hispanic, African American, and Asian American female breast cancer patients compared with non- Hispanic white patients with and without Ashkenazi Jewish ancestry. Design, Setting, and Participants We estimated race/ ethnicity- specific prevalence of BRCA1 in a population- based, multiethnic series of female breast cancer patients younger than 65 years at diagnosis who were enrolled at the Northern California site of the Breast Cancer Family Registry during the period 1996- 2005. Race/ ethnicity and religious ancestry were based on self- report. Weighted estimates of prevalence and 95% confidence intervals ( CIs) were based on Horvitz- Thompson estimating equations. Main Outcome Measure Estimates of BRCA1 prevalence. Results Estimates of BRCA1 prevalence were 3.5% ( 95% CI, 2.1%- 5.8%) in Hispanic patients ( n = 393), 1.3% ( 95% CI, 0.6%- 2.6%) in African American patients ( n = 341), and 0.5% ( 95% CI, 0.1%- 2.0%) in Asian American patients ( n = 444), compared with 8.3% ( 95% CI, 3.1%- 20.1%) in Ashkenazi Jewish patients ( n= 41) and 2.2% ( 95% CI, 0.7%- 6.9%) in other non- Hispanic white patients ( n= 508). Prevalence was particularly high in young ( < 35 years) African American patients ( 5/30 patients [ 16.7%]; 95% CI, 7.1%- 34.3%). 185delAG was the most common mutation in Hispanics, found in 5 of 21 carriers ( 24%). Conclusions Among African American, Asian American, and Hispanic patients in the Northern California Breast Cancer Family Registry, the prevalence of BRCA1 mutation carriers was highest in Hispanics and lowest in Asian Americans. The higher carrier prevalence in Hispanics may reflect the presence of unrecognized Jewish ancestry in this population.	No Calif Canc Ctr, Fremont, CA 94538 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Stanford University; Harvard University; Dana-Farber Cancer Institute	John, EM (corresponding author), No Calif Canc Ctr, 2201 Walnut Ave,Ste 300, Fremont, CA 94538 USA.	ejohn@nccc.org			NCI NIH HHS [CA78564, U01 CA069417-10, CA-95-003, CA94069, U01 CA69417, U01 CA069417] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078564, R01CA095003, U01CA069417, R01CA094069] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; *BREAST CANC INF C, BRCA1 MUT DAT; Brown MA, 2002, HUM MUTAT, V19, P435, DOI 10.1002/humu.10055; Chen WY, 2002, J CLIN ONCOL, V20, P4485, DOI 10.1200/JCO.2002.08.147; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Emi M, 1998, JPN J CANCER RES, V89, P12, DOI 10.1111/j.1349-7006.1998.tb00472.x; Fackenthal JD, 2005, J MED GENET, V42, P276, DOI 10.1136/jmg.2004.020446; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Gad S, 2002, ONCOGENE, V21, P6841, DOI 10.1038/sj.onc.1205685; Gallardo M, 2006, BREAST CANCER RES TR, V95, P81, DOI 10.1007/s10549-005-9047-1; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gao Q, 2000, HUM GENET, V107, P186, DOI 10.1007/s004390000290; Gao Q, 2000, HUM GENET, V107, P192, DOI 10.1007/s004390000342; Gao Q, 1997, AM J HUM GENET, V60, P1233; Haffty BG, 2006, J MED GENET, V43, P133, DOI 10.1136/jmg.2005.034744; Ho GH, 2000, CANCER-AM CANCER SOC, V89, P811, DOI 10.1002/1097-0142(20000815)89:4<811::AID-CNCR13>3.0.CO;2-R; Hogervorst FBL, 2003, CANCER RES, V63, P1449; Infante M, 2006, J HUM GENET, V51, P611, DOI 10.1007/s10038-006-0404-7; Jara L, 2006, CANCER GENET CYTOGEN, V166, P36, DOI 10.1016/j.cancergencyto.2005.08.019; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Liede A, 2002, HUM MUTAT, V20, P413, DOI 10.1002/humu.10154; Llort Gemma, 2002, Hum Mutat, V19, P307, DOI 10.1002/humu.9014.abs; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Makriyianni I, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029785; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Malone KE, 1998, JAMA-J AM MED ASSOC, V279, P922, DOI 10.1001/jama.279.12.922; Martin-Philips O, 2003, TULSA STUD WOMEN LIT, V22, P417, DOI 10.2307/20059163; Matsuda MLD, 2002, INT J CANCER, V98, P596, DOI 10.1002/ijc.10194; McKean-Cowdin R, 2005, HUM GENET, V116, P497, DOI 10.1007/s00439-004-1240-5; Mew NA, 2002, CLIN GENET, V62, P151, DOI 10.1034/j.1399-0004.2002.620208.x; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Pal T, 2004, CANCER EPIDEM BIOMAR, V13, P1794; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Polite BN, 2005, PERSPECT BIOL MED, V48, pS166; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Ruiz-Flores P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9084; Shen Dejun, 2000, Journal of the National Medical Association, V92, P29; Sng JH, 2000, BRIT J CANCER, V82, P538; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; Suter NM, 2004, CANCER EPIDEM BIOMAR, V13, P181, DOI 10.1158/1055-9965.EPI-03-0196; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; van Orsouw NJ, 1999, J MED GENET, V36, P747, DOI 10.1136/jmg.36.10.747; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Whittemore AS, 2004, CANCER EPIDEM BIOMAR, V13, P2078; Whittemore AS, 1997, STAT MED, V16, P153, DOI 10.1002/(SICI)1097-0258(19970130)16:2<153::AID-SIM477>3.0.CO;2-7; Wolfram Research Inc, 2005, MATH VERS 5 2	60	235	236	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2869	2876		10.1001/jama.298.24.2869	http://dx.doi.org/10.1001/jama.298.24.2869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159056	Bronze			2022-12-24	WOS:000251816000019
J	Redelmeier, DA; Greenwald, JA				Redelmeier, Donald A.; Greenwald, J. Ari			Competing risks of mortality with marathons: retrospective analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY CARDIAC-ARREST; CARDIOVASCULAR-DISEASE; SUDDEN-DEATH; EXERCISE; RECOMMENDATIONS; REHABILITATION; PREVENTION; INJURIES; RUNNERS	Objective To determine from a societal perspective the risk of sudden cardiac death associated with running in an organised marathon compared with the risk of dying from a motor vehicle crash that might otherwise have taken place if the roads had not been closed. Design Population based retrospective analysis with linked ecological comparisons of sudden death. Setting Marathons with at least 1000 participants that had two decades of history and took place on public roads in the United States, 1975-2004. Main outcome measures Sudden death attributed to cardiac causes or to motorvehicle trauma. Results The marathons provided results for 3 292 268 runners on 750 separate days encompassing about 14 million hours of exercise. There were 26 sudden cardiac deaths observed, equivalent to a rate of 0.8 per 100000 participants (95% confidence interval 0.5 to 1.1). Because of road closure, an estimated 46 motorvehicle fatalities were prevented, equivalent to a relative risk reduction of 35% (95% confidence interval 17% to 49%). The net reduction in sudden death during marathons amounted to a ratio of about 1.8 crash deaths saved for each case of sudden cardiac death observed (95% confidence interval: 0.7 to 3.8). The net reduction in total deaths could not be explained by re-routing traffic to other regions or days and was consistent across different parts of the country, decades of the century, seasons of the year, days of the week, degree of competition, and course difficulty. Conclusion Organised marathons are not associated with an increase in sudden deaths from a societal perspective, contrary to anecdotal impressions fostered by news media.	[Redelmeier, Donald A.; Greenwald, J. Ari] Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Serv Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada.	Redelmeierdar@ices.on.ca						[Anonymous], 2004, WORLD REP ROAD TRAFF; ARMNOLD D, 2002, BOSTON GLOBE    0419, pB3; ARNOLD D, 2002, BOSTON GLOBE    0419, pB3; BRODY JE, 2006, NY TIMES        0620; Caselli MA, 1997, J AM PODIAT MED ASSN, V87, P34, DOI 10.7547/87507315-87-1-34; CERIO R, 1985, ARCH EMERG MED, V2, P89; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Evans L., 2004, TRAFFIC SAFETY; Girasek DC, 2006, INJURY PREV, V12, P71, DOI 10.1136/ip.2005.008839; Greenidge J, 1996, BOSTON GLOBE    0416, P51; Hecht HS, 2001, CIRCULATION, V104, pE58; Jaworski Carrie A, 2005, Curr Sports Med Rep, V4, P137; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; MANIER J, 1998, CHICAGO TRIBUNE 1122, P1; Maron BJ, 2000, NEW ENGL J MED, V343, P1409, DOI 10.1056/NEJM200011093431911; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; Maron BJ, 2001, CIRCULATION, V103, P327; Mitten MJ, 2002, JOHNS L REV, V76, P5; NOAKES TD, 1987, MED SCI SPORT EXER, V19, P187; Ratliff NB, 2002, LANCET, V360, P542, DOI 10.1016/S0140-6736(02)09744-1; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Redelmeier DA, 2003, NEW ENGL J MED, V348, P368, DOI 10.1056/NEJM200301233480423; REDELMEIER DA, 2004, CHANCE, V17, P19; REYNODLS G, 2006, NY TIMES        1207; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Sanchez LD, 2006, AM J EMERG MED, V24, P608, DOI 10.1016/j.ajem.2006.01.023; SAPERSTEIN S, 1986, WASHINGTON POST 1104, pB1; Sedivy R, 1997, MODERN PATHOL, V10, P247; SHAFIR E, 2004, PREFERECE BELIEF SIM; Simons Stephen M, 2004, Curr Sports Med Rep, V3, P112; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; U.S. Bureau of the Census, 2004, STAT ABSTR US 2004 2; *US BUR CENS, STAT ABSTR US 2004 2; *US DEP TRANSP, 2003, TRAFF SAF FACTS; WEBER B, 1994, NY TIMES        1108, pB13; WEINREB A, 2004, CANADA FREE PRE 1020; WILSON T, 2000, CHICAGO TRIBUNE 1024, P5; Woolley P.J., 2006, WASH POST, pA19; WRIGHT W, 2002, HONOLULU ADVERT 1209, pA1	43	61	64	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1275	1277		10.1136/bmj.39384.551539.25	http://dx.doi.org/10.1136/bmj.39384.551539.25			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156224	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000252182700004
J	Blow, N				Blow, Nathan			Delivering the future	NATURE			English	Article							IN-VIVO; GENE											Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Medarova Z, 2007, NAT MED, V13, P372, DOI 10.1038/nm1486; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	5	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1117	1122		10.1038/4501117a	http://dx.doi.org/10.1038/4501117a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075597	Bronze			2022-12-24	WOS:000251579900094
J	Soberon, M; Pardo-Lopez, L; Lopez, I; Gomez, I; Tabashnik, BE; Bravo, A				Soberon, Mario; Pardo-Lopez, Liliana; Lopez, Idalia; Gomez, Isabel; Tabashnik, Bruce E.; Bravo, Alejandra			Engineering modified Bt toxins to counter insect resistance	SCIENCE			English	Article							THURINGIENSIS CRY1AB TOXIN; BACILLUS-THURINGIENSIS; PINK-BOLLWORM; HELIOTHIS-VIRESCENS; PORE FORMATION; DOMAIN-II; BINDING; RECEPTOR; OLIGOMERIZATION; LEPIDOPTERA	The evolution of insect resistance threatens the effectiveness of Bacillus thuringiensis (Bt) toxins that are widely used in sprays and transgenic crops. Resistance to Bt toxins in some insects is linked with mutations that disrupt a toxin-binding cadherin protein. We show that susceptibility to the Bt toxin Cry1Ab was reduced by cadherin gene silencing with RNA interference in Manduca sexta, confirming cadherin's role in Bt toxicity. Native Cry1A toxins required cadherin to form oligomers, but modified Cry1A toxins lacking one alpha-helix did not. The modified toxins killed cadherin-silenced M. sexta and Bt-resistant Pectinophora gossypiella that had cadherin deletion mutations. Our findings suggest that cadherin promotes Bt toxicity by facilitating toxin oligomerization and demonstrate that the modified Bt toxins may be useful against pests resistant to standard Bt toxins.	Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico; Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; University of Arizona	Soberon, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico.	mario@ibt.unam.mx; bravo@ibt.unam.mx	Fernández-López, Sara/B-5573-2015; de la Parra, Maria Alejandra Bravo/R-6740-2017	Fernández-López, Sara/0000-0003-2496-4333; Bravo, Alejandra/0000-0002-7573-7475; Pardo Lopez, Liliana/0000-0002-8927-1733	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER; NIAID NIH HHS [1R01 AI066014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aronson AI, 1999, APPL ENVIRON MICROB, V65, P2503; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Jackson RE, 2007, J ECON ENTOMOL, V100, P180, DOI 10.1603/0022-0493(2007)100[180:CROCHV]2.0.CO;2; JAMES C, 2006, ISAAA BRIEFS, V35, P1; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Likitvivatanavong S, 2006, ARCH BIOCHEM BIOPHYS, V445, P46, DOI 10.1016/j.abb.2005.11.007; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Munoz-Garay C, 2006, J MEMBRANE BIOL, V212, P61, DOI 10.1007/s00232-006-0003-8; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tigue NJ, 2001, APPL ENVIRON MICROB, V67, P5715, DOI 10.1128/AEM.67.12.5715-5720.2001; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	28	177	208	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1640	1642		10.1126/science.1146453	http://dx.doi.org/10.1126/science.1146453			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	17975031				2022-12-24	WOS:000251421700050
J	Behuniak, SM				Behuniak, Susan M.			Words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												behuniak@lemoyne.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2458	2458		10.1001/jama.298.21.2458	http://dx.doi.org/10.1001/jama.298.21.2458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237GJ	18056896				2022-12-24	WOS:000251361900001
J	Monath, TP				Monath, Thomas P.			Dengue and yellow fever - Challenges for the developments and use of vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Kleiner Perkins Caulfield & Byers, Menlo Pk, CA 94025 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Monath, TP (corresponding author), Kleiner Perkins Caulfield & Byers, Menlo Pk, CA 94025 USA.							Edelman R, 2007, CLIN INFECT DIS, V45, pS56, DOI 10.1086/518148; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; MONATH TP, IN PRESS VACCINES	5	61	70	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2222	2225		10.1056/NEJMp0707161	http://dx.doi.org/10.1056/NEJMp0707161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046026	Bronze			2022-12-24	WOS:000251176400003
J	Camblong, J; Iglesias, N; Fickentscher, C; Dieppois, G; Stutz, F				Camblong, Jurgi; Iglesias, Nahid; Fickentscher, Celine; Dieppois, Guennaelle; Stutz, Francoise			Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in s. cerevisiae	CELL			English	Article							EXOSOME SUBUNIT RRP6P; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; POLY(A) POLYMERASE; HDA1 DEACETYLASE; YEAST; GENOME; DEGRADATION; COMPLEX; EXPRESSION	Genome-wide studies in S. cerevisiae reveal that the transcriptome includes numerous antisense RNAs as well as intergenic transcripts regulated by the exosome component Rrp6. We observed that upon the loss of Rrp6 function, two PHO84 antisense transcripts are stabilized, and PHO84 gene transcription is repressed. Interestingly, the same phenotype is observed in wild-type cells during chronological aging. Epistasis and chromatin immunoprecipitation experiments indicate that the loss of Rrp6 function is paralleled by the recruitment of Hda1 histone deacetylase to PHO84 and neighboring genes. However, histone deacetylation is restricted to PHO84, suggesting that Hda1 activity depends on antisense RNA. Accordingly, the knockdown of antisense production prevents PHO84 gene repression, even in the absence of Rrp6. Together, our data indicate that the stabilization of antisense transcripts results in PHO84 gene repression via a mechanism distinct from transcription interference and that the modulation of Rrp6 function contributes to gene regulation by inducing RNA-dependent epigenetic modifications.	Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Stutz, F (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	francoise.stutz@cellbio.unige.ch	Stutz, Françoise C/N-4329-2017	Iglesias, Nahid/0000-0001-5185-846X				Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Ciaudo C, 2006, PLOS GENET, V2, P874, DOI 10.1371/journal.pgen.0020094; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Escusa S, 2006, MOL MICROBIOL, V60, P1014, DOI 10.1111/j.1365-2958.2006.05153.x; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MOAZED D, 2006, QUANT BIOL, V71, P461; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roth KM, 2005, MOL CELL BIOL, V25, P1577, DOI 10.1128/MCB.25.5.1577-1585.2005; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wu JS, 2001, P NATL ACAD SCI USA, V98, P4391, DOI 10.1073/pnas.081560698; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	38	287	295	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					706	717		10.1016/j.cell.2007.09.014	http://dx.doi.org/10.1016/j.cell.2007.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022365	Bronze			2022-12-24	WOS:000250966300018
J	Steinbrook, R				Steinbrook, Robert			Closing the affordability gap for drugs in low-income countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Danzon PM, 2007, NATURE, V449, P176, DOI 10.1038/449176a; Gelders S., 2006, PRICE AVAILABILITY A; *MED SANS FRONT, 2007, UNT WEB PRIC RED; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Steinbrook R, 2007, NEW ENGL J MED, V356, P544, DOI 10.1056/NEJMp068297	5	28	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					1996	1999		10.1056/NEJMp0706918	http://dx.doi.org/10.1056/NEJMp0706918			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230RV	18003957				2022-12-24	WOS:000250894500002
J	Karnik, SK; Chen, HN; McLean, GW; Heit, JJ; Gu, XY; Zhang, AY; Fontaine, M; Yen, MH; Kim, SK				Karnik, Satyajit K.; Chen, Hainan; McLean, Graeme W.; Heit, Jeremy J.; Gu, Xueying; Zhang, Andrew Y.; Fontaine, Magali; Yen, Michael H.; Kim, Seung K.			Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; DEPENDENT KINASE INHIBITORS; INSULIN-SECRETION; PLACENTAL-LACTOGEN; ISLET FUNCTION; EXPRESSION; GENE; PROLACTIN; PROLIFERATION; BCL-6	During pregnancy, maternal pancreatic islets grow to match dynamic physiological demands, but the mechanisms regulating adaptive islet growth in this setting are poorly understood. Here we show that menin, a protein previously characterized as an endocrine tumor suppressor and transcriptional regulator, controls islet growth in pregnant mice. Pregnancy stimulated proliferation of maternal pancreatic islet beta-cells that was accompanied by reduced islet levels of menin and its targets. Transgenic expression of menin in maternal beta-cells prevented islet expansion and led to hyperglycemia and impaired glucose tolerance, hallmark features of gestational diabetes. Prolactin, a hormonal regulator of pregnancy, repressed islet menin levels and stimulated beta-cell proliferation. These results expand our understanding of mechanisms underlying diabetes pathogenesis and reveal potential targets for therapy in diabetes.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu		Zhang, Andrew/0000-0002-6309-9947; Kim, Seung/0000-0001-6135-7810; Heit, Jeremy/0000-0003-1055-8000	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32DK007217-32] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwal SK, 2004, ANN NY ACAD SCI, V1014, P189, DOI 10.1196/annals.1294.020; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Horvath E, 1999, Pituitary, V1, P169, DOI 10.1023/A:1009952930425; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Labriola L, 2007, MOL CELL ENDOCRINOL, V264, P16, DOI 10.1016/j.mce.2006.10.004; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NIELSEN JH, 1982, ENDOCRINOLOGY, V110, P600, DOI 10.1210/endo-110-2-600; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; Yao JC, 2007, BEST PRACT RES CL EN, V21, P163, DOI 10.1016/j.beem.2007.01.006; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	27	267	282	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					806	809		10.1126/science.1146812	http://dx.doi.org/10.1126/science.1146812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975067				2022-12-24	WOS:000250583900043
J	Sohn, J; Grant, RA; Sauer, RT				Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.			Allosteric activation of DegS, a stress sensor PDZ protease	CELL			English	Article							ESCHERICHIA-COLI SIGMA(E); CRYSTAL-STRUCTURE; SERINE-PROTEASE; HTRA FAMILY; PROTEOLYSIS; PROTEINS; BINDING; DOMAIN; YAEL; SUBSTRATE	Regulated intramembrane proteolysis is a method for transducing signals between cellular compartments. When protein folding is compromised in the periplasm of E. coli, the C termini of outer-membrane proteins (OMPs) bind to the PDZ domains of the trimeric DegS protease and activate cleavage of RseA, a transmembrane transcriptional regulator. We show here that DegS is an allosteric enzyme. OMP binding shifts the equilibrium from a nonfunctional state, in which the active sites are unreactive, to the functional proteolytic conformation. Crystallographic, biochemical, and mutagenic experiments show that the unliganded PDZ domains are inhibitory and suggest that OMP binding per se is sufficient to stabilize the relaxed conformation and activate DegS. OMP-induced activation and RseA binding are both positively cooperative, allowing switch-like behavior of the OMP-DegS-RseA system. Residues involved in the DegS allosteric switch are conserved in the DegP/HtrA and HtrA2/Omi families, suggesting that many PDZ proteases use a common mechanism of allosteric activation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER; NCRR NIH HHS [RR15301] Funding Source: Medline; NIAID NIH HHS [AI16892] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grigorova IL, 2006, P NATL ACAD SCI USA, V103, P5332, DOI 10.1073/pnas.0600828103; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kim DY, 2003, J BIOL CHEM, V278, P6543, DOI 10.1074/jbc.M208148200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	40	99	101	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					572	583		10.1016/j.cell.2007.08.044	http://dx.doi.org/10.1016/j.cell.2007.08.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981123	Bronze			2022-12-24	WOS:000250618500023
J	Begg, CB; Haile, RW; Borg, A; Malone, KE; Concannon, P; Thomas, DC; Langholz, B; Bernstein, L; Olsen, JH; Lynch, CF; Anton-Culver, H; Capanu, M; Liang, XL; Hummer, AJ; Sima, C; Bernstein, JL				Begg, Colin B.; Haile, Robert W.; Borg, Ake; Malone, Kathleen E.; Concannon, Patrick; Thomas, Duncan C.; Langholz, Bryan; Bernstein, Leslie; Olsen, Jorgen H.; Lynch, Charles F.; Anton-Culver, Hoda; Capanu, Marinela; Liang, Xiaolin; Hummer, Amanda J.; Sima, Cami; Bernstein, Jonine L.			Variation of breast cancer risk among BRCA1/2 carriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; FAMILY-HISTORY; MUTATION CARRIERS; ESTIMATING PENETRANCE; OVARIAN-CANCER; KIN-COHORT; SUSCEPTIBILITY; GENE; PREVALENCE; SERIES	Context The risk of breast cancer in BRCA1 and BRCA2 mutation carriers has been examined in many studies, but relatively little attention has been paid to the degree to which the risk may vary among carriers. Objectives To determine the extent to which risks for BRCA1 and BRCA2 carriers vary with respect to observable and unobservable characteristics. Design, Setting, and Participants Probands were identified from a population-based, case- control study ( Women's Environmental Cancer and Radiation Epidemiology [ WECARE]) of asynchronous contralateral breast cancer conducted during the period of January 2000 to July 2004. Participants previously diagnosed with contralateral breast cancer or unilateral breast cancer were genotyped for mutations in BRCA1 and BRCA2. All participants had their initial breast cancer diagnosed during the period of January 1985 to December 2000, before the age of 55 years. Main Outcome Measure Incidence of breast cancer in first- degree female relatives of the probands was examined and compared on the basis of proband characteristics and on the basis of variation between families. Results Among the 1394 participants with unilateral breast cancer, 73 ( 5.2%) were identified as carriers of deleterious mutations ( 42 with BRCA1 and 31 with BRCA2). Among the 704 participants with contralateral breast cancer, 108 ( 15.3%) were identified as carriers of deleterious mutations ( 67 with BRCA1 and 41 with BRCA2). Among relatives of carriers, risk was significantly associated with younger age at diagnosis in the proband ( P =. 04), and there was a trend toward higher risk for relatives of contralateral breast cancer vs unilateral breast cancer participants ( odds ratio, 1.4 [ 95% confidence interval, 0.8- 2.4]; P =. 28). In addition, there were significant differences in risk between carrier families after adjusting for these observed characteristics. Conclusion There exists broad variation in breast cancer risk among carriers of BRCA1 and BRCA2 mutations.	[Begg, Colin B.; Capanu, Marinela; Liang, Xiaolin; Hummer, Amanda J.; Sima, Cami; Bernstein, Jonine L.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Haile, Robert W.; Thomas, Duncan C.; Langholz, Bryan; Bernstein, Leslie] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Borg, Ake] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Concannon, Patrick] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Olsen, Jorgen H.] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Lynch, Charles F.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Memorial Sloan Kettering Cancer Center; University of Southern California; Lund University; Skane University Hospital; Fred Hutchinson Cancer Center; University of Virginia; Danish Cancer Society; University of Iowa; University of California System; University of California Irvine	Begg, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St, New York, NY 10021 USA.	beggc@mskcc.org		Olsen, Jorgen Helge/0000-0001-9633-5662; Concannon, Patrick/0000-0002-5801-1859	NATIONAL CANCER INSTITUTE [R01CA097397, R01CA131010, R01CA098438, R01CA129639, U01CA083178] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098438, CA097397, U01 CA083178-01, R01 CA129639, CA098438, R01 CA097397, R01 CA131010, R01 CA097397-01, R01 CA098438-01A1, CA083178, U01 CA083178] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Andrieu N, 2006, JNCI-J NATL CANCER I, V98, P535, DOI 10.1093/jnci/djj132; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1630; Begg CB, 2002, J NATL CANCER I, V94, P1221; Bernstein JL, 2004, BREAST CANCER RES, V6, pR199, DOI 10.1186/bcr771; Bernstein JL, 2003, HUM MUTAT, V21, P542, DOI 10.1002/humu.10206; BONDY ML, 1994, J CLIN EPIDEMIOL, V47, P89, DOI 10.1016/0895-4356(94)90037-X; Chatterjee N, 2001, BIOMETRICS, V57, P245, DOI 10.1111/j.0006-341X.2001.00245.x; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; GARBER JE, 1991, CANCER RES, V51, P6094; Gong G, 2003, GENET EPIDEMIOL, V24, P173, DOI 10.1002/gepi.10219; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Lang AE, 1996, MOVEMENT DISORD, V11, P1, DOI 10.1002/mds.870110102; Langholz B, 1999, BIOMETRICS, V55, P1129, DOI 10.1111/j.0006-341X.1999.01129.x; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Mitchell G, 2006, CANCER RES, V66, P1866, DOI 10.1158/0008-5472.CAN-05-3368; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ponder BAJ, 2005, COLD SH Q B, V70, P35, DOI 10.1101/sqb.2005.70.029; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; THOMAS DC, 2004, STAT METHODS GENETIC, P137; Thompson D, 2002, CANCER EPIDEM BIOMAR, V11, P329; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241; Whittemore AS, 2003, J NATL CANCER I, V95, P76, DOI 10.1093/jnci/95.1.76; Ziogas A, 2003, AM J PREV MED, V24, P190, DOI 10.1016/S0749-3797(02)00593-7	38	217	224	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					194	201		10.1001/jama.2007.55-a	http://dx.doi.org/10.1001/jama.2007.55-a			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182601	Green Accepted, Bronze			2022-12-24	WOS:000252182600019
J	Chan, PS; Krumholz, HM; Nichol, G; Nallamothu, BK				Chan, Paul S.; Krumholz, Harlan M.; Nichol, Graham; Nallamothu, Brahmajee K.		Amer Heart Assoc	Delayed time to defibrillation after in-hospital cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; AUSTRALIAN RESUSCITATION COUNCIL; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; RECOMMENDED GUIDELINES; UTSTEIN STYLE; STROKE FOUNDATION; TASK-FORCE; STATEMENT	Background: Expert guidelines advocate defibrillation within 2 minutes after an in-hospital cardiac arrest caused by ventricular arrhythmia. However, empirical data on the prevalence of delayed defibrillation in the United States and its effect on survival are limited. Methods: We identified 6789 patients who had cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia at 369 hospitals participating in the National Registry of Cardiopulmonary Resuscitation. Using multivariable logistic regression, we identified characteristics associated with delayed defibrillation. We then examined the association between delayed defibrillation (more than 2 minutes) and survival to discharge after adjusting for differences in patient and hospital characteristics. Results: The overall median time to defibrillation was 1 minute (interquartile range, <1 to 3 minutes); delayed defibrillation occurred in 2045 patients (30.1%). Characteristics associated with delayed defibrillation included black race, noncardiac admitting diagnosis, and occurrence of cardiac arrest at a hospital with fewer than 250 beds, in an unmonitored hospital unit, and during after-hours periods (5 p.m. to 8 a.m. or weekends). Delayed defibrillation was associated with a significantly lower probability of surviving to hospital discharge (22.2%, vs. 39.3% when defibrillation was not delayed; adjusted odds ratio, 0.48; 95% confidence interval, 0.42 to 0.54; P<0.001). In addition, a graded association was seen between increasing time to defibrillation and lower rates of survival to hospital discharge for each minute of delay (P for trend <0.001). Conclusions: Delayed defibrillation is common and is associated with lower rates of survival after in-hospital cardiac arrest.	St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Univ Washington, Harborview Ctr Prehosp Emergency Care, Seattle, WA 98195 USA; Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Michigan System; University of Michigan; Yale University; Yale University; Yale University; Yale University; Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 5th Fl,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	Nichol, Graham/Z-4996-2019; , Harlan/AAI-2875-2020		NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017607] Funding Source: NIH RePORTER; NCRR NIH HHS [K12 RR017607-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ballew KA, 1995, RESUSCITATION, V30, P203, DOI 10.1016/0300-9572(95)00894-2; Castren M, 2005, RESUSCITATION, V64, P293, DOI 10.1016/j.resuscitation.2004.08.017; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Cummins RO, 1997, ANN EMERG MED, V29, P647, DOI 10.1016/S0196-0644(97)70255-5; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Fredriksson M, 2006, RESUSCITATION, V68, P351, DOI 10.1016/j.resuscitation.2005.07.011; Hajbaghery MA, 2005, RESUSCITATION, V66, P317, DOI 10.1016/j.resuscitation.2005.04.004; Herlitz J, 2005, RESUSCITATION, V66, P159, DOI 10.1016/j.resuscitation.2005.03.018; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Kaye W, 2005, RESUSCITATION, V65, P285, DOI 10.1016/j.resuscitation.2004.12.020; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Skrifvars MB, 2003, RESUSCITATION, V56, P275, DOI 10.1016/S0300-9572(02)00373-8; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	18	414	427	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					9	17		10.1056/NEJMoa0706467	http://dx.doi.org/10.1056/NEJMoa0706467			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172170				2022-12-24	WOS:000252031200003
J	Nutt, SL				Nutt, Stephen L.			B-cell identity - Commitment is not forever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAX5		Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Nutt, SL (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.		Nutt, Stephen L/C-9256-2013	Nutt, Stephen L/0000-0002-0020-6637				Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					82	83		10.1056/NEJMcibr0707112	http://dx.doi.org/10.1056/NEJMcibr0707112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172181				2022-12-24	WOS:000252031200014
J	Shelton, JD				Shelton, James D.			Ten myths and one truth about generalised HIV epidemics	LANCET			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov						Cassell MM, 2007, LANCET INFECT DIS, V7, P491, DOI 10.1016/S1473-3099(07)70114-7; *CDCP KEN, 2004, KEN DEM HLTH SURV 20; Gray RH, 2007, LANCET, V370, P200, DOI 10.1016/S0140-6736(07)61058-7; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; *MIN HLTH SOC WELF, 2005, LES DEM HLTH SURV 20; Shelton JD, 2006, LANCET, V368, P1947, DOI 10.1016/S0140-6736(06)69787-0; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; *UNAIDS WHO, 2007, AIDS EP UPD; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI	12	51	51	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1809	1811		10.1016/S0140-6736(07)61755-3	http://dx.doi.org/10.1016/S0140-6736(07)61755-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061042	Green Submitted			2022-12-24	WOS:000251588700008
J	Fliessbach, K; Weber, B; Trautner, P; Dohmen, T; Sunde, U; Elger, CE; Falk, A				Fliessbach, K.; Weber, B.; Trautner, P.; Dohmen, T.; Sunde, U.; Elger, C. E.; Falk, A.			Social comparison affects reward-related brain activity in the human ventral striatum	SCIENCE			English	Article							NEURAL RESPONSES; FAIRNESS; INCOME; GAINS	Whether social comparison affects individual well-being is of central importance for understanding behavior in any social environment. Traditional economic theories focus on the role of absolute rewards, whereas behavioral evidence suggests that social comparisons influence well-being and decisions. We investigated the impact of social comparisons on reward-related brain activity using functional magnetic resonance imaging ( fMRI). While being scanned in two adjacent MRI scanners, pairs of subjects had to simultaneously perform a simple estimation task that entailed monetary rewards for correct answers. We show that a variation in the comparison subject's payment affects blood oxygenation level-dependent responses in the ventral striatum. Our results provide neurophysiological evidence for the importance of social comparison on reward processing in the human brain.	Univ Bonn, Dept Econ, D-5300 Bonn, Germany; Life & Brain Ctr Bonn, Dept NeuroCognit, Bonn, Germany; Clin Epileptol, Bonn, Germany; Inst Study Labor, Bonn, Germany; Univ Bonn, Dept Econ, D-5300 Bonn, Germany	University of Bonn; University of Bonn; IZA Institute Labor Economics; University of Bonn	Falk, A (corresponding author), Univ Bonn, Dept Econ, D-5300 Bonn, Germany.	armin.falk@uni-bonn.de	Weber, Bernd/H-5244-2012	Weber, Bernd/0000-0002-7811-9605				Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; BOSKIN MJ, 1978, Q J ECON, V92, P589, DOI 10.2307/1883177; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Carroll Christopher D., 2000, DOES ATLAS SHRUG EC; Clark AE, 1996, J PUBLIC ECON, V61, P359, DOI 10.1016/0047-2727(95)01564-7; CLARK AE, IN PRESS J EC LIT; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Ferrer-i-Carbonell A, 2005, J PUBLIC ECON, V89, P997, DOI 10.1016/j.jpubeco.2004.06.003; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frank RH, 2005, AM ECON REV, V95, P137, DOI 10.1257/000282805774670392; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Neumark D, 1998, J PUBLIC ECON, V70, P157, DOI 10.1016/S0047-2727(98)00065-6; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Olson James M., 1986, RELATIVE DEPRIVATION; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525	25	369	376	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1305	1308		10.1126/science.1145876	http://dx.doi.org/10.1126/science.1145876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033886	Green Published			2022-12-24	WOS:000251086600045
J	Sartori, AA; Lukas, C; Coates, J; Mistrik, M; Fu, S; Bartek, J; Baer, R; Lukas, J; Jackson, SP				Sartori, Alessandro A.; Lukas, Claudia; Coates, Julia; Mistrik, Martin; Fu, Shuang; Bartek, Jiri; Baer, Richard; Lukas, Jiri; Jackson, Stephen P.			Human CtIP promotes DNA end resection	NATURE			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST SAE2; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; MRE11 COMPLEX; CELL-CYCLE; CHECKPOINT CONTROL; PROTEIN-KINASES; BINDING PROTEIN	In the S and G2 phases of the cell cycle, DNA double-strand breaks (DSBs) are processed into single-stranded DNA, triggering ATR-dependent checkpoint signalling and DSB repair by homologous recombination. Previous work has implicated the MRE11 complex in such DSB-processing events. Here, we show that the human CtIP (RBBP8) protein confers resistance to DSB-inducing agents and is recruited to DSBs exclusively in the S and G2 cell-cycle phases. Moreover, we reveal that CtIP is required for DSB resection, and thereby for recruitment of replication protein A (RPA) and the protein kinase ATR to DSBs, and for the ensuing ATR activation. Furthermore, we establish that CtIP physically and functionally interacts with the MRE11 complex, and that both CtIP and MRE11 are required for efficient homologous recombination. Finally, we reveal that CtIP has sequence homology with Sae2, which is involved in MRE11-dependent DSB processing in yeast. These findings establish evolutionarily conserved roles for CtIP-like proteins in controlling DSB resection, checkpoint signalling and homologous recombination.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY 10032 USA	University of Cambridge; University of Cambridge; Danish Cancer Society; Danish Cancer Society; Columbia University	Sartori, AA (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Sartori, Alessandro/AAK-7840-2021; Bartek, Jiri/G-5870-2014; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Sartori, Alessandro/0000-0003-2770-0333; Jackson, Stephen Philip/0000-0001-9317-7937; Lukas, Jiri/0000-0001-9087-506X; Lukas, Claudia/0000-0001-7169-6883; Mistrik, Martin/0000-0002-2321-0348	NATIONAL CANCER INSTITUTE [P01CA097403] Funding Source: NIH RePORTER; Cancer Research UK [A5290] Funding Source: Medline; NCI NIH HHS [P01 CA097403] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; DARPA P, 1990, CANCER RES, V50, P6919; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; McKee AHZ, 1997, GENETICS, V146, P797; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Prinz S, 1997, GENETICS, V146, P781; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rattray AJ, 2001, GENETICS, V158, P109; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Vilkki S, 2002, J MED GENET, V39, P785, DOI 10.1136/jmg.39.11.785; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu GK, 2006, CELL CYCLE, V5, P1592, DOI 10.4161/cc.5.15.3127; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	49	962	979	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					509	U6		10.1038/nature06337	http://dx.doi.org/10.1038/nature06337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17965729	Green Accepted			2022-12-24	WOS:000251158500038
J	Gelson, E; Gatzoulis, M; Johnson, M				Gelson, E.; Gatzoulis, M.; Johnson, M.			Pregnancy plus - Valvular heart disease	BRITISH MEDICAL JOURNAL			English	Article							STENOSIS; WOMEN	Valvular disease may be unmasked in pregnancy when physiological changes increase demands on the heart. Women with valvular heart disease require close follow-up during pregnancy, delivery, and postpartum.	Univ London Imperial Coll Sci Technol & Med, Acad Dept Obstet & Gynaecol, London SW10 9NH, England; Royal Brompton Hosp, Natl Heart & Lung Inst, Adult Congenital Heart Ctr, London SW3 6NP, England	Imperial College London; Imperial College London; Royal Brompton Hospital	Gelson, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Obstet & Gynaecol, London SW10 9NH, England.	egelson@imperial.ac.uk						Bastos Barbosa PJ, 2000, ARQ BRAS CARDIOL, V75, P220, DOI DOI 10.1590/S0066-782X2000000900003; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Gei AF, 2001, OBSTET GYN CLIN N AM, V28, P465, DOI 10.1016/S0889-8545(05)70214-X; Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0; Lesniak-Sobelga A, 2004, INT J CARDIOL, V94, P15, DOI 10.1016/j.ijcard.2003.03.017; Sawhney H, 2003, INT J GYNECOL OBSTET, V80, P9, DOI 10.1016/S0020-7292(02)00029-2; Silversides CK, 2003, AM J CARDIOL, V91, P1386, DOI 10.1016/S0002-9149(03)00340-0; Silversides CK, 2003, AM J CARDIOL, V91, P1382, DOI 10.1016/S0002-9149(03)00339-4; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Uebing A, 2006, BMJ-BRIT MED J, V332, P401, DOI 10.1136/bmj.332.7538.401	10	11	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 17	2007	335	7628					1042	1045		10.1136/bmj.39365.655833.AE	http://dx.doi.org/10.1136/bmj.39365.655833.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	18007005	Green Published			2022-12-24	WOS:000251402800034
J	Spence, MS; Balaratnam, MS; Gatzoulis, MA				Spence, Mark S.; Balaratnam, Michelle S.; Gatzoulis, Michael A.			Clinical update: cyanotic adult congenital heart disease	LANCET			English	Article							BLOOD-VISCOSITY; POLYCYTHEMIA; SURVIVAL; INDEXES		Royal Brompton Hosp, Adult Congenital Heart Ctr, London SW3 6NP, England; Imperial Coll, Natl Heart & Lung Inst, London SW3 6NP, England; Royal Jubilee Hosp, Victoria Heart Inst Fdn, Victoria, BC, Canada	Royal Brompton Hospital; Imperial College London	Spence, MS (corresponding author), Royal Brompton Hosp, Adult Congenital Heart Ctr, London SW3 6NP, England.	markspence1@yahoo.co.uk						Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; BERK PD, 1986, SEMIN HEMATOL, V23, P132; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Broberg CS, 2006, J AM COLL CARDIOL, V48, P356, DOI 10.1016/j.jacc.2006.03.040; Dedkov EI, 2006, CIRCULATION, V114, P196, DOI 10.1161/CIRCULATIONAHA.105.602771; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Diller GP, 2006, EUR HEART J, V27, P1737, DOI 10.1093/eurheartj/ehl116; FAIRBANKS VF, 1995, WILLIAMS HEMATOLOGY, P490; Kaemmerer H, 2004, AM J CARDIOL, V94, P825, DOI 10.1016/j.amjcard.2004.06.014; Katayama Y, 2006, CLIN HEMORHEOL MICRO, V35, P499; MILLIGAN DW, 1982, BRIT J HAEMATOL, V50, P467, DOI 10.1111/j.1365-2141.1982.tb01942.x; MOLLER JH, 1994, CIRCULATION, V89, P923, DOI 10.1161/01.CIR.89.2.923; Niwa K, 2004, INT J CARDIOL, V96, P211, DOI 10.1016/j.ijcard.2003.06.019; Oechslin E, 2003, DIAGNOSIS MANAGEMENT, P363; Perloff JK, 2001, CIRCULATION, V103, P2637; PERLOFF JK, 1993, CIRCULATION, V87, P1954, DOI 10.1161/01.CIR.87.6.1954; ROSOVE MH, 1986, LANCET, V2, P313; Thorne SA, 1998, HEART, V79, P315, DOI 10.1136/hrt.79.4.315; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438	20	43	43	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1530	1532		10.1016/S0140-6736(07)61647-X	http://dx.doi.org/10.1016/S0140-6736(07)61647-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227AE	17980725				2022-12-24	WOS:000250628800010
J	Mertens, C; Darnell, JE				Mertens, Claudia; Darnell, James E., Jr.			SnapShot: JAK-STAT signaling	CELL			English	Editorial Material							IMMUNE-SYSTEM; TRANSCRIPTION; PROTEINS		Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA	Rockefeller University	Mertens, C (corresponding author), Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA.							Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Hartman SE, 2005, GENE DEV, V19, P2953, DOI 10.1101/gad.1371305; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226	9	90	91	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3							612.e1	10.1016/j.cell.2007.10.033	http://dx.doi.org/10.1016/j.cell.2007.10.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981126	Bronze			2022-12-24	WOS:000250618500026
J	Ezzie, ME; Janssen, WJ; O'Brien, JM; Fox, CC; Schwarz, MI				Ezzie, Michael E.; Janssen, William J.; O'Brien, James M.; Fox, Charity C.; Schwarz, Marvin I.			Failure to respond	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							THYMOMA; IMMUNODEFICIENCY		Ohio State Univ, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, Columbus, OH 43210 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	Ohio State University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ezzie, ME (corresponding author), Ohio State Univ, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, 201 Davis HLRI,473 W 12th Ave, Columbus, OH 43210 USA.	michael.ezzie@osumc.edu	O'Brien, James M/A-2624-2009					Croskerry P, 2002, ACAD EMERG MED, V9, P1184, DOI 10.1111/j.1553-2712.2002.tb01574.x; Kelleher P, 2003, J CLIN PATHOL, V56, P12, DOI 10.1136/jcp.56.1.12; MAGGI G, 1991, ANN THORAC SURG, V51, P152, DOI 10.1016/0003-4975(91)90478-9; MITCHELL EB, 1983, CLIN LAB HAEMATOL, V5, P253; RA G., 1954, B U MINNESOTA HOSP M, P1; SOUADJIAN JV, 1974, ARCH INTERN MED, V134, P374, DOI 10.1001/archinte.134.2.374; Tarr PE, 2001, MEDICINE, V80, P123, DOI 10.1097/00005792-200103000-00005; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	8	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					70	74		10.1056/NEJMcps067266	http://dx.doi.org/10.1056/NEJMcps067266			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172177				2022-12-24	WOS:000252031200010
J	Emmelot-Vonk, MH; Verhaar, HJJ; Pour, HRN; Aleman, A; Lock, TMTW; Bosch, JLHR; Grobbee, DE; van der Schouw, YT				Emmelot-Vonk, Marielle H.; Verhaar, Harald J. J.; Pour, Hamid R. Nakhai; Aleman, Andre; Lock, Tycho M. T. W.; Bosch, J. L. H. Ruud; Grobbee, Diederick E.; van der Schouw, Yvonne T.			Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; HORMONE-BINDING GLOBULIN; SENSITIVITY CHECK INDEX; LATE-ONSET HYPOGONADISM; REPLACEMENT THERAPY; METABOLIC SYNDROME; INSULIN SENSITIVITY; ALZHEIMER-DISEASE; PROSTATE-CANCER; MUSCLE STRENGTH	Context Serum testosterone levels decline significantly with aging. Testosterone supplementation to older men might beneficially affect the aging processes. Objective To investigate the effect of testosterone supplementation on functional mobility, cognitive function, bone mineral density, body composition, plasma lipids, quality of life, and safety parameters in older men with low normal testosterone levels. Design, Setting, and Participants Double-blind, randomized, placebo-controlled trial of 237 healthy men between the ages of 60 and 80 years with a testosterone level lower than 13.7 nmol/L conducted from January 2004 to April 2005 at a university medical center in the Netherlands. Intervention Participants were randomly assigned to receive 80 mg of testosterone undecenoate or a matching placebo twice daily for 6 months. Main Outcome Measures Functional mobility (Stanford Health Assessment questionnaire, timed get up and go test, isometric handgrip strength, isometric leg extensor strength), cognitive function (8 different cognitive instruments), bone mineral density of the hip and lumbar spine (dual-energy x-ray absorptiometry scanning), body composition (total body dual-energy x-ray absorptiometry and abdominal ultrasound of fat mass), metabolic risk factors (fasting plasma lipids, glucose, and insulin), quality of life (Short-Form Health 36 Survey and the Questions on Life Satisfaction Modules), and safety parameters (serum prostate-specific antigen level, ultrasonographic prostate volume, International Prostate Symptom score, serum levels of creatinine, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, hemoglobin, and hematocrit). Results A total of 207 men completed the study. During the study, lean body mass increased and fat mass decreased in the testosterone group compared with the placebo group but these factors were not accompanied by an increase of functional mobility or muscle strength. Cognitive function and bone mineral density did not change. Insulin sensitivity improved but high-density lipoprotein cholesterol decreased; by the end of the study, 47.8% in the testosterone group vs 35.5% in the placebo group had the metabolic syndrome (P=.07). Quality-of -life measures were no different except for one hormone-related quality-of-life measure that improved. No negative effects on prostate safety were detected. Conclusion Testosterone supplementation during 6 months to older men with a low normal testosterone concentration did not affect functional status or cognition but increased lean body mass and had mixed metabolic effects. Trial Registration isrctn.org Identifier: ISRCTN23688581.	[Emmelot-Vonk, Marielle H.; Verhaar, Harald J. J.; Pour, Hamid R. Nakhai] Univ Med Ctr Utrecht, Dept Geriatr Med, NL-3508 GA Utrecht, Netherlands; [Lock, Tycho M. T. W.; Bosch, J. L. H. Ruud] Univ Med Ctr Utrecht, Dept Urol, NL-3508 GA Utrecht, Netherlands; [Emmelot-Vonk, Marielle H.; Pour, Hamid R. Nakhai; Grobbee, Diederick E.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	Emmelot-Vonk, MH (corresponding author), Univ Med Ctr Utrecht, Dept Geriatr Med, POB 85500,Room B05-256, NL-3508 GA Utrecht, Netherlands.	m.h.emmelotvonk@umcutrecht.nl	Aleman, Andre/E-1341-2012; Grobbee, Diederick/C-7651-2014; van der Schouw, Yvonne T./F-8327-2014	Grobbee, Diederick/0000-0003-4472-4468; van der Schouw, Yvonne T./0000-0002-4605-435X				Badia X, 1997, EUR UROL, V31, P129; BAILLIE SP, 1992, AGE AGEING, V21, P139, DOI 10.1093/ageing/21.2.139; Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P3681, DOI 10.1210/jc.84.10.3681; Benton A., 1983, CONTRIBUTION NEUROPS; Bhasin S, 2003, J ANDROL, V24, P299; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P1659, DOI 10.1210/jc.82.6.1659; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boyanov M A, 2003, Aging Male, V6, P1; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *COMM ASS NEED CLI, 2004, REPL THER TEST AG CL; Curran MJ, 1999, UROLOGY, V53, P423, DOI 10.1016/S0090-4295(98)00348-3; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Gaylis FD, 2005, J UROLOGY, V174, P534, DOI 10.1097/01.ju.0000165166.36280.60; Gouras GK, 2000, P NATL ACAD SCI USA, V97, P1202, DOI 10.1073/pnas.97.3.1202; Hamilton A, 1994, J Hand Ther, V7, P163; Hanninen T, 1996, AGE AGEING, V25, P201, DOI 10.1093/ageing/25.3.201; Haren MT, 2005, MATURITAS, V50, P124, DOI 10.1016/j.maturitas.2004.05.002; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Herschbach P, 2001, EUR J ENDOCRINOL, V145, P255, DOI 10.1530/eje.0.1450255; Houwing NS, 2003, PHARMACOTHERAPY, V23, P1257, DOI 10.1592/phco.23.12.1257.32707; Hrebicek J, 2002, J CLIN ENDOCR METAB, V87, P144, DOI 10.1210/jc.87.1.144; HUBER D, 1988, PHARMACOPSYCHIATRY, V21, P453, DOI 10.1055/s-2007-1017050; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Janowsky JS, 2006, NEUROSCIENCE, V138, P1015, DOI 10.1016/j.neuroscience.2005.09.007; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Kenny AM, 2001, J GERONTOL A-BIOL, V56, pM266, DOI 10.1093/gerona/56.5.M266; Kenny AM, 2004, J GERONTOL A-BIOL, V59, P75; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LEE F, 1985, PROSTATE, V7, P117, DOI 10.1002/pros.2990070202; LEZAK MD, 1995, NEUROPSYCHOLOGIAL AS; Lu PH, 2006, ARCH NEUROL-CHICAGO, V63, P177, DOI 10.1001/archneur.63.2.nct50002; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210/jc.86.9.4078; Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351; Moffat SD, 2004, NEUROLOGY, V62, P188, DOI 10.1212/WNL.62.2.188; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Moncada I, 2006, AGING MALE, V9, P189, DOI 10.1080/13685530601003180; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Muller M, 2005, NEUROLOGY, V64, P866, DOI 10.1212/01.WNL.0000153072.54068.E3; Nieschlag E, 2006, J ANDROL, V27, P135, DOI 10.2164/jandrol.05047; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Park N C, 2003, Aging Male, V6, P86, DOI 10.1080/713604766; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pour HRN, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-24; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rhoden EL, 2004, NEW ENGL J MED, V350, P482, DOI 10.1056/NEJMra022251; Rhodes T, 1999, J UROLOGY, V161, P1174, DOI 10.1016/S0022-5347(01)61621-5; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Schatzl G, 2001, PROSTATE, V47, P52; Schnabel PG, 2007, CLIN ENDOCRINOL, V66, P579, DOI 10.1111/j.1365-2265.2007.02781.x; Scuteri A, 2005, DIABETES CARE, V28, P882, DOI 10.2337/diacare.28.4.882; SIEGERT CEH, 1984, CLIN RHEUMATOL, V3, P305, DOI 10.1007/BF02032335; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Silverman I, 1999, PSYCHONEUROENDOCRINO, V24, P813, DOI 10.1016/S0306-4530(99)00031-1; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; STANLEY HL, 1991, J AM GERIATR SOC, V39, P766, DOI 10.1111/j.1532-5415.1991.tb02698.x; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; Tirassa P, 1997, J NEUROSCI RES, V47, P198, DOI 10.1002/(SICI)1097-4547(19970115)47:2<198::AID-JNR8>3.0.CO;2-A; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x; ZMUDA JM, 1993, METABOLISM, V42, P446, DOI 10.1016/0026-0495(93)90101-S	77	367	378	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					39	52		10.1001/jama.2007.51	http://dx.doi.org/10.1001/jama.2007.51			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167405	Bronze			2022-12-24	WOS:000252052000015
J	Dong, KC; Berger, JM				Dong, Ken C.; Berger, James M.			Structural basis for gate-DNA recognition and bending by type IIA topoisomerases	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI PRIMASE; CRYSTAL-STRUCTURE; 2-GATE MECHANISM; PROTEIN; GYRASE; TOPOLOGY; DOMAIN; TRANSPORT; COMPLEX	Type II topoisomerases disentangle DNA to facilitate chromosome segregation, and represent a major class of therapeutic targets. Although these enzymes have been studied extensively, a molecular understanding of DNA binding has been lacking. Here we present the structure of a complex between the DNA- binding and cleavage core of Saccharomyces cerevisiae Topo II ( also known as Top2) and a gate- DNA segment. The structure reveals that the enzyme enforces a 150 degrees DNA bend through a mechanism similar to that of remodelling proteins such as integration host factor. Large protein conformational changes accompany DNA deformation, creating a bipartite catalytic site that positions the DNA backbone near a reactive tyrosine and a coordinated magnesium ion. This configuration closely resembles the catalytic site of type IA topoisomerases, reinforcing an evolutionary link between these structurally and functionally distinct enzymes. Binding of DNA facilitates opening of an enzyme dimerization interface, providing visual evidence for a key step in DNA transport.	Univ Calif Berkeley, Div Biochem & Mol Biol, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Chem Biol Grad Program, Dept Chem, Coll Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Div Biochem & Mol Biol, Dept Mol & Cell Biol, Inst QB3, Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BERGER JM, 1995, THESIS HARVARD U; Buck GR, 2004, J MOL BIOL, V340, P933, DOI 10.1016/j.jmb.2004.05.034; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; GOTO T, 1984, J BIOL CHEM, V259, P422; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; HOOPER DC, 2003, QUINOLONE ANTIMICROB, pR14; HOWARD MT, 1991, J MOL BIOL, V217, P53, DOI 10.1016/0022-2836(91)90610-I; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P6402, DOI 10.1021/bi00394a015; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podobnik M, 2000, J MOL BIOL, V300, P353, DOI 10.1006/jmbi.2000.3844; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; ROCA J, 1993, J BIOL CHEM, V268, P14250; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; THOMSEN B, 1990, J MOL BIOL, V215, P237, DOI 10.1016/S0022-2836(05)80342-0; Trigueros S, 2004, J MOL BIOL, V335, P723, DOI 10.1016/j.jmb.2003.11.011; TSE YC, 1980, J BIOL CHEM, V255, P5560; Vologodskii AV, 2001, P NATL ACAD SCI USA, V98, P3045, DOI 10.1073/pnas.061029098; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2000, NUCLEIC ACIDS RES, V28, P4815, DOI 10.1093/nar/28.24.4815; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	50	218	226	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1201	U4		10.1038/nature06396	http://dx.doi.org/10.1038/nature06396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097402				2022-12-24	WOS:000251786200043
J	Stremlau, M				Stremlau, Matthew			GE prize-winning essay - Why old world monkeys are resistant to HIV-1	SCIENCE			English	Editorial Material							TRIM5-ALPHA RESTRICTION FACTOR; RETROVIRAL RESTRICTION; B30.2(SPRY) DOMAIN; INFECTION; PRIMATES; CAPSIDS; DEFENSE; AIDS		US Dept State, US Global AIDS Coordinators Off, Washington, DC 20522 USA		Stremlau, M (corresponding author), US Dept State, US Global AIDS Coordinators Off, Washington, DC 20522 USA.	stremlauMH@state.gov	Liu, FL/D-1795-2009					ALTER HJ, 1984, SCIENCE, V226, P549, DOI 10.1126/science.6093251; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bieniasz PD, 2003, TRENDS MICROBIOL, V11, P286, DOI 10.1016/S0966-842X(03)00123-9; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343	16	8	9	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1565	1566		10.1126/science.1152905	http://dx.doi.org/10.1126/science.1152905			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063779				2022-12-24	WOS:000251421700026
J	Sharfstein, JM; North, M; Serwint, JR				Sharfstein, Joshua M.; North, Marisa; Serwint, Janet R.			Over the counter but no longer under the radar - Pediatric cough and cold medications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University								*CONS HEALTHC PROD, BRIEF INF FOOD DR; *FOOD DRUG ADM, 2007, NONPR DRUG ADV COMM, P29; Srinivasan A., 2007, Morbidity and Mortality Weekly Report, V56, P1	3	92	96	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2321	2324		10.1056/NEJMp0707400	http://dx.doi.org/10.1056/NEJMp0707400			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057333				2022-12-24	WOS:000251389200001
J	Dandona, L; Dandona, R				Dandona, Lalit; Dandona, Rakhi			Drop of HIV estimate for India to less than half	LANCET			English	Editorial Material							SOUTH-INDIA; PREVALENCE; HIV/AIDS		George Inst Int Hlth India, Hyderabad 500033, Andhra Pradesh, India; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Dandona, L (corresponding author), George Inst Int Hlth India, Hyderabad 500033, Andhra Pradesh, India.	ldandona@george.org.in		Dandona, Rakhi/0000-0003-0926-788X				Alnwick D., 2007, BRINGING HIV PREVENT; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2004, NATL MED J INDIA, V17, P160; Dandona L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-308; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Gupte N, 2007, JAIDS-J ACQ IMM DEF, V45, P570, DOI 10.1097/QAI.0b013e3181161c8b; Halperin DT, 2004, LANCET, V364, P1035, DOI 10.1016/S0140-6736(04)17054-2; *JOINT UN PROGR HI, 2006, 2006 REP GLOB AIDS E; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; *NAT FAM HLTH SURV, HIV PREV; *UNAIDS, Q A IND REV AIDS EST; *UNAIDS WHO, 2007, AIDS EP UPD; 2007, NEWS POST INDIA 0706	13	28	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1811	1813		10.1016/S0140-6736(07)61756-5	http://dx.doi.org/10.1016/S0140-6736(07)61756-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240LI	18061043				2022-12-24	WOS:000251588700009
J	Lohmander, LS; Roos, EM				Lohmander, L. Stefan; Roos, Ewa M.			Clinical update: treating osteoarthritis	LANCET			English	Editorial Material							EVIDENCE BASED RECOMMENDATIONS; EULAR-STANDING-COMMITTEE; TASK-FORCE; KNEE OSTEOARTHRITIS; MANAGEMENT; COMBINATION; RISK		[Lohmander, L. Stefan; Roos, Ewa M.] Lund Univ, Clin Sci Lund, Dept Orthopaed, SE-22185 Lund, Sweden; [Roos, Ewa M.] Univ So Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark	Lund University; University of Southern Denmark	Lohmander, LS (corresponding author), Lund Univ, Clin Sci Lund, Dept Orthopaed, SE-22185 Lund, Sweden.	stefan.lohmander@med.lu.se	Lohmander, Stefan/I-8326-2012; Lohmander, Stefan/AAL-8314-2021; Roos, Ewa M/A-5416-2012	Lohmander, Stefan/0000-0002-5424-9448; Roos, Ewa M/0000-0001-5425-2199				Brouwer RW, 2005, COCHRANE DB SYST REV, V1; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Fransen M, 2003, COCHRANE DB SYST REV, V3; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; MCGETTIGAN P, 2006, JAMA-J AM MED ASSOC, V296, P1653; Mikesky AE, 2006, ARTHRIT RHEUM-ARTHR, V55, P690, DOI 10.1002/art.22245; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Roddy E, 2006, BEST PRACT RES CL RH, V20, P81, DOI 10.1016/j.berh.2005.09.006; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Turner AP, 2007, ARTHRIT RHEUM-ARTHR, V57, P267, DOI 10.1002/art.22537; *UK NAT I HLTH CLI, 2007, OST DRAFT GUID CONS; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886	20	77	87	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2082	2084		10.1016/S0140-6736(07)61879-0	http://dx.doi.org/10.1016/S0140-6736(07)61879-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247DY	18156017				2022-12-24	WOS:000252058600010
J	Sorensen, HT; Horvath-Puho, E; Pedersen, L; Baron, JA; Prandoni, P				Sorensen, Henrik Toft; Horvath-Puho, Erzsebet; Pedersen, Lars; Baron, John A.; Prandoni, Paolo			Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study	LANCET			English	Article							DEEP-VEIN THROMBOSIS; ACUTE MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; RISK-FACTORS; GENERAL-POPULATION; SUBCLINICAL ATHEROSCLEROSIS; DISEASE; EPIDEMIOLOGY; STROKE; DIAGNOSIS	Background In some studies, venous thromboembolism has been associated with atherosclerosis and with the risk of arterial cardiovascular events such as myocardial infarction and stroke. Other studies, however, do not show this association. To help clarify these discrepant findings, we aimed to investigate the risk of arterial cardiovascular events in patients who were diagnosed with venous thromboembolism. Methods We undertook a 20-year population-based cohort study using data from nationwide Danish medical databases. After excluding those with known cardiovascular disease, we assessed the risk of myocardial infarction and stroke in 25199 patients with deep venous thrombosis, 16925 patients with pulmonary embolism, and 163 566 population controls. Findings For patients with deep venous thrombosis, the relative risks varied from 1.60 for myocardial infarction (95% Cl 1.35-1-91) to 2.19 (1.85-2.60) for stroke in the first year after the thrombotic event. For patients with pulmonary embolism, the relative risks in that year were 2.60 (2.14-3.14) for myocardial infarction and 2.93 (2.34-3.66) for stroke. The relative risks were also raised, though less markedly, during the subsequent 20 years of follow-up, with 20-40% increases in risk for arterial cardiovascular events. Relative risks were similar for those with provoked and unprovoked deep venous thrombosis and pulmonary embolism. Interpretation Patients with venous thromboembolism have a substantially increased long-term risk of subsequent arterial cardiovascular events.	Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; Dartmouth Med Sch, Dept Med, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Univ Padua, Dept Med & Surg Sci, Thromboembolism Unit, I-35100 Padua, Italy	Aarhus University; Boston University; Dartmouth College; Dartmouth College; University of Padua	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Ole Worms Alle 1150, DK-8000 Aarhus C, Denmark.	hts@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Horvath-Puho, Erzsebet/0000-0002-3594-2212				Ageno W, 2006, J THROMB HAEMOST, V4, P1914, DOI 10.1111/j.1538-7836.2006.02132.x; Agnelli G, 2006, J THROMB HAEMOST, V4, P1886, DOI 10.1111/j.1538-7836.2006.02138.x; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; Andersen TF, 1999, DAN MED BULL, V46, P263; Becattini C, 2005, EUR HEART J, V26, P77, DOI 10.1093/eurheartj/ehi018; Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2; Bova C, 2006, THROMB HAEMOSTASIS, V96, P132, DOI 10.1160/TH-06-05-0231; *DAN SOC THROMB HE, 2000, 3 DAN SOC THROMB HEM; Eliasson A, 2006, J THROMB HAEMOST, V4, P1897, DOI 10.1111/j.1538-7836.2006.02152.x; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GOLDHABER SZ, 1983, AM J MED, V74, P1023, DOI 10.1016/0002-9343(83)90805-7; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P111, DOI 10.1160/TH06-07-0380; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Hong C, 2005, ATHEROSCLEROSIS, V183, P169, DOI 10.1016/j.atherosclerosis.2005.03.047; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Libby P, 2000, CLIN CARDIOL, V23, P3, DOI 10.1002/clc.4960231103; Lowe GDO, 2006, J THROMB HAEMOST, V4, P1882, DOI 10.1111/j.1538-7836.2006.02130.x; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Prandoni P, 2006, J THROMB HAEMOST, V4, P1891, DOI 10.1111/j.1538-7836.2006.02058.x; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ray JG, 2004, J THROMB HAEMOST, V2, P695, DOI 10.1111/j.1538-7836.2004.00705.x; Reich LM, 2006, J THROMB HAEMOST, V4, P1909, DOI 10.1111/j.1538-7836.2006.02121.x; SAMKOFF JS, 1981, AM J EPIDEMIOL, V114, P488, DOI 10.1093/oxfordjournals.aje.a113214; Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van der Hagen PB, 2006, J THROMB HAEMOST, V4, P1903, DOI 10.1111/j.1538-7836.2006.02096.x; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	41	300	311	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1773	1779						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037081				2022-12-24	WOS:000251140500021
J	Flatt, T; Promislow, DEL				Flatt, Thomas; Promislow, Daniel E. L.			Still pondering an age-old question	SCIENCE			English	Editorial Material							LIFE-SPAN; LONGEVITY; COST		Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA	Brown University; University System of Georgia; University of Georgia	Flatt, T (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	thomas_flatt@brown.edu; promislow@uga.edu	Flatt, Thomas/AAE-7329-2019; Flatt, Thomas/A-7384-2009	Flatt, Thomas/0000-0002-5990-1503; Promislow, Daniel/0000-0001-7088-4495				Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fisher R.A., 1930, GENETICAL THEORY NAT; Gems D, 1998, GENETICS, V150, P129; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medawar P., 1952, UNSOLVED PROBLEM BIO; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Silbermann R, 2000, EVOLUTION, V54, P2038; Stearns SC, 2001, HDB BIOL AGING, P353; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	17	37	38	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1255	1256		10.1126/science.1147491	http://dx.doi.org/10.1126/science.1147491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033874	Green Submitted			2022-12-24	WOS:000251086600031
J	Raval, A; Akhavan-Toyserkani, G; Brinker, A; Avigan, M				Raval, Angela; Akhavan-Toyserkani, Gita; Brinker, Allen; Avigan, Mark			Brief communication: Characteristics of spontaneous cases of tuberculosis associated with infliximab	ANNALS OF INTERNAL MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; MANAGEMENT	Background: A warning for tuberculosis was added to the approved labeling for infliximab in October 2001. Objective: To describe adverse event reports of tuberculosis during infliximab therapy after labeling changes. Design: Case series. Setting: Spontaneous adverse event reports maintained in the Adverse Event Reporting System database in the United States. Patients: 130 patients with infliximab-associated tuberculosis. Measurements: Clinical and laboratory data. Results: The U. S. Food and Drug Administration received 130 domestic, spontaneous reports of tuberculosis in patients treated with infliximab between 1 November 2001 and 30 May 2006, including 59 (45%) with extrapulmonary disease. The most commonly reported risk factors included concomitant immunosuppressant use (n = 89), history of latent or active tuberculosis (n = 33), and being born into or having spent extensive time in an area where tuberculosis is endemic (n = 25). In the subset of 67 cases with documented initiation of infliximab therapy after the drug labeling change, 34 patients with a negative tuberculin skin test result before initiation of infliximab therapy developed tuberculosis after receiving infliximab. Limitation: Conclusions from spontaneous case reports may not be generalizable to the entire infliximab-receiving population. Conclusion: Clinicians should be vigilant in screening and monitoring for tuberculosis in patients receiving infliximab.	Ctr Drug Evaluat & Res Food & Drug Adm, Div Drug Risk Evaluat, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Akhavan-Toyserkani, G (corresponding author), Ctr Drug Evaluat & Res Food & Drug Adm, Div Drug Risk Evaluat, Off Surveillance & Epidemiol, 10903 New Hampshire Ave,Bldg 22,Rm 3469, Silver Spring, MD 20993 USA.							Brinker A, 2002, CLIN PHARMACOL THER, V71, P99, DOI 10.1067/mcp.2002.120677; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Goldman SA, 1998, CLIN THER, V20, pC40, DOI 10.1016/S0149-2918(98)80007-6; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KESSLER DA, 1993, JAMA-J AM MED ASSOC, V269, P2765, DOI 10.1001/jama.269.21.2765; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307	7	58	61	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					699	U124		10.7326/0003-4819-147-10-200711200-00006	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025446				2022-12-24	WOS:000251259500004
J	O'Brien, P; Nathanson, V				O'Brien, Pat; Nathanson, Vivienne			Is it all right for women to drink small amounts of alcohol in pregnancy?	BRITISH MEDICAL JOURNAL			English	Editorial Material												patrick.obrien@ucth.nhs.uk							0	17	18	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 27	2007	335	7625					856	857		10.1136/bmj.39371.381308.AD	http://dx.doi.org/10.1136/bmj.39371.381308.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BA	17962286	Green Published			2022-12-24	WOS:000250631000035
J	Schultz, WB				Schultz, William B.			Bolstering the FDA's drug-safety authority	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Zuckerman Spaeder LLP, Washington, DC USA		Schultz, WB (corresponding author), Zuckerman Spaeder LLP, Washington, DC USA.							HARRIS G, 2005, NY TIMES        0302; Institute of Medicine, 2007, FUT DRUG SAF PROM PR	2	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2007	357	22					2217	2219		10.1056/NEJMp078212	http://dx.doi.org/10.1056/NEJMp078212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234PQ	18046024				2022-12-24	WOS:000251176400001
J	Gelis, I; Bonvin, AMJJ; Keramisanou, D; Koukaki, M; Gouridis, G; Karamanou, S; Economou, A; Kalodimos, CG				Gelis, Ioannis; Bonvin, Alexandre M. J. J.; Keramisanou, Dimitra; Koukaki, Marina; Gouridis, Giorgos; Karamanou, Spyridoula; Economou, Anastassios; Kalodimos, Charalampos G.			Structural basis for signal-sequence recognition by the translocase motor SecA as determined by NMR	CELL			English	Article							PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; PEPTIDE; COMPLEX; CYCLE; SITE; IDENTIFICATION; CONFORMATION; INTERACTS	Recognition of signal sequences by cognate receptors controls the entry of virtually all proteins to export pathways. Despite its importance, this process remains poorly understood. Here, we present the solution structure of a signal peptide bound to SecA, the 204 kDa ATPase motor of the Sec translocase. Upon encounter, the signal peptide forms an alpha-helix that inserts into a flexible and elongated groove in SecA. The mode of binding is bimodal, with both hydrophobic and electrostatic interactions mediating recognition. The same groove is used by SecA to recognize a diverse set of signal sequences. Impairment of the signal-peptide binding to SecA results in significant translocation defects. The C-terminal tail of SecA occludes the groove and inhibits signal-peptide binding, but autoinhibition is relieved by the SecB chaperone. Finally, it is shown that SecA interconverts between two conformations in solution, suggesting a simple mechanism for polypeptide translocation.	Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; FORTH, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece; Univ Crete, Dept Biol, GR-71110 Iraklion, Greece	Rutgers State University Newark; Rutgers State University New Brunswick; Utrecht University; Foundation for Research & Technology - Hellas (FORTH); University of Crete	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018; Bonvin, Alexandre M.J.J./A-5420-2009; Gouridis, GIORGOS/ABF-7948-2021; Economou, Anastassios/P-8292-2017; Kalodimos, Charalampos/C-5380-2008; Karamanou, Spyridoula/H-7485-2018	Kalodimos, Charalampos/0000-0001-6354-2796; Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Gouridis, GIORGOS/0000-0002-2255-0455; Economou, Anastassios/0000-0002-1770-507X; Karamanou, Spyridoula/0000-0002-8803-1404	NIGMS NIH HHS [R01 GM073854, GM-73854, R01 GM073854-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; AKITA M, 1990, J BIOL CHEM, V265, P8164; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou YT, 2005, J BIOL CHEM, V280, P32753, DOI 10.1074/jbc.M507532200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fak JJ, 2004, BIOCHEMISTRY-US, V43, P7307, DOI 10.1021/BI0357208; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Karamanou S, 2007, EMBO J, V26, P2904, DOI 10.1038/sj.emboj.7601721; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Keramisanou D, 2006, NAT STRUCT MOL BIOL, V13, P594, DOI 10.1038/nsmb1108; KIMURA E, 1991, J BIOL CHEM, V266, P6600; Kourtz L, 2000, MOL MICROBIOL, V37, P1342, DOI 10.1046/j.1365-2958.2000.02078.x; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 1997, BBA-BIOMEMBRANES, V1326, P23, DOI 10.1016/S0005-2736(97)00004-7; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Musial-Siwek M, 2007, J MOL BIOL, V365, P637, DOI 10.1016/j.jmb.2006.10.027; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; Wang LG, 2004, BIOCHEMISTRY-US, V43, P13185, DOI 10.1021/bi049485k; WANG ZL, 1993, BIOCHEMISTRY-US, V32, P13991, DOI 10.1021/bi00213a032; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980	50	319	322	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					756	769		10.1016/j.cell.2007.09.039	http://dx.doi.org/10.1016/j.cell.2007.09.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022369	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000250966300022
J	Reczek, D; Schwake, M; Schroder, J; Hughes, H; Blanz, J; Jin, XY; Brondyk, W; Van Patten, S; Edmunds, T; Saftig, P				Reczek, David; Schwake, Michael; Schroeder, Jenny; Hughes, Heather; Blanz, Judith; Jin, Xiaoying; Brondyk, William; Van Patten, Scott; Edmunds, Tim; Saftig, Paul			LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-Glucocerebrosidase	CELL			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; GAUCHER-DISEASE; CYTOPLASMIC TAIL; IN-VITRO; PROTEIN; ENZYMES; BINDING; SIALOGLYCOPROTEIN; PURIFICATION; TRAFFICKING	beta-glucocerebrosidase, the enzyme defective in Gaucher disease, is targeted to the lysosome independently of the mannose-6-phosphate receptor. Affinity-chromatography experiments revealed that the lysosomal integral membrane protein LIMP-2 is a specific binding partner of beta-glucocerebrosidase. This interaction involves a coiled-coil domain within the lumenal domain. beta-glucocerebrosidase activity and protein levels were severely decreased in LIMP-2-deficient mouse tissues. Analysis of fibroblasts and macrophages isolated from these mice indicated that the majority of beta-glucocerebrosidase was secreted. Missorting of beta-glucocerebrosidase was also evident in vivo, as protein and activity levels were significantly higher in sera from LIMP-2-deficient mice compared to wild-type. Reconstitution of LIMP-2 in LIMP-2-deficient fibroblasts led to a rescue of beta-glucocerebrosidase levels and distribution. LIMP-2 expression also led to lysosomal transport of a beta-glucocerebrosidase endoplasmic reticulum retention mutant. These data support a role for LIMP-2 as the mannose-6-phosphate-independent trafficking receptor for beta-glucocerebrosidase.	Genzyme Corp, Framingham, MA 01701 USA; Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Sanofi-Aventis; Genzyme Corporation; University of Kiel	Reczek, D (corresponding author), Genzyme Corp, 1 Mt Rd, Framingham, MA 01701 USA.	david.reczek@genzyme.com; psaftig@biochem.uni-kiel.de		Schwake, Michael/0000-0002-4173-2166				AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1986, P NATL ACAD SCI USA, V83, P7472, DOI 10.1073/pnas.83.19.7472; Beutler E, 2006, ACTA PAEDIATR, V95, P103, DOI 10.1080/08035320600619039; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; Dittmer F, 1999, J CELL SCI, V112, P1591; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fujita H, 1999, BIOCHEM BIOPH RES CO, V255, P54, DOI 10.1006/bbrc.1998.0140; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Gamp AC, 2003, HUM MOL GENET, V12, P631, DOI 10.1093/hmg/ddg062; GINSEL LA, 1991, CELL BIOL INT REP, V15, P1167, DOI 10.1016/0309-1651(91)90088-Z; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Knipper M, 2006, J PHYSIOL-LONDON, V576, P73, DOI 10.1113/jphysiol.2006.116889; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Leonova T, 2000, MOL GENET METAB, V70, P281, DOI 10.1006/mgme.2000.3035; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; LUDWIG T, 1995, TRENDS CELL BIOL, V5, P202, DOI 10.1016/S0962-8924(00)89000-5; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; NILSSON O, 1982, J NEUROCHEM, V39, P709, DOI 10.1111/j.1471-4159.1982.tb07950.x; NILSSON O, 1985, CLIN GENET, V27, P443; OKAZAKI I, 1992, J BIOCHEM, V111, P763, DOI 10.1093/oxfordjournals.jbchem.a123833; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; RIJNBOUTT S, 1991, J BIOL CHEM, V266, P4862; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; SUAREZQUIAN CA, 1987, TISSUE CELL, V19, P495, DOI 10.1016/0040-8166(87)90043-7; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; VANDONGEN JM, 1985, EUR J CELL BIOL, V39, P179; VEGA MA, 1991, J BIOL CHEM, V266, P16269; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	44	345	366	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					770	783		10.1016/j.cell.2007.10.018	http://dx.doi.org/10.1016/j.cell.2007.10.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022370	Bronze			2022-12-24	WOS:000250966300023
J	Hocking, WK; Carey-Smith, T; Tarasick, DW; Argall, PS; Strong, K; Rochon, Y; Zawadzki, I; Taylor, PA				Hocking, W. K.; Carey-Smith, T.; Tarasick, D. W.; Argall, P. S.; Strong, K.; Rochon, Y.; Zawadzki, I.; Taylor, P. A.			Detection of stratospheric ozone intrusions by windprofiler radars	NATURE			English	Article							CROSS-TROPOPAUSE EXCHANGE; DISPERSION MODEL FLEXPART; TROPOSPHERE EXCHANGE; BACKGROUND OZONE; UNITED-STATES; VHF; AIR	Stratospheric ozone attenuates harmful ultraviolet radiation and protects the Earth's biosphere(1). Ozone is also of fundamental importance for the chemistry of the lowermost part of the atmosphere, the troposphere(1-8). At ground level, ozone is an important by-product of anthropogenic pollution(7), damaging forests and crops(5,6), and negatively affecting human health(9). Ozone is critical to the chemical and thermal balance of the troposphere(10) because, via the formation of hydroxyl radicals, it controls the capacity of tropospheric air to oxidize and remove other pollutants(1). Moreover, ozone is an important greenhouse gas, particularly in the upper troposphere(1). Although photochemistry in the lower troposphere is the major source of tropospheric ozone(2,7,11), the stratosphere-troposphere transport of ozone(12-19) is important to the overall climatology, budget and long-term trends of tropospheric ozone(3,4,8,12). Stratospheric intrusion events, however, are still poorly understood. Here we introduce the use of modern windprofiler radars(20-22) to assist in such transport investigations. By hourly monitoring the radar-derived tropopause height(23-25) in combination with a series of frequent ozonesonde balloon launches, we find numerous intrusions of ozone from the stratosphere into the troposphere in southeastern Canada. On some occasions, ozone is dispersed at altitudes of two to four kilometres, but on other occasions it reaches the ground, where it can dominate the ozone density variability. We observe rapid changes in radar tropopause height immediately preceding these intrusion events. Such changes therefore serve as a valuable diagnostic for the occurrence of ozone intrusion events. Our studies emphasize the impact that stratospheric ozone can have on tropospheric ozone, and show that windprofiler data can be used to infer the possibility of ozone intrusions, as well as better represent tropopause motions in association with stratosphere-troposphere transport.	Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; Environm Canada, Toronto, ON M3H 5T4, Canada; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ H3A 2K6, Canada; York Univ, Dept Earth & Space Sci & Engn, Toronto, ON M3J 1P3, Canada	Western University (University of Western Ontario); Environment & Climate Change Canada; University of Toronto; McGill University; York University - Canada	Hocking, WK (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	whocking@uwo.ca	Strong, Kimberly/D-2563-2012	Strong, Kimberly/0000-0001-9947-1053; Tarasick, David/0000-0001-9869-0692				Altshuller AP, 1996, J AIR WASTE MANAGE, V46, P134, DOI 10.1080/10473289.1996.10467445; Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Beekmann M, 1997, J ATMOS CHEM, V28, P29, DOI 10.1023/A:1005897314623; Cooper OR, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007306; Cote J, 1998, MON WEATHER REV, V126, P1373, DOI 10.1175/1520-0493(1998)126<1373:TOCMGE>2.0.CO;2; Forster C, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003589; Gage K.S., 1990, RADAR METEOROLOGY, P534, DOI [10.1007/978-1-935704-15-7_37, DOI 10.1007/978-1-935704-15-7_37]; GAGE KS, 1982, J APPL METEOROL, V21, P1150, DOI 10.1175/1520-0450(1982)021<1150:AOMFTD>2.0.CO;2; Hirsch AI, 1996, J GEOPHYS RES-ATMOS, V101, P12659, DOI 10.1029/96JD00557; HOCKING WK, 1986, J ATMOS TERR PHYS, V48, P131, DOI 10.1016/0021-9169(86)90077-2; Hocking WK, 1997, RADIO SCI, V32, P2241, DOI 10.1029/97RS02781; Hogrefe C, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004690; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; LARSEN MF, 1982, B AM METEOROL SOC, V63, P996, DOI 10.1175/1520-0477(1982)063<0996:VAUDRA>2.0.CO;2; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Lin CYC, 2000, GEOPHYS RES LETT, V27, P3465, DOI 10.1029/2000GL011762; Naja M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002477; ROETTGER J, 1990, RADAR METEOROLOGY, P235; Sprenger M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002587; Stevenson DS, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006338; Stohl A, 2000, ATMOS ENVIRON, V34, P1323, DOI 10.1016/S1352-2310(99)00320-9; Stohl A, 2005, ATMOS CHEM PHYS, V5, P2461, DOI 10.5194/acp-5-2461-2005; Stohl A, 2003, B AM METEOROL SOC, V84, P1565, DOI 10.1175/BAMS-84-11-1565; Stohl A, 2002, ATMOS ENVIRON, V36, P4635, DOI 10.1016/S1352-2310(02)00416-8; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tarasick DW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004643; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; Wernli H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000812; WHO World Health Organization, 2003, HLTH ASP AIR POLL PA; *WMO, 1999, 44 WMO GLOB OZ RES	30	64	67	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					281	284		10.1038/nature06312	http://dx.doi.org/10.1038/nature06312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994096				2022-12-24	WOS:000250746200057
J	Rosenberg, AA				Rosenberg, Andrew A.			Fishing for certainty	NATURE			English	Editorial Material									Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Rosenberg, AA (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Morse Hall 142, Durham, NH 03824 USA.								0	26	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					989	989		10.1038/449989a	http://dx.doi.org/10.1038/449989a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960225	Bronze			2022-12-24	WOS:000250395000033
J	Carbia-Nagashima, A; Gerez, J; Perez-Castro, C; Paez-Pereda, M; Silberstein, S; Stalla, GK; Holsboer, F; Arzt, E				Carbia-Nagashima, Alberto; Gerez, Juan; Perez-Castro, Carolina; Paez-Pereda, Marcelo; Silberstein, Susana; Stalla, Guenter K.; Holsboer, Florian; Arzt, Eduardo			RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1 alpha during hypoxia	CELL			English	Article							E3 LIGASE ACTIVITY; KAPPA-B; CHAIN FORMATION; UBIQUITIN; COMPLEX; CANCER; UBC9; EXPRESSION; INDUCTION; PATHWAY	SUMO conjugation to proteins is involved in the regulation of diverse cellular functions. We have identified a protein, RWD-containing sumoylation enhancer ( RSUME), that enhances overall SUMO-1, -2, and -3 conjugation by interacting with the SUMO conjugase Ubc9. RSUME increases noncovalent binding of SUMO-1 to Ubc9 and enhances Ubc9 thioester formation and SUMO polymerization. RSUME enhances the sumoylation of IkB in vitro and in cultured cells, leading to an inhibition of NF-kB transcriptional activity. RSUME is induced by hypoxia and enhances the sumoylation of HIF-1 alpha, promoting its stabilization and transcriptional activity during hypoxia. Disruption of the RWD domain structure of RSUME demonstrates that this domain is critical for RSUME action. Together, these findings point to a central role of RSUME in the regulation of sumoylation and, hence, several critical regulatory pathways in mammalian cells.	Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; IFIBYNE CONICET, Buenos Aires, DF, Argentina; Max Planck Inst Psychiat, D-80804 Munich, Germany; Affectis Pharmaceut, D-80804 Munich, Germany	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society	Arzt, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol & Biol Mol & Celular, C1428EHA, Buenos Aires, DF, Argentina.	earzt@fbmc.fcen.uba.ar		Paez-Pereda, Marcelo/0000-0001-6029-0706				ARZT E, 1992, J CLIN INVEST, V90, P1944, DOI 10.1172/JCI116072; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Castro CP, 2003, ENDOCRINOLOGY, V144, P693, DOI 10.1210/en.2002-220891; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Richard DE, 1999, BIOCHEM BIOPH RES CO, V266, P718, DOI 10.1006/bbrc.1999.1889; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7	44	235	263	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					309	323		10.1016/j.cell.2007.07.044	http://dx.doi.org/10.1016/j.cell.2007.07.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956732	Bronze, Green Published			2022-12-24	WOS:000250507700021
J	Magos, A				Magos, Adam			Does hysterectomy cause urinary incontinence?	LANCET			English	Editorial Material							WOMEN; RISK		Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Magos, A (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	a.magos@medsch.ucl.ac.uk						Altman D, 2007, LANCET, V370, P1494, DOI 10.1016/S0140-6736(07)61635-3; Altman Daniel, 2003, Int Urogynecol J Pelvic Floor Dysfunct, V14, P418, DOI 10.1007/s00192-003-1097-5; Babalola EO, 2007, AM J OBSTET GYNECOL, V196, P214, DOI 10.1016/j.ajog.2006.10.390; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; de Tayrac R, 2007, EUR J OBSTET GYN R B, V130, P258, DOI 10.1016/j.ejogrb.2006.01.032; Engh MAE, 2006, ACTA OBSTET GYN SCAN, V85, P614, DOI 10.1080/00016340600555942; Gustafsson C, 2006, UROLOGY, V68, P769, DOI 10.1016/j.urology.2006.04.001; *HES ONL, MAIN OP SUMM; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Swithinbank LV, 1999, BRIT J GEN PRACT, V49, P897; Thakar R, 2002, NEW ENGL J MED, V347, P1318, DOI 10.1056/NEJMoa013336; Thakar R, 2004, BJOG-INT J OBSTET GY, V111, P20, DOI 10.1111/j.1471-0528.2004.00461.x	12	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1462	1463		10.1016/S0140-6736(07)61613-4	http://dx.doi.org/10.1016/S0140-6736(07)61613-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964333				2022-12-24	WOS:000250487000005
J	Colaluca, IN; Tosoni, D; Nuciforo, P; Senic-Matuglia, F; Galimberti, V; Viale, G; Pece, S; Di Fiore, PP				Colaluca, Ivan N.; Tosoni, Daniela; Nuciforo, Paolo; Senic-Matuglia, Francesca; Galimberti, Viviana; Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo			NUMB controls p53 tumour suppressor activity	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; BREAST-CANCER; NEGATIVE REGULATION; ENDOCYTIC PROTEIN; ALPHA-ADAPTIN; HISTONE H2AX; STEM-CELLS; MDM2; EXPRESSION; GENE	NUMB is a cell fate determinant, which, by asymmetrically partitioning at mitosis, controls cell fate choices by antagonising the activity of the plasma membrane receptor of the NOTCH family(1). NUMB is also an endocytic protein(2), and the NOTCH-NUMB counteraction has been linked to this function(3,4). There might be, however, additional functions of NUMB, as witnessed by its proposed role as a tumour suppressor in breast cancer(5). Here we describe a previously unknown function for human NUMB as a regulator of tumour protein p53 ( also known as TP53). NUMB enters in a tricomplex with p53 and the E3 ubiquitin ligase HDM2( also known as MDM2), thereby preventing ubiquitination and degradation of p53. This results in increased p53 protein levels and activity, and in regulation of p53- dependent phenotypes. In breast cancers there is frequent loss of NUMB expression(5). We show that, in primary breast tumour cells, this event causes decreased p53 levels and increased chemoresistance. In breast cancers, loss of NUMB expression causes increased activity of the receptor NOTCH5. Thus, in these cancers, a single event - loss of NUMB expression - determines activation of an oncogene ( NOTCH) and attenuation of the p53 tumour suppressor pathway. Biologically, this results in an aggressive tumour phenotype, as witnessed by findings that NUMB- defective breast tumours display poor prognosis. Our results uncover a previously unknown tumour suppressor circuitry.	[Colaluca, Ivan N.; Tosoni, Daniela; Nuciforo, Paolo; Senic-Matuglia, Francesca; Pece, Salvatore; Di Fiore, Pier Paolo] FIRC Inst Mol Oncol Fdn, IFOM, I-20139 Milan, Italy; [Colaluca, Ivan N.; Tosoni, Daniela; Galimberti, Viviana; Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo] European Inst Oncol, I-20141 Milan, Italy; [Viale, Giuseppe; Pece, Salvatore; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Pece, S (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM, Via Adamello 16, I-20139 Milan, Italy.	salvatore.pece@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	高, 雨莉/HGU-8187-2022; Senic-Matuglia, Francesca/AAQ-3815-2020; Tosoni, Daniela/K-4524-2014; Di Fiore, Pier Paolo/K-2130-2012; Nuciforo, Paolo/Q-2885-2019; colaluca, ivan nicola/AAB-2571-2019; Pece, Salvatore/B-9609-2013; GALIMBERTI, Viviana Enrica/AAS-3963-2020; Viale, Giuseppe/AAE-8921-2019; Colaluca, Ivan Nicola/K-9776-2016	Di Fiore, Pier Paolo/0000-0002-2252-0950; Pece, Salvatore/0000-0003-1764-3929; GALIMBERTI, Viviana Enrica/0000-0002-5036-7439; Nuciforo, Paolo/0000-0003-1380-0990; Colaluca, Ivan Nicola/0000-0002-3371-112X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MCCANN AH, 1995, BRIT J CANCER, V71, P981, DOI 10.1038/bjc.1995.189; MORNAND J, 1992, CELL, V69, P1237; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; SHERLEY JL, 1995, P NATL ACAD SCI USA, V92, P136, DOI 10.1073/pnas.92.1.136; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Silva J, 2001, ONCOGENE, V20, P4586, DOI 10.1038/sj.onc.1204617; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; VESTEY SB, 1999, CURR OPIN GENE DEV, V9, P22; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	32	287	338	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					76	U11		10.1038/nature06412	http://dx.doi.org/10.1038/nature06412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172499				2022-12-24	WOS:000252079300037
J	Saif-ur-Rehman; Rasoul, MZ; Wodak, A; Claeson, M; Friedman, J; Sayed, GD				Saif-ur-Rehman; Rasoul, Mohammad Zafar; Wodak, Alex; Claeson, Mariam; Friedman, Jed; Sayed, Ghulam Dastagir			Responding to HIV in Afghanistan	LANCET			English	Editorial Material									[Claeson, Mariam] World Bank, AIDS S Asia Reg, Washington, DC 20433 USA; [Saif-ur-Rehman] Minist Publ Hlth, Natl AIDS Control Programme, Kabul, Afghanistan; [Rasoul, Mohammad Zafar] Minist Counter Narcot, Kabul, Afghanistan; [Wodak, Alex] St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia; [Friedman, Jed] World Bank, Dev Econ Res Grp, Washington, DC 20433 USA; [Sayed, Ghulam Dastagir] World Bank, Kabul, Afghanistan	The World Bank; St Vincents Hospital Sydney; The World Bank; The World Bank	Claeson, M (corresponding author), World Bank, AIDS S Asia Reg, 1818 H St NW, Washington, DC 20433 USA.	mclaeson@worldbank.org	Friedman, Jed/AAA-1326-2020					*2004 AFGH NAT HLT, 2006, HLTH SEEK BEH HLTH; ATANASIJEVIC M, 2007, MDM HARM REDUCTION N; BEALL J, URBAN LIVELIHOODS AF; BERTOZZI S, 2006, HIV AIDS PREVENTION, P331; *CENTR INT AG, WORLD FACT BOOK AFGH; International Monetary Fund, 2006, WORLD EC OUTL DAT; KASSI M, INJECTING DRUG USERS; MILLS A, CHALLENGE PAPER COMM; MOSES S, 2006, AIDS S ASIA UND RESP; Razzaghi E, 2006, LANCET, V368, P434, DOI 10.1016/S0140-6736(06)69132-0; Saidel T. J., 2003, International Journal of Drug Policy, V14, P63, DOI 10.1016/S0955-3959(02)00209-8; SAIDEL TJ, 2006, HARM REDUCTION J, V3, P26; TODD CS, 2006, PREVALENCE HIV VIRAL; TODD CS, 2007, EMERGING INFECT DIS; *UN OFF DRUGS CRIM, AFGH DRUG IND STRUCT; *UN OFF DRUGS CRIM, 2005, GOV AFGH MIN COUNT; *UN OFF DRUGS CRIM, 2007, OP SURV; UNICEF, AFGH STAT; United Nations Office on Drugs and Crime, 2006, AFGH OP SURV; Waldman Ronald, 2006, BRIEFING PAPER SERIE; Zaba B, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200406002-00001	21	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2007	370	9605					2167	2169		10.1016/S0140-6736(07)61911-4	http://dx.doi.org/10.1016/S0140-6736(07)61911-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247DY	18156038				2022-12-24	WOS:000252058600039
J	Brayne, C; Fox, C; Boustani, M				Brayne, Carol; Fox, Chris; Boustani, Malaz			Dementia screening in primary care - Is it time?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALZHEIMERS-DISEASE; OLDER-ADULTS; MANAGEMENT; DIAGNOSIS		Indiana Univ, Ctr Aging Res, Regenstrief Inst Inc, Indianapolis, IN 46202 USA; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; Univ Kent, Kent Inst Med & Hlth Sci, Canterbury CT2 7NZ, Kent, England	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Cambridge; University of Kent	Boustani, M (corresponding author), Indiana Univ, Ctr Aging Res, Regenstrief Inst Inc, 410 W 10th St,Ste 2000, Indianapolis, IN 46202 USA.	mboustani@regenstrief.org	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X; Fox, Chris/0000-0001-9480-5704; Robinson, Louise/0000-0003-0209-2503	NATIONAL INSTITUTE ON AGING [R01AG029884, K23AG026770] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG029884, R01AG029884-01, K23 AG 26770-01, K23 AG026770] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alzheimer's Association, ALZH DIS FACTS FIG; Alzheimer's Foundation of America, 2005, ACT HOM PLANN DAY PE, P1; Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Bates J, 2004, J ADV NURS, V45, P644, DOI 10.1046/j.1365-2648.2003.02959.x; Boise L, 1999, GERONTOLOGIST, V39, P457, DOI 10.1093/geront/39.4.457; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2003, INT J GERIATR PSYCH, V18, P780, DOI 10.1002/gps.918; BOUSTANI M, SCREENING DEMENTIA S; Boustani M, 2006, INT J GERIATR PSYCH, V21, P556, DOI 10.1002/gps.1524; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chiu HFK, 2000, INT J GERIATR PSYCH, V15, P947, DOI 10.1002/1099-1166(200010)15:10<947::AID-GPS222>3.3.CO;2-D; Chong MS, 2005, LANCET NEUROL, V4, P576, DOI 10.1016/S1474-4422(05)70168-X; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Galasko D, 2005, J ALZHEIMERS DIS, V8, P339; Gureje O, 2006, J PSYCHOSOM RES, V61, P327, DOI 10.1016/j.jpsychores.2006.07.016; Hopkins JS, 2006, J AM GERIATR SOC, V54, pS189; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Iliffe S, 2006, FAM PRACT, V23, P353, DOI 10.1093/fampra/cmi116; ILLIFFE S, 2004, LEARN HLTH SOC CARE, V3, P5; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Solomon PR, 2005, GERIATRICS-US, V60, P26	24	94	94	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2409	2411		10.1001/jama.298.20.2409	http://dx.doi.org/10.1001/jama.298.20.2409			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042918				2022-12-24	WOS:000251163400022
J	Banez, LL; Hamilton, RJ; Partin, AW; Vollmer, RT; Sun, L; Rodriguez, C; Wang, YT; Terris, MK; Aronson, WJ; Presti, JC; Kane, CJ; Amling, CL; Moul, JW; Freedland, SJ				Banez, Lionel L.; Hamilton, Robert J.; Partin, Alan W.; Vollmer, Robin T.; Sun, Leon; Rodriguez, Carmen; Wang, Yiting; Terris, Martha K.; Aronson, William J.; Presti, Joseph C., Jr.; Kane, Christopher J.; Amling, Christopher L.; Moul, Judd W.; Freedland, Stephen J.			Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; RADICAL PROSTATECTOMY; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; WEIGHT CHANGE; SERUM-LEVELS; ANTIGEN PSA; RISK; HEIGHT; RECURRENCE	Context Recent studies have suggested that obese men have lower serum prostate-specific antigen (PSA) concentrations than nonobese men. Because men with higher body mass index (BMI) have greater circulating plasma volumes, lower PSA concentrations among obese men may be due to hemodilution. Objective To determine the association between hemodilution and PSA concentration in obese men with prostate cancer. Design, Setting, and Participants Retrospective study of men who underwent radical prostatectomy for prostate adenocarcinoma from 1988 to 2006, using data from the databases of the Shared Equal Access Regional Cancer Hospital (n=1373), Duke Prostate Center (n=1974), and Johns Hopkins Hospital (n=10 287). Multivariate linear regression models adjusting for clinicopathological characteristics were used to analyze the main outcome measures. Main Outcome Measures Associations between BMI and mean adjusted PSA concentrations, mean plasma volume, and mean adjusted PSA mass ( total circulating PSA protein, calculated as PSA concentration multiplied by plasma volume), assessed by determining P values for trend. Results After controlling for clinicopathological characteristics, higher BMI was significantly associated with higher plasma volume ( P < .001 for trend) and lower PSA concentrations ( P <= .02 for trend) in all cohorts. In 2 of the 3 cohorts, PSA mass did not change significantly with increasing BMI. In the third cohort, higher BMI was associated with increased PSA mass ( P <. 001 for trend), but only between BMI category less than 25 and the other categories. Conclusions In men undergoing radical prostatectomy, higher BMI was associated with higher plasma volume hemodilution may therefore be responsible for the lower serum PSA concentrations among obese men with prostate cancer. Prospective studies are needed to evaluate this association in screened populations.	Duke Univ, Med Ctr, Div Urol Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Duke Prostate Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Vet Affairs Med Ctr, Urol Sect, Durham, NC USA; Vet Affairs Med Ctr, Dept Pathol, Durham, NC USA; Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21205 USA; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Vet Affairs Med Ctr, Urol Sect, Augusta, GA USA; Med Coll Georgia, Urol Sect, Augusta, GA 30912 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Urol Sect, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Urol, Los Angeles, CA USA; Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA; Vet Affairs Med Ctr, Urol Sect, Palo Alto, CA 94304 USA; Vet Affairs Med Ctr, Urol Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA; Univ Alabama Birmingham, Dept Urol, Birmingham, AL USA	Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Johns Hopkins University; Johns Hopkins Medicine; American Cancer Society; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham	Freedland, SJ (corresponding author), Duke Univ, Med Ctr, Div Urol Surg, Box 2626, Durham, NC 27710 USA.	steve.freedland@duke.edu	wang, yiting/GYU-5306-2022; FENTON, MIRIAM C/B-6430-2011	Terris, Martha/0000-0002-3843-7270; Hamilton, Robert/0000-0002-6715-5934	NCI NIH HHS [R01CA100938, P50 CA92131-01A1, P50 CA58236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA100938, P50CA092131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; Baillargeon J, 2005, CANCER-AM CANCER SOC, V103, P1092, DOI 10.1002/cncr.20856; Barqawi AB, 2005, UROLOGY, V65, P708, DOI 10.1016/j.urology.2004.10.074; Bassett WW, 2005, UROLOGY, V66, P1060, DOI 10.1016/j.urology.2005.05.040; BOER P, 1984, AM J PHYSIOL, V247, pF632, DOI 10.1152/ajprenal.1984.247.4.F632; Bray GA, 2002, J NUTR, V132, p3451S, DOI 10.1093/jn/132.11.3451S; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fowke JH, 2006, CANCER-AM CANCER SOC, V107, P2361, DOI 10.1002/cncr.22249; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Freedland SJ, 2005, J UROLOGY, V174, P1798, DOI 10.1097/01.ju.0000177077.53037.72; Freedland SJ, 2004, J CLIN ONCOL, V22, P446, DOI 10.1200/JCO.2004.04.181; Giovannucci E, 2003, J NATL CANCER I, V95, P1240, DOI 10.1093/jnci/djg009; Gray MA, 2004, ANTICANCER RES, V24, P2069; HAKIM R, 1994, HDB DIALYSIS; Henderson RJ, 1997, J NATL CANCER I, V89, P134, DOI 10.1093/jnci/89.2.134; Ku JH, 2003, UROLOGY, V61, P132, DOI 10.1016/S0090-4295(02)02001-0; Mavropoulos JC, 2007, UROLOGY, V69, P1138, DOI 10.1016/j.urology.2007.01.102; MOUL JW, 1995, JAMA-J AM MED ASSOC, V274, P1277, DOI 10.1001/jama.274.16.1277; NYHOLM HCJ, 1993, BRIT J OBSTET GYNAEC, V100, P1115, DOI 10.1111/j.1471-0528.1993.tb15176.x; Porter MP, 2005, PROSTATE, V62, P316, DOI 10.1002/pros.20121; Purohit A, 2002, STEROIDS, V67, P979, DOI 10.1016/S0039-128X(02)00046-6; Rodriguez C, 2001, CANCER EPIDEM BIOMAR, V10, P345; Rodriguez C, 2007, CANCER EPIDEM BIOMAR, V16, P63, DOI 10.1158/1055-9965.EPI-06-0754; SCHWARTZ LM, 2004, JAMA-J AM MED ASSOC, V291, P711; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Tzanakis I, 2002, NEPHRON, V90, P230, DOI 10.1159/000049051; Vollmer RT, 2003, AM J CLIN PATHOL, V119, P80, DOI 10.1309/UNAQJTFPB1RQBQD4; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; Wolff JM, 2000, ANTICANCER RES, V20, P5191; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443	37	261	272	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2275	2280		10.1001/jama.298.19.2275	http://dx.doi.org/10.1001/jama.298.19.2275			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029831	Bronze			2022-12-24	WOS:000251055900027
J	Konig, H; Matter, N; Bader, R; Thiele, W; Muller, F				Koenig, Harald; Matter, Nathalie; Bader, Ruediger; Thiele, Wilko; Mueller, Ferenc			Splicing segregation: The minor spliceosome acts outside the nucleus and controls cell proliferation	CELL			English	Article							POLYMERASE-II TRANSCRIPTION; U12-TYPE INTRONS; EMBRYONIC-DEVELOPMENT; MORPHOLINO OLIGOMERS; GENE-EXPRESSION; ZEBRAFISH; PROTEINS; ABUNDANCE; INSIGHTS; SNRNA	The functional relevance and the evolution of two parallel mRNA splicing systems in eukaryotes - a major and minor spliceosome that differ in abundance and splicing rate - are poorly understood. We report here that partially spliced pre-mRNAs containing minor-class introns undergo nuclear export and that minor-class snRNAs are predominantly cytoplasmic in vertebrates. Cytoplasmic interference with the minor spliceosome further indicated its functional segregation from the nucleus. In keeping with this, minor splicing was only weakly affected during mitosis. By selectively interfering with snRNA function in zebrafish development and in mammalian cells, we revealed a conserved role for minor splicing in cell-cycle progression. We argue that the segregation of the splicing systems allows for processing of partially unspliced cytoplasmic transcripts, emerging as a result of different splicing rates. The segregation offers a mechanism accounting for spliceosome evolution in a single lineage and provides a means for nucleus-independent control of gene expression.	Forschungszentrum Karlsruhe, Inst Genet & Toxikol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Muller, F (corresponding author), Forschungszentrum Karlsruhe, Inst Genet & Toxikol, Postfach 3640, D-76021 Karlsruhe, Germany.	harald.koenig@itg.fzk.de; f.mueller@bham.ac.uk	Thiele, Wilko/AAF-7856-2020; Muller, Ferenc/C-6426-2009	Thiele, Wilko/0000-0002-8978-4192; Konig, Harald/0000-0002-0117-0939; mueller, ferenc/0000-0002-0996-774X				Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; CARMOFONSECA M, 1991, EMBO J, V10, P195, DOI 10.1002/j.1460-2075.1991.tb07936.x; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; HUANG S, 1992, P NATL ACAD SCI USA, V89, P305, DOI 10.1073/pnas.89.1.305; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kane DA, 1996, DEVELOPMENT, V123, P57; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lynch M, 2002, CURR OPIN GENET DEV, V12, P701, DOI 10.1016/S0959-437X(02)00360-X; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Meunier L, 1999, NUCLEIC ACIDS RES, V27, P2730, DOI 10.1093/nar/27.13.2730; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Nelson MH, 2005, BIOCONJUGATE CHEM, V16, P959, DOI 10.1021/bc0501045; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarng YS, 1996, INT J ADV MANUF TECH, V11, P12, DOI 10.1007/BF01177179; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	42	75	77	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					718	729		10.1016/j.cell.2007.09.043	http://dx.doi.org/10.1016/j.cell.2007.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022366	Bronze			2022-12-24	WOS:000250966300019
J	Kouzarides, T				Kouzarides, Tony			SnapShot: Histone-modifying enzymes	CELL			English	Editorial Material							LYSINE METHYLATION; TRANSCRIPTION; CODE		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.			Kouzarides, Tony/0000-0002-8918-4162				HSILATIFARD A, 2006, ANNU REV BIOCHEM, V75, P243; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Thompson PR, 2006, ACS CHEM BIOL, V1, P433, DOI 10.1021/cb6002306; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	10	99	102	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4							822.e1	10.1016/j.cell.2007.11.005	http://dx.doi.org/10.1016/j.cell.2007.11.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022374	Bronze			2022-12-24	WOS:000250966300027
J	Xu, SZ; Sukumar, P; Zeng, FN; Li, J; Jairaman, A; English, A; Naylor, J; Ciurtin, C; Majeed, Y; Milligan, CJ; Bahnasi, YM; Al-Shawaf, E; Porter, KE; Jiang, LH; Emery, P; Sivaprasadarao, A; Beech, DJ				Xu, Shang-Zhong; Sukumar, Piruthivi; Zeng, Fanning; Li, Jing; Jairaman, Amit; English, Anne; Naylor, Jacqueline; Ciurtin, Coziana; Majeed, Yasser; Milligan, Carol J.; Bahnasi, Yahya M.; Al-Shawaf, Eman; Porter, Karen E.; Jiang, Lin-Hua; Emery, Paul; Sivaprasadarao, Asipu; Beech, David J.			TRPC channel activation by extracellular thioredoxin	NATURE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; CATION CHANNELS; REDUCTASE; CELL; SUBUNIT; DISEASE; BRAIN	Mammalian homologues of Drosophila melanogaster transient receptor potential ( TRP) are a large family of multimeric cation channels that act, or putatively act, as sensors of one or more chemical factor(1,2). Major research objectives are the identification of endogenous activators and the determination of cellular and tissue functions of these channels. Here we show the activation of TRPC5 ( canonical TRP 5) homomultimeric and TRPC5-TRPC1 heteromultimeric channels(3-5) by extracellular reduced thioredoxin, which acts by breaking a disulphide bridge in the predicted extracellular loop adjacent to the ion- selectivity filter of TRPC5. Thioredoxin is an endogenous redox protein with established intracellular functions, but it is also secreted and its extracellular targets are largely unknown(6-9). Particularly high extracellular concentrations of thioredoxin are apparent in rheumatoid arthritis(8,10-12), an inflammatory joint disease that disables millions of people worldwide(13). We show that TRPC5 and TRPC1 are expressed in secretory fibroblast- like synoviocytes from patients with rheumatoid arthritis, that endogenous TRPC5 - TRPC1 channels of the cells are activated by reduced thioredoxin, and that blockade of the channels enhances secretory activity and prevents the suppression of secretion by thioredoxin. The data indicate the presence of a previously unrecognized ion- channel activation mechanism that couples extracellular thioredoxin to cell function.	[Xu, Shang-Zhong; Sukumar, Piruthivi; Zeng, Fanning; Li, Jing; Jairaman, Amit; Naylor, Jacqueline; Ciurtin, Coziana; Majeed, Yasser; Milligan, Carol J.; Bahnasi, Yahya M.; Al-Shawaf, Eman; Jiang, Lin-Hua; Sivaprasadarao, Asipu; Beech, David J.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [English, Anne; Emery, Paul] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England	University of Leeds; University of Leeds; Chapel Allerton Hospital; University of Leeds	Beech, DJ (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	Ciurtin, Coziana/P-1230-2018; Xu, Shang-Zhong/P-2807-2015; Naguib, Yahya/R-2949-2019; Jiang, Lin-Hua/D-2030-2010; Majeed, Yasser/ABG-3662-2021; emery, paul/B-3560-2013; Jiang, Lin-Hua/AAU-1078-2020; Coziana Ciurtin, C Ciurtin/ABA-3848-2021	Ciurtin, Coziana/0000-0002-8911-4113; Xu, Shang-Zhong/0000-0002-7295-9347; Naguib, Yahya/0000-0001-5851-7238; Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Coziana Ciurtin, C Ciurtin/0000-0002-8911-4113; Sivaprasadarao, Asipu/0000-0002-6755-3502; Sukumar, Piruthivi/0000-0002-3294-989X; Beech, David/0000-0002-7683-9422	Arthritis Research UK [18475] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: Medline; Wellcome Trust [083857, 077424] Funding Source: Medline; BBSRC [BB/D524875/1] Funding Source: UKRI	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Beech D. J., 2007, V179, P109; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Flockerzi V., 2007, V179, P1; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Lemarechal H, 2006, CLIN CHIM ACTA, V367, P156, DOI 10.1016/j.cca.2005.12.006; Lemarechal H, 2007, FREE RADICAL RES, V41, P688, DOI 10.1080/10715760701294468; Maurice MM, 1999, ARTHRITIS RHEUM, V42, P2430, DOI 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Porter KE, 2002, J VASC SURG, V36, P150, DOI 10.1067/mva.2002.122029; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; SMOLEN JS, 2007, LANCET          0613, DOI DOI 10.1016/S0140-6736(07)60784-3; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Xu SZ, 2006, AM J PHYSIOL-HEART C, V291, pH2653, DOI 10.1152/ajpheart.00495.2006; Xu SZ, 2006, CIRC RES, V98, P1381, DOI 10.1161/01.RES.0000225284.36490.a2; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; Yoshida S, 1999, J IMMUNOL, V163, P351; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391	27	215	221	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					69	U9		10.1038/nature06414	http://dx.doi.org/10.1038/nature06414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172497	Green Accepted			2022-12-24	WOS:000252079300035
J	Kopka, A				Kopka, Andreas			Ghost in the machine?	BRITISH MEDICAL JOURNAL			English	Editorial Material									So Gen Hosp, Greater Glasgow Univ Hosp, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Kopka, A (corresponding author), So Gen Hosp, Greater Glasgow Univ Hosp, Glasgow G51 4TF, Lanark, Scotland.	a.kopka@doctors.org.uk						DAVIS PD, 1998, BASIC PHYS MEASUREME; Pilotto S, 2001, LASER MED SCI, V16, P2, DOI 10.1007/PL00011332	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1298	1298		10.1136/bmj.39408.651053.AD	http://dx.doi.org/10.1136/bmj.39408.651053.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156237	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000252182700018
J	Cheng, J; Kang, XL; Zhang, S; Yeh, ETH				Cheng, Jinke; Kang, Xunlei; Zhang, Sui; Yeh, Edward T. H.			SUMO-Specific protease 1 is essential for stabilization of HIF1 alpha during hypoxia	CELL			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; PROLYL HYDROXYLATION/; O-2 TENSION; HIF-ALPHA; DEGRADATION; VHL; HIF-1-ALPHA	SUMOylation is a dynamic process, catalyzed by SUMO-specific ligases and reversed by Sentrin/SUMO-specific proteases (SENPs). The physiologic consequences of SUMOylation and deSUMOylation are not fully understood. Here we investigate the phenotypes of mice lacking SENP1 and find that SENP1(-/-) embryos show severe fetal anemia stemming from deficient erythropoietin (Epo) production and die midgestation. We determine that SENP1 controls Epo production by regulating the stability of hypoxia-inducible factor 1 alpha (HIF1 alpha) during hypoxia. Hypoxia induces SUMOylation of HIF1a, which promotes its binding to a ubiquitin ligase, von Hippel-Lindau (VHL) protein, through a proline hydroxylation-independent mechanism, leading to its ubiquitination and degradation. In SENP1(-/-) MEFs, hypoxia-induced transcription of HIF1 alpha-dependent genes such as vascular endothelial growth factor (VEGF) and glucose transporter 1 (Glut-1) is markedly reduced. These results show that SENP1 plays a key role in the regulation of the hypoxic response through regulation of HIF1a stability and that SUMOylation can serve as a direct signal for ubiquitin-dependent degradation.	Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Brown Fdn Inst Mol Med, Cardiovasc Res Ctr, Houston, TX 77030 USA; Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Shanghai Jiao Tong University	Yeh, ETH (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	etyeh@mdanderson.org		Kang, Xunlei/0000-0003-1853-1881	NCI NIH HHS [R01 CA080089-05, R01 CA139520, R01 CA080089, R01 CA080089-01A1, R01 CA80089, R01 CA080089-02, R01 CA080089-03, R01 CA080089-04, CA16672, P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA139520, R01CA080089, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Ebert BL, 1999, BLOOD, V94, P1864; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamashita K, 2001, BIOMACROMOLECULES, V2, P25, DOI 10.1021/bm0000844; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	41	480	515	2	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					584	595		10.1016/j.cell.2007.08.045	http://dx.doi.org/10.1016/j.cell.2007.08.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981124	Green Accepted, Bronze			2022-12-24	WOS:000250618500024
J	Hunter, DJ; Khoury, MJ; Drazen, JM				Hunter, David J.; Khoury, Muin J.; Drazen, Jeffrey M.			Letting the genome out of the bottle - Will we get our wish?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICINE		[Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA	Hunter, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.		Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Haddow JE, 2004, HUMAN GENOME EPIDEMI, P217; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	4	293	298	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					105	107		10.1056/NEJMp0708162	http://dx.doi.org/10.1056/NEJMp0708162			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184955				2022-12-24	WOS:000252204200001
J	Taylor, AL; Gostin, LO; Pagonis, KA				Taylor, Allyn L.; Gostin, Lawrence O.; Pagonis, Katrina A.			Ensuring effective pain treatment - A national and global perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEVELOPING-COUNTRIES; PALLIATIVE CARE; MANAGEMENT; AVAILABILITY; DISPARITIES; PHARMACIES		[Taylor, Allyn L.; Gostin, Lawrence O.; Pagonis, Katrina A.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; De Lima Liliana, 2004, J Palliat Med, V7, P97, DOI 10.1089/109662104322737368; Farmer P, 2005, PATHOLOGIES POWER HL; Fishman SM, 2004, PAIN MED, V5, P309, DOI 10.1111/j.1526-4637.2004.04049.x; Forbes Karen, 2006, J Pain Palliat Care Pharmacother, V20, P33, DOI 10.1300/J354v20n03_08; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Green CR, 2005, J PAIN, V6, P689, DOI 10.1016/j.jpain.2005.06.002; Joranson DE, 2007, J PAIN SYMPTOM MANAG, V33, P527, DOI 10.1016/j.jpainsymman.2007.02.013; Koshy RC, 1998, SUPPORT CARE CANCER, V6, P430, DOI 10.1007/s005200050190; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; MCNEIL DG, 2007, NY TIMES        0910, pA15; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Mosoiu D, 2007, J PAIN SYMPTOM MANAG, V33, P610, DOI 10.1016/j.jpainsymman.2007.02.023; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Stjernsward J, 2007, J PUBLIC HEALTH POL, V28, P42, DOI 10.1057/palgrave.jphp.3200115; Sullivan LW, 2005, PAIN MED, V6, P5, DOI 10.1111/j.1526-4637.2005.05016.x; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; *U WISC PAIN POL S, 2006, SINGL CONV NARC DRUG; Webster R, 2007, J PUBLIC HEALTH POL, V28, P28, DOI 10.1057/palgrave.jphp.3200097; Won AB, 2004, J AM GERIATR SOC, V52, P867, DOI 10.1111/j.1532-5415.2004.52251.x	20	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					89	91		10.1001/jama.2007.25	http://dx.doi.org/10.1001/jama.2007.25			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167410				2022-12-24	WOS:000252052000021
J	Kmietowicz, Z				Kmietowicz, Zosia			Better safe than sorry?	BRITISH MEDICAL JOURNAL			English	Article												zkmietowicz@bmj.com						ALLAN PL, MED HEADLINES; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; *CLIN ADV COMM DIA, 2007, REP SAF EFF CT SCREE; McMahon PM, 2007, BRIT MED J, V334, P271, DOI 10.1136/bmj.39090.662963.80; *ROYAL COLL RAD, 1998, MAK BEST US CLIN RAD; *US FDA, WHOL BOD SCANN US CO; 2000, IONISING RAD MED EXP	7	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1182	1184		10.1136/bmj.39415.528623.AD	http://dx.doi.org/10.1136/bmj.39415.528623.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063642	Green Published			2022-12-24	WOS:000251707800028
J	Goldacre, B				Goldacre, Ben			Behold the Christmas miracle of antioxidants	BRITISH MEDICAL JOURNAL			English	Editorial Material												ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728					0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1124	1124		10.1136/bmj.39413.403750.59	http://dx.doi.org/10.1136/bmj.39413.403750.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048537	Green Published			2022-12-24	WOS:000251596100029
J	Miwa, K; Takano, J; Omori, H; Seki, M; Shinozaki, K; Fujiwara, T				Miwa, Kyoko; Takano, Junpei; Omori, Hiroyuki; Seki, Motoaki; Shinozaki, Kazuo; Fujiwara, Toru			Plants tolerant of high boron levels	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TRANSPORTER		Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Tokyo 1030027, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	Shinozaki, Kazuo/G-4202-2013; Takano, Junpei/A-5255-2012; FUJIWARA, Toru/A-4119-2011; Seki, Motoaki/I-2854-2012; MIWA, Kyoko/D-4220-2009	Shinozaki, Kazuo/0000-0002-6317-9867; Seki, Motoaki/0000-0001-8288-0467; Miwa, Kyoko/0000-0001-7328-3628; Takano, Junpei/0000-0002-7474-3101				CARTWRIGHT B, 1984, AUST J SOIL RES, V22, P261, DOI 10.1071/SR9840261; Hayes JE, 2004, PLANT PHYSIOL, V136, P3376, DOI 10.1104/pp.103.037028; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102	6	202	216	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1417	1417		10.1126/science.1146634	http://dx.doi.org/10.1126/science.1146634			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048682				2022-12-24	WOS:000251246100036
J	Scheiermann, C; Meda, P; Aurrand-Lions, M; Madani, R; Yiangou, Y; Coffey, P; Salt, TE; Ducrest-Gay, D; Caille, D; Howell, O; Reynolds, R; Lobrinus, A; Adams, RH; Yu, ASL; Anand, P; Imhof, BA; Nourshargh, S				Scheiermann, Christoph; Meda, Paolo; Aurrand-Lions, Michel; Madani, Rime; Yiangou, Yiangos; Coffey, Peter; Salt, Thomas E.; Ducrest-Gay, Dominique; Caille, Dorothee; Howell, Owain; Reynolds, Richard; Lobrinus, Alexander; Adams, Ralf H.; Yu, Alan S. L.; Anand, Praveen; Imhof, Beat A.; Nourshargh, Sussan			Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves	SCIENCE			English	Article							AUTOTYPIC ADHERENS JUNCTIONS; JAM FAMILY; E-CADHERIN; AXONS; MICE; DIFFERENTIATION; PROTEINS; CELLS	JAM-C is an adhesion molecule that is expressed on cells within the vascular compartment and epithelial cells and, to date, has been largely studied in the context of inflammatory events. Using immunolabeling procedures in conjunction with confocal and electron microscopy, we show here that JAM-C is also expressed in peripheral nerves and that this expression is localized to Schwann cells at junctions between adjoining myelin end loops. Sciatic nerves from JAM-C-deficient [having the JAM-C gene knocked out (KO)] mice exhibited loss of integrity of the myelin sheath and defective nerve conduction as indicated by morphological and electrophysiological studies, respectively. In addition, behavioral tests showed motor abnormalities in the KO animals. JAM-C was also expressed in human sural nerves with an expression profile similar to that seen in mice. These results demonstrate that JAM-C is a component of the autotypic junctional attachments of Schwann cells and plays an important role in maintaining the integrity and function of myelinated peripheral nerves.	Imperial Coll London, Natl Heart & Lung Inst, London, England; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; Univ Geneva, Fac Med, Ctr Med Univ, Geneva, Switzerland; Inst J Paoli I Calmettes, INSERM, UMR 599, F-13009 Marseille, France; Imperial Coll London, Div Neurosci & Mental Hlth, Peripheral Neuropathy Unit, London, England; UCL, Inst Ophthalmol, London, England; Imperial Coll London, Dept Cellular & Mol Neurosci, Div Neurosci & Mental Hlth, London, England; Canc Res UK, London Res Inst, London, England; Univ So Calif, Keck Sch Med, Dept Med, Div Nephrol, Los Angeles, CA USA	Imperial College London; University of London; Queen Mary University London; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Imperial College London; University of London; University College London; Imperial College London; Cancer Research UK; University of Southern California	Nourshargh, S (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	s.nourshargh@qmul.ac.uk	Yu, Alan/AID-7467-2022; Adams, Ralf H/AAE-9274-2019; Scheiermann, Christoph/B-8261-2014; Aurrand-Lions, Michel/O-9953-2016	Scheiermann, Christoph/0000-0002-9212-0995; Aurrand-Lions, Michel/0000-0002-8361-3034; Yiangou, Yiangos/0000-0003-3518-5474; Nourshargh, Sussan/0000-0001-5677-1806; Yu, Alan/0000-0002-1776-2533; Coffey, Peter/0000-0002-5427-2939; Howell, Owain/0000-0003-2157-9157	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; British Heart Foundation [PG/03/123/16102] Funding Source: Medline; NIDDK NIH HHS [R01 DK062283] Funding Source: Medline; Wellcome Trust [064920] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2005, J IMMUNOL, V174, P6406, DOI 10.4049/jimmunol.174.10.6406; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Imhof BA, 2007, J PATHOL, V212, P198, DOI 10.1002/path.2163; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Scherer SS, 2002, J PERIPHER NERV SYST, V7, P1, DOI 10.1046/j.1529-8027.2002.02001.x; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	17	48	49	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1472	1475		10.1126/science.1149276	http://dx.doi.org/10.1126/science.1149276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048693	Green Accepted			2022-12-24	WOS:000251246100052
J	Riebesell, U; Schulz, KG; Bellerby, RGJ; Botros, M; Fritsche, P; Meyerhofer, M; Neill, C; Nondal, G; Oschlies, A; Wohlers, J; Zollner, E				Riebesell, U.; Schulz, K. G.; Bellerby, R. G. J.; Botros, M.; Fritsche, P.; Meyerhoefer, M.; Neill, C.; Nondal, G.; Oschlies, A.; Wohlers, J.; Zoellner, E.			Enhanced biological carbon consumption in a high CO2 ocean	NATURE			English	Article							MARINE; TEMPERATURE; SEAWATER; SINK	The oceans have absorbed nearly half of the fossil-fuel carbon dioxide (CO2) emitted into the atmosphere since pre-industrial times(1), causing a measurable reduction in seawater pH and carbonate saturation(2). If CO2 emissions continue to rise at current rates, upper-ocean pH will decrease to levels lower than have existed for tens of millions of years and, critically, at a rate of change 100 times greater than at any time over this period(3). Recent studies have shown effects of ocean acidification on a variety of marine life forms, in particular calcifying organisms(4-6). Consequences at the community to ecosystem level, in contrast, are largely unknown. Here we show that dissolved inorganic carbon consumption of a natural plankton community maintained in mesocosm enclosures at initial CO2 partial pressures of 350, 700 and 1,050 mu atm increases with rising CO2. The community consumed up to 39% more dissolved inorganic carbon at increased CO2 partial pressures compared to present levels, whereas nutrient uptake remained the same. The stoichiometry of carbon to nitrogen drawdown increased from 6.0 at low CO2 to 8.0 at high CO2, thus exceeding the Redfield carbon:nitrogen ratio of 6.6 in today's ocean(7). This excess carbon consumption was associated with higher loss of organic carbon from the upper layer of the stratified mesocosms. If applicable to the natural environment, the observed responses have implications for a variety of marine biological and biogeochemical processes, and underscore the importance of biologically driven feedbacks in the ocean to global change.	IFM, GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Inst Geophys, N-5007 Bergen, Norway	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Bjerknes Centre for Climate Research; University of Bergen; University of Bergen	Riebesell, U (corresponding author), IFM, GEOMAR, Leibniz Inst Marine Sci, D-24105 Kiel, Germany.	uriebesell@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Bellerby, Richard/ABD-6590-2021; Bellerby, Richard/B-5277-2012; Schulz, Kai G./Q-5608-2017; Schulz, Kai/AEZ-9073-2022; Oschlies, Andreas/F-9749-2012	Bellerby, Richard/0000-0003-3598-4006; Schulz, Kai G./0000-0002-8481-4639; Schulz, Kai/0000-0002-8481-4639; Oschlies, Andreas/0000-0002-8295-4013; Riebesell, Ulf/0000-0002-9442-452X				ANTIA NJ, 1963, LIMNOL OCEANOGR, V8, P166, DOI 10.4319/lo.1963.8.2.0166; BANSE K, 1994, GLOBAL BIOGEOCHEM CY, V8, P81, DOI 10.1029/93GB02865; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; Diehl S, 2005, ECOLOGY, V86, P2931, DOI 10.1890/04-1512; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gran G, 1952, OCEANOL ACTA, V5, P209; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; HEEMANN C, 2002, THESIS U BREMEN; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houghton J. T., 2001, CLIMATE CHANGE 2001; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Kortzinger A, 2001, DEEP-SEA RES PT I, V48, P661, DOI 10.1016/S0967-0637(00)00051-0; Kuss J, 2004, MAR CHEM, V91, P165, DOI 10.1016/j.marchem.2004.06.007; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; MaierReimer E, 1996, CLIM DYNAM, V12, P711, DOI 10.1007/s003820050138; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; Qian JG, 1996, ANAL CHEM, V68, P3090, DOI 10.1021/ac960370z; RAVEN J, 2005, 12 ROY SOC; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Riebesell U., 2000, NATURE, V407, P634, DOI DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SAMBROTTO RN, 1993, NATURE, V363, P248, DOI 10.1038/363248a0; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; TOGGWEILER JR, 1993, NATURE, V363, P210, DOI 10.1038/363210a0; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WANNINKHOF R, 1993, MAR CHEM, V44, P189, DOI 10.1016/0304-4203(93)90202-Y; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Zeebe RE, 2001, ELSEVIER OCEANOGR SE, V65	38	564	596	12	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					545	U10		10.1038/nature06267	http://dx.doi.org/10.1038/nature06267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17994008				2022-12-24	WOS:000251158500046
J	Frescas, D; Guardavaccaro, D; Bassermann, F; Koyama-Nasu, R; Pagano, M				Frescas, David; Guardavaccaro, Daniele; Bassermann, Florian; Koyama-Nasu, Ryo; Pagano, Michele			JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes	NATURE			English	Article							POLYMERASE-I TRANSCRIPTION; DOMAIN-CONTAINING PROTEINS; INSERTIONAL MUTAGENESIS; HISTONE DEMETHYLATION; MEDIATED DEGRADATION; UBIQUITIN LIGASE; CELL-GROWTH; DNA; IDENTIFICATION; METHYLATION	JHDM1B is an evolutionarily conserved and ubiquitously expressed member of the JHDM (JmjC-domain-containing histone demethylase) family(1-3). Because it contains an F-box motif, this protein is also known as FBXL10 (ref. 4). With the use of a genome-wide RNAi screen, the JHDM1B worm orthologue (T26A5.5) was identified as a gene that regulates growth(5). In the mouse, four independent screens have identified JHDM1B as a putative tumour suppressor by retroviral insertion analysis(6-9). Here we identify human JHDM1B as a nucleolar protein and show that JHDM1B preferentially binds the transcribed region of ribosomal DNA to repress the transcription of ribosomal RNA genes. We also show that repression of ribosomal RNA genes by JHDM1B is dependent on its JmjC domain, which is necessary for the specific demethylation of trimethylated lysine 4 on histone H3 in the nucleolus. In agreement with the notion that ribosomal RNA synthesis and cell growth are coupled processes, we show a JmjC-domain-dependent negative effect of JHDM1B on cell size and cell proliferation. Because aberrant ribosome biogenesis and the disruption of epigenetic control mechanisms contribute to cellular transformation, these results, together with the low levels of JHDM1B expression found in aggressive brain tumours, suggest a role for JHDM1B in cancer development.	NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA	New York University	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, 550 1st Ave, New York, NY 10016 USA.	michele.pagano@nyumc.org	Hu, Ruogu/B-2203-2008	pagano, michele/0000-0003-3210-2442; Guardavaccaro, Daniele/0000-0002-4517-1765				Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brock GJR, 1997, HUM MOL GENET, V6, P451, DOI 10.1093/hmg/6.3.451; Bukhari MH, 2007, PAK J MED SCI, V23, P206; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Frescas D, 2006, J CELL BIOL, V173, P219, DOI 10.1083/jcb.200601156; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koyama-Nasu R, 2007, NAT CELL BIOL, V9, P1074, DOI 10.1038/ncb1628; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4	31	204	218	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					309	U17		10.1038/nature06255	http://dx.doi.org/10.1038/nature06255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994099				2022-12-24	WOS:000250746200063
J	Petersen, CP; Reddien, PW				Petersen, Christian P.; Reddien, Peter W.			Smed-beta-catenin-1 is required for anteroposterior blastema polarity in planarian regeneration	SCIENCE			English	Article							BETA-CATENIN; SPEMANNS ORGANIZER; WNT; EVOLUTION; PATHWAY; EMBRYOS; XENOPUS	Planarian flatworms can regenerate heads at anterior- facing wounds and tails at posterior- facing wounds throughout the body. How this regeneration polarity is specified has been a classic problem for more than a century. We identified a planarian gene, Smed-beta catenin-1, that controls regeneration polarity. Posterior- facing blastemas regenerate a head instead of a tail in Smed-beta catenin- 1( RNAi) animals. Smed-beta catenin- 1 is required after wounding and at any posterior- facing wound for polarity. Additionally, intact Smed-beta catenin- 1( RNAi) animals display anteriorization during tissue turnover. Five Wnt genes and a secreted Frizzled- related Wnt antagonist- like gene are expressed in domains along the anteroposterior axis that reset to new positions during regeneration, which suggests that Wnts control polarity through Smed-beta catenin-1. Our data suggest that beta-catenin specifies the posterior character of the anteroposterior axis throughout the Bilateria and specifies regeneration polarity in planarians.	[Petersen, Christian P.; Reddien, Peter W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu	Petersen, Christian P./GZG-4541-2022	Petersen, Christian P./0000-0001-7552-6865; /0000-0002-5569-333X				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BRONDSTED HV, 1969, PLANARIAN REGENERATI, P276; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Miyawaki K, 2004, MECH DEVELOP, V121, P119, DOI 10.1016/j.mod.2004.01.002; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; RANDOLPH H, 1897, ARCH ENTW MECH ORG, V5, P352; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	25	267	275	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2008	319	5861					327	330		10.1126/science.1149943	http://dx.doi.org/10.1126/science.1149943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18063755				2022-12-24	WOS:000252436200037
J	Berendt, L; Hakansson, C; Bach, KF; Dalhoff, K; Andreasen, PB; Petersen, LG; Andersen, E; Poulsen, HE				Berendt, Louise; Hakansson, Cecilia; Bach, Karin Friis; Dalhoff, Kim; Andreasen, Per Buch; Petersen, Lene Grejs; Andersen, Elin; Poulsen, Henrik Enghusen			Effect of European clinical trials directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency, 1993-2006	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine the impact of the European Union's Clinical Trials Directive on the number of academic drug trials carried out in Denmark. Design Retrospective review of applications ford rug trials to the Danish Medicines Agency, 1993-2006. Review methods Applications for drug trials for alternate years were classified as academic or commercial trials. A random subset of academic trials was reviewed for number of participants in and intended monitoring of the trials. Results Academic and commercial drug trials showed an identical steady decline from 1993 to 2006 and no noticeable change after 2004 when good clinical practice became mandatory for academic trials. Conclusion The Clinical Trials Directive introduced in May 2004 to ensure good clinical practice for academic drug trials was not associated with a decline in research activity in Denmark; presumably because good clinical practice units had already been in place in Danish universities since 1999. With such an infrastructure academic researchers can do drug trials under the same regulations as drug companies.	[Berendt, Louise; Hakansson, Cecilia; Dalhoff, Kim; Poulsen, Henrik Enghusen] Rigshosp, Dept Clin Pharmacol Q7642, DK-2100 Copenhagen, Denmark; [Berendt, Louise; Hakansson, Cecilia; Petersen, Lene Grejs; Andersen, Elin] Danish Med Agcy, DK-2300 Copenhagen, Denmark; [Bach, Karin Friis; Andreasen, Per Buch] Copenhagen Univ Hosp, Gentofte Hosp, GCP Unit, Hellerup, Denmark; [Dalhoff, Kim; Poulsen, Henrik Enghusen] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Poulsen, HE (corresponding author), Rigshosp, Dept Clin Pharmacol Q7642, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	hepo@rh.dk		Poulsen, Henrik Enghusen/0000-0003-4242-9924				Hemminki A, 2006, BMJ-BRIT MED J, V332, P501, DOI 10.1136/bmj.332.7540.501; Mayor S, 2004, BRIT MED J, V328, P1036, DOI 10.1136/bmj.328.7447.1036; Morice AH, 2003, LANCET, V361, P1568, DOI 10.1016/S0140-6736(03)13211-4; SINGER E, 2007, BASIC CLIN PHARM S1, V101, P11	4	18	19	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					33	35		10.1136/bmj.39401.470648.BE	http://dx.doi.org/10.1136/bmj.39401.470648.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18063611	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000252327500033
J	Kamerow, D				Kamerow, Douglas			Waiting for the genetic revolution - Will 2008 be the year that genomics delivers on its promises?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957					0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 5	2008	336	7634					22	22		10.1136/bmj.39437.453102.0F	http://dx.doi.org/10.1136/bmj.39437.453102.0F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18174596	Green Published			2022-12-24	WOS:000252327500029
J	Plaisier, E; Gribouval, O; Alamowitch, S; Mougenot, B; Prost, C; Verpont, MC; Marro, B; Desmettre, T; Cohen, SY; Roullet, E; Dracon, M; Fardeau, M; Van Agtmael, T; Kerjaschki, D; Antignac, C; Ronco, P				Plaisier, Emmanuelle; Gribouval, Olivier; Alamowitch, Sonia; Mougenot, Beatrice; Prost, Catherine; Verpont, Marie Christine; Marro, Beatrice; Desmettre, Thomas; Cohen, Salomon Yves; Roullet, Etienne; Dracon, Michel; Fardeau, Michel; Van Agtmael, Tom; Kerjaschki, Dontscho; Antignac, Corinne; Ronco, Pierre			COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC KIDNEY-DISEASE; RETINAL ARTERIOLAR TORTUOSITY; INTRACRANIAL ANEURYSMS; COLLAGEN-IV; EXPRESSION; STROKE; DYSGENESIS; MATRIX; GENE; WALL	Background: COL4A3, COL4A4, and COL4A5 are the only collagen genes that have been implicated in inherited nephropathies in humans. However, the causative genes for a number of hereditary multicystic kidney diseases, myopathies with cramps, and heritable intracranial aneurysms remain unknown. Methods: We characterized the renal and extrarenal phenotypes of subjects from three families who had an autosomal dominant hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC), which we propose is a syndrome. Linkage studies involving microsatellite markers flanking the COL4A1-COL4A2 locus were performed, followed by sequence analysis of COL4A1 complementary DNA extracted from skin-fibroblast specimens from the subjects. Results: We identified three closely located glycine mutations in exons 24 and 25 of the gene COL4A1, which encodes procollagen type IV alpha 1. The clinical renal manifestations of the HANAC syndrome in these families include hematuria and bilateral, large cysts. Histologic analysis revealed complex basement-membrane defects in kidney and skin. The systemic angiopathy of the HANAC syndrome appears to affect both small vessels and large arteries. Conclusions: COL4A1 may be a candidate gene in unexplained familial syndromes with autosomal dominant hematuria, cystic kidney disease, intracranial aneurysms, and muscle cramps.	Univ Paris 06, INSERM, U702, F-75020 Paris, France; Hop Tenon, Assistance Publ Hop Paris, Unite Mixte Rech Sci 702, F-75970 Paris, France; Hop Tenon, Assistance Publ Hop Paris, Unite Mixte Rech Sci 582, F-75970 Paris, France; Hop Avicenne, Paris, France; Hop La Pitie Salpetriere, Paris, France; Hop Necker Enfants Malad, Paris, France; INSERM, U574, Paris, France; Paris 15, Ctr Ophthalmol, Paris, France; INSERM, U582, Paris, France; Univ Paris 05, Fac Med Rene Descartes, Unite Mixte Rech Sci 574, Paris, France; Univ Lille 2, Lille, France; Ctr Hosp Reg Univ Lille, F-59037 Lille, France; Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of Edinburgh; Medical University of Vienna	Plaisier, E (corresponding author), Hop Tenon, Dept Nephrol, 4 Rue Chine, F-75020 Paris, France.	emmanuelle.plaisier@tnn.aphp.fr	Ronco, Pierre/AAC-8390-2022; ANTIGNAC, Corinne/H-8945-2017; Gribouval, Olivier/A-7689-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Gribouval, Olivier/0000-0003-0238-8224; Van Agtmael, Tom/0000-0003-4282-449X	MRC [G0601268] Funding Source: UKRI; Medical Research Council [G0601268] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; CHYATTE D, 1990, NEUROSURGERY, V26, P939, DOI 10.1227/00006123-199006000-00003; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Joly D, 2003, AM J PATHOL, V163, P1791, DOI 10.1016/S0002-9440(10)63539-0; KATZ SK, 1989, ANN CLIN LAB SCI, V19, P352; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Petrini S, 2005, MOL CELL NEUROSCI, V30, P408, DOI 10.1016/j.mcn.2005.08.005; Plaisier E, 2005, KIDNEY INT, V67, P2354, DOI 10.1111/j.1523-1755.2005.00341.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Ruigrok YM, 2006, HUM MOL GENET, V15, P3361, DOI 10.1093/hmg/ddl412; Shannon MB, 2006, J AM SOC NEPHROL, V17, P1913, DOI 10.1681/ASN.2005121298; Skirgaudas M, 1996, NEUROSURGERY, V39, P537, DOI 10.1097/00006123-199609000-00021; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; van der Knaap MS, 2006, ANN NEUROL, V59, P504, DOI 10.1002/ana.20715; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200	26	223	227	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2687	2695		10.1056/NEJMoa071906	http://dx.doi.org/10.1056/NEJMoa071906			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160688	Bronze			2022-12-24	WOS:000251964500007
J	Srivastava, R				Srivastava, Ranjana			In search of redemption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												docranjana@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2837	2839		10.1001/jama.298.24.2837	http://dx.doi.org/10.1001/jama.298.24.2837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159047				2022-12-24	WOS:000251816000001
J	DeVita, MA; Caplan, AL				DeVita, Michael A.; Caplan, Arthur L.			Caring for organs or for patients? Ethical concerns about the uniform anatomical gift act (2006)	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDERS; LIFE; PREFERENCES; PROGRAM; CARE; END	In 2006, the National Conference of Commissioners on Uniform State Laws rewrote the Uniform Anatomical Gift Act. To overcome the problem of family members prohibiting organ donation from their deceased loved ones even when a donor card existed, the commissioners modified the act to prevent end-of-life care from precluding organ donation, An unintended consequence of the new wording creates the potential for end-of-life care that prioritizes care of the potential donor organs over care and comfort of the dying person. The commissioners have now revised the act, but the original version has already been legislated in many states, with others poised to follow. To protect dying patients' wishes about their end-of-life care, states that have legislated or are considering the original act must replace it with the revised version. A long-term and important ethical precept must stand: Care of dying patients takes precedence over organs. Another laudable goal must be promoted as well: Organ donation is an important part of end-of-life care.	Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ Penn, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania	DeVita, MA (corresponding author), Univ Pittsburgh, Presbyterian Hosp, Med Ctr, Rm C-111,200 Lothrop St, Pittsburgh, PA 15213 USA.							Arnold RM, 1996, CRIT CARE CLIN, V12, P29, DOI 10.1016/S0749-0704(05)70213-X; CAPLAN A, 2007, LAW MUST RIGHT DYING, pA16; *COMM INCR RAT ORG, 2006, ORG DON OPP ACT, P109; Hickman SE, 2004, J AM GERIATR SOC, V52, P1424, DOI 10.1111/j.1532-5415.2004.52402.x; Lee MA, 2000, J AM GERIATR SOC, V48, P1219, DOI 10.1111/j.1532-5415.2000.tb02594.x; Siminoff LA, 2006, J GEN INTERN MED, V21, P995, DOI 10.1007/BF02743151; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017	8	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2007	147	12					876	879		10.7326/0003-4819-147-12-200712180-00008	http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243HO	18087059				2022-12-24	WOS:000251787600008
J	Davenport, A; Gura, V; Ronco, C; Beizai, M; Ezon, C; Rambod, E				Davenport, Andrew; Gura, Victor; Ronco, Claudio; Beizai, Masoud; Ezon, Carlos; Rambod, Edmond			A wearable haemodialysis device for patients with end-stage renal failure: a pilot study	LANCET			English	Article							REPLACEMENT THERAPY; DIALYSIS; DISEASE; WALES	Background More frequent haemodialysis can improve both survival and quality of life of patients with chronic kidney disease. However, there is little capacity in the UK to allow patients to have more frequent haemodialysis treatments in hospital and satellite haemodialysis units. New means of delivering haemodialysis are therefore required. Our aim was to assess the safety and efficiency of a wearable haemodialysis device. Methods Eight patients with end-stage kidney failure (five men, three women, mean age 51.7 [SD 13.8] years) who were established on regular haemodialysis were fitted with a wearable haemodialysis device for 4-8 h. Patients were given unfractionated heparin for anticoagulation, as they would be for standard haemodialysis. Findings There were no important cardiovascular changes and no adverse changes in serum electrolytes or acid-base balance. There was no evidence of clinically significant haemolysis in any patient. Mean blood flow was 58 . 6 (SD 11 . 7) mL/min, with a dialysate flow of 47.1 (7.8) mL/min. The mean plasma urea. clearance rate was 22.7 (5.2) mL/min and the mean plasma creatinine clearance rate was 20.7 (4-8) mL/min. Clotting of the vascular access occurred in two patients when the dose of heparin was decreased and the partial thromboplastin time returned towards the normal reference range in both of these patients. The fistula needle became dislodged in one patient, but safety mechanisms prevented blood loss, the needle was replaced, and treatment continued. Interpretation This wearable haemodialysis device shows promising safety and efficacy results, although further studies will be necessary to confirm these results.	Royal Free & Univ Coll Hosp Med Sch, Ctr Nephrol, Div Med, London, England; Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA USA; Osped San Bortolo, Div Nefrol, Vicenza, Italy; Xcorporeal Inc, Los Angeles, CA USA; BioQuantetics Inc, Los Angeles, CA USA	University of London; University College London; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Davenport, A (corresponding author), Royal Free & Univ Coll Med Sch, UCL Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk	Gura, Victor/HGA-8677-2022	Ronco, Claudio/0000-0002-6697-4065				Blagg Christopher R, 2006, Hemodial Int, V10, P371, DOI 10.1111/j.1542-4758.2006.00132.x; Daugirdas JT, 2005, SEMIN NEPHROL, V25, P76, DOI 10.1016/j.semnephrol.2004.09.013; Davenport Andrew, 2006, Hemodial Int, V10, P162; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Gura V, 2006, ASAIO J, V52, P59, DOI 10.1097/01.mat.0000195283.58995.83; Gura V, 2005, CONTRIB NEPHROL, V149, P325, DOI 10.1159/000085694; GURA V, IN PRESS KIDNEY INT; Kutner N G, 1998, Geriatr Nephrol Urol, V8, P77, DOI 10.1023/A:1008384814079; Lindsay RM, 2004, CURR OPIN NEPHROL HY, V13, P631, DOI 10.1097/00041552-200411000-00008; Lindsay RM, 2003, AM J KIDNEY DIS, V42, pS5, DOI 10.1016/S0272-6386(03)00531-6; MACTIER R, 2007, MODULE 3A HAEMODIALY; Nissenson Allen R, 2005, Hemodial Int, V9, P210, DOI 10.1111/j.1492-7535.2005.01135.x; Pierratos A, 2006, Minerva Urol Nefrol, V58, P99; Raj DSC, 1999, AM J KIDNEY DIS, V34, P597, DOI 10.1016/S0272-6386(99)70382-3; Roderick P, 2005, HEALTH TECHNOL ASSES, V9, P1; Stephens R L, 1976, Proc Eur Dial Transplant Assoc, V12, P511; Twardowski ZJ, 2007, BLOOD PURIFICAT, V25, P90, DOI 10.1159/000096403; White P, 2006, QJM-INT J MED, V99, P445, DOI 10.1093/qjmed/hcl054	19	130	139	3	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					2005	2010		10.1016/S0140-6736(07)61864-9	http://dx.doi.org/10.1016/S0140-6736(07)61864-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083402				2022-12-24	WOS:000251698600027
J	Westley, H				Westley, Hannah			Thin living	BRITISH MEDICAL JOURNAL			English	Editorial Material												hannah.westley@wanadoo.fr							0	20	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1236	1237		10.1136/bmj.39409.451678.AD	http://dx.doi.org/10.1136/bmj.39409.451678.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079544	Green Published			2022-12-24	WOS:000251832200029
J	Daar, AS; Singer, PA; Persad, DL; Pramming, SK; Matthews, DR; Beaglehole, R; Bernstein, A; Borysiewicz, LK; Colagiuri, S; Ganguly, N; Glass, RI; Finegood, DT; Koplan, J; Nabel, EG; Sarna, G; Sarrafzadegan, N; Smith, R; Yach, D; Bell, J				Daar, Abdallah S.; Singer, Peter A.; Persad, Deepa Leah; Pramming, Stig K.; Matthews, David R.; Beaglehole, Robert; Bernstein, Alan; Borysiewicz, Leszek K.; Colagiuri, Stephen; Ganguly, Nirmal; Glass, Roger I.; Finegood, Diane T.; Koplan, Jeffrey; Nabel, Elizabeth G.; Sarna, George; Sarrafzadegan, Nizal; Smith, Richard; Yach, Derek; Bell, John			Grand challenges in chronic non-communicable diseases	NATURE			English	Article							HEALTH		Univ Toronto, Univ Hlth Network, Program Life Sci Eth & Policy, Toronto, ON M5G 1L7, Canada; Oxford Hlth Alliance, London W1W 8RZ, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Auckland, Fac Med & Hlth Sci, Auckland 1142, New Zealand; Canadian Inst Hlth Res, Ottawa, ON K1A 0W9, Canada; MRC, London W1B 1AL, England; Univ Sydney, Prince Wales Hosp, Ctr Diabet, Randwick, NSW 2031, Australia; Univ Sydney, Prince Wales Hosp, Dept Diabet Endocrinol & Metab, Randwick, NSW 2031, Australia; Indian Council Med Res, New Delhi 110029, India; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Canadian Inst Hlth Res, Inst Nutr Metab & Diabet, Ottawa, ON K1A 0W9, Canada; Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Isfahan Univ Med Sci, Seddigheh Tahereh Res & Treatment Hosp, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; Unitedhlth Europe, Ovat Chron Dis Initiat, London SW1P 1SB, England; PepsiCo, Purchase, NY 10577 USA; Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Oxford; University of Auckland; Institute for Work & Health; University of Sydney; University of Sydney; Indian Council of Medical Research (ICMR); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Institute for Work & Health; Emory University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Isfahan University Medical Science; PepsiCo; University of Oxford	Daar, AS (corresponding author), Univ Toronto, Univ Hlth Network, Program Life Sci Eth & Policy, 101 Coll St, Toronto, ON M5G 1L7, Canada.		Sarrafzadegan, Nizal/V-5826-2017	Sarrafzadegan, Nizal/0000-0002-8352-0540; Colagiuri, Stephen/0000-0002-2398-4781	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200334] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2007, LANCET, V370, P630; [Anonymous], 2005, PREV CHRON DIS VIT I; Berndtson K, 2007, PLOS MED, V4, P1445, DOI 10.1371/journal.pmed.0040268; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Hilbert D., 1902, B AM MATH SOC, V8, P437, DOI [DOI 10.1090/S0002-9904-1902-00923-3, 10.1090/S0002-9904-1902-00923-3]; Jamison DT, 2006, PRIORITIES HLTH; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MARTIN BR, 1995, TECHNOL ANAL STRATEG, V7, P139, DOI 10.1080/09537329508524202; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Rowe G, 2001, INT SER OPER RES MAN, V30, P125, DOI 10.1007/978-0-306-47630-3_7; Singer PA, 2007, NATURE, V449, P160, DOI 10.1038/449160a; Suhrcke M., 2006, CHRONIC DIS EC PERSP; *UNAIDS AIDS EP UP, 2006, SPEC REP HIV AIDS; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769	16	449	460	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					494	496		10.1038/450494a	http://dx.doi.org/10.1038/450494a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033288				2022-12-24	WOS:000251158500032
J	Rosland, AM				Rosland, A. -M.			Assuming the worst	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIAS					arosland@umich.edu		Rosland, Ann-Marie/0000-0002-5809-5861				Burgess D, 2007, J GEN INTERN MED, V22, P882, DOI 10.1007/s11606-007-0160-1; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Smedley B, 2002, UNEQUAL TREATMENT CO, P169	3	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					144	145		10.1001/jama.2007.54-b	http://dx.doi.org/10.1001/jama.2007.54-b			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182591				2022-12-24	WOS:000252182600001
J	Spruit, MA; Vanderhoven-Augustin, I; Janssen, PP; Wouters, EFM				Spruit, Martijn A.; Vanderhoven-Augustin, Ingrid; Janssen, Paul P.; Wouters, Emiel F. M.			Integration of pulmonary rehabilitation in COPD	LANCET			English	Editorial Material							DISEASE; MANAGEMENT		[Spruit, Martijn A.; Vanderhoven-Augustin, Ingrid; Janssen, Paul P.; Wouters, Emiel F. M.] Ctr Integrated Rehabil Organ Failure, NL-6085 NM Horn, Netherlands; [Wouters, Emiel F. M.] Univ Hosp Maastricht, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Spruit, MA (corresponding author), Ctr Integrated Rehabil Organ Failure, NL-6085 NM Horn, Netherlands.	martijnspruit@proteion.nl	Wouters, Emiel/ABD-6200-2021					Baarends EM, 1997, EUR RESPIR J, V10, P2807, DOI 10.1183/09031936.97.10122807; Griffiths TL, 2001, THORAX, V56, P779, DOI 10.1136/thorax.56.10.779; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jones Paul W, 2005, COPD, V2, P75; LACASSE Y, 2007, COCHRANE DB SYST REV, V3; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Spruit MA, 2007, SPORTS MED, V37, P501, DOI 10.2165/00007256-200737060-00004; Weitzenblum E, 2004, SLEEP MED REV, V8, P281, DOI 10.1016/j.smrv.2004.03.006; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009; Wouters EFM, 2004, LANCET, V364, P883, DOI 10.1016/S0140-6736(04)16984-5	14	93	95	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2008	371	9606					12	13		10.1016/S0140-6736(08)60048-3	http://dx.doi.org/10.1016/S0140-6736(08)60048-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177760				2022-12-24	WOS:000252192600010
J	Wald, HL; Kramer, AM				Wald, Heidi L.; Kramer, Andrew M.			Nonpayment for harms resulting from medical care - Catheter-associated urinary tract infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NOSOCOMIAL INFECTIONS; PREVENTION; PHYSICIANS; FEEDBACK		Univ Colorado Denver, Div Hlth Care Policy & Res, Aurora, CO 80111 USA; Hlth Sci Ctr, Aurora, CO 80111 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wald, HL (corresponding author), Univ Colorado Denver, Div Hlth Care Policy & Res, 13611 E Colfax Ave,Ste 100, Aurora, CO 80111 USA.	heidi.wald@uchsc.edu						Centers for Medicare and Medicaid Services (CMS) HHS, 2007, Fed Regist, V72, P47129; Coffey R, 2006, HCUP METHODS SERIES; Dumigan D G, 1998, Clin Perform Qual Health Care, V6, P172; DUNN S, 2000, MANAGEMENT SHORT TER; Goetz AM, 1999, AM J INFECT CONTROL, V27, P402, DOI 10.1016/S0196-6553(99)70005-2; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; JAIN P, 1995, ARCH INTERN MED, V155, P1425, DOI 10.1001/archinte.155.13.1425; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; KRIEGER JN, 1983, J INFECT DIS, V148, P57, DOI 10.1093/infdis/148.1.57; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; MICHELSON JD, 1988, NEW ENGL J MED, V319, P321; Reilly L, 2006, AACN ADV CRIT CARE, V17, P272, DOI 10.1097/01256961-200607000-00007; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Topal J, 2005, AM J MED QUAL, V20, P121, DOI 10.1177/1062860605276074; WALD HL, IN PRESS ARCH SURG; Wong ES, GUIDELINE PREVENTION	18	110	110	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2782	2784		10.1001/jama.298.23.2782	http://dx.doi.org/10.1001/jama.298.23.2782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165672				2022-12-24	WOS:000251716000024
J	Matthews, AGW; Kuo, AJ; Ramon-Maiques, S; Han, SM; Champagne, KS; Ivanov, D; Gallardo, M; Carney, D; Cheung, P; Ciccone, DN; Walter, KL; Utz, PJ; Shi, Y; Kutateladze, TG; Yang, W; Gozani, O; Oettinger, MA				Matthews, Adam G. W.; Kuo, Alex J.; Ramon-Maiques, Santiago; Han, Sunmi; Champagne, Karen S.; Ivanov, Dmitri; Gallardo, Mercedes; Carney, Dylan; Cheung, Peggie; Ciccone, David N.; Walter, Kay L.; Utz, Paul J.; Shi, Yang; Kutateladze, Tatiana G.; Yang, Wei; Gozani, Or; Oettinger, Marjorie A.			RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination	NATURE			English	Article							C-TERMINUS; B-CELL; GENE REARRANGEMENT; PLANT HOMEODOMAIN; PRE-B; METHYLATION; BINDING; TRANSPOSITION; TRANSCRIPTION; ACTIVATION	Nuclear processes such as transcription, DNA replication and recombination are dynamically regulated by chromatin structure. Eukaryotic transcription is known to be regulated by chromatin-associated proteins containing conserved protein domains that specifically recognize distinct covalent post- translational modifications on histones. However, it has been unclear whether similar mechanisms are involved in mammalian DNA recombination. Here we show that RAG2 - an essential component of the RAG1/2 V(D)J recombinase, which mediates antigen- receptor gene assembly(1) - contains a plant homeodomain ( PHD) finger that specifically recognizes histone H3 trimethylated at lysine 4 ( H3K4me3). The high- resolution crystal structure of the mouse RAG2 PHD finger bound to H3K4me3 reveals the molecular basis of H3K4me3- recognition by RAG2. Mutations that abrogate RAG2's recognition of H3K4me3 severely impair V( D) J recombination in vivo. Reducing the level of H3K4me3 similarly leads to a decrease in V(D)J recombination in vivo. Notably, a conserved tryptophan residue ( W453) that constitutes a key structural component of the K4me3- binding surface and is essential for RAG2's recognition of H3K4me3 is mutated in patients with immunodeficiency syndromes. Together, our results identify a new function for histone methylation in mammalian DNA recombination. Furthermore, our results provide the first evidence indicating that disrupting the read- out of histone modifications can cause an inherited human disease.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Stanford University; Harvard University; Harvard Medical School	Oettinger, MA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ogozani@stanford.edu; oettinger@frodo.mgh.harvard.edu	Kuo, Alex/AAL-2845-2020; Yang, Wei/ABB-4785-2020; Glass, Karen C./AAV-1076-2021	Yang, Wei/0000-0002-3591-2195; Glass, Karen C./0000-0002-2761-733X; Gozani, Or/0000-0002-1365-4463; Ramon-Maiques, Santiago/0000-0001-9674-8088; Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048026] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NIGMS NIH HHS [R01 GM048026-12, R01 GM048026] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Baumann M, 2003, EMBO J, V22, P5197, DOI 10.1093/emboj/cdg487; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Elkin SK, 2003, EMBO J, V22, P1931, DOI 10.1093/emboj/cdg184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAUSS GH, 1993, MOL CELL BIOL, V13, P3900, DOI 10.1128/MCB.13.7.3900; Gomez CA, 2000, MOL CELL BIOL, V20, P5653, DOI 10.1128/MCB.20.15.5653-5664.2000; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perkins EJ, 2004, NUCLEIC ACIDS RES, V32, P1942, DOI 10.1093/nar/gkh523; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; West KL, 2005, IMMUNITY, V23, P203, DOI 10.1016/j.immuni.2005.07.004; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	40	361	369	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1106	U18		10.1038/nature06431	http://dx.doi.org/10.1038/nature06431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18033247	Green Accepted			2022-12-24	WOS:000251579900092
J	Behrens, MM; Ali, SS; Dao, DN; Lucero, J; Shekhtman, G; Quick, KL; Dugan, LL				Behrens, M. Margarita; Ali, Sameh S.; Dao, Diep N.; Lucero, Jacinta; Shekhtman, Grigoriy; Quick, Kevin L.; Dugan, Laura L.			Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase	SCIENCE			English	Article							DECARBOXYLASE-67 MESSENGER-RNA; NMDA RECEPTOR HYPOFUNCTION; PREFRONTAL CORTEX; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOPHRENIA; NEURONS; PHENCYCLIDINE; IMMUNOREACTIVITY; PARVALBUMIN	Abuse of the dissociative anesthetic ketamine can lead to a syndrome indistinguishable from schizophrenia. In animals, repetitive exposure to this N-methyl-D-aspartate-receptor antagonist induces the dysfunction of a subset of cortical fast-spiking inhibitory interneurons, with loss of expression of parvalbumin and the gamma-aminobutyric acid-producing enzyme GAD67. We show here that exposure of mice to ketamine induced a persistent increase in brain superoxide due to activation in neurons of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Decreasing superoxide production prevented the effects of ketamine on inhibitory interneurons in the prefrontal cortex. These results suggest that NADPH oxidase may represent a novel target for the treatment of ketamine-induced psychosis.	Univ Calif San Diego, Dept Med, Div Geriatr Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Behrens, MM (corresponding author), Univ Calif San Diego, Dept Med, Div Geriatr Med, La Jolla, CA 92093 USA.	mbehrens@ucsd.edu; ladugan@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Nanozymes, Nanozymes/D-8197-2019	Ali, Sameh Saad/0000-0002-0339-6106				AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Ali SS, 2004, FREE RADICAL BIO MED, V37, P1191, DOI 10.1016/j.freeradbiomed.2004.07.002; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Cochran SM, 2002, SYNAPSE, V46, P206, DOI 10.1002/syn.10126; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P67, DOI 10.1113/jphysiol.2003.042598; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hart B A, 1992, Biotechnol Ther, V3, P119; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Kato-Negishi M, 2004, DEV BRAIN RES, V152, P99, DOI 10.1016/j.devbrainres.2004.05.013; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; Morrow BA, 2007, PSYCHOPHARMACOLOGY, V192, P283, DOI 10.1007/s00213-007-0708-0; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Woo TUW, 2004, ARCH GEN PSYCHIAT, V61, P649, DOI 10.1001/archpsyc.61.7.649; Xia S, 2002, NEUROBIOL DIS, V9, P282, DOI 10.1006/nbdi.2002.0478; Zuo DY, 2007, PHARMACOL BIOCHEM BE, V86, P1, DOI 10.1016/j.pbb.2006.05.010	29	432	458	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1645	1647		10.1126/science.1148045	http://dx.doi.org/10.1126/science.1148045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063801				2022-12-24	WOS:000251421700052
J	Sui, XM; LaMonte, MJ; Laditka, JN; Hardin, JW; Chase, N; Hooker, SP; Blair, SN				Sui, Xuemei; LaMonte, Michael J.; Laditka, James N.; Hardin, James W.; Chase, Nancy; Hooker, Steven P.; Blair, Steven N.			Cardiorespiratory fitness and adiposity as mortality predictors in older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; TO-HIP RATIO; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; PUBLIC-HEALTH; GRIP STRENGTH; OBESITY; WOMEN	Context Although levels of physical activity and aerobic capacity decline with age and the prevalence of obesity tends to increase with age, the independent and joint associations among fitness, adiposity, and mortality in older adults have not been adequately examined. Objective To determine the association among cardiorespiratory fitness ("fitness"), adiposity, and mortality in older adults. Design, Setting, and Patients Cohort of 2603 adults aged 60 years or older ( mean age, 64.4 [SD, 4.8] years; 19.8% women) enrolled in the Aerobics Center Longitudinal Study who completed a baseline health examination during 1979-2001. Fitness was assessed by a maximal exercise test, and adiposity was assessed by body mass index (BMI), waist circumference, and percent body fat. Low fitness was defined as the lowest fifth of the sex-specific distribution of maximal treadmill exercise test duration. The distributions of BMI, waist circumference, and percent body fat were grouped for analysis according to clinical guidelines. Main Outcome Measure All-cause mortality through December 31, 2003. Results There were 450 deaths during a mean follow-up of 12 years and 31 236 person-years of exposure. Death rates per 1000 person-years, adjusted for age, sex, and examination year were 13.9, 13.3, 18.3, and 31.8 across BMI groups of 18.524.9, 25.0-29.9, 30.0-34.9, and >= 35.0, respectively (P=.01 for trend); 13.3 and 18.2 for normal and high waist circumference (>= 88 cm in women; >= 102 cm in men) (P=. 004); 13.7 and 14.6 for normal and high percent body fat (>= 30% in women; >= 25% in men) ( P=. 51); and 32.6, 16.6, 12.8, 12.3, and 8.1 across incremental fifths of fitness ( P <. 001 for trend). The association between waist circumference and mortality persisted after further adjustment for smoking, baseline health status, and BMI ( P=. 02) but not after additional adjustment for fitness ( P=. 86). Fitness predicted mortality risk after further adjustment for smoking, baseline health, and either BMI, waist circumference, or percent body fat ( P <. 001 for trend). Conclusions In this study population, fitness was a significant mortality predictor in older adults, independent of overall or abdominal adiposity. Clinicians should consider the importance of preserving functional capacity by recommending regular physical activity for older individuals, normal-weight and overweight alike.	Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; Univ S Carolina, Ctr Hlth Serv & Policy Res, Columbia, SC 29208 USA; Univ S Carolina, Prevent Res Ctr, Columbia, SC 29208 USA; Univ Buffalo, Dept Social & Prevent Med, Buffalo, NY USA; Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Texas System; University of North Texas Denton	Sui, XM (corresponding author), Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA.	msui@gwm.sc.edu	Hardin, James/P-4772-2019; Hardin, James W/Q-7617-2016; LaMonte, Mike/AAC-9953-2021	Hardin, James/0000-0003-0506-5500; Hardin, James W/0000-0003-0506-5500; Hooker, Steven/0000-0001-9969-6244	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006945, R37AG006945] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL062508-04, R01 HL062508-01, R01 HL062508, R01 HL062508-02, R01 HL062508-03, HL62508] Funding Source: Medline; NIA NIH HHS [R37 AG006945, R01 AG006945-15, R01 AG006945-13, R01 AG006945, AG06945, R01 AG006945-14] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; ANDERSON LH, 2005, PREV CHRONIC DIS, V2; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BARLOW CE, 1995, INT J OBESITY, V19, pS41; Blair SN, 2000, AM J HEALTH PROMOT, V15, P1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Bray G A, 1993, Obes Res, V1, P203; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Elia M, 2001, OBES RES, V9, p244S, DOI 10.1038/oby.2001.126; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; HASKELL WL, 1992, MED SCI SPORT EXER, V24, pS201, DOI 10.1249/00005768-199206001-00004; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Lindqvist P, 2006, EUR J EPIDEMIOL, V21, P789, DOI 10.1007/s10654-006-9074-1; Lurie N, 2000, ACAD MED, V75, P12, DOI 10.1097/00001888-200001000-00006; Dolan CM, 2007, AM J PUBLIC HEALTH, V97, P913, DOI 10.2105/AJPH.2005.084178; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; SCHOENBORN CA, 2004, VITAL HLTH STAT, V10, P1; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Sui XM, 2007, AM J EPIDEMIOL, V165, P1413, DOI 10.1093/aje/kwm031; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	46	410	423	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2007	298	21					2507	2516		10.1001/jama.298.21.2507	http://dx.doi.org/10.1001/jama.298.21.2507			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	237GJ	18056904	Green Accepted, Bronze			2022-12-24	WOS:000251361900016
J	Flegal, KM; Graubard, BI; Williamson, DF; Gail, MH				Flegal, Katherine M.; Graubard, Barry I.; Williamson, David F.; Gail, Mitchell H.			Cause-specific excess deaths associated with underweight, overweight, and obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; FOLLOW-UP; CANCER; COHORT; RISK; MEN; OUTCOMES; WEIGHT; PARADOX	Context The association of body mass index (BMI) with cause-specific mortality has not been reported for the US population. Objective To estimate cause-specific excess deaths associated with underweight (BMI < 18.5), overweight (BMI 25- <30), and obesity (BMI >= 30). Design, Setting, and Participants Cause-specific relative risks of mortality from the National Health and Nutrition Examination Survey (NHANES) I, 1971-1975; II, 19761980; and III, 1988-1994, with mortality follow-up through 2000 (571 042 person-years of follow-up) were combined with data on BMI and other covariates from NHANES 1999-2002 with underlying cause of death information for 2.3 million adults 25 years and older from 2004 vital statistics data for the United States. Main Outcome Measures Cause-specific excess deaths in 2004 by BMI levels for categories of cardiovascular disease (CVD), cancer, and all other causes (noncancer, non-CVD causes). Results Based on total follow-up, underweight was associated with significantly increased mortality from noncancer, non-CVD causes (23 455 excess deaths; 95% confidence interval [CI], 11 848 to 35 061) but not associated with cancer or CVD mortality. Overweight was associated with significantly decreased mortality from noncancer, non-CVD causes (-69 299 excess deaths; 95% CI, -100 702 to -37 897) but not associated with cancer or CVD mortality. Obesity was associated with significantly increased CVD mortality (112 159 excess deaths; 95% CI, 87 842 to 136 476) but not associated with cancer mortality or with noncancer, non-CVD mortality. In further analyses, overweight and obesity combined were associated with increased mortality from diabetes and kidney disease (61 248 excess deaths; 95% CI, 49 685 to 72 811) and decreased mortality from other noncancer, non-CVD causes (-105 572 excess deaths; 95% CI, -161 816 to -49 328). Obesity was associated with increased mortality from cancers considered obesity-related (13 839 excess deaths; 95% CI, 1920 to 25 758) but not associated with mortality from other cancers. Comparisons across surveys suggested a decrease in the association of obesity with CVD mortality over time. Conclusions The BMI-mortality association varies by cause of death. These results help to clarify the associations of BMI with all-cause mortality.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4201, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X				*3 NAT HLTH NUTR E, 1994, VIT HLTH STAT, V1, P1; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Batty GD, 2005, INT J OBESITY, V29, P1267, DOI 10.1038/sj.ijo.0803020; Bender R, 2006, J CLIN EPIDEMIOL, V59, P1064, DOI 10.1016/j.jclinepi.2006.01.006; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; COHEN JS, 1987, TRADITION, V22, P1; Cox C S, 1997, Vital Health Stat 1, P1; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Engel A, 1978, Vital Health Stat 1, P1; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2006, INT J OBESITY, V30, P1171, DOI 10.1038/sj.ijo.0803313; Flegal KM, 2003, NEW ENGL J MED, V349, P502; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Garrouste-Orgeas M, 2004, INTENS CARE MED, V30, P437, DOI 10.1007/s00134-003-2095-2; Graubard BI, 2007, STAT MED, V26, P2639, DOI 10.1002/sim.2734; Gregg EW, 2005, JAMA-J AM MED ASSOC, V294, P182; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2005, AM J PUBLIC HEALTH, V95, P932, DOI 10.2105/AJPH.2005.062836; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Korn E. L., 1999, ANAL HLTH SURVEYS; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Krueger PM, 2004, RES AGING, V26, P82, DOI 10.1177/0164027503258518; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; Loria C M, 1999, Vital Health Stat 1, P1; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; McDowell A, 1981, Vital Health Stat 1, P1; McEwen LN, 2006, DIABETES CARE, V29, P247, DOI 10.2337/diacare.29.02.06.dc05-0998; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mhurchu CN, 2005, PUBLIC HEALTH NUTR, V8, P402, DOI 10.1079/PHN2004704; MILLIMAN JD, 1973, BIOL GEOLOGY CORAL R, V1, P1; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; National Heart Lung and Blood Institute National Institutes of Health, CLIN GUID ID EV TREA; *NCI, 2004, NCI FACT SHEET; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; SHAH BV, 2004, SURV METHODOL, V30, P29; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; Thorogood M, 2003, J EPIDEMIOL COMMUN H, V57, P130, DOI 10.1136/jech.57.2.130; Tremblay A, 2003, CHEST, V123, P1202, DOI 10.1378/chest.123.4.1202; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190	55	1057	1099	0	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2028	2037		10.1001/jama.298.17.2028	http://dx.doi.org/10.1001/jama.298.17.2028			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986696	Bronze			2022-12-24	WOS:000250718200023
J	Psaty, BM; Arnett, D; Burke, G				Psaty, Bruce M.; Arnett, Donna; Burke, Gregory			A new era of cardiovascular disease epidemiology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; BIG		Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; Univ Alabama, Dept Epidemiol, Birmingham, AL USA; Wake Forest Univ, Div Publ Hlth Sci, Winston Salem, NC 27109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; Wake Forest University	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu						*FRAM SNP HLTH ASS, NAT CTR BIOT INF; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kaplan GA, 2007, EPIDEMIOLOGY, V18, P18, DOI 10.1097/01.ede.0000249507.52550.90; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; *NAT HEART LUNG BL, NHLBI LTD ACC DAT PR; Ness RB, 2007, EPIDEMIOLOGY, V18, P9, DOI 10.1097/01.ede.0000249529.86885.5a; *NHLBI DAT US C, INSTR APPL NHLBI AUT; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	13	5	6	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2060	2062		10.1001/jama.298.17.2060	http://dx.doi.org/10.1001/jama.298.17.2060			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986701				2022-12-24	WOS:000250718200028
J	Jonsson, TJ; Johnson, LC; Lowther, WT				Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd			Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace	NATURE			English	Article							CYSTEINE-SULFINIC ACID; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; REDUCTION; SULFIREDOXIN; PEROXIDASE; MECHANISM; STATE; H2O2	Typical 2-Cys peroxiredoxins ( Prxs) have an important role in regulating hydrogen peroxide-mediated cell signalling(1). In this process, Prxs can become inactivated through the hyperoxidation of an active site Cys residue to Cys sulphinic acid. The unique repair of this moiety by sulphiredoxin ( Srx) restores peroxidase activity and terminates the signal(2). The hyperoxidized form of Prx exists as a stable decameric structure with each active site buried. Therefore, it is unclear how Srx can access the sulphinic acid moiety. Here we present the 2.6 angstrom crystal structure of the human Srx - PrxI complex. This complex reveals the complete unfolding of the carboxy terminus of Prx, and its unexpected packing onto the backside of Srx away from the Srx active site. Binding studies and activity analyses of site- directed mutants at this interface show that the interaction is required for repair to occur. Moreover, rearrangements in the Prx active site lead to a juxtaposition of the Prx Gly- Gly- Leu- Gly and Srx ATP- binding motifs, providing a structural basis for the first step of the catalytic mechanism. The results also suggest that the observed interactions may represent a common mode for other proteins to bind to Prxs.	[Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Winston Salem, NC 27157 USA; [Jonsson, Thomas J.; Johnson, Lynnette C.; Lowther, W. Todd] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Lowther, WT (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Struct Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tlowther@wfubmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072866, R01 GM072866-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Harris JR, 2001, BBA-PROTEIN STRUCT M, V1547, P221, DOI 10.1016/S0167-4838(01)00184-4; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hong SK, 2006, FREE RADICAL BIO MED, V40, P275, DOI 10.1016/j.freeradbiomed.2005.08.029; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jonsson TJ, 2005, BIOCHEMISTRY-US, V44, P8634, DOI 10.1021/bi050131i; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee DY, 2006, BIOCHEMISTRY-US, V45, P15301, DOI 10.1021/bi061824h; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiao NZ, 2005, FEBS J, V272, P3929, DOI 10.1111/j.1742-4658.2005.04809.x	36	109	112	5	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					98	U16		10.1038/nature06415	http://dx.doi.org/10.1038/nature06415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172504	Green Accepted			2022-12-24	WOS:000252079300042
J	Merks, JHM; Ozgen, HM; Koster, J; Zwinderman, AH; Caron, HN; Hennekam, RCM				Merks, Johannes H. M.; Ozgen, Heval M.; Koster, Jan; Zwinderman, Aeilko H.; Caron, Huib N.; Hennekam, Raoul C. M.			Prevalence and patterns of morphological abnormalities in patients with childhood cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYELOID-LEUKEMIA; MINOR ANOMALIES; FRASER-SYNDROME; MILD ERRORS; MUTATIONS; CHILDREN; GENE; MORPHOGENESIS; MALIGNANCY; PROTEIN	Context Constitutional gene defects predispose to cancer in children. Such tumor predisposition syndromes can be recognized by specific patterns of morphological abnormalities. Objectives To assess the prevalence of morphological abnormalities in a large cohort of patients with childhood cancer and to identify new tumor predisposition syndromes. Design, Setting, and Participants Patients were recruited from Emma Children's Hospital, Academic Medical Center, Amsterdam, the Netherlands, between January 2000 and March 2003. A total of 1073 patients underwent a physical examination directed at 683 morphological abnormalities. The patient cohort consisted of 898 long-term survivors of childhood cancer and 175 newly diagnosed pediatric patients with cancer. The control group consisted of 1007 schoolchildren examined in an identical way. Mean ages of patients and controls were 21.2 and 10.4 years, respectively. Main Outcome Measures Prevalence and patterns of morphological abnormalities in patients compared with controls. To prevent age bias, only age-independent abnormalities were used for overall prevalence analysis. Patients younger than 9 years were excluded from the pattern analysis. The sample was restricted to white patients to prevent ethnicity bias. Results Morphological abnormalities were significantly more prevalent in pediatric patients with cancer. Major abnormalities were present in 26.8% of patients vs 15.5% of controls (P<.001) and minor anomalies in 65.1 % of patients vs 56.2% of controls (P<.001). Three or more minor anomalies were detected in 15.2% of patients vs 8.3% in controls (P<.001). Forty-two patients were diagnosed with an established tumor predisposition syndrome. Multivariate analyses showed 14 morphological abnormalities to occur significantly more often in the patient group. For 2 of these (blepharophimosis and asymmetric lower limbs), we identified statistically significant patterns of co-occurring morphological abnormalities suggestive of new tumor predisposition syndromes. Thirty-four patients fit 1 of the 2 novel tumor predisposition patterns. Conclusions Pediatric patients with cancer show a significantly higher prevalence of morphological abnormalities compared with controls. Specific patterns of morphological abnormalities indicate possible unrecognized tumor predisposition syndromes, but validation in an independent sample is needed.	[Merks, Johannes H. M.; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Ozgen, Heval M.; Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Ozgen, Heval M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Psychiat, Utrecht, Netherlands; [Hennekam, Raoul C. M.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London, England; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Merks, JHM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, Floor F8,Room 245,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.h.merks@amc.uva.nl	Ozgen, mihriban/H-6635-2018; Ozgen, Heval/J-2056-2019; Koster, Jan/C-5934-2008	Ozgen, mihriban/0000-0002-8933-7122; Ozgen, Heval/0000-0002-8933-7122; Koster, Jan/0000-0002-0890-7585				Aase JM, 1990, DIAGNOSTIC DYSMORPHO; Altmann AE, 1998, BRIT J CANCER, V78, P1244, DOI 10.1038/bjc.1998.662; ANTHONY S, 2003, AANGEBOREN AFWIJKING; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CLUITMANS TLM, 2002, GEZONDHEIDSPROFIEL K; FEKETE G, 1987, Orvosi Hetilap, V128, P725; Frias J L, 1996, Adv Pediatr, V43, P27; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; Kobayashi N, 1968, Paediatr Univ Tokyo, V16, P31; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Mehes K, 1998, AM J MED GENET, V75, P22, DOI 10.1002/(SICI)1096-8628(19980106)75:1<22::AID-AJMG6>3.3.CO;2-D; MEHES K, 1985, EUR J PEDIATR, V144, P243, DOI 10.1007/BF00451951; MEHES K, 1994, FAMILY INVESTIGATION, P177; Merks JHM, 2005, AM J MED GENET A, V134A, P132, DOI 10.1002/ajmg.a.30603; Merks JHM, 2003, AM J MED GENET A, V123A, P211, DOI 10.1002/ajmg.a.20249; Merks JHM, 2006, AM J MED GENET A, V140A, P2091, DOI 10.1002/ajmg.a.31355; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; OPITZ JM, 1985, EUR J PEDIATR, V144, P252, DOI 10.1007/BF00451953; Roganovic J, 2002, MED PEDIATR ONCOL, V38, P128, DOI 10.1002/mpo.1288.abs; Stiller CA, 2006, EUR J CANCER, V42, P1952, DOI 10.1016/j.ejca.2006.05.017; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; STOJIMIROVIC E, 1981, Srpski Arkhiv za Tselokupno Lekarstvo, V109, P1275; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; VANLIER A, 2005, STERFTE NOORDHOLLAND; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; WINTER RM, 1990, CLIN GENET, V37, P494; Winter RM, 2001, LONDON DYSMORPHOLOGY	33	47	48	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					61	69		10.1001/jama.2007.66	http://dx.doi.org/10.1001/jama.2007.66			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167407	Bronze			2022-12-24	WOS:000252052000017
J	Hsia, KC; Stavropoulos, P; Blobel, G; Hoelz, A				Hsia, Kuo-Chiang; Stavropoulos, Pete; Blobel, Guenter; Hoelz, Andre			Architecture of a coat for the nuclear pore membrane	CELL			English	Article							MESSENGER-RNA EXPORT; BIOGENESIS PATHWAY; NUP107-160 COMPLEX; PROTEOMIC ANALYSIS; NUCLEOPORINS; KINETOCHORES; NUP145P; IMPORT; NUP133; TOOL	The symmetric core of the nuclear pore complex can be considered schematically as a series of concentric cylinders. A peripheral cylinder coating the pore membrane contains the previously characterized, elongated heptamer that harbors Sec13-Nup145C in its middle section. Strikingly, Sec13-Nup145C crystallizes as a hetero-octamer in two space groups. Oligomerization of Sec13-Nup145C was confirmed biochemically. Importantly, the numerous interacting surfaces in the hetero-octamer are evolutionarily highly conserved, further underlining the physiological relevance of the oligomerization. The hetero-octamer forms a slightly curved, yet rigid rod of sufficient length to span the entire height of the proposed membrane-adjacent cylinder. In concordance with the dimensions and symmetry of the nuclear pore complex core, we suggest that the cylinder is constructed of four antiparallel rings, each ring being composed of eight heptamers arranged in a head-to-tail fashion. Our model proposes that the hetero-octamer would vertically traverse and connect the four stacked rings.	[Hsia, Kuo-Chiang; Stavropoulos, Pete; Blobel, Guenter; Hoelz, Andre] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	blobel@rockefeller.edu; hoelza@rockefeller.edu	Hsia, Kuo-Chiang/AAS-8056-2021; Hoelz, Andre/AAB-6978-2021	Hsia, Kuo-Chiang/0000-0002-4409-6732; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117360] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR015301-05S10101] Funding Source: Medline; NIGMS NIH HHS [R01 GM117360] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Bai SW, 2004, MOL CELL BIOL, V24, P6379, DOI 10.1128/MCB.24.14.6379-6392.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dockendorff TC, 1997, MOL CELL BIOL, V17, P906, DOI 10.1128/MCB.17.2.906; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LAFORTELLE ED, 1997, METHOD ENZYMOL, V276, P476; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Saxena K, 1996, BIOCHEMISTRY-US, V35, P15215, DOI 10.1021/bi961616x; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	51	102	105	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1313	1326		10.1016/j.cell.2007.11.038	http://dx.doi.org/10.1016/j.cell.2007.11.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160040	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000252217200020
J	Keeley, P				Keeley, Paul			Pimp my slang	BRITISH MEDICAL JOURNAL			English	Editorial Material									Glasgow Royal Infirm, Dept Palliat Med, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Keeley, P (corresponding author), Glasgow Royal Infirm, Dept Palliat Med, Glasgow G4 0SF, Lanark, Scotland.	paul.keeley@northglasgow.scot.nhs.uk		Keeley, Paul/0000-0002-3169-8187					0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1295	1295		10.1136/bmj.39414.699005.94	http://dx.doi.org/10.1136/bmj.39414.699005.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156235	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000252182700016
J	Heath, I				Heath, Iona			The road to hell ...	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com						McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 8	2007	335	7631					1185	1185		10.1136/bmj.39414.473600.59	http://dx.doi.org/10.1136/bmj.39414.473600.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18063643	Green Published			2022-12-24	WOS:000251707800029
J	Watters, TR; Campbell, B; Carter, L; Leuschen, CJ; Plaut, JJ; Picardi, G; Orosei, R; Safaeinili, A; Clifford, SM; Farrell, WM; Ivanov, AB; Phillips, RJ; Stofan, ER				Watters, Thomas R.; Campbell, Bruce; Carter, Lynn; Leuschen, Carl J.; Plaut, Jeffrey J.; Picardi, Giovanni; Orosei, Roberto; Safaeinili, Ali; Clifford, Stephen M.; Farrell, William M.; Ivanov, Anton B.; Phillips, Roger J.; Stofan, Ellen R.			Radar sounding of the Medusae Fossae Formation Mars: Equatorial ice or dry, low-density deposits?	SCIENCE			English	Article							GLOBAL SURVEYOR; ORBITER CAMERA; THARSIS; REGION; SUBSURFACE; RECORD	The equatorial Medusae Fossae Formation (MFF) is enigmatic and perhaps among the youngest geologic deposits on Mars. They are thought to be composed of volcanic ash, eolian sediments, or an ice-rich material analogous to polar layered deposits. The Mars Advanced Radar for Subsurface and Ionospheric Sounding (MARSIS) instrument aboard the Mars Express Spacecraft has detected nadir echoes offset in time-delay from the surface return in orbits over MFF material. These echoes are interpreted to be from the subsurface interface between the MFF material and the underlying terrain. The delay time between the MFF surface and subsurface echoes is consistent with massive deposits emplaced on generally planar lowlands materials with a real dielectric constant of similar to 2.9 +/- 0.4. The real dielectric constant and the estimated dielectric losses are consistent with a substantial component of water ice. However, an anomalously low-density, ice-poor material cannot be ruled out. If ice-rich, the MFF must have a higher percentage of dust and sand than polar layered deposits. The volume of water in an ice-rich MFF deposit would be comparable to that of the south polar layered deposits.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lunar & Planetary Inst, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Proxemy Res, Laytonville, MD 20882 USA	Smithsonian Institution; University of Kansas; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL)	Watters, TR (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	watterst@si.edu	Carter, Lynn/D-2937-2012; Ivanov, Anton B/C-8944-2014; Farrell, William/I-4865-2013	Carter, Lynn/0000-0002-6245-4142; Ivanov, Anton B/0000-0001-8376-8581; 				Bradley BA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001537; Carr M.H, 1996, WATER MARS; Carrier I., 1991, LUNAR SOURCEBOOK USE, P475; Dohm JM, 2001, J GEOPHYS RES-PLANET, V106, P12301, DOI 10.1029/2000JE001352; Edgett KS, 1997, J GEOPHYS RES-PLANET, V102, P21545, DOI 10.1029/97JE01685; ELBAZ F, 1979, J GEOPHYS RES, V84, P8205, DOI 10.1029/JB084iB14p08205; Harmon JK, 1999, J GEOPHYS RES-PLANET, V104, P14065, DOI 10.1029/1998JE900042; Head J.W., 2004, LUNAR PLANETARY SCI, V35, P1635; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Lanagan PD, 2001, GEOPHYS RES LETT, V28, P2365, DOI 10.1029/2001GL012932; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MCEWEN AS, 2007, LUNAR PLANET SCI, V38, P2031; MUHLEMAN DO, 1991, SCIENCE, V253, P1508, DOI 10.1126/science.253.5027.1508; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; PORCELLO LJ, 1974, P IEEE, V62, P769, DOI 10.1109/PROC.1974.9517; Sakimoto SEH, 1999, J GEOPHYS RES-PLANET, V104, P24141, DOI 10.1029/1999JE001044; SCHULTZ PH, 1988, ICARUS, V73, P91, DOI 10.1016/0019-1035(88)90087-5; SCOTT DH, 1982, J GEOPHYS RES, V87, P1179, DOI 10.1029/JB087iB02p01179; Ulaby F. T., 1988, MICROWAVE DIELECTRIC; WARD AW, 1979, J GEOPHYS RES, V84, P814; WELLS GL, 1997, ARID ZONE GEOMORPHOL, P659; ZIMBELMAN J, 1999, LUNAR PLANET SCI, V30, P1652	24	109	115	4	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1125	1128		10.1126/science.1148112	http://dx.doi.org/10.1126/science.1148112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	17975034				2022-12-24	WOS:000250957900042
J	Alley, DE; Chang, VW				Alley, Dawn E.; Chang, Virginia W.			The changing relationship of obesity and disability, 1988-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS-INDEX; UNITED-STATES; RECENT TRENDS; RISK-FACTORS; PREVALENCE; OVERWEIGHT; AGE; DISEASE; HEALTH; POPULATION	Context Recent studies suggest that the obese population may have been growing healthier since the 1960s, as indicated by a decrease in mortality and cardiovascular risk factors. However, whether these improvements have conferred decreased risk for disability is unknown. The obese population may be living longer with better-controlled risk factors but paradoxically experiencing more disability. Objective To determine whether the association between obesity and disability has changed over time. Design, Setting, and Participants Adults aged 60 years and older (N = 9928) with measured body mass index from 2 waves of the nationally representative National Health and Nutrition Examination Surveys (NHANES III [1988-1994] and NHANES 19992004). Main Outcome Measures Reports of much difficulty or inability to perform tasks in 2 disability domains: functional limitations (walking one-fourth mile, walking up 10 steps, stooping, lifting 10 lb, walking between rooms, and standing from an armless chair) and activities of daily living (ADL) limitations (transferring, eating, and dressing). Results Among obese individuals, the prevalence of functional impairment increased 5.4% (from 36.8%-42.2%; P = .03) between the 2 surveys, and ADL impairment did not change. At time 1 (1988-1994), the odds of functional impairment for obese individuals were 1.78 times greater than for normal-weight individuals (95% confidence interval [CI], 1.47-2.16). At time 2 (1999-2004), this odds ratio increased to 2.75 (95% CI, 2.39-3.17), because the odds of functional impairment increased by 43% (OR 1.43; 95% CI, 1.18-1.75) among obese individuals during this period, but did not change among nonobese individuals. With respect to ADL impairment, odds for obese individuals were not significantly greater than for individuals with normal weight (OR, 1.31; 95% CI, 0.92-1.88) at time 1, but increased to 2.05 (95% CI, 1.45-2.88) at time 2. This was because the odds of ADL impairment did not change for obese individuals but decreased by 34% among nonobese individuals (OR, 0.66; 95% CI, 0.50-0.88). Conclusions Recent cardiovascular improvements have not been accompanied by reduced disability within the obese older population. Rather, obese participants surveyed during 1999-2004 were more likely to report functional impairments than obese participants surveyed during 1988-1994, and reductions in ADL impairment observed for nonobese older individuals did not occur in those who were obese. Over time, declines in obesity-related mortality, along with a younger age at onset of obesity, could lead to an increased burden of disability within the obese older population.	Univ Penn, Robert Wood Johnson Hlth & Soc Scholars Program, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia Vet Affairs Med Ctr, Dept Med,Sch Med, Dept Sociol, Philadelphia, PA 19104 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Alley, DE (corresponding author), Univ Penn, Robert Wood Johnson Hlth & Soc Scholars Program, 3641 Locust Walk,Ste 302, Philadelphia, PA 19104 USA.	alley@wharton.upenn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043459] Funding Source: NIH RePORTER; NICHD NIH HHS [K12-HD043459] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Callahan D, 1999, JAMA-J AM MED ASSOC, V282, P2077, DOI 10.1001/jama.282.21.2077; Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman VA, 1999, DEMOGRAPHY, V36, P461, DOI 10.2307/2648084; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2003, HEALTH AFFAIR, V22, P154, DOI 10.1377/hlthaff.22.4.154; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; GELMAN A, 2007, DATA ANAL USING REGR, P533; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Himes CL, 2000, DEMOGRAPHY, V37, P73, DOI 10.2307/2648097; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P94, DOI DOI 10.1001/JAMA.1963.03060120024016; Kramarow E, 2007, HEALTH AFFAIR, V26, P1417, DOI 10.1377/hlthaff.26.5.1417; Krauss R M, 1998, Circulation, V98, P1472; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Preston SH, 2005, NEW ENGL J MED, V352, P1135, DOI 10.1056/NEJMe058009; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Schoeni RF, 2001, J GERONTOL B-PSYCHOL, V56, pS206, DOI 10.1093/geronb/56.4.S206; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1	32	317	319	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2020	2027		10.1001/jama.298.17.2020	http://dx.doi.org/10.1001/jama.298.17.2020			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228GP	17986695	Bronze			2022-12-24	WOS:000250718200022
J	Galinha, C; Hofhuis, H; Luijten, M; Willemsen, V; Blilou, I; Heidstra, R; Scheres, B				Galinha, Carla; Hofhuis, Hugo; Luijten, Marijn; Willemsen, Viola; Blilou, Ikram; Heidstra, Renze; Scheres, Ben			PLETHORA proteins as dose-dependent master regulators of Arabidopsis root development	NATURE			English	Article							STEM-CELLS; GENE; EMBRYO; TRANSFORMATION; REGENERATION; EXPRESSION; GRADIENTS; ENCODES	Factors with a graded distribution can program fields of cells in a dose-dependent manner(1,2), but no evidence has hitherto surfaced for such mechanisms in plants. In the Arabidopsis thaliana root, two PLETHORA (PLT) genes encoding AP2-domain transcription factors have been shown to maintain the activity of stem cells(3). Here we show that a clade of four PLT homologues is necessary for root formation. Promoter activity and protein fusions of PLT homologues display gradient distributions with maxima in the stem cell area. PLT activities are largely additive and dosage dependent. High levels of PLT activity promote stem cell identity and maintenance; lower levels promote mitotic activity of stem cell daughters; and further reduction in levels is required for cell differentiation. Our findings indicate that PLT protein dosage is translated into distinct cellular responses.	Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Scheres, B (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, NL-3584 CH Utrecht, Netherlands.	b.scheres@uu.nl		Scheres, Ben/0000-0001-5400-9578; hofhuis, hugo/0000-0001-7882-7380; Blilou, Ikram/0000-0001-8003-3782				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790	24	556	598	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1053	1057		10.1038/nature06206	http://dx.doi.org/10.1038/nature06206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960244	Green Published			2022-12-24	WOS:000250395000053
J	Altman, D; Granath, F; Cnattingius, S; Falconer, C				Altman, Daniel; Granath, Fredrik; Cnattingius, Sven; Falconer, Christian			Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study	LANCET			English	Article							NORWEGIAN EPINCONT; UNITED-STATES	Background Hysterectomy for benign indications has been associated with an increased risk for lower-urinary-tract sequela, but results have been inconclusive. We aimed to establish the risk for stress-urinary-incontinence surgery after hysterectomy for benign indications. Methods We did a nationwide, population-based, cohort study from 1973 to 2003 in Sweden. We identified our population from the Swedish Inpatient Registry. We selected 165 260 women who had undergone hysterectomy (exposed cohort) and a control group of 479 506 individuals who had not had this procedure (unexposed cohort), matched by year of birth and county of residence. In both cohorts, occurrence of stress-urinary-incontinence surgery was established from the Swedish Inpatient Registry. Hazard ratios with 95% CIs were calculated by Cox's proportional-hazards regression. Findings During the 30-year observational period, the rate of stress-urinary-incontinence surgery per 100000 person-years was 179 (95% CI 173-186) in the exposed cohort versus 76 (73-79) in the unexposed cohort. Correspondingly, individuals in the exposed cohort were at increased risk for stress-urinary-incontinence surgery compared with those in the unexposed cohort (hazard ratio 2-4; 95% CI 2.3-2.5), irrespective of surgical technique. Risk for stress-urinaryincontinence surgery varied slightly with time of follow-up: the highest overall risk was recorded within 5 years of surgery (2.7; 2.5-2.9) and the lowest risk was seen after an observation period of 10 years or more (2.1, 1.9-2.2). Interpretation Hysterectomy for benign indications, irrespective of surgical technique, increases the risk for subsequent stress-urinary-incontinence surgery. Women should be counselled on associated risks related to hysterectomy, and other treatment options should be considered before surgery.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; Karolinska Inst, Dept Clin Sci, Div Obstet & Gynecol, Danderyd Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet	Altman, D (corresponding author), Danderyd Hosp, Div Obstet & Gynecol, SE-18288 Stockholm, Sweden.	daniel.altman@ds.se						Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Broder MS, 2000, OBSTET GYNECOL, V95, P199, DOI 10.1016/S0029-7844(99)00519-0; Brown JS, 2000, LANCET, V356, P535, DOI 10.1016/S0140-6736(00)02577-0; CARLSON KJ, 1993, NEW ENGL J MED, V328, P856; Davies A, 2001, J Obstet Gynaecol, V21, P166; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; DeLancey JOL, 1997, WORLD J UROL, V15, P268, DOI 10.1007/BF02202011; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Gimbel H, 2003, BJOG-INT J OBSTET GY, V110, P1088; Gimbel H, 2001, ACTA OBSTET GYN SCAN, V80, P267, DOI 10.1034/j.1600-0412.2001.080003267.x; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Hannestad YS, 2002, SCAND J PRIM HEALTH, V20, P102, DOI 10.1080/713796408; Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0; Johnson N, 2005, BMJ-BRIT MED J, V330, P1478, DOI 10.1136/bmj.330.7506.1478; JOHNSON N, 2005, COCHRANE DB SYST REV, V1; Kenton K, 2006, BJU INT, V98, P1, DOI 10.1111/j.1464-410X.2006.06299.x; KILKKU P, 1985, ACTA OBSTET GYN SCAN, V64, P375, DOI 10.3109/00016348509155151; Lethaby A, 2006, COCHRANE DB SYST REV, V2; Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056; Nilsson A C, 1994, Lakartidningen, V91, P603; PRIOR A, 1992, GUT, V33, P264, DOI 10.1136/gut.33.2.264; Siddique SA, 2006, INT UROGYNECOL J, V17, P642, DOI 10.1007/s00192-006-0088-8; SMITH PH, 1968, BRIT J SURG, V55, P929, DOI 10.1002/bjs.1800551212; Thakar R, 2002, NEW ENGL J MED, V347, P1318, DOI 10.1056/NEJMoa013336; Thakar R, 2005, BEST PRACT RES CL OB, V19, P403, DOI 10.1016/j.bpobgyn.2005.01.008; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x; WILCOX LS, 1994, OBSTET GYNECOL, V83, P549, DOI 10.1097/00006250-199404000-00011	27	121	126	1	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT-NOV	2007	370	9597					1494	1499		10.1016/S0140-6736(07)61635-3	http://dx.doi.org/10.1016/S0140-6736(07)61635-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964350				2022-12-24	WOS:000250487000026
J	Clark, S				Clark, Stephanie			Waiting times for scoliosis surgery	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Clark, S (corresponding author), The Lancet, London NW1 7BY, England.							AHN H, 2007, 42 ANN M SCOL RES SO, P45; DABKE HV, 2007, 42 ANN M SCOL RES SO, P46	2	8	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2008	371	9606					10	11		10.1016/S0140-6736(08)60047-1	http://dx.doi.org/10.1016/S0140-6736(08)60047-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248YH	18177759				2022-12-24	WOS:000252192600009
J	Stott, R				Stott, Robin			Climate change - 2057	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Medact, London N1 6HT, England		Stott, R (corresponding author), Medact, London N1 6HT, England.	stott@dircon.co.uk						Ferriman A, 2007, BRIT MED J, V334, P111, DOI 10.1136/bmj.39097.611806.DB; Sachs JD, 2005, SCI AM, V293, P56, DOI 10.1038/scientificamerican0905-56; Simmons M. R., 2005, TWILIGHT DESERT; [World Wildlife Fund Nature WWF], 2006, LIV PLAN REP 2006	4	0	0	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1318	1319		10.1136/bmj.39420.654583.25	http://dx.doi.org/10.1136/bmj.39420.654583.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156247	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000252182700030
J	Lin, OS				Lin, Otto S.			Clinical update: postpolypectomy colonoscopy surveillance	LANCET			English	Article							COLORECTAL-CANCER; POLYP; POLYPECTOMY; PREVENTION; GUIDELINES; ADENOMAS		Virginia Mason Med Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Seattle, WA USA	Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Lin, OS (corresponding author), Virginia Mason Med Ctr, Seattle, WA 98101 USA.	Otto.Lin@vmmc.org						Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Bensen S, 1999, AM J GASTROENTEROL, V94, P194; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; BRENNER H, 2007, AM J GASTROENTEROL, V102, P1; Colquhoun P, 2004, Colorectal Dis, V6, P158, DOI 10.1111/j.1463-1318.2004.00585.x; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; Hawk ET, 2004, GASTROENTEROLOGY, V126, P1423, DOI 10.1053/j.gastro.2004.03.002; JORGENSEN OD, 1995, SCAND J GASTROENTERO, V30, P686, DOI 10.3109/00365529509096314; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Ransohoff DF, 2005, GASTROENTEROLOGY, V128, P1685, DOI 10.1053/j.gastro.2005.04.005; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Sanaka MR, 2006, GASTROINTEST ENDOSC, V63, P97, DOI 10.1016/j.gie.2005.08.048; Taupin D, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-82; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	20	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 17	2007	370	9600					1674	1676		10.1016/S0140-6736(07)61707-3	http://dx.doi.org/10.1016/S0140-6736(07)61707-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233LA	18022025				2022-12-24	WOS:000251091200008
J	Edelman, GM				Edelman, Gerald M.			Perspective - Learning in and from brain-based devices	SCIENCE			English	Editorial Material							SYSTEMS	Biologically based mobile devices have been constructed that differ from robots based on artificial intelligence. These brain-based devices (BBDs) contain simulated brains that autonomously categorize signals from the environment without a priori instruction. Two such BBDs, Darwin VII and Darwin X, are described here. Darwin VII recognizes objects and links categories to behavior through instrumental conditioning. Darwin X puts together the "what," "when," and "where" from cues in the environment into an episodic memory that allows it to find a desired target. Although these BBDs are designed to provide insights into how the brain works, their principles may find uses in building hybrid machines. These machines would combine the learning ability of BBDs with explicitly programmed control systems.	Inst Neurosci, San Diego, CA 92121 USA		Edelman, GM (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	edelman@nsi.edu						Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; EDELMAN GM, 1992, P NATL ACAD SCI USA, V89, P7267, DOI 10.1073/pnas.89.15.7267; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Holland O., 2003, MACHINE CONSCIOUSNES; Krichmar JL, 2005, ARTIF LIFE, V11, P63, DOI 10.1162/1064546053278946; Krichmar JL, 2005, P NATL ACAD SCI USA, V102, P2111, DOI 10.1073/pnas.0409792102; NOLFE S, 2000, EVOLUTIONARY ROBOTIC; Seth AK, 2005, NEUROINFORMATICS, V3, P167, DOI 10.1385/NI:3:3:167; Thrun S., 2005, PROBABILISTIC ROBOTI; Thrun S., 2005, ROBOTICS SCI SYSTEMS, VMassachusetts, P2005	10	44	50	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1103	1105		10.1126/science.1148677	http://dx.doi.org/10.1126/science.1148677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006739				2022-12-24	WOS:000250957900036
J	Jockusch, WJ; Speidel, D; Sigler, A; Sorensen, JB; Varoqueaux, F; Rhee, JS; Brose, N				Jockusch, Wolf J.; Speidel, Dina; Sigler, Albrecht; Sorensen, Jakob B.; Varoqueaux, Frederique; Rhee, Jeong-Seop; Brose, Nils			CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins	CELL			English	Article							DENSE-CORE VESICLE; UNC-31 CAPS; RELEASE; EXOCYTOSIS; MUNC13-1; CELL; EXPRESSION; SECRETION; DEFINITION; MECHANISMS	Before transmitter-filled synaptic vesicles can fuse with the plasma membrane upon stimulation they have to be primed to fusion competence. The regulation of this priming process controls the strength and plasticity of synaptic transmission between neurons, which in turn determines many complex brain functions. We show that CAPS-1 and CAPS-2 are essential components of the synaptic vesicle priming machinery. CAPS-deficient neurons contain no or very few fusion competent synaptic vesicles, which causes a selective impairment of fast phasic transmitter release. Increases in the intracellular Ca2+ levels can transiently revert this defect. Our findings demonstrate that CAPS proteins generate and maintain a highly fusion competent synaptic vesicle pool that supports phasic Ca2+ triggered release of transmitters.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Rhee, JS (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	rhee@em.mpg.de; brose@em.mpg.de	Varoqueaux, Frederique/AAC-1834-2021	Varoqueaux, Frederique/0000-0002-3614-3121; Sorensen, Jakob/0000-0001-5465-3769				Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Beinfeld MC, 2005, J BIOL CHEM, V280, P38410, DOI 10.1074/jbc.M500055200; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Cawley NX, 2004, ENDOCRINOLOGY, V145, P5807, DOI 10.1210/en.2004-0847; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Dimova K, 2006, BBA-MOL CELL RES, V1763, P1256, DOI 10.1016/j.bbamcr.2006.09.017; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; Otsu Y, 2004, J NEUROSCI, V24, P9076, DOI 10.1523/JNEUROSCI.2060-04.2004; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	48	134	136	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					796	808		10.1016/j.cell.2007.11.002	http://dx.doi.org/10.1016/j.cell.2007.11.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022372	Bronze, Green Submitted			2022-12-24	WOS:000250966300025
J	Lehmann, E; Brueckner, F; Cramer, P				Lehmann, Elisabeth; Brueckner, Florian; Cramer, Patrick			Molecular basis of RNA-dependent RNA polymerase II activity	NATURE			English	Article							HEPATITIS-DELTA ANTIGEN; ELONGATION COMPLEX; ESCHERICHIA-COLI; STRUCTURAL BASIS; LID ELEMENT; DNA HYBRID; IN-VITRO; TRANSCRIPTION; TFIIS; ARCHITECTURE	RNA polymerase (Pol) II catalyses DNA-dependent RNA synthesis during gene transcription. There is, however, evidence that Pol II also possesses RNA-dependent RNA polymerase (RdRP) activity. Pol II can use a homopolymeric RNA template(1), can extend RNA by several nucleotides in the absence of DNA(2), and has been implicated in the replication of the RNA genomes of hepatitis delta virus (HDV)(3,4) and plant viroids(5). Here we show the intrinsic RdRP activity of Pol II with only pure polymerase, an RNA template-product scaffold and nucleoside triphosphates (NTPs). Crystallography reveals the template-product duplex in the site occupied by the DNA-RNA hybrid during transcription. RdRP activity resides at the active site used during transcription, but it is slower and less processive than DNA-dependent activity. RdRP activity is also obtained with part of the HDV antigenome. The complex of transcription factor IIS (TFIIS) with Pol II can cleave one HDV strand, create a reactive stem-loop in the hybrid site, and extend the new RNA 3' end. Short RNA stem-loops with a 5' extension suffice for activity, but their growth to a critical length apparently impairs processivity. The RdRP activity of Pol II provides a missing link in molecular evolution, because it suggests that Pol II evolved from an ancient replicase that duplicated RNA genomes.	Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; Univ Munich, Ctr Integrated Prot Sci, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; DEZELEE S, 1974, J BIOL CHEM, V249, P5978; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; RACKWITZ HR, 1981, NATURE, V291, P297, DOI 10.1038/291297a0; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Taylor JM, 2003, TRENDS MICROBIOL, V11, P185, DOI 10.1016/S0966-842X(03)00045-3; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yamaguchi Y, 2001, SCIENCE, V293, P124, DOI 10.1126/science.1057925; Yamaguchi Y, 2007, GENES CELLS, V12, P863, DOI 10.1111/j.1365-2443.2007.01094.x; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	24	95	96	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					445	449		10.1038/nature06290	http://dx.doi.org/10.1038/nature06290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004386	Green Published			2022-12-24	WOS:000250918600060
J	Park, D; Tosello-Trampont, AC; Elliott, MR; Lu, MJ; Haney, LB; Ma, Z; Klibanov, AL; Mandell, JW; Ravichandran, KS				Park, Daeho; Tosello-Trampont, Annie-Carole; Elliott, Michael R.; Lu, Mingjian; Haney, Lisa B.; Ma, Zhong; Klibanov, Alexander L.; Mandell, James W.; Ravichandran, Kodi S.			BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module	NATURE			English	Article							RAC ACTIVATION; PHOSPHATIDYLSERINE; THROMBOSPONDIN; MACROPHAGES; REPEATS; DOCK180; ANGIOGENESIS; PHAGOCYTOSIS; RECOGNITION; CED-12/ELMO	Engulfment and subsequent degradation of apoptotic cells is an essential step that occurs throughout life in all multicellular organisms(1-3). ELMO/ Dock(180)/Rac proteins are a conserved signalling module for promoting the internalization of apoptotic cell corpses(4,5); ELMO and Dock180 function together as a guanine nucleotide exchange factor (GEF) for the small GTPase Rac, and thereby regulate the phagocyte actin cytoskeleton during engulfment(4 -6). However, the receptor(s) upstream of the ELMO/ Dock180/ Rac module are still unknown. Here we identify brain-specific angiogenesis inhibitor 1 (BAI1) as a receptor upstream of ELMO and as a receptor that can bind phosphatidylserine on apoptotic cells. BAI1 is a seven-transmembrane protein belonging to the adhesion-type G-protein-coupled receptor family, with an extended extracellular region(7-9) and no known ligands. We show that BAI1 functions as an engulfment receptor in both the recognition and subsequent internalization of apoptotic cells. Through multiple lines of investigation, we identify phosphatidylserine, a key `eat-me' signal exposed on apoptotic cells(10-13), as a ligand for BAI1. The thrombospondin type 1 repeats within the extracellular region of BAI1 mediate direct binding to phosphatidylserine. As with intracellular signalling, BAI1 forms a trimeric complex with ELMO and Dock180, and functional studies suggest that BAI1 cooperates with ELMO/ Dock180/Rac to promote maximal engulfment of apoptotic cells. Last, decreased BAI1 expression or interference with BAI1 function inhibits the engulfment of apoptotic targets ex vivo and in vivo. Thus, BAI1 is a phosphatidylserine recognition receptor that can directly recruit a Rac-GEF complex to mediate the uptake of apoptotic cells.	Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Div Cardiovasc, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Lu, Mingjian/AAO-6179-2021; Lu, Mingjian/AGK-0751-2022	Lu, Mingjian/0000-0001-9328-4935; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	NIAID NIH HHS [T32 AI055432] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adang LA, 2006, J VIROL, V80, P10073, DOI 10.1128/JVI.01156-06; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cho HJ, 2007, PHYSIOL GENOMICS, V29, P149, DOI 10.1152/physiolgenomics.00051.2006; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gregory CD, 2005, NAT CELL BIOL, V7, P1161, DOI 10.1038/ncb1205-1161; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; Kang X, 2006, CANCER GENE THER, V13, P385, DOI 10.1038/sj.cgt.7700898; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Lu MJ, 2006, METHOD ENZYMOL, V406, P388, DOI 10.1016/S0076-6879(06)06028-9; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	25	570	588	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					430	U10		10.1038/nature06329	http://dx.doi.org/10.1038/nature06329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17960134	Bronze			2022-12-24	WOS:000250918600057
J	Helsing, E				Helsing, Elisabet			A patient's journey - The reluctant patient: Parkinson's disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												Helsing.ehel@online.no							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					989	990		10.1136/bmj.39329.606840.AD	http://dx.doi.org/10.1136/bmj.39329.606840.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991981	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000250990400046
J	Schelhaas, M; Malmstrom, J; Pelkmans, L; Haugstetter, J; Ellgaard, L; Grunewald, K; Helenius, A				Schelhaas, Mario; Malmstrom, Johan; Pelkmans, Lucas; Haugstetter, Johannes; Ellgaard, Lars; Gruenewald, Kay; Helenius, Ari			Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells	CELL			English	Article							ENDOPLASMIC-RETICULUM; SIMIAN VIRUS-40; CAVEOLAR ENDOCYTOSIS; RETRO-TRANSLOCATION; CRYSTAL-STRUCTURE; TRANSPORT; VP1; POLYOMAVIRUS; RESOLUTION; COMPLEXES	Cell entry of Simian Virus 40 (SV40) involves caveolar/lipid raft-mediated endocytosis, vesicular transport to the endoplasmic reticulum (ER), translocation into the cytosol, and import into the nucleus. We analyzed the effects of ER-associated processes and factors on infection and on isolated viruses and found that SV40 makes use of the thiol-disulfide oxidoreductases, ERp57 and PDI, as well as the retrotranslocation proteins Derlin-1 and SeI1L. ERp57 isomerizes specific interchain disulfides connecting the major capsid protein, VP1, to a crosslinked network of neighbors, thus uncoupling about 12 of 72 VP1 pentamers. Cryo-electron tomography indicated that loss of interchain disulfides coupled with calcium depletion induces selective dissociation of the 12 vertex pentamers, a step likely to mimic uncoating of the virus in the cytosol. Thus, the virus utilizes the protein folding machinery for initial uncoating before exploiting the ER-associated degradation machinery presumably to escape from the ER lumen into the cytosol.	ETH, Inst Biochem, ETH Honggerberg, CH-8093 Zurich, Switzerland; ETH, Inst Mol Syst Biol, ETH Honggerberg, CH-8093 Zurich, Switzerland; Univ Copenhagen, Dept Mol Biol, DK-2100 Copenhagen, Denmark; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Copenhagen; Max Planck Society	Helenius, A (corresponding author), ETH, Inst Biochem, ETH Honggerberg, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	Malmström, Johan A/B-7660-2009; Ellgaard, Lars/I-9034-2014; Grünewald, Kay/AAW-3652-2020	Malmström, Johan A/0000-0002-2889-7169; Ellgaard, Lars/0000-0002-7018-0137; Grünewald, Kay/0000-0002-4788-2691; Schelhaas, Mario/0000-0002-6735-583X; Pelkmans, Lucas/0000-0002-6754-9730				CLEVER J, 1991, P NATL ACAD SCI USA, V88, P7333, DOI 10.1073/pnas.88.16.7333; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Daniels R, 2006, MOL CELL, V24, P955, DOI 10.1016/j.molcel.2006.11.001; ESTES MK, 1971, J VIROL, V7, P635, DOI 10.1128/JVI.7.5.635-641.1971; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gharakhanian E, 2001, J GEN VIROL, V82, P1935, DOI 10.1099/0022-1317-82-8-1935; HARTMANN JP, 1981, J VIROL, V37, P908, DOI 10.1128/JVI.37.3.908-915.1981; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; ISHII N, 1994, J VIROL, V68, P8209, DOI 10.1128/JVI.68.12.8209-8216.1994; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li PP, 2003, J VIROL, V77, P7527, DOI 10.1128/JVI.77.13.7527-7538.2003; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Magnuson B, 2005, MOL CELL, V20, P289, DOI 10.1016/j.molcel.2005.08.034; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakanishi A, 1996, P NATL ACAD SCI USA, V93, P96, DOI 10.1073/pnas.93.1.96; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; SCHARFF O, 1988, BIOCHIM BIOPHYS ACTA, V972, P257, DOI 10.1016/S0005-2728(88)80056-2; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; VARSHAVSKY AJ, 1977, NUCLEIC ACIDS RES, V4, P3303, DOI 10.1093/nar/4.10.3303; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	35	250	257	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					516	529		10.1016/j.cell.2007.09.038	http://dx.doi.org/10.1016/j.cell.2007.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981119	Bronze			2022-12-24	WOS:000250618500019
J	Yin, W; Basu, A; Zhang, JX; Rabbani, A; Meltzer, DO; Alexander, GC				Yin, Wesley; Basu, Anirban; Zhang, James X.; Rabbani, Atonu; Meltzer, David O.; Alexander, G. Caleb			The effect of the medicare Part D prescription benefit on drug utilization and expenditures	ANNALS OF INTERNAL MEDICINE			English	Article							COVERAGE	Background: information about the effect of the Medicare Part D Prescription Drug Benefit on drug utilization and expenditures is limited. Objective: To estimate changes in prescription utilization and out-of-pocket expenditures attributable to Part D among a sample of persons eligible for the benefit. Design: Generalized estimating equations were used to estimate changes in expenditures and utilization among beneficiaries. A control group was included to control for secular trends unrelated to the Part D benefit. Setting: National pharmacy chain representing approximately 15% of all U.S. retail pharmacy sales. Participants: Persons age 66 to 79 years (those eligible for Part D) and a control group of persons age 60 to 63 years (those ineligible for Part D). The final sample represented approximately 5.1 million unique beneficiaries and 1.8 million unique control individuals. Measurements: Prescription utilization (measured in pill-days) and out-of-pocket expenditures, as determined from pharmacy claims from September 2004 to April 2007. Results: During the penalty-free Part D enrollment period (January 2006 to May 2006), average monthly drug utilization increased by 1.1% (95% CI, 0.5% to 1.7%; P< 0.001) and out-of-pocket expenditures decreased by 8.8% (CI, 6.6% to 11.0%; P < 0.001). After enrollment stabilized (June 2006 to April 2007), average monthly drug utilization increased by 5.9% (CI, 5.1% to 6.7%; P < 0.001) and out-of-pocket expenditures decreased by 13.1 % (CI, 9.6% to 16.6%; P = 0.003). Compared with eligible non-enrollees, enrollees had higher out-of-pocket expenditures and utilization at baseline but experienced significantly larger decreases in expenditures and increases in utilization after enrollment. Limitations: Analyses were limited to claims within 1 pharmacy chain. The effect of the "doughnut hole" and the effect of changes on clinical outcomes were not evaluated. Conclusion: The Medicare Part D prescription benefit resulted in modest increases in average drug utilization and decreases in average out-of-pocket expenditures among Part D beneficiaries. Further research is needed to examine patterns among other beneficiaries and to evaluate the effect of these changes on health outcomes.	[Alexander, G. Caleb] Univ Chicago, Chicago, IL 60637 USA; Harvard Univ, Robert Wood Johnson Scholars Hlth Policy Program, Cambridge, MA 02138 USA; Univ Chicago, Harris Sch Publ Policy, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; MacLean Ctr Clin Med Eth, Chicago, IL USA; Univ Illinois, Chicago Sch Pharm, Chicago, IL USA; Virginia Commonwealth Univ, Richmond, VA USA	University of Chicago; Harvard University; Robert Wood Johnson Foundation (RWJF); University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Virginia Commonwealth University	Alexander, GC (corresponding author), Univ Chicago, 5841 S Maryland,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	Zhang, James/HHS-8616-2022; Zhang, James X./AFN-7901-2022; Meltzer, David/C-2926-2009; Rabbani, Atonu/R-3033-2017	Zhang, James X./0000-0002-6251-0474; Meltzer, David/0000-0003-2790-7393; Rabbani, Atonu/0000-0002-3821-4106	AHRQ HHS [K08 HS15699-01A1] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Berkowitz SA, 2007, JAMA-J AM MED ASSOC, V297, P868, DOI 10.1001/jama.297.8.868; Cline RR, 2003, AAPS PHARMSCI, V5; *CTR MED MED SERV, MED DRUG PLANS STRON; Doherty RB, 2004, ANN INTERN MED, V141, P391, DOI 10.7326/0003-4819-141-5-200409070-00100; Gaynor M, 2006, 12758 NBER; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; *KAIS FAM FDN, 2006, CHARTP SEN EARL EXP; *KAIS FAM FDN, 2006, PUBL KAIS FAM FDN, V7453; *KAIS FAM FDN, 2006, PUBL KAIS FAM FDN, V7201; KHAN N, 2007, 12848 NBER; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Pauly MV, 2004, HEALTH AFFAIR, V23, P113, DOI 10.1377/hlthaff.23.1.113; RUBIN DB, 1974, J EDUC PSYCHOL, V66, P688, DOI 10.1037/h0037350; Stuart B, 2006, MED CARE, V44, P243, DOI 10.1097/01.mlr.0000199652.15293.fc	20	145	145	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2008	148	3					169	177		10.7326/0003-4819-148-3-200802050-00200	http://dx.doi.org/10.7326/0003-4819-148-3-200802050-00200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258DX	18180465				2022-12-24	WOS:000252849700001
J	Pelliccia, A; Di Paolo, FM; Quattrini, FM; Basso, C; Culasso, F; Popoli, G; De Luca, R; Spataro, A; Biffi, A; Thiene, G; Maron, BJ				Pelliccia, Antonio; Di Paolo, Fernando M.; Quattrini, Filippo M.; Basso, Cristina; Culasso, Franco; Popoli, Gloria; De Luca, Rosanna; Spataro, Antonio; Biffi, Alessandro; Thiene, Gaetano; Maron, Barry J.			Outcomes in athletes with marked ECG repolarization abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-WAVE ABNORMALITIES; LEFT-VENTRICULAR HYPERTROPHY; BINDING PROTEIN-C; SUDDEN-DEATH; HEART; ELECTROCARDIOGRAMS; CARDIOMYOPATHY; DIAGNOSIS; PATTERNS; SPORTS	Background: Young, trained athletes may have abnormal 12-lead electrocardiograms (ECGs) without evidence of structural cardiac disease. Whether such ECG patterns represent the initial expression of underlying cardiac disease with potential long-term adverse consequences remains unresolved. We assessed long-term clinical outcomes in athletes with ECGs characterized by marked repolarization abnormalities. Methods: From a database of 12,550 trained athletes, we identified 81 with diffusely distributed and deeply inverted T waves (>= 2 mm in at least three leads) who had no apparent cardiac disease and who had undergone serial clinical, ECG, and echocardiographic studies for a mean (+/-SD) of 9+/-7 years (range, 1 to 27). Comparisons were made with 229 matched control athletes with normal ECGs from the same database. Results: Of the 81 athletes with abnormal ECGs, 5 (6%) ultimately proved to have cardiomyopathies, including one who died suddenly at the age of 24 years from clinically undetected arrhythmogenic right ventricular cardiomyopathy. Of the 80 surviving athletes, clinical and phenotypic features of hypertrophic cardiomyopathy developed in 3 after 12+/-5 years (at the ages of 27, 32, and 50 years), including 1 who had an aborted cardiac arrest. The fifth athlete demonstrated dilated cardiomyopathy after 9 years of follow-up. In contrast, none of the 229 athletes with normal ECGs had a cardiac event or received a diagnosis of cardiomyopathy 9+/-3 years after initial evaluation (P=0.001). Conclusions: Markedly abnormal ECGs in young and apparently healthy athletes may represent the initial expression of underlying cardiomyopathies that may not be evident until many years later and that may ultimately be associated with adverse outcomes. Athletes with such ECG patterns merit continued clinical surveillance.	[Pelliccia, Antonio; Di Paolo, Fernando M.; Quattrini, Filippo M.; De Luca, Rosanna; Spataro, Antonio; Biffi, Alessandro] Italian Natl Olymp Comm, Inst Sports Med & Sci, I-00197 Rome, Italy; [Basso, Cristina; Thiene, Gaetano] Univ Padua, Sch Med, Inst Pathol, Padua, Italy; [Culasso, Franco] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Popoli, Gloria] Univ Modena & Reggio Emilia, Dept Diagnost & Lab Serv & Forens Med, Modena, Italy; [Maron, Barry J.] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA	University of Padua; Sapienza University Rome; Universita di Modena e Reggio Emilia; Minneapolis Heart Institute Foundation	Pelliccia, A (corresponding author), Italian Natl Olymp Comm, Inst Sports Med & Sci, Via Campi Sport 46, I-00197 Rome, Italy.	ant.pelliccia@libero.it		QUATTRINI, Filippo Maria/0000-0001-5309-140X; Spataro, Antonio/0000-0002-7727-665X; basso, cristina/0000-0002-0195-9753				Antzelevitch C, 2003, J AM COLL CARDIOL, V41, P1665, DOI 10.1016/S0735-1097(03)00310-3; ARMITAGE P, 1994, STAT METHODS MED RES, P277; BALADY GJ, 1984, AM J CARDIOL, V53, P1339, DOI 10.1016/0002-9149(84)90090-0; BJORNSTAD H, 1993, CARDIOLOGY, V82, P66, DOI 10.1159/000175856; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; DOUGLAS PS, 1988, AM HEART J, V116, P784, DOI 10.1016/0002-8703(88)90338-9; GAVAZZI A, 1993, AM HEART J, V125, P410; HANNEPAPARO N, 1971, AM HEART J, V81, P743, DOI 10.1016/0002-8703(71)90078-0; HUSTON TP, 1985, NEW ENGL J MED, V313, P24, DOI 10.1056/NEJM198507043130106; LICHTMAN J, 1973, ARCH INTERN MED, V132, P763, DOI 10.1001/archinte.132.5.763; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1983, AM J CARDIOL, V51, P189, DOI 10.1016/S0002-9149(83)80034-4; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V91, P1596, DOI 10.1161/01.CIR.91.5.1596; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; NISHIMURA T, 1981, J ELECTROCARDIOL, V14, P357, DOI 10.1016/S0022-0736(81)81008-4; OAKLEY DG, 1982, AM J CARDIOL, V50, P985, DOI 10.1016/0002-9149(82)90406-4; Pelliccia A, 2000, CIRCULATION, V102, P278; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; PELLICCIA A, 1993, AM J CARDIOL, V72, P978, DOI 10.1016/0002-9149(93)91120-7; Pelliccia A, 1999, ANN INTERN MED, V130, P23, DOI 10.7326/0003-4819-130-1-199901050-00005; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; ROESKE WR, 1976, CIRCULATION, V53, P286, DOI 10.1161/01.CIR.53.2.286; Serra-Grima R, 2000, J AM COLL CARDIOL, V36, P1310, DOI 10.1016/S0735-1097(00)00853-6; SHARMA S, 1999, BRIT J SPORT MED, V33, P39; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VENERANDO A, 1964, J Sports Med Phys Fitness, V4, P135; ZEHENDER M, 1990, AM HEART J, V119, P1378, DOI 10.1016/S0002-8703(05)80189-9; ZEPPILLI P, 1980, AM HEART J, V100, P213, DOI 10.1016/0002-8703(80)90117-9	33	211	219	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2008	358	2					152	161		10.1056/NEJMoa060781	http://dx.doi.org/10.1056/NEJMoa060781			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249CJ	18184960				2022-12-24	WOS:000252204200006
J	Shen, B; Dong, L; Xiao, SH; Kowalewski, M				Shen, Bing; Dong, Lin; Xiao, Shuhai; Kowalewski, Michal			The Avalon explosion: Evolution of Ediacara morphospace	SCIENCE			English	Article							MORPHOLOGICAL DISPARITY; STANLY COUNTY; FOSSILS; BODY; BIOTAS; ORIGIN; SHALE; AREA; SEA	Ediacara fossils [ 575 to 542 million years ago ( Ma)] represent Earth's oldest known complex macroscopic life forms, but their morphological history is poorly understood. A comprehensive quantitative analysis of these fossils indicates that the oldest Ediacara assemblage- the Avalon assemblage ( 575 to 565 Ma)- already encompassed the full range of Ediacara morphospace. A comparable morphospace range was occupied by the subsequent White Sea ( 560 to 550 Ma) and Nama ( 550 to 542 Ma) assemblages, although it was populated differently. In contrast, taxonomic richness increased in the White Sea assemblage and declined in the Nama assemblage. These diversity changes, occurring while morphospace range remained relatively constant, led to inverse shifts in morphological variance. The Avalon morphospace expansion mirrors the Cambrian explosion, and both events may reflect similar underlying mechanisms.	[Shen, Bing; Dong, Lin; Xiao, Shuhai; Kowalewski, Michal] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	xiao@vt.edu	Kowalewski, Michal/B-4263-2008; Shen, Bing/D-5355-2009; Xiao, Shuhai/A-2190-2009	Kowalewski, Michal/0000-0002-8575-4711; Shen, Bing/0000-0002-7955-0704; Xiao, Shuhai/0000-0003-4655-2663				Amthor JE, 2003, GEOLOGY, V31, P431, DOI 10.1130/0091-7613(2003)031<0431:EOCANA>2.0.CO;2; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRIGGS DEG, 1992, SCIENCE, V256, P1670, DOI 10.1126/science.256.5064.1670; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Dzik J, 2003, INTEGR COMP BIOL, V43, P114, DOI 10.1093/icb/43.1.114; FARMER J, 1992, GEOL MAG, V129, P181, DOI 10.1017/S001675680000827X; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; FOOTE M, 1992, P NATL ACAD SCI USA, V89, P7325, DOI 10.1073/pnas.89.16.7325; FOOTE M, 1992, SCIENCE, V258, P1816, DOI 10.1126/science.258.5089.1816; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; GIBSON GG, 1984, GEOLOGY, V12, P387, DOI 10.1130/0091-7613(1984)12<387:EFFTCS>2.0.CO;2; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; Grazhdankin D, 2002, PALAEONTOLOGY, V45, P57, DOI 10.1111/1475-4983.00227; GROIZINGER JP, 1995, SCIENCE, V270, P598; Hagadorn JW, 2000, J PALEONTOL, V74, P349, DOI 10.1666/0022-3360(2000)074<0349:EFFTSG>2.0.CO;2; HOFMANN HJ, 1991, CAN J EARTH SCI, V28, P1541, DOI 10.1139/e91-138; Huntley JW, 2006, PRECAMBRIAN RES, V144, P52, DOI 10.1016/j.precamres.2005.11.003; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 1987, PALAEONTOLOGY, V30, P647; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Smith AG, 2001, PERS PALEOB, P11; SOKOLOV BS, 1990, VENDIAN SYSTEM, V1; SUN WG, 1986, PRECAMBRIAN RES, V31, P361, DOI 10.1016/0301-9268(86)90040-9; Waggoner B, 2003, INTEGR COMP BIOL, V43, P104, DOI 10.1093/icb/43.1.104; Weaver PG, 2006, PRECAMBRIAN RES, V150, P123, DOI 10.1016/j.precamres.2006.07.002; Xiao SH, 2005, P NATL ACAD SCI USA, V102, P10227, DOI 10.1073/pnas.0502176102; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2	34	114	124	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					81	84		10.1126/science.1150279	http://dx.doi.org/10.1126/science.1150279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174439				2022-12-24	WOS:000252084000035
J	Chekanova, JA; Gregory, BD; Reverdatto, SV; Chen, H; Kumar, R; Hooker, T; Yazaki, J; Li, P; Skiba, N; Peng, Q; Alonso, J; Brukhin, V; Grossniklaus, U; Ecker, JR; Belostotsky, DA				Chekanova, Julia A.; Gregory, Brian D.; Reverdatto, Sergei V.; Chen, Huaming; Kumar, Ravi; Hooker, Tanya; Yazaki, Junshi; Li, Pinghua; Skiba, Nikolai; Peng, Qian; Alonso, Jose; Brukhin, Vladimir; Grossniklaus, Ueli; Ecker, Joseph R.; Belostotsky, Dmitry A.			Genome-wide high-resolution mapping of exosome substrates reveals hidden features in the Arabidopsis transcriptome	CELL			English	Article							MESSENGER-RNA; RIBOSOMAL-RNA; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; DECAPPING COMPLEX; DNA METHYLATION; YEAST EXOSOME; DEGRADATION; PROTEIN; SUBUNIT	The exosome complex plays a central and essential role in RNA metabolism. However, comprehensive studies of exosome substrates and functional analyses of its subunits are lacking. Here, we demonstrate that as opposed to yeast and metazoans the plant exosome core possesses an unanticipated functional plasticity and present a genome-wide atlas of Arabidopsis exosome targets. Additionally, our study provides evidence for widespread polyadenylation- and exosome-mediated RNA quality control in plants, reveals unexpected aspects of stable structural RNA metabolism, and uncovers numerous novel exosome substrates. These include a select subset of mRNAs, miRNA processing intermediates, and hundreds of noncoding RNAs, the vast majority of which have not been previously described and belong to a layer of the transcriptome that can only be visualized upon inhibition of exosome activity. These first genome-wide maps of exosome substrates will aid in illuminating new fundamental components and regulatory mechanisms of eukaryotic transcriptomes.	[Gregory, Brian D.; Yazaki, Junshi; Peng, Qian; Alonso, Jose; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Gregory, Brian D.; Chen, Huaming; Yazaki, Junshi; Ecker, Joseph R.] Salk Inst Biol Studies, Genome Anal Lab, La Jolla, CA 92037 USA; [Chekanova, Julia A.; Kumar, Ravi; Hooker, Tanya; Belostotsky, Dmitry A.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Chekanova, Julia A.; Reverdatto, Sergei V.; Li, Pinghua; Belostotsky, Dmitry A.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Skiba, Nikolai] Harvard Univ, Sch Med, Howe Lab Ophthalmol, Boston, MA 02114 USA; [Peng, Qian] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92037 USA; [Brukhin, Vladimir; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Brukhin, Vladimir; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	Salk Institute; Salk Institute; University of Missouri System; University of Missouri Kansas City; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of Zurich; University of Zurich	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu; belostotskyd@umkc.edu	Grossniklaus, Ueli/A-2736-2012; Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Yazaki, Junshi/B-1557-2012; Gregory, Brian D/G-2890-2010; Grossniklaus, Ueli/E-9995-2016; Brukhin, Vladimir/F-9779-2015	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Grossniklaus, Ueli/0000-0002-0522-8974; Brukhin, Vladimir/0000-0003-1836-0437; Yazaki, Junshi/0000-0002-0697-8320; Chen, Huaming/0000-0001-5289-7882; Chekanova, Julia/0000-0002-2214-8896				Akama K, 1997, FEBS LETT, V417, P213, DOI 10.1016/S0014-5793(97)01288-X; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Baker RE, 1998, GENETICS, V149, P73; Barneche F, 2000, J BIOL CHEM, V275, P27212; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brouwer R, 2001, J BIOL CHEM, V276, P6177, DOI 10.1074/jbc.M007603200; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Chekanova JA, 2002, NUCLEIC ACIDS RES, V30, P695, DOI 10.1093/nar/30.3.695; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Houalla R, 2006, YEAST, V23, P439, DOI 10.1002/yea.1369; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kopcewicz KA, 2007, MOL CELL BIOL, V27, P2821, DOI 10.1128/MCB.02159-06; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	54	257	271	0	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1340	1353		10.1016/j.cell.2007.10.056	http://dx.doi.org/10.1016/j.cell.2007.10.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160042	Bronze			2022-12-24	WOS:000252217200022
J	Steinbrook, R				Steinbrook, Robert			One step forward, two steps back - Will there ever be an AIDS vaccine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIAL					rsteinbrook@attglobal.net						Cohen Jon, 2001, SHOTS DARK WAYWARD S; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; *HIV VACC MICR RES, 2006, ADD IT ALL HIV VACC; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748	5	99	106	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2653	2655		10.1056/NEJMp0708117	http://dx.doi.org/10.1056/NEJMp0708117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	245UO	18160684				2022-12-24	WOS:000251964500003
J	Bos, MJ; van Rijn, MJE; Witteman, JCM; Hofman, A; Koudstaal, PJ; Breteler, MMB				Bos, Michiel J.; van Rijn, Marie Josee E.; Witteman, Jacqueline C. M.; Hofman, Albert; Koudstaal, Peter J.; Breteler, Monique M. B.			Incidence and prognosis of transient neurological attacks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHORT-TERM PROGNOSIS; ISCHEMIC ATTACK; FOLLOW-UP; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; GLOBAL AMNESIA; MINOR STROKE; RISK-FACTORS; ROTTERDAM; DIAGNOSIS	Context Transient neurological attacks ( TNAs) are attacks with temporary ( < 24 hours) neurological symptoms. These symptoms can be focal, nonfocal, or a mixture of both. The prognostic significance of TNAs with focal symptoms ( better known as transient ischemic attacks [ TIAs]) is well understood. Conversely, hardly anything is known about the prognostic significance of TNAs with nonfocal or mixed symptoms. Objective To study the incidence and prognosis of focal TNAs ( or TIAs), nonfocal TNAs, and mixed TNAs. Design, Setting, and Participants The study population comprised 6062 community-dwelling Rotterdam Study participants who were aged 55 years or older and free from stroke, myocardial infarction, and dementia at baseline ( 1990-1993). They were followed up for events until January 1, 2005. We analyzed the associations between incident TNAs and subsequent adverse events with age- and sex- adjusted Cox regression models. Main Outcome Measures Stroke, ischemic heart disease, or dementia. Results During 60 535 person- years, 548 participants developed TNA ( 282 focal, 228 nonfocal, and 38 mixed). The incidence rate per 1000 person- years was 4.7 ( 95% confidence interval [ CI], 4.1- 5.2) for focal TNA, 3.8 ( 95% CI, 3.3- 4.3) for nonfocal TNA, and 0.6 ( 95% CI, 0.4- 0.9) for mixed TNA. Participants with focal TNA were at higher risk of subsequent stroke than participants without TNA ( n= 46 vs 540; hazard ratio [ HR], 2.14; 95% confidence interval [ CI]; 1.57- 2.91) but had an equal risk of ischemic heart disease and dementia. Nonfocal TNA patients were at higher risk of stroke ( 27 vs 540; HR, 1.56; 95% CI, 1.08- 2.28) and dementia ( 30 vs 552; HR, 1.59; 95% CI, 1.11- 2.26) than participants without TNA. Mixed TNA patients were at higher risk of stroke ( 6 vs 540; HR, 2.48; 95% CI, 1.11- 5.56), ischemic heart disease ( 8 vs 779; HR, 2.26; 95% CI, 1.07- 4.78), vascular death ( 8 vs 594; HR, 2.54; 95% CI, 1.31-4.91), and dementia ( 7 vs 552; HR, 3.46; 95% CI, 1.72- 6.98) than participants without TNA. Conclusion Patients who experience nonfocal TNAs, and especially those with mixed TNAs, have a higher risk of major vascular diseases and dementia than persons without TNA.	Erasmus Sch Ctr, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Erasmus Sch Ctr, Dept Neurol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam	Breteler, MMB (corresponding author), Erasmus Sch Ctr, Dept Epidemiol & Biostat, Dr Molewaterpl 50,POB 2040, NL-3000 CA Rotterdam, Netherlands.		Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305				[Anonymous], 1975, Stroke, V6, P564; Bos MJ, 2006, CIRCULATION, V114, P1591, DOI 10.1161/CIRCULATIONAHA.106.619833; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Bots ML, 1997, STROKE, V28, P768, DOI 10.1161/01.STR.28.4.768; BOTS ML, 1997, STROKE, V28, P763; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Daffertshofer M, 2004, STROKE, V35, P2453, DOI 10.1161/01.STR.0000144050.90132.8e; EVANS JG, 1990, AGE AGEING, V19, P43, DOI 10.1093/ageing/19.1.43; GANDOLFO C, 1992, EUR NEUROL, V32, P52, DOI 10.1159/000116787; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2005, STROKE, V36, P724, DOI 10.1161/str.36.4.724; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; KOUDSTAAL PJ, 1992, LANCET, V340, P630, DOI 10.1016/0140-6736(92)92170-K; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pantoni L, 2005, EUR J NEUROL, V12, P350, DOI 10.1111/j.1468-1331.2004.00982.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Strickberger SA, 2006, CIRCULATION, V113, P316, DOI 10.1161/CIRCULATIONAHA.105.170274; Tinetti ME, 2000, ANN INTERN MED, V132, P337, DOI 10.7326/0003-4819-132-5-200003070-00002; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4	28	114	117	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2877	2885		10.1001/jama.298.24.2877	http://dx.doi.org/10.1001/jama.298.24.2877			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159057	Bronze			2022-12-24	WOS:000251816000020
J	Hanna, J; Wernig, M; Markoulaki, S; Sun, CW; Meissner, A; Cassady, JP; Beard, C; Brambrink, T; Wu, LC; Townes, TM; Jaenisch, R				Hanna, Jacob; Wernig, Marius; Markoulaki, Styliani; Sun, Chiao-Wang; Meissner, Alexander; Cassady, John P.; Beard, Caroline; Brambrink, Tobias; Wu, Li-Chen; Townes, Tim M.; Jaenisch, Rudolf			Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin	SCIENCE			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; DISEASE	It has recently been demonstrated that mouse and human fibroblasts can be reprogrammed into an embryonic stem cell- like state by introducing combinations of four transcription factors. However, the therapeutic potential of such induced pluripotent stem ( iPS) cells remained undefined. By using a humanized sickle cell anemia mouse model, we show that mice can be rescued after transplantation with hematopoietic progenitors obtained in vitro from autologous iPS cells. This was achieved after correction of the human sickle hemoglobin allele by gene- specific targeting. Our results provide proof of principle for using transcription factor- induced reprogramming combined with gene and cell therapy for disease treatment in mice. The problems associated with using retroviruses and oncogenes for reprogramming need to be resolved before iPS cells can be considered for human therapy.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Townes, TM (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA.	ttownes@uab.edu; Jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012; wang, baocheng/B-7805-2008	Hanna, Jacob/0000-0003-2042-9974; wang, baocheng/0000-0002-8236-8014	NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057619] Funding Source: NIH RePORTER; NCI NIH HHS [5-R37-CA084198, 5-RO1-CA087869] Funding Source: Medline; NHLBI NIH HHS [2-R01-HL057619] Funding Source: Medline; PHS HHS [5-RO1-HDO45022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weissman IL, 2006, NATURE, V439, P145, DOI 10.1038/439145a; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	1089	1320	4	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1920	1923		10.1126/science.1152092	http://dx.doi.org/10.1126/science.1152092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18063756				2022-12-24	WOS:000251786600058
J	de Kroon, H				de Kroon, Hans			Ecology - How do roots interact?	SCIENCE			English	Editorial Material							PLANT; COMPETITION		Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	de Kroon, H (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands.	H.deKroon@science.ru.nl	de Kroon, Hans/B-3359-2009	de Kroon, Hans/0000-0001-6151-3561				Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; De Kroon H, 2003, ECOL STU AN, V168, P215; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Falik O, 2003, J ECOL, V91, P525, DOI 10.1046/j.1365-2745.2003.00795.x; Gersani M, 1998, EVOL ECOL, V12, P223, DOI 10.1023/A:1006587813950; Hess L, 2007, J ECOL, V95, P241, DOI 10.1111/j.1365-2745.2006.01204.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Mahall BE, 1996, AM J BOT, V83, P93, DOI 10.2307/2445959; Maina GG, 2002, PLANT ECOL, V160, P235, DOI 10.1023/A:1015822003011; Schenk HJ, 1999, ADV ECOL RES, V28, P145, DOI 10.1016/S0065-2504(08)60032-X; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Turnbull LA, 2007, J ECOL, V95, P79, DOI 10.1111/j.1365-2745.2006.01184.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529	16	99	104	13	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1562	1563		10.1126/science.1150726	http://dx.doi.org/10.1126/science.1150726			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063777				2022-12-24	WOS:000251421700024
J	Douketis, JD; Gu, CS; Schulman, S; Ghirarduzzi, A; Pengo, V; Prandoni, P				Douketis, James D.; Gu, Chu Shu; Schulman, Sam; Ghirarduzzi, Angelo; Pengo, Vittorio; Prandoni, Paolo			The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; DURATION; WARFARIN; EPISODE; AUTOPSY	Background: The long-term risk for fatal pulmonary embolism ( PE) after treatment of venous thromboembolism (VTE) may be an important factor in the decision to discontinue this treatment. Objective: To provide reliable and precise estimates of the annual risk for fatal PE and the case-fatality rate of disease recurrence and to assess these outcomes according to the initial presentation of VTE (deep venous thrombosis [DVT], PE, or both) and its etiology (secondary or idiopathic) in patients who have discontinued anticoagulant therapy. Design: Prospective cohort study. Setting: Academic medical centers. Patients: Inception cohort of patients with a first episode of symptomatic VTE who discontinued anticoagulant therapy. Measurements: Incidence rates of any fatal PE (which included sudden death from possible fatal PE) and definite or probable PE per 100 person-years of follow-up and case-fatality rate of recurrent VTE. Results: Of 2052 patients studied, 1450 had DVT, 310 had PE, and 292 had DVT and PE. The mean duration of previous anticoagulant therapy was 6 months (range, 3 to 39 months), and the mean duration of follow-up after discontinuation of treatment was 54 months (range, 1 to 120 months). The annual risk for any fatal PE and definite or probable fatal PE after discontinuation of anticoagulation was 0.49 events (95% Cl, 0.36 to 0.64 events) per 100 person-years and 0.19 events (Cl, 0.12 to 0.30 events) per 100 person-years, respectively. The case-fatality rate of recurrent disease was 9.0% (Cl, 6.8% to 11.8%) for any fatal PE and 3.8% (Cl, 2.4% to 5.9%) for definite or probable fatal PE. Limitation: The findings are less pertinent to patients with active cancer, permanent immobility, or high-risk thrombophilia. Conclusion: The risk for fatal PE is 0.19 to 0.49 events per 100 person-years for patients who have finished a course of anticoagulant therapy for a first episode of symptomatic VTE. The casefatality rate for death from recurrent PE is 4% to 9%. This information helps to inform patient prognosis and may assist clinicians in deciding whether to discontinue anticoagulant therapy for VTE.	McMaster Univ, Hamilton, ON, Canada; Karolinska Univ Hosp, Stockholm, Sweden; Arcispedale Santa Maria Nouva, Reggio Emilia, Italy; Univ Padua, Padua, Italy	McMaster University; Karolinska Institutet; Karolinska University Hospital; IRCCS Arcispedale S. Maria Nuova; University of Padua	Douketis, JD (corresponding author), St Josephs Hosp, Rm F-544, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	jdouket@mcmaster.ca	Pengo, Vittorio/GSE-5972-2022; Pengo, Vittorio/AAV-9491-2020; Douketis, James/AAO-5659-2021; Schulman, Sam/I-7559-2019	Pengo, Vittorio/0000-0003-2064-6071; Pengo, Vittorio/0000-0003-2064-6071; Schulman, Sam/0000-0002-8512-9043				Aalten CM, 2006, NETH J MED, V64, P186; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Attems Johannes, 2004, Wien Med Wochenschr, V154, P159, DOI 10.1007/s10354-004-0057-0; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Burton EC, 2004, AM J MED, V117, P255, DOI 10.1016/j.amjmed.2004.01.028; Cushman M, 2004, AM J MED, V117, P19, DOI 10.1016/j.amjmed.2004.01.018; Douketis JD, 2006, ARCH INTERN MED, V166, P853, DOI 10.1001/archinte.166.8.853; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Douketis JD, 2000, ARCH INTERN MED, V160, P3431, DOI 10.1001/archinte.160.22.3431; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Janke RM, 2000, J CLIN EPIDEMIOL, V53, P103, DOI 10.1016/S0895-4356(99)00147-X; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Keeling D, 2006, BLOOD REV, V20, P173, DOI 10.1016/j.blre.2005.09.001; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Loughrey MB, 2000, ULSTER MED J, V69, P83; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piccioli A, 1996, AM HEART J, V132, P1010, DOI 10.1016/S0002-8703(96)90014-9; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Stein PD, 2004, AM J CARDIOL, V93, P1197, DOI 10.1016/j.amjcard.2004.01.058; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	28	165	171	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2007	147	11					766	U36		10.7326/0003-4819-147-11-200712040-00007	http://dx.doi.org/10.7326/0003-4819-147-11-200712040-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239SX	18056660				2022-12-24	WOS:000251539100003
J	Gallo, EM; Winslow, MM; Cante-Barrett, K; Radermacher, AN; Ho, L; McGinnis, L; Iritani, B; Neilson, JR; Crabtree, GR				Gallo, Elena M.; Winslow, Monte M.; Cante-Barrett, Kirsten; Radermacher, Amy N.; Ho, Lena; McGinnis, Lisa; Iritani, Brian; Neilson, Joel R.; Crabtree, Gerald R.			Calcineurin sets the bandwidth for discrimination of signals during thymocyte development	NATURE			English	Article							T-CELL DEVELOPMENT; POSITIVE SELECTION; NEGATIVE SELECTION; CD4+8+ THYMOCYTES; ALPHA-BETA; ACTIVATION; EXPRESSION; MATURATION; REQUIREMENT; TOLERANCE	At critical times in development, cells are able to convert graded signals into discrete developmental outcomes; however, the mechanisms involved are poorly understood. During thymocyte development, cell fate is determined by signals originating from the alpha beta T-cell receptor. Low-affinity/avidity interactions between the T-cell receptor and peptide-MHC complexes direct differentiation to the single-positive stage (positive selection), whereas high-affinity/avidity interactions induce death by apoptosis (negative selection)(1,2). Here we show that mice deficient in both calcineurin and nuclear factor of activated T cells (NFAT) c2/c3 lack a population of preselection thymocytes with enhanced ability to activate the mitogen-activated protein kinase (Raf-MEK-ERK) pathway, and fail to undergo positive selection. This defect can be partially rescued with constitutively active Raf, indicating that calcineurin controls MAPK signalling. Analysis of mice deficient in both Bim (which is required for negative selection) and calcineurin revealed that calcineurin-induced ERK (extracellular signal-regulated kinase) sensitization is required for differentiation in response to 'weak' positive selecting signals but not in response to 'strong' negative selecting signals (which normally induce apoptosis). These results indicate that early calcineurin/NFAT signalling produces a developmental period of ERK hypersensitivity, allowing very weak signals to induce positive selection. This mechanism might be generally useful in the discrimination of graded signals that induce different cell fates.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Program Immunol, Stanford, CA 94305 USA; Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Ho, Lena/0000-0002-9358-621X; Iritani, Brian/0000-0003-1903-7850; Cante-Barrett, Kirsten/0000-0003-0418-8445; Neilson, Joel R./0000-0002-3408-608X	NCRR NIH HHS [K26 RR024462] Funding Source: Medline; NIAID NIH HHS [T32 AI007290, R01 AI053568] Funding Source: Medline; NIH HHS [K26 OD011060] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI053568, K08AI001445] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011060] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cante-Barrett K, 2006, J IMMUNOL, V176, P2299, DOI 10.4049/jimmunol.176.4.2299; Cante-Barrett K, 2007, J IMMUNOL, V179, P103, DOI 10.4049/jimmunol.179.1.103; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Iritani BM, 1999, IMMUNITY, V10, P713, DOI 10.1016/S1074-7613(00)80070-9; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEVELT CN, 1993, J EXP MED, V178, P1867, DOI 10.1084/jem.178.6.1867; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; PENIT C, 1986, J IMMUNOL, V137, P2115; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892	28	45	45	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					731	U11		10.1038/nature06305	http://dx.doi.org/10.1038/nature06305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046413	Green Accepted			2022-12-24	WOS:000251209700056
J	Fusar-Poli, P; Valmaggia, L; McGuire, P				Fusar-Poli, Paolo; Valmaggia, Lucia; McGuire, Philip			Can antidepressants prevent psychoses?	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SCHIZOPHRENIA PRODROME; CLINICAL-SAMPLE; MENTAL-HEALTH; RISK; EXPERIENCES; PEOPLE		S London & Maudsley NHS Trust, Outreach & Support S London, London, England; Kings Coll London, Inst Psychiat, London SE5 8AF, England; Univ Pavia, Dept Psychobehav Hlth Sci, I-27100 Pavia, Italy	South London & Maudsley NHS Trust; University of London; King's College London; University of Pavia	Fusar-Poli, P (corresponding author), S London & Maudsley NHS Trust, Outreach & Support S London, London, England.	p.fusar@libero.it	Valmaggia, Lucia/E-9653-2012; Valmaggia, Lucia R./O-1377-2019; Fusar-Poli, Paolo/D-8605-2011	Valmaggia, Lucia/0000-0001-6099-8464; Valmaggia, Lucia R./0000-0001-6099-8464; Fusar-Poli, Paolo/0000-0003-3582-6788; McGuire, Philip/0000-0003-4381-0532				Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Broome MR, 2005, EUR PSYCHIAT, V20, P372, DOI 10.1016/j.eurpsy.2005.03.001; Cantor-Graae E, 2007, CAN J PSYCHIAT, V52, P277, DOI 10.1177/070674370705200502; Cornblatt BA, 2007, J CLIN PSYCHIAT, V68, P546, DOI 10.4088/JCP.v68n0410; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; Krabbendam L, 2005, BRIT J CLIN PSYCHOL, V44, P113, DOI 10.1348/014466504X19767; McGlashan TH, 2006, AM J PSYCHIAT, V163, P790, DOI 10.1176/appi.ajp.163.5.790; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; Morrison AP, 2007, SCHIZOPHRENIA BULL, V33, P682, DOI 10.1093/schbul/sbl042; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Rosen JL, 2006, SCHIZOPHR RES, V85, P124, DOI 10.1016/j.schres.2006.03.034; Yung AR, 2007, SCHIZOPHR RES, V91, P246, DOI 10.1016/j.schres.2006.11.026; Yung AR, 2004, SCHIZOPHR RES, V67, P131, DOI 10.1016/S0920-9964(03)00192-0	14	68	75	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2007	370	9601					1746	1748		10.1016/S0140-6736(07)61732-2	http://dx.doi.org/10.1016/S0140-6736(07)61732-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234DI	18037073				2022-12-24	WOS:000251140500008
J	Manganas, LN; Zhang, XY; Li, Y; Hazel, RD; Smith, SD; Wagshul, ME; Henn, F; Benveniste, H; Djuric, PM; Enikolopov, G; Maletic-Savatic, M				Manganas, Louis N.; Zhang, Xueying; Li, Yao; Hazel, Raphael D.; Smith, S. David; Wagshul, Mark E.; Henn, Fritz; Benveniste, Helene; Djuric, Petar M.; Enikolopov, Grigori; Maletic-Savatic, Mirjana			Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; N-ACETYLASPARTATE; DENTATE GYRUS; ADULT BRAIN; NEUROGENESIS; STEM; PROLIFERATION; HIPPOCAMPUS; DECREASE; THERAPY	The identification of neural stem and progenitor cells (NPCs) by in vivo brain imaging could have important implications for diagnostic, prognostic, and therapeutic purposes. We describe a metabolic biomarker for the detection and quantification of NPCs in the human brain in vivo. We used proton nuclear magnetic resonance spectroscopy to identify and characterize a biomarker in which NPCs are enriched and demonstrated its use as a reference for monitoring neurogenesis. To detect low concentrations of NPCs in vivo, we developed a signal processing method that enabled the use of magnetic resonance spectroscopy for the analysis of the NPC biomarker in both the rodent brain and the hippocampus of live humans. Our findings thus open the possibility of investigating the role of NPCs and neurogenesis in a wide variety of human brain disorders.	SUNY Stony Brook, Stony Brook, NY 11794 USA; Brookhaven Natl Lab, Upton, NY 11719 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; Cold Spring Harbor Laboratory	Enikolopov, G (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	enikolop@cshl.edu; mmaleticsava@notes.cc.sunysb.edu	Enikolopov, Grigori N/B-7771-2009; Enikolopov, Grigori/P-5731-2019; Mordwinkin, Nicholas M/A-4347-2010	Enikolopov, Grigori N/0000-0001-8178-8917; Enikolopov, Grigori/0000-0001-8178-8917; Maletic-Savatic, Mirjana/0000-0002-6548-4662; Djuric, Petar M./0000-0001-7791-3199	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053875, K08NS044276, R01NS032764] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007521, T32DK07521-16] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [K08 NS044276, K08 NS044276-01, R21 NS053875, 5K08 NS044276, R21 NS053875-01A1, R21NS05875-1, R01 NS032764, R01-NS32764] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arbab AS, 2006, EXPERT REV MED DEVIC, V3, P427, DOI 10.1586/17434440.3.4.427; BARKHUIJSEN H, 1987, J MAGN RESON, V73, P553, DOI 10.1016/0022-2364(87)90023-0; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; CAVASSILA S, 1997, J MAGN RESON ANAL, V3, P87; Chin BB, 2003, NUCL MED COMMUN, V24, P1149, DOI 10.1097/00006231-200311000-00005; Cicchetti F, 2007, CONTRAST MEDIA MOL I, V2, P130, DOI 10.1002/cmmi.138; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Goldman SA, 2006, PHILOS T R SOC B, V361, P1463, DOI 10.1098/rstb.2006.1886; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Shinno H, 2007, J NEUROL SCI, V260, P132, DOI 10.1016/j.jns.2007.04.017; SPARLING ML, 1989, ANAL BIOCHEM, V178, P67, DOI 10.1016/0003-2697(89)90358-8; Stengel A, 2004, MAGN RESON MED, V52, P228, DOI 10.1002/mrm.20171; Stoica P, 2003, J MAGN RESON, V165, P80, DOI 10.1016/S1090-7807(03)00188-5; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Viant Mark R., 2007, V358, P229, DOI 10.1007/978-1-59745-244-1_13; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156	28	328	350	3	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					980	985		10.1126/science.1147851	http://dx.doi.org/10.1126/science.1147851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991865	Green Accepted			2022-12-24	WOS:000250788500045
J	Jasanoff, S				Jasanoff, Sheila			Technologies of humility	NATURE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, 79 John F Kennedy St, Cambridge, MA 02138 USA.								0	152	154	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					33	33		10.1038/450033a	http://dx.doi.org/10.1038/450033a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972866	Bronze			2022-12-24	WOS:000250585800025
J	Cheke, RA				Cheke, Robert A.			Thinking long term	SCIENCE			English	Editorial Material							OUTBREAKS; PLAGUES		Univ Greenwich Medway, Nat Resources Inst, Chatham ME4 4TB, Kent, England	University of Greenwich	Cheke, RA (corresponding author), Univ Greenwich Medway, Nat Resources Inst, Chatham ME4 4TB, Kent, England.	r.a.cheke@greenwich.ac.uk	Cheke, Robert/AAF-5017-2020	Cheke, Robert/0000-0002-7437-1934				CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Cheke RA, 2007, BIOSCIENCE, V57, P145, DOI 10.1641/B570209; Esper J, 2007, P ROY SOC B-BIOL SCI, V274, P671, DOI 10.1098/rspb.2006.0191; MA SHIHCHUN, 1965, Acta Entomologica Sinica, V14, P319; Stige LC, 2007, P NATL ACAD SCI USA, V104, P16188, DOI 10.1073/pnas.0706813104; SUGIHARA G, 1995, NATURE, V378, P559, DOI 10.1038/378559a0; Todd MC, 2002, J APPL ECOL, V39, P31, DOI 10.1046/j.1365-2664.2002.00691.x; TSAO C, 1950, CHINESE J AGR RES, V1, P57; WRIGHT DE, 1987, AUST J ECOL, V12, P423, DOI 10.1111/j.1442-9993.1987.tb00959.x; Zhang D.E, 2013, COMPENDIUM CHINESE M, P371	10	6	7	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					577	578		10.1126/science.1150636	http://dx.doi.org/10.1126/science.1150636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962543				2022-12-24	WOS:000250409200025
J	Sanai, N; Mirzadeh, Z; Berger, MS				Sanai, Nader; Mirzadeh, Zaman; Berger, Mitchel S.			Functional outcome after language mapping for glioma resection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOW-GRADE; PROGNOSTIC-FACTORS; CORTICAL LOCALIZATION; MOTOR CORTEX; BRAIN-TUMORS; ASTROCYTOMAS; ADULTS; REORGANIZATION; COMPLICATIONS	Background: Language sites in the cortex of the brain vary among patients. Language mapping while the patient is awake is an intraoperative technique designed to minimize language deficits associated with brain-tumor resection. Methods: To study language function after brain-tumor resection with language mapping, we examined 250 consecutive patients with gliomas. Positive language sites (i.e., language regions in the cortex of the brain, 1 cm by 1 cm, which were temporarily inactivated by means of a bipolar electrode) were identified and categorized into cortical language maps. The tumors were resected up to 1 cm from the cortical areas where intraoperative stimulation produced a disturbance in language. Our resection strategy did not require identification of the stimulation-induced language sites within the field of exposure. Results: A total of 145 of the 250 patients (58.0%) had at least one site with an intraoperative stimulation-induced speech arrest, 82 patients had anomia, and 23 patients had alexia. Overall, 3094 of 3281 cortical sites (94.3%) were not associated with stimulation-induced language deficits. A total of 159 patients (63.6%) had intact speech preoperatively. One week after surgery, baseline language function remained in 194 patients (77.6%), it worsened in 21 patients (8.4%), and 35 patients (14.0%) had new speech deficits. However, 6 months after surgery, only 4 of 243 surviving patients (1.6%) had a persistent language deficit. Cortical maps generated with intraoperative language data also showed surprising variability in language localization within the dominant hemisphere. Conclusions: Craniotomies tailored to limit cortical exposure, even without localization of positive language sites, permit most gliomas to be aggressively resected without language deficits. The composite language maps generated in our study suggest that our current models of human language organization insufficiently account for observed language function.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sanai, N (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M-779, San Francisco, CA 94143 USA.	sanain@neurosurg.ucsf.edu						BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Buckner JC, 2001, CANCER-AM CANCER SOC, V92, P420, DOI 10.1002/1097-0142(20010715)92:2<420::AID-CNCR1338>3.0.CO;2-3; Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; CIRIC I, 1987, NEUROSURGERY, V21, P21, DOI 10.1227/00006123-198707000-00005; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Duffau H, 1999, ACTA NEUROCHIR, V141, P1157, DOI 10.1007/s007010050413; Fandino J, 1999, J NEUROSURG, V91, P238, DOI 10.3171/jns.1999.91.2.0238; Farias ST, 2005, AM J NEURORADIOL, V26, P2492; GRADY MS, 1989, J NEUROSURG, V71, P534, DOI 10.3171/jns.1989.71.4.0534; HAGLUND MM, 1994, NEUROSURGERY, V34, P567, DOI 10.1227/00006123-199404000-00001; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Nicolato A, 1995, SURG NEUROL, V44, P208, DOI 10.1016/0090-3019(95)00184-0; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Ojemann G. A., 1990, SEMINARS NEUROSCIENC, V2, P297; OJEMANN GA, 1978, BRAIN LANG, V6, P239, DOI 10.1016/0093-934X(78)90061-5; OJEMANN GA, 1979, J NEUROSURG, V50, P164, DOI 10.3171/jns.1979.50.2.0164; OJEMANN GA, 1991, J NEUROSCI, V11, P2281; Ojemann JG, 1996, NEUROSURGERY, V39, P253, DOI 10.1097/00006123-199608000-00003; Peraud A, 1998, ACTA NEUROCHIR, V140, P1213, DOI 10.1007/s007010050241; PHILIPPON JH, 1993, NEUROSURGERY, V32, P554; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Scerrati M, 1996, J NEUROL NEUROSUR PS, V61, P291, DOI 10.1136/jnnp.61.3.291; SEITZ RJ, 1995, NEUROREPORT, V6, P742, DOI 10.1097/00001756-199503270-00009; Skirboll SS, 1996, NEUROSURGERY, V38, P678, DOI 10.1227/00006123-199604000-00008; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Taylor MD, 1999, J NEUROSURG, V90, P35, DOI 10.3171/jns.1999.90.1.0035; Tortosa A, 2003, CANCER, V97, P1063, DOI 10.1002/cncr.11120; Vorster S J, 1998, Neurosurg Focus, V4, pe2; WEDER B, 1994, NEUROREPORT, V5, P457, DOI 10.1097/00001756-199401120-00022; Wunderlich G, 1998, NEUROSURGERY, V42, P18, DOI 10.1097/00006123-199801000-00005	36	679	711	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2008	358	1					18	27		10.1056/NEJMoa067819	http://dx.doi.org/10.1056/NEJMoa067819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246TW	18172171				2022-12-24	WOS:000252031200004
J	Mak, TW				Mak, Tak Wah			Gene targeting in embryonic stem cells scores a knockout in Stockholm	CELL			English	Article							PLURIPOTENTIAL CELLS; MOUSE EMBRYOS; LINE		Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Mak, Tak Wah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Mak, Tak Wah] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Mak, TW (corresponding author), Univ Toronto, Campbell Family Inst Breast Canc Res, Ontario Canc Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca						Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Callaway E, 2007, NATURE, V448, P516, DOI 10.1038/448516a; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; PALMITER RD, 1985, CELL, V41, P343, DOI 10.1016/S0092-8674(85)80004-0; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rossant J, 2007, NATURE, V448, P260, DOI 10.1038/448260a; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; YU J, 2007, SCIENCE         1120, DOI DOI 10.1126/SCIENCE.1151526	13	43	47	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1027	1031		10.1016/j.cell.2007.11.033	http://dx.doi.org/10.1016/j.cell.2007.11.033			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083089	Bronze			2022-12-24	WOS:000252217100007
J	Nejentsev, S; Howson, JMM; Walker, NM; Szeszko, J; Field, SF; Stevens, HE; Reynolds, P; Hardy, M; King, E; Masters, J; Hulme, J; Maier, LM; Smyth, D; Bailey, R; Cooper, JD; Ribas, G; Campbell, RD; Clayton, DG; Todd, JA				Nejentsev, Sergey; Howson, Joanna M. M.; Walker, Neil M.; Szeszko, Jeffrey; Field, Sarah F.; Stevens, Helen E.; Reynolds, Pamela; Hardy, Matthew; King, Erna; Masters, Jennifer; Hulme, John; Maier, Lisa M.; Smyth, Deborah; Bailey, Rebecca; Cooper, Jason D.; Ribas, Gloria; Campbell, R. Duncan; Clayton, David G.; Todd, John A.		Wellcome Trust Case Control Consor	Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A	NATURE			English	Article							CD8 T-CELLS; NOD MICE; MELLITUS; REGION; ASSOCIATION; REVEALS; RISK; PREDISPOSITION; INFILTRATION; DESTRUCTION	The major histocompatibility complex (MHC) on chromosome 6 is associated with susceptibility to more common diseases than any other region of the human genome, including almost all disorders classified as autoimmune. In type 1 diabetes the major genetic susceptibility determinants have been mapped to the MHC class II genes HLA-DQB1 and HLA-DRB1(refs 1-3), but these genes cannot completely explain the association between type 1 diabetes and the MHC region(4-11). Owing to the region's extreme gene density, the multiplicity of disease-associated alleles, strong associations between alleles, limited genotyping capability, and inadequate statistical approaches and sample sizes, which, and how many, loci within the MHC determine susceptibility remains unclear. Here, in several large type 1 diabetes data sets, we analyse a combined total of 1,729 polymorphisms, and apply statistical methods-recursive partitioning and regression-to pinpoint disease susceptibility to the MHC class I genes HLA-B and HLA-A (risk ratios > 1.5; P(combined) = 2.01 X 10(-19) and 2.35 X 10(-13), respectively) in addition to the established associations of the MHC class II genes. Other loci with smaller and/or rarer effects might also be involved, but to find these, future searches must take into account both the HLA class II and class I genes and use even larger samples. Taken together with previous studies(4-8,10-16), we conclude that MHC-class-I-mediated events, principally involving HLA-B*39, contribute to the aetiology of type 1 diabetes.	Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge CB2 0XY, England; MRC Rosalind Franklin Ctr Genom Res, Cambridge CB10 1SB, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Cambridge; University of Oxford	Howson, JMM (corresponding author), Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge CB2 0XY, England.	Joanna.Howson@cimr.cam.ac.uk; John.Todd@cimr.cam.ac.uk	Worthington, Jane/M-9770-2014; eyre, stephen/K-3776-2017; Mathew, Christopher G/G-3434-2015; Ribas-Despuig, Gloria/M-6190-2017; Attrill, Lauren/V-1688-2018; Brown, Matthew A/E-5749-2010; O'Donovan, Michael C/P-7005-2018; Timpson, Nicholas John/O-7548-2015; Todd, John A/A-3542-2010; Hinks, Anne/E-1853-2015; Barton, Anne/N-2053-2014; Evans, David/H-6325-2013; Prescott, Natalie/F-6490-2011; Breen, Gerome/A-5540-2010; McCarthy, Mark/M-3763-2015; Ribas, Gloria/K-3379-2013; dobson, richard/C-9269-2011; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Worthington, Jane/0000-0003-0544-042X; eyre, stephen/0000-0002-1251-6974; Mathew, Christopher G/0000-0003-4178-1838; Brown, Matthew A/0000-0003-0538-8211; O'Donovan, Michael C/0000-0001-7073-2379; Timpson, Nicholas John/0000-0002-7141-9189; Todd, John A/0000-0003-2740-8148; Hinks, Anne/0000-0001-8843-3967; Wallace, Chris/0000-0001-9755-1703; Parkes, Miles/0000-0002-6467-0631; Jones, Lisa/0000-0002-5122-8334; Barton, Anne/0000-0003-3316-2527; Thomson, Wendy/0000-0002-9022-5179; Bruce, Ian/0000-0003-3047-500X; Walker, Neil/0000-0001-9796-7688; Evans, David/0000-0003-0663-4621; Prescott, Natalie/0000-0002-5901-7371; Symmons, Deborah/0000-0002-8625-1200; Escott-Price, Valentina/0000-0003-1784-5483; Bowcock, Anne/0000-0001-8691-9090; Tobin, Martin/0000-0002-3596-7874; Kirov, George/0000-0002-3427-3950; Breen, Gerome/0000-0003-2053-1792; smyth, deborah/0000-0002-6330-2669; McCarthy, Mark/0000-0002-4393-0510; s, hema/0000-0002-3440-9475; Newport, Melanie/0000-0002-8946-7525; Hall, Alistair/0000-0003-0306-7887; Grozeva, Detelina/0000-0003-3239-8415; Ribas, Gloria/0000-0001-6883-4130; Caulfield, Mark/0000-0001-9295-3594; Howson, Joanna/0000-0001-7618-0050; Bishop, Tim/0000-0002-8752-8785; Simmonds, Matt/0000-0003-3154-3510; dobson, richard/0000-0003-4224-9245; Lango Allen, Hana/0000-0002-7803-8688; Lindgren, Cecilia/0000-0002-4903-9374; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Cummings, Fraser/0000-0002-9659-3247; Hardy, Matthew/0000-0001-6420-1715	MRC [G0600681, G0000934] Funding Source: UKRI; Medical Research Council [G0600681, G0000934] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aly TA, 2007, CLIN IMMUNOL, V123, pS133, DOI 10.1016/j.clim.2007.03.018; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; BREIMAN L., 1984, CRC PRESS; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Jersey J, 2007, P NATL ACAD SCI USA, V104, P1295, DOI 10.1073/pnas.0610057104; FENNESSY M, 1994, DIABETOLOGIA, V37, P937, DOI 10.1007/s001250050200; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Herr M, 2000, HUM MOL GENET, V9, P1291, DOI 10.1093/hmg/9.9.1291; HONEYMAN MC, 1995, MOL MED, V1, P576, DOI 10.1007/BF03401595; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; Marron MP, 2002, P NATL ACAD SCI USA, V99, P13753, DOI 10.1073/pnas.212221199; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Noble JA, 1996, AM J HUM GENET, V59, P1134; Noble JA, 2002, HUM IMMUNOL, V63, P657, DOI 10.1016/S0198-8859(02)00421-4; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; R Development Core Team, 2006, LANG ENV STAT COMP; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Therneau T. M, 1997, 61 MAYO CLIN SECT ST; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Utsugi T, 1996, DIABETES, V45, P1121, DOI 10.2337/diabetes.45.8.1121; Valdes AM, 2005, HUM IMMUNOL, V66, P301, DOI 10.1016/j.humimm.2004.12.001; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500	30	402	416	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					887	U19		10.1038/nature06406	http://dx.doi.org/10.1038/nature06406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004301	Green Accepted			2022-12-24	WOS:000251394900058
J	Yarden, Y; Shilo, BZ				Yarden, Yosef; Shilo, Ben-Zion			SnapShot: EGFR signaling pathway	CELL			English	Editorial Material							ACTIVATION		[Yarden, Yosef; Shilo, Ben-Zion] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.		YARDEN, YOSEF/K-1467-2012	Shilo, Ben Zion/0000-0003-4903-8889				Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	12	130	137	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5							1018.e1	10.1016/j.cell.2007.11.013	http://dx.doi.org/10.1016/j.cell.2007.11.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045542	Bronze			2022-12-24	WOS:000251800900022
J	Zhang, XW; Pickin, KA; Bose, R; Jura, N; Cole, PA; Kuriyan, J				Zhang, Xuewu; Pickin, Kerry A.; Bose, Ron; Jura, Natalia; Cole, Philip A.; Kuriyan, John			Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NEGATIVE REGULATOR; LUNG-CANCER; SIGNAL; COMPLEX; RALT; CONFORMATION; MUTATIONS; GEFITINIB; MECHANISM	Members of the epidermal growth factor receptor family (EGFR/ERBB1, ERBB2/HER2, ERBB3/HER3 and ERBB4/HER4) are key targets for inhibition in cancer therapy(1). Critical for activation is the formation of an asymmetric dimer by the intracellular kinase domains, in which the carboxy-terminal lobe (C lobe) of one kinase domain induces an active conformation in the other(2). The cytoplasmic protein MIG6 (mitogen-induced gene 6; also known as ERRFI1) interacts with and inhibits the kinase domains of EGFR and ERBB2 (refs 3-5). Crystal structures of complexes between the EGFR kinase domain and a fragment of MIG6 show that a similar to 25-residue epitope (segment 1) from MIG6 binds to the distal surface of the Clobe of the kinase domain. Biochemical and cell-based analyses confirm that this interaction contributes to EGFR inhibition by blocking the formation of the activating dimer interface. A longer MIG6 peptide that is extended C terminal to segment 1 has increased potency as an inhibitor of the activated EGFR kinase domain, while retaining a critical dependence on segment 1. We show that signalling by EGFR molecules that contain constitutively active kinase domains still requires formation of the asymmetric dimer, underscoring the importance of dimer interface blockage in MIG6-mediated inhibition.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Calif Inst Quantitat Sci, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA096504, R01 CA096504-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasi S, 2003, ONCOGENE, V22, P4221, DOI 10.1038/sj.onc.1206516; ANASTASI S, 2007, ONCOGENE        0618; Ballaro C, 2005, EMBO REP, V6, P755, DOI 10.1038/sj.embor.7400458; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Hackel PO, 2001, BIOL CHEM, V382, P1649, DOI 10.1515/BC.2001.200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang YW, 2007, ONCOGENE, V26, P269, DOI 10.1038/sj.onc.1209790	22	268	274	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					741	U13		10.1038/nature05998	http://dx.doi.org/10.1038/nature05998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046415	Green Accepted, Green Submitted			2022-12-24	WOS:000251209700058
J	Wakeman, SE				Wakeman, Sarah Elizabeth			It's simple, really	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sarah_wakeman@brown.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2351	2351		10.1001/jama.298.20.2351	http://dx.doi.org/10.1001/jama.298.20.2351			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042908				2022-12-24	WOS:000251163400001
J	Spies, M; Amitani, I; Baskin, RJ; Kowalczykowski, SC				Spies, Maria; Amitani, Ichiro; Baskin, Ronald J.; Kowalczykowski, Stephen C.			RecBCD enzyme switches lead motor Subunits in response to chi recognition	CELL			English	Article							RECOMBINATION HOTSPOT-CHI; ESCHERICHIA-COLI; DNA HELICASE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; STRAND SPECIFICITY; NUCLEASE ACTIVITY; TRANSLOCATION; SEQUENCE; MOLECULES	RecBCD is a DNA helicase comprising two motor subunits, RecB and RecD. Recognition of the recombination hotspot, chi, causes RecBCD to pause and reduce translocation speed. To understand this control of translocation, we used single-molecule visualization to compare RecBCD to the RecBCD(K177Q) mutant with a defective RecD motor. RecBCD(K177Q) paused at chi but did not change its translocation velocity. RecBCD(K177Q) translocated at the same rate as the wild-type post-chi enzyme, implicating RecB as the leadmotor after chi. P1 nuclease treatment eliminated the wild-type enzyme's velocity changes, revealing a chi-containing ssDNA loop preceding chi recognition and showing that RecD is the faster motor before chi. We conclude that before chi, RecD is the lead motor but after chi, the slower RecB motor leads, implying a switch in motors at chi. We suggest that degradation of foreign DNA needs fast translocation, whereas DNA repair uses slower translocation to coordinate RecA loading onto ssDNA.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cell Biol, Davis, CA 95616 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Illinois System; University of Illinois Urbana-Champaign	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Spies, Maria/0000-0002-7375-8037	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041347, R01 GM041347-13, R01 GM041347-14, GM-41347, R01 GM041347-12] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bianco PR, 2000, NATURE, V405, P368, DOI 10.1038/35012652; BRAEDT G, 1989, P NATL ACAD SCI USA, V86, P871, DOI 10.1073/pnas.86.3.871; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; Chedin F, 2006, J BIOL CHEM, V281, P18610, DOI 10.1074/jbc.M600882200; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; KORANGY F, 1992, J BIOL CHEM, V267, P1727; Kulkarni A, 2004, NUCLEIC ACIDS RES, V32, P3672, DOI 10.1093/nar/gkh675; LAM ST, 1974, GENETICS, V77, P425; MUSKAVITCH KMT, 1982, J BIOL CHEM, V257, P2641; MYERS RS, 1995, GENETICS, V141, P805; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies Maria, 2005, P389; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; Taylor AF, 1999, GENE DEV, V13, P890, DOI 10.1101/gad.13.7.890; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	37	96	96	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					694	705		10.1016/j.cell.2007.09.023	http://dx.doi.org/10.1016/j.cell.2007.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022364	Green Accepted, Bronze			2022-12-24	WOS:000250966300017
J	Milliken, CS; Auchterlonie, JL; Hoge, CW				Milliken, Charles S.; Auchterlonie, Jennifer L.; Hoge, Charles W.			Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VETERANS; THERAPY; AFGHANISTAN; TRAUMA	Context To promote early identification of mental health problems among combat veterans, the Department of Defense initiated population-wide screening at 2 time points, immediately on return from deployment and 3 to 6 months later. A previous article focusing only on the initial screening is likely to have underestimated the mental health burden. Objective To measure the mental health needs among soldiers returning from Iraq and the association of screening with mental health care utilization. Design, Setting, and Participants Population-based, longitudinal descriptive study of the initial large cohort of 88 235 US soldiers returning from Iraq who completed both a Post-Deployment Health Assessment ( PDHA) and a Post-Deployment Health Re-Assessment (PDHRA) with a median of 6 months between the 2 assessments. Main Outcome Measures Screening positive for posttraumatic stress disorder ( PTSD), major depression, alcohol misuse, or other mental health problems; referral and use of mental health services. Results Soldiers reported more mental health concerns and were referred at significantly higher rates from the PDHRA than from the PDHA. Based on the combined screening, clinicians identified 20.3% of active and 42.4% of reserve component soldiers as requiring mental health treatment. Concerns about interpersonal conflict increased 4-fold. Soldiers frequently reported alcohol concerns, yet very few were referred to alcohol treatment. Most soldiers who used mental health services had not been referred, even though the majority accessed care within 30 days following the screening. Although soldiers were much more likely to report PTSD symptoms on the PDHRA than on the PDHA, 49% to 59% of those who had PTSD symptoms identified on the PDHA improved by the time they took the PDHRA. There was no direct relationship of referral or treatment with symptom improvement. Conclusions Rescreening soldiers several months after their return from Iraq identified a large cohort missed on initial screening. The large clinical burden recently reported among veterans presenting to Veterans Affairs facilities seems to exist within months of returning home, highlighting the need to enhance military mental health care during this period. Increased relationship problems underscore shortcomings in services for family members. Reserve component soldiers who had returned to civilian status were referred at higher rates on the PDHRA, which could reflect their concerns about their ongoing health coverage. Lack of confidentiality may deter soldiers with alcohol problems from accessing treatment. In the context of an overburdened system of care, the effectiveness of population mental health screening was difficult to ascertain.	USA, Walter Reed Army Inst Res, Div Psychiat & Neurosci, Med Res & Mat Command, Silver Spring, MD 20910 USA; USA, Ctr Hlth Promot & Prevent Med, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Milliken, CS (corresponding author), USA, Walter Reed Army Inst Res, Div Psychiat & Neurosci, Med Res & Mat Command, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	charles.milliken@us.army.mil						ADLER AB, 2007, 115 ANN CONV AM PSYC; *AM PSYCH ASS WORK, 2004, PRACT GUID TREATM AC; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI [DOI 10.1037/1541-1559.4.3.141, 10.1037/1541-1559.4.3.141]; Bliese PD, 2005, POST DEPLOYMENT PSYC; Brown R L, 2001, J Am Board Fam Pract, V14, P95; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Defense Health Board Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Foa E.B., 2019, PROLONGED EXPOSURE T, V2, DOI [10.1093/med-psych/9780190926939.001.0001/med-9780190926939, DOI 10.1093/MED-PSYCH/9780190926939.001.0001/MED-9780190926939]; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Grunebaum M, 1996, PSYCHIAT SERV, V47, P848; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Katon WJ, 2006, J TRAUMA STRESS, V19, P611, DOI 10.1002/jts.20147; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Resick P. A., 2008, COGN PROCESS; Rona RJ, 2005, JAMA-J AM MED ASSOC, V293, P1257, DOI 10.1001/jama.293.10.1257; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; THOMAS JL, 2007, 115 ANN CONV AM PSYC; *TRICARE MAN ACT, TRANS ASS MAN PROGR; *US DEP DEF, 1997, REQ MENT HLTH EV MEM; *US DEP DEF, 1985, REH REF SERV ALC DRU; *VET HLTH ADM, 2002, COMB VET AR EL MED S; WINKENWERDER W, 2005, COMMUNICATION   0310; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004; BATTLEMIND TRAINING	35	1178	1187	2	115	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2007	298	18					2141	2148		10.1001/jama.298.18.2141	http://dx.doi.org/10.1001/jama.298.18.2141			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230II	18000197	Bronze			2022-12-24	WOS:000250869800019
J	Belizan, JM; Cafferata, ML; Belizan, M; Althabe, F				Belizan, Jose M.; Cafferata, Maria L.; Belizan, Maria; Althabe, Fernando			Health inequality in Latin America	LANCET			English	Editorial Material									Inst Clin Effectivenss & Hlth Policy, Buenos Aires, DF, Argentina; Clin & Epidemiol Res Unit Montevideo, Montevideo, Uruguay		Althabe, F (corresponding author), Inst Clin Effectivenss & Hlth Policy, Buenos Aires, DF, Argentina.	althabef@gmail.com		Belizan, Jose/0000-0002-8412-3010				Belizan JM, 2003, LANCET, V362, P916, DOI 10.1016/S0140-6736(03)14311-5; Belizan JM, 1998, PAEDIATR PERINAT EP, V12, P1, DOI 10.1046/j.1365-3016.12.s2.4.x; CDS-Government of Kerala, 2006, HUMAN DEV REPORT 200; *MIN SAL MED AMB A, 2005, PROGR MAT INF EST VI; *MIN SAL PER, 1999, SIT SAL PER IND BAS; *MIN SAL PUBL BIEN, 2002, IND BAS SAL; MUNOZ MTF, 2003, ANAL PRODUCCION CIEN; *UN CHILDR FUND, 2006, STAT WORLDS CHILDR S; UN Educ. Sci. Cult. Organ, 2005, UN DECL BIOETH HUM R; *WORLD BANK, DAT STAT COUNTR DAT	10	31	34	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1599	1600		10.1016/S0140-6736(07)61673-0	http://dx.doi.org/10.1016/S0140-6736(07)61673-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993351				2022-12-24	WOS:000250883400010
J	Alt, A; Lammens, K; Chiocchini, C; Lammens, A; Pieck, JC; Kuch, D; Hopfner, KP; Carell, T				Alt, Aaron; Lammens, Katja; Chiocchini, Claudia; Lammens, Alfred; Pieck, J. Carsten; Kuch, David; Hopfner, Karl-Peter; Carell, Thomas			Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase	SCIENCE			English	Article							THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; ETA; MUTATIONS; DAMAGE	DNA polymerase eta (Pol eta) is a eukaryotic lesion bypass polymerase that helps organisms to survive exposure to ultraviolet (UV) radiation, and tumor cells to gain resistance against cisplatin-based chemotherapy. It allows cells to replicate across cross-link lesions such as 1,2-d(GpG) cisplatin adducts (Pt-GG) and UV-induced cis-syn thymine dimers. We present structural and biochemical analysis of how Pol eta copies Pt-GG-containing DNA. The damaged DNA is bound in an open DNA binding rim. Nucleotidyl transfer requires the DNA to rotate into an active conformation, driven by hydrogen bonding of the templating base to the dNTP. For the 3 ' dG of the Pt-GG, this step is accomplished by a Watson-Crick base pair to dCTP and is biochemically efficient and accurate. In contrast, bypass of the 5 ' dG of the Pt-GG is less efficient and promiscuous for dCTP and dATP as a result of the presence of the rigid Pt cross-link. Our analysis reveals the set of structural features that enable Pol eta to replicate across strongly distorting DNA lesions.	Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de; thomas.carell@cup.uni-muenchen.de	Carell, Thomas/G-4799-2012; Hopfner, Karl-Peter/B-6864-2014; Alt, Aaron/A-1551-2017	Carell, Thomas/0000-0001-7898-2831; Hopfner, Karl-Peter/0000-0002-4528-8357; Alt, Aaron/0000-0002-6708-9826				Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9	16	167	169	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					967	970		10.1126/science.1148242	http://dx.doi.org/10.1126/science.1148242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991862				2022-12-24	WOS:000250788500041
J	Pospisilik, JA; Knauf, C; Joza, N; Benit, P; Orthofer, M; Cani, PD; Ebersberger, I; Nakashima, T; Sarao, R; Neely, G; Esterbauer, H; Kozlov, A; Kahn, CR; Kroemer, G; Rustin, P; Burcelin, R; Penninger, JM				Pospisilik, J. Andrew; Knauf, Claude; Joza, Nicholas; Benit, Paule; Orthofer, Michael; Cani, Patrice D.; Ebersberger, Ingo; Nakashima, Tomoki; Sarao, Renu; Neely, Gregory; Esterbauer, Harald; Kozlov, Andrey; Kahn, C. Ronald; Kroemer, Guido; Rustin, Pierre; Burcelin, Remy; Penninger, Josef M.			Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes	CELL			English	Article							APOPTOSIS-INDUCING FACTOR; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; SKELETAL-MUSCLE; DOWN-REGULATION; DUAL ROLES; GENE; DYSFUNCTION; DISEASE	Type-2 diabetes results from the development of insulin resistance and a concomitant impairment of insulin secretion. Recent studies place altered mitochondrial oxidative phosphorylation (OxPhos) as an underlying genetic element of insulin resistance. However, the causative or compensatory nature of these OxPhos changes has yet to be proven. Here, we show that muscle-and liver-specific AIF ablation in mice initiates a pattern of OxPhos deficiency closely mimicking that of human insulin resistance, and contrary to current expectations, results in increased glucose tolerance, reduced fat mass, and increased insulin sensitivity. These results are maintained upon high-fat feeding and in both genetic mosaic and ubiquitous OxPhos-deficient mutants. Importantly, the effects of AIF on glucose metabolism are acutely inducible and reversible. These findings establish that tissue-specific as well as global OxPhos defects in mice can counteract the development of insulin resistance, diabetes, and obesity.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; CHU Rangueil, IFR31, INSERM, U858,Equipe 2,Inst Med Mol Rangueil, F-31432 Toulouse, France; Hop Robert Debre, INSERM, U676, F-75019 Paris, France; Catholic Univ Louvain, Fac Med, Unit PMNT, B-1200 Brussels, Belgium; Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, A-1030 Vienna, Austria; Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; Lorenz Boehler Hosp, Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria; Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr, Boston, MA 02215 USA; INSERM, U848, F-94805 Villejuif, France; Inst Gustave Roussy, F-94805 Villejuif, France; Univ Paris 11, F-94805 Villejuif, France	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Ludwig Boltzmann Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Kahn, Ronald/AAY-2435-2021; neely, graham/A-6511-2011; burcelin, remy/M-6013-2014; Penninger, Josef M/I-6860-2013; D., Cani Patrice/M-8055-2016; KROEMER, Guido/B-4263-2013; Neely, Greg/AAB-4642-2020; Kroemer, Guido/AAY-9859-2020	Kahn, Ronald/0000-0002-7583-9228; Penninger, Josef M/0000-0002-8194-3777; D., Cani Patrice/0000-0003-2040-2448; KROEMER, Guido/0000-0002-9334-4405; Neely, Greg/0000-0002-1957-9732; Knauf, Claude/0000-0001-5213-5378; Esterbauer, Harald/0000-0001-7343-7455; Kozlov, Andrey/0000-0002-0834-4997	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31036] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane N, 2006, NATURE, V440, P600, DOI 10.1038/440600a; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029	40	320	330	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					476	491		10.1016/j.cell.2007.08.047	http://dx.doi.org/10.1016/j.cell.2007.08.047			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981116	Bronze			2022-12-24	WOS:000250618500016
J	Kesavan, J; Borisovska, M; Bruns, D				Kesavan, Jaideep; Borisovska, Maria; Bruns, Dieter			v-SNARE actions during Ca2+-triggered exocytosis	CELL			English	Article							CORE VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; CHROMAFFIN CELLS; MEMBRANE HEMIFUSION; CA2+ SENSOR; FUSION; SYNAPTOTAGMIN; COMPLEX; INTERMEDIATE; PROTEINS	Assembly of SNARE proteins between opposing membranes mediates fusion of synthetic liposomes, but it is unknown whether SNAREs act during exocytosis at the moment of Ca2+ increase, providing the molecular force for fusion of secretory vesicles. Here, we show that execution of pre- and postfusional steps during chromaffin granule exocytosis depends crucially on a short molecular distance between the complex forming SNARE motif and the transmembrane anchor of the vesicular SNARE protein synaptobrevin II. Extending the juxtamembrane region of synaptobrevin by insertion of flexible `` linkers'' reduces priming of granules, delays initiation of exocytosis upon stepwise elevation of intracellular calcium, attenuates fluctuations of early fusion pores, and slows rapid expansion of the pore in a linker-length dependent fashion. These observations provide evidence that v-SNARE proteins drive Ca2+- triggered membrane fusion at millisecond time scale and support a model wherein continuous molecular pulling by SNAREs guides the vesicle throughout the consecutive stages of exocytosis.	Univ Saarland, Inst Physiol, D-66424 Homburg, Germany	Saarland University	Bruns, D (corresponding author), Univ Saarland, Inst Physiol, Kirrberger St 8, D-66424 Homburg, Germany.	dieter.bruns@uniklinik-saarland.de		Kesavan, Jaideep/0000-0003-1933-1187; Borisovska, Maria/0000-0003-4087-0679				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Bruns D, 2004, METHODS, V33, P312, DOI 10.1016/j.ymeth.2004.01.004; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colquhoun David, 1995, P483; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; Hannah MJ, 1998, METHODS, V16, P170, DOI 10.1006/meth.1998.0664; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HIGUCHI R, 1989, USING PCR ENG DNA; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yang L, 2002, SCIENCE, V297, P1877, DOI 10.1126/science.1074354; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zimmerberg J, 2006, NAT STRUCT MOL BIOL, V13, P301, DOI 10.1038/nsmb0406-301	52	93	93	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					351	363		10.1016/j.cell.2007.09.025	http://dx.doi.org/10.1016/j.cell.2007.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956735	Bronze, Green Submitted			2022-12-24	WOS:000250507700024
J	Schiermeier, Q; Tollefson, J				Schiermeier, Quirin; Tollefson, Jeff			Climate change: a Nobel cause	NATURE			English	News Item																			0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					766	767		10.1038/news.2007.164	http://dx.doi.org/10.1038/news.2007.164			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17968408				2022-12-24	WOS:000250230600008
J	Bitterman, Y; Mukamel, R; Malach, R; Fried, I; Nelken, I				Bitterman, Y.; Mukamel, R.; Malach, R.; Fried, I.; Nelken, I.			Ultra-fine frequency tuning revealed in single neurons of human auditory cortex	NATURE			English	Article							RECEPTIVE-FIELDS; DISCRIMINATION; RESPONSES; MODEL; ORGANIZATION; TONES; CUES	Just- noticeable differences of physical parameters are often limited by the resolution of the peripheral sensory apparatus. Thus, two- point discrimination in vision is limited by the size of individual photoreceptors. Frequency selectivity is a basic property of neurons in the mammalian auditory pathway(1,2). However, just- noticeable differences of frequency are substantially smaller than the bandwidth of the peripheral sensors(3). Here we report that frequency tuning in single neurons recorded from human auditory cortex in response to random- chord stimuli is far narrower than that typically described in any other mammalian species ( besides bats), and substantially exceeds that attributed to the human auditory periphery. Interestingly, simple spectral filter models failed to predict the neuronal responses to natural stimuli, including speech and music. Thus, natural sounds engage additional processing mechanisms beyond the exquisite frequency tuning probed by the random- chord stimuli.	[Bitterman, Y.; Nelken, I.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Bitterman, Y.; Nelken, I.] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; [Mukamel, R.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Mukamel, R.; Fried, I.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; [Mukamel, R.; Fried, I.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Malach, R.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fried, I.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; [Fried, I.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	ifried@mednet.ucla.edu; israel@cc.huji.ac.il	Nelken, Israel/B-7753-2011; bitterman, yael/GRS-6144-2022; Mukamel, Roy/AAV-2900-2021	Nelken, Israel/0000-0002-6645-107X; Mukamel, Roy/0000-0001-9359-8950; bitterman, yael/0000-0002-4153-3888	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033221] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS033221, R01 NS033221-10] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banai K, 2004, AUDIOL NEURO-OTOL, V9, P328, DOI 10.1159/000081282; Banai K, 2006, CEREB CORTEX, V16, P1718, DOI 10.1093/cercor/bhj107; Benasich AA, 2002, BEHAV BRAIN RES, V136, P31, DOI 10.1016/S0166-4328(02)00098-0; Bleeck S, 2004, ACTA ACUST UNITED AC, V90, P781; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; EVANS EF, 1977, PSYCHOPHYSICS PHYSL, P185; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Gaese BH, 2001, J NEUROPHYSIOL, V86, P1062, DOI 10.1152/jn.2001.86.2.1062; Heinz MG, 2001, NEURAL COMPUT, V13, P2273, DOI 10.1162/089976601750541804; Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0; Hsu A, 2004, NETWORK-COMP NEURAL, V15, P91, DOI 10.1088/0954-898X/15/2/002; McArthur GM, 2005, BRAIN LANG, V94, P260, DOI 10.1016/j.bandl.2005.01.002; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MOORE B, 1982, INTRO PSYCHOL HEARIN, P74; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nelken I, 2002, SPR HDB AUD, V15, P358; Qin L, 2003, NEUROSCI RES, V46, P145, DOI 10.1016/S0168-0102(03)00034-8; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; SCHWARZ DWF, 1990, J NEUROPHYSIOL, V64, P282, DOI 10.1152/jn.1990.64.1.282; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tramo MJ, 2002, J NEUROPHYSIOL, V87, P122, DOI 10.1152/jn.00104.1999; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006	29	124	124	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					197	U9		10.1038/nature06476	http://dx.doi.org/10.1038/nature06476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185589	Green Accepted			2022-12-24	WOS:000252214400044
J	Sidow, A; Lacroute, P				Sidow, Arend; Lacroute, Philippe			Fruit fly family fun	CELL			English	Editorial Material							DROSOPHILA; EVOLUTION; GENOMES		[Sidow, Arend; Lacroute, Philippe] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sidow, Arend; Lacroute, Philippe] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Pathol, SUMC L235, Stanford, CA 94305 USA.	arend@stanford.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kuhn, 1962, STRUCTURE SCI REVOLU, P148; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340	8	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1222	1223		10.1016/j.cell.2007.12.003	http://dx.doi.org/10.1016/j.cell.2007.12.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160030	Bronze			2022-12-24	WOS:000252217200009
J	McSharry, PE				McSharry, Patrick E.			Altitude and athletic performance: statististical analysis using football results	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To assess the effect of altitude on match results and physiological performance of a large and diverse population of professional athletes. Design Statistical analysis of international football (soccer) scores and results. Data resources FIFA extensive database of 1460 football matches in 10 countries spanning over 100 years. Results Altitude had a significant (P<0.001) negative impact on physiological performance as revealed through the overall underperformance of low altitude teams when playing against high altitude teams in South America. High altitude teams score more and concede fewer goals with increasing altitude difference. Each additional 1000 m of altitude difference increases the goal difference by about half of a goal. The probability of the home team winning for two teams from the same altitude is 0.537, whereas this rises to 0.825 for a home team with an altitude difference of 3695 m (such as Bolivia v Brazil) and falls to 0.213 when the altitude difference is -3695 m (such as Brazil v Bolivia). Conclusions Altitude provides a significant advantage for high altitude teams when playing international football games at both low and high altitudes. Lowland teams are unable to acclimatise to high altitude, reducing physiological performance. As physiological performance does not protect against the effect of altitude, better predictors of individual susceptibility to altitude illness would facilitate team selection.	Univ Oxford, Dept Engn Sci, Syst Anal Modelling & Predict Grp, Oxford OX1 3PJ, England	University of Oxford	McSharry, PE (corresponding author), Univ Oxford, Dept Engn Sci, Syst Anal Modelling & Predict Grp, Parks Rd, Oxford OX1 3PJ, England.	patrick@mcsharry.net	Rodríguez, Ferran A. A/H-4892-2011; MCSHARRY, PATRICK/AGJ-2462-2022	Rodríguez, Ferran A. A/0000-0002-2280-8962; 					0	28	30	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1278	1281		10.1136/bmj.39393.451516.AD	http://dx.doi.org/10.1136/bmj.39393.451516.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156225	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000252182700005
J	Zhang, Q; Stelzer, AC; Fisher, CK; Al-Hashimi, HM				Zhang, Qi; Stelzer, Andrew C.; Fisher, Charles K.; Al-Hashimi, Hashim M.			Visualizing spatially correlated dynamics that directs RNA conformational transitions	NATURE			English	Article							RESIDUAL DIPOLAR COUPLINGS; HIV-1 TAR RNA; LIQUID-CRYSTALLINE PHASE; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; BACKBONE DYNAMICS; PROTEIN-STRUCTURE; RELAXATION; RECOGNITION; REVEALS	RNAs fold into three- dimensional ( 3D) structures that subsequently undergo large, functionally important, conformational transitions in response to a variety of cellular signals(1-3). RNA structures are believed to encode spatially tuned flexibility that can direct transitions along specific conformational pathways(4,5). However, this hypothesis has proved difficult to examine directly because atomic movements in complex biomolecules cannot be visualized in 3D by using current experimental methods. Here we report the successful implementation of a strategy using NMR that has allowed us to visualize, with complete 3D rotational sensitivity, the dynamics between two RNA helices that are linked by a functionally important trinucleotide bulge over timescales extending up to milliseconds. The key to our approach is to anchor NMR frames of reference onto each helix and thereby directly measure their dynamics, one relative to the other, using 'relativistic' sets of residual dipolar couplings ( RDCs)(6,7). Using this approach, we uncovered super- large amplitude helix motions that trace out a surprisingly structured and spatially correlated 3D dynamic trajectory. The two helices twist around their individual axes by approximately 536 and 1106 in a highly correlated manner ( R = 0.97) while simultaneously ( R = 0.81 - 0.92) bending by about 94 degrees. Remarkably, the 3D dynamic trajectory is dotted at various positions by seven distinct ligand- bound conformations of the RNA. Thus even partly unstructured RNAs can undergo structured dynamics that directs ligand- induced transitions along specific predefined conformational pathways.	Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	hashimi@umich.edu	Zhang, Qi/E-1722-2011; Zhang, Qi/B-5869-2014; Zhang, Qi/F-3323-2010	Zhang, Qi/0000-0003-1754-4058; 				AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974; ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Al-Hashimi HM, 2005, CHEMBIOCHEM, V6, P1506, DOI 10.1002/cbic.200500002; Al-Hashimi HM, 2002, J MOL BIOL, V315, P95, DOI 10.1006/jmbi.2001.5235; Bailor MH, 2007, NAT PROTOC, V2, P1536, DOI 10.1038/nprot.2007.221; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; Clore GM, 2004, BIOCHEMISTRY-US, V43, P10678, DOI 10.1021/bi049357w; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Du ZH, 2002, CHEM BIOL, V9, P707, DOI 10.1016/S1074-5521(02)00151-5; Faber C, 2000, J BIOL CHEM, V275, P20660, DOI 10.1074/jbc.M000920200; Furtig B, 2007, BIOPOLYMERS, V86, P360, DOI 10.1002/bip.20761; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Leulliot N, 2001, BIOCHEMISTRY-US, V40, P7947, DOI 10.1021/bi010680y; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z; Meissner A, 1999, J MAGN RESON, V139, P439, DOI 10.1006/jmre.1999.1788; Micura R, 2003, CHEMBIOCHEM, V4, P984, DOI 10.1002/cbic.200300664; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Saenger W., 1984, PRINCIPLES NUCL ACID; SAUPE A, 1968, ANGEW CHEM INT EDIT, V7, P97, DOI 10.1002/anie.196800971; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; ZHANG Q, UNPUB NATURE METHODS; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	36	204	206	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1263	U14		10.1038/nature06389	http://dx.doi.org/10.1038/nature06389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097416	Green Published			2022-12-24	WOS:000251786200057
J	Watson, R				Watson, Rory			Steps to a leaner Europe	BRITISH MEDICAL JOURNAL			English	Editorial Material												RoryWatson@compuserve.com							0	10	10	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2007	335	7632					1238	1238		10.1136/bmj.39423.452106.AD	http://dx.doi.org/10.1136/bmj.39423.452106.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243YC	18079545	Green Published			2022-12-24	WOS:000251832200030
J	Thase, ME				Thase, Michael E.			Molecules that mediate mood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thase, ME (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							Berton O, 2007, NEURON, V55, P289, DOI 10.1016/j.neuron.2007.06.033; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905	3	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2400	2402		10.1056/NEJMcibr0706377	http://dx.doi.org/10.1056/NEJMcibr0706377			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057345				2022-12-24	WOS:000251389200014
J	Tuffs, A				Tuffs, Annette			Medicine and the media - Thalidomide - the drama continues	BRITISH MEDICAL JOURNAL			English	Editorial Material												ATuffs@web.de						Tuffs A, 2007, BRIT MED J, V334, P933, DOI 10.1136/bmj.39199.637986.59	1	1	1	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1125	1125		10.1136/bmj.39409.445058.59	http://dx.doi.org/10.1136/bmj.39409.445058.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048538	Green Published			2022-12-24	WOS:000251596100030
J	Lockwood, CA; Menter, CG; Moggi-Cecchi, J; Keyser, AW				Lockwood, Charles A.; Menter, Colin G.; Moggi-Cecchi, Jacopo; Keyser, Andre W.			Extended male growth in a fossil hominin species	SCIENCE			English	Article							SEXUAL-DIMORPHISM; PRIMATES; DISPERSAL; EVOLUTION; BEHAVIOR; DRIMOLEN; SPHINX; SIZE	In primates that are highly sexually dimorphic, males often reach maturity later than females, and young adult males do not show the size, morphology, and coloration of mature males. Here we describe extended male development in a hominin species, Paranthropus robustus. Ranking a large sample of facial remains on the basis of dental wear stages reveals a difference in size and robusticity between young adult and old adult males. Combined with estimates of sexual dimorphism, this pattern suggests that male reproductive strategy focused on monopolizing groups of females, in a manner similar to that of silverback gorillas.	UCL, Dept Anthropol, London WC1E 6BT, England; Univ Witwatersrand, Inst Human Evolut, ZA-2050 Wits, South Africa; Univ Johannesburg, Dept Anthropol & Dev Studies, Johannesburg, South Africa; Univ Florence, Dipartimento Biol Anim & Genet, Lab Antropol, I-50122 Florence, Italy; Univ Florence, Museo Storia Nat, I-50122 Florence, Italy	University of London; University College London; University of Witwatersrand; University of Johannesburg; University of Florence; University of Florence	Lockwood, CA (corresponding author), UCL, Dept Anthropol, Gower St, London WC1E 6BT, England.	c.lockwood@ucl.ac.uk		MOGGI CECCHI, IACOPO/0000-0001-5055-8369				ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; Brain C, 1993, TRANSVAAL MUSEUM MON, P23; Brain C. K., 1981, HUNTERS HUNTED INTRO; Carlson KJ, 2003, J HUM EVOL, V44, P431, DOI 10.1016/S0047-2484(03)00025-3; COWLISHAW G, 1994, BEHAVIOUR, V131, P293, DOI 10.1163/156853994X00488; Dean M.C., 1988, P43; DEAN MC, 1981, FOLIA PRIMATOL, V36, P111, DOI 10.1159/000156011; FOLEY RA, 1989, SCIENCE, V243, P901, DOI 10.1126/science.2493158; Hillson S., 2005, TEETH; Janson Charles H., 1993, P57; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; Keyser AW, 2000, S AFR J SCI, V96, P193; Keyser AW, 2000, S AFR J SCI, V96, P189; LEIGH SR, 1995, AM J PHYS ANTHROPOL, V97, P339, DOI 10.1002/ajpa.1330970402; Lockwood CA, 1999, AM J PHYS ANTHROPOL, V108, P97, DOI 10.1002/(SICI)1096-8644(199901)108:1<97::AID-AJPA6>3.0.CO;2-O; MCHENRY HM, 1994, J HUM EVOL, V27, P77, DOI 10.1006/jhev.1994.1036; Pickering TR, 2004, AM J PHYS ANTHROPOL, V125, P1, DOI 10.1002/ajpa.10278; Plavcan JM, 2002, J HUM EVOL, V42, P579, DOI 10.1006/jhev.2001.0542; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Pusey A.E., 1987, P250; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Setchell JM, 2004, FOLIA PRIMATOL, V75, P121, DOI 10.1159/000078302; Setchell JM, 2006, AM J PHYS ANTHROPOL, V131, P498, DOI 10.1002/ajpa.20478; Setchell Joanna M., 2004, P175, DOI 10.1017/CBO9780511542459.012; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stokes EJ, 2003, BEHAV ECOL SOCIOBIOL, V54, P329, DOI 10.1007/s00265-003-0630-3; Vrba E.S., 1985, P195; Watts David P., 1993, P148; Wolpoff M.H., 1975, P245	32	74	79	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1443	1446		10.1126/science.1149211	http://dx.doi.org/10.1126/science.1149211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048687	Green Published			2022-12-24	WOS:000251246100043
J	Choi, JK; Bowles, S				Choi, Jung-Kyoo; Bowles, Samuel			The coevolution of parochial altruism and war	SCIENCE			English	Article							VISCOUS POPULATIONS; GROUP SELECTION; EVOLUTION; COOPERATION; CHIMPANZEES; HUMANS	Altruism-benefiting fellow group members at a cost to oneself-and parochialism-hostility toward individuals not of one's own ethnic, racial, or other group-are common human behaviors. The intersection of the two-which we term "parochial altruism"-is puzzling from an evolutionary perspective because altruistic or parochial behavior reduces one's payoffs by comparison to what one would gain by eschewing these behaviors. But parochial altruism could have evolved if parochialism promoted intergroup hostilities and the combination of altruism and parochialism contributed to success in these conflicts. Our game-theoretic analysis and agent-based simulations show that under conditions likely to have been experienced by late Pleistocene and early Holocene humans, neither parochialism nor altruism would have been viable singly, but by promoting group conflict, they could have evolved jointly.	Kyungpook Natl Univ, Sch Econ & Trade, Taegu 702701, South Korea; Santa Fe Inst, Santa Fe, NM USA; Univ Siena, Dipartimento Econ Polit, I-53100 Siena, Italy	Kyungpook National University; The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu						AOKI K, 1982, EVOLUTION, V36, P832, DOI [10.2307/2407896, 10.1111/j.1558-5646.1982.tb05449.x]; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Darwin Charles, 1998, DESCENT MAN; EMBER CR, 1992, J CONFLICT RESOLUT, V36, P242, DOI 10.1177/0022002792036002002; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hammond RA, 2006, THEOR POPUL BIOL, V69, P333, DOI 10.1016/j.tpb.2005.12.002; Keeley LH., 1996, WAR CIVILIZATION; Kelly R.C., 2000, WARLESS SOC ORIGIN W; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; LeBlanc SA, 2003, CONSTANT BATTLES; Lourandos H., 1997, CONTINENT HUNTER GAT; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; PEARSON K, 1894, FORTNIGHTLY REV, V56, P1; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Wiessner P, 2002, EVOL HUM BEHAV, V23, P407, DOI 10.1016/S1090-5138(02)00096-X; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Yamagishi T, 1999, ADV GROUP, V16, P161	28	593	607	6	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					636	640		10.1126/science.1144237	http://dx.doi.org/10.1126/science.1144237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962562				2022-12-24	WOS:000250409200044
J	Tanabe, KK; Lemoine, A; Finkelstein, DM; Kawasaki, H; Fujii, T; Chung, RT; Lauwers, GY; Kulu, Y; Muzikansky, A; Kuruppu, D; Lanuti, M; Goodwin, JM; Azoulay, D; Fuchs, BC				Tanabe, Kenneth K.; Lemoine, Antoinette; Finkelstein, Dianne M.; Kawasaki, Hiroshi; Fujii, Tsutomu; Chung, Raymond T.; Lauwers, Gregory Y.; Kulu, Yakup; Muzikansky, Alona; Kuruppu, Darshini; Lanuti, Michael; Goodwin, Jonathan M.; Azoulay, Daniel; Fuchs, Bryan C.			Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EGF GENE; EXPRESSION; CANCER; LIVER; RESPONSIVENESS; HEPATOCYTES; ASSOCIATION; INHIBITOR; GEFITINIB; MELANOMA	Context Overexpression of epidermal growth factor (EGF) in the liver induces transformation to hepatocellular carcinoma in animal models. Polymorphisms in the EGF gene modulate EGF levels. Objective To assess the relationship among human EGF gene single-nucleotide polymorphism, EGF expression, and risk of hepatocellular carcinoma. Design, Setting, and Participants Molecular mechanisms linking the 61*G allele polymorphism to EGF expression were examined in human hepatocellular carcinoma cell lines and human liver tissue. A case-control study involving 207 patients with cirrhosis was conducted at the Massachusetts General Hospital (1999-2006) and a validation case-control study involving 121 patients with cirrhosis was conducted at Hopital Paul Brousse (1993-2006). Restriction fragment-length polymorphism was used to determine the EGF gene polymorphism genotype. Logistic regression analysis was used to assess the association between the EGF polymorphism and hepatocellular carcinoma risk. Main Outcome Measures Mechanisms by which the EGF gene polymorphism modulates EGF levels and associations among EGF gene polymorphism, EGF levels, and hepatocellular carcinoma. Results Transcripts from the EGF 61*G allele exhibited more than a 2-fold longer half-life than those from the 61*A allele, and EGF secretion was 2.3-fold higher in G/G hepatocellular carcinoma cell lines than A/A cell lines. Serum EGF levels were 1.8-fold higher in G/G patients than A/A patients, and liver EGF levels were 2.4-fold higher in G/G patients than A/A patients. Among the 207 patients with cirrhosis in the Massachusetts study population, 59 also had hepatocellular carcinoma. Analysis of the distribution of allelic frequencies revealed that there was a 4-fold odds of hepatocellular carcinoma in G/G patients compared with A/A patients in the Massachusetts study population (odds ratio, 4.0; 95% confidence interval [0], 1.6-9.6; P=.002). Logistic regression analysis demonstrated that the number of copies of G was significantly associated with hepatocellular carcinoma after adjusting for age, sex, race, etiology, and severity of cirrhosis (G/G or A/G vs A/A; hazard ratio, 3.49; 95% Cl, 1.29-9.44; P=.01). The significant association was validated in the French patients with alcoholic cirrhosis and hepatocellular carcinoma. Conclusion The EGF gene polymorphism genotype is associated with risk for development of hepatocellular carcinoma in liver cirrhosis through modulation of EGF levels.	[Tanabe, Kenneth K.; Kawasaki, Hiroshi; Fujii, Tsutomu; Kulu, Yakup; Kuruppu, Darshini; Fuchs, Bryan C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Finkelstein, Dianne M.; Muzikansky, Alona] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Chung, Raymond T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Lauwers, Gregory Y.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lanuti, Michael; Goodwin, Jonathan M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA; [Lemoine, Antoinette; Azoulay, Daniel] Hop Paul Brousse, Assistance Publ Hop Paris, Ctr Chirurg Hepatobiliaire, Villejuif, France; Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France; INSERM, U602, Villejuif, France	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tanabe, KK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Surg Oncol, Yawkey 7-924,55 Fruit St, Boston, MA 02114 USA.	ktanabe@partners.org	Azoulay, Daniel/Q-7887-2018; Fujii, Tsutomu/M-4838-2014		NATIONAL CANCER INSTITUTE [P01CA111519, P30CA006516, R01CA076183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI006993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK078772] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006516, 2R01CA76183, 5P01CA111519, 2P30 CA06516-43] Funding Source: Medline; NIAID NIH HHS [AI06993] Funding Source: Medline; NIDDK NIH HHS [DK078772] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amend KL, 2004, CANCER RES, V64, P2668, DOI 10.1158/0008-5472.CAN-03-3855; Berrahmoune H, 2007, J INVEST DERMATOL, V127, P969, DOI 10.1038/sj.jid.5700650; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; BLANC P, 1992, GASTROENTEROLOGY, V102, P1340; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COHEN S, 1962, J BIOL CHEM, V237, P1555; Ding CM, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-8; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; HOFFMANN B, 1989, J CELL PHYSIOL, V139, P654, DOI 10.1002/jcp.1041390328; *IARC, 2004, MON EV CARC RISKS HU, V59; Komuves LG, 2000, J HISTOCHEM CYTOCHEM, V48, P821, DOI 10.1177/002215540004800610; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MULLHAUPT B, 1994, J BIOL CHEM, V269, P19667; OKA Y, 1983, J CLIN INVEST, V72, P249, DOI 10.1172/JCI110964; PARK JG, 1995, INT J CANCER, V62, P276, DOI 10.1002/ijc.2910620308; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; ROBERTS AB, 1985, NATURE, V315, P237, DOI 10.1038/315237a0; Rosenthal N, 1998, NEW ENGL J MED, V338, P122, DOI 10.1056/NEJM199801083380210; Saffroy R, 2004, CARCINOGENESIS, V25, P1443, DOI 10.1093/carcin/bgh147; SAINSBURY JRC, 1985, LANCET, V1, P364; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; SINGLETARY SE, 1987, CANCER RES, V47, P403; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; STOSCHECK CM, 1986, CANCER RES, V46, P1030; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; TONJES RR, 1995, ONCOGENE, V10, P765; Yoon SS, 2000, FASEB J, V14, P301, DOI 10.1096/fasebj.14.2.301; Yoon SS, 1998, ANN SURG, V228, P366, DOI 10.1097/00000658-199809000-00009	33	172	175	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2008	299	1					53	60		10.1001/jama.2007.65	http://dx.doi.org/10.1001/jama.2007.65			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247BL	18167406	Bronze			2022-12-24	WOS:000252052000016
J	Schmidt, AR; Dorfelt, H; Perrichot, V				Schmidt, Alexander R.; Doerfelt, Heinrich; Perrichot, Vincent			Carnivorous fungi from Cretaceous amber	SCIENCE			English	Article							EVOLUTION		Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; Univ Halle Wittenberg, Inst Geobot, D-06108 Halle, Germany; Univ Halle Wittenberg, Bot Garten, D-06108 Halle, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Schmidt, AR (corresponding author), Humboldt Univ, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	alexander.schmidt@museum.hu-berlin.de	Perrichot, Vincent/I-4134-2019	Perrichot, Vincent/0000-0002-7973-0430				Ahren D, 2003, J NEMATOL, V35, P194; Barron G.L., 1977, NEMATODE DESTROYING, VI, P144; Hao Y, 2005, AQUAT MICROB ECOL, V40, P175, DOI 10.3354/ame040175; JANSSON HB, 1986, T BRIT MYCOL SOC, V87, P471, DOI 10.1016/S0007-1536(86)80227-3; Perrichot V, 2007, AFR INVERTEBR, V48, P213; Yang Y, 2007, P NATL ACAD SCI USA, V104, P8379, DOI 10.1073/pnas.0702770104	6	41	43	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1743	1743		10.1126/science.1149947	http://dx.doi.org/10.1126/science.1149947			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079393				2022-12-24	WOS:000251616800030
J	Daily, JP; Scanfeld, D; Pochet, N; Le Roch, K; Plouffe, D; Kamal, M; Sarr, O; Mboup, S; Ndir, O; Wypij, D; Levasseur, K; Thomas, E; Tamayo, P; Dong, C; Zhou, Y; Lander, ES; Ndiaye, D; Wirth, D; Winzeler, EA; Mesirov, JP; Regev, A				Daily, J. P.; Scanfeld, D.; Pochet, N.; Le Roch, K.; Plouffe, D.; Kamal, M.; Sarr, O.; Mboup, S.; Ndir, O.; Wypij, D.; Levasseur, K.; Thomas, E.; Tamayo, P.; Dong, C.; Zhou, Y.; Lander, E. S.; Ndiaye, D.; Wirth, D.; Winzeler, E. A.; Mesirov, J. P.; Regev, A.			Distinct physiological states of Plasmodium falciparum in malaria-infected patients	NATURE			English	Article							GENE-FUNCTION; TRANSCRIPTOME; CHILDREN; PARASITE; STAGE; AQUAGLYCEROPORIN; MITOCHONDRIA; ANNOTATION; DISCOVERY; DATABASE	Infection with the malaria parasite Plasmodium falciparum leads to widely different clinical conditions in children, ranging from mild flu- like symptoms to coma and death(1). Despite the immense medical implications, the genetic and molecular basis of this diversity remains largely unknown(2). Studies of in vitro gene expression have found few transcriptional differences between different parasite strains(3). Here we present a large study of in vivo expression profiles of parasites derived directly from blood samples from infected patients. The in vivo expression profiles define three distinct transcriptional states. The biological basis of these states can be interpreted by comparison with an extensive compendium of expression data in the yeast Saccharomyces cerevisiae. The three states in vivo closely resemble, first, active growth based on glycolytic metabolism, second, a starvation response accompanied by metabolism of alternative carbon sources, and third, an environmental stress response. The glycolytic state is highly similar to the known profile of the ring stage in vitro, but the other states have not been observed in vitro. The results reveal a previously unknown physiological diversity in the in vivo biology of the malaria parasite, in particular evidence for a functional mitochondrion in the asexual- stage parasite, and indicate in vivo and in vitro studies to determine how this variation may affect disease manifestations and treatment.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Cheikh Anta Diop Univ, Dantec Hosp, Lab Bacteriol & Virol, Dakar, Senegal; Cheikh Anta Diop Univ, Dantec Hosp, Dept Parasitol & Mycol, Dakar, Senegal; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of California System; University of California Riverside; Novartis; University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute	Mesirov, JP (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mesirov@broad.mit.edu; aregev@broad.mit.edu	Mesirov, Jill/AGF-7626-2022; Pochet, Nathalie/Q-1322-2017; Winzeler, Elizabeth/AAP-6752-2020	Pochet, Nathalie/0000-0003-1820-5656; Winzeler, Elizabeth/0000-0002-4049-2113; Wypij, David/0000-0001-8367-8711	NIAID NIH HHS [K23 AI054518] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054518] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashburner M, 2003, COLD SPRING HARB SYM, V68, P227, DOI 10.1101/sqb.2003.68.227; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Daily JP, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-30; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Faye O, 1995, Dakar Med, V40, P201; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Happi CT, 2004, AM J TROP MED HYG, V70, P20, DOI 10.4269/ajtmh.2004.70.20; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Planche T, 2006, CURR MOL MED, V6, P141, DOI 10.2174/156652406776055177; Promeneur D, 2007, P NATL ACAD SCI USA, V104, P2211, DOI 10.1073/pnas.0610843104; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Uyemura SA, 2004, J BIOL CHEM, V279, P385, DOI 10.1074/jbc.M307264200; White NJ, 2002, MANSONS TROPICAL DIS, P1205; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	41	177	179	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1091	U15		10.1038/nature06311	http://dx.doi.org/10.1038/nature06311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18046333	Bronze			2022-12-24	WOS:000251579900089
J	Hudis, C; Modi, S				Hudis, Clifford; Modi, Shanu			Preoperative chemotherapy for breast cancer - Miracle or mirage?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEOADJUVANT CHEMOTHERAPY; NODE BIOPSY; ADJUVANT; RECURRENCE; THERAPY; MASTECTOMY; PREDICT; WOMEN		Cornell Univ, Weill Coll Med, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10024 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Hudis, C (corresponding author), Cornell Univ, Weill Coll Med, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, 1275 York Ave,Box 206, New York, NY 10024 USA.	hudisc@mskcc.org	Hudis, Clifford/AAW-9482-2021	Hudis, Clifford/0000-0001-7144-8791; Modi, Shanu/0000-0001-6427-7373				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Brito RA, 2001, J CLIN ONCOL, V19, P628, DOI 10.1200/JCO.2001.19.3.628; Buchholz TA, 2002, INT J RADIAT ONCOL, V53, P880, DOI 10.1016/S0360-3016(02)02850-X; Buchholz TA, 2002, J CLIN ONCOL, V20, P17, DOI 10.1200/JCO.20.1.17; Charfare H, 2005, BRIT J SURG, V92, P14, DOI 10.1002/bjs.4840; Colozzaa M, 2006, ONCOLOGIST, V11, P111, DOI 10.1634/theoncologist.11-2-111; EAR HD, 2003, J CLIN ONCOL, V21, P4165; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; HENDERSON IC, 1985, J CLIN ONCOL, V3, P140, DOI 10.1200/JCO.1985.3.2.140; Honkoop AH, 1998, ONCOLOGY-BASEL, V55, P218, DOI 10.1159/000011861; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hunt KK, 1996, SURG CLIN N AM, V76, P393, DOI 10.1016/S0039-6109(05)70446-1; Jones JL, 2005, AM J SURG, V190, P517, DOI 10.1016/j.amjsurg.2005.06.004; Kuerer HM., 2002, SEMIN BREAST DIS, V5, P80; Newman EA, 2007, SURG CLIN N AM, V87, P353, DOI 10.1016/j.suc.2007.01.013; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pectasides D, 2005, EUR UROL, V48, P60, DOI 10.1016/j.eururo.2005.03.025; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Smith IC, 2002, J CLIN ONCOL, V20, P1456, DOI 10.1200/JCO.20.6.1456; Valero Vicente, 2002, Clin Breast Cancer, V3 Suppl 2, pS63, DOI 10.3816/CBC.2002.s.014; von Minckwitz G, 2005, ANN ONCOL, V16, P56, DOI 10.1093/annonc/mdi001; Vyzula R, 2004, NEOPLASMA, V51, P471; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	25	11	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2007	298	22					2665	2667		10.1001/jama.298.22.2665	http://dx.doi.org/10.1001/jama.298.22.2665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239VJ	18073362				2022-12-24	WOS:000251546100018
J	Lowe, S				Lowe, Siri			A patient's journey - Pemphigus vulgaris	BRITISH MEDICAL JOURNAL			English	Editorial Material									Pemphigus Vulgaris Network, London, England		Lowe, S (corresponding author), Pemphigus Vulgaris Network, London, England.	siri.lowe@btopenworld.com							0	0	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1152	1154		10.1136/bmj.39374.504884.BE	http://dx.doi.org/10.1136/bmj.39374.504884.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048542	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000251596100038
J	Overholtzer, M; Mailleux, AA; Mouneimne, G; Normand, G; Schnitt, SJ; King, RW; Cibas, ES; Brugge, JS				Overholtzer, Michael; Mailleux, Arnaud A.; Mouneimne, Ghassan; Normand, Guillaume; Schnitt, Stuart J.; King, Randall W.; Cibas, Edmund S.; Brugge, Joan S.			A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion	CELL			English	Article							PROTEIN-KINASE; CARCINOMA; CANNIBALISM; APOPTOSIS; PHOSPHATIDYLSERINE; CONTRACTION; DISRUPTION; ACTIVATION; ONCOGENE; MATRIX	Epithelial cells require attachment to extracellular matrix (ECM) to suppress an apoptotic cell death program termed anoikis. Here we describe a nonapoptotic cell death program in matrix-detached cells that is initiated by a previously unrecognized and unusual process involving the invasion of one cell into another, leading to a transient state in which a live cell is contained within a neighboring host cell. Live internalized cells are either degraded by lysosomal enzymes or released. We term this cell internalization process entosis and present evidence for entosis as a mechanism underlying the commonly observed "cell-in-cell'' cytological feature in human cancers. Further we propose that entosis is driven by compaction force associated with adherens junction formation in the absence of integrin engagement and may represent an intrinsic tumor suppression mechanism for cells that are detached from ECM.	[Overholtzer, Michael; Mailleux, Arnaud A.; Mouneimne, Ghassan; Normand, Guillaume; King, Randall W.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; [Cibas, Edmund S.] Brigham & Womens Hosp, Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA.	joan_brugge@hms.harvard.edu	Normand, Guillaume/A-1975-2010; Mailleux, Arnaud/AAH-8799-2021; Mailleux, Arnaud A/J-3576-2017	Mailleux, Arnaud/0000-0003-4191-1778; Mailleux, Arnaud A/0000-0003-4191-1778; Normand, Guillaume/0000-0003-1228-3813; Overholtzer, Michael/0000-0003-3007-4986; King, Randall/0000-0001-7882-8180	NATIONAL CANCER INSTITUTE [P50CA089393, P01CA080111, T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R56GM066492] Funding Source: NIH RePORTER; NCI NIH HHS [CA080111, CA089393, T32CA09361] Funding Source: Medline; NIGMS NIH HHS [GM66492] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abodief WT, 2006, CYTOPATHOLOGY, V17, P304, DOI 10.1111/j.1365-2303.2006.00326.x; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; BROUWER M, 1984, CANCER RES, V44, P2947; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; CRAIG ID, 1983, ACTA CYTOL, V27, P293; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; DESIMONE PA, 1980, HUM PATHOL, V11, P535; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gupta K, 2003, DIAGN CYTOPATHOL, V28, P86, DOI 10.1002/dc.10234; HONG IS, 1981, ACTA CYTOL, V25, P277; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; McIlroy D, 2000, GENE DEV, V14, P549; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Opitz C, 2002, MOL MICROBIOL, V45, P597, DOI 10.1046/j.1365-2958.2002.03056.x; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; UEI Y, 1980, ACTA CYTOL, V24, P522; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102	36	446	475	8	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					966	979		10.1016/j.cell.2007.10.040	http://dx.doi.org/10.1016/j.cell.2007.10.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045538	Bronze			2022-12-24	WOS:000251800900018
J	Farber, J; Siu, A; Bloom, P				Farber, Jeffrey; Siu, Albert; Bloom, Patricia			How much time do physicians spend providing care outside of office visits?	ANNALS OF INTERNAL MEDICINE			English	Article							TELEPHONE	Background: People with chronic illness require care outside of office visits, much of which is not reimbursed under current Medicare guidelines. Objective: To describe the amount of time geriatricians spend and the nature of care they provide outside of office visits. Design: Cross-sectional study on the time spent by physicians in clinical interactions outside of patient visits during 3 randomly sampled, 1-week periods. Setting: An academic geriatric medicine ambulatory practice. Participants: 16 physicians. Measurements: Information on the method, content, outcome, and participants in clinical interactions outside of office visits was collected on a structured form. Results: There were 472 discrete interactions, representing 296 episodes of care for 226 patients. Fifty-four percent of interactions were linked as multistep episodes, whose mean duration (range; 25th, 75th percentiles) was 18.9 minutes (3 to 70 minutes; 9, 21 minutes). Thirty-six percent of episodes involving a new medical symptom resulted in medication use, 27% resulted in an office visit, and 9% resulted in a referral to another physician. Mean time spent per physician per week was 112.2 minutes (range, 36 to 260 minutes), which represents an additional 6.7 minutes (range, 1.7 to 13.8) of care provided outside of office visits for every 30 minutes of time spent scheduled to see ambulatory patients. For a full-time physician scheduled to see 14 patients per day in 30-minute visits over a 5-day workweek, this would represent an extra 7.8 hours of clinical work per week. Limitation: Data were self-reported and were limited to an academic geriatric medicine practice. Conclusion: Physicians spend a considerable amount of time providing care outside of office visits for patients with chronic illness. This study suggests that collecting empirical data on the amount and nature of nonreimbursed care activities is feasible and should be done in more generalizable settings to inform debates about reimbursement reform.	Mt Sinai Sch Med, New York, NY 10029 USA; Bronx Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Farber, J (corresponding author), Mt Sinai Sch Med, Box 1070, New York, NY 10029 USA.	jeffrey.farber@mssm.edu						*AM GER SOC ASS DI, 2006, GER MED CLIN IMP AG; Anderson GF, 2005, NEW ENGL J MED, V353, P305, DOI 10.1056/NEJMsb044133; *ASS DIR GER ACAD, 2006, TRAINING PRACTICE UP, V2; *ASS DIR GER ACAD, 2007, STAT GER WORKF STUD; BABBOTT SF, 2006, POLICY MONOGRAPH SOC; Delichatsios H, 1998, J GEN INTERN MED, V13, P579, DOI 10.1046/j.1525-1497.1998.00179.x; Elnicki DM, 2000, J GEN INTERN MED, V15, P337, DOI 10.1046/j.1525-1497.2000.06459.x; HALLAM L, 1989, FAM PRACT, V6, P47, DOI 10.1093/fampra/6.1.47; Loder E, 2002, HEADACHE, V42, P883, DOI 10.1046/j.1526-4610.2002.02207.x	9	67	70	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2007	147	10					693	U119		10.7326/0003-4819-147-10-200711200-00005	http://dx.doi.org/10.7326/0003-4819-147-10-200711200-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235UJ	18025445				2022-12-24	WOS:000251259500003
J	Gilbert, CE; Shah, SP; Jadoon, MZ; Bourne, R; Dineen, B; Khan, MA; Johnson, GJ; Khan, MD				Gilbert, Clare E.; Shah, S. P.; Jadoon, M. Z.; Bourne, R.; Dineen, B.; Khan, M. A.; Johnson, G. J.; Khan, M. D.		Pakistan Natl Eye Survey Study Grp	Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL SERVICES; VISION IMPAIRMENT; EYE SURVEY; PREVALENCE; BURDEN; DEPRIVATION; POPULATION; ADULTS; COST; LIFE	Objective To explore the association between blindness and deprivation in a nationally representative sample of adults in Pakistan. Design Cross sectional population based survey. Setting 221 rural and urban clusters selected randomly throughout Pakistan. Participants Nationally representative sample of 16 507 adults aged 30 or above (95.3% response rate). Main outcome measures Associations between visual impairment and poverty assessed by a cluster level deprivation index and a household level poverty indicator; prevalence and causes of blindness; measures of the rate of uptake and quality of eye care services. Results561 blind participants (<3/60 in the better eye) were identified during the survey. Clusters in urban Sindh province were the most affluent, whereas rural areas in Balochistan were the poorest. The prevalence of blindness in adults living in affluent clusters was 2.2%, compared with 3.7% in medium clusters and 3.9% in poor clusters (P<0.001). The highest prevalence of blindness was found in rural Balochistan (5.2%). The prevalence of total blindness (bilateral no light perception) was more than three times higher in poor clusters than in affluent clusters (0.24% v 0.07%, P<0.001). The prevalences of blindness caused by cataract, glaucoma, and corneal opacity were tower in affluent clusters and households. Reflecting access to eye care services, cataract surgical coverage was higher in affluent clusters (80.6%) than in medium (76.8%) and poor areas (75.1%). Intraocular tens implantation rates were significantly lower in participants from poorer households. 10.2% of adults living in affluent clusters presented to the examination station wearing spectacles, compared with 6.7% in medium clusters and 4.4% in poor cluster areas. Spectacle coverage in affluent areas was more than double that in poor clusters (23.5% v 11.1%, P<0.001). Conclusion Blindness is associated with poverty in Pakistan; lower access to eye care services was one contributory factor. To reduce blindness, strategies targeting poor people will be needed. These interventions may have an impact on deprivation in Pakistan.	[Gilbert, Clare E.; Shah, S. P.; Dineen, B.; Johnson, G. J.] Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1E 7HT, England; [Jadoon, M. Z.; Khan, M. A.; Khan, M. D.] Pakistan Inst Community Ophthalmol, Peshawar, Pakistan; [Bourne, R.] Hinchingbrooke Hosp, Dept Ophthalmol, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine	Gilbert, CE (corresponding author), Univ London London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Keppel St, London WC1E 7HT, England.	clare.gilbert@lshtm.ac.uk		Dineen, Brendan/0000-0002-9619-8044				Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Bourne R, 2005, OPHTHAL EPIDEMIOL, V12, P321, DOI 10.1080/09286580500230948; Bourne RRA, 2004, INVEST OPHTH VIS SCI, V45, P410, DOI 10.1167/iovs.03-0129; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Dineen BP, 2003, BRIT J OPHTHALMOL, V87, P820, DOI 10.1136/bjo.87.7.820; Elwan A., 1999, 9932 WORLD BANK; Fletcher AE, 1997, ARCH OPHTHALMOL-CHIC, V115, P767, DOI 10.1001/archopht.1997.01100150769013; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Frick KD, 2005, ARCH OPHTHALMOL-CHIC, V123, P239, DOI 10.1001/archopht.123.2.239; GOODING K, 2006, POVERTY BLINDNESS SU; *GOV PAK MIN EC AF, 1998, POP CENS OGR; *GOV PAK MIN EC AF, 1998, POP CENS ORG; HUSSEIN A, 2003, PAKISTAN NATL HUMAN; Jadoon MZ, 2006, INVEST OPHTH VIS SCI, V47, P4749, DOI 10.1167/iovs.06-0374; Jadoon Z, 2007, BRIT J OPHTHALMOL, V91, P1269, DOI 10.1136/bjo.2006.106914; JAVITT J, 1983, ACTA 24 INT C OPHTH, P1308; Johnson GJ, 1998, EP EYE DIS, P8; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; McCarty CA, 2001, BRIT J OPHTHALMOL, V85, P322, DOI 10.1136/bjo.85.3.322; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Narayan D., 2000, VOICES POOR CAN ANYO, DOI DOI 10.1002/JID.793; *NAT TASK FORC TRA, 2002, REP TRACH RAP ASS PA; Nirmalan PK, 2003, BRIT J OPHTHALMOL, V87, P847, DOI 10.1136/bjo.87.7.847; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SMITH LK, 1994, J PUBLIC HEALTH MED, V16, P348; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; VALE D, 2004, UNSEEN NEGLECT ISOLA; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; *WHO, 2004, 282 WO; *WHO, 2004, 282 WHO; *WHO, 1988, COD INSTR WHO PBL EY; *WHO, 2005, GLO DAT BOD MASS IND; 2001, PROFILE REGIONAL INE, P80	39	72	74	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2008	336	7634					29	32B		10.1136/bmj.39395.500046.AE	http://dx.doi.org/10.1136/bmj.39395.500046.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250UT	18087076	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000252327500032
J	Higgins, DA; Pomianek, ME; Kraml, CM; Taylor, RK; Semmelhack, MF; Bassler, BL				Higgins, Douglas A.; Pomianek, Megan E.; Kraml, Christina M.; Taylor, Ronald K.; Semmelhack, Martin F.; Bassler, Bonnie L.			The major Vibrio cholerae autoinducer and its role in virulence factor production	NATURE			English	Article							QUORUM-SENSING SIGNAL; TO-CELL COMMUNICATION; STRUCTURAL IDENTIFICATION; GENE-EXPRESSION; COLONIZATION; PHEROMONE	Vibrio cholerae, the causative agent of the human disease cholera, uses cell-to-cell communication to control pathogenicity and biofilm formation(1,2). This process, known as quorum sensing, relies on the secretion and detection of signalling molecules called autoinducers. At low cell density V. cholerae activates the expression of virulence factors and forms biofilms. At high cell density the accumulation of two quorum-sensing autoinducers represses these traits. These two autoinducers, cholerae autoinducer-1 (CAI-1) and autoinducer-2 (AI-2), function synergistically to control gene regulation, although CAI-1 is the stronger of the two signals. V. cholerae AI-2 is the furanosyl borate diester ( 2S, 4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran borate(3). Here we describe the purification of CAI-1 and identify the molecule as ( S)-3-hydroxytridecan-4-one, a new type of bacterial autoinducer. We provide a synthetic route to both the R and S isomers of CAI-1 as well as simple homologues, and we evaluate their relative activities. Synthetic ( S)-3-hydroxytridecan-4-one functions as effectively as natural CAI-1 in repressing production of the canonical virulence factor TCP ( toxin co-regulated pilus). These findings suggest that CAI-1 could be used as a therapy to prevent cholera infection and, furthermore, that strategies to manipulate bacterial quorum sensing hold promise in the clinical arena.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Lotus Separat LLC, Princeton, NJ 08544 USA; Dartmouth Coll, Sch Med, Dept Microbiol & Immunol, Hanover, NH 03755 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Princeton University; Dartmouth College; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu		Bassler, Bonnie/0000-0002-0043-746X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054442] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Flavier AB, 1997, MOL MICROBIOL, V26, P251, DOI 10.1046/j.1365-2958.1997.5661945.x; Hall DR, 2006, J CHEM ECOL, V32, P195, DOI 10.1007/s10886-006-9360-0; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x; LEAL WS, 1995, P NATL ACAD SCI USA, V92, P1038, DOI 10.1073/pnas.92.4.1038; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; SAKAI T, 1984, CHEM LETT, P263, DOI 10.1246/cl.1984.263; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Taga ME, 2003, P NATL ACAD SCI USA, V100, P14549, DOI 10.1073/pnas.1934514100; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Wang LH, 2004, MOL MICROBIOL, V51, P903, DOI 10.1046/j.1365-2958.2003.03883.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	29	312	332	4	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					883	886		10.1038/nature06284	http://dx.doi.org/10.1038/nature06284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004304				2022-12-24	WOS:000251394900057
J	Loncarek, J; Kisurina-Evgenieva, O; Vinogradova, T; Hergert, P; La Terra, S; Kapoor, TM; Khodjakov, A				Loncarek, Jadranka; Kisurina-Evgenieva, Olga; Vinogradova, Tatiana; Hergert, Polla; La Terra, Sabrina; Kapoor, Tarun M.; Khodjakov, Alexey			The centromere geometry essential for keeping mitosis error free is controlled by spindle forces	NATURE			English	Article							KINETOCHORE FIBERS CONTRIBUTES; SMALL-MOLECULE INHIBITOR; CELL-CYCLE PROGRESSION; CHROMOSOME CONGRESSION; MITOTIC CHROMOSOMES; MICROTUBULE; TENSION; CHECKPOINT; ATTACHMENT; VERTEBRATES	Accurate segregation of chromosomes, essential for the stability of the genome, depends on 'bi-orientation'-simultaneous attachment of each individual chromosome to both poles of the mitotic spindle(1). On bi-oriented chromosomes, kinetochores (macromolecular complexes that attach the chromosome to the spindle) reside on the opposite sides of the chromosome's centromere(2). In contrast, sister kinetochores shift towards one side of the centromere on 'syntelic' chromosomes that erroneously attach to one spindle pole with both sister kinetochores. Syntelic attachments often arise during spindle assembly and must be corrected to prevent chromosome loss(3). It is assumed that restoration of proper centromere architecture occurs automatically owing to elastic properties of the centromere(1,2). Here we test this assumption by combining laser microsurgery and chemical biology assays in cultured mammalian cells. We find that kinetochores of syntelic chromosomes remain juxtaposed on detachment from spindle microtubules. These findings reveal that correction of syntelic attachments involves an extra step that has previously been overlooked: external forces must be applied to move sister kinetochores to the opposite sides of the centromere. Furthermore, we demonstrate that the shape of the centromere is important for spindle assembly, because bipolar spindles do not form in cells lacking centrosomes when multiple chromosomes with juxtaposed kinetochores are present. Thus, proper architecture of the centromere makes an important contribution to achieving high fidelity of chromosome segregation.	New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rockefeller University	Khodjakov, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Albany, NY 12201 USA.	kapoor@rockefeller.edu; khodj@wadsworth.org	Kisurina-Evgenieva, Olga/ABC-4520-2020	Loncarek, Jadranka/0000-0003-1879-5473	NIGMS NIH HHS [R01 GM065933, R01 GM059363-09, R01 GM059363] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363, R01GM065933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; CASSIMERIS L, 1994, J CELL SCI, V107, P285; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Compton DA, 1998, J CELL SCI, V111, P1477; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; MAGIDSON V, 2007, LASER MANIPULATIONS, P237; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sullivan KF, 1999, METHOD CELL BIOL, V58, P183; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181	31	77	77	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					745	U14		10.1038/nature06344	http://dx.doi.org/10.1038/nature06344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046416	Green Accepted			2022-12-24	WOS:000251209700059
J	Milne, JC; Lambert, PD; Schenk, S; Carney, DP; Smith, JJ; Gagne, DJ; Jin, L; Boss, O; Perni, RB; Vu, CB; Bemis, JE; Xie, R; Disch, JS; Ng, PY; Nunes, JJ; Lynch, AV; Yang, HY; Galonek, H; Israelian, K; Choy, W; Iffland, A; Lavu, S; Medvedik, O; Sinclair, DA; Olefsky, JM; Jirousek, MR; Elliott, PJ; Westphal, CH				Milne, Jill C.; Lambert, Philip D.; Schenk, Simon; Carney, David P.; Smith, Jesse J.; Gagne, David J.; Jin, Lei; Boss, Olivier; Perni, Robert B.; Vu, Chi B.; Bemis, Jean E.; Xie, Roger; Disch, Jeremy S.; Ng, Pui Yee; Nunes, Joseph J.; Lynch, Amy V.; Yang, Hongying; Galonek, Heidi; Israelian, Kristine; Choy, Wendy; Iffland, Andre; Lavu, Siva; Medvedik, Oliver; Sinclair, David A.; Olefsky, Jerrold M.; Jirousek, Michael R.; Elliott, Peter J.; Westphal, Christoph H.			Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes	NATURE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; SIR2-LIKE PROTEINS; INSULIN-RESISTANCE; CELL-SURVIVAL; LONGEVITY; NAD; DEACETYLASE; GLUCOSE	Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes(1,2). SIRT1, an NAD(+)-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity(3-9). Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival10-14. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.	Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School	Westphal, CH (corresponding author), Sirtris Pharmaceut Inc, 790 Mem Dr, Cambridge, MA 02139 USA.	cwestphal@sirtrispharma.com		Sinclair, David/0000-0002-9936-436X; Disch, Jeremy/0000-0002-0357-1672; Schenk, Simon/0000-0002-8224-3203	NIA NIH HHS [P01 AG027916-030003, R01 AG028730-03, P01 AG027916, R01 AG019719, P01 AG027916-040003, R01 AG028730-02, R01 AG019719-07, R01 AG028730] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG027916, R01AG028730, R01AG019719] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; BANKS A, 2007, DIABETES, V56; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sarabu R, 2005, CURR OPIN DRUG DISC, V8, P631; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	28	1348	1431	11	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 29	2007	450	7170					712	716		10.1038/nature06261	http://dx.doi.org/10.1038/nature06261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	235BY	18046409	Green Accepted			2022-12-24	WOS:000251209700052
J	Halloy, J; Sempo, G; Caprari, G; Rivault, C; Asadpour, M; Tache, F; Said, I; Durier, V; Canonge, S; Ame, JM; Detrain, C; Correll, N; Martinoli, A; Mondada, F; Siegwart, R; Deneubourg, JL				Halloy, J.; Sempo, G.; Caprari, G.; Rivault, C.; Asadpour, M.; Tache, F.; Said, I.; Durier, V.; Canonge, S.; Ame, J. M.; Detrain, C.; Correll, N.; Martinoli, A.; Mondada, F.; Siegwart, R.; Deneubourg, J. L.			Social integration of robots into groups of cockroaches to control self-organized choices	SCIENCE			English	Article							DECISION-MAKING; AGGREGATION; INSECTA	Collective behavior based on self-organization has been shown in group-living animals from insects to vertebrates. These findings have stimulated engineers to investigate approaches for the coordination of autonomous multirobot systems based on self-organization. In this experimental study, we show collective decision-making by mixed groups of cockroaches and socially integrated autonomous robots, leading to shared shelter selection. Individuals, natural or artificial, are perceived as equivalent, and the collective decision emerges from nonlinear feedbacks based on local interactions. Even when in the minority, robots can modulate the collective decision-making process and produce a global pattern not observed in their absence. These results demonstrate the possibility of using intelligent autonomous devices to study and control self-organized behavioral patterns in group-living animals.	Univ Libre Bruxelles, Serv Ecol Sociale, B-1050 Brussels, Belgium; Univ Rennes 1, CNRS, UMR Ethol Evolut Ecol 6652, F-35042 Rennes, France; ETH, Swiss Fed Inst Technol, Autonomous Syst Lab, CH-8092 Zurich, Switzerland; Ecole Polytech Fed Lausanne, Swarm Intelligent Syst Grp, EPFL IC ISC GR MA, CH-1015 Lausanne, Switzerland; Ecole Polytech Fed Lausanne, Lab Syst Robot, EPFL STI IPR LSRO, CH-1015 Lausanne, Switzerland	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Halloy, J (corresponding author), Univ Libre Bruxelles, Serv Ecol Sociale, CP231,Ave FD Roosevelt 50, B-1050 Brussels, Belgium.	jhalloy@ulb.ac.be	Siegwart, Roland/A-4495-2008; Mondada, Francesco/E-4279-2015	Siegwart, Roland/0000-0002-2760-7983; Mondada, Francesco/0000-0001-8641-8704; Halloy, Jose/0000-0003-1555-2484; Martinoli, Alcherio/0000-0002-5201-7862				Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; [Anonymous], 2014, PHEROMONES ANIMAL BE; Beni G, 2005, LECT NOTES COMPUT SC, V3342, P1; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Butler Z, 2006, INT J ROBOT RES, V25, P485, DOI 10.1177/0278364906065375; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Caprari G, 2005, IEEE ROBOT AUTOM MAG, V12, P58, DOI 10.1109/MRA.2005.1458325; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; De Schutter G, 2001, ANN MATH ARTIF INTEL, V31, P223, DOI 10.1023/A:1016638723526; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Ishii H, 2004, IEEE INT CONF ROBOT, P2758, DOI 10.1109/ROBOT.2004.1307478; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Martinoli A, 2004, INT J ROBOT RES, V23, P415, DOI 10.1177/0278364904042197; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Mondada F, 2004, AUTON ROBOT, V17, P193, DOI 10.1023/B:AURO.0000033972.50769.1c; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Said I, 2005, J INSECT PHYSIOL, V51, P1384, DOI 10.1016/j.jinsphys.2005.09.001; Said I, 2005, J INSECT PHYSIOL, V51, P995, DOI 10.1016/j.jinsphys.2005.04.017; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6	27	339	343	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1155	1158		10.1126/science.1144259	http://dx.doi.org/10.1126/science.1144259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006751				2022-12-24	WOS:000250957900051
J	Wiseman, RL; Powers, ET; Buxbaum, JN; Kelly, JW; Balch, WE				Wiseman, R. Luke; Powers, Evan T.; Buxbaum, Joel N.; Kelly, Jeffery W.; Balch, William E.			An adaptable standard for protein export from the endoplasmic reticulum	CELL			English	Article							MOLECULAR CHAPERONES; ER; SECRETION; ROLES; MODEL; CEREVISIAE; EXPRESSION; HSP90; CFTR; BIP	To provide an integrated view of endoplasmic reticulum (ER) function in protein export, we have described the interdependence of protein folding energetics and the adaptable biology of cellular protein folding and transport through the exocytic pathway. A simplified treatment of the protein homeostasis network and a formalism for how this network of competing pathways interprets protein folding kinetics and thermodynamics provides a framework for understanding cellular protein trafficking. We illustrate how folding and misfolding energetics, in concert with the adjustable biological capacities of the folding, degradation, and export pathways, collectively dictate an adaptable standard for protein export from the ER. A model of folding for export (FoldEx) establishes that no single feature dictates folding and transport efficiency. Instead, a network view provides insight into the basis for cellular diversity, disease origins, and protein homeostasis, and predicts strategies for restoring protein homeostasis in protein-misfolding diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu; webalch@scripps.edu		Powers, Evan/0000-0001-8185-8487; Wiseman, Luke/0000-0001-9287-6840	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046335, R01DK075295, R01DK051870, R37DK046335, R29DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06784] Funding Source: Medline; NIA NIH HHS [AG19259] Funding Source: Medline; NIDDK NIH HHS [DK46335, DK051870, DK075295] Funding Source: Medline; NIGMS NIH HHS [GM42336, GM33301] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; Li MS, 2004, POLYMER, V45, P573, DOI 10.1016/j.polymer.2003.10.066; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Perlmutter DH, 2006, PEDIATR RES, V60, P233, DOI 10.1203/01.pdr.0000228350.61496.90; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rakestraw A, 2006, BIOTECHNOL BIOENG, V93, P896, DOI 10.1002/bit.20780; Rieger TR, 2006, BIOPHYS J, V90, P886, DOI 10.1529/biophysj.105.066662; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Robinson AS, 1996, AICHE J, V42, P1443, DOI 10.1002/aic.690420525; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shimizu Y, 2007, ADV EXP MED BIOL, V594, P37; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu P, 2005, METAB ENG, V7, P269, DOI 10.1016/j.ymben.2005.04.002; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	35	123	124	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					809	821		10.1016/j.cell.2007.10.025	http://dx.doi.org/10.1016/j.cell.2007.10.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022373	Bronze			2022-12-24	WOS:000250966300026
J	Magnussen, EB; Vatten, LJ; Lund-Nilsen, TI; Salvesen, KA; Smith, GD; Romundstad, PR				Magnussen, Elisabeth Balstad; Vatten, Lars Johan; Lund-Nilsen, Tom Ivar; Salvesen, Kjell Asmund; Smith, George Davey; Romundstad, Pal Richard			Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; LOW-DENSITY-LIPOPROTEIN; HYPERTENSIVE DISORDERS; HEART-DISEASE; PREGNANCY COMPLICATIONS; RETROSPECTIVE COHORT; CIGARETTE-SMOKING; FAMILY-HISTORY; WOMEN; CHOLESTEROL	Objective To examine the effect of cardiovascular risk factors before pregnancy on risk of pre-eclampsia. Design Population based prospective study. Setting Linkage between a Norwegian population based study (Nord-Trondelag health study, HUNT-2) and Norway's medical birth registry. Participants 3494 women who gave birth after participating in the Nord-Trondelag health study at baseline; of whom 133 (3.81%) delivered after a preeclamptic pregnancy. Main outcome measure Odds ratio of developing preeclampsia. Results After adjustment for smoking; previous preeclampsia; parity; maternal age, education, and socioeconomic position; and duration between baseline measurements and delivery, positive associations were found between prepregnancy serum levels of trigtycerides, cholesterol, low density lipoprotein cholesterol, non-high density lipoprotein cholesterol, and blood pressure and risk of pre-eclampsia. The odds ratio of developing preectampsia for women with baseline systolic blood pressures greater than 130 mm fig (highest fifth) was 7.3 (95% confidence interval 3.1 to 17.2) compared with women with systolic blood pressures less than 111 mm Hg (lowest fifth). Similar results were found for nulliparous and parous women. Women who used oral contraceptives at baseline had half the risk of pre-eclampsia compared with never or former users (0.5, 0.3 to 0.9). Conclusion Women with cardiovascular risk factors may be predisposed to pre-eclampsia.	Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7489 Trondheim, Norway; Trondheim Univ Hosp St Olav, Dept Obstet, Trondheim, Norway; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	Norwegian University of Science & Technology (NTNU); University of Bristol	Magnussen, EB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7489 Trondheim, Norway.	elisabeth.b.magnussen@ntnu.no	Vatten, Lars/AFK-2073-2022; Davey Smith, George/A-7407-2013; Vatten, Lars/AAF-9380-2022	Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Romundstad, Pal Richard/0000-0003-2061-4336; s, hema/0000-0002-3440-9475				Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Beste LA, 2005, PAEDIATR PERINAT EP, V19, P12, DOI 10.1111/j.1365-3016.2004.00617.x; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Clausen T, 2001, BRIT J OBSTET GYNAEC, V108, P1081, DOI 10.1016/S0306-5456(01)00247-9; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Craig SR, 2000, J GEN INTERN MED, V15, P395, DOI 10.1046/j.1525-1497.2000.03509.x; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GOODE GK, 1995, LANCET, V345, P362, DOI 10.1016/S0140-6736(95)90345-3; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KLONOFFCOHEN HS, 1989, JAMA-J AM MED ASSOC, V262, P3143, DOI 10.1001/jama.262.22.3143; Ness RB, 2004, HYPERTENS PREGNANCY, V23, P227, DOI 10.1081/PRG-200030293; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Packard Chris J, 2004, J Atheroscler Thromb, V11, P6; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Qiu CF, 2003, HYPERTENSION, V41, P408, DOI 10.1161/01.HYP.0000056996.25503.F5; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Salafia C, 1999, PLACENTA, V20, P273, DOI 10.1053/plac.1998.0378; Sattar N, 1997, J CLIN ENDOCR METAB, V82, P2483, DOI 10.1210/jc.82.8.2483; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Sattar N, 1997, OBSTET GYNECOL, V89, P403, DOI 10.1016/S0029-7844(96)00514-5; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Thadhani R, 1999, OBSTET GYNECOL, V94, P543, DOI 10.1016/S0029-7844(99)00400-7; Thadhani R, 1999, CONTRACEPTION, V60, P145, DOI 10.1016/S0010-7824(99)00079-7; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563	38	256	269	3	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	NOV 10	2007	335	7627					978	981		10.1136/bmj.39366.416817.BE	http://dx.doi.org/10.1136/bmj.39366.416817.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17975256	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000250990400043
J	Partridge, L; Gems, D				Partridge, Linda; Gems, David			Benchmarks for ageing studies	NATURE			English	Editorial Material							LIFE-SPAN; DROSOPHILA-MELANOGASTER; EXTEND LIFE		UCL, Dept Biol, Ctr Res Ageing, London WC1E 6BT, England	University of London; University College London	Partridge, L (corresponding author), UCL, Dept Biol, Ctr Res Ageing, Darwin Bldg,Gower St, London WC1E 6BT, England.		Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094; Gems, David/0000-0002-6653-4676				Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB117, DOI 10.1093/gerona/55.3.B117; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Piper M. D. W., 2005, DRUG DISCOV TODAY DI, V2, P249; Sgro CM, 2000, AM NAT, V156, P341, DOI 10.1086/303394; Smith ED, 2007, MECH AGEING DEV, V128, P106, DOI 10.1016/j.mad.2006.11.017; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095	14	87	87	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					165	167		10.1038/450165a	http://dx.doi.org/10.1038/450165a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994065				2022-12-24	WOS:000250746200021
J	Romer, P; Hahn, S; Jordan, T; Strauss, T; Bonas, U; Lahaye, T				Roemer, Patrick; Hahn, Simone; Jordan, Tina; Strauss, Tina; Bonas, Ulla; Lahaye, Thomas			Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene	SCIENCE			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; BACTERIAL AVIRULENCE PROTEIN; CAMPESTRIS PV. VESICATORIA; AVRBS3 PROTEIN; CELL-DEATH; XANTHOMONAS; ARABIDOPSIS; EXPRESSION; SPECIFICITY; INSIGHTS	Plant disease resistance (R) proteins recognize matching pathogen avirulence proteins. Alleles of the pepper R gene Bs3 mediate recognition of the Xanthomonas campestris pv. vesicatoria (Xcv) type III effector protein AvrBs3 and its deletion derivative AvrBs3 Delta rep16. Pepper Bs3 and its allelic variant Bs3-E encode flavin monooxygenases with a previously unknown structure and are transcriptionally activated by the Xcv effector proteins AvrBs3 and AvrBs3 Delta rep16, respectively. We found that recognition specificity resides in the Bs3 and Bs3-E promoters and is determined by binding of AvrBs3 or AvrBs3 Delta rep16 to a defined promoter region. Our data suggest a recognition mechanism in which the Avr protein binds and activates the promoter of the cognate R gene.	Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06099 Halle, Germany	Martin Luther University Halle Wittenberg	Lahaye, T (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06099 Halle, Germany.	lahaye@genetik.uni-halle.de	Strauss, Tina/N-9889-2018					Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jordan T, 2006, THEOR APPL GENET, V113, P895, DOI 10.1007/s00122-006-0349-4; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; KNOOP V, 1991, J BACTERIOL, V173, P7142, DOI 10.1128/jb.173.22.7142-7150.1991; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Olszak B, 2006, PLANT SCI, V170, P614, DOI 10.1016/j.plantsci.2005.10.016; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schornack S, 2006, J PLANT PHYSIOL, V163, P256, DOI 10.1016/j.jplph.2005.12.001; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5	21	320	394	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					645	648		10.1126/science.1144958	http://dx.doi.org/10.1126/science.1144958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962564				2022-12-24	WOS:000250409200047
J	Segal, E; Raveh-Sadka, T; Schroeder, M; Unnerstall, U; Gaul, U				Segal, Eran; Raveh-Sadka, Tali; Schroeder, Mark; Unnerstall, Ulrich; Gaul, Ulrike			Predicting expression patterns from regulatory sequence in Drosophila segmentation	NATURE			English	Article							TRANSCRIPTION-FACTOR BINDING; COOPERATIVE DNA-BINDING; GENE-EXPRESSION; MORPHOGEN GRADIENT; DIRECT REPRESSION; DEPENDENT MANNER; IN-VIVO; EMBRYO; MELANOGASTER; POLARITY	The establishment of complex expression patterns at precise times and locations is key to metazoan development, yet a mechanistic understanding of the underlying transcription control networks is still missing. Here we describe a novel thermodynamic model that computes expression patterns as a function of cis- regulatory sequence and of the binding- site preferences and expression of participating transcription factors. We apply this model to the segmentation gene network of Drosophila melanogaster and find that it predicts expression patterns of cis- regulatory modules with remarkable accuracy, demonstrating that positional information is encoded in the regulatory sequence and input factor distribution. Our analysis reveals that both strong and weaker binding sites contribute, leading to high occupancy of the module DNA, and conferring robustness against mutation; short- range homotypic clustering of weaker sites facilitates cooperative binding, which is necessary to sharpen the patterns. Our computational framework is generally applicable to most protein - DNA interaction systems.	[Segal, Eran; Raveh-Sadka, Tali] Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel; [Schroeder, Mark; Unnerstall, Ulrich; Gaul, Ulrike] Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10065 USA	Weizmann Institute of Science; Rockefeller University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Appl Math & Comp Sci, IL-76100 Rehovot, Israel.	eran@weizmann.ac.il; gaul@mail.rockefeller.edu	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164				Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Arnosti DN, 1996, EMBO J, V15, P3659, DOI 10.1002/j.1460-2075.1996.tb00735.x; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Biggin Mark D., 2001, Functional and Integrative Genomics, V1, P223, DOI 10.1007/s101420000021; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Gray S, 1996, GENE DEV, V10, P700, DOI 10.1101/gad.10.6.700; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1992, SCIENCE, V256, P94, DOI 10.1126/science.1348871; JACKLE H, 1992, J CELL SCI, P39; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; LaRosee A, 1997, EMBO J, V16, P4403, DOI 10.1093/emboj/16.14.4403; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; MEINHARDT H, 1986, J CELL SCI, P357; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; NASIADKA A, 2002, ADV DEV BIOL BIOCH, P155; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; PTASHNE M, 2002, GENES SIGNALS, P26; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; SAUER F, 1995, EMBO J, V14, P4773, DOI 10.1002/j.1460-2075.1995.tb00159.x; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STJOHNSTON D, 1992, CELL, V68, P201; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Sutrias-Grau M, 2004, MOL CELL BIOL, V24, P5953, DOI 10.1128/MCB.24.13.5953-5966.2004; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	48	347	358	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					535	U1		10.1038/nature06496	http://dx.doi.org/10.1038/nature06496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18172436				2022-12-24	WOS:000252739900033
J	Egloff, S; O'Reilly, D; Chapman, RD; Taylor, A; Tanzhaus, K; Pitts, L; Eick, D; Murphy, S				Egloff, Sylvain; O'Reilly, Dawn; Chapman, Rob D.; Taylor, Alice; Tanzhaus, Katrin; Pitts, Laura; Eick, Dirk; Murphy, Shona			Serine-7 of the RNA polymerase IICTD is specifically required for snRNA gene expression	SCIENCE			English	Article							C-TERMINAL DOMAIN; HUMAN U2 SNRNA; POL-II; TRANSCRIPTION; CTD; STABILITY; PROTEIN	RNA polymerase II ( Pol II) transcribes genes that encode proteins and noncoding small nuclear RNAs ( snRNAs). The carboxyl- terminal repeat domain ( CTD) of the largest subunit of mammalian RNA Pol II, comprising tandem repeats of the heptapeptide consensus Tyr(1)-Ser(2)-Pro(3)Thr(4)- Ser(5)-Pro(6)-Ser(7), is required for expression of both gene types. We show that mutation of serine-7 to alanine causes a specific defect in snRNA gene expression. We also present evidence that phosphorylation of serine-7 facilitates interaction with the snRNA gene- specific Integrator complex. These findings assign a biological function to this amino acid and highlight a gene type-specific requirement for a residue within the CTD heptapeptide, supporting the existence of a CTD code.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, D-81377 Munich, Germany	University of Oxford; University of Munich	Murphy, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	shona.murphy@path.ox.ac.uk		Murphy, Shona/0000-0001-5276-9645; EGLOFF, Sylvain/0000-0002-9798-125X	Medical Research Council [G9826944, G0400653, G0400653(71330)] Funding Source: Medline; Wellcome Trust [072107, 081312] Funding Source: Medline; MRC [G0400653, G9826944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cuello P, 1999, EMBO J, V18, P2867, DOI 10.1093/emboj/18.10.2867; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Fong N, 2003, EMBO J, V22, P4274, DOI 10.1093/emboj/cdg396; Fury MG, 1996, EXP CELL RES, V228, P160, DOI 10.1006/excr.1996.0311; GERBER HP, 1995, NATURE, V374, P660, DOI 10.1038/374660a0; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; YOON JB, 1995, MOL CELL BIOL, V15, P2019	18	200	200	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1777	1779		10.1126/science.1145989	http://dx.doi.org/10.1126/science.1145989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079403	Green Accepted			2022-12-24	WOS:000251616800042
J	Samb, B; Celletti, F; Holloway, J; Van Damme, W; De Cock, KM; Dybul, M				Samb, Badara; Celletti, Francesca; Holloway, Joan; Van Damme, Wim; De Cock, Kevin M.; Dybul, Mark			Rapid expansion of the health workforce in response to the HIV epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NURSE-PRACTITIONERS; PRIMARY-CARE; THERAPY		WHO, CH-1211 Geneva, Switzerland; US Dept State, Off US Global AIDS Coordinator, Washington, DC 20520 USA; Inst Trop Med, B-2000 Antwerp, Belgium	World Health Organization; Institute of Tropical Medicine (ITM)	Samb, B (corresponding author), WHO, CH-1211 Geneva, Switzerland.		Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Abbatt F., 2005, SCALING HLTH ED WORK; Behforouz HL, 2004, CLIN INFECT DIS, V38, pS429, DOI 10.1086/421408; Bell D, 2001, B WORLD HEALTH ORGAN, V79, P933; CLARKE M, 2005, COST EFFECTIVE TUBER; *DEP STAT, 2006, PRES EM PLAN AIDS RE; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; DUALE S, 1992, INT J GYNECOL OBSTET, V38, pS33, DOI 10.1016/0020-7292(92)90027-G; Hirschhorn Lisa R, 2006, Hum Resour Health, V4, P1, DOI 10.1186/1478-4491-4-1; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; *INT LAB OFF, 2004, HIV AIDS WORK GLOB E; LANKSHEAR A, 2005, HLTH POLICY MATT JUL, P1; LEHMANN U, 2004, 41 JLI; Lewin SA, 2005, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD004015.PUB2; Marston Barbara J, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P106, DOI 10.1177/1545109707300688; *MED SANS FRONT, 2006, ACH SUST UN ACC ANT; Miles K, 2006, INT NURS REV, V53, P290, DOI 10.1111/j.1466-7657.2006.00491.x; Pienaar D, 2006, MODELS CARE ANTIRETR; SHERWOOD GD, 1997, INTERNET J ADV NURS, V1; *STOP TB DEP, 2003, COMM CONTR TB CAR PR; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; Yong CS, 2006, MED J AUSTRALIA, V185, P27, DOI 10.5694/j.1326-5377.2006.tb00446.x; 1981, ANN SOC BELG MED T S, V60, P5	23	136	136	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2007	357	24					2510	2514		10.1056/NEJMsb071889	http://dx.doi.org/10.1056/NEJMsb071889			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240CK	18077816				2022-12-24	WOS:000251564400016
J	Jack, A				Jack, Andrew			Bitter pills	BRITISH MEDICAL JOURNAL			English	Article									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				*AEG, BELG EXP; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; European Commission Tax And Customs Union, 2006, SUMM COMM CUST ACT C; JACK A, 2007, FINANCIAL TIMES 1122; JACK A, 2007, FINANCIAL TIMES 0514; Organisation for Economic Co-operation and Development, 2007, EC IMP COUNT PIR; *US FDA, FDA COUNT DRUG TASK; *WHO, 2007, IMPACT M; *WHO INT MED PROD, 2007, IMPACT TECHN SUBGR M; World Health Organization (WHO), 2006, COUNT MED	10	18	18	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 1	2007	335	7630					1120	1121		10.1136/bmj.39412.431655.AD	http://dx.doi.org/10.1136/bmj.39412.431655.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240OE	18048535	Green Published			2022-12-24	WOS:000251596100027
J	Massberg, S; Schaerli, P; Knezevic-Maramica, I; Kollnberger, M; Tubo, N; Moseman, EA; Huff, IV; Junt, T; Wagers, AJ; Mazo, IB; von Andrian, UH				Massberg, Steffen; Schaerli, Patrick; Knezevic-Maramica, Irina; Koellnberger, Maria; Tubo, Noah; Moseman, E. Ashley; Huff, Ines V.; Junt, Tobias; Wagers, Amy J.; Mazo, Irina B.; von Andrian, Ulrich H.			Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues	CELL			English	Article							STEM-CELLS; BONE-MARROW; SPHINGOSINE 1-PHOSPHATE; MICE DEFICIENT; T-CELLS; SPHINGOSINE-1-PHOSPHATE; MIGRATION; ORGANS; MOBILIZATION; AGONISTS	Constitutive egress of bone marrow (BM)-resident hematopoietic stem and progenitor cells (HSPCs) into the blood is a well-established phenomenon, but the ultimate fate and functional relevance of circulating HSPCs is largely unknown. We show that mouse thoracic duct (TD) lymph contains HSPCs that possess short- and long-term multilineage reconstitution capacity. TD-derived HSPCs originate in the BM, enter the blood, and traffic to multiple peripheral organs, where they reside for at least 36 hr before entering draining lymphatics to return to the blood and, eventually, the BM. HSPC egress from extramedullary tissues into lymph depends on sphingosine-1-phosphate receptors. Migratory HSPCs proliferate within extramedullary tissues and give rise to tissue-resident myeloid cells, preferentially dendritic cells. HSPC differentiation is amplified upon exposure to Toll-like receptor agonists. Thus, HSPCs can survey peripheral organs and can foster the local production of tissue-resident innate immune cells under both steady-state conditions and in response to inflammatory signals.	[Massberg, Steffen; Schaerli, Patrick; Knezevic-Maramica, Irina; Koellnberger, Maria; Tubo, Noah; Moseman, E. Ashley; Huff, Ines V.; Junt, Tobias; Wagers, Amy J.; Mazo, Irina B.; von Andrian, Ulrich H.] Harvard Med Sch, Immune Dis Inst, Dept Pathol, Boston, MA 02115 USA; [Wagers, Amy J.] Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; [Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.; Harvard University	von Andrian, UH (corresponding author), Harvard Med Sch, Immune Dis Inst, Dept Pathol, Boston, MA 02115 USA.	uva@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021; Massberg, Steffen/AAN-6054-2021		NCRR NIH HHS [S10 RR021190-010001, S10 RR021190] Funding Source: Medline; NHLBI NIH HHS [P01 HL056949-129001, P01 HL056949-119001, P01 HL056949-099001, P01 HL056949-09, P01 HL056949-12, P01 HL056949-089001, P01 HL056949-08, P01 HL056949, P01 HL056949-10, HL56949, P01 HL056949-11, P01 HL056949-109001] Funding Source: Medline; NIAID NIH HHS [R01 AI072252, R01 AI061663-05, R01 AI069259-03, R01 AI072252-01, AI061663, R01 AI069259, R01 AI061663] Funding Source: Medline; NIAMS NIH HHS [AR42689, P30 AR042689] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021190] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, R01AI072252, R01AI061663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cardier JE, 1997, HEPATOLOGY, V26, P165; Chiba K, 1998, J IMMUNOL, V160, P5037; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ionac M, 2003, MICROSURG, V23, P239, DOI 10.1002/micr.10136; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; MACVITTIE TJ, 1977, J CELL PHYSIOL, V92, P203, DOI 10.1002/jcp.1040920208; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Singer II, 2005, J IMMUNOL, V175, P7151, DOI 10.4049/jimmunol.175.11.7151; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stein JV, 2000, J EXP MED, V191, P61, DOI 10.1084/jem.191.1.61; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278	40	529	537	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					994	1008		10.1016/j.cell.2007.09.047	http://dx.doi.org/10.1016/j.cell.2007.09.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045540	Green Accepted, Bronze			2022-12-24	WOS:000251800900020
J	Nallagatla, SR; Hwang, J; Toroney, R; Zheng, XF; Cameron, CE; Bevilacqua, PC				Nallagatla, Subba Rao; Hwang, Jungwook; Toroney, Rebecca; Zheng, Xiaofeng; Cameron, Craig E.; Bevilacqua, Philip C.			5 '-triphosphate-dependent activation of PKR by RNAs with short stem-loops	SCIENCE			English	Article							PROTEIN-KINASE PKR; DOUBLE-STRANDED-RNA; MESSENGER-RNA; RIG-I; BINDING; CELLS; RECOGNITION; POLYMERASE; VIRUSES	Molecular patterns in pathogenic RNAs can be recognized by the innate immune system, and a component of this response is the interferon-induced enzyme RNA-activated protein kinase (PKR). The major activators of PKR have been proposed to be long double-stranded RNAs. We report that RNAs with very limited secondary structures activate PKR in a 5'-triphosphate-dependent fashion in vitro and in vivo. Activation of PKR by 5'-triphosphate RNA is independent of RIG-I and is enhanced by treatment with type 1 interferon (IFN-alpha). Surveillance of molecular features at the 5' end of transcripts by PKR presents a means of allowing pathogenic RNA to be distinguished from self-RNA. The evidence presented here suggests that this form of RNA-based discrimination may be a critical step in mounting an early immune response.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Peking Univ, Life Sci Coll, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	cec9@psu.edu; pcb@chem.psu.edu	Hwang, Jungwook/P-1614-2015	Hwang, Jungwook/0000-0002-2290-1649; Bevilacqua, Philip/0000-0001-8074-3434	NIGMS NIH HHS [GM58709] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058709] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; BIEGER CD, 1989, J BACTERIOL, V171, P141, DOI 10.1128/jb.171.1.141-147.1989; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dever T.E., 2007, TRANSLATIONAL CONTRO, P319; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Knipe DM, 2007, FIELDS VIROLOGY; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Robertson HD, 1996, J VIROL, V70, P5611, DOI 10.1128/JVI.70.8.5611-5617.1996; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Ucci JW, 2004, BIOPHYS CHEM, V108, P127, DOI 10.1016/j.bpc.2003.10.033; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	22	185	189	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1455	1458		10.1126/science.1147347	http://dx.doi.org/10.1126/science.1147347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048689				2022-12-24	WOS:000251246100047
J	Scott, J				Scott, James			The liver X receptor and atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE		Imperial Coll, London, England	Imperial College London	Scott, J (corresponding author), Imperial Coll, London, England.							Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	4	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2007	357	21					2195	2197		10.1056/NEJMcibr075951	http://dx.doi.org/10.1056/NEJMcibr075951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	233FT	18032771				2022-12-24	WOS:000251076500015
J	Ashar, BS; Ferriter, A				Ashar, Binita S.; Ferriter, Ann			Radiofrequency identification technology in health care - Benefits and potential risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA	US Food & Drug Administration (FDA)	Ashar, BS (corresponding author), US FDA, Off Device Evaluat, Ctr Devices & Radiol Hlth, HFZ 410,9200 Corp Blvd, Rockville, MD 20850 USA.	binita.ashar@fda.hhs.gov						[Anonymous], 2005, HLTH DEVICES, V34, P149; Austin SM, 2007, MAYO CLIN PROC, V82, P383; *AUSTR COMP EM RES, 2004, 80211 IEEE AUSTR COM; CHEVROLLIER N, US WIR NETW TECHN HE; *FED COMM COMM, FILL COMPL FCC IS EA; Gimbel JR, 2007, MAYO CLIN PROC, V82, P318; HARROP P, 2006, RFID HEALTHCARE IDTE; *US FDA, 2007, DRAFT GUID IND FDA S; *US FDA, 2005, WIR PHYS MON SYST 51; *US FDA, 2006, D SPECT CARD SCANN S; *US FDA, 2004, SURG TAG 510 K K0425; *US FDA, ADV EV REP US FDA; *US FDA, 2006, STRYK ORTH RFID INST; *US FDA, 2004, VER HLTH INF MICR SY; *US FDA, MEDW FDA SAF INF ADV; *US FDA, FDA MAUDE DAT CTR DE	16	37	37	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2305	2307		10.1001/jama.298.19.2305	http://dx.doi.org/10.1001/jama.298.19.2305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029835				2022-12-24	WOS:000251055900031
J	Chand, K; Califano, J				Chand, Kaillash; Califano, Joseph			Should drugs be decriminalised?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY 10017 USA	Columbia University		Kailash.Chand@gp-P89609.nhs.uk; info@casacolumbia.org							0	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2007	335	7627					966	967		10.1136/bmj.39360.489132.AD	http://dx.doi.org/10.1136/bmj.39360.489132.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232AL	17991976	Green Published			2022-12-24	WOS:000250990400034
J	Sturgill, D; Zhang, Y; Parisi, M; Oliver, B				Sturgill, David; Zhang, Yu; Parisi, Michael; Oliver, Brian			Demasculinization of X chromosomes in the Drosophila genus	NATURE			English	Article							SEX-BIASED GENES; EXPRESSION; EVOLUTION	X chromosomes evolve differently from autosomes, but general governing principles have not emerged(1). For example, genes with male-biased expression are under-represented on the X chromosome of D. melanogaster(2), but are randomly distributed in the genome of Anopheles gambiae(3). In direct global profiling experiments using species-specific microarrays, we find a nearly identical paucity of genes with male-biased expression on D. melanogaster, D. simulans, D. yakuba, D. ananassae, D. virilis and D. mojavensis X chromosomes. We observe the same under-representation on the neo-X of D. pseudoobscura. It has been suggested that precocious meiotic silencing of the X chromosome accounts for reduced X chromosome male-biased expression in nematodes(4), mammals(5) and Drosophila(6). We show that X chromosome genes with male-biased expression are under-represented in somatic cells and in mitotic male germ cells. These data are incompatible with simple X chromosome inactivation models. Using expression profiling and comparative sequence analysis, we show that selective gene extinction on the X chromosome, creation of new genes on autosomes and changed genomic location of existing genes contribute to the unusual X chromosome gene content.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sturgill, D (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.	davidsturgill@niddk.nih.gov; oliver@helix.nih.gov		Sturgill, David/0000-0002-7902-3605	Intramural NIH HHS [Z01 DK015600-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M., 2004, DROSOPHILA LAB HDB; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Charif D, 2005, BIOINFORMATICS, V21, P545, DOI 10.1093/bioinformatics/bti037; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang W, 2004, NAT GENET, V36, P523, DOI 10.1038/ng1338; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1	25	177	178	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					238	U3		10.1038/nature06330	http://dx.doi.org/10.1038/nature06330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994090	Bronze, Green Accepted			2022-12-24	WOS:000250746200045
J	Ajioka, I; Martins, RAP; Bayazitov, IT; Donovan, S; Johnson, DA; Frase, S; Cicero, SA; Boyd, K; Zakharenko, SS; Dyer, MA				Ajioka, Itsuki; Martins, Rodrigo A. P.; Bayazitov, Ildar T.; Donovan, Stacy; Johnson, Dianna A.; Frase, Sharon; Cicero, Samantha A.; Boyd, Kelli; Zakharenko, Stanislav S.; Dyer, Michael A.			Differentiated horizontal Interneurons clonally expand to form metastatic retinoblastoma in mice	CELL			English	Article							PROGENITOR-CELL PROLIFERATION; SUBVENTRICULAR ZONE; RETINAL DEVELOPMENT; MAMMALIAN RETINA; MOUSE RETINA; MULLER GLIA; NEURONS; RB; REGENERATION; FOREBRAIN	During neurogenesis, the progression from a progenitor cell to a differentiated neuron is believed to be unidirectional and irreversible. The Rb family of proteins ( Rb, p107, and p130) regulates cell-cycle exit and differentiation during retinogenesis. Rb and p130 are redundantly expressed in the neurons of the inner nuclear layer (INL) of the retina. We have found that in the adult Rb; p130-deficient retinae p107 compensation prevents ectopic proliferation of INL neurons. However, p107 is haploinsufficient in this process. Differentiated Rb (-/-); p107(+/-); p130(-/-) horizontal interneurons re-entered the cell cycle, clonally expanded, and formed metastatic retinoblastoma. Horizontal cells were not affected in Rb+/-; p107(-/-); p130(-/-) or Rb-/-; p107(-/-); p130(+/-), retinae suggesting that one copy of Rb or p130 was sufficient to prevent horizontal proliferation. We hereby report that differentiated neurons can proliferate and form cancer while maintaining their differentiated state including neurites and synaptic connections.	St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38105 USA; Univ Memphis, Integrated Microscopy Ctr, Memphis, TN 38152 USA; St Jude Childrens Hosp, Anim Resources Ctr, Div Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; St Jude Children's Research Hospital	Dyer, MA (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Martins, Rodrigo/W-7604-2019; Dyer, Michael/N-8134-2018; Zakharenko, Stanislav/D-3287-2013; Martins, Rodrigo A. P./A-4701-2010	Martins, Rodrigo/0000-0002-8420-6991; Zakharenko, Stanislav/0000-0001-8115-202X; Martins, Rodrigo A. P./0000-0002-8420-6991	NEI NIH HHS [R01 EY014867, R01 EY014867-05] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014867] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Cunningham JJ, 2002, MOL CELL NEUROSCI, V19, P359, DOI 10.1006/mcne.2001.1090; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fischer AJ, 2002, J NEUROSCI, V22, P9387; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Johnson DA, 2007, CANCER RES, V67, P2701, DOI 10.1158/0008-5472.CAN-06-3754; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Skapek SX, 2001, ONCOGENE, V20, P6742, DOI 10.1038/sj.onc.1204876; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Zhang JK, 2004, CELL CYCLE, V3, P952; Zhang JK, 2004, NAT GENET, V36, P351, DOI 10.1038/ng1318	27	150	153	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2007	131	2					378	390		10.1016/j.cell.2007.09.036	http://dx.doi.org/10.1016/j.cell.2007.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956737	Green Accepted, Bronze			2022-12-24	WOS:000250507700026
J	Williams, G; Dharmaraj, P				Williams, Gareth; Dharmaraj, Poonam			Dissent of the testis	BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBERTY		[Williams, Gareth] Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England; [Dharmaraj, Poonam] Royal Victoria Infirm, Dept Paediat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Bristol; Newcastle University - UK	Williams, G (corresponding author), Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England.							Bhalla P, 2001, BRIT MED J, V323, P1486, DOI 10.1136/bmj.323.7327.1486; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 22	2007	335	7633					1287	1287		10.1136/bmj.39415.755752.AD	http://dx.doi.org/10.1136/bmj.39415.755752.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156230	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000252182700010
J	Augui, S; Filion, GJ; Huart, S; Nora, E; Guggiari, M; Maresca, M; Stewart, AF; Heard, E				Augui, S.; Filion, G. J.; Huart, S.; Nora, E.; Guggiari, M.; Maresca, M.; Stewart, A. F.; Heard, E.			Sensing X chromosome pairs before X inactivation via a novel X-pairing region of the Xic	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; XIST LOCUS; HISTONE H3; TSIX; TRANSCRIPTION; METHYLATION; CENTERS; CHOICE; LYS-9	Mammalian dosage compensation involves silencing of one of the two X chromosomes in females and is controlled by the X-inactivation center (Xic). The Xic, which includes Xist and its antisense transcription unit Tsix/Xite, somehow senses the number of X chromosomes and triggers Xist up-regulation from one of the two X chromosomes in females. We found that a segment of the mouse Xic lying several hundred kilobases upstream of Xist brings the two Xics together before the onset of X inactivation. This region can autonomously drive Xic trans-interactions even as an ectopic single-copy transgene. Its introduction into male embryonic stem cells is strongly selected against, consistent with a possible role in trans-activating Xist. We propose that homologous associations driven by this novel X-pairing region (Xpr) of the Xic enable a cell to sense that more than one X chromosome is present and coordinate reciprocal Xist/Tsix expression.	Inst Curie, CNRS, UMR218, F-75005 Paris, France; Tech Univ Dresden, BioInnovat Zentrum, D-01307 Dresden, Germany	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Technische Universitat Dresden	Heard, E (corresponding author), Inst Curie, CNRS, UMR218, 26 Rue Ulm, F-75005 Paris, France.	edith.heard@curie.fr	Filion, Guillaume/G-9619-2015; Stewart, A. Francis/E-7789-2010; Nora, Elphège/AAW-9646-2021; Heard, Edith/D-7197-2017	Filion, Guillaume/0000-0002-3473-1632; Nora, Elphège/0000-0002-8347-4396; Heard, Edith/0000-0001-8052-7117				Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heard E, 1999, MOL CELL BIOL, V19, P3156; HEARD E, 1994, HUM MOL GENET, V3, P1481, DOI 10.1093/hmg/3.suppl_1.1481; Henikoff S, 1998, CELL, V93, P329, DOI 10.1016/S0092-8674(00)81161-7; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	19	147	149	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1632	1636		10.1126/science.1149420	http://dx.doi.org/10.1126/science.1149420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063799				2022-12-24	WOS:000251421700048
J	Mackey, DC; Lui, LY; Cawthon, PM; Bauer, DC; Nevitt, MC; Cauley, JA; Hillier, TA; Lewis, CE; Barrett-Connor, E; Cummings, SR				Mackey, Dawn C.; Lui, Li-Yung; Cawthon, Peggy M.; Bauer, Douglas C.; Nevitt, Michael C.; Cauley, Jane A.; Hillier, Teresa A.; Lewis, Cora E.; Barrett-Connor, Elizabeth; Cummings, Steven R.		SOF Res Grp; MrOS Res Grp	High-trauma fractures and low bone mineral density in older women and men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOPOROTIC FRACTURES; HIP FRACTURE; POSTMENOPAUSAL WOMEN; NONVERTEBRAL FRACTURES; SUBSEQUENT FRACTURE; FRAGILITY FRACTURES; RISK-FACTORS; EPIDEMIOLOGY; PREDICTORS; COMMUNITY	Context It is widely believed that fractures resulting from high trauma are not osteoporotic; however, this assumption has not been studied prospectively. Objective To examine the association between bone mineral density (BMD) and high-trauma fracture and between high-trauma fracture and subsequent fracture in older women and men. Design, Setting, and Participants Two prospective US cohort studies in community-dwelling adults 65 years or older from geographically diverse sites. The Study of Osteoporotic Fractures followed up 8022 women for 9.1 years (1988-2006). The Osteoporotic Fractures in Men Study followed up 5995 men for 5.1 years (2000-2007). Main Outcome Measures Hip and spine BMD were assessed by dual-energy x-ray absorptiometry. Incident nonspine fractures were confirmed by radiographic report. Fractures were classified, without knowledge of BMD, as high trauma (due to motor vehicle crashes and falls from greater than standing height) or as low trauma (due to falls from standing height and less severe trauma). Results Overall, 264 women and 94 men sustained an initial high-trauma fracture and 3211 women and 346 men sustained an initial low-trauma fracture. For women, each 1-SD reduction in total hip BMD was similarly associated with an increased risk of high-trauma fracture (multivariate relative hazard [RH], 1.45; 95% confidence interval [CI], 1.23-1.72) and low-trauma fracture (RH, 1.49; 95% CI, 1.42-1.57). Results were consistent in men ( high-trauma fracture RH, 1.54; 95% CI, 1.20-1.96; low-trauma fracture RH, 1.69; 95% CI, 1.49-1.91). Risk of subsequent fracture was 34%( 95% Cl, 7%-67%) greater among women with an initial high-trauma fracture and 31%( 95% Cl, 20%-43%) greater among women with an initial low-trauma fracture, compared with women having no high- or low trauma fracture, respectively. Risk of subsequent fracture was not modeled for men. Conclusions Similar to low-trauma nonspine fractures, high- trauma nonspine fractures are associated with low BMD and increased risk of subsequent fracture in older adults. High-trauma nonspine fractures should be included as outcomes in osteoporosis trials and observational studies.	Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA 94107 USA; Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; NW Hawaii, Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego	Mackey, DC (corresponding author), Calif Pacific Med Ctr, San Francisco Coordinating Ctr, 185 Berry St,Lobby 4,Ste 5700, San Francisco, CA 94107 USA.	dmackey@sfcc-cpmc.net	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045580, R01AR035582, U01AR045632, U01AR045614, U01AR045583, U01AR045654, R01AR035584, U01AR045647, R01AR035583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005394, R01AG005407, U01AG018197, U01AG027810, R01AG027574, R01AG027576] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024140] Funding Source: Medline; NIAMS NIH HHS [U01 AR45654, U01 AR45647, AR35582, AR35583, U01 AR45632, U01 AR45580, U01 AR45614, U01 AR45583, AR35584] Funding Source: Medline; NIA NIH HHS [R01 AG005407, R01 AG027576-22, R01 AG005394-22A1, 2 R01 AG027574-22A1, AG05394, AG05407, U01 AG18197, U01-AG027810] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albrand G, 2003, BONE, V32, P78, DOI 10.1016/S8756-3282(02)00919-5; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; *BON HLTH OST, 2004, REP SURG GEN 2004; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COURTNEY AC, 1995, J BONE JOINT SURG AM, V77A, P387, DOI 10.2106/00004623-199503000-00008; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Garnero P, 2000, J BONE MINER RES, V15, P1526, DOI 10.1359/jbmr.2000.15.8.1526; Hayes WC, 1996, BONE, V18, pS77, DOI 10.1016/8756-3282(95)00383-5; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; KARLSSON MK, 1993, CALCIFIED TISSUE INT, V53, P229, DOI 10.1007/BF01320906; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Meier C, 2005, J BONE MINER RES, V20, P579, DOI 10.1359/JBMR.041207; MELTON LJ, 1982, CLIN ORTHOP RELAT R, P144; Melton LJ, 1997, J BONE MINER RES, V12, P16, DOI 10.1359/jbmr.1997.12.1.16; Melton LJ, 1998, J BONE MINER RES, V13, P1915, DOI 10.1359/jbmr.1998.13.12.1915; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; OWEN RA, 1982, AM J PUBLIC HEALTH, V72, P605, DOI 10.2105/AJPH.72.6.605; Papadimitropoulos EA, 1997, CAN MED ASSOC J, V157, P1357; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; STEIGER P, 1992, J BONE MINER RES, V7, P625; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; WASNICH RD, 1994, OSTEOPOROSIS INT, V4, P1, DOI 10.1007/BF02352253; 2004, OSTEOPOROS INT S4, V8, pS7	33	252	255	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2381	2388		10.1001/jama.298.20.2381	http://dx.doi.org/10.1001/jama.298.20.2381			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042915	Bronze			2022-12-24	WOS:000251163400018
J	Illies, C; Gromada, J; Fiume, R; Leibiger, B; Yu, J; Juhl, K; Yang, SN; Barma, DK; Falck, JR; Saiardi, A; Barker, CJ; Berggren, PO				Illies, Christopher; Gromada, Jesper; Fiume, Roberta; Leibiger, Barbara; Yu, Jia; Juhl, Kirstine; Yang, Shao-Nian; Barma, Deb K.; Falck, John R.; Saiardi, Adolfo; Barker, Christopher J.; Berggren, Per-Olof			Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells	SCIENCE			English	Article							INSULIN; COMPLEX	Inositol pyrophosphates are recognized components of cellular processes that regulate vesicle trafficking, telomere length, and apoptosis. We observed that pancreatic beta cells maintain high basal concentrations of the pyrophosphate diphosphoinositol pentakisphosphate (InsP(7) or IP7). Inositol hexakisphosphate kinases (IP6Ks) that can generate IP7 were overexpressed. This overexpression stimulated exocytosis of insulin-containing granules from the readily releasable pool. Exogenously applied IP7 dose-dependently enhanced exocytosis at physiological concentrations. We determined that IP6K1 and IP6K2 were present in b cells. RNA silencing of IP6K1, but not IP6K2, inhibited exocytosis, which suggests that IP6K1 is the critical endogenous kinase. Maintenance of high concentrations of IP7 in the pancreatic b cell may enhance the immediate exocytotic capacity and consequently allow rapid adjustment of insulin secretion in response to increased demand.	Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; Novartis Inst BioMed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; UCL, UK Med Res Council, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, Mol Cell Biol Lab, London WC1E 6BT, England	Karolinska Institutet; Novartis; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Barker, CJ (corresponding author), Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden.	chris.barker@ki.se	Falck, John R/B-3030-2011; Tuluc, Petronel/C-2527-2011	Falck, John R/0000-0002-9219-7845; FIUME, ROBERTA/0000-0001-7757-4000; Berggren, Per-Olof/0000-0001-8991-413X	MRC [MC_U122680443] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER; Medical Research Council [MC_U122680443] Funding Source: Medline; NIGMS NIH HHS [GM31278] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Barker CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1113, DOI 10.1152/ajpendo.00088.2002; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Berridge MJ, 1995, ANN NY ACAD SCI, V766, P31, DOI 10.1111/j.1749-6632.1995.tb26646.x; Efanov AM, 1997, P NATL ACAD SCI USA, V94, P4435, DOI 10.1073/pnas.94.9.4435; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Hoy M, 2003, J BIOL CHEM, V278, P35168, DOI 10.1074/jbc.M303927200; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kamimura J, 2004, J HUM GENET, V49, P360, DOI 10.1007/s10038-004-0158-z; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Renstrom E, 1996, J PHYSIOL-LONDON, V494, P41, DOI 10.1113/jphysiol.1996.sp021474; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Shears SB, 2004, BIOCHEM J, V377, P265, DOI 10.1042/BJ20031428; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535	23	136	143	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1299	1302		10.1126/science.1146824	http://dx.doi.org/10.1126/science.1146824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033884				2022-12-24	WOS:000251086600043
J	Brisson, JA; Nuzhdin, SV				Brisson, Jennifer A.; Nuzhdin, Sergey V.			Rarity of males in pea aphids results in mutational decay	SCIENCE			English	Article							SELECTION; EVOLUTION; GENOME		[Brisson, Jennifer A.; Nuzhdin, Sergey V.] Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Brisson, JA (corresponding author), Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA.	jabrisson@ucdavis.edu		Brisson, Jennifer/0000-0001-7000-0709				Brisson JA, 2007, EVOL DEV, V9, P338, DOI 10.1111/j.1525-142X.2007.00170.x; Civetta A, 1999, GENOME, V42, P1033, DOI 10.1139/gen-42-6-1033; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; VIA S, 1992, ENTOMOL EXP APPL, V65, P119, DOI 10.1007/BF00221362; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035	7	20	21	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					58	58		10.1126/science.1147919	http://dx.doi.org/10.1126/science.1147919			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174433	Green Published			2022-12-24	WOS:000252084000027
J	Beebe, K; Mock, M; Merriman, E; Schimmel, P				Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul			Distinct domains of tRNA synthetase recognize the same base pair	NATURE			English	Article							HAEMOPHILUS-INFLUENZAE YBAK; AMINO-ACID; ESCHERICHIA-COLI; MAJOR DETERMINANT; CRYSTAL-STRUCTURE; CELL VIABILITY; GENETIC-CODE; DISCRIMINATION; IDENTITY; MISTRANSLATION	Synthesis of proteins containing errors ( mistranslation) is prevented by aminoacyl transfer RNA synthetases through their accurate aminoacylation of cognate tRNAs and their ability to correct occasional errors of aminoacylation by editing reactions(1-5). A principal source of mistranslation comes from mistaking glycine or serine for alanine, which can lead to serious cell and animal pathologies, including neurodegeneration(3). A single specific GNU base pair ( G3 center dot U70) marks a tRNA for aminoacylation by alanyl-tRNA synthetase(6-9). Mistranslation occurs when glycine or serine is joined to the G3 center dot U70- containing tRNAs, and is prevented by the editing activity that clears the mischarged amino acid. Previously it was assumed that the specificity for recognition of tRNA(Ala) for editing was provided by the same structural determinants as used for aminoacylation. Here we show that the editing site of alanyl-tRNA synthetase, as an artificial recombinant fragment, targets mischarged tRNA(Ala) using a structural motif unrelated to that for aminoacylation so that, remarkably, two motifs ( one for aminoacylation and one for editing) in the same enzyme independently can provide determinants for tRNA(Ala) recognition. The structural motif for editing is also found naturally in genome-encoded protein fragments that are widely distributed in evolution(10-12). These also recognize mischarged tRNA(Ala). Thus, through evolution, three different complexes with the same tRNA can guard against mistaking glycine or serine for alanine.	[Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol & Chem, La Jolla, CA 92037 USA; [Beebe, Kirk; Mock, Marissa; Merriman, Eve; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol & Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu						Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Beebe K, 2003, J BIOL CHEM, V278, P45056, DOI 10.1074/jbc.M307080200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Pauling L., 1957, FESTSCHRIFT ARTHUR S, P597; PUTNEY SD, 1981, SCIENCE, V213, P1497, DOI 10.1126/science.7025207; REGAN L, 1987, SCIENCE, V235, P1651, DOI 10.1126/science.2435005; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; Schimmel P, 2001, COLD SPRING HARB SYM, V66, P161, DOI 10.1101/sqb.2001.66.161; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Waas WF, 2007, BIOCHEMISTRY-US, V46, P12062, DOI 10.1021/bi7007454	29	61	68	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					90	U14		10.1038/nature06454	http://dx.doi.org/10.1038/nature06454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172502				2022-12-24	WOS:000252079300040
J	Paukstelis, PJ; Chen, JH; Chase, E; Lambowitz, AM; Golden, BL				Paukstelis, Paul J.; Chen, Jui-Hui; Chase, Elaine; Lambowitz, Alan M.; Golden, Barbara L.			Structure of a tyrosyl-tRNA synthetase splicing factor bound to a group I intron RNA	NATURE			English	Article							NEUROSPORA-CRASSA; CATALYTIC CORE; CRYSTAL-STRUCTURE; CYT-18 PROTEIN; TETRAHYMENA RIBOZYME; TERTIARY STRUCTURE; P4-P6 DOMAIN; BINDING; DEFECTS; PROGRAM	The 'RNA world' hypothesis holds that during evolution the structural and enzymatic functions initially served by RNA were assumed by proteins, leading to the latter's domination of biological catalysis. This progression can still be seen in modern biology, where ribozymes, such as the ribosome and RNase P, have evolved into protein- dependent RNA catalysts ('RNPzymes'). Similarly, group I introns use RNA- catalysed splicing reactions, but many function as RNPzymes bound to proteins that stabilize their catalytically active RNA structure(1,2). One such protein, the Neurospora crassa mitochondrial tyrosyl- tRNA synthetase ( TyrRS; CYT- 18), is bifunctional and both aminoacylates mitochondrial tRNA(Tyr) and promotes the splicing of mitochondrial group I introns(3). Here we determine a 4.5-angstrom co-crystal structure of the Twort orf142-I2 group I intron ribozyme bound to splicing-active, carboxy- terminally truncated CYT- 18. The structure shows that the group I intron binds across the two subunits of the homodimeric protein with a newly evolved RNA- binding surface distinct from that which binds tRNA(Tyr). This RNA binding surface provides an extended scaffold for the phosphodiester backbone of the conserved catalytic core of the intron RNA, allowing the protein to promote the splicing of a wide variety of group I introns. The group I intron- binding surface includes three small insertions and additional structural adaptations relative to non- splicing bacterial TyrRSs, indicating a multistep adaptation for splicing function. The co- crystal structure provides insight into how CYT- 18 promotes group I intron splicing, how it evolved to have this function, and how proteins could have incrementally replaced RNA structures during the transition from an RNA world to an RNP world.	[Paukstelis, Paul J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA; [Paukstelis, Paul J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Chen, Jui-Hui; Chase, Elaine; Golden, Barbara L.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lambowitz, AM (corresponding author), Univ Texas Austin, Sch Biol Sci, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	lambowitz@mail.utexas.edu; barbgolden@purdue.edu	Paukstelis, Paul/D-6320-2011; Paukstelis, Paul/C-9599-2009	Golden, Barbara/0000-0002-9741-882X				Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caprara MG, 1996, J MOL BIOL, V257, P512, DOI 10.1006/jmbi.1996.0182; Caprara MG, 1996, CELL, V87, P1135, DOI 10.1016/S0092-8674(00)81807-3; Caprara MG, 2001, J MOL BIOL, V308, P165, DOI 10.1006/jmbi.2001.4581; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen X, 2000, J MOL BIOL, V301, P265, DOI 10.1006/jmbi.2000.3963; Chen X, 2004, RNA, V10, P634, DOI 10.1261/rna.5212604; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; GUO QB, 1992, GENE DEV, V6, P1357, DOI 10.1101/gad.6.8.1357; KAMPER U, 1992, MOL CELL BIOL, V12, P499; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOHR G, 1992, CELL, V69, P483, DOI 10.1016/0092-8674(92)90449-M; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr G, 2001, J MOL BIOL, V307, P75, DOI 10.1006/jmbi.2000.4460; Myers CA, 1996, J MOL BIOL, V262, P87, DOI 10.1006/jmbi.1996.0501; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldsich C, 2002, GENE DEV, V16, P2300, DOI 10.1101/gad.231302; Webb AE, 2001, J MOL BIOL, V309, P1087, DOI 10.1006/jmbi.2001.4714; Weeks KM, 1996, SCIENCE, V271, P345, DOI 10.1126/science.271.5247.345; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	34	66	71	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					94	U15		10.1038/nature06413	http://dx.doi.org/10.1038/nature06413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172503				2022-12-24	WOS:000252079300041
J	Grant, GB; Fridkin, S; Chang, DC; Park, BJ				Grant, Gavin B.; Fridkin, Scott; Chang, Douglas C.; Park, Benjamin J.			Postrecall surveillance following a multistate Fusarium keratitis outbreak, 2004 through 2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SINGAPORE		CDCP, Epidem Intelligence Serv, Office Workforce & Career Dev, Atlanta, GA USA; CDCP, Coordinating Ctr Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Div Bacterial Foodborne & Mycot Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grant, GB (corresponding author), CDCP, Epidem Intelligence Serv, Office Workforce & Career Dev, Atlanta, GA USA.	gbgrant@cdc.gov		Grant, Gavin/0000-0002-3271-5735				Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Donnio A, 2007, AM J OPHTHALMOL, V143, P356, DOI 10.1016/j.ajo.2006.09.021; Khor WB, 2006, JAMA-J AM MED ASSOC, V295, P2867, DOI 10.1001/jama.295.24.2867; Saw SM, 2007, ARCH OPHTHALMOL-CHIC, V125, P611, DOI 10.1001/archopht.125.5.611; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114	5	17	17	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2007	298	24					2867	2868		10.1001/jama.298.24.2867	http://dx.doi.org/10.1001/jama.298.24.2867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243RW	18159055	Bronze			2022-12-24	WOS:000251816000018
J	Nishtar, S				Nishtar, Sania			Time for a global partnership on non-communicable diseases	LANCET			English	Editorial Material									Heartfile, Islamabad 44000, Pakistan		Nishtar, S (corresponding author), Heartfile, Islamabad 44000, Pakistan.	sania@heartfile.org						Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2005, PREV CHRON DIS VIT I; Buse K., 2004, BROWN J WORLD AFFAIR, VX, P225; *GLOB PREV ALL, 2006, GLOB PREV ALL B; Nishtar Sania, 2004, Health Res Policy Syst, V2, P5, DOI 10.1186/1478-4505-2-5; Widdus R, 2003, B WORLD HEALTH ORGAN, V81, P235	6	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1887	1888		10.1016/S0140-6736(07)61791-7	http://dx.doi.org/10.1016/S0140-6736(07)61791-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239KQ	18068498				2022-12-24	WOS:000251517600008
J	Bibbins-Domingo, K; Coxson, P; Pletcher, MJ; Lightwood, J; Goldman, L				Bibbins-Domingo, Kirsten; Coxson, Pamela; Pletcher, Mark J.; Lightwood, James; Goldman, Lee			Adolescent overweight and future adult coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; RISK-FACTORS; MYOCARDIAL-INFARCTION; US ADULTS; PROSPECTIVE COHORT; PREDICTIVE-VALUE; OBESE CHILDREN; SECULAR TRENDS; CARDIAC-ARREST; MORTALITY	Background: The effect of adolescent overweight on future adult coronary heart disease (CHD) is not known. Methods: We estimated the prevalence of obese 35-year-olds in 2020 on the basis of adolescent overweight in 2000 and historical trends regarding overweight adolescents who become obese adults. We then used the CHD Policy Model, a state-transition computer simulation of U.S. residents who are 35 years of age or older, to project the annual excess incidence and prevalence of CHD, the total number of excess CHD events, and excess deaths from both CHD and other causes attributable to obesity from 2020 to 2035. We also modeled the effect of treating obesity-related increases in blood pressure and dyslipidemia. Results: Adolescent overweight is projected to increase the prevalence of obese 35-year-olds in 2020 to a range of 30 to 37% in men and 34 to 44% in women. As a consequence of this increased obesity, an increase in the incidence of CHD and in the total number of CHD events and deaths is projected to occur in young adulthood. The increase is projected to continue in both absolute and relative terms as the population reaches middle age. By 2035, it is estimated that the prevalence of CHD will increase by a range of 5 to 16%, with more than 100,000 excess cases of CHD attributable to the increased obesity. Aggressive treatment with currently available therapies to reverse modifiable obesity-related risk factors would reduce, but not eliminate, the projected increase in the number of CHD events. Conclusions: Although projections 25 or more years into the future are subject to innumerable uncertainties, extrapolation from current data suggests that adolescent overweight will increase rates of CHD among future young and middle-aged adults, resulting in substantial morbidity and mortality.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharm, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu						Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; *CA OFF STAT HLTH, 2000, CAL PAT DISCH DAT; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; *DEP HLTH HUM SERV, 2005, FRAM HEART STUD CD R; Dietz WH, 1998, PEDIATRICS, V101, P518; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Gregg EW, 2005, JAMA-J AM MED ASSOC, V294, P182; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Groeneveld PW, 2003, CIRCULATION, V108, P286, DOI 10.1161/01.CIR.0000079164.95019.5A; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; KUCZ, 2002, VITAL HLTH STAT 11, V246; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; MALLORY GB, 1989, J PEDIATR-US, V115, P892, DOI 10.1016/S0022-3476(89)80738-3; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Must Aviva, 2003, Nutr Clin Care, V6, P4; *NAT CTR HLTH STAT, 2000, NAT HLTH INT SURV DA; *NAT CTR HLTH STAT, 2003, PREV OV CHILDR AD; *NAT CTR HLTH STAT, DEATHS 358 SEL CAUS; National Center for Health Statistics, NAT HOSP DISCH SURV; National Center for Health Statistics, 2004, ICD10 COD; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Packer M, 1999, AM J CARDIOL, V83, p1A; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; PEDERSEN TR, 1994, LANCET, V344, P1383; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rea TD, 2003, CIRCULATION, V108, P1196, DOI 10.1161/01.CIR.0000087403.24467.A4; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; United States Census Bureau, 2004, US INT PROJ AG SEX R; *US BUR CENS, 2000, US CENS SUMM FIL 1; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilsgaard T, 2004, ANN EPIDEMIOL, V14, P265, DOI 10.1016/j.annepidem.2003.08.004; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	47	344	369	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2371	2379		10.1056/NEJMsa073166	http://dx.doi.org/10.1056/NEJMsa073166			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057339				2022-12-24	WOS:000251389200007
J	Jaffe, HW; Valdiserri, RO; De Cock, KM				Jaffe, Harold W.; Valdiserri, Ronald O.; De Cock, Kevin M.			The reemerging HIV/AIDS epidemic in men who have sex with men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; HIV-INFECTION; RISK BEHAVIORS; INTERVENTIONS; PREVENTION; RECOMMENDATIONS; TRENDS		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; US Dept Vet Affairs, Off Publ Hlth & Environm Hazards, Washington, DC USA; WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland	University of Oxford; US Department of Veterans Affairs; World Health Organization	Jaffe, HW (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						[Anonymous], 1981, MORBIDITY MORTALITY, V30, P250; BEZEMER D, 2007, 14 C RETR OPP INF FE; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; European Centre for the Epidemiological Monitoring of AIDS, HIV AIDS SURV EUR EN; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Herbst JH, 2007, AM J PREV MED, V32, pS36, DOI 10.1016/j.amepre.2006.12.005; Huebner DM, 2002, AM J COMMUN PSYCHOL, V30, P327, DOI 10.1023/A:1015325303002; Klausner JD, 2006, J HOMOSEXUAL, V51, P137, DOI 10.1300/J082v51n04_07; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; *NAT CTR HIV EP CL, 2006, HIV AIDS VIR HEP SEX; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Osmond DH, 2007, AM J PUBLIC HEALTH, V97, P1677, DOI 10.2105/AJPH.2005.062851; *PUBL HLTH AG CAN, 2006, HIV AIDS CAN SURV RE; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; *US DHHS, 2005, CAS HIV INF AIDS US; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868	23	121	123	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2007	298	20					2412	2414		10.1001/jama.298.20.2412	http://dx.doi.org/10.1001/jama.298.20.2412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234KR	18042919				2022-12-24	WOS:000251163400023
J	Dodds, DR; Gross, RA				Dodds, David R.; Gross, Richard A.			Chemicals from biomass	SCIENCE			English	Editorial Material									Dodds & Associates LLC, Manlius, NY 13104 USA; Polytech Univ, NSF Ctr Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA	National Science Foundation (NSF); New York University; Polytechnic University Puerto Rico	Dodds, DR (corresponding author), Dodds & Associates LLC, Manlius, NY 13104 USA.	rgross@poly.edu						Carlson TL, 2006, U.S. Patent application, Patent No. [US2006/094093 A1, 2006094093]; Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50; Donnelly M, 1998, U.S. Patent, Patent No. 5770435; EMPTAGE M, 2005, Patent No. 1586647A1; Frost JW, 1996, United States Patent, Patent No. [5,487,987, 5487987]; FROST JW, 1997, Patent No. 5629181; Guettler M. V., 1996, US patent, Patent No. 5504004; Kumar A, 2003, MACROMOLECULES, V36, P8219, DOI 10.1021/ma0351827; Lee IY, 1998, ENZYME MICROB TECH, V23, P261, DOI 10.1016/S0141-0229(98)00044-1; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; LIPINSKY ES, 1981, SCIENCE, V212, P1465, DOI 10.1126/science.212.4502.1465; Lorenz P, 2005, TRENDS BIOTECHNOL, V23, P570, DOI 10.1016/j.tibtech.2005.10.003; Mccoy M, 2007, CHEM ENG NEWS, V85, P12, DOI 10.1021/cen-v085n012.p012; Petersen G., TOP VALUE ADDED CHEM, VI; Ritter SK, 2007, CHEM ENG NEWS, V85, P35, DOI 10.1021/cen-v085n028.p035; Tullo A, 2007, CHEM ENG NEWS, V85, P14, DOI 10.1021/cen-v085n019.p014a; [No title captured]	17	339	356	10	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1250	1251		10.1126/science.1146356	http://dx.doi.org/10.1126/science.1146356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033870				2022-12-24	WOS:000251086600027
J	Foote, M; Crampton, JS; Beu, AG; Marshall, BA; Cooper, RA; Maxwell, PA; Matcham, I				Foote, Michael; Crampton, James S.; Beu, Alan G.; Marshall, Bruce A.; Cooper, Roger A.; Maxwell, Phillip A.; Matcham, Iain			Rise and fall of species occupancy in Cenozoic fossil mollusks	SCIENCE			English	Article							COMMUNITIES; MACROEVOLUTIONARY; PALEOBIOLOGY; ABUNDANCE; PATTERNS; QUALITY; RECORD	In the time between speciation and extinction, a species' ecological and biogeographic footprint-its occupancy-will vary in response to macroecological drivers and historical contingencies. Despite their importance for understanding macroecological processes, general patterns of long-term species occupancy remain largely unknown. We documented the occupancy histories of Cenozoic marine mollusks from New Zealand. For both genera and species, these show a distinct pattern of increase to relatively short-lived peak occupancy at mid-duration, followed by a decline toward extinction. Thus, species at greatest risk for extinction are those that have already been in decline for a substantial period of time. This pattern of protracted rise and fall stands in contrast to that of incumbency, insofar as species show no general tendency to stay near maximal occupancy once established.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; GNS Sci, Lower Hutt, New Zealand; Museum New Zealand Ta Papa Tongarewa, Wellington, New Zealand	University of Chicago; GNS Science - New Zealand	Foote, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	mfoote@uchicago.edu	Crampton, James/G-1381-2012	Crampton, James/0000-0003-3270-9981				Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Cooper R. A., 2004, I GEOLOGICAL NUCL SC, P1; Crampton JS, 2006, PALEOBIOLOGY, V32, P509, DOI 10.1666/06014.1; Crampton JS, 2006, PALAIOS, V21, P86, DOI 10.2110/palo.2004.p04-90; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Foote M, 2007, PALEOBIOLOGY, V33, P517, DOI 10.1666/06084.1; Frost MT, 2004, ECOGRAPHY, V27, P643; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Holland SM, 2000, PALEOBIOLOGY, V26, P148, DOI 10.1666/0094-8373(2000)26[148:TQOTFR]2.0.CO;2; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; JABLONSKI D, 1980, PALEOBIOLOGY, V6, P397, DOI 10.1017/S0094837300003584; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; Jablonski D, 2000, PALEOBIOLOGY, V26, P15, DOI 10.1666/0094-8373(2000)26[15:MAMSAH]2.0.CO;2; Jackson JBC, 2000, PALEOBIOLOGY, V26, P221, DOI 10.1666/0094-8373(2000)26[221:LITLFM]2.0.CO;2; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jernvall J, 2004, AM NAT, V164, P614, DOI 10.1086/424967; Kiessling W, 2007, J BIOGEOGR, V34, P1473, DOI 10.1111/j.1365-2699.2007.01709.x; Liow LH, 2007, P R SOC B, V274, P2745, DOI 10.1098/rspb.2007.1006; MANN KO, 1995, SOC EC PALEONTOL MIN, V53; McPeek MA, 2007, PALAEONTOLOGY, V50, P111, DOI 10.1111/j.1475-4983.2006.00616.x; Miller AI, 1997, PALEOBIOLOGY, V23, P410, DOI 10.1017/S0094837300019813; Mora C, 2005, ECOLOGY, V86, P1771, DOI 10.1890/04-0883; Raia P, 2006, EVOL ECOL RES, V8, P181; ROSENZWEIG ML, 1991, PALEOBIOLOGY, V17, P202, DOI 10.1017/S0094837300010563	26	117	117	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1131	1134		10.1126/science.1146303	http://dx.doi.org/10.1126/science.1146303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006744				2022-12-24	WOS:000250957900044
J	Varfolomeev, E; Blankenship, JW; Wayson, SM; Fedorova, AV; Kayagaki, N; Garg, P; Zobel, K; Dynek, JN; Elliott, LO; Wallweber, HJA; Flygare, JA; Fairbrother, WJ; Deshayes, K; Dixit, VM; Vucic, D				Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj			IAP antagonists induce autoubiquitination of c-IAPs, NF-kappa B activation, and TNF alpha-dependent apoptosis	CELL			English	Article							CASPASE ACTIVATION; STRUCTURAL BASIS; ML-IAP; PROTEIN; SMAC; INHIBITOR; POTENT; UBIQUITINATION; BINDING; C-IAP1	Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappa B signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappa B pathway.	Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Med Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	dixit@gene.com; domagoj@gene.com	dixit, vishva m/A-4496-2012; 高, 雨莉/HGU-8187-2022	dixit, vishva m/0000-0001-6983-0326; Blankenship, John/0000-0003-4192-7059				Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gan XQ, 2000, J BIOL CHEM, V275, P8469, DOI 10.1074/jbc.275.12.8469; GAO Z, 2007, IN PRESS J BIOL CHEM; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HOFMANN K, 2007, APOPTOSIS, V12, P1543; Johnston M D, 1981, Methods Enzymol, V78, P394; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sharma SK, 2006, INT J PEPT RES THER, V12, P21, DOI 10.1007/s10989-005-9003-2; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun HY, 2004, J AM CHEM SOC, V126, P16686, DOI 10.1021/ja047438+; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2000, CURR BIOL, V10, P1359, DOI 10.1016/S0960-9822(00)00781-8; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Vucic D, 2002, J BIOL CHEM, V277, P12275, DOI 10.1074/jbc.M112045200; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	50	972	1005	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					669	681		10.1016/j.cell.2007.10.030	http://dx.doi.org/10.1016/j.cell.2007.10.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022362	Bronze			2022-12-24	WOS:000250966300015
J	Alabi, AA; Bahamonde, MI; Jung, HJ; Kim, JI; Swartz, KJ				Alabi, AbdulRasheed A.; Bahamonde, Maria Isabel; Jung, Hoi Jong; Kim, Jae Il; Swartz, Kenton J.			Portability of paddle motif function and pharmacology in voltage sensors	NATURE			English	Article							DEPENDENT K+ CHANNEL; GATED ION CHANNELS; POTASSIUM CHANNEL; GATING-CHARGE; TOXIN RECEPTOR; LIPID-MEMBRANE; KVAP; HANATOXIN; MODIFIER; INHIBITOR	Voltage-sensing domains enable membrane proteins to sense and react to changes in membrane voltage. Although identifiable S1-S4 voltage-sensing domains are found in an array of conventional ion channels and in other membrane proteins that lack pore domains, the extent to which their voltage-sensing mechanisms are conserved is unknown. Here we show that the voltage-sensor paddle, a motif composed of S3b and S4 helices, can drive channel opening with membrane depolarization when transplanted from an archaebacterial voltage-activated potassium channel (KvAP) or voltage-sensing domain proteins (Hv1 and Ci-VSP) into eukaryotic voltage-activated potassium channels. Tarantula toxins that partition into membranes can interact with these paddle motifs at the protein-lipid interface and similarly perturb voltage-sensor activation in both ion channels and proteins with a voltage-sensing domain. Our results show that paddle motifs are modular, that their functions are conserved in voltage sensors, and that they move in the relatively unconstrained environment of the lipid membrane. The widespread targeting of voltage-sensor paddles by toxins demonstrates that this modular structural motif is an important pharmacological target.	NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Gwangju Institute of Science & Technology (GIST)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945, Z01NS003017] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LAMPE RA, 1993, MOL PHARMACOL, V44, P451; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2004, BIOCHEMISTRY-US, V43, P10071, DOI 10.1021/bi049463y; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396	49	180	185	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					370	+		10.1038/nature06266	http://dx.doi.org/10.1038/nature06266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004375	Green Accepted			2022-12-24	WOS:000250918600044
J	Kumar, A; Godwin, JW; Gates, PB; Garza-Garcia, AA; Brockes, JP				Kumar, Anoop; Godwin, James W.; Gates, Phillip B.; Garza-Garcia, A. Acely; Brockes, Jeremy P.			Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate	SCIENCE			English	Article							ESTROGEN-RECEPTOR; PATTERN-FORMATION; NEWT; BLASTEMA; GROWTH; AMPUTATION; FORELIMBS; IDENTITY; CLONING; HAG-2	The limb blastemal cells of an adult salamander regenerate the structures distal to the level of amputation, and the surface protein Prod 1 is a critical determinant of their proximodistal identity. The anterior gradient protein family member nAG is a secreted ligand for Prod 1 and a growth factor for cultured newt blastemal cells. nAG is sequentially expressed after amputation in the regenerating nerve and the wound epidermis-the key tissues of the stem cell niche-and its expression in both locations is abrogated by denervation. The local expression of nAG after electroporation is sufficient to rescue a denervated blastema and regenerate the distal structures. Our analysis brings together the positional identity of the blastema and the classical nerve dependence of limb regeneration.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Brockes, JP (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	j.brockes@ucl.ac.uk		Garza-Garcia, Acely/0000-0003-0307-0138; Brockes, Jeremy/0000-0002-3395-5159; Godwin, James/0000-0002-9234-7807	MRC [G0600229, G9537983] Funding Source: UKRI; Medical Research Council [MC_U117574559, G0600229(77696), G9537983, G9537983(56733), G0600229] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; BROCKES JP, 1984, SCIENCE, V225, P1280, DOI 10.1126/science.6474177; BROCKES JP, 1986, CELL, V45, P301, DOI 10.1016/0092-8674(86)90394-6; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Carlson B. M., 2007, PRINCIPLES REGENERAT; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DRACHMAN DB, 1971, EXP NEUROL, V32, P1, DOI 10.1016/0014-4886(71)90159-2; Echeverri K, 2005, DEV BIOL, V279, P391, DOI 10.1016/j.ydbio.2004.12.029; EGAR MW, 1988, ANAT REC, V221, P550, DOI 10.1002/ar.1092210111; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; GLOBUS M, 1991, ANN NY ACAD SCI, V632, P396, DOI 10.1111/j.1749-6632.1991.tb33135.x; Goss RJ., 1969, PRINCIPLES REGENERAT; ITEN LE, 1973, ROUX ARCH DEV BIOL, V173, P263, DOI 10.1007/BF00575834; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; LEMKE G, 2006, SCI STKE, pPE11; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MESCHER AL, 1976, J EXP ZOOL, V195, P117, DOI 10.1002/jez.1401950111; Mescher AL, 1997, DEV GROWTH DIFFER, V39, P677; Mullen LM, 1996, DEVELOPMENT, V122, P3487; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; PARSON A, 2007, J LIFE SCI       SEP, P60; Pecorino LT, 1996, CURR BIOL, V6, P563, DOI 10.1016/S0960-9822(02)00542-0; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Rosel M, 1998, ONCOGENE, V17, P1989, DOI 10.1038/sj.onc.1202079; SALLEY JD, 1981, J EXP ZOOL, V215, P183, DOI 10.1002/jez.1402150208; Sidman R. L., 1951, American Journal of Physiology, V165, P257; SINGER M, 1967, J EXP ZOOL, V166, P89, DOI 10.1002/jez.1401660110; SINGER M, 1948, J EXP ZOOL, V108, P279, DOI 10.1002/jez.1401080207; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; STOCUM DL, 2001, CURR TOP MICROBIOL I, V280, P1; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; THOMS SD, 1984, DEV BIOL, V103, P319, DOI 10.1016/0012-1606(84)90320-8; THORNTON CS, 1970, J EXP ZOOL, V173, P293, DOI 10.1002/jez.1401730308; Wang LS, 2000, J NEUROBIOL, V43, P150, DOI 10.1002/(SICI)1097-4695(200005)43:2<150::AID-NEU5>3.0.CO;2-G; YNTEMA CL, 1959, J EXP ZOOL, V142, P423, DOI 10.1002/jez.1401420119	40	357	370	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					772	777		10.1126/science.1147710	http://dx.doi.org/10.1126/science.1147710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975060	Green Accepted			2022-12-24	WOS:000250583900034
J	Smith, J; Theodoris, C; Davidson, EH				Smith, Joel; Theodoris, Christina; Davidson, Eric H.			A gene regulatory network subcircuit drives a dynamic pattern of gene expression	SCIENCE			English	Article							SEA-URCHIN EMBRYO; NUCLEAR BETA-CATENIN; STRONGYLOCENTROTUS-PURPURATUS; ENDOMESODERM NETWORK; APPEARANCE; RATES; WNT	Early specification of endomesodermal territories in the sea urchin embryo depends on a moving torus of regulatory gene expression. We show how this dynamic patterning function is encoded in a gene regulatory network (GRN) subcircuit that includes the otx, wnt8, and blimp1 genes, the cis-regulatory control systems of which have all been experimentally defined. A cis-regulatory reconstruction experiment revealed that blimp1 autorepression accounts for progressive extinction of expression in the center of the torus, whereas its outward expansion follows reception of the Wnt8 ligand by adjacent cells. GRN circuitry thus controls not only static spatial assignment in development but also dynamic regulatory patterning.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.	davidson@caltech.edu	Theodoris, Christina/N-4403-2016	Theodoris, Christina/0000-0003-1658-1447; Smith, Joel/0000-0003-0311-7055	EPSRC [EP/D073626/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-37105] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; CABRERA CV, 1984, J MOL BIOL, V174, P85, DOI 10.1016/0022-2836(84)90366-8; Chuang CK, 1996, DEV GENET, V19, P231, DOI 10.1002/(SICI)1520-6408(1996)19:3<231::AID-DVG6>3.0.CO;2-A; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Davidson E. H, 1987, GENE ACTIVITY EARLY; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; LIVANT DL, 1991, DEVELOPMENT, V113, P385; Livi CB, 2006, DEV BIOL, V293, P513, DOI 10.1016/j.ydbio.2006.02.021; Logan CY, 1999, DEVELOPMENT, V126, P345; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Range RC, 2005, DEV BIOL, V279, P252, DOI 10.1016/j.ydbio.2004.12.023; SICK S, 2006, SCIENCE         1102; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; [No title captured]	18	102	104	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					794	797		10.1126/science.1146524	http://dx.doi.org/10.1126/science.1146524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975065				2022-12-24	WOS:000250583900040
J	Gazin, C; Wajapeyee, N; Gobeil, S; Virbasius, CM; Green, MR				Gazin, Claude; Wajapeyee, Narendra; Gobeil, Stephane; Virbasius, Ching-Man; Green, Michael R.			An elaborate pathway required for Ras-mediated epigenetic silencing	NATURE			English	Article							DNA HYPERMETHYLATION; ONCOGENIC RAS; METHYLATION; EXPRESSION; MECHANISM; APOPTOSIS; PROMOTER; GENES; FAS	The conversion of a normal cell to a cancer cell occurs in several steps and typically involves the activation of oncogenes and the inactivation of tumour suppressor and pro-apoptotic genes(1). In many instances, inactivation of genes critical for cancer development occurs by epigenetic silencing, often involving hypermethylation of CpG-rich promoter regions(2,3). It remains to be determined whether silencing occurs by random acquisition of epigenetic marks that confer a selective growth advantage or through a specific pathway initiated by an oncogene(4-6). Here we perform a genome-wide RNA interference (RNAi) screen in K-ras-transformed NIH 3T3 cells and identify 28 genes required for Ras-mediated epigenetic silencing of the pro-apoptotic Fas gene. At least nine of these RESEs (Ras epigenetic silencing effectors), including the DNA methyltransferase DNMT1, are directly associated with specific regions of the Fas promoter in K-ras-transformed NIH 3T3 cells but not in untransformed NIH3T3 cells. RNAi-mediated knockdown of any of the 28 RESEs results in failure to recruit DNMT1 to the Fas promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression. Analysis of five other epigenetically repressed genes indicates that Ras directs the silencing of multiple unrelated genes through a largely common pathway. Last, we show that nine RESEs are required for anchorage-independent growth and tumorigenicity of K-ras-transformed NIH 3T3 cells; these nine genes have not previously been implicated in transformation by Ras. Our results show that Ras-mediated epigenetic silencing occurs through a specific, complex, pathway involving components that are required for maintenance of a fully transformed phenotype.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, 364 Plantat St, Worcester, MA 01605 USA.	michael.green@umassmed.edu	Wajapeyee, Narendra/F-3011-2012		Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM033977-23, R01 GM033977] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Alfonso P, 2006, PROTEOMICS, V6, pS262, DOI 10.1002/pmic.200500350; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; Ehmann F, 2006, LEUKEMIA LYMPHOMA, V47, P1387, DOI 10.1080/10428190600565925; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Fenton RG, 1998, CANCER RES, V58, P3391; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jones PA, 1996, CANCER RES, V56, P2463; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranganathan P, 2005, ANN NY ACAD SCI, V1059, P76, DOI 10.1196/annals.1339.046; Rubin JS, 2006, FRONT BIOSCI, V11, P2093, DOI 10.2741/1952; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	25	218	228	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1073	U10		10.1038/nature06251	http://dx.doi.org/10.1038/nature06251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960246	Green Accepted			2022-12-24	WOS:000250395000057
J	McNamara, JM; Barta, Z; Fromhage, L; Houston, AI				McNamara, John M.; Barta, Zoltan; Fromhage, Lutz; Houston, Alasdair I.			The coevolution of choosiness and cooperation	NATURE			English	Article							PRISONERS-DILEMMA; EVOLUTION; DIVORCE; RECIPROCITY; CONFLICT; ALTRUISM; BEHAVIOR; MODELS; PARENT	Explaining the rise and maintenance of cooperation is central to our understanding of biological systems(1,2) and human societies(3,4). When an individual's cooperativeness is used by other individuals as a choice criterion, there can be competition to be more generous than others, a situation called competitive altruism(5). The evolution of cooperation between non- relatives can then be driven by a positive feedback between increasing levels of cooperativeness and choosiness(6). Here we use evolutionary simulations to show that, in a situation where individuals have the opportunity to engage in repeated pairwise interactions, the equilibrium degree of cooperativeness depends critically on the amount of behavioural variation that is being maintained in the population by processes such as mutation. Because our model does not invoke complex mechanisms such as negotiation behaviour, it can be applied to a wide range of species. The results suggest an important role of lifespan in the evolution of cooperation.	[Fromhage, Lutz; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [McNamara, John M.] Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England; [Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, H-4010 Debrecen, Hungary	University of Bristol; University of Bristol; University of Debrecen	Fromhage, L (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	lutzfromhage@web.de	Fromhage, Lutz/B-2936-2009	Fromhage, Lutz/0000-0001-5560-6673; Barta, Zoltan/0000-0002-7121-9865				Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Brown M, 2004, ECONOMETRICA, V72, P747, DOI 10.1111/j.1468-0262.2004.00511.x; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; ENS BJ, 1993, ANIM BEHAV, V45, P1199, DOI 10.1006/anbe.1993.1142; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Hamilton IM, 2005, P ROY SOC B-BIOL SCI, V272, P2259, DOI 10.1098/rspb.2005.3248; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Houston A.I., 1985, P471; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; Killingback T, 2002, AM NAT, V160, P421, DOI 10.1086/342070; Maynard Smith J., 1982, pi; McNamara JM, 1996, AM NAT, V147, P609, DOI 10.1086/285869; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; McNamara JM, 2003, BEHAV ECOL, V14, P301, DOI 10.1093/beheco/14.3.301; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 1999, PHILOS T R SOC B, V354, P223, DOI 10.1098/rstb.1999.0374; Moody AT, 2005, BEHAV ECOL SOCIOBIOL, V57, P224, DOI 10.1007/s00265-004-0856-8; PARKER GA, 1985, ANIM BEHAV, V33, P519, DOI 10.1016/S0003-3472(85)80075-0; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sherratt TN, 1998, J THEOR BIOL, V193, P167, DOI 10.1006/jtbi.1998.0703; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Triefenbach F, 1998, ANIM BEHAV, V55, P1263, DOI 10.1006/anbe.1997.0690; Trivers R. L., 1985, SOCIAL EVOLUTION; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	30	158	161	2	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					189	192		10.1038/nature06455	http://dx.doi.org/10.1038/nature06455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185587				2022-12-24	WOS:000252214400042
J	Morens, DM; Fauci, AS				Morens, David M.; Fauci, Anthony S.			Dengue and hemorrhagic fever - A potential threat to public health in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SHOCK SYNDROME; PUERTO-RICO; INFECTION; TYPE-2; THAILAND; DISEASE; RISK		[Morens, David M.; Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, NIH, Bldg 31,Room 7A-03, Bethesda, MD 20892 USA.	dmorens@niaid.nih.gov						Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; Ayala A., 2006, Morbidity and Mortality Weekly Report, V55, P700; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bock G., 2006, NEW TREATMENT STRATE; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; HALSTEAD SB, 1978, ASIAN J INFECTIOUS D, V2, P85; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; MORENS DM, 1991, AM J TROP MED HYG, V45, P644, DOI 10.4269/ajtmh.1991.45.644; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; MORENS DM, 1986, AM J TROP MED HYG, V35, P197, DOI 10.4269/ajtmh.1986.35.197; MORENS DM, 1987, AM J TROP MED HYG, V36, P424, DOI 10.4269/ajtmh.1987.36.424; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P392; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rigau-Perez JG, 2006, CLIN INFECT DIS, V42, P1241, DOI 10.1086/501355; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; TABACHNICK W J, 1991, American Entomologist, V37, P14; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; *WHO, 1999, WHO REG PUBL, V29	22	124	131	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2008	299	2					214	216		10.1001/jama.2007.31-a	http://dx.doi.org/10.1001/jama.2007.31-a			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UN	18182605				2022-12-24	WOS:000252182600023
J	Moore, EE; Knudson, MM; Schwab, CW; Trunkey, DD; Johannigman, JA; Holcomb, JB				Moore, Ernest E.; Knudson, M. Margaret; Schwab, C. William; Trunkey, Donald D.; Johannigman, Jay A.; Holcomb, John B.			Military-civilian collaboration in trauma care and the senior visiting surgeon program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPERATION IRAQI FREEDOM; RECOMBINANT-FACTOR-VIIA; COMBAT CASUALTY CARE; US ARMY; UNITED-STATES; EXPERIENCE; TERRORISM; CENTERS; INJURY; THROMBOEMBOLISM		Univ Colorado, Denver Hlth Med Ctr, Dept Surg, Denver, CO 80202 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA; Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; Oregon Hlth & Sci Univ, Dept Surg, Portland, OR USA; Univ Penn, Med Ctr, Dept Surg, Philadelphia, PA 19104 USA; Brooke Army Med Ctr, USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA	Denver Health Medical Center; University of Colorado System; University of Colorado Denver; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; Oregon Health & Science University; University of Pennsylvania; San Antonio Military Medical Center; United States Department of Defense; United States Army	Moore, EE (corresponding author), Univ Colorado, Denver Hlth Med Ctr, Dept Surg, Denver, CO 80202 USA.			holcomb, john/0000-0001-8312-9157				Aharonson-Daniel L, 2006, ANN SURG, V244, P1018, DOI 10.1097/01.sla.0000225355.06362.0f; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Bruce Sandra, 2003, Crit Care Nurs Clin North Am, V15, P149, DOI 10.1016/S0899-5885(02)00080-1; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Champion HR, 2006, J AM COLL SURGEONS, V203, P951, DOI 10.1016/j.jamcollsurg.2006.08.019; Chung KK, 2006, J BURN CARE RES, V27, P606, DOI 10.1097/01.BCR.0000235466.57137.f2; CHUNG KK, IN PRESS J TRAUMA; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Crommett John W, 2002, Respir Care Clin N Am, V8, P105, DOI 10.1016/S1078-5337(02)00019-9; DeBakey ME, 1996, MIL MED, V161, P711, DOI 10.1093/milmed/161.12.711; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; *GEN ACC OFF, 1998, PUBL GAO; Griffith ME, 2007, INFECT CONT HOSP EP, V28, P720, DOI 10.1086/518966; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holcomb JB, 2005, J TRAUMA, V59, P990, DOI 10.1097/01.ta.0000188010.65920.26; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Kapur GB, 2005, J TRAUMA, V59, P1436, DOI 10.1097/01.ta.0000197853.49084.3c; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Knuth TE, 1998, MIL MED, V163, P608, DOI 10.1093/milmed/163.9.608; Knuth TE, 1996, MIL MED, V161, P137, DOI 10.1093/milmed/161.3.137; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; Mattox K, 2001, CRIT CARE, V5, P323, DOI 10.1186/cc1062; NISKA RW, 2005, ADV DATA, P3641; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; Perkins RM, 2007, CLIN J AM SOC NEPHRO, V2, P313, DOI 10.2215/CJN.03070906; Pruitt BA, 2006, ANN SURG, V243, P715, DOI 10.1097/01.sla.0000220038.66466.b5; Rasmussen TE, 2006, J TRAUMA, V61, P8, DOI 10.1097/01.ta.0000220668.84405.17; Sariego Jack, 2006, Disaster Manag Response, V4, P114, DOI 10.1016/j.dmr.2006.09.001; Schreiber MA, 2002, J SURG RES, V104, P8, DOI 10.1006/jsre.2002.6391; Schwab CW, 2007, J TRAUMA, V62, P1, DOI 10.1097/TA.0b013e31802f734a; Slater MS, 1997, ARCH SURG-CHICAGO, V132, P1059; TRUNKEY DD, 1992, J TRAUMA, V32, P526, DOI 10.1097/00005373-199204000-00018; TRUNKEY DD, IN PRESS ARCH SURG	38	43	44	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2007	357	26					2723	2727		10.1056/NEJMsr073207	http://dx.doi.org/10.1056/NEJMsr073207			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	245UO	18160694				2022-12-24	WOS:000251964500014
J	Howes, OD; Weinstein, S; Tabraham, P; Valmaggia, L; Broome, M; McGuire, P				Howes, Oliver D.; Weinstein, Sara; Tabraham, Paul; Valmaggia, Lucia; Broome, Matthew; McGuire, Philip			Slang and schizophrenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THOUGHT		[Howes, Oliver D.; Weinstein, Sara; Tabraham, Paul; Valmaggia, Lucia; Broome, Matthew; McGuire, Philip] Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Howes, OD (corresponding author), Inst Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	o.howes@iop.kcl.ac.uk	Valmaggia, Lucia R./O-1377-2019; Valmaggia, Lucia/E-9653-2012; Howes, Oliver/E-7156-2010; Broome, Matthew Richard/AAA-2265-2020	Valmaggia, Lucia R./0000-0001-6099-8464; Valmaggia, Lucia/0000-0001-6099-8464; Howes, Oliver/0000-0002-2928-1972; Broome, Matthew Richard/0000-0002-6963-8884; McGuire, Philip/0000-0003-4381-0532	Medical Research Council [MC_U120097115] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Haroun N, 2006, SCHIZOPHRENIA BULL, V32, P166, DOI 10.1093/schbul/sbj007; Kuperberg GR, 2000, PSYCHOL MED, V30, P345, DOI 10.1017/S0033291700001744; Liddle PF, 2002, BRIT J PSYCHIAT, V181, P326, DOI 10.1192/bjp.181.4.326; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785	4	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2007	335	7633					1294	1294		10.1136/bmj.39419.647118.25	http://dx.doi.org/10.1136/bmj.39419.647118.25			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	248UO	18156234	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000252182700015
J	Korenkov, M; Sauerland, S				Korenkov, Michael; Sauerland, Stefan			Clinical update: bariatric surgery	LANCET			English	Article							WEIGHT-LOSS; MORTALITY; OBESITY		Johannes Gutenberg Univ Mainz, Dept Abdominal Surg, D-55101 Mainz, Germany; Univ Witten Herdecke, Inst Res Operat Med, Witten, Germany	Johannes Gutenberg University of Mainz; Witten Herdecke University	Korenkov, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Abdominal Surg, D-55101 Mainz, Germany.	korenkov@ach.klinik.uni-mainz.de		Sauerland, Stefan/0000-0003-1048-796X				Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Black DW, 2003, OBES SURG, V13, P746, DOI 10.1381/096089203322509327; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; De Luca M, 2004, OBES SURG, V14, pS33, DOI 10.1007/BF03342136; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Han SM, 2005, OBES SURG, V15, P1469; National Institutes of Health, 1991, OBES SURG, V1, P257, DOI DOI 10.1381/096089291765560962; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Puzziferri N, 2006, ANN SURG, V243, P181, DOI 10.1097/01.sla.0000197381.01214.76; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sauerland S, 2005, SURG ENDOSC, V19, P200, DOI 10.1007/s00464-004-9194-1; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Suter M, 2005, ANN SURG, V241, P55, DOI 10.1097/01.sla.0000150071.86934.36; Weiner Rudolph A, 2006, Surg Technol Int, V15, P63	20	24	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2007	370	9604					1988	1990		10.1016/S0140-6736(07)61844-3	http://dx.doi.org/10.1016/S0140-6736(07)61844-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242BD	18083389				2022-12-24	WOS:000251698600011
J	Horton, R				Horton, Richard			Chronic diseases: the case for urgent global action	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2005, PREV CHRON DIS VIT I; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2	2	42	43	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2007	370	9603					1881	1882		10.1016/S0140-6736(07)61701-2	http://dx.doi.org/10.1016/S0140-6736(07)61701-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18063030				2022-12-24	WOS:000251517600004
J	Kenealy, T; Elley, CR; Arroll, B				Kenealy, Tim; Elley, C. Raina; Arroll, Bruce			Screening for diabetes and prediabetes	LANCET			English	Editorial Material							GLUCOSE; ASSOCIATION; MORTALITY; CRITERIA		Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1142, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1142, New Zealand.	b.arroll@auckland.ac.nz		Kenealy, Timothy/0000-0001-6002-4766				Borch-Johnsen K, 1999, LANCET, V354, P617; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Genuth S, 2003, DIABETES CARE, V26, P3160; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; WAUGH N, 2007, HEALTH TECHNOL ASSES, P11	10	12	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 8	2007	370	9603					1888	1889		10.1016/S0140-6736(07)61792-9	http://dx.doi.org/10.1016/S0140-6736(07)61792-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239KQ	18068499				2022-12-24	WOS:000251517600009
J	Roell, W; Lewalter, T; Sasse, P; Tallini, YN; Choi, BR; Breitbach, M; Doran, R; Becher, UM; Hwang, SM; Bostani, T; von Maltzahn, J; Hofmann, A; Reining, S; Eiberger, B; Gabris, B; Pfeifer, A; Welz, A; Willecke, K; Salama, G; Schrickel, JW; Kotlikoff, MI; Fleischmann, BK				Roell, Wilhelm; Lewalter, Thorsten; Sasse, Philipp; Tallini, Yvonne N.; Choi, Bum-Rak; Breitbach, Martin; Doran, Robert; Becher, Ulrich M.; Hwang, Seong-Min; Bostani, Toktam; von Maltzahn, Julia; Hofmann, Andreas; Reining, Shaun; Eiberger, Britta; Gabris, Bethann; Pfeifer, Alexander; Welz, Armin; Willecke, Klaus; Salama, Guy; Schrickel, Jan W.; Kotlikoff, Michael I.; Fleischmann, Bernd K.			Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia	NATURE			English	Article							ISCHEMIC-HEART FAILURE; MYOCARDIAL-INFARCTION; STEM-CELLS; CELLULAR CARDIOMYOPLASTY; VENTRICULAR-TACHYCARDIA; IN-VIVO; CARDIOMYOCYTES; TRANSDIFFERENTIATE; ELECTROPHYSIOLOGY; TRANSPLANTATION	Ventricular tachyarrhythmias are the main cause of sudden death in patients after myocardial infarction. Here we show that transplantation of embryonic cardiomyocytes ( eCMs) in myocardial infarcts protects against the induction of ventricular tachycardia ( VT) in mice. Engraftment of eCMs, but not skeletal myoblasts ( SMs), bone marrow cells or cardiac myofibroblasts, markedly decreased the incidence of VT induced by in vivo pacing. eCM engraftment results in improved electrical coupling between the surrounding myocardium and the infarct region, and Ca2(+) signals from engrafted eCMs expressing a genetically encoded Ca2(+) indicator could be entrained during sinoatrial cardiac activation in vivo. eCM grafts also increased conduction velocity and decreased the incidence of conduction block within the infarct. VT protection is critically dependent on expression of the gap- junction protein connexin 43 ( Cx43; also known as Gja1): SMs genetically engineered to express Cx43 conferred a similar protection to that of eCMs against induced VT. Thus, engraftment of Cx43- expressing myocytes has the potential to reduce life- threatening post- infarct arrhythmias through the augmentation of intercellular coupling, suggesting autologous strategies for cardiac cell- based therapy.	Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; Univ Bonn, Dept Cardiac Surg, D-53105 Bonn, Germany; Univ Bonn, Dept Internal Med 2, D-53105 Bonn, Germany; Univ Bonn, Inst Genet, D-53105 Bonn, Germany; Univ Bonn, Inst Pharmacol, D-53105 Bonn, Germany; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; Rhode Isl Hosp, Cardiovasc Res Ctr, Providence, RI 02903 USA; Brown Med Sch, Providence, RI 02903 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University of Bonn; University of Bonn; University of Bonn; University of Bonn; University of Bonn; Cornell University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fleischmann, BK (corresponding author), Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany.	mik7@cornell.edu; bernd.fleischmann@uni-bonn.de	Salama, Guy/GWQ-9862-2022; Sasse, Philipp/G-9866-2013; von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017	Sasse, Philipp/0000-0002-8502-9472; von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Roell, Wilhelm/0000-0002-2213-5024; Hwang, Seong-min/0000-0003-1282-8828				ALLESSIE MA, 1989, EUR HEART J, V10, P2, DOI 10.1093/eurheartj/10.suppl_E.2; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Choi BR, 2000, J PHYSIOL-LONDON, V529, P171, DOI 10.1111/j.1469-7793.2000.00171.x; Dowell JD, 2003, CARDIOVASC RES, V58, P336, DOI 10.1016/S0008-6363(03)00254-2; Fleischmann M, 1998, FEBS LETT, V440, P370, DOI 10.1016/S0014-5793(98)01476-8; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; GOTTLIEB GJ, 1981, AM J PATHOL, V103, P292; GRANT AO, 1978, J PHARMACOL EXP THER, V205, P193; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; Henkel DM, 2006, AM HEART J, V151, P806, DOI 10.1016/j.ahj.2005.05.015; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kreuzberg MM, 2006, P NATL ACAD SCI USA, V103, P5959, DOI 10.1073/pnas.0508512103; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Makkar RR, 2003, J AM COLL CARDIOL, V42, P2070, DOI 10.1016/j.jacc.2003.09.018; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; MITCHELL GFF, 1998, BASIC RES CARDIOL, V274, pH747; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Pouzet B, 2001, CIRCULATION, V104, pI223; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Roell W, 2002, TRANSPLANTATION, V73, P462, DOI 10.1097/00007890-200202150-00022; Roell W, 2002, CIRCULATION, V105, P2435, DOI 10.1161/01.CIR.0000016063.66513.BB; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; SALAMA G, 1994, CIRC RES, V74, P604, DOI 10.1161/01.RES.74.4.604; Schrickel JW, 2002, BASIC RES CARDIOL, V97, P452, DOI 10.1007/s003950200052; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Takahashi T, 2004, HEART RHYTHM, V1, P451, DOI 10.1016/j.hrthm.2004.05.005; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TRAUB O, 1994, EUR J CELL BIOL, V64, P101; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	40	326	342	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					819	U3		10.1038/nature06321	http://dx.doi.org/10.1038/nature06321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064002				2022-12-24	WOS:000251394900044
J	Chambers, JQ; Fisher, JI; Zeng, HC; Chapman, EL; Baker, DB; Hurtt, GC				Chambers, Jeffrey Q.; Fisher, Jeremy I.; Zeng, Hongcheng; Chapman, Elise L.; Baker, David B.; Hurtt, George C.			Hurricane Katrina's carbon footprint on U. S. Gulf Coast forests	SCIENCE			English	Article							LAND; SINK		Tulane Univ, New Orleans, LA 70118 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA	Tulane University; University System Of New Hampshire; University of New Hampshire	Chambers, JQ (corresponding author), Tulane Univ, 400 Lindy Boggs, New Orleans, LA 70118 USA.	chambers@tulane.edu	Chambers, Jeffrey Q/J-9021-2014; Chambers, Jeffrey Q/AAU-7097-2021; Hurtt, George/A-8450-2012	Chambers, Jeffrey Q/0000-0003-3983-7847; Hurtt, George/0000-0001-7278-202X				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Fisher JI, 2007, REMOTE SENS ENVIRON, V109, P261, DOI 10.1016/j.rse.2007.01.004; Hurtt GC, 2002, P NATL ACAD SCI USA, V99, P1389, DOI 10.1073/pnas.012249999; IPCC, 2007, CLIM CHANG 2007 PHYS; McNulty SG, 2002, ENVIRON POLLUT, V116, pS17, DOI 10.1016/S0269-7491(01)00242-1; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Powell MD, 1998, J WIND ENG IND AEROD, V77-8, P53, DOI 10.1016/S0167-6105(98)00131-7	9	219	233	13	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1107	1107		10.1126/science.1148913	http://dx.doi.org/10.1126/science.1148913			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006740				2022-12-24	WOS:000250957900037
J	Jack, A				Jack, Andrew			Obesity plan lacks foresight	LANCET			English	Editorial Material									Financial Times, London SE1 9HL, England		Jack, A (corresponding author), Financial Times, London SE1 9HL, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], 2007, FORESIGHT TACKLING O, V2nd; Boseley S., 2007, GUARDIAN        1017; *BRIT HEART FDN, 2007, FOR REP BRIT HEART F; CAMPBELL D, 2007, OBSERVER        1014	4	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 3	2007	370	9598					1528	1529		10.1016/S0140-6736(07)61645-6	http://dx.doi.org/10.1016/S0140-6736(07)61645-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227AE	17980723				2022-12-24	WOS:000250628800008
J	Komili, S; Farny, NG; Roth, FP; Silver, PA				Komili, Suzanne; Farny, Natalie G.; Roth, Frederick P.; Silver, Pamela A.			Functional specificity among ribosomal proteins regulates gene expression	CELL			English	Article							ASH1 MESSENGER-RNA; MASS-SPECTROMETRIC ANALYSIS; SACCHAROMYCES-CEREVISIAE; BIOACTIVE COMPOUNDS; GERM PLASM; LOCALIZATION; GENOME; SCREEN; EXPORT; MUTATION	Duplicated genes escape gene loss by conferring a dosage benefit or evolving diverged functions. The yeast Saccharomyces cerevisiae contains many duplicated genes encoding ribosomal proteins. Prior studies have suggested that these duplicated proteins are functionally redundant and affect cellular processes in proportion to their expression. In contrast, through studies of ASH1 mRNA in yeast, we demonstrate paralog-specific requirements for the translation of localized mRNAs. Intriguingly, these paralog-specific effects are limited to a distinct subset of duplicated ribosomal proteins. Moreover, transcriptional and phenotypic profiling of cells lacking specific ribosomal proteins reveals differences between the functional roles of ribosomal protein paralogs that extend beyond effects on mRNA localization. Finally, we show that ribosomal protein paralogs exhibit differential requirements for assembly and localization. Together, our data indicate complex specialization of ribosomal proteins for specific cellular processes and support the existence of a ribosomal code.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02119 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02119 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Roth, FP (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02119 USA.	fritz_roth@hms.harvard.edu; pamela_silver@hms.harvard.edu	Farny, Natalie/ABD-4468-2020; Roth, Frederick P/H-6308-2011	Farny, Natalie/0000-0003-1143-4560; Roth, Frederick/0000-0002-6628-649X	NHGRI NIH HHS [R01 HG003224, HG003224, R01 HG003224-02, R01 HG003224-03, R01 HG003224-01A2] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABOVICH N, 1984, MOL CELL BIOL, V4, P1871, DOI 10.1128/MCB.4.9.1871; Amikura R, 2001, P NATL ACAD SCI USA, V98, P9133, DOI 10.1073/pnas.171286998; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; BaudinBaillieu A, 1997, MOL CELL BIOL, V17, P5023, DOI 10.1128/MCB.17.9.5023; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Brodsky AS, 2002, METHODS, V26, P151, DOI 10.1016/S1046-2023(02)00017-8; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enyenihi AH, 2003, GENETICS, V163, P47; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; HERRUER MH, 1987, NUCLEIC ACIDS RES, V15, P10133, DOI 10.1093/nar/15.24.10133; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Ito T, 2000, PLANT J, V22, P257, DOI 10.1046/j.1365-313x.2000.00728.x; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruse C, 2002, J CELL BIOL, V159, P971, DOI 10.1083/jcb.200207101; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LEER RJ, 1984, FEBS LETT, V175, P371, DOI 10.1016/0014-5793(84)80771-1; LEER RJ, 1985, NUCLEIC ACIDS RES, V13, P5027, DOI 10.1093/nar/13.14.5027; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; LUCIOLI A, 1988, MOL CELL BIOL, V8, P4792, DOI 10.1128/MCB.8.11.4792; Ma ZR, 2004, PLANT J, V37, P92, DOI 10.1046/j.1365-313X.2003.01942.x; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oka T, 1999, DEV GROWTH DIFFER, V41, P1; Page N, 2003, GENETICS, V163, P875; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; ROTENBERG MO, 1988, GENE DEV, V2, P160, DOI 10.1101/gad.2.2.160; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SELKER EU, 1985, SCIENCE, V227, P1340, DOI 10.1126/science.2579431; Tsugeki R, 1996, PLANT J, V10, P479, DOI 10.1046/j.1365-313X.1996.10030479.x; Urbinati CR, 2006, MOL GENET GENOMICS, V276, P369, DOI 10.1007/s00438-006-0151-7; Weijers D, 2001, DEVELOPMENT, V128, P4289; WILLIAMS ME, 1995, PLANT J, V8, P65, DOI 10.1046/j.1365-313X.1995.08010065.x; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	59	254	258	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					557	571		10.1016/j.cell.2007.08.037	http://dx.doi.org/10.1016/j.cell.2007.08.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981122	Bronze, Green Accepted			2022-12-24	WOS:000250618500022
J	Wilson, RI				Wilson, Rachel I.			Neural circuits underlying chemical perception	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266	NIDCD NIH HHS [R01 DC008174, R01 DC008174-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BHANDAWAT V, 2007, NAT NEUROSCI    1007; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	11	4	4	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					584	585		10.1126/science.1151362	http://dx.doi.org/10.1126/science.1151362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962548	Green Accepted			2022-12-24	WOS:000250409200030
J	Tran, EJ; Bolger, TA; Wente, SR				Tran, Elizabeth J.; Bolger, Timothy A.; Wente, Susan R.			SnapShot: Nuclear transport	CELL			English	Editorial Material							EXPORT RECEPTOR; IMPORT; RNA; LOCALIZATION		Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Tran, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.		Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X	NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009582] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bradatsch B, 2007, MOL CELL, V27, P767, DOI 10.1016/j.molcel.2007.06.034; Caesar S, 2006, MOL CELL BIOL, V26, P3170, DOI 10.1128/MCB.26.8.3170-3180.2006; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PRADEEPA MM, 2007, MOL CELL BIOL; Seiser RM, 2006, GENETICS, V174, P679, DOI 10.1534/genetics.106.062117; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	18	43	43	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2							420.e1	10.1016/j.cell.2007.10.015	http://dx.doi.org/10.1016/j.cell.2007.10.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956740	Bronze			2022-12-24	WOS:000250507700001
J	Gerken, T; Girard, CA; Tung, YCL; Webby, CJ; Saudek, V; Hewitson, KS; Yeo, GSH; McDonough, MA; Cunliffe, S; McNeill, LA; Galvanovskis, J; Rorsman, P; Robins, P; Prieur, X; Coll, AP; Ma, M; Jovanovic, Z; Farooqi, IS; Sedgwick, B; Barroso, I; Lindahl, T; Ponting, CP; Ashcroft, FM; O'Rahilly, S; Schofield, CJ				Gerken, Thomas; Girard, Christophe A.; Tung, Yi-Chun Loraine; Webby, Celia J.; Saudek, Vladimir; Hewitson, Kirsty S.; Yeo, Giles S. H.; McDonough, Michael A.; Cunliffe, Sharon; McNeill, Luke A.; Galvanovskis, Juris; Rorsman, Patrik; Robins, Peter; Prieur, Xavier; Coll, Anthony P.; Ma, Marcella; Jovanovic, Zorica; Farooqi, I. Sadaf; Sedgwick, Barbara; Barroso, Ines; Lindahl, Tomas; Ponting, Chris P.; Ashcroft, Frances M.; O'Rahilly, Stephen; Schofield, Christopher J.			The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; HIF-ALPHA; OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; ESCHERICHIA-COLI; ADULT OBESITY; DNA; REPAIR; RNA; 3-METHYLTHYMINE	Variants in the FTO ( fat mass and obesity associated) gene are associated with increased body mass index in humans. Here, we show by bioinformatics analysis that FTO shares sequence motifs with Fe(II)- and 2-oxoglutarate-dependent oxygenases. We find that recombinant murine Fto catalyzes the Fe( II)- and 2OG-dependent demethylation of 3-methylthyminein single-stranded DNA, with concomitant production of succinate, formaldehyde, and carbon dioxide. Consistent with a potential role in nucleic acid demethylation, Fto localizes to the nucleus in transfected cells. Studies of wild-type mice indicate that Fto messenger RNA ( mRNA) is most abundant in the brain, particularly in hypothalamic nuclei governing energy balance, and that Fto mRNA levels in the arcuate nucleus are regulated by feeding and fasting. Studies can now be directed toward determining the physiologically relevant FTO substrate and how nucleic acid methylation status is linked to increased fat mass.	Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; Univ Oxford, Chem Res Lab, Oxford OX1 3TA, Oxon, England; Univ Oxford, Oxford Ctr Integrat Syst, Oxford OX1 3TA, Oxon, England; Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; ReOx Ltd, Magdalen Ctr, Oxford OX4 4GA, Oxon, England; Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Cancer Research UK; Wellcome Trust Sanger Institute	Ponting, CP (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genet Unit, S Pks Rd, Oxford OX1 3QX, England.	chris.ponting@dpag.ox.ac.uk; so104@medschl.cam.ac.uk; christopher.schofield@chem.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Girard, Christophe/O-8455-2016; O'Rahilly, Stephen/ABF-6509-2020; Rorsman, Patrik/A-4331-2016; McDonough, Michael A/G-2744-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Prieur, Xavier/D-4760-2015; McDonough, Michael/N-8913-2019	Girard, Christophe/0000-0002-4560-4479; O'Rahilly, Stephen/0000-0003-2199-4449; Rorsman, Patrik/0000-0001-7578-0767; McDonough, Michael A/0000-0003-4664-6942; Prieur, Xavier/0000-0003-0215-5447; McDonough, Michael/0000-0003-4664-6942; Coll, Anthony Patrick/0000-0003-2594-7463; Barroso, Ines/0000-0001-5800-4520; Yeo, Giles See How/0000-0001-8823-3615; Ponting, Chris/0000-0003-0202-7816; Farooqi, Sadaf/0000-0001-7609-3504; Schofield, Christopher/0000-0002-0290-6565	Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: Medline; Medical Research Council [MC_U137761446, G108/617, G9824984] Funding Source: Medline; NIGMS NIH HHS [U54 GM064346] Funding Source: Medline; Wellcome Trust [068086, 077016] Funding Source: Medline; BBSRC [BB/D011523/1] Funding Source: UKRI; MRC [G108/617, MC_U137761446, G9824984] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Aravind L, 2001, GENOME BIOL, V2; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103	28	1117	1186	4	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1469	1472		10.1126/science.1151710	http://dx.doi.org/10.1126/science.1151710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	17991826	Green Accepted			2022-12-24	WOS:000251246100051
J	Alber, F; Dokudovskaya, S; Veenhoff, LM; Zhang, WZ; Kipper, J; Devos, D; Suprapto, A; Karni-Schmidt, O; Williams, R; Chait, BT; Rout, MP; Sali, A				Alber, Frank; Dokudovskaya, Svetlana; Veenhoff, Liesbeth M.; Zhang, Wenzhu; Kipper, Julia; Devos, Damien; Suprapto, Adisetyantari; Karni-Schmidt, Orit; Williams, Rosemary; Chait, Brian T.; Rout, Michael P.; Sali, Andrej			Determining the architectures of macromolecular assemblies	NATURE			English	Article							NUCLEAR-PORE COMPLEX; PROTEIN; TRANSPORT; NUCLEOPORINS; IDENTIFICATION; PREDICTION; SUBUNIT; SHAPE	To understand the workings of a living cell, we need to know the architectures of its macromolecular assemblies. Here we show how proteomic data can be used to determine such structures. The process involves the collection of sufficient and diverse high-quality data, translation of these data into spatial restraints, and an optimization that uses the restraints to generate an ensemble of structures consistent with the data. Analysis of the ensemble produces a detailed architectural map of the assembly. We developed our approach on a challenging model system, the nuclear pore complex (NPC). The NPC acts as a dynamic barrier, controlling access to and from the nucleus, and in yeast is a 50 MDa assembly of 456 proteins. The resulting structure, presented in an accompanying paper, reveals the configuration of the proteins in the NPC, providing insights into its evolution and architectural principles. The present approach should be applicable to many other macromolecular assemblies.	Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University; Rockefeller University	Sali, A (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Byers Hall,Suite 503B,1700 4th St, San Francisco, CA 94158 USA.	chait@rockefeller.edu; rout@rockefeller.edu; sali@salilab.org	devos, damien/ABH-5348-2020; Rout, Michael/Y-7090-2018	Devos, Damien/0000-0002-9453-4753; Veenhoff, Liesbeth/0000-0002-0158-4728; Rout, Michael/0000-0003-2010-706X; Svetlana, Dokudovskaya/0000-0001-6032-622X	NCRR NIH HHS [U54 RR022220] Funding Source: Medline; NIGMS NIH HHS [R01 GM062427, R01 GM083960] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062427, R01GM083960] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Harding S E, 1994, Methods Mol Biol, V22, P61; HAVEL T, 1984, B MATH BIOL, V46, P673, DOI 10.1007/BF02459510; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MALHOTRA A, 1990, P NATL ACAD SCI USA, V87, P1950, DOI 10.1073/pnas.87.5.1950; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murphy R, 1996, MOL BIOL CELL, V7, P1921, DOI 10.1091/mbc.7.12.1921; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; STRAMBIODECASTILLIA C, 1995, J CELL BIOL, V131, P19, DOI 10.1083/jcb.131.1.19; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o	44	411	418	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					683	694		10.1038/nature06404	http://dx.doi.org/10.1038/nature06404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046405				2022-12-24	WOS:000251209700047
J	Vince, JE; Wong, WWL; Khan, N; Feltham, R; Chau, D; Ahmed, AU; Benetatos, CA; Chunduru, SK; Condon, SM; McKinlay, M; Brink, R; Leverkus, M; Tergaonkar, V; Schneider, P; Callus, BA; Koentgen, F; Vaux, DL; Silke, J				Vince, James E.; Wong, W. Wei-Lynn; Khan, Nufail; Feltham, Rebecca; Chau, Diep; Ahmed, Afsar U.; Benetatos, Christopher A.; Chunduru, Srinivas K.; Condon, Stephen M.; McKinlay, Mark; Brink, Robert; Leverkus, Martin; Tergaonkar, Vinay; Schneider, Pascal; Callus, Bernard A.; Koentgen, Frank; Vaux, David L.; Silke, John			IAP antagonists target cIAP1 to induce TNF alpha- dependent apoptosis	CELL			English	Article							KAPPA-B ACTIVATION; SIGNALING COMPLEX; GENE-EXPRESSION; CELL-DEATH; XIAP; CANCER; SMAC/DIABLO; INHIBITOR; PROTEINS; C-IAP1	XIAP prevents apoptosis by binding to and inhibiting caspases, and this inhibition can be relieved by IAP antagonists, such as Smac/DIA-BLO. IAP antagonist compounds (IACs) have therefore been designed to inhibit XIAP to kill tumor cells. Because XIAP inhibits post-mitochondrial caspases, caspase 8 inhibitors should not block killing by IACs. Instead, we show that apoptosis caused by an IAC is blocked by the caspase 8 inhibitor crmA and that IAP antagonists activate NF-kappa B signaling via inhibtion of cIAP1. In sensitive tumor lines, IAP antagonist induced NF-kappa B-stimulated production of TNF alpha that killed cells in an autocrine fashion. Inhibition of NF-kappa B reduced TNF alpha production, and blocking NF-kappa B activation or TNF alpha allowed tumor cells to survive IAC-induced apoptosis. Cells treated with an IAC, or those in which cIAP1 was deleted, became sensitive to apoptosis induced by exogenous TNF alpha, suggesting novel uses of these compounds in treating cancer.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Tetralog Pharmaceut, Malvern, PA 19355 USA; Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; Univ Magdeburg, Dept Dermatol & Venerol, Lab Expt Dermatol, D-39106 Magdeburg, Germany; IMCB, Singapore 138673, Singapore; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland; Ozgene Pty Ltd, Bentley, WA 6983, Australia	La Trobe University; Garvan Institute of Medical Research; Otto von Guericke University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Lausanne	Silke, J (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Melbourne, Vic 3086, Australia.	j.silke@latrobe.edu.au	Brink, Robert/B-7910-2010; Vaux, David L/C-7249-2013; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015; Ahmed, Afsar/I-7084-2013	Brink, Robert/0000-0002-9586-3655; Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Ahmed, Afsar/0000-0001-9209-7089; Feltham, Rebecca/0000-0001-8376-6869; Ahmed, Afsar Uddin/0000-0001-8788-6518; Schneider, Pascal/0000-0003-0677-9409				Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Creagh EM, 2004, J BIOL CHEM, V279, P26906, DOI 10.1074/jbc.M313859200; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Nowakowski GS, 2006, CLIN CANCER RES, V12, P6087, DOI 10.1158/1078-0432.CCR-06-1015; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAN AD, 1996, SCIENCE, V274, P787; VAROLOMEEV E, 2006, J BIOL CHEM, V281, P29022; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	35	868	899	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					682	693		10.1016/j.cell.2007.10.037	http://dx.doi.org/10.1016/j.cell.2007.10.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022363	Bronze			2022-12-24	WOS:000250966300016
J	Wiita, AP; Perez-Jimenez, R; Walther, KA; Grater, F; Berne, BJ; Holmgren, A; Sanchez-Ruiz, JM; Fernandez, JM				Wiita, Arun P.; Perez-Jimenez, Raul; Walther, Kirstin A.; Graeter, Frauke; Berne, B. J.; Holmgren, Arne; Sanchez-Ruiz, Jose M.; Fernandez, Julio M.			Probing the chemistry of thioredoxin catalysis with force	NATURE			English	Article							ESCHERICHIA-COLI THIOREDOXIN; ACTIVE-SITE; SINGLE PROTEIN; DISULFIDE; MECHANISM; BOND; REDUCTION; RESIDUES; KINETICS; PEPTIDE	Thioredoxins are enzymes that catalyse disulphide bond reduction in all living organisms(1). Although catalysis is thought to proceed through a substitution nucleophilic bimolecular (S(N)2) reaction(1,2), the role of the enzyme in modulating this chemical reaction is unknown. Here, using single-molecule force-clamp spectroscopy(3,4), we investigate the catalytic mechanism of Escherichia coli thioredoxin (Trx). We applied mechanical force in the range of 25-600 pN to a disulphide bond substrate and monitored the reduction of these bonds by individual enzymes. We detected two alternative forms of the catalytic reaction, the first requiring a reorientation of the substrate disulphide bond, causing a shortening of the substrate polypeptide by 0.79 +/- 0.09 angstrom (+/- s.e.m.), and the second elongating the substrate disulphide bond by 0.17 +/- 0.02 angstrom (+/- s.e.m.). These results support the view that the Trx active site regulates the geometry of the participating sulphur atoms with sub-angstrom precision to achieve efficient catalysis. Our results indicate that substrate conformational changes may be important in the regulation of Trx activity under conditions of oxidative stress and mechanical injury, such as those experienced in cardiovascular disease(5,6). Furthermore, single-molecule atomic force microscopy techniques, as shown here, can probe dynamic rearrangements within an enzyme's active site during catalysis that cannot be resolved with any other current structural biological technique.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Grad Program Neurobiol & Behav, New York, NY 10027 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain	Columbia University; Columbia University; Columbia University; Columbia University; Karolinska Institutet; University of Granada	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfernandez@columbia.edu	Perez-Jimenez, Raul/C-3085-2017; Sanchez-Ruiz, Jose/H-2849-2015; Gräter, Frauke/D-3450-2009	Perez-Jimenez, Raul/0000-0001-7094-6799; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Gräter, Frauke/0000-0003-2891-3381	NIGMS NIH HHS [R01 GM043340, R01 GM043340-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043340] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1967, EUR J BIOCHEM, V2, P187, DOI 10.1111/j.1432-1033.1967.tb00125.x; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1979, BIOCHEMISTRY-US, V18, P5591, DOI 10.1021/bi00592a011; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; JORGENSEN WL, 1985, J AM CHEM SOC, V107, P569, DOI 10.1021/ja00289a008; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; PAPPAS JA, 1977, J AM CHEM SOC, V99, P2926, DOI 10.1021/ja00451a013; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Perez-Jimenez R, 2005, BIOPHYS CHEM, V115, P105, DOI 10.1016/j.bpc.2004.12.012; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; ROSENFIELD RE, 1977, J AM CHEM SOC, V99, P4860, DOI 10.1021/ja00456a072; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; World CJ, 2006, J MOL MED-JMM, V84, P997, DOI 10.1007/s00109-006-0109-6	42	214	221	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					124	+		10.1038/nature06231	http://dx.doi.org/10.1038/nature06231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972886	Green Accepted			2022-12-24	WOS:000250585800050
J	Semenov, MV; Habas, R; MacDonald, BT; He, X				Semenov, Mikhail V.; Habas, Raymond; MacDonald, Bryan T.; He, Xi			SnapShot: Noncanonical Wnt signaling pathways	CELL			English	Editorial Material							CELL POLARITY; PROTEIN		[Semenov, Mikhail V.; MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Childrens Hosp, F M Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Habas, Raymond] Univ Med & Dent New Jersey, Dept Biochem, Piscataway, NJ 08854 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center	Semenov, MV (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, F M Kirby Neurobiol Ctr, Boston, MA 02115 USA.				NIGMS NIH HHS [R01 GM078172, R01 GM078172-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078172] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	9	241	253	2	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7							1378.e1	10.1016/j.cell.2007.12.011	http://dx.doi.org/10.1016/j.cell.2007.12.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160045	Bronze			2022-12-24	WOS:000252217200001
J	Bieling, P; Laan, L; Schek, H; Munteanu, EL; Sandblad, L; Dogterom, M; Brunner, D; Surrey, T				Bieling, Peter; Laan, Liedewij; Schek, Henry; Munteanu, E. Laura; Sandblad, Linda; Dogterom, Marileen; Brunner, Damian; Surrey, Thomas			Reconstitution of a microtubule plus-end tracking system in vitro	NATURE			English	Article							FISSION YEAST; PROTEINS; DYNAMICS; EB1; KINESIN; BINDING; TIP1P; MECHANISMS; MOVEMENT; BEHAVIOR	The microtubule cytoskeleton is essential to cell morphogenesis. Growing microtubule plus ends have emerged as dynamic regulatory sites in which specialized proteins, called plus- end- binding proteins ( + TIPs), bind and regulate the proper functioning of microtubules(1-4). However, the molecular mechanism of plus- end association by + TIPs and their ability to track the growing end are not well understood. Here we report the in vitro reconstitution of a minimal plus- end tracking system consisting of the three fission yeast proteins Mal3, Tip1 and the kinesin Tea2. Using time- lapse total internal reflection fluorescence microscopy, we show that the EB1 homologue Mal3 has an enhanced affinity for growing microtubule end structures as opposed to the microtubule lattice. This allows it to track growing microtubule ends autonomously by an end recognition mechanism. In addition, Mal3 acts as a factor that mediates loading of the processive motor Tea2 and its cargo, the Clip170 homologue Tip1, onto the microtubule lattice. The interaction of all three proteins is required for the selective tracking of growing microtubule plus ends by both Tea2 and Tip1. Our results dissect the collective interactions of the constituents of this plus-end tracking system and show how these interactions lead to the emergence of its dynamic behaviour. We expect that such in vitro reconstitutions will also be essential for the mechanistic dissection of other plus- end tracking systems.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands	European Molecular Biology Laboratory (EMBL); AMOLF	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	dogterom@amolf.nl; brunner@embl.de; surrey@embl.de	Surrey, Thomas/AAC-4608-2021; Brunner, Damian/F-2024-2011	Surrey, Thomas/0000-0001-9082-1870; Brunner, Damian/0000-0001-5250-492X; Laan, Liedewij/0000-0002-7138-9004; Bieling, Peter/0000-0002-7458-4358				Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Brunner D, 2000, PHILOS T ROY SOC B, V355, P873, DOI 10.1098/rstb.2000.0622; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Ding DQ, 1998, J CELL SCI, V111, P701; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lata S, 2005, ANAL CHEM, V77, P1096, DOI 10.1021/ac048813j; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2003, J BIOCHEM, V134, P321, DOI 10.1093/jb/mvg148; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Ohkura H, 2001, J CELL SCI, V114, P3805; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2005, CURR BIOL, V15, pR126, DOI 10.1016/j.cub.2005.02.010	30	334	340	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1100	1105		10.1038/nature06386	http://dx.doi.org/10.1038/nature06386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18059460				2022-12-24	WOS:000251579900091
J	Feng, L; Yan, HC; Wu, ZR; Yan, N; Wang, Z; Jeffrey, PD; Shi, YG				Feng, Liang; Yan, Hanchi; Wu, Zhuoru; Yan, Nieng; Wang, Zhe; Jeffrey, Philip D.; Shi, Yigong			Structure of a site-2 protease family intramembrane metalloprotease	SCIENCE			English	Article							CRYSTAL-STRUCTURE; PROTEOLYSIS; CLEAVAGE; MECHANISM; SREBPS; THERMOLYSIN; PROTEINS	Regulated intramembrane proteolysis by members of the site- 2 protease (S2P) family is an important signaling mechanism conserved from bacteria to humans. Here we report the crystal structure of the transmembrane core domain of an S2P metalloprotease from Methanocaldococcus jannaschii. The protease consists of six transmembrane segments, with the catalytic zinc atom coordinated by two histidine residues and one aspartate residue similar to 14 angstroms into the lipid membrane surface. The protease exhibits two distinct conformations in the crystals. In the closed conformation, the active site is surrounded by transmembrane helices and is impermeable to substrate peptide; water molecules gain access to zinc through a polar, central channel that opens to the cytosolic side. In the open conformation, transmembrane helices alpha 1 and alpha 6 separate from each other by 10 to 12 angstroms, exposing the active site to substrate entry. The structure reveals how zinc embedded in an integral membrane protein can catalyze peptide cleavage.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada	Princeton University; University of British Columbia	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Yan, Hanchi/E-3639-2010	Yan, Hanchi/0000-0003-1055-5459; Jeffrey, Philip/0000-0002-4351-5341; Shi, Yigong/0000-0003-2030-168X				Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; English AC, 1999, PROTEINS, V37, P628, DOI 10.1002/(SICI)1097-0134(19991201)37:4<628::AID-PROT13>3.0.CO;2-G; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lewis AP, 1999, PROTEIN SCI, V8, P439; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 2002, ESSAYS BIOCHEM, V38, P155, DOI 10.1042/bse0380155; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000	31	178	181	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2007	318	5856					1608	1612		10.1126/science.1150755	http://dx.doi.org/10.1126/science.1150755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063795				2022-12-24	WOS:000251421700041
J	Petrascheck, M; Ye, XL; Buck, LB				Petrascheck, Michael; Ye, Xiaolan; Buck, Linda B.			An antidepressant that extends lifespan in adult Caenorhabditis elegans	NATURE			English	Article							CALORIC RESTRICTION; SEROTONIN; RECEPTORS; EXTENSION; GENETICS; FLUOXETINE; OCTOPAMINE; MUTATIONS; LONGEVITY; FOOD	The mechanisms that determine the lifespan of an organism are still largely a mystery(1). One goal of ageing research is to find drugs that would increase lifespan and vitality when given to an adult animal. To this end, we tested 88,000 chemicals for the ability to extend the lifespan of adult Caenorhabditis elegans nematodes. Here we report that a drug used as an antidepressant in humans increases C. elegans lifespan. In humans, this drug blocks neural signalling by the neurotransmitter serotonin. In C. elegans, the effect of the drug on lifespan is reduced or eradicated by mutations that affect serotonin synthesis, serotonin re-uptake at synapses, or either of two G-protein-coupled receptors: one that recognizes serotonin and the other that detects another neurotransmitter, octopamine. In vitro studies show that the drug acts as an antagonist at both receptors. Testing of the drug on dietary-restricted animals or animals with mutations that affect lifespan indicates that its effect on lifespan involves mechanisms associated with lifespan extension by dietary restriction. These studies indicate that lifespan can be extended by blocking certain types of neurotransmission implicated in food sensing in the adult animal, possibly leading to a state of perceived, although not real, starvation.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buck, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	lbuck@fhcrc.org	Petrascheck, Michael/R-7832-2019	Petrascheck, Michael/0000-0002-1010-145X				BRENNER S, 1974, GENETICS, V77, P71; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Gillman PK, 2006, HUM PSYCHOPHARM CLIN, V21, P117, DOI 10.1002/hup.750; HARRIS B, 1980, LANCET, V1, P590; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Johnson TE, 2001, EXP GERONTOL, V36, P1609, DOI 10.1016/S0531-5565(01)00144-9; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Komuniecki RW, 2004, MOL BIOCHEM PARASIT, V137, P1, DOI 10.1016/j.molbiopara.2004.05.010; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Murakami H, 2007, AGING CELL, V6, P483, DOI 10.1111/j.1474-9726.2007.00303.x; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; RODIN G, 2004, CURR ONCOL, V14, P180; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	29	192	217	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					553	U12		10.1038/nature05991	http://dx.doi.org/10.1038/nature05991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033297				2022-12-24	WOS:000251158500048
J	Vaquero, A; Scher, M; Erdjument-Bromage, H; Tempst, P; Serrano, L; Reinberg, D				Vaquero, Alejandro; Scher, Michael; Erdjument-Bromage, Hediye; Tempst, Paul; Serrano, Lourdes; Reinberg, Danny			SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation	NATURE			English	Article							LYSINE-9 METHYLATION; DOMINANT ROLE; METHYLTRANSFERASE; DEACETYLASE; CHROMATIN; YEAST; H4	In contrast to stably repressive, constitutive heterochromatin and stably active, euchromatin, facultative heterochromatin has the capacity to alternate between repressive and activated states of transcription(1). As such, it is an instructive source to understand the molecular basis for changes in chromatin structure that correlate with transcriptional status. Sirtuin 1 (SIRT1) and suppressor of variegation 3-9 homologue 1 ( SUV39H1) are amongst the enzymes responsible for chromatin modulations associated with facultative heterochromatin formation. SUV39H1 is the principal enzyme responsible for the accumulation of histone H3 containing a trimethyl group at its lysine 9 position (H3K9me3) in regions of heterochromatin(2). SIRT1 is an NAD+-dependent deacetylase that targets histone H4 at lysine 16 (refs 3 and 4), and through an unknown mechanism facilitates increased levels of H3K9me3 (ref. 3). Here we show that the mammalian histone methyltransferase SUV39H1 is itself targeted by the histone deacetylase SIRT1 and that SUV39H1 activity is regulated by acetylation at lysine residue 266 in its catalytic SET domain. SIRT1 interacts directly with, recruits and deacetylates SUV39H1, and these activities independently contribute to elevated levels of SUV39H1 activity resulting in increased levels of the H3K9me3 modification. Loss of SIRT1 greatly affects SUV39H1-dependent H3K9me3 and impairs localization of heterochromatin protein 1. These findings demonstrate a functional link between the heterochromatin-related histone methyltransferase SUV39H1 and the histone deacetylase SIRT1.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; Rutgers State Univ, Inst Human Genet, Dept Genet, Piscataway, NJ 08854 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; New York University; Memorial Sloan Kettering Cancer Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.	reinbdO1@med.nyu.edu	Vaquero, Alejandro/I-9845-2014; Vaquero, Alejandro/ABG-8634-2020	Vaquero, Alejandro/0000-0002-8735-4156; Tempst, Paul/0000-0002-6680-3987; Reinberg, Danny/0000-0003-4288-2016; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Craig JM, 2005, BIOESSAYS, V27, P17, DOI 10.1002/bies.20145; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0	17	299	321	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					440	444		10.1038/nature06268	http://dx.doi.org/10.1038/nature06268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004385				2022-12-24	WOS:000250918600059
J	Andang, M; Hjerling-Leffler, J; Moliner, A; Lundgren, TK; Castelo-Branco, G; Nanou, E; Pozas, E; Bryja, V; Halliez, S; Nishimaru, H; Wilbertz, J; Arenas, E; Koltzenburg, M; Charnay, P; El Manira, A; Ibanez, CF; Ernfors, P				Andang, Michael; Hjerling-Leffler, Jens; Moliner, Annalena; Lundgren, T. Kalle; Castelo-Branco, Goncalo; Nanou, Evanthia; Pozas, Ester; Bryja, Vitezslav; Halliez, Sophie; Nishimaru, Hiroshi; Wilbertz, Johannes; Arenas, Ernest; Koltzenburg, Martin; Charnay, Patrick; El Manira, Abdeljabbar; Ibanez, Carlos F.; Ernfors, Patrik			Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation	NATURE			English	Article							DNA-DAMAGE; BOUNDARY CAP; H2AX; PHOSPHORYLATION; DIFFERENTIATION; EXPRESSION; HINDBRAIN; PHASE; ATM	Stem cell self- renewal implies proliferation under continued maintenance of multipotency. Small changes in numbers of stem cells may lead to large differences in differentiated cell numbers, resulting in significant physiological consequences. Proliferation is typically regulated in the G1 phase, which is associated with differentiation and cell cycle arrest(1). However, embryonic stem ( ES) cells may lack a G1 checkpoint(2,3). Regulation of proliferation in the 'DNA damage' S/G2 cell cycle checkpoint pathway is known for its role in the maintenance of chromatin structural integrity(4). Here we show that autocrine/paracrine gamma-aminobutyric acid ( GABA) signalling by means of GABA(A) receptors negatively controls ES cell and peripheral neural crest stem ( NCS) cell proliferation, preimplantation embryonic growth and proliferation in the boundary- cap stem cell niche, resulting in an attenuation of neuronal progenies from this stem cell niche. Activation of GABA(A) receptors leads to hyperpolarization, increased cell volume and accumulation of stem cells in S phase, thereby causing a rapid decrease in cell proliferation. GABA(A) receptors signal through S- phase checkpoint kinases of the phosphatidylinositol-3-OH kinase- related kinase family and the histone variant H2AX. This signalling pathway critically regulates proliferation independently of differentiation, apoptosis and overt damage to DNA. These results indicate the presence of a fundamentally different mechanism of proliferation control in these stem cells, in comparison with most somatic cells, involving proteins in the DNA damage checkpoint pathway.	[Andang, Michael; Hjerling-Leffler, Jens; Lundgren, T. Kalle; Pozas, Ester; Bryja, Vitezslav; Arenas, Ernest; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; [Moliner, Annalena; Castelo-Branco, Goncalo; Nanou, Evanthia; Nishimaru, Hiroshi; El Manira, Abdeljabbar; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Lab Mol Neurodev, S-17177 Stockholm, Sweden; [Wilbertz, Johannes] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Halliez, Sophie; Charnay, Patrick] Ecole Normale Super, INSERM, U784, F-75230 Paris 05, France; [Koltzenburg, Martin] UCL, Inst Child Hlth, Neural Plast Unit, London WC1E 6BT, England	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of London; University College London	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Arenas, Ernest/AAO-5231-2020; Castelo-Branco, Gonçalo/B-1635-2009; Bryja, Vítězslav/P-4217-2019; Hjerling-Leffler, Jens/B-3307-2008; Hjerling-Leffler, Jens/E-3775-2012; Castelo-Branco, Gonçalo/O-9162-2019; Bryja, Vít?zslav/H-1925-2014; Koltzenburg, Martin/C-1349-2008; Castelo-Branco, Goncalo/A-8357-2015; Halliez, Sophie/ABA-1356-2020; Lundgren, Kalle/E-9056-2015; Andäng, Michael/GRE-9898-2022	Arenas, Ernest/0000-0003-0197-6577; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vítězslav/0000-0002-9136-5085; Hjerling-Leffler, Jens/0000-0002-4539-1776; Castelo-Branco, Gonçalo/0000-0003-2247-9393; Bryja, Vít?zslav/0000-0002-9136-5085; Koltzenburg, Martin/0000-0001-9181-5966; Halliez, Sophie/0000-0002-6173-9752; Lundgren, Kalle/0000-0001-6781-762X; Andang, Michael/0000-0002-2886-7891; Charnay, Patrick/0000-0002-3847-6042; Ernfors, Patrik/0000-0002-1140-3986; El Manira, Abdel/0000-0001-5920-9384	Medical Research Council [G0601943] Funding Source: Medline; MRC [G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Lundgren TK, 2006, J BIOL CHEM, V281, P29886, DOI 10.1074/jbc.M600473200; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; MCGANN LE, 1988, CYTOMETRY, V9, P33, DOI 10.1002/cyto.990090106; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; SAVATIER P, 1994, ONCOGENE, V9, P809; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhu L, 2001, CURR OPIN GENET DEV, V11, P91, DOI 10.1016/S0959-437X(00)00162-3	21	210	216	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2008	451	7177					460	U4		10.1038/nature06488	http://dx.doi.org/10.1038/nature06488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	253YS	18185516	Bronze			2022-12-24	WOS:000252554100044
J	Janecka, JE; Miller, W; Pringle, TH; Wiens, F; Zitzmann, A; Helgen, KM; Springer, MS; Murphy, WJ				Janecka, Jan E.; Miller, Webb; Pringle, Thomas H.; Wiens, Frank; Zitzmann, Annette; Helgen, Kristofer M.; Springer, Mark S.; Murphy, William J.			Molecular and genomic data identify the closest living relative of primates	SCIENCE			English	Article							PLACENTAL MAMMALS; TREE; PHYLOGENY; ORIGINS; FOSSIL; RNA	A full understanding of primate morphological and genomic evolution requires the identification of their closest living relative. In order to resolve the ancestral relationships among primates and their closest relatives, we searched multispecies genome alignments for phylogenetically informative rare genomic changes within the superordinal group Euarchonta, which includes the orders Primates, Dermoptera (colugos), and Scandentia (treeshrews). We also constructed phylogenetic trees from 14 kilobases of nuclear genes for representatives from most major primate lineages, both extant colugos, and multiple treeshrews, including the pentail treeshrew, Ptilocercus lowii, the only living member of the family Ptilocercidae. A relaxed molecular clock analysis including Ptilocercus suggests that treeshrews arose approximately 63 million years ago. Our data show that colugos are the closest living relatives of primates and indicate that their divergence occurred in the Cretaceous.	Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Sperling Fdn, Eugene, OR 97405 USA; Univ Bayreuth, Dept Anim Physiol, D-95440 Bayreuth, Germany; Univ Frankfurt, Inst Zool, D-60054 Frankfurt, Germany; Smithsonian Inst, Natl Museum Amer Hist, Washington, DC 20013 USA; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Bayreuth; Goethe University Frankfurt; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Riverside	Murphy, WJ (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, Vet Med Adm Bldg,Room 107, College Stn, TX 77843 USA.	wmurphy@cvm.tamu.edu	Helgen, Kristofer M./AAB-8348-2019	Helgen, Kristofer M./0000-0002-8776-4040	NHGRI NIH HHS [HG02238] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADKINS RM, 1991, P NATL ACAD SCI USA, V88, P10317, DOI 10.1073/pnas.88.22.10317; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; Emmons L.H., 2000, TUPAI FIELD STUDY BO; Goodman M, 2005, TRENDS GENET, V21, P511, DOI 10.1016/j.tig.2005.06.012; Helgen K.M., 2005, MAMMAL SPECIES WORLD, P104; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Martin R.D., 1990, PRIMATE ORIGINS EVOL; McKenna MC, 1997, CLASSIFICATION MAMMA; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Pennisi E, 2007, SCIENCE, V316, P218, DOI 10.1126/science.316.5822.218; Sargis EJ, 2004, EVOL ANTHROPOL, V13, P56, DOI 10.1002/evan.10131; Sargis EJ, 2002, SCIENCE, V298, P1564, DOI 10.1126/science.1079034; Schmitz J, 2002, MOL BIOL EVOL, V19, P2308, DOI 10.1093/oxfordjournals.molbev.a004054; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 2003, MOL PHYLOGENET EVOL, V28, P197, DOI 10.1016/S1055-7903(03)00115-5	28	215	235	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					792	794		10.1126/science.1147555	http://dx.doi.org/10.1126/science.1147555			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975064				2022-12-24	WOS:000250583900039
J	Ferrand, Y; Crump, MP; Davis, AP				Ferrand, Yann; Crump, Matthew P.; Davis, Anthony P.			A synthetic lectin analog for biomimetic disaccharide recognition	SCIENCE			English	Article							CARBOHYDRATE-RECOGNITION; RECEPTOR; AFFINITY; BINDING; PROTEINS; NMR	Carbohydrate recognition is biologically important but intrinsically challenging, for both nature and host-guest chemists. Saccharides are complex, subtly variable, and camouflaged by hydroxyl groups that hinder discrimination between substrate and water. We have developed a rational strategy for the biomimetic recognition of carbohydrates with all-equatorial stereochemistry (beta-glucose, analogs, and homologs) and have now applied it to disaccharides such as cellobiose. Our synthetic receptor showed good affinities, not unlike those of some lectins (carbohydrate-binding proteins). Binding was demonstrated by nuclear magnetic resonance, induced circular dichroism, fluorescence spectroscopy, and calorimetry, all methods giving self-consistent results. Selectivity for the target substrates was exceptional; minor changes to disaccharide structure (for instance, cellobiose to lactose) caused almost complete suppression of complex formation.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Davis, AP (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	anthony.davis@bristol.ac.uk	Davis, Anthony/F-2794-2017	Davis, Anthony/0000-0001-5213-624X; Crump, Matthew/0000-0002-7868-5818; Ferrand, Yann/0000-0002-6552-6914	Engineering and Physical Sciences Research Council [EP/D060192/1] Funding Source: researchfish; EPSRC [EP/D060192/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Aboitiz N, 2004, CHEMBIOCHEM, V5, P1245, DOI 10.1002/cbic.200400025; Alpturk O, 2006, P NATL ACAD SCI USA, V103, P9756, DOI 10.1073/pnas.0603758103; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451; Davis AP, 2005, FUNCTIONAL SYNTHETIC RECEPTORS, P45, DOI 10.1002/352760572X.ch2; Davis AP, 1999, ANGEW CHEM INT EDIT, V38, P2978; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P2270, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2270::AID-ANIE2270>3.0.CO;2-6; Dwek RA, 2002, CHEM REV, V102, P283, DOI 10.1021/cr010385j; Francesconi O, 2006, ANGEW CHEM INT EDIT, V45, P6693, DOI 10.1002/anie.200602412; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Hubbard RD, 2001, J AM CHEM SOC, V123, P5810, DOI 10.1021/ja003712y; Klein E, 2005, ANGEW CHEM INT EDIT, V44, P298, DOI 10.1002/anie.200461409; Koning SM, 2001, J BACTERIOL, V183, P4979, DOI 10.1128/JB.183.17.4979-4984.2001; Larsson EA, 2004, J PHYS CHEM A, V108, P3932, DOI 10.1021/jp049714c; Lecollinet G, 2002, ANGEW CHEM INT EDIT, V41, P4093, DOI 10.1002/1521-3773(20021104)41:21<4093::AID-ANIE4093>3.0.CO;2-I; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Lutzen A., 2004, HIGHLIGHTS BIOORGANI, P109; Mazik M, 2006, J ORG CHEM, V71, P2957, DOI 10.1021/jo052479p; Mazik M, 2006, J ORG CHEM, V71, P7854, DOI 10.1021/jo0610309; Nativi C, 2007, J AM CHEM SOC, V129, P4377, DOI 10.1021/ja068754m; Neidlein U, 1996, CHEM COMMUN, P1493, DOI 10.1039/cc9960001493; NEUROHR KJ, 1981, BIOCHEMISTRY-US, V20, P3499, DOI 10.1021/bi00515a030; Ryan TJ, 2002, P NATL ACAD SCI USA, V99, P4863, DOI 10.1073/pnas.062013499; Schmuck C, 2005, ORG LETT, V7, P3517, DOI 10.1021/ol051230r; Striegler S, 2003, CURR ORG CHEM, V7, P81, DOI 10.2174/1385272033373201; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Waki M, 2006, CHEM-EUR J, V12, P7839, DOI 10.1002/chem.200600315	29	260	262	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					619	622		10.1126/science.1148735	http://dx.doi.org/10.1126/science.1148735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962557				2022-12-24	WOS:000250409200039
J	Bhaskaran, H; Russell, R				Bhaskaran, Hari; Russell, Rick			Kinetic redistribution of native and misfolded RNAs by a DEAD-box chaperone	NATURE			English	Article							GROUP-I INTRON; TETRAHYMENA RIBOZYME; PERIPHERAL ELEMENT; FOLDING LANDSCAPE; STRUCTURED RNA; PROTEIN; HELICASES; SEQUENCE; HELIX; INTERMEDIATE	DExD/H-box proteins are ubiquitously involved in RNA-mediated processes and use ATP to accelerate conformational changes in RNA. However, their mechanisms of action, and what determines which RNA species are targeted, are not well understood. Here we show that the DExD/H-box protein CYT-19, a general RNA chaperone, mediates ATP-dependent unfolding of both the native conformation and a long-lived misfolded conformation of a group I catalytic RNA with efficiencies that depend on the stabilities of the RNA species but not on specific structural features. CYT-19 then allows the RNA to refold, changing the distribution from equilibrium to kinetic control. Because misfolding is favoured kinetically, conditions that allow unfolding of the native RNA yield large increases in the population of misfolded species. Our results suggest that DExD/H-box proteins act with sufficient breadth and efficiency to allow structured RNAs to populate a wider range of conformations than would be present at equilibrium. Thus, RNAs may face selective pressure to stabilize their active conformations relative to inactive ones to avoid significant redistribution by DExD/H-box proteins. Conversely, RNAs whose functions depend on forming multiple conformations may rely on DExD/H-box proteins to increase the populations of less stable conformations, thereby increasing their overall efficiencies.	Univ Texas, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Russell, R (corresponding author), Univ Texas, Dept Chem & Biochem, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	rick_russell@mail.utexas.edu	Russell, Rick/A-9256-2012		NIGMS NIH HHS [R01 GM070456-04, R01 GM070456] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; DELCAMPO M, IN PRESS MOL CELL; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Grossberger R, 2005, NUCLEIC ACIDS RES, V33, P2280, DOI 10.1093/nar/gki515; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; JOYCE GF, 1989, NUCLEIC ACIDS RES, V17, P7879, DOI 10.1093/nar/17.19.7879; KARPEL RL, 1982, BIOCHEMISTRY-US, V21, P2102, DOI 10.1021/bi00538a019; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Mahen EM, 2005, MOL CELL, V19, P27, DOI 10.1016/j.molcel.2005.05.025; MOHR G, 1994, NATURE, V370, P147, DOI 10.1038/370147a0; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Pan J, 2000, J MOL BIOL, V296, P133, DOI 10.1006/jmbi.1999.3439; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Russell R, 2000, NAT STRUCT BIOL, V7, P367; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2007, BIOCHEMISTRY-US, V46, P4951, DOI 10.1021/bi0620149; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; SHUMAN S, 1992, P NATL ACAD SCI USA, V89, P10935, DOI 10.1073/pnas.89.22.10935; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Thirumalai D, 2005, BIOCHEMISTRY-US, V44, P4957, DOI 10.1021/bi047314+; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Treiber DK, 2001, J MOL BIOL, V305, P11, DOI 10.1006/jmbi.2000.4253; VANDERHORST G, 1991, P NATL ACAD SCI USA, V88, P184, DOI 10.1073/pnas.88.1.184; Yang QS, 2007, J MOL BIOL, V368, P1087, DOI 10.1016/j.jmb.2007.02.071; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008	48	85	88	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1014	U2		10.1038/nature06235	http://dx.doi.org/10.1038/nature06235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960235	Green Accepted			2022-12-24	WOS:000250395000043
J	Gofflot, F; Chartoire, N; Vasseur, L; Heikkinen, S; Dembele, D; Le Merrer, J; Auwerx, J				Gofflot, Francoise; Chartoire, Nathalie; Vasseur, Laurent; Heikkinen, Sami; Dembele, Doulaye; Le Merrer, Julie; Auwerx, Johan			Systematic gene expression mapping clusters nuclear receptors according to their function in the brain	CELL			English	Article							ESTROGEN-RECEPTORS; MICE LACKING; BODY-WEIGHT; FOOD-INTAKE; MEMORY; MOUSE; HIPPOCAMPUS; ALPHA; RAT; PATTERNS	Nuclear receptors (NRs) compose a large family of transcription factors that operate at the interface between genes and environment, acting as sensors and effectors that translate endocrine and metabolic cues into well-defined gene expression programs. We report here on a systematic quantitative and anatomical expression atlas of the 49 NR genes in 104 regions of the adult mouse brain, organized in the interactive MousePat database. MousePat defines NR expression patterns to cellular resolution, a requirement for functional genomic strategies to understand the function of a highly heterogeneous and complex organ such as the brain. Using MousePat data, NR expression patterns can be clustered into anatomical and regulatory networks that delineate the role of NRs in brain functions, like the control of feeding and learning/ memory. Mining the MousePat resource will improve the understanding of NR function in the brain and elucidate hierarchical networks that control behavior and whole body homeostasis.	Inst Clin Souris, F-67404 Iiikirch, France; Univ Strasbourg 1, INSERM, CNRS, Inst Genet Biol Mol & Cellulaire, F-67404 Iiikirch, France; Univ Kuopio, AI Virtanen Inst & Biol Mol & Cellulaire, Kuopio 70211, Finland	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Eastern Finland	Gofflot, F (corresponding author), Inst Clin Souris, F-67404 Iiikirch, France.	auwerx@igbmc.u-strasbg.fr	Le Merrer, Julie/P-3648-2016; stephan, aline/A-5613-2010; Dembélé, Doulaye/O-6513-2017; Auwerx, Johan/ABE-9307-2021; Heikkinen, Sami P/L-1460-2013	Le Merrer, Julie/0000-0002-8670-4273; Dembélé, Doulaye/0000-0003-3879-6940; Heikkinen, Sami P/0000-0002-6083-2402; Auwerx, Johan/0000-0002-5065-5393				Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Chotteau-Lelievre Anne, 2006, Methods Mol Biol, V326, P61; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; FULTON JOHN F., 1954, QUART BULL NORTHWESTERN UNIV MED SCH, V28, P10; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Herzig U, 2001, NOVART FDN SYMP, V239, P129; Hof PR., 2000, COMP CYTOARCHITECTON; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Jiang X, 2004, J BIOL CHEM, V279, P38480, DOI 10.1074/jbc.M403948200; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Koester SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-212; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-19; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ponnio T, 2004, MOL CELL BIOL, V24, P9070, DOI 10.1128/MCB.24.20.9070-9078.2004; REEVES AG, 1969, ARCH NEUROL-CHICAGO, V20, P616, DOI 10.1001/archneur.1969.00480120062005; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Stallings NR, 2002, MOL ENDOCRINOL, V16, P2360, DOI 10.1210/me.2002-0003; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Vasudevan N, 2005, ENDOCRINE, V26, P25, DOI 10.1385/ENDO:26:1:025; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; WEILAND NG, 1992, ENDOCRINOLOGY, V131, P2697, DOI 10.1210/en.131.6.2697; Werme M, 2000, MOL BRAIN RES, V76, P18, DOI 10.1016/S0169-328X(99)00327-7; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Wilcoxon JS, 2007, BEHAV BRAIN RES, V177, P109, DOI 10.1016/j.bbr.2006.10.030; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zurkovsky L, 2006, NEUROBIOL LEARN MEM, V86, P336, DOI 10.1016/j.nlm.2006.07.008	49	128	137	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					405	418		10.1016/j.cell.2007.09.012	http://dx.doi.org/10.1016/j.cell.2007.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956739	Bronze			2022-12-24	WOS:000250507700028
J	Lemos, B; Araripe, LO; Hartl, DL				Lemos, Bernardo; Araripe, Luciana O.; Hartl, Daniel L.			Polymorphic Y chromosomes harbor cryptic variation with manifold functional consequences	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER HETEROCHROMATIN; GENE COPY NUMBER; SEX-CHROMOSOMES; MALE-STERILITY; MALE FITNESS; EVOLUTION; POPULATIONS; EXPRESSION; CHROMATIN; SIMULANS	The paucity of polymorphisms in single- copy genes on the Y chromosome of Drosophila contrasts with data indicating that this chromosome has polymorphic phenotypic effects on sex ratio, temperature sensitivity, behavior, and fitness. We show that the Y chromosome of D. melanogaster harbors substantial genetic diversity in the form of polymorphisms for genetic elements that differentially affect the expression of hundreds of X- linked and autosomal genes. The affected genes are more highly expressed in males, more meagerly expressed in females, and more highly divergent between species. Functionally, they affect microtubule stability, lipid and mitochondrial metabolism, and the thermal sensitivity of spermatogenesis. Our findings provide a mechanism for adaptive phenotypic variation associated with the Y chromosome.	[Lemos, Bernardo; Araripe, Luciana O.; Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Lemos, B (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	blemos@oeb.harvard.edu	Lemos, Bernardo/AAL-2429-2020	Lemos, Bernardo/0000-0001-6996-9483; O Araripe, Luciana/0000-0001-5878-1792	NIGMS NIH HHS [GM068465, GM065169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068465, R01GM065169] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Carvalho AB, 1997, GENETICS, V146, P891; Charlesworth D, 2005, CURR BIOL, V15, pR129, DOI 10.1016/j.cub.2005.02.011; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; CLARK AG, 1990, GENETICS, V125, P527; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Hartl D., 2007, PRINCIPLES POPULATIO; Huttunen S, 2003, BEHAV GENET, V33, P17, DOI 10.1023/A:1021095331850; Liu XW, 2007, J BIOL CHEM, V282, P20868, DOI 10.1074/jbc.M702547200; LYCKEGAARD EMS, 1991, MOL BIOL EVOL, V8, P458; LYCKEGAARD EMS, 1989, P NATL ACAD SCI USA, V86, P1944, DOI 10.1073/pnas.86.6.1944; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Montchamp-Moreau C, 2001, EVOLUTION, V55, P728, DOI 10.1554/0014-3820(2001)055[0728:TYCODS]2.0.CO;2; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Schulze SR, 2007, ANNU REV ENTOMOL, V52, P171, DOI 10.1146/annurev.ento.51.110104.151007; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Stoltenberg SF, 1997, ANIM BEHAV, V53, P853, DOI 10.1006/anbe.1996.0351; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Zurovcova M, 1999, GENETICS, V153, P1709	28	173	173	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					91	93		10.1126/science.1148861	http://dx.doi.org/10.1126/science.1148861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174442				2022-12-24	WOS:000252084000038
J	Nash, DR; Als, TD; Maile, R; Jones, GR; Boomsma, JJ				Nash, David R.; Als, Thomas D.; Maile, Roland; Jones, Graeme R.; Boomsma, Jacobus J.			A mosaic of chemical coevolution in a large blue butterfly	SCIENCE			English	Article							HOST-ANT SPECIFICITY; MACULINEA-REBELI; LOCAL ADAPTATION; SOCIAL PARASITES; CUCULUS-CANORUS; CUCKOO; ALCON; CATERPILLARS; COLONIES	Mechanisms of recognition are essential to the evolution of mutualistic and parasitic interactions between species. One such example is the larval mimicry that Maculinea butterfly caterpillars use to parasitize Myrmica ant colonies. We found that the greater the match between the surface chemistry of Maculinea alcon and two of its host Myrmica species, the more easily ant colonies were exploited. The geographic patterns of surface chemistry indicate an ongoing coevolutionary arms race between the butterflies and Myrmica rubra, which has significant genetic differentiation between populations, but not between the butterflies and a second, sympatric host, Myrmica ruginodis, which has panmictic populations. Alternative hosts may therefore provide an evolutionary refuge for a parasite during periods of counteradaptation by their preferred hosts.	[Nash, David R.; Boomsma, Jacobus J.] Univ Copenhagen, Inst Biol, DK-2100 Copenhagen, Denmark; [Als, Thomas D.] Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus C, Denmark; [Maile, Roland; Jones, Graeme R.] Univ Keele, Sch Chem, Keele ST5 5BG, Staffs, England	University of Copenhagen; Aarhus University; Keele University	Nash, DR (corresponding author), Univ Copenhagen, Inst Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.	DRNash@bi.ku.dk	Nash, David R./B-2916-2009; Boomsma, Jacobus J/M-2785-2014	Nash, David R./0000-0002-0462-6794; Boomsma, Jacobus J/0000-0002-3598-1609				Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Als TD, 2002, ECOL ENTOMOL, V27, P403, DOI 10.1046/j.1365-2311.2002.00427.x; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; D'Ettorre P, 2002, P ROY SOC B-BIOL SCI, V269, P1911, DOI 10.1098/rspb.2002.2110; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; Elmes Graham W., 1994, Memorabilia Zoologica, V48, P55; Elmes GW, 2004, ENTOMOL EXP APPL, V110, P53, DOI 10.1111/j.0013-8703.2004.00121.x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Foitzik S, 2003, BEHAV ECOL, V14, P80, DOI 10.1093/beheco/14.1.80; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Holldobler B., 1990, pi; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Michener C.D., 2000, BEES WORLD, V1st; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Nuismer SL, 2006, EVOLUTION, V60, P24, DOI 10.1111/j.0014-3820.2006.tb01078.x; SEPPA P, 1995, HEREDITY, V74, P200, DOI 10.1038/hdy.1995.28; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas Jeremy, 1999, British Wildlife, V11, P22; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Turillazzi S., 1996, NATURAL HIST EVOLUTI; van Swaay C. M., 1999, RED DATA BOOK EUROPE; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Wynhoff I, 1998, J INSECT CONSERV, V2, P47, DOI 10.1023/A:1009692723056	27	140	146	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2008	319	5859					88	90		10.1126/science.1149180	http://dx.doi.org/10.1126/science.1149180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174441				2022-12-24	WOS:000252084000037
J	Hambley, TW				Hambley, Trevor W.			Chemistry - Metal-based therapeutics	SCIENCE			English	Editorial Material							COMPLEXES; CYTOTOXICITY; INHIBITORS		Univ Sydney, Sch Chem, Ctr Heavy Met Res, Sydney, NSW 2006, Australia	University of Sydney	Hambley, TW (corresponding author), Univ Sydney, Sch Chem, Ctr Heavy Met Res, Sydney, NSW 2006, Australia.	t.hambley@chem.usyd.edu.au						Ang WH, 2005, J AM CHEM SOC, V127, P1382, DOI 10.1021/ja0432618; Barnard PJ, 2007, COORDIN CHEM REV, V251, P1889, DOI 10.1016/j.ccr.2007.04.006; Barnes KR, 2004, CHEM BIOL, V11, P557, DOI 10.1016/j.chembiol.2004.03.024; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Davies NM, 2004, J PHARM PHARM SCI, V7, P332; *DURH U, 2007, DALT DISC, V10; Failes TW, 2007, CHEM-EUR J, V13, P2974, DOI 10.1002/chem.200601137; Grimley J, 2006, CHEM ENG NEWS, V84, P17, DOI 10.1021/cen-v084n049.p017; HAMBLEY TW, 2007, J CHEM SOC DA, P4929; Hutchinson E, 2006, NAT REV DRUG DISCOV, V5, P720, DOI 10.1038/nrd2142; Kabolizadeh P, 2007, BIOCHEM PHARMACOL, V73, P1270, DOI 10.1016/j.bcp.2006.12.016; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sessler J.L., 2003, MED INORGANIC CHEM; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Thompson KH, 2003, SCIENCE, V300, P936, DOI 10.1126/science.1083004; Ware DC, 2000, J CHEM SOC DALTON, P925, DOI 10.1039/a909447d; Weder JE, 2002, COORDIN CHEM REV, V232, P95, DOI 10.1016/S0010-8545(02)00086-3	17	180	183	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1392	1393		10.1126/science.1150504	http://dx.doi.org/10.1126/science.1150504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048674				2022-12-24	WOS:000251246100028
J	Romer, W; Berland, L; Chambon, V; Gaus, K; Windschiegl, B; Tenza, D; Aly, MRE; Fraisier, V; Florent, JC; Perrais, D; Lamaze, C; Raposo, G; Steinem, C; Sens, P; Bassereau, P; Johannes, L				Roemer, Winfried; Berland, Ludwig; Chambon, Valerie; Gaus, Katharina; Windschiegl, Barbara; Tenza, Daniele; Aly, Mohamed R. E.; Fraisier, Vincent; Florent, Jean-Claude; Perrais, David; Lamaze, Christophe; Raposo, Graca; Steinem, Claudia; Sens, Pierre; Bassereau, Patricia; Johannes, Ludger			Shiga toxin induces tubular membrane invaginations for its uptake into cells	NATURE			English	Article							RETROGRADE TRANSPORT; CRYSTAL-STRUCTURE; ENDOCYTOSIS; CURVATURE; DYNAMIN; PROTEINS; IDENTIFICATION; MECHANISMS; SEPARATION; CAVEOLAE	Clathrin seems to be dispensable for some endocytic processes and, in several instances, no cytosolic coat protein complexes could be detected at sites of membrane invagination. Hence, new principles must in these cases be invoked to account for the mechanical force driving membrane shape changes. Here we show that the Gb3 (glycolipid)-binding B-subunit of bacterial Shiga toxin induces narrow tubular membrane invaginations in human and mouse cells and model membranes. In cells, tubule occurrence increases on energy depletion and inhibition of dynamin or actin functions. Our data thus demonstrate that active cellular processes are needed for tubule scission rather than tubule formation. We conclude that the B-subunit induces lipid reorganization that favours negative membrane curvature, which drives the formation of inward membrane tubules. Our findings support a model in which the lateral growth of B-subunit-Gb3 microdomains is limited by the invagination process, which itself is regulated by membrane tension. The physical principles underlying this basic cargo-induced membrane uptake may also be relevant to other internalization processes, creating a rationale for conceptualizing the perplexing diversity of endocytic routes.	Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Physicochim, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Struct & Compartiments Membranaires, F-75248 Paris 05, France; Inst Curie, Ctr Rech, Lab Chim Organ Vectorisat, F-75248 Paris 05, France; Univ Paris 06, CNRS, UMR168, F-75252 Paris 05, France; CNRS, UMR176, F-75700 Paris, France; Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Hosp, Dept Haematol, Sydney, NSW 2031, Australia; Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; CNRS, UMR 5091, Lab Physiol Cellulaire Synapse, F-33077 Bordeaux, France; Univ Bordeaux 2, Inst Francois Magendie, F-33077 Bordeaux, France; CNRS, ESPCI, UMR Gulliver 7083, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of New South Wales Sydney; University of Gottingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Johannes, L (corresponding author), Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, 26 Rue Ulm, F-75248 Paris 05, France.	johannes@curie.fr	Steinem, Claudia/O-4801-2019; Perrais, David/W-9360-2019; Johannes, Ludger/M-9778-2017; Wunder, Stephanie L/B-5066-2012; sens, pierre/C-3537-2011; Lamaze, Christophe/M-4912-2017; Johannes, Ludger/W-8593-2019; Steinem, Claudia/K-7534-2018; Zdilla, Michael J/B-4145-2011; Bassereau, Patricia/P-8657-2018	Steinem, Claudia/0000-0001-8778-9283; Perrais, David/0000-0002-5878-5408; Johannes, Ludger/0000-0002-2168-0004; sens, pierre/0000-0003-4523-3791; Johannes, Ludger/0000-0002-2168-0004; Gaus, Katharina/0000-0002-8009-9658; Bassereau, Patricia/0000-0002-8544-6778; LAMAZE, Christophe/0000-0001-5430-2707; florent, jean-claude/0000-0001-9837-5094; Raposo, graca/0000-0001-9590-1298				Aly MRE, 2006, CARBOHYD RES, V341, P2026, DOI 10.1016/j.carres.2006.03.044; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bast DJ, 1999, MOL MICROBIOL, V32, P953, DOI 10.1046/j.1365-2958.1999.01405.x; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Figueroa-Perez S, 2000, CARBOHYD RES, V328, P95, DOI 10.1016/S0008-6215(00)00092-6; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hagnerelle X, 2002, J STRUCT BIOL, V139, P113, DOI 10.1016/S1047-8477(02)00504-X; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; ISRAELACHVILI J, 1991, INTRAMOLECULAR SUR 3; Jensen MH, 2007, LANGMUIR, V23, P8135, DOI 10.1021/la700647v; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manzoni L, 1998, J CARBOHYD CHEM, V17, P739, DOI 10.1080/07328309808002349; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; QIU DX, 1992, LIEBIGS ANN CHEM, P217; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sarasij RC, 2007, BIOPHYS J, V92, P3140, DOI 10.1529/biophysj.106.085662; Sarasij RC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.088101; SCHMIDT RR, 1986, TETRAHEDRON LETT, V27, P481, DOI 10.1016/S0040-4039(00)85510-0; Sens P, 2004, BIOPHYS J, V86, P2049, DOI 10.1016/S0006-3495(04)74266-6; Sens P, 2000, EUR PHYS J E, V1, P237, DOI 10.1007/s101890050026; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	50	444	446	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					670	U3		10.1038/nature05996	http://dx.doi.org/10.1038/nature05996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046403				2022-12-24	WOS:000251209700045
J	Diggle, SP; Griffin, AS; Campbell, GS; West, SA				Diggle, Stephen P.; Griffin, Ashleigh S.; Campbell, Genevieve S.; West, Stuart A.			Cooperation and conflict in quorum-sensing bacterial populations	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; COMPETITION; EVOLUTION; LACTONE; SIGNAL; IDENTIFICATION; COMMUNICATION; EXPRESSION; VIRULENCE; ALTRUISM	It has been suggested that bacterial cells communicate by releasing and sensing small diffusible signal molecules in a process commonly known as quorum sensing (QS)(1-4). It is generally assumed that QS is used to coordinate cooperative behaviours at the population level(3,5). However, evolutionary theory predicts that individuals who communicate and cooperate can be exploited(6-10). Here we examine the social evolution of QS experimentally in the opportunistic pathogen Pseudomonas aeruginosa, and show that although QS can provide a benefit at the group level, exploitative individuals can avoid the cost of producing the QS signal or of performing the cooperative behaviour that is coordinated by QS, and can therefore spread. We also show that a solution to the problem of exploitation is kin selection, if interacting bacterial cells tend to be close relatives. These results show that the problem of exploitation, which has been the focus of considerable attention in animal communication, also arises in bacteria.	Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Nottingham NG7 2RD, England; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Nottingham; University of Edinburgh	Diggle, SP (corresponding author), Univ Nottingham, Ctr Biomol Sci, Inst Infect Immun & Inflammat, Univ Pk, Nottingham NG7 2RD, England.	steve.diggle@nottingham.ac.uk; stu.west@ed.ac.uk	Griffin, Ashleigh/C-6244-2014; West, Stuart A/M-3608-2014	Griffin, Ashleigh/0000-0001-7674-9825; West, Stuart A/0000-0003-2152-3153				Brown SP, 2001, P ROY SOC B-BIOL SCI, V268, P961, DOI 10.1098/rspb.2001.1609; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; Fletcher MP, 2007, ENVIRON MICROBIOL, V9, P2683, DOI 10.1111/j.1462-2920.2007.01380.x; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Heurlier K, 2005, J BACTERIOL, V187, P4875, DOI 10.1128/JB.187.14.4875-4883.2005; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000	33	544	558	5	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					411	U7		10.1038/nature06279	http://dx.doi.org/10.1038/nature06279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004383				2022-12-24	WOS:000250918600053
J	Ramadan, K; Bruderer, R; Spiga, FM; Popp, O; Baur, T; Gotta, M; Meyer, HH				Ramadan, Kristijan; Bruderer, Roland; Spiga, Fabio M.; Popp, Oliver; Baur, Tina; Gotta, Monica; Meyer, Hemmo H.			Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin	NATURE			English	Article							CAENORHABDITIS-ELEGANS; AAA-ATPASE; MEMBRANE-FUSION; CONDENSIN-I; HISTONE H3; ENVELOPE; P97; PHOSPHORYLATION; ACTIVATION; UBIQUITIN	During division of metazoan cells, the nucleus disassembles to allow chromosome segregation, and then reforms in each daughter cell. Reformation of the nucleus involves chromatin decondensation and assembly of the double- membrane nuclear envelope around the chromatin; however, regulation of the process is still poorly understood(1,2). In vitro, nucleus formation requires p97 ( ref. 3), a hexameric ATPase implicated in membrane fusion and ubiquitin- dependent processes(4,5). However, the role and relevance of p97 in nucleus formation have remained controversial. Here we show that p97 stimulates nucleus reformation by inactivating the chromatin- associated kinase Aurora B. During mitosis, Aurora B inhibits nucleus reformation by preventing chromosome decondensation and formation of the nuclear envelope membrane. During exit from mitosis, p97 binds to Aurora B after its ubiquitylation and extracts it from chromatin. This leads to inactivation of Aurora B on chromatin, thus allowing chromatin decondensation and nuclear envelope formation. These data reveal an essential pathway that regulates reformation of the nucleus after mitosis and defines ubiquitin- dependent protein extraction as a common mechanism of Cdc48/p97 activity also during nucleus formation.	ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Meyer, HH (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	hemmo.meyer@bc.biol.ethz.ch	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Gotta, Monica/0000-0002-4336-7860; Spiga, Fabio/0000-0002-0541-3141; Bruderer, Roland/0000-0002-1049-5524				Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Lohka MJ, 1998, METHOD CELL BIOL, V53, P367; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Yamauchi S, 2006, BIOCHEM BIOPH RES CO, V345, P746, DOI 10.1016/j.bbrc.2006.04.160; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	33	204	211	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1258	U13		10.1038/nature06388	http://dx.doi.org/10.1038/nature06388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097415				2022-12-24	WOS:000251786200056
J	Chapman, RD; Heidemann, M; Albert, TK; Mailhammer, R; Flatley, A; Meisterernst, M; Kremmer, E; Eick, D				Chapman, Rob D.; Heidemann, Martin; Albert, Thomas K.; Mailhammer, Reinhard; Flatley, Andrew; Meisterernst, Michael; Kremmer, Elisabeth; Eick, Dirk			Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7	SCIENCE			English	Article							CARBOXYL-TERMINAL DOMAIN; LARGEST-SUBUNIT; TRANSCRIPTION; DELETION	RNA polymerase II is distinguished by its large carboxyl- terminal repeat domain ( CTD), composed of repeats of the consensus heptapeptide Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). Differential phosphorylation of serine-2 and serine-5 at the 5 ' and 3 ' regions of genes appears to coordinate the localization of transcription and RNA processing factors to the elongating polymerase complex. Using monoclonal antibodies, we reveal serine-7 phosphorylation on transcribed genes. This position does not appear to be phosphorylated in CTDs of less than 20 consensus repeats. The position of repeats where serine-7 is substituted influenced the appearance of distinct phosphorylated forms, suggesting functional differences between CTD regions. Our results indicate that restriction of serine-7 epitopes to the Linker- proximal region limits CTD phosphorylation patterns and is a requirement for optimal gene expression.	Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, D-81377 Munich, Germany; Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich	Eick, D (corresponding author), Munich Ctr Integrated Prot Sci, GSF Res Ctr Environm & Hlth, Inst Clin Mol Biol & Tumour Genet, Marchioninistr 25, D-81377 Munich, Germany.	eick@gsf.de		Albert, Thomas Karl/0000-0002-2488-0706				BARRONCASELLA E, 1992, J MOL EVOL, V35, P405, DOI 10.1007/BF00171818; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pei Y, 2001, J BIOL CHEM, V276, P28075, DOI 10.1074/jbc.M102170200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; WEST ML, 1995, GENETICS, V140, P1223	15	235	235	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1780	1782		10.1126/science.1145977	http://dx.doi.org/10.1126/science.1145977			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079404				2022-12-24	WOS:000251616800043
J	Yin, L; Wu, N; Curtin, JC; Qatanani, M; Szwergold, NR; Reid, RA; Waitt, GM; Parks, DJ; Pearce, KH; Wisely, GB; Lazar, MA				Yin, Lei; Wu, Nan; Curtin, Joshua C.; Qatanani, Mohammed; Szwergold, Nava R.; Reid, Robert A.; Waitt, Gregory M.; Parks, Derek J.; Pearce, Kenneth H.; Wisely, G. Bruce; Lazar, Mitchell A.			Rev-erb alpha, a heme sensor that coordinates metabolic and circadian pathways	SCIENCE			English	Article							WIDE EXPRESSION ANALYSIS; NUCLEAR RECEPTOR E75; CLOCK; TRANSCRIPTION; BIOSYNTHESIS; COMPONENT; BIOLOGY; OBESITY; BMAL1; MOUSE	The circadian clock temporally coordinates metabolic homeostasis in mammals. Central to this is heme, an iron- containing porphyrin that serves as prosthetic group for enzymes involved in oxidative metabolism as well as transcription factors that regulate circadian rhythmicity. The circadian factor that integrates this dual function of heme is not known. We show that heme binds reversibly to the orphan nuclear receptor Rev-erb alpha, a critical negative component of the circadian core clock, and regulates its interaction with a nuclear receptor corepressor complex. Furthermore, heme suppresses hepatic gluconeogenic gene expression and glucose output through Rev-erb alpha-mediated gene repression. Thus, Rev-erb alpha serves as a heme sensor that coordinates the cellular clock, glucose homeostasis, and energy metabolism.	Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; GlaxoSmithKline, Mol Discovery Res, Dept Computat & Struct Chem, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Mol Discovery Res, Dept Biol Reagents & Assay Dev, Res Triangle Pk, NC 27709 USA	University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline; GlaxoSmithKline	Lazar, MA (corresponding author), Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019		NIDDK NIH HHS [R01 DK45586] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Boehning D, 2002, SCIENCE, V298, P2339, DOI 10.1126/science.1080339; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; de Rosny E, 2006, BIOCHEMISTRY-US, V45, P9727, DOI 10.1021/bi060537a; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Ripperger Jurgen A, 2006, Chronobiol Int, V23, P135, DOI 10.1080/07420520500464411; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; SASSA S, 1983, J CLIN INVEST, V71, P625, DOI 10.1172/JCI110809; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	30	537	562	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1786	1789		10.1126/science.1150179	http://dx.doi.org/10.1126/science.1150179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18006707				2022-12-24	WOS:000251616800045
J	Kuijl, C; Savage, NDL; Marsman, M; Tuin, AW; Janssen, L; Egan, DA; Ketema, M; van den Nieuwendijk, R; van den Eeden, SJF; Geluk, A; Poot, A; van der Marel, G; Beijersbergen, RL; Overkleeft, H; Ottenhoff, THM; Neefjes, J				Kuijl, Coenraad; Savage, Nigel D. L.; Marsman, Marije; Tuin, Adriaan W.; Janssen, Lennert; Egan, David A.; Ketema, Mirjam; van den Nieuwendijk, Rian; van den Eeden, Susan J. F.; Geluk, Annemieke; Poot, Alex; van der Marel, Gijs; Beijersbergen, Roderick L.; Overkleeft, Hermen; Ottenhoff, Tom H. M.; Neefjes, Jacques			Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; ENTERICA SEROVAR TYPHIMURIUM; PROTEIN-KINASE; RNAI SCREEN; PHOSPHOINOSITIDE METABOLISM; GLUT4 TRANSLOCATION; MATURATION ARREST; EPITHELIAL-CELLS; GTPASE; INFECTION	With the emergence of multidrug resistant (MDR) bacteria, it is imperative to develop new intervention strategies. Current antibiotics typically target pathogen rather than host-specific biochemical pathways(1). Here we have developed kinase inhibitors that prevent intracellular growth of unrelated pathogens such as Salmonella typhimurium and Mycobacterium tuberculosis. An RNA interference screen of the human kinome using automated microscopy revealed several host kinases capable of inhibiting intracellular growth of S. typhimurium. The kinases identified clustered in one network around AKT1 (also known as PKB). Inhibitors of AKT1 prevent intracellular growth of various bacteria including MDR-M. tuberculosis. AKT1 is activated by the S. typhimurium effector SopB, which promotes intracellular survival by controlling actin dynamics through PAK4, and phagosome-lysosome fusion through the AS160 (also known as TBC1D4)-RAB14 pathway. AKT1 inhibitors counteract the bacterial manipulation of host signalling processes, thus controlling intracellular growth of bacteria. By using a reciprocal chemical genetics approach, we identified kinase inhibitors with antibiotic properties and their host targets, and we determined host signalling networks that are activated by intracellular bacteria for survival.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Leiden Med Univ Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; Leiden Med Univ Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Leiden Inst Chem, Bioorgan Chem Lab, NL-2300 RA Leiden, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University - Excl LUMC	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Janssen, Lennert/0000-0001-9705-0204; Overkleeft, Herman/0000-0001-6976-7005; Beijersbergen, Roderick/0000-0003-0116-4130; Kuijl, Coen/0000-0003-4378-1428				Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kashina AS, 2004, CURR BIOL, V14, P1877, DOI 10.1016/j.cub.2004.10.003; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Meresse S, 1999, EMBO J, V18, P4394, DOI 10.1093/emboj/18.16.4394; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Patterson GH, 2004, METHODS, V32, P445, DOI 10.1016/j.ymeth.2003.10.006; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Rupper AC, 2001, J CELL SCI, V114, P1283; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Smith AC, 2007, J CELL BIOL, V176, P263, DOI 10.1083/jcb.200611056; STROM BL, 1995, CANCER, V76, P1747, DOI 10.1002/1097-0142(19951115)76:10<1747::AID-CNCR2820761011>3.0.CO;2-L; Uchiya K, 2004, INFECT IMMUN, V72, P6860, DOI 10.1128/IAI.72.12.6860-6869.2004; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vesterlund S, 2004, J MICROBIOL METH, V57, P23, DOI 10.1016/j.mimet.2003.11.014; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	48	246	258	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					725	U10		10.1038/nature06345	http://dx.doi.org/10.1038/nature06345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046412	Green Published			2022-12-24	WOS:000251209700055
J	Chalasani, SH; Chronis, N; Tsunozaki, M; Gray, JM; Ramot, D; Goodman, MB; Bargmann, CI				Chalasani, Sreekanth H.; Chronis, Nikos; Tsunozaki, Makoto; Gray, Jesse M.; Ramot, Daniel; Goodman, Miriam B.; Bargmann, Cornelia I.			Dissecting a circuit for olfactory behaviour in Caenorhabditis elegans	NATURE			English	Article							GLR-1 GLUTAMATE-RECEPTOR; GATED CHLORIDE CHANNEL; STEP-RESPONSE ANALYSIS; C-ELEGANS; NEURAL ACTIVITY; NERVOUS-SYSTEM; NEURONS ENCODE; THERMOTAXIS; CHEMOTAXIS; EXPRESSION	Although many properties of the nervous system are shared among animals and systems, it is not known whether different neuronal circuits use common strategies to guide behaviour. Here we characterize information processing by Caenorhabditis elegans olfactory neurons (AWC) and interneurons (AIB and AIY) that control food- and odour-evoked behaviours. Using calcium imaging and mutations that affect specific neuronal connections, we show that AWC neurons are activated by odour removal and activate the AIB interneurons through AMPA-type glutamate receptors. The level of calcium in AIB interneurons is elevated for several minutes after odour removal, a neuronal correlate to the prolonged behavioural response to odour withdrawal. The AWC neuron inhibits AIY interneurons through glutamate-gated chloride channels; odour presentation relieves this inhibition and results in activation of AIY interneurons. The opposite regulation of AIY and AIB interneurons generates a coordinated behavioural response. Information processing by this circuit resembles information flow from vertebrate photoreceptors to 'OFF' bipolar and 'ON' bipolar neurons, indicating a conserved or convergent strategy for sensory information processing.	Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; Stanford Univ, Program Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Rockefeller University; Stanford University; Stanford University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu	CHRONIS, NIKOS/AAJ-5084-2021	CHRONIS, NIKOS/0000-0003-3830-1979; Bargmann, Cornelia/0000-0002-8484-0618; Goodman, Miriam B./0000-0002-5810-1272	NINDS NIH HHS [R01 NS047715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chou JH, 2001, GENETICS, V157, P211; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; DAVIS RE, 1989, J NEUROSCI, V9, P415; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dillon J, 2006, BIOCHEM SOC T, V34, P942, DOI 10.1042/BST0340942; DUSENBERY DB, 1980, J COMP PHYSIOL, V136, P327, DOI 10.1007/BF00657352; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GRANT GB, 1995, J NEUROSCI, V15, P3852; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Horoszok L, 2001, BRIT J PHARMACOL, V132, P1247, DOI 10.1038/sj.bjp.0703937; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Ryu WS, 2002, J NEUROSCI, V22, P5727; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wenick AS, 2004, DEV CELL, V6, P757, DOI 10.1016/j.devcel.2004.05.004; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Zariwala HA, 2003, J NEUROSCI, V23, P4369; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	50	399	412	5	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					63	+		10.1038/nature06292	http://dx.doi.org/10.1038/nature06292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972877				2022-12-24	WOS:000250585800036
J	Weiss, LA; Shen, YP; Korn, JM; Arking, DE; Miller, DT; Fossdal, R; Saemundsen, E; Stefansson, H; Ferreira, MAR; Green, T; Platt, OS; Ruderfer, DM; Walsh, CA; Altshuler, D; Chakravarti, A; Tanzi, RE; Stefansson, K; Santangelo, SL; Gusella, JF; Sklar, P; Wu, B; Daly, MJ				Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Arking, Dan E.; Miller, David T.; Fossdal, Ragnheidur; Saemundsen, Evald; Stefansson, Hreinn; Ferreira, Manuel A. R.; Green, Todd; Platt, Orah S.; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Chakravarti, Aravinda; Tanzi, Rudolph E.; Stefansson, Kari; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.		Autism Consortium	Association between microdeletion and microduplication at 16p11.2 and autism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REARRANGEMENTS; DISORDERS; DUPLICATION; GENOME	Background: Autism spectrum disorder is a heritable developmental disorder in which chromosomal abnormalities are thought to play a role. Methods: As a first component of a genomewide association study of families from the Autism Genetic Resource Exchange (AGRE), we used two novel algorithms to search for recurrent copy-number variations in genotype data from 751 multiplex families with autism. Specific recurrent de novo events were further evaluated in clinical-testing data from Children's Hospital Boston and in a large population study in Iceland. Results: Among the AGRE families, we observed five instances of a de novo deletion of 593 kb on chromosome 16p11.2. Using comparative genomic hybridization, we observed the identical deletion in 5 of 512 children referred to Children's Hospital Boston for developmental delay, mental retardation, or suspected autism spectrum disorder, as well as in 3 of 299 persons with autism in an Icelandic population; the deletion was also carried by 2 of 18,834 unscreened Icelandic control subjects. The reciprocal duplication of this region occurred in 7 affected persons in AGRE families and 4 of the 512 children from Children's Hospital Boston. The duplication also appeared to be a high-penetrance risk factor. Conclusions: We have identified a novel, recurrent microdeletion and a reciprocal microduplication that carry substantial susceptibility to autism and appear to account for approximately 1% of cases. We did not identify other regions with similar aggregations of large de novo mutations. `	[Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Altshuler, David; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Weiss, Lauren A.; Shen, Yiping; Korn, Joshua M.; Miller, David T.; Green, Todd; Platt, Orah S.; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Autism Consortium, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Weiss, Lauren A.; Platt, Orah S.; Walsh, Christopher A.; Altshuler, David; Tanzi, Rudolph E.; Santangelo, Susan L.; Gusella, James F.; Sklar, Pamela; Wu, Bai-Lin; Daly, Mark J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Shen, Yiping; Miller, David T.; Platt, Orah S.; Walsh, Christopher A.; Wu, Bai-Lin] Harvard Univ, Sch Publ Hlth, Dept Lab Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Shen, Yiping; Miller, David T.; Platt, Orah S.; Walsh, Christopher A.; Wu, Bai-Lin] Harvard Univ, Sch Publ Hlth, Div Genet, Childrens Hosp Boston, Boston, MA 02115 USA; [Santangelo, Susan L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Weiss, Lauren A.; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, Broad Inst Harvard, Cambridge, MA 02138 USA; [Weiss, Lauren A.; Korn, Joshua M.; Ferreira, Manuel A. R.; Green, Todd; Ruderfer, Douglas M.; Walsh, Christopher A.; Altshuler, David; Gusella, James F.; Sklar, Pamela; Daly, Mark J.] Harvard Univ, MIT, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02139 USA; [Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Fossdal, Ragnheidur; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Saemundsen, Evald] State Diagnost & Counseling Ctr, Kopavogur, Iceland; [Ferreira, Manuel A. R.] Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld, Australia	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Johns Hopkins University; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Daly, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu	Ferreira, Manuel A R/D-3609-2013; Warfield, Simon/B-3352-2009; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Ruderfer, Douglas M/M-5795-2016; Stefansson, Kari/AAE-7187-2019; Tanzi, Rudolph/AAE-9622-2019	Ferreira, Manuel A R/0000-0001-9059-1825; Warfield, Simon/0000-0002-7659-3880; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Tanzi, Rudolph/0000-0002-7032-1454; Stefansson, Hreinn/0000-0002-9331-6666; Graybiel, Ann/0000-0002-4326-7720	OMHHE CDC HHS [R01-MN071425-01A1] Funding Source: Medline	OMHHE CDC HHS		Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Berg JS, 2007, GENET MED, V9, P427, DOI 10.1097/GIM.0b013e3180986192; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Finelli P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016311; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Hernando C, 2002, J Med Genet, V39, pE24, DOI 10.1136/jmg.39.5.e24; KIM HG, IN PRESS AM J HUM GE; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	17	1188	1248	0	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2008	358	7					667	675		10.1056/NEJMoa075974	http://dx.doi.org/10.1056/NEJMoa075974			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262CX	18184952				2022-12-24	WOS:000253127700003
J	Houweling, AR; Brecht, M				Houweling, Arthur R.; Brecht, Michael			Behavioural report of single neuron stimulation in somatosensory cortex	NATURE			English	Article							IN-VIVO; CORTICAL MICROSTIMULATION; NEOCORTICAL NEURONS; WHISKER DEFLECTION; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; RAT; REPRESENTATION; DISCRIMINATION; POPULATION	Understanding how neural activity in sensory cortices relates to perception is a central theme of neuroscience. Action potentials of sensory cortical neurons can be strongly correlated to properties of sensory stimuli(1) and reflect the subjective judgements of an individual about stimuli(2). Microstimulation experiments have established a direct link from sensory activity to behaviour(3,4), suggesting that small neuronal populations can influence sensory decisions(5). However, microstimulation does not allow identification and quantification of the stimulated cellular elements(6). The sensory impact of individual cortical neurons therefore remains unknown. Here we show that stimulation of single neurons in somatosensory cortex affects behavioural responses in a detection task. We trained rats to respond to microstimulation of barrel cortex at low current intensities. We then initiated short trains of action potentials in single neurons by juxtacellular stimulation. Animals responded significantly more often in single- cell stimulation trials than in catch trials without stimulation. Stimulation effects varied greatly between cells, and on average in 5% of trials a response was induced. Whereas stimulation of putative excitatory neurons led to weak biases towards responding, stimulation of putative inhibitory neurons led to more variable and stronger sensory effects. Reaction times for single- cell stimulation were long and variable. Our results demonstrate that single neuron activity can cause a change in the animal's detection behaviour, suggesting a much sparser cortical code for sensations than previously anticipated.	[Houweling, Arthur R.; Brecht, Michael] Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Houweling, Arthur R.; Brecht, Michael] Humboldt Univ, D-10115 Berlin, Germany; [Houweling, Arthur R.; Brecht, Michael] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Humboldt University of Berlin; Erasmus University Rotterdam; Erasmus MC	Houweling, AR (corresponding author), Bernstein Ctr Computat Neurosci, Philippstr 13,House 6, D-10115 Berlin, Germany.	arthur.houweling@bccn-berlin.de; michael.brecht@bccn-berlin.de		Brecht, Michael/0000-0002-5387-0953				Afraz SR, 2006, NATURE, V442, P692, DOI 10.1038/nature04982; BARTLETT JR, 1980, ACTA NEUROBIOL EXP, V40, P713; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KRAUSS A, 2003, ANN M SOC NEUR; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Penfield W, 1950, CEREBRAL CORTEX MAN; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rieke F., 1997, SPIKES EXPLORING NEU; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; SWADLOW HA, 1992, J NEUROPHYSIOL, V68, P605, DOI 10.1152/jn.1992.68.2.605; Talwar SK, 1998, HEARING RES, V126, P135, DOI 10.1016/S0378-5955(98)00162-2; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; VALLBO AB, 1984, BRAIN, V107, P727, DOI 10.1093/brain/107.3.727; WARREN RA, 1992, SOMATOSENS MOT RES, V9, P297, DOI 10.3109/08990229209144779; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Zilles Karl, 1995, P649	31	291	293	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					65	U8		10.1038/nature06447	http://dx.doi.org/10.1038/nature06447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18094684				2022-12-24	WOS:000252079300034
J	Takai, H; Wang, RC; Takai, KK; Yang, H; de Lange, T				Takai, Hiroyuki; Wang, Richard C.; Takai, Kaori K.; Yang, Haijuan; de lange, Titia			TeI2 regulates the stability of PI3K-related protein kinases	CELL			English	Article							TELOMERE LENGTH REGULATION; SACCHAROMYCES-CEREVISIAE; ATAXIA-TELANGIECTASIA; C-ELEGANS; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE; MTOR; CHECKPOINT; MOUSE	We report an unexpected role for Tel2 in the expression of all mammalian phosphatidylinositol 3-kinase-related protein kinases (PIKKs). Although Tel2 was identified as a budding yeast gene required for the telomere length maintenance, we found no obvious telomeric function for mammalian Tel2. Targeted gene deletion showed that mouse Tel2 is essential in embryonic development, embryonic stem (ES) cells, and embryonic fibroblasts. Conditional deletion of Tel2 from embryonic fibroblasts compromised their response to IR and UV, diminishing the activation of checkpoint kinases and their downstream effectors. The effects of Tel2 deletion correlated with significantly reduced protein levels for the PI3K-related kinases ataxia telangiectasia mutated (ATM), ATM and Rad3 related (ATR), DNA-dependent protein kinase catalytic subunit ataxia (DNA-PKcs). Tel2 deletion also elicited specific depletion of the mammalian target of rapamycin (mTOR), suppressor with morphological effect on genitalia 1 (SMG1), and transformation/transcription domain-associated protein (TRRAP), and curbed mTOR signaling, indicating that Tel2 affects all six mammalian PIKKs. While Tel2 deletion did not alter PIKK mRNA levels, in vivo pulse labeling experiments showed that Tel2 controls the stability of ATM and mTOR. Each of the PIKK family members associated with Tel2 in vivo and in vitro experiments indicated that Tel2 binds to part of the HEAT repeat segments of ATM and mTOR. These data identify Tel2 as a highly conserved regulator of PIKK stability.	[Takai, Hiroyuki; Wang, Richard C.; Takai, Kaori K.; de lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA; [Yang, Haijuan] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@rockefeller.edu	Wang, Richard/AAW-3066-2021; Takai, Hiroyuki/B-8352-2011; de Lange, Titia/B-8263-2011	Wang, Richard/0000-0003-4543-8295; de Lange, Titia/0000-0002-9267-367X	NCI NIH HHS [K08 CA164047, CA076027] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA164047, R01CA076027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Badea TC, 2003, J NEUROSCI, V23, P2314; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Benard C, 2001, DEVELOPMENT, V128, P4045; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; HARTMAN PS, 1982, GENETICS, V102, P159; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herceg Z, 2005, CELL CYCLE, V4, P383, DOI 10.4161/cc.4.3.1546; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LAVIN MF, 1995, TRENDS BIOCHEM SCI, V20, P382, DOI 10.1016/S0968-0004(00)89083-0; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Runge KW, 1996, MOL CELL BIOL, V16, P3094; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360	44	173	178	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1248	1259		10.1016/j.cell.2007.10.052	http://dx.doi.org/10.1016/j.cell.2007.10.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160036	Bronze			2022-12-24	WOS:000252217200015
J	Beyer, M; Nesterov, A; Block, I; Konig, K; Felgenhauer, T; Fernandez, S; Leibe, K; Torralba, G; Hausmann, M; Trunk, U; Lindenstruth, V; Bischoff, FR; Stadler, V; Breitling, F				Beyer, Mario; Nesterov, Alexander; Block, Ines; Koenig, Kai; Felgenhauer, Thomas; Fernandez, Simon; Leibe, Klaus; Torralba, Gloria; Hausmann, Michael; Trunk, Ulrich; Lindenstruth, Volker; Bischoff, F. Ralf; Stadler, Volker; Breitling, Frank			Combinatorial synthesis of peptide arrays onto a microchip	SCIENCE			English	Article							PARALLEL CHEMICAL SYNTHESIS; SUPPORT		Univ Heidelberg, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Lindenstruth, V (corresponding author), Univ Heidelberg, Kirchhoff Inst Phys, INF 227, D-69120 Heidelberg, Germany.	voli@kip.uni-heidelberg.de; r.bischoff@dkfz.de; v.stadler@dkfz.de; f.breitling@dkfz.de	Nesterov-Mueller, Alexander/H-1333-2013; /I-1543-2013; Block, Ines/Q-5507-2016	Block, Ines/0000-0003-1964-6031; Nesterov-Mueller, Alexander/0000-0001-8446-2728				Beyer M, 2006, BIOMATERIALS, V27, P3505, DOI 10.1016/j.biomaterials.2006.01.046; Egeland RD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni117; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Heller MJ, 2000, ELECTROPHORESIS, V21, P157, DOI 10.1002/(SICI)1522-2683(20000101)21:1<157::AID-ELPS157>3.0.CO;2-E; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723	6	100	108	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1888	1888		10.1126/science.1149751	http://dx.doi.org/10.1126/science.1149751			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096799				2022-12-24	WOS:000251786600048
J	Euston, DR; Tatsuno, M; McNaughton, BL				Euston, David R.; Tatsuno, Masami; McNaughton, Bruce L.			Fast-forward playback of recent memory sequences in prefrontal cortex during sleep	SCIENCE			English	Article							SLOW-WAVE SLEEP; REM-SLEEP; CONSOLIDATION; REACTIVATION; HIPPOCAMPUS; EXPERIENCE; REPLAY; TRACE; REORGANIZATION; COMPRESSION	As previously shown in the hippocampus and other brain areas, patterns of firing-rate correlations between neurons in the rat medial prefrontal cortex during a repetitive sequence task were preserved during subsequent sleep, suggesting that waking patterns are reactivated. We found that, during sleep, reactivation of spatiotemporal patterns was coherent across the network and compressed in time by a factor of 6 to 7. Thus, when behavioral constraints are removed, the brain's intrinsic processing speed may be much faster than it is in real time. Given recent evidence implicating the medial prefrontal cortex in retrieval of long-term memories, the observed replay may play a role in the process of memory consolidation.	Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	University of Arizona	McNaughton, BL (corresponding author), Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA.	bruce@nsma.arizona.edu		Tatsuno, Masami/0000-0003-2698-2762	NIMH NIH HHS [MH046823] Funding Source: Medline; NINDS NIH HHS [NS020331] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046823, R01MH046823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SKAGGS WE, 1998, MULTIPLE CHANNEL REC, P235; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Takehara-Nishiuchi K, 2006, J NEUROSCI, V26, P5049, DOI 10.1523/JNEUROSCI.4381-05.2006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	33	356	364	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1147	1150		10.1126/science.1148979	http://dx.doi.org/10.1126/science.1148979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006749				2022-12-24	WOS:000250957900049
J	Galloway, LF; Etterson, JR				Galloway, Laura F.; Etterson, Julie R.			Transgenerational plasticity is adaptive in the wild	SCIENCE			English	Article							SHADE-AVOIDANCE RESPONSES; GERMINATION	Plants exhibit adaptive responses to light, but it is not known whether parental plants transmit environmental cues that elicit adaptive responses in offspring. We show that offspring life history (annual versus biennial) is influenced by the maternal light environment (understory versus light gap). This transgenerational plasticity is adaptive when offspring are grown in their maternal light environment, where seeds typically disperse. Projections of population growth show that plants that are appropriately cued for their light environment through maternal effects have 3.4 times greater fitness than otherwise. Transgenerational plasticity has evolved in response to natural variation in light and provides a flexible mechanism by which sedentary organisms cope with heterogeneous environments.	Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Virginia; University of Minnesota System; University of Minnesota Duluth	Galloway, LF (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	lgalloway@virginia.edu; jetterso@d.umn.edu		Etterson, Julie/0000-0001-6657-0610				Bell DL, 2007, FUNCT ECOL, V21, P1146, DOI 10.1111/j.1365-2435.2007.01327.x; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; Donohue K, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P137; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Galloway LF, 2003, HEREDITY, V90, P308, DOI 10.1038/sj.hdy.6800242; Galloway LF, 2002, INT J PLANT SCI, V163, P133, DOI 10.1086/324556; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Lacey EP, 2000, EVOLUTION, V54, P1207, DOI 10.1111/j.0014-3820.2000.tb00555.x; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Metcalf JC, 2003, TRENDS ECOL EVOL, V18, P471, DOI 10.1016/S0169-5347(03)00162-9; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff Derek, 2002, pi; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Schmitt J, 1995, AM NAT, V146, P937, DOI 10.1086/285832; Wardle GM, 1998, ECOLOGY, V79, P2539, DOI 10.1890/0012-9658(1998)079[2539:AGTATD]2.0.CO;2; Weinig C, 2000, EVOLUTION, V54, P124, DOI 10.1111/j.0014-3820.2000.tb00013.x; WILLSON MF, 1993, VEGETATIO, V108, P261	21	384	399	9	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1134	1136		10.1126/science.1148766	http://dx.doi.org/10.1126/science.1148766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006745				2022-12-24	WOS:000250957900045
J	Sharot, T; Riccardi, AM; Raio, CM; Phelps, EA				Sharot, Tali; Riccardi, Alison M.; Raio, Candace M.; Phelps, Elizabeth A.			Neural mechanisms mediating optimism bias	NATURE			English	Article							FUTURE LIFE EVENTS; PREFRONTAL CORTEX; CINGULATE CORTEX; AMYGDALA; SELF; EMOTION; ANXIETY; MEMORY; HEALTH	Humans expect positive events in the future even when there is no evidence to support such expectations. For example, people expect to live longer and be healthier than average(1), they underestimate their likelihood of getting a divorce(1), and overestimate their prospects for success on the job market(2). We examined how the brain generates this pervasive optimism bias. Here we report that this tendency was related specifically to enhanced activation in the amygdala and in the rostral anterior cingulate cortex when imagining positive future events relative to negative ones, suggesting a key role for areas involved in monitoring emotional salience in mediating the optimism bias. These are the same regions that show irregularities in depression(3), which has been related to pessimism(4). Across individuals, activity in the rostral anterior cingulate cortex was correlated with trait optimism. The current study highlights how the brain may generate the tendency to engage in the projection of positive future events, suggesting that the effective integration and regulation of emotional and autobiographical information supports the projection of positive future events in healthy individuals, and is related to optimism.	NYU, Dept Psychol, New York, NY 10003 USA; UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	New York University; University of London; University College London	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu	Raio, Candace/GON-5368-2022					Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cunningham WA, 2005, COGN AFFECT BEHAV NE, V5, P202, DOI 10.3758/CABN.5.2.202; D'Argembeau A, 2004, EMOTION, V4, P173, DOI 10.1037/1528-3542.4.2.173; DREVETS WC, 1997, NATURE, V386, P827; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HOCH S, 1984, J EXP PSYCHOL, V11, P719; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Lovallo D, 2003, HARVARD BUS REV, V81, P56; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1987, J PERS, V55, P169, DOI 10.1111/j.1467-6494.1987.tb00434.x; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816	27	421	437	1	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					102	+		10.1038/nature06280	http://dx.doi.org/10.1038/nature06280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17960136				2022-12-24	WOS:000250585800045
J	Hansen, AK; Wisborg, K; Uldbjerg, N; Henriksen, TB				Hansen, Anne Kirkeby; Wisborg, Kirsten; Uldbjerg, Niels; Henriksen, Tine Brink			Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTETRICIANS PERSONAL PREFERENCE; SPONTANEOUS LABOR; VAGINAL DELIVERY; LUNG LIQUID; DISTRESS; FETAL; ABSORPTION; PREGNANCY; REQUEST; HEALTH	Objective To investigate the association between elective Caesarean sections and neonatal respiratory morbidity and the importance of timing of elective Caesarean sections. Design Cohort study with prospectively collected data from the Aarhus birth cohort, Denmark. Setting Obstetric department and neonatal department of a university hospital in Denmark. Participants All liveborn babies without malformations, with gestational ages between 37 and 41 weeks, and delivered between 1 January 1998 and 31 December 2006 (34 458 pregnancies). Main outcome measures Respiratory morbidity (transitory tachypnoea of the newborn, respiratory distress syndrome, persistent pulmonary hypertension of the newborn) and serious respiratory morbidity (oxygen therapy for more than two days, nasal continuous positive airway pressure, or need for mechanical ventilation). Results 2687 infants were delivered by elective caesarean section. Compared with newborns intended for vaginal delivery, an increased risk of respiratory morbidity was found for infants delivered by elective Caesarean section at 37 weeks' gestation (odds ratio 3.9, 95% confidence interval 2.4 to 6.5), 38 weeks' gestation (3.0, 2.1 to 4.3), and 39 weeks' gestation (1.9, 1.2 to 3.0). The increased risks of serious respiratory morbidity showed the same pattern but with higher odds ratios: a fivefold increase was found at 37 weeks (5.0, 1.6 to16.0). These results remained essentially unchanged after exclusion of pregnancies complicated by diabetes, pre-eclampsia, and intrauterine growth retardation, or by breech presentation. Conclusion Compared with newborns delivered vaginally or by emergency caesarean sections, those delivered by elective Caesarean section around term have an increased risk of overall and serious respiratory morbidity. The relative risk increased with decreasing gestational age.	[Hansen, Anne Kirkeby] Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; [Wisborg, Kirsten; Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus N, Denmark; [Uldbjerg, Niels] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8200 Aarhus N, Denmark	Aarhus University; Aarhus University; Aarhus University	Hansen, AK (corresponding author), Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.	AKH@svf.au.dk	Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426				*ACOB COMM, 2003, OBSTET GYNECOL 1, V102, P1101; AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Bergholt T, 2004, ACTA OBSTET GYN SCAN, V83, P262, DOI 10.1111/j.0001-6349.2004.0312.x; BOWERS SK, 1982, AM J OBSTET GYNECOL, V143, P186, DOI 10.1016/0002-9378(82)90653-6; BROWN MJ, 1983, J PHYSIOL-LONDON, V344, P137, DOI 10.1113/jphysiol.1983.sp014929; COHEN M, 1985, OBSTET GYNECOL, V65, P818; FAXELIUS G, 1983, ARCH DIS CHILD, V58, P262, DOI 10.1136/adc.58.4.262; Hannah ME, 2004, CAN MED ASSOC J, V170, P813, DOI 10.1503/cmaj.1032002; Hansen AK, 2007, ACTA OBSTET GYN SCAN, V86, P389, DOI 10.1080/00016340601159256; IRESTEDT L, 1982, AM J OBSTET GYNECOL, V142, P1004, DOI 10.1016/0002-9378(82)90783-9; Jackson Nikki V., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P115; Kolas T, 2003, AM J OBSTET GYNECOL, V188, P864, DOI 10.1067/mob.2003.217; LAWSON EE, 1978, AM REV RESPIR DIS, V118, P1023; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Madar J, 1999, ACTA PAEDIATR, V88, P1244, DOI 10.1080/080352599750030365; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Scott JR, 2006, OBSTET GYNECOL, V107, P1222, DOI 10.1097/01.AOG.0000221482.51250.3c; Steer PJ, 2005, BMJ-BRIT MED J, V331, P645, DOI 10.1136/bmj.331.7518.645; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; WALTERS DV, 1978, PEDIATR RES, V12, P239, DOI 10.1203/00006450-197803000-00017; WENNERGREN M, 1986, BRIT J OBSTET GYNAEC, V93, P799; Wisborg K, 2003, BRIT MED J, V326, P420, DOI 10.1136/bmj.326.7386.420	24	366	391	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					85	87		10.1136/bmj.39405.539282.BE	http://dx.doi.org/10.1136/bmj.39405.539282.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	18077440	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000252494800030
J	Berry, DL; Baehrecke, EH				Berry, Deborah L.; Baehrecke, Eric H.			Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila	CELL			English	Article							STEROID REGULATION; DEATH; APOPTOSIS; INDUCTION; SIZE; CASPASES; SURVIVAL; MUTANTS; PATHWAY; DISEASE	Autophagy is a catabolic process that is negatively regulated by growth and has been implicated in cell death. We find that autophagy is induced following growth arrest and precedes developmental autophagic cell death of Drosophila salivary glands. Maintaining growth by expression of either activated Ras or positive regulators of the class I phosphoinositide 3-kinase (PI3K) pathway inhibits autophagy and blocks salivary gland cell degradation. Developmental degradation of salivary glands is also inhibited in autophagy gene (atg) mutants. Caspases are active in PI3K-expressing and atg mutant salivary glands, and combined inhibition of both autophagy and caspases increases suppression of gland degradation. Further, induction of autophagy is sufficient to induce premature cell death in a caspase-independent manner. Our results provide in vivo evidence that growth arrest, autophagy, and atg genes are required for physiological autophagic cell death and that multiple degradation pathways cooperate in the efficient clearance of cells during development.	[Berry, Deborah L.; Baehrecke, Eric H.] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA.	eric.baehrecke@umassmed.edu			NIGMS NIH HHS [R56 GM059136, R01 GM059136-09, R01 GM059136-10, R01 GM079431-01, R01 GM079431, GM59136, R01 GM059136-06, GM079431, R01 GM059136-08, R01 GM059136, R01 GM059136-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059136, R01GM079431, R56GM059136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FOX H, 1975, J EMBRYOL EXP MORPH, V34, P191; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Lee CY, 2001, DEVELOPMENT, V128, P1443; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Martin DN, 2007, CELL DEATH DIFFER, V14, P916, DOI 10.1038/sj.cdd.4402098; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schreiber AM, 2003, P NATL ACAD SCI USA, V100, P1769, DOI 10.1073/pnas.252774999; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	48	461	476	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1137	1148		10.1016/j.cell.2007.10.048	http://dx.doi.org/10.1016/j.cell.2007.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083103	Green Accepted, Bronze			2022-12-24	WOS:000252217100021
J	Kang, HJ; Coulibaly, F; Clow, F; Proft, T; Baker, EN				Kang, Hae Joo; Coulibaly, Fasseli; Clow, Fiona; Proft, Thomas; Baker, Edward N.			Stabilizing isopeptide bonds revealed in Gram-positive bacterial pilus structure	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN; PATHOGENESIS; ANTIGENS; ADHESION; COLLAGEN; BINDING; SURFACE; PILIN	Many bacterial pathogens have long, slender pili through which they adhere to host cells. The crystal structure of the major pilin subunit from the Gram- positive human pathogen Streptococcus pyogenes at 2.2 angstroms resolution reveals an extended structure comprising two all-beta domains. The molecules associate in columns through the crystal, with each carboxyl terminus adjacent to a conserved lysine of the next molecule. This lysine forms the isopeptide bonds that link the subunits in native pili, validating the relevance of the crystal assembly. Each subunit contains two lysine-asparagine isopeptide bonds generated by an intramolecular reaction, and we find evidence for similar isopeptide bonds in other cell surface proteins of Gram- positive bacteria. The present structure explains the strength and stability of such Gram- positive pili and could facilitate vaccine development.	Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; Univ Auckland, Sch Med Sci, Auckland 1023, New Zealand	University of Auckland; University of Auckland; University of Auckland	Proft, T (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand.	t.proft@auckland.ac.nz; ted.baker@auckland.ac.nz	Kang, H J/D-4845-2009; Proft, Thomas/H-4686-2019	Proft, Thomas/0000-0002-9275-5042; Coulibaly, Fasseli/0000-0003-3380-2117; Baker, Edward/0000-0003-2456-7661				Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LANCEFIELD RC, 1946, J EXP MED, V84, P449, DOI 10.1084/jem.84.5.449; Lancefield RC, 1940, J EXP MED, V71, P521, DOI 10.1084/jem.71.4.521; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	23	271	283	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1625	1628		10.1126/science.1145806	http://dx.doi.org/10.1126/science.1145806			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063798				2022-12-24	WOS:000251421700046
J	Fuentealba, LC; Eivers, E; Ikeda, A; Hurtado, C; Kuroda, H; Pera, EM; De Robertis, EM				Fuentealba, Luis C.; Eivers, Edward; Ikeda, Atsushi; Hurtado, Cecilia; Kuroda, Hiroki; Pera, Edgar M.; De Robertis, Edward M.			Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal	CELL			English	Article							NEURAL INDUCTION; BETA-CATENIN; SMAD1 PHOSPHORYLATION; SPEMANNS ORGANIZER; XENOPUS EMBRYOS; BMP; WNT; PATHWAYS; ACTIVATION; DIFFERENTIATION	BMP receptors determine the intensity of BMP signals via Smad1 C-terminal phosphorylations. Here we show that a finely controlled cell biological pathway terminates this activity. The duration of the activated pSmad1(Cter) signal was regulated by sequential Smad1 linker region phosphorylations at conserved MAPK and GSK3 sites required for its polyubiquitinylation and transport to the centrosome. Proteasomal degradation of activated Smad1 and total polyubiquitinated proteins took place in the centrosome. Inhibitors of the Erk, p38, and JNK MAPKs, as well as GSK3 inhibitors, prolonged the duration of a pulse of BMP7. Wnt signaling decreased pSmad1(GSK3) antigen levels and redistributed it from the centrosome to cytoplasmic LRP6 signalosomes. In Xenopus embryos, it was found that Wnts induce epidermis and that this required an active BMP-Smad pathway. Epistatic experiments suggested that the dorsoventral (BMP) and anteroposterior (Wnt/GSK3) patterning gradients are integrated at the level of Smad1 phosphorylations during embryonic pattern formation.	[Fuentealba, Luis C.; Eivers, Edward; Ikeda, Atsushi; Hurtado, Cecilia; Kuroda, Hiroki; Pera, Edgar M.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		De Robertis, Edward/0000-0002-7843-1869	NICHD NIH HHS [R01 HD021502, R37 HD021502, R01 HD021502-21A1, HD21502-21] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502, R37HD021502] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Beck CW, 2001, DEV BIOL, V238, P303, DOI 10.1006/dbio.2001.0407; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Koay MA, 2005, TRENDS MOL MED, V11, P129, DOI 10.1016/j.molmed.2005.01.004; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuroda H, 2005, GENE DEV, V19, P1022, DOI 10.1101/gad.1306605; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marcus EA, 1998, MOL CELL NEUROSCI, V12, P269, DOI 10.1006/mcne.1998.0713; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Wilson E.B., 1906, CELL DEV INHERITANCE; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	40	405	420	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					980	993		10.1016/j.cell.2007.09.027	http://dx.doi.org/10.1016/j.cell.2007.09.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045539	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000251800900019
J	Huen, MSY; Grant, R; Manke, I; Minn, K; Yu, XC; Yaffe, MB; Chen, JJ				Huen, Michael S. Y.; Grant, Robert; Manke, Isaac; Minn, Kay; Yu, Xiaochun; Yaffe, Michael B.; Chen, Junjie			RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly	CELL			English	Article							DOUBLE-STRAND BREAKS; RING FINGER PROTEIN; FHA DOMAIN; FANCONI-ANEMIA; UBIQUITIN STRUCTURES; GENOMIC STABILITY; REPAIR; BRCA1; MDC1; H2AX	DNA-damage signaling utilizes a multitude of posttranslational modifiers as molecular switches to regulate cell-cycle checkpoints, DNA repair, cellular senescence, and apoptosis. Here we show that RNF8, a FHA/RING domain-containing protein, plays a critical role in the early DNA-damage response. We have solved the X-ray crystal structure of the FHA domain structure at 1.35 angstrom. We have shown that RNF8 facilitates the accumulation of checkpoint mediator proteins BRCA1 and 53BP1 to the damaged chromatin, on one hand through the phospho-dependent FHA domain-mediated binding of RNF8 to MDC1, on the other hand via its role in ubiquitylating H2AX and possibly other substrates at damage sites. Moreover, RNF8-depleted cells displayed a defective G2/M checkpoint and increased IR sensitivity. Together, our study implicates RNF8 as a novel DNA-damage-responsive protein that integrates protein phosphorylation and ubiquitylation signaling and plays a critical role in the cellular response to genotoxic stress.	[Huen, Michael S. Y.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Grant, Robert; Manke, Isaac; Yaffe, Michael B.] Ctr Canc Res, MIT, Dept Biol & Biol Engn, Cambridge, MA 02132 USA; [Minn, Kay] Mayo Clin, Coll Med, Dept Oncol Res, Rochester, MN 55905 USA; [Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA	Yale University; Massachusetts Institute of Technology (MIT); Mayo Clinic; University of Michigan System; University of Michigan	Yu, XC (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	xiayu@med.umich.edu; myaffe@mit.edu; junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010	Huen, Michael Shing-Yan/0000-0003-1774-2425	NCI NIH HHS [CA100109, R01 CA100109, R01 CA089239-08, R01 CA100109-06, R01 CA092312-08, CA92312, R01 CA092312, P50 CA116201, CA89239, R01 CA089239] Funding Source: Medline; NIGMS NIH HHS [GM 60594, R01 GM060594] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA116201, R01CA089239, R01CA100109, R01CA092312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Li J, 2000, J CELL SCI, V113, P4143; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Takano Y, 2004, J BIOL CHEM, V279, P18926, DOI 10.1074/jbc.M309148200; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	47	797	832	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					901	914		10.1016/j.cell.2007.09.041	http://dx.doi.org/10.1016/j.cell.2007.09.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18001825	Green Accepted, Bronze			2022-12-24	WOS:000251800900013
J	Harvey, CD; Svoboda, K				Harvey, Christopher D.; Svoboda, Karel			Locally dynamic synaptic learning rules in pyramidal neuron dendrites	NATURE			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; PROTEIN-SYNTHESIS; HIPPOCAMPAL-NEURONS; CELL-TYPE; IN-VIVO; SPINES; MEMORY; SYNAPSES; LTP	Long- term potentiation ( LTP) of synaptic transmission underlies aspects of learning and memory. LTP is input- specific at the level of individual synapses, but neural network models predict interactions between plasticity at nearby synapses. Here we show in mouse hippocampal pyramidal cells that LTP at individual synapses reduces the threshold for potentiation at neighbouring synapses. After input- specific LTP induction by two- photon glutamate uncaging or by synaptic stimulation, subthreshold stimuli, which by themselves were too weak to trigger LTP, caused robust LTP and spine enlargement at neighbouring spines. Furthermore, LTP induction broadened the presynaptic - postsynaptic spike interval for spike- timing- dependent LTP within a dendritic neighbourhood. The reduction in the threshold for LTP induction lasted similar to 10 min and spread over similar to 10 mm of dendrite. These local interactions between neighbouring synapses support clustered plasticity models of memory storage and could allow for the binding of behaviourally linked information on the same dendritic branch.	HHMI, Ashburn, VA 20147 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mehta MR, 2004, TRENDS NEUROSCI, V27, P69, DOI 10.1016/j.tins.2003.12.004; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; POLOGRUTO TA, 2004, THESIS HARVARD U; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; YASUDA R, 2004, SCI STKE 2004; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	53	391	400	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1195	U3		10.1038/nature06416	http://dx.doi.org/10.1038/nature06416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097401	Green Accepted			2022-12-24	WOS:000251786200042
J	Larson, DM; Menssen, KM; Sharkey, SW; Duval, S; Schwartz, RS; Harris, J; Meland, JT; Unger, BT; Henry, TD				Larson, David M.; Menssen, Katie M.; Sharkey, Scott W.; Duval, Sue; Schwartz, Robert S.; Harris, James; Meland, Jeffrey T.; Unger, Barbara T.; Henry, Timothy D.			"False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; THROMBOLYTIC THERAPY; ELECTROCARDIOGRAM; EMERGENCY; DIAGNOSIS; SYSTEM	Context Allowing the emergency department physician to activate the cardiac catheterization laboratory is a key strategy to reduce door- to- balloon times in patients with ST- segment elevation myocardial infarction ( STEMI). There are limited data on the frequency of "false- positive" catheterization laboratory activation in patients undergoing percutaneous coronary intervention for suspected STEMI. Objective To determine the prevalence, etiology, and outcomes of false- positive cardiac catheterization laboratory activation in patients with a suspected STEMI. Design, Setting, and Patients Prospective registry from a regional system that includes transfer of patients with STEMI from 30 community and rural hospitals with pretransfer catheterization laboratory activation for percutaneous coronary intervention at a tertiary cardiovascular center in Minnesota. A total of 1345 patients were enrolled from March 2003 to November 2006. Main Outcome Measure Prevalence of false- positive catheterization laboratory activation in patients with suspected STEMI by 3 criteria: no culprit coronary artery, no significant coronary artery disease, and negative cardiac biomarker results. Results Of the 1335 patients with suspected STEMI who underwent angiography, 187 ( 14%; 95% confidence interval [ CI], 12.2%- 16.0%) had no culprit coronary artery and 127 ( 9.5%; 95% CI, 8.0%- 11.2%) did not have significant coronary artery disease. Cardiac biomarker levels were negative in 11.2% ( 95% CI, 9.6%-13.0%) of patients. The combination of no culprit artery with negative cardiac biomarker results was present in 9.2% ( 95% CI, 7.7%- 10.9%) of patients. Thirty- day mortality was 2.7% ( 95% CI, 0.4%- 5.0%) without vs 4.6% ( 95% CI, 3.4%- 5.8%) with a culprit coronary artery ( P =. 33). Conclusions The frequency of false- positive cardiac catheterization laboratory activation for suspected STEMI is relatively common in community practice, depending on the definition of false- positive. Recent emphasis on rapid door- to- balloon times must also consider the consequences of false- positive catheterization laboratory activation.	Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA; Ridgeview Med Ctr, Dept Emergency Med, Waconia, MN USA; Riverwood Healthcare Ctr, Aitkin, MN USA; Northfield Hosp, Northfield, MN USA; Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities	Henry, TD (corresponding author), Abbott NW Hosp, Minneapolis Heart Inst Fdn, 920 E 28th St,Ste 40, Minneapolis, MN 55407 USA.	henry003@umn.edu	Duval, Susan/AAI-1874-2020	Duval, Sue/0000-0003-1025-8665				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Barbagelata A, 2006, J ELECTROCARDIOL, V39, pS73, DOI 10.1016/j.jelectrocard.2006.06.006; BLANKENSHIP JC, 1989, J AM COLL CARDIOL, V14, P1579, DOI 10.1016/0735-1097(89)90402-6; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brady WJ, 2006, EMERG MED CLIN N AM, V24, P91, DOI 10.1016/j.emc.2005.08.004; Brady WJ, 2001, ACAD EMERG MED, V8, P349, DOI 10.1111/j.1553-2712.2001.tb02113.x; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Henry TD, 2005, AM HEART J, V150, P373, DOI 10.1016/j.ahj.2005.01.059; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; KAHN JK, 1993, CLIN CARDIOL, V16, P67, DOI 10.1002/clc.4960160115; Khoury NE, 1996, ANN EMERG MED, V28, P289, DOI 10.1016/S0196-0644(96)70027-6; Laissy JP, 2005, RADIOLOGY, V237, P75, DOI 10.1148/radiol.2371041322; Mahajan N, 2006, INT J CARDIOL, V111, P442, DOI 10.1016/j.ijcard.2005.08.029; MILLER DH, 1987, ARCH INTERN MED, V147, P257, DOI 10.1001/archinte.147.2.257; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; SHARKEY SW, 1994, AM J CARDIOL, V73, P550, DOI 10.1016/0002-9149(94)90331-X; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Turnipseed SD, 2006, ACAD EMERG MED, V13, P961, DOI 10.1197/j.aem.2006.04.014; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580; Zimetbaum PJ, 2003, NEW ENGL J MED, V348, P933, DOI 10.1056/NEJMra022700	26	231	235	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2007	298	23					2754	2760		10.1001/jama.298.23.2754	http://dx.doi.org/10.1001/jama.298.23.2754			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242HK	18165668	Bronze			2022-12-24	WOS:000251716000020
J	Whitcome, KK; Shapiro, LJ; Lieberman, DE				Whitcome, Katherine K.; Shapiro, Liza J.; Lieberman, Daniel E.			Fetal load and the evolution of lumbar lordosis in bipedal hominins	NATURE			English	Article							BACK-PAIN; PREGNANCY; SHAPE; SIZE; HOMO; MORPHOMETRICS; MORPHOLOGY; POSTURE; GROWTH; JOINTS	As predicted by Darwin(1), bipedal posture and locomotion are key distinguishing features of the earliest known hominins(2,3). Hominin axial skeletons show many derived adaptations for bipedalism, including an elongated lumbar region, both in the number of vertebrae and their lengths, as well as a marked posterior concavity of wedged lumbar vertebrae, known as a lordosis(4-6). The lordosis stabilizes the upper body over the lower limbs in bipeds by positioning the trunk's centre of mass ( COM) above the hips. However, bipedalism poses a unique challenge to pregnant females because the changing body shape and the extra mass associated with pregnancy shift the trunk's COM anterior to the hips. Here we show that human females have evolved a derived curvature and reinforcement of the lumbar vertebrae to compensate for this bipedal obstetric load. Similarly dimorphic morphologies in fossil vertebrae of Australopithecus suggest that this adaptation to fetal load preceded the evolution of Homo.	Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA	Harvard University; University of Texas System; University of Texas Austin	Whitcome, KK (corresponding author), Harvard Univ, Dept Anthropol, 11 Divin Ave, Cambridge, MA 02138 USA.	whitcome@fas.harvard.edu						ADAMS MA, 1980, J BONE JOINT SURG BR, V62, P358, DOI 10.1302/0301-620X.62B3.6447702; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; ARENSBURG B, 1991, SQUELETTE MOUSTERIEN, V2, P113; Bogduk N., 1997, CLIN ANATOMY LUMBAR, V3; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; CORRUCCINI RS, 1987, AM J PHYS ANTHROPOL, V73, P289, DOI 10.1002/ajpa.1330730303; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Darwin Charles, 1871, DESCENT MAN; DeSilva J, 2006, J HUM EVOL, V51, P207, DOI 10.1016/j.jhevol.2006.05.006; DIGIOVANNI BF, 1989, SPINE, V14, P712, DOI 10.1097/00007632-198907000-00011; DUMAS GA, 1995, CLIN BIOMECH, V10, P98, DOI 10.1016/0268-0033(95)92046-O; DUNLOP RB, 1984, J BONE JOINT SURG BR, V66, P706, DOI 10.1302/0301-620X.66B5.6501365; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; *I MED NAT AC, 1990, NUTR PREGN 1; JACCARD J, 1996, LISREL APPROACHES IN; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Latimer Bruce, 1993, P266; LEE DR, 1991, AM J PRIMATOL, V24, P289, DOI 10.1002/ajp.1350240315; LORENZ M, 1983, SPINE, V8, P122, DOI 10.1097/00007632-198303000-00002; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; OSTGAARD HC, 1993, SPINE, V18, P61; PAL GP, 1987, J ANAT, V152, P93; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; ROSENBERG KR, 1996, EVOLUTIONARY ANTHR, V4, P161; Ruff C, 1998, PRIMATE LOCOMOTION, P449; Sanders WJ, 1998, J HUM EVOL, V34, P249, DOI 10.1006/jhev.1997.0193; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Schultz AH, 1949, AM J PHYS ANTHROP-NE, V7, P401, DOI 10.1002/ajpa.1330070307; Shapiro Liza, 1993, P121; Sokal R. R., 2012, BIOMETRY; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Trinkaus, 2014, SHANIDAR NEANDERTALS; Ubelaker DH, 2002, J FORENSIC SCI, V47, P19; Washburn S, 1952, AM J PHYS ANTHROPOL, V10, P251; Washburn SL, 1948, AM J PHYS ANTHROP-NE, V6, P199, DOI 10.1002/ajpa.1330060210; White A.A., 1990, CLIN BIOMECH; Zatsiorsky VM, 1998, J BIOMECH, V31, P161, DOI 10.1016/S0021-9290(97)00116-4; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	42	176	182	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1075	U11		10.1038/nature06342	http://dx.doi.org/10.1038/nature06342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075592	Green Published			2022-12-24	WOS:000251579900085
J	Anderson, AC; Anderson, DE; Bregoli, L; Hastings, WD; Kassam, N; Lei, C; Chandwaskar, R; Karman, J; Su, EW; Hirashima, M; Bruce, JN; Kane, LP; Kuchroo, VK; Hafler, DA				Anderson, Ana C.; Anderson, David E.; Bregoli, Lisa; Hastings, William D.; Kassam, Nasim; Lei, Charles; Chandwaskar, Rucha; Karman, Jozsef; Su, Ee W.; Hirashima, Mitsuomi; Bruce, Jeffrey N.; Kane, Lawrence P.; Kuchroo, Vijay K.; Hafler, David A.			Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells	SCIENCE			English	Article							MULTIPLE-SCLEROSIS; MICROGLIA; GALECTIN-9; BRAIN; ASTROCYTES; AUTOIMMUNE; TOLERANCE; RESPONSES; DISEASE	CD4(+) T helper 1 (T(H)1) cells are important mediators of inflammation and are regulated by numerous pathways, including the negative immune receptor Tim-3. We found that Tim-3 is constitutively expressed on cells of the innate immune system in both mice and humans, and that it can synergize with Toll-like receptors. Moreover, an antibody agonist of Tim-3 acted as an adjuvant during induced immune responses, and Tim-3 ligation induced distinct signaling events in T cells and dendritic cells; the latter finding could explain the apparent divergent functions of Tim-3 in these cell types. Thus, by virtue of differential expression on innate versus adaptive immune cells, Tim-3 can either promote or terminate T(H)1 immunity and may be able to influence a range of inflammatory conditions.	Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; Kagawa Univ, Sch Med, Takamatsu, Kagawa 760, Japan; Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, Gabriele Bartoli Brain Tumor Res Lab, New York, NY 10032 USA	Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kagawa University; Columbia University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, 75 Francis St, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Bruce, Jeffrey N/AAC-5307-2022; Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932; Kane, Lawrence/0000-0001-5198-516X; Bregoli, Lisa/0000-0001-9376-1914	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067544, R56AI067544] Funding Source: NIH RePORTER; NIAID NIH HHS [R56 AI067544, R01 AI067544, R01 AI067544-01A2, R56 AI067544-01A1, R56 AI067544-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvord EC, 1984, EXPT ALLERGIC ENCEPH; Baranzini SE, 2000, J IMMUNOL, V165, P6576, DOI 10.4049/jimmunol.165.11.6576; FORD AL, 1995, J IMMUNOL, V154, P4309; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Roussel E, 1996, CLIN EXP IMMUNOL, V105, P344, DOI 10.1046/j.1365-2249.1996.d01-753.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sui L, 2006, INT J MOL MED, V17, P1093; WILLIAMS K, 1992, J NEUROPATH EXP NEUR, V51, P538, DOI 10.1097/00005072-199209000-00009; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	19	510	588	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1141	1143		10.1126/science.1148536	http://dx.doi.org/10.1126/science.1148536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006747				2022-12-24	WOS:000250957900047
J	Brady, SM; Orlando, DA; Lee, JY; Wang, JY; Koch, J; Dinneny, JR; Mace, D; Ohler, U; Benfey, PN				Brady, Siobhan M.; Orlando, David A.; Lee, Ji-Young; Wang, Jean Y.; Koch, Jeremy; Dinneny, Jose R.; Mace, Daniel; Ohler, Uwe; Benfey, Philip N.			A high-resolution root spatiotemporal map reveals dominant expression patterns	SCIENCE			English	Article							CELL; GENES; IDENTITY	Transcriptional programs that regulate development are exquisitely controlled in space and time. Elucidating these programs that underlie development is essential to understanding the acquisition of cell and tissue identity. We present microarray expression profiles of a high-resolution set of developmental time points within a single Arabidopsis root and a comprehensive map of nearly all root cell types. These cell type-specific transcriptional signatures often predict previously unknown cellular functions. A computational pipeline identified dominant expression patterns that demonstrate transcriptional similarity between disparate cell types. Dominant expression patterns along the root's longitudinal axis do not strictly correlate with previously defined developmental zones, and in many cases, we observed expression fluctuation along this axis. Both robust co-regulation of gene expression and potential phasing of gene expression were identified between individual roots. Methods that combine these profiles demonstrate transcriptionally rich and complex programs that define Arabidopsis root development in both space and time.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; Duke Univ, Dept Comp Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	benfeyp@duke.edu	Brady, Siobhan/AAY-1729-2021; Dinneny, Jose/J-8312-2012; Lee, Ji-Young/E-2196-2012; Lee, Ji-Young/F-7455-2013	Dinneny, Jose/0000-0002-3998-724X; Lee, Ji-Young/0000-0002-7631-5127; Brady, Siobhan/0000-0001-9424-8055				Benfey PN, 2000, CURR BIOL, V10, pR813, DOI 10.1016/S0960-9822(00)00814-9; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Laplaze L, 2005, J EXP BOT, V56, P2433, DOI 10.1093/jxb/eri236; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Saslowsky D, 2001, PLANT J, V27, P37, DOI 10.1046/j.1365-313x.2001.01073.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x	23	814	833	8	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					801	806		10.1126/science.1146265	http://dx.doi.org/10.1126/science.1146265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975066				2022-12-24	WOS:000250583900042
J	Brandman, O; Liou, J; Park, WS; Meyer, T				Brandman, Onn; Liou, Jen; Park, Wei Sun; Meyer, Tobias			STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels	CELL			English	Article							STROMAL INTERACTION MOLECULE-1; PLASMA-MEMBRANE; CHANNEL FUNCTION; STORE DEPLETION; CRAC CHANNEL; CALCIUM; DISEASE; HOMEOSTASIS; ORAI1; SENSOR	Deviations in basal Ca2+ levels interfere with receptor-mediated Ca2+ signaling as well as endoplasmic reticulum ( ER) and mitochondrial function. While defective basal Ca2+ regulation has been linked to various diseases, the regulatory mechanism that controls basal Ca2+ is poorly understood. Here we performed an siRNA screen of the human signaling proteome to identify regulators of basal Ca2+ concentration and found STIM2 as the strongest positive regulator. In contrast to STIM1, a recently discovered signal transducer that triggers Ca2+ influx in response to receptor-mediated depletion of ER Ca2+ stores, STIM2 activated Ca2+ influx upon smaller decreases in ER Ca2+. STIM2, like STIM1, caused Ca2+ influx via activation of the plasma membrane Ca2+ channel Orai1. Our study places STIM2 at the center of a feedback module that keeps basal cytosolic and ER Ca2+ concentrations within tight limits.	[Brandman, Onn; Liou, Jen; Park, Wei Sun; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Biox Clark Ctr W200, Stanford, CA 94305 USA	Stanford University	Brandman, O (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Biox Clark Ctr W200, Stanford, CA 94305 USA.	onn@stanford.edu; tobias1@stanford.edu	Liou, Jen/AAN-1105-2021	Meyer, Tobias/0000-0003-4339-3804	NCI NIH HHS [R33 CA083229-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM030179, GM030179, R01 GM030179-26, R37 GM030179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA083229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030179, R01GM030179] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Campanella M, 2004, BIOL RES, V37, P653; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 2005, CELL CALCIUM, V38, P281, DOI 10.1016/j.ceca.2005.06.032; Kusters JMAM, 2005, BIOPHYS J, V89, P3741, DOI 10.1529/biophysj.105.062984; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Montero M, 2001, CELL CALCIUM, V30, P181, DOI 10.1054/ceca.2001.0224; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Raza M, 2007, NEUROSCI LETT, V418, P77, DOI 10.1016/j.neulet.2007.03.005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schulman Ivonne Hernandez, 2005, Aging Clin Exp Res, V17, P40; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Ter Keurs HEDJ, 2007, PHYSIOL REV, V87, P457, DOI 10.1152/physrev.00011.2006; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thebault S, 2006, ADV CHRONIC KIDNEY D, V13, P110, DOI 10.1053/j.ackd.2006.01.002; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	37	514	529	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1327	1339		10.1016/j.cell.2007.11.039	http://dx.doi.org/10.1016/j.cell.2007.11.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160041	Green Accepted, Bronze			2022-12-24	WOS:000252217200021
J	Dodd, AN; Gardner, MJ; Hotta, CT; Hubbard, KE; Dalchau, N; Love, J; Assie, JM; Robertson, FC; Jakobsen, MK; Goncalves, J; Sanders, D; Webb, AAR				Dodd, Antony N.; Gardner, Michael J.; Hotta, Carlos T.; Hubbard, Katharine E.; Dalchau, Neil; Love, John; Assie, Jean-Maurice; Robertson, Fiona C.; Jakobsen, Mia Kyed; Goncalves, Jorge; Sanders, Dale; Webb, Alex A. R.			The Arabidopsis circadian clock incorporates a cADPR-based feedback loop	SCIENCE			English	Article							CYCLIC ADP-RIBOSE; FREE CALCIUM; OSCILLATIONS; RHYTHMS; CA2+; TRANSCRIPTION; EXPRESSION; CYCLASE; PLANTS	Transcriptional feedback loops are a feature of circadian clocks in both animals and plants. We show that the plant circadian clock also incorporates the cytosolic signaling molecule cyclic adenosine diphosphate ribose (cADPR). cADPR modulates the circadian oscillator's transcriptional feedback loops and drives circadian oscillations of Ca2+ release. The effects of antagonists of cADPR signaling, manipulation of cADPR synthesis, and mathematical simulation of the interaction of cADPR with the circadian clock indicate that cADPR forms a feedback loop within the plant circadian clock.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Cambridge; University of Cambridge; University of York - UK	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	alex.webb@plantsci.cam.ac.uk	Goncalves, Jorge M/GRN-8101-2022; Goncalves, Jorge/GYD-3756-2022; Rosa, Bruce/F-6393-2010; Hotta, Carlos Takeshi/G-9760-2012; Hubbard, Katharine/ABF-1833-2021; Dalchau, Neil/E-1323-2011	Goncalves, Jorge M/0000-0002-5228-6165; Hotta, Carlos Takeshi/0000-0003-3349-6121; Hubbard, Katharine/0000-0002-4862-0466; Dalchau, Neil/0000-0002-4872-6914; Webb, Alex/0000-0003-0261-4375	BBSRC [BB/E002692/1] Funding Source: UKRI; EPSRC [EP/E02761X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E02761X/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E002692/1, P19207] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Very AA, 2000, P NATL ACAD SCI USA, V97, P9801, DOI 10.1073/pnas.160250397; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	22	160	164	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1789	1792		10.1126/science.1146757	http://dx.doi.org/10.1126/science.1146757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18084825				2022-12-24	WOS:000251616800046
J	Komatsu, M; Waguri, S; Koike, M; Sou, Y; Ueno, T; Hara, T; Mizushima, N; Iwata, J; Ezaki, J; Murata, S; Hamazaki, J; Nishito, Y; Iemura, S; Natsume, T; Yanagawa, T; Uwayama, J; Warabi, E; Yoshida, H; Ishii, T; Kobayashi, A; Yamamoto, M; Yue, Z; Uchiyama, Y; Kominami, E; Tanaka, K				Komatsu, Masaaki; Waguri, Satoshi; Koike, Masato; Sou, Yu-shin; Ueno, Takashi; Hara, Taichi; Mizushima, Noboru; Iwata, Jun-ichi; Ezaki, Junji; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Iemura, Shun-ichiro; Natsume, Tohru; Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro; Kobayashi, Akira; Yamamoto, Masayuki; Yue, Zhenyu; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji			Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice	CELL			English	Article							BINDING PROTEIN P62; SYSTEM; AGGREGATION; DISSECTION; HUNTINGTIN; DISEASE	Inactivation of constitutive autophagy results in formation of cytoplasmic protein inclusions and leads to liver injury and neurodegeneration, but the details of abnormalities related to impaired autophagy are largely unknown. Here we used mouse genetic analyses to define the roles of autophagy in the aforementioned events. Were-port that the ubiquitin-and LC3-binding protein "p62'' regulates the formation of protein aggregates and is removed by autophagy. Thus, genetic ablation of p62 suppressed the appearance of ubiquitin-positive protein aggregates in hepatocytes and neurons, indicating that p62 plays an important role in inclusion body formation. Moreover, loss of p62 markedly attenuated liver injury caused by autophagy deficiency, whereas it had little effect on neuronal degeneration. Our findings highlight the unexpected role of homeostatic level of p62, which is regulated by autophagy, in controlling intracellular inclusion body formation, and indicate that the pathologic process associated with autophagic deficiency is cell-type specific.	[Komatsu, Masaaki; Sou, Yu-shin; Iwata, Jun-ichi; Murata, Shigeo; Hamazaki, Jun; Nishito, Yasumasa; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; [Waguri, Satoshi; Sou, Yu-shin; Ueno, Takashi; Iwata, Jun-ichi; Ezaki, Junji; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan; [Koike, Masato; Uchiyama, Yasuo] Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; [Hara, Taichi; Mizushima, Noboru] Tokyo Med & Dent Univ, Grad Sch, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Hara, Taichi; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Bunkyo Ku, Tokyo 1138519, Japan; [Mizushima, Noboru] Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Biol Informat Res Ctr JBIRC, Natl Inst Adv Ind Sci & Technol, Kohtoh Ku, Tokyo 1350064, Japan; [Yanagawa, Toru; Uwayama, Junya; Warabi, Eiji; Yoshida, Hiroshi; Ishii, Tetsuro] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Akira; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO JST, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Tokyo Metropolitan Institute of Medical Science; Juntendo University; Japan Science & Technology Agency (JST); Fukushima Medical University; Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Kominami, Eiki/D-3802-2009; Yanagawa, Toru/GYU-6448-2022; Yamamoto, Masayuki/A-4873-2010; Koike, Masato/F-9584-2010; Murata, Shigeo/A-1426-2010; Natsume, Tohru/M-7627-2018; Komatsu, Masaaki/B-8321-2011; hamazaki, jun/AAG-4823-2019; Mizushima, Noboru/C-3635-2009; Kobayashi, Akira/AAN-8003-2020	Yanagawa, Toru/0000-0003-0868-2563; Yamamoto, Masayuki/0000-0002-9073-9436; Koike, Masato/0000-0002-3174-5684; Murata, Shigeo/0000-0002-3177-3503; Natsume, Tohru/0000-0002-1510-2582; Komatsu, Masaaki/0000-0001-7672-7722; hamazaki, jun/0000-0002-7145-3424; Mizushima, Noboru/0000-0002-6258-6444; Kobayashi, Akira/0000-0001-9727-1218; Sou, Yu-shin/0000-0002-7219-9106				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fortun J, 2003, J NEUROSCI, V23, P10672; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishii T, 1996, BIOCHEM BIOPH RES CO, V226, P456, DOI 10.1006/bbrc.1996.1377; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Nakano T, 2004, ACTA NEUROPATHOL, V107, P359, DOI 10.1007/s00401-004-0821-7; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079	36	1660	1715	2	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1149	1163		10.1016/j.cell.2007.10.035	http://dx.doi.org/10.1016/j.cell.2007.10.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083104	Bronze			2022-12-24	WOS:000252217100022
J	Liu, SS; De Barro, PJ; Xu, J; Luan, JB; Zang, LS; Ruan, YM; Wan, FH				Liu, Shu-Sheng; De Barro, P. J.; Xu, Jing; Luan, Jun-Bo; Zang, Lian-Sheng; Ruan, Yong-Ming; Wan, Fang-Hao			Asymmetric mating interactions drive widespread invasion and displacement in a whitefly	SCIENCE			English	Article							BEMISIA-TABACI HEMIPTERA; NON-B-BIOTYPE; ALEYRODIDAE; INSECTS; POPULATIONS; COMPETITION; AUSTRALIA; BEHAVIOR; ZHEJIANG; BIOLOGY		Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Peoples R China; CSIRO Entomol, Indooroopilly, Qld 4068, Australia; Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100081, Peoples R China	Zhejiang University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, SS (corresponding author), Zhejiang Univ, Inst Insect Sci, Hangzhou 310029, Peoples R China.	shshliu@zju.edu.cn	Liu, Shu-Sheng/D-2300-2013; De Barro, Paul J/C-1724-2008	Liu, Shu-Sheng/0000-0001-7711-6405				Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Butlin Roger, 1995, P327; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; De Barro PJ, 2006, BIOL INVASIONS, V8, P287, DOI 10.1007/s10530-005-1261-6; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; De Barro PJ, 2000, B ENTOMOL RES, V90, P103, DOI 10.1017/S0007485300000201; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; GUNNING RV, 1995, J AUST ENTOMOL SOC, V34, P116; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; LAWTON JH, 1981, NATURE, V289, P793, DOI 10.1038/289793a0; Lima LHC, 2002, GENET MOL BIOL, V25, P217, DOI 10.1590/S1415-47572002000200016; Lookwood J.L., 2007, INVASION ECOLOGY; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; MCLAIN DK, 1987, OIKOS, V49, P291, DOI 10.2307/3565763; Perring Thomas M., 1996, P3; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ruan YM, 2007, ENTOMOL EXP APPL, V124, P229, DOI 10.1111/j.1570-7458.2007.00575.x; Takafuji A, 1997, EXP APPL ACAROL, V21, P379, DOI 10.1023/A:1018423711166; Yoshimura J, 1997, RES POPUL ECOL, V39, P191, DOI 10.1007/BF02765265; Zang LS, 2007, J INSECT BEHAV, V20, P157, DOI 10.1007/s10905-006-9066-8; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x	26	341	431	10	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1769	1772		10.1126/science.1149887	http://dx.doi.org/10.1126/science.1149887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	17991828				2022-12-24	WOS:000251616800039
J	Hessa, T; Meindl-Beinker, NM; Bernsel, A; Kim, H; Sato, Y; Lerch-Bader, M; Nilsson, I; White, SH; von Heijne, G				Hessa, Tara; Meindl-Beinker, Nadja M.; Bernsel, Andreas; Kim, Hyun; Sato, Yoko; Lerch-Bader, Mirjam; Nilsson, IngMarie; White, Stephen H.; von Heijne, Gunnar			Molecular code for transmembrane-helix recognition by the Sec61 translocon	NATURE			English	Article							CHANNEL VOLTAGE SENSOR; MEMBRANE-PROTEIN; HYDROPHOBIC MISMATCH; CHARGED RESIDUES; ER MEMBRANE; INTEGRATION; DERIVATION; SEQUENCES; INSERTION; COMPLEX	Transmembrane alpha-helices in integral membrane proteins are recognized co-translationally and inserted into the membrane of the endoplasmic reticulum by the Sec61 translocon. A full quantitative description of this phenomenon, linking amino acid sequence to membrane insertion efficiency, is still lacking. Here, using in vitro translation of a model protein in the presence of dog pancreas rough microsomes to analyse a large number of systematically designed hydrophobic segments, we present a quantitative analysis of the position- dependent contribution of all 20 amino acids to membrane insertion efficiency, as well as of the effects of transmembrane segment length and flanking amino acids. The emerging picture of translocon- mediated transmembrane helix assembly is simple, with the critical sequence characteristics mirroring the physical properties of the lipid bilayer.	Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; Stockholm Univ, AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA	Stockholm University; Stockholm University; University of California System; University of California Irvine; University of California System; University of California Irvine	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	White, Stephen H/B-1053-2009; von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019; Nilsson, IngMarie/H-2887-2012; White, Stephen/N-1507-2019	White, Stephen H/0000-0001-8540-7907; von Heijne, Gunnar/0000-0002-4490-8569; 				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Meindl-Beinker NM, 2006, EMBO REP, V7, P1111, DOI 10.1038/sj.embor.7400818; Monne M, 2001, FEBS LETT, V496, P96, DOI 10.1016/S0014-5793(01)02415-2; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Sadlish H, 2004, J MEMBRANE BIOL, V202, P115, DOI 10.1007/s00232-004-0715-6; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; SIMLEY WC, 1996, BIOCHEMISTRY-US, V35, P5109; Ulmschneider MB, 2005, PROTEINS, V59, P252, DOI 10.1002/prot.20334; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	30	520	526	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1026	U2		10.1038/nature06387	http://dx.doi.org/10.1038/nature06387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075582				2022-12-24	WOS:000251579900075
J	Pal, C; Macia, MD; Oliver, A; Schachar, I; Buckling, A				Pal, Csaba; Macia, Maria D.; Oliver, Antonio; Schachar, Ira; Buckling, Angus			Coevolution with viruses drives the evolution of bacterial mutation rates	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ASEXUAL POPULATIONS; ADAPTIVE EVOLUTION; LOCAL ADAPTATION; HIGH-FREQUENCY; GENES; INFECTION; PARASITES; MUTANTS	Bacteria with greatly elevated mutation rates ( mutators) are frequently found in natural(1-3) and laboratory(4,5) populations, and are often associated with clinical infections(6,7). Although mutators may increase adaptability to novel environmental conditions, they are also prone to the accumulation of deleterious mutations. The long-term maintenance of high bacterial mutation rates is therefore likely to be driven by rapidly changing selection pressures(8-14), in addition to the possible slow transition rate by point mutation from mutators to non- mutators(15). One of the most likely causes of rapidly changing selection pressures is antagonistic coevolution with parasites(16,17). Here we show whether coevolution with viral parasites could drive the evolution of bacterial mutation rates in laboratory populations of the bacterium Pseudomonas fluorescens(18). After fewer than 200 bacterial generations, 25% of the populations coevolving with phages had evolved 10- to 100- fold increases in mutation rates owing to mutations in mismatch-repair genes; no populations evolving in the absence of phages showed any significant change in mutation rate. Furthermore, mutator populations had a higher probability of driving their phage populations extinct, strongly suggesting that mutators have an advantage against phages in the coevolutionary arms race. Given their ubiquity, bacteriophages may play an important role in the evolution of bacterial mutation rates.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; IUNICS, Hosp Son Dureta, Microbiol Serv, Palma de Mallorca 07014, Spain; IUNICS, Hosp Son Dureta, Unidad Invest, Palma de Mallorca 07014, Spain	University of Oxford; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universitat de les Illes Balears	Buckling, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	cpal@ramet.elte.hu; angus.buckling@zoo.ox.ac.uk	Oliver, Antonio/E-4048-2012; Oliver, Antonio/V-5541-2019; Sandstedt, Sara A/A-3001-2010	Oliver, Antonio/0000-0001-9327-1894; Oliver, Antonio/0000-0001-9327-1894; Buckling, Angus/0000-0003-1170-4604; Macia, Maria Dolores/0000-0001-5038-1356	NERC [NE/D014115/1] Funding Source: UKRI; Natural Environment Research Council [NE/D014115/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agrawal A, 2002, EVOL ECOL RES, V4, P79; Andre JB, 2006, GENETICS, V172, P611, DOI 10.1534/genetics.105.046680; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Denamur E, 2002, J BACTERIOL, V184, P605, DOI 10.1128/JB.184.2.605-609.2002; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; ISHII K, 1989, GENETICS, V121, P163; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; Luria SE, 1943, GENETICS, V28, P491; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Morgan AD, 2006, J EVOLUTION BIOL, V19, P1956, DOI 10.1111/j.1420-9101.2006.01148.x; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Palmer ME, 2006, GENETICS, V173, P461, DOI 10.1534/genetics.105.049445; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tanaka MM, 2003, GENETICS, V164, P843; Tenaillon O, 1999, GENETICS, V152, P485; Trong HNG, 2005, ANTIMICROB AGENTS CH, V49, P2098, DOI 10.1128/AAC.49.5.2098-2101.2005; West SA, 1999, J EVOLUTION BIOL, V12, P1003	30	216	219	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1079	1081		10.1038/nature06350	http://dx.doi.org/10.1038/nature06350			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18059461				2022-12-24	WOS:000251579900086
J	Barreto, ML; Genser, B; Strina, A; Teixeira, MG; Assis, AMO; Rego, RF; Teles, CA; Prado, MS; Matos, SMA; Santos, DN; dos Santos, LA; Caimcross, S				Barreto, Mauricio L.; Genser, Bernd; Strina, Agostino; Teixeira, Maria Gloria; Assis, Ana Marlucia O.; Rego, Rita F.; Teles, Carlos A.; Prado, Matildes S.; Matos, Sheila M. A.; Santos, Darci N.; dos Santos, Lenaldo A.; Caimcross, Sandy			Effect of city-wide sanitation programme on reduction in rate of childhood diarrhoea in northeast Brazil: assessment by two cohort studies	LANCET			English	Article							HYGIENE BEHAVIOR; WATER; PREVALENCE; DISEASES; SALVADOR; BURDEN; IMPACT	Background A city-wide sanitation intervention was started in Salvador, Brazil, in 1997 to improve sewerage coverage from 26% of households to 80%. Our aim was to investigate the epidemiological effect of this city-wide sanitation programme on diarrhoea morbidity in children less than 3 years of age. Methods The investigation was composed of two longitudinal studies done in 1997-98 before the intervention (the sanitation programme) and in 2003-04 after the intervention had been completed. Each study consisted of a cohort of children (841 in the preintervention study and 1007 in the postintervention. study; age 0-36 months at baseline) who were followed up for a maximum of 8 months. Children were sampled from 24 sentinel areas that were randomly chosen to represent the range of environmental conditions in the study site. At the start of each study an individual or household questionnaire was applied by trained fieldworkers; an environmental survey was done in each area before and after introduction of the sanitation programme to assess basic neighbourhood and household sanitation conditions. Daily diarrhoea data were obtained during home visits twice per week. The effect of the intervention was estimated by a hierarchical modelling approach fitting a sequence of multivariate regression models. Findings Diarrhoea prevalence fell by 21% (95% CI 18-25%)-from 9.2 (9-0-9-5) days per child-year before the intervention to 7.3 (7.0-7.5) days per child-year afterwards. After adjustment for baseline sewerage coverage and potential confounding variables, we estimated an overall prevalence reduction of 22% (19-26%). Interpretation Our results show that urban sanitation is a highly effective health measure that can no longer be ignored, and they provide a timely support for the launch of 2008 as the International Year of Sanitation.	Univ Fed Bahia, Inst Saude Coletiva, BR-40110040 Salvador, BA, Brazil; London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1, England; Univ Fed Bahia, Sch Nutr, Salvador, BA, Brazil; Univ Fed Bahia, Sch Med, Dept Prevent Med, Salvador, BA, Brazil	Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal da Bahia; Universidade Federal da Bahia	Barreto, ML (corresponding author), Univ Fed Bahia, Inst Saude Coletiva, Rua Basilio Gama S-N, BR-40110040 Salvador, BA, Brazil.	mauricio@ufba.br	Teixeira, Maria Gloria L C/G-4808-2012; /ABH-9107-2020; Barreto, Mauricio L/B-1752-2008; rego, rita f/P-7061-2015	Teixeira, Maria Gloria L C/0000-0003-3318-3408; /0000-0002-0632-4546; Barreto, Mauricio L/0000-0002-0215-4930; rego, rita f/0000-0001-9350-722X; Genser, Bernd/0000-0001-5787-0902	Wellcome Trust [072405/Z/03/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alderman H, 2003, SOC SCI MED, V56, P2019, DOI 10.1016/S0277-9536(02)00183-1; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; BARRETO ML, 1997, SANEAMENTO SAUDE PAI, P7; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; Briscoe J., 1986, EVALUATING HLTH IMPA; Cairncross S, 1996, TROP MED INT HEALTH, V1, P27, DOI 10.1046/j.1365-3156.1996.d01-9.x; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Genser B, 2006, EPIDEMIOLOGY, V17, P658, DOI 10.1097/01.ede.0000239728.75215.86; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Milroy CA, 2001, ENVIRON URBAN, V13, P235, DOI 10.1177/095624780101300117; Moraes LRS, 2003, T ROY SOC TROP MED H, V97, P153, DOI 10.1016/S0035-9203(03)90104-0; Morris SS, 1996, AM J EPIDEMIOL, V144, P582, DOI 10.1093/oxfordjournals.aje.a008968; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Sastry N, 2005, SOC SCI MED, V60, P923, DOI 10.1016/j.socscimed.2004.06.051; Schmid J E, 1991, J Biopharm Stat, V1, P103; Schmidt WP, 2007, EPIDEMIOLOGY, V18, P537, DOI 10.1097/EDE.0b013e318093f3ce; Strina A, 2005, T ROY SOC TROP MED H, V99, P407, DOI 10.1016/j.trstmh.2004.07.007; Strina A, 2003, AM J EPIDEMIOL, V157, P1032, DOI 10.1093/aje/kwg075; *TCEB, 2005, AV PROGR SAN AMB BAH; Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011; United Nations Development Programme, 2006, HUMAN DEV REPORT 200; *WHO UNICEF, 2005, WAT LIF MAK IT HAPP; WHO/ UNICEF, 2000, GLOB WAT SUPPL SAN A	27	182	186	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2007	370	9599					1622	1628		10.1016/S0140-6736(07)61638-9	http://dx.doi.org/10.1016/S0140-6736(07)61638-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	230NO	17993362	Green Published, Green Accepted			2022-12-24	WOS:000250883400021
J	Mansouri, FA; Buckley, MJ; Tanaka, K				Mansouri, Farshad A.; Buckley, Mark J.; Tanaka, Keiji			Mnemonic function of the dorsolateral prefrontal cortex in conflict-induced behavioral adjustment	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; TASK; PERFORMANCE; INTERFERENCE; INFORMATION; MECHANISMS; CORTICES; MONKEYS	Our cognitive abilities in performing tasks are influenced by experienced competition/ conflict between behavioral choices. To determine the role of the anterior cingulate cortex (ACC) and dorsolateral prefrontal cortex (DLPFC) in the conflict detection-resolution process, we conducted complementary lesion and single-cell recording studies in monkeys that were resolving a conflict between two rules. We observed conflict-induced behavioral adjustment that persisted after lesions within the ACC but disappeared after lesions within the DLPFC. In the DLPFC, activity was modulated in some cells by the current conflict level and in other cells by the conflict experienced in the previous trial. These results show that the DLPFC, but not the ACC, is essential for the conflict-induced behavioral adjustment and suggest that encoding and maintenance of information about experienced conflict is mediated by the DLPFC.	RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; University of Oxford; Saitama University	Mansouri, FA (corresponding author), RIKEN, Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan.	farshad@postman.riken.jp	Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427				Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; GOLDMAN PS, 1971, J COMP PHYSIOL PSYCH, V77, P212, DOI 10.1037/h0031649; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Heaton R.K., 1993, WISCONSIN CARD SORTI; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lauwereyns J, 2000, J EXP PSYCHOL ANIM B, V26, P352, DOI 10.1037/0097-7403.26.3.352; Levy R, 1999, J NEUROSCI, V19, P5149; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mansouri FA, 2002, BEHAV BRAIN RES, V136, P415, DOI 10.1016/S0166-4328(02)00182-1; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Petrides M, 2000, EXP BRAIN RES, V133, P44, DOI 10.1007/s002210000399; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837	27	132	133	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					987	990		10.1126/science.1146384	http://dx.doi.org/10.1126/science.1146384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17962523				2022-12-24	WOS:000250788500047
J	Liu, L; Li, YH; Wang, RO; Yin, C; Dong, Q; Hing, H; Kim, C; Welsh, MJ				Liu, Lei; Li, Yuhong; Wang, Runping; Yin, Chong; Dong, Qian; Hing, Huey; Kim, Changsoo; Welsh, Michael J.			Drosophila hygrosensation requires the TRP channels water witch and nanchung	NATURE			English	Article							PERIPLANETA-AMERICANA; THERMORECEPTIVE SENSILLA; COCKROACH PERIPLANETA; OLFACTORY SENSILLA; ION CHANNELS; NEURONS; ANTENNA; IDENTIFICATION; ORGANIZATION; EXPRESSION	The ability to detect variations in humidity is critical for many animals. Birds, reptiles and insects all show preferences for specific humidities that influence their mating, reproduction and geographic distribution(1,2). Because of their large surface area to volume ratio, insects are particularly sensitive to humidity, and its detection can influence their survival(3-7). Two types of hygroreceptors exist in insects: one responds to an increase (moist receptor) and the other to a reduction (dry receptor) in humidity(4,6,8). Although previous data indicated that mechanosensation might contribute to hygrosensation(6,9), the cellular basis of hygrosensation and the genes involved in detecting humidity remain unknown. To understand better the molecular bases of humidity sensing, we investigated several genes encoding channels associated with mechanosensation, thermosensing or water transport. Here we identify two Drosophila melanogaster transient receptor potential channels needed for sensing humidity: CG31284, named by us water witch (wtrw), which is required to detect moist air, and nanchung (nan), which is involved in detecting dry air. Neurons associated with specialized sensory hairs in the third segment of the antenna express these channels, and neurons expressing wtrw and nan project to central nervous system regions associated with mechanosensation. Construction of the hygrosensing system with opposing receptors may allow an organism to very sensitively detect changes in environmental humidity.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; Chonnam National University	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	li, Yu/HCI-9086-2022; li, yu/HGL-9518-2022	Welsh, Michael/0000-0002-1646-6206; Liu, Lei/0000-0002-6387-7745				ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Desbordes SC, 2005, GENETICS, V170, P749, DOI 10.1534/genetics.105.040667; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; ITOH T, 1984, ZOOL SCI, V1, P533; Iwasaki M, 1995, ZOOL SCI, V12, P725, DOI 10.2108/zsj.12.725; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Niemeyer BA, 2005, N-S ARCH PHARMACOL, V371, P285, DOI 10.1007/s00210-005-1053-7; NISHIKAWA M, 1995, J COMP NEUROL, V361, P165, DOI 10.1002/cne.903610113; Rein K, 1999, CURR BIOL, V9, P93, DOI 10.1016/S0960-9822(99)80021-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shelford VE, 1918, SCIENCE, V48, P225, DOI 10.1126/science.48.1235.225; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TICHY H, 1979, J COMP PHYSIOL, V132, P149, DOI 10.1007/BF00610718; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Welsh MJ, 2002, J BIOL CHEM, V277, P2369, DOI 10.1074/jbc.R100060200; Wolff T, 2000, DROSOPHILA PROTOCOLS, P229; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	30	141	143	5	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					294	U14		10.1038/nature06223	http://dx.doi.org/10.1038/nature06223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994098				2022-12-24	WOS:000250746200060
J	Hayashi, T; Su, TP				Hayashi, Teruo; Su, Tsung-Ping			Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival	CELL			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; SIGMA(1) BINDING-SITES; ENDOPLASMIC-RETICULUM; CALCIUM OSCILLATIONS; MEMBRANE-FRACTION; DYNAMICS; MICRODOMAINS; AGONISTS; TARGET; ROLES	Communication between the endoplasmic reticulum (ER) and mitochondrion is important for bioenergetics and cellular survival. The ER supplies Ca2+ directly to mitochondria via inositol 1,4,5- trisphosphate receptors (IP3Rs) at close contacts between the two organelles referred to as mitochondrion-associated ER membrane (MAM). We found here that the ER protein sigma-1 receptor (Sig-1R), which is implicated in neuroprotection, carcinogenesis, and neuroplasticity, is a Ca2+- sensitive and ligand-operated receptor chaperone at MAM. Normally, Sig-1Rs form a complex at MAM with another chaperone, BiP. Upon ER Ca2+ depletion or via ligand stimulation, Sig-1Rs dissociate from BiP, leading to a prolonged Ca2+ signaling into mitochondria via IP3Rs. Sig-1Rs can translocate under chronic ER stress. Increasing Sig-1Rs in cells counteracts ER stress response, whereas decreasing them enhances apoptosis. These results reveal that the orchestrated ER chaperone machinery at MAM, by sensing ER Ca2+ concentrations, regulates ER-mitochondrial interorganellar Ca2+ signaling and cell survival.	NIDA, Cellular Pathobiol Unit, Plast & Dev Sect, Cellular Neurobiol Res Branch,Intramural Res Prog, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Hayashi, T (corresponding author), NIDA, Cellular Pathobiol Unit, Plast & Dev Sect, Cellular Neurobiol Res Branch,Intramural Res Prog, Room 3418,Room 3304,Triad Bldg,333 Cassell Dr, Baltimore, MD 21224 USA.	thayashi@intra.nida.nih.gov; tsu@intra.nida.nih.gov	Hayashi, Teruo/A-9690-2008		Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206, Z01DA000206] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2004, CNS DRUGS, V18, P269, DOI 10.2165/00023210-200418050-00001; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Joseph SK, 1999, BIOCHEM J, V342, P153, DOI 10.1042/0264-6021:3420153; Kauffman FC, 1998, CHEM-BIOL INTERACT, V109, P169, DOI 10.1016/S0009-2797(97)00131-2; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Marrazzo A, 2005, NEUROREPORT, V16, P1223, DOI 10.1097/00001756-200508010-00018; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Matsumoto RR, 2003, EUR J PHARMACOL, V469, P1, DOI 10.1016/S0014-2999(03)01723-0; MATTSON MP, 1999, NEUROCHEM RES, V57, P557; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; RIZZUTO R, 2004, FLIRTING LITTLE SPAC; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; SU TP, 1982, J PHARMACOL EXP THER, V223, P284; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Vagnerova K, 2006, ANESTH ANALG, V103, P430, DOI 10.1213/01.ane.0000226133.85114.91; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VILNER BJ, 1995, CANCER RES, V55, P408; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x	38	1240	1285	10	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 2	2007	131	3					596	610		10.1016/j.cell.2007.08.036	http://dx.doi.org/10.1016/j.cell.2007.08.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981125	Bronze			2022-12-24	WOS:000250618500025
J	Tang, C; Schwieters, CD; Clore, GM				Tang, Chun; Schwieters, Charles D.; Clore, G. Marius			Open-to-closed transition in apo maltose-binding protein observed by paramagnetic NMR	NATURE			English	Article							DIPOLAR COUPLINGS; ACTIVE-TRANSPORT; MACROMOLECULES; SPECTROSCOPY; DYNAMICS; REFINEMENT; RECEPTOR; DATABASE; DOMAINS; MOTIONS	Large-scale domain rearrangements in proteins have long been recognized to have a critical function in ligand binding and recognition, catalysis and regulation(1-5). Crystal structures have provided a static picture of the apo (usually open) and holo usually closed) states. The general question arises as to whether the apo state exists as a single species in which the closed state is energetically inaccessible and interdomain rearrangement is induced by ligand or substrate binding, or whether the predominantly open form already coexists in rapid equilibrium with a minor closed species. The maltose-binding protein (MBP), a member of the bacterial periplasmic binding protein family(6), provides a model system for investigating this problem because it has been the subject of extensive studies by crystallography(7,8), NMR9-11 and other biophysical techniques(11-13). Here we show that although paramagnetic relaxation enhancement (PRE) data for the sugar-bound form are consistent with the crystal structure of holo MBP, the PRE data for the apo state are indicative of a rapidly exchanging mixture (ns to mu s regime) of a predominantly (similar to 95%) open form (represented by the apo crystal structure) and a minor (similar to 5%) partially closed species. Using ensemble simulated annealing refinement against the PRE data we are able to determine a [r(-6)] ensemble average structure of the minor apo species and show that it is distinct from the sugar-bound state.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NIH, Div Computat Biosci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500	CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090, Z01CT000090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029023, ZIADK029023, Z01DK029043, Z01DK029042] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J MAGN RESON, V154, P329, DOI 10.1006/jmre.2001.2489; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; PERUVSHIN K, 1997, P NATL ACAD SCI USA, V94, P12366; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SKYNNIKOV NR, 2000, J MOL BIOL, V295, P1265; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Zhang YH, 1999, P NATL ACAD SCI USA, V96, P939, DOI 10.1073/pnas.96.3.939; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	35	325	330	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1078	U12		10.1038/nature06232	http://dx.doi.org/10.1038/nature06232			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960247				2022-12-24	WOS:000250395000058
J	Sacchetti, B; Funari, A; Michienzi, S; Di Cesare, S; Piersanti, S; Saggio, I; Tagliafico, E; Ferrari, S; Robey, PG; Riminucci, M; Bianco, P				Sacchetti, Benedetto; Funari, Alessia; Michienzi, Stefano; Di Cesare, Silvia; Piersanti, Stefania; Saggio, Isabella; Tagliafico, Enrico; Ferrari, Stefano; Robey, Pamela Gehron; Riminucci, Mara; Bianco, Paolo			Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment	CELL			English	Article							MESENCHYMAL STEM-CELLS; TYROSINE KINASE GENES; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; TIE2 RECEPTOR; GROWTH-FACTOR; IN-VITRO; EXPRESSION; ANGIOPOIETIN-1	The identity of cells that establish the hematopoietic microenvironment (HME) in human bone marrow ( BM), and of clonogenic skeletal progenitors found in BM stroma, has long remained elusive. We show that MCAM/CD146 expressing, subendothelial cells in human BM stroma are capable of transferring, upon transplantation, the HME to heterotopic sites, coincident with the establishment of identical subendothelial cells within a miniature bone organ. Establishment of subendothelial stromal cells in developing heterotopic BM in vivo occurs via specific, dynamic interactions with developing sinusoids. Subendothelial stromal cells residing on the sinusoidal wall are major producers of Angiopoietin-1-(a pivotal molecule of the HSC `` niche'' involved in vascular remodeling). Our data reveal the functional relationships between establishment of the HME in vivo, establishment of skeletal progenitors in BM sinusoids, and angiogenesis.	Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; Univ Roma La Sapienza, Dept Genet & Mol Biol, I-00161 Rome, Italy; Biomed Sci Pk San Raffaele, I-00128 Rome, Italy; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; CNR, Inst Mol Biol & Pathol, Rome, Italy; Univ Modena, Dept Biochem, I-59100 Modena, Italy; Natl Inst Dental & Craniofacial Res, NIH, Craniofacial & Skeletal Dis Branch, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	Sapienza University Rome; Sapienza University Rome; University of L'Aquila; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Universita di Modena e Reggio Emilia; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bianco, P (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy.	p.bianco@flashnet.it	DI CESARE, SILVIA/AAB-5754-2020; sacchetti, benedetto/A-3314-2009; Tagliafico, Enrico/C-9079-2009; Riminucci, Mara/AAC-3906-2022; Saggio, Isabella/H-2417-2015; Robey, Pamela Gehron/H-1429-2011; FUNARI, ALESSIA/A-3298-2009	DI CESARE, SILVIA/0000-0002-9912-7997; Tagliafico, Enrico/0000-0003-0981-2542; Robey, Pamela Gehron/0000-0002-5316-5576; saggio, isabella/0000-0002-9497-7415	Telethon [GGP04263] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; BIANCO P, 1993, HISTOCHEMISTRY, V100, P93, DOI 10.1007/BF00572894; Bianco Paolo, 2015, Development, V142, P1023, DOI 10.1242/dev.102210; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; FRIEDENSTEIN A J, 1990, P353; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; MANIATIS A, 1971, BLOOD-J HEMATOL, V38, P569, DOI 10.1182/blood.V38.5.569.569; Miura Y, 1998, CELL TRANSPLANT, V7, P453, DOI 10.1016/S0963-6897(98)00033-5; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OWEN M, 1988, CIBA F SYMP, V136, P42; Pickl WF, 1997, J IMMUNOL, V158, P2107; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; SIMMONS PJ, 1991, BLOOD, V78, P55; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; TAVASSOLI M, 1983, AM J HEMATOL, V15, P195, DOI 10.1002/ajh.2830150211; Vogel W, 2003, HAEMATOLOGICA, V88, P126; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; Zannettino ACW, 2003, J CELL BIOCHEM, V89, P56, DOI 10.1002/jcb.10481; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	48	1583	1641	3	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					324	336		10.1016/j.cell.2007.08.025	http://dx.doi.org/10.1016/j.cell.2007.08.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956733	Bronze			2022-12-24	WOS:000250507700022
J	Park, IH; Zhao, R; West, JA; Yabuuchi, A; Huo, HG; Ince, TA; Lerou, PH; Lensch, MW; Daley, GQ				Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Ince, Tan A.; Lerou, Paul H.; Lensch, M. William; Daley, George Q.			Reprogramming of human somatic cells to pluripotency with defined factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; FIBROBLASTS; GENERATION; DIFFERENTIATION; INDUCTION; SELECTION; SURVIVAL; REGIONS; NANOG; LINES	Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo- derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors ( Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem ( iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune- deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient- specific cells might be established in culture.	[Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lerou, Paul H.; Lensch, M. William; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Park, In-Hyun; Zhao, Rui; West, Jason A.; Yabuuchi, Akiko; Huo, Hongguang; Lensch, M. William; Daley, George Q.] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Ince, Tan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lerou, Paul H.] Brigham & Womens Hosp, Div Newborn Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	West, Jason/I-4445-2014	West, Jason/0000-0002-7252-8651; Ince, Tan/0000-0003-0315-6425				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yu J, 2007, SCIENCE, V318, P1917; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	24	2179	2504	8	749	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					141	U1		10.1038/nature06534	http://dx.doi.org/10.1038/nature06534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18157115				2022-12-24	WOS:000252214400032
J	Krkosek, M; Ford, JS; Morton, A; Lele, S; Myers, RA; Lewis, MA				Krkosek, Martin; Ford, Jennifer S.; Morton, Alexandra; Lele, Subhash; Myers, Ransom A.; Lewis, Mark A.			Declining wild salmon populations in relation to parasites from farm salmon	SCIENCE			English	Article							PACIFIC SALMON; ATLANTIC SALMON; SEA LICE; LEPEOPHTHEIRUS-SALMONIS; ONCORHYNCHUS-GORBUSCHA; DENSITY-DEPENDENCE; MARINE-ENVIRONMENT; PINK SALMON; TIME-SERIES; FISH	Rather than benefiting wild fish, industrial aquaculture may contribute to declines in ocean fisheries and ecosystems. Farm salmon are commonly infected with salmon lice ( Lepeophtheirus salmonis), which are native ectoparasitic copepods. We show that recurrent louse infestations of wild juvenile pink salmon ( Oncorhynchus gorbuscha), all associated with salmon farms, have depressed wild pink salmon populations and placed them on a trajectory toward rapid local extinction. The louse- induced mortality of pink salmon is commonly over 80% and exceeds previous fishing mortality. If outbreaks continue, then local extinction is certain, and a 99% collapse in pink salmon population abundance is expected in four salmon generations. These results suggest that salmon farms can cause parasite outbreaks that erode the capacity of a coastal ecosystem to support wild salmon populations.	Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada; Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; Dalhousie Univ, Dept Biol, Halifax, NS, Canada; Salmon Coast Field Stn, Simoom Sound, BC, Canada	University of Alberta; University of Alberta; Dalhousie University	Krkosek, M (corresponding author), Univ Alberta, Dept Math & Stat Sci, Ctr Math Biol, Edmonton, AB, Canada.	mkrkosek@ualberta.ca	Lewis, Mark/A-2659-2014; Krkosek, Martin/A-4003-2012; Lewis, Mark A/C-5015-2008	Lewis, Mark A/0000-0002-7155-7426				Beamish RJ, 2006, ICES J MAR SCI, V63, P1326, DOI 10.1016/j.icesjms.2006.04.011; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; DENNIS B, 1991, ECOL MONOGR, V61, P115, DOI 10.2307/1943004; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Goldburg R, 2005, FRONT ECOL ENVIRON, V3, P21, DOI 10.2307/3868441; Groot C, 1991, PACIFIC SALMON LIFE; Heard W.R., 1991, P119; Hilborn R, 2006, P NATL ACAD SCI USA, V103, P15277, DOI 10.1073/pnas.0607419103; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McVicar AH, 1997, ICES J MAR SCI, V54, P1093, DOI 10.1016/S1054-3139(97)80014-8; McVicar AH, 2004, AQUAC RES, V35, P751, DOI 10.1111/j.1365-2109.2004.01097.x; Morton A, 2005, N AM J FISH MANAGE, V25, P811, DOI 10.1577/M04-149.1; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Morton AB, 2003, CAN FIELD NAT, V117, P634, DOI 10.22621/cfn.v117i4.834; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Noakes DJ, 2000, AQUACULTURE, V183, P363, DOI 10.1016/S0044-8486(99)00294-X; PEET CR, 2007, THESIS U VICTORIA; Pike AW, 2000, ADV PARASIT, V44, P233; Pinheiro JC, 2004, MIXED EFFECTS MODELS; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Volpe JP, 2001, CAN J FISH AQUAT SCI, V58, P197, DOI 10.1139/cjfas-58-1-197	30	284	288	5	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1772	1775		10.1126/science.1148744	http://dx.doi.org/10.1126/science.1148744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079401				2022-12-24	WOS:000251616800040
J	Gottwein, E; Mukherjee, N; Sachse, C; Frenzel, C; Majoros, WH; Chi, JTA; Braich, R; Manoharan, M; Soutschek, J; Ohler, U; Cullen, BR				Gottwein, Eva; Mukherjee, Neelanjan; Sachse, Christoph; Frenzel, Corina; Majoros, William H.; Chi, Jen-Tsan A.; Braich, Ravi; Manoharan, Muthiah; Soutschek, Jurgen; Ohler, Uwe; Cullen, Bryan R.			A viral microRNA functions as an orthologue of cellular miR-155	NATURE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; EXPRESSION; LYMPHOMA; CELLS; THOUSANDS; TARGETS; GENOME; RNAS	All metazoan eukaryotes express microRNAs ( miRNAs), roughly 22- nucleotide regulatory RNAs that can repress the expression of messenger RNAs bearing complementary sequences(1). Several DNA viruses also express miRNAs in infected cells, suggesting a role in viral replication and pathogenesis(2). Although specific viral miRNAs have been shown to autoregulate viral mRNAs(3,4) or downregulate cellular mRNAs(5,6), the function of most viral miRNAs remains unknown. Here we report that the miR- K12- 11 miRNA encoded by Kaposi's- sarcoma- associated herpes virus ( KSHV) shows significant homology to cellular miR- 155, including the entire miRNA 'seed' region(7). Using a range of assays, we show that expression of physiological levels of miR- K12- 11 or miR- 155 results in the downregulation of an extensive set of common mRNA targets, including genes with known roles in cell growth regulation. Our findings indicate that viral miR- K12- 11 functions as an orthologue of cellular miR- 155 and probably evolved to exploit a preexisting gene regulatory pathway in B cells. Moreover, the known aetiological role of miR- 155 in B- cell transformation(8-10) suggests that miR- K12- 11 may contribute to the induction of KSHV-positive B- cell tumours in infected patients.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Cenix BioSci GmbH, D-01307 Dresden, Germany; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	culle002@mc.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Mukherjee, Neelanjan/0000-0003-0017-1400	NIAID NIH HHS [R01 AI067968-01A1, R01 AI067968, R01 AI067968-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067968] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gottwein E, 2007, METHOD ENZYMOL, V427, P229, DOI 10.1016/S0076-6879(07)27013-2; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Grimaldi E, 2005, CLIN LAB HAEMATOL, V27, P91, DOI 10.1111/j.1365-2257.2005.00676.x; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	32	457	493	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2007	450	7172					1096	U17		10.1038/nature05992	http://dx.doi.org/10.1038/nature05992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075594	Green Accepted			2022-12-24	WOS:000251579900090
J	Klein, TA; Neumann, J; Reuter, M; Hennig, J; von Cramon, DY; Ullsperger, M				Klein, Tilmann A.; Neumann, Jane; Reuter, Martin; Hennig, Juergen; von Cramon, D. Yves; Ullsperger, Markus			Genetically determined differences in learning from errors	SCIENCE			English	Article							DOPAMINE-RECEPTOR GENE; REWARD DEFICIENCY SYNDROME; MEDIAL FRONTAL-CORTEX; HEALTHY-VOLUNTEERS; A1 ALLELE; MEMORY; POLYMORPHISMS; PARKINSONISM; PREDICTION; DISORDERS	The role of dopamine in monitoring negative action outcomes and feedback-based learning was tested in a neuroimaging study in humans grouped according to the dopamine D2 receptor gene polymorphism DRD2-TAQ-IA. In a probabilistic learning task, A1-allele carriers with reduced dopamine D2 receptor densities learned to avoid actions with negative consequences less efficiently. Their posterior medial frontal cortex (pMFC), involved in feedback monitoring, responded less to negative feedback than others' did. Dynamically changing interactions between pMFC and hippocampus found to underlie feedback-based learning were reduced in A1-allele carriers. This demonstrates that learning from errors requires dopaminergic signaling. Dopamine D2 receptor reduction seems to decrease sensitivity to negative action consequences, which may explain an increased risk of developing addictive behaviors in A1-allele carriers.	Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; Univ Bonn, D-5300 Bonn, Germany; Univ Giessen, Giessen, Germany; Max Planck Inst Neurol Res, Cologne, Germany	Max Planck Society; University of Bonn; Justus Liebig University Giessen; Max Planck Society	Klein, TA (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	tklein@cbs.mpg.de; ullsperger@nf.mpg.de	Ullsperger, Markus/E-2797-2010; Ullsperger, Markus/I-4760-2019	Ullsperger, Markus/0000-0003-3970-1982; Ullsperger, Markus/0000-0003-3970-1982	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH74457] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bowirrat A, 2005, AM J MED GENET B, V132B, P29, DOI 10.1002/ajmg.b.30080; Comings DE, 2000, PROG BRAIN RES, V126, P325; Cools R, 2004, J NEUROSCI, V24, P1129, DOI 10.1523/JNEUROSCI.4312-03.2004; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Heekeren HR, 2007, NEUROREPORT, V18, P951, DOI 10.1097/WNR.0b013e3281532bd7; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Neumann J, 2003, NEUROIMAGE, V20, P1346, DOI 10.1016/S1053-8119(03)00443-9; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162	28	316	320	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1642	1645		10.1126/science.1145044	http://dx.doi.org/10.1126/science.1145044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18063800				2022-12-24	WOS:000251421700051
J	Rubin, GJ; Page, L; Morgan, O; Pinder, RJ; Riley, P; Hatch, S; Maguire, H; Catchpole, M; Simpson, J; Wessely, S				Rubin, G. James; Page, Lisa; Morgan, Oliver; Pinder, Richard J.; Riley, Paul; Hatch, Stephani; Maguire, Helen; Catchpole, Mike; Simpson, John; Wessely, Simon			Public information needs after the poisoning of Alexander Litvinenko with polonium-210 in London: cross sectional telephone survey and qualitative analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNICATION	Objectives To identify public perceptions of the risk to health after the poisoning of Alexander Litvinenko with polonium-210 (Po-210) in London and to assess the impact of public health communications. Design Cross sectional telephone survey and qualitative interviews. Setting London, United Kingdom. Participants 1000 people completed the cross sectional survey and 86 potentially exposed people completed the qualitative interviews. Main outcome measures Perception of risk to personal health after the Po-210 incident. Qualitative interviews were analysed with an emphasis on information needs. Results 11.7% of the survey sample (n=117) perceived their health to be at risk. Aside from personal variables the main predictors of perceived risk to health were believing that the incident was related to terrorism (odds ratio 2.7, 95% confidence interval 1.5 to 4.6) rather than to espionage, that it was targeted at the wider public rather than one person (5.9, 3.2 to 10.9), and that it could affect people who had not been in the contaminated area (3.2, 2.1 to 5.1). Participants in the qualitative interviews were generally satisfied with the information they had received, although they would have preferred more information about their individual risk of exposure, the results of their urine tests, and the health implications of the incident. Conclusions Perceptions of the public that the Po-210 incident in London 2006 was related to espionage helped to reassure them that the risks to personal health were low. In the event of future incidents it is important to ensure that detailed, comprehensible information about the risks of any exposure is available.	Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England; Hlth Protect Agcy, London Reg, London, England; Hlth Protect Agcy, Ctr Infect, London, England; Hlth Protect Agcy, Ctr Emergency Preparedness & Response, Porton Down, Wilts, England	University of London; King's College London; Health Protection Agency; Health Protection Agency; Health Protection Agency	Rubin, GJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychol Med, London SE5 9RJ, England.	g.rubin@iop.kcl.ac.uk	Pinder, Richard/K-6200-2019; Hatch, Stephani L/B-4235-2010; Wessely, Simon C/A-8713-2008	Pinder, Richard/0000-0002-7010-6009; Hatch, Stephani/0000-0001-9103-2427				Becker SM, 2004, BIOSECUR BIOTERROR, V2, P195, DOI 10.1089/15387130460759263; BLENDON RJ, 2003, MEDSCAPE GEN MED, V4; Bryman A., 2004, SOCIAL RES METHODS; BRYMAN A, 2004, SOCIAL RES METHODS E, V2; Covello V.T., 1989, EFFECTIVE RISK COMMU; Fischhoff B, 2004, RISK ANAL, V24, P1301, DOI 10.1111/j.0272-4332.2004.00527.x; Freimuth VS, 2006, HEALTH COMMUN, V20, P141, DOI 10.1207/s15327027hc2002_5; GILK DC, 2007, ANNU REV PUBL HEALTH, V28; GLIK DC, 2007, ANNU REV PUBL HEALTH, V28; GRAVES R, 2000, PUBLIC OPIN QUART, V64, P288; GROVES RM, 2000, PUBLIC OPIN QUART, V64, P288; Harrison DE, 1999, PATIENT EDUC COUNS, V38, P217, DOI 10.1016/S0738-3991(99)00009-9; Hunter N, 2006, RADIAT ENVIRON BIOPH, V45, P17, DOI 10.1007/s00411-006-0040-9; Keselman A, 2005, J BIOMED INFORM, V38, P331, DOI 10.1016/j.jbi.2005.05.001; LaRossa R, 2005, J MARRIAGE FAM, V67, P837, DOI 10.1111/j.1741-3737.2005.00179.x; Petrie KJ, 2007, BRIT MED J, V334, P352, DOI 10.1136/bmj.39093.464190.55; Rubin GJ, 2005, BRIT MED J, V331, P606, DOI 10.1136/bmj.38583.728484.3A; Slovic P., 2001, PERCEPTION RISK; Stather JW, 2007, J RADIOL PROT, V27, P1, DOI 10.1088/0952-4746/27/1/E02; Vanderford ML, 2004, BIOSECUR BIOTERROR, V2, P193, DOI 10.1089/bsp.2004.2.193; 2002, COMMUNICATING CRISIS	21	44	45	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2007	335	7630					1143	1146B		10.1136/bmj.39367.455243.BE	http://dx.doi.org/10.1136/bmj.39367.455243.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	240OE	17975252	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000251596100036
J	Chupp, GL; Lee, CG; Jarjour, N; Shim, YM; Holm, CT; He, S; Dziura, JD; Reed, J; Coyle, AJ; Kiener, P; Cullen, M; Grandsaigne, M; Dombret, M; Aubier, M; Pretolani, M; Elias, JA				Chupp, Geoffrey L.; Lee, Chun Geun; Jarjour, Nizar; Shim, Yun Michael; Holm, Carole T.; He, Susan; Dziura, James D.; Reed, Jennifer; Coyle, Anthony J.; Kiener, Peter; Cullen, Mark; Grandsaigne, Martine; Dombret, Marie-Christine; Aubier, Michel; Pretolani, Marina; Elias, Jack A.			A chitinase-like protein in the lung and circulation of patients with severe asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACIDIC MAMMALIAN CHITINASE; BRUGIA-MALAYI; SERUM; YKL-40; CHITOTRIOSIDASE; IDENTIFICATION; MICROFILARIAE; INFLAMMATION; MEMBER; FAMILY	Background: The evolutionarily conserved 18-glycosyl-hydrolase family contains true chitinases and chitinase-like proteins that lack enzymatic activity. Acidic mammalian chitinase has recently been associated with animal models of asthma. The related chitinase-like protein, YKL-40 (also called human cartilage glycoprotein 39 [HCgp-39] and chitinase 3-like 1), can be readily measured in the serum. However, its relationship to asthma has not been evaluated. Methods: We quantified serum YKL-40 levels in three cohorts of patients with asthma-one recruited from the patient population at Yale University, one from the University of Paris, and one from the University of Wisconsin-as well as in controls from the surrounding communities. In the Paris cohort, immunohistochemical analysis and morphometric quantitation were used to evaluate the locus of expression of YKL-40 in the lung. The clinical characteristics of the patients with high serum or lung YKL-40 levels were also evaluated. Results: Serum YKL-40 levels were significantly elevated in patients with asthma as compared with controls. In the Paris cohort, lung YKL-40 levels were elevated and were correlated with circulating YKL-40 levels (r=0.55, P<0.001) and with airway remodeling (measured as the thickness of the subepithelial basement membrane) (r=0.51, P=0.003). In all three cohorts, serum YKL-40 levels correlated positively with the severity of asthma and inversely with the forced expiratory volume in 1 second. Patients with elevated levels of YKL-40 had significantly more frequent rescue-inhaler use, greater oral corticosteroid use, and a greater rate of hospitalization than patients with lower levels. Conclusions: YKL-40 is found in increased quantities in the serum and lungs in a subgroup of patients with asthma, in whom expression of chitinase in both compartments correlates with the severity of asthma. The recovery of YKL-40 from these patients indicates either a causative or a sentinel role for this molecule in asthma.	Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; Univ Wisconsin, Sch Med, Madison, WI USA; MedImmune, Gaithersburg, MD USA; Univ Paris 07, INSERM, U700, F-75221 Paris 05, France; Ctr Hosp Univ Bichat Claude Bernard, Paris, France	Yale University; University of Wisconsin System; University of Wisconsin Madison; AstraZeneca; Medimmune; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Chupp, GL (corresponding author), Yale Univ, Sch Med, Pulm & Crit Care Med Sect, POB 208057,300 Cedar St,TAC 441, New Haven, CT 06520 USA.	geoffrey.chupp@yale.edu; jack.elias@yale.edu	Shim, Yun Michael/N-2049-2017; Pretolani, Marina/G-6643-2017; Lee, Chun Geun/AAC-2838-2021	Shim, Yun Michael/0000-0002-3780-3371; Lee, Chun Geun/0000-0002-9514-3658; cullen, mark/0000-0001-7996-1864	NHLBI NIH HHS [K08 HL091127, R01-HL-081639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081639] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2000, AM J RESP CRIT CARE, V162, P2341; ARAUJO ACG, 1993, J HISTOCHEM CYTOCHEM, V41, P571, DOI 10.1177/41.4.8450196; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Couzin J, 2004, SCIENCE, V304, P1577, DOI 10.1126/science.304.5677.1577; de Marco R, 2006, J ALLERGY CLIN IMMUN, V117, P1249, DOI 10.1016/j.jaci.2006.03.019; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; GOLDSTEIN RA, 1985, AM REV RESPIR DIS, V132, P180; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Johansen JS, 2006, DAN MED BULL, V53, P172; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; LEE CG, 2007, AM J RESP CRIT CARE, V175, pA253; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Ostergaard C, 2002, CLIN DIAGN LAB IMMUN, V9, P598, DOI 10.1128/CDLI.9.3.598-604.2002; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066; Suzuki M, 2001, FEBS LETT, V506, P127, DOI 10.1016/S0014-5793(01)02893-9; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; 2003, J ALLERGY CLIN IMMUN, V111, P466; 2002, J ALLERGY CLIN IM S5, V110, pS141	26	432	454	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2007	357	20					2016	2027		10.1056/NEJMoa073600	http://dx.doi.org/10.1056/NEJMoa073600			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230RV	18003958				2022-12-24	WOS:000250894500004
J	Long, SB; Tao, X; Campbell, EB; MacKinnon, R				Long, Stephen B.; Tao, Xiao; Campbell, Ernest B.; MacKinnon, Roderick			Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environment	NATURE			English	Article							POTASSIUM CHANNEL; GATING-CHARGE; S4 SEGMENT; SHAKER; ACTIVATION; MOVEMENT; PROTEIN; FAMILY; SENSOR; PORE	Voltage-dependent K+ (Kv) channels repolarize the action potential in neurons and muscle. This type of channel is gated directly by membrane voltage through protein domains known as voltage sensors, which are molecular voltmeters that read the membrane voltage and regulate the pore. Here we describe the structure of a chimaeric voltage-dependent K+ channel, which we call the 'paddle-chimaera channel', in which the voltage-sensor paddle has been transferred from Kv2.1 to Kv1.2. Crystallized in complex with lipids, the complete structure at 2.4 angstrom resolution reveals the pore and voltage sensors embedded in a membrane-like arrangement of lipid molecules. The detailed structure, which can be compared directly to a large body of functional data, explains charge stabilization within the membrane and suggests a mechanism for voltage-sensor movements and pore gating.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@mail.rockefeller.edu		Long, Stephen/0000-0002-8144-1398	NIGMS NIH HHS [R01 GM043949] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Branden C.-I., 1999, INTRO PROTEIN STRUCT, V2nd, P15; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KING GI, 1986, BIOPHYS J, V49, P1047, DOI 10.1016/S0006-3495(86)83733-X; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; Miller C., 1986, ION CHANNEL RECONSTI; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NISHIDAM, 2007, EMBO J, V26, P4005; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	44	1125	1148	1	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					376	U3		10.1038/nature06265	http://dx.doi.org/10.1038/nature06265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004376				2022-12-24	WOS:000250918600045
J	Fontaine, S; Barot, S; Barre, P; Bdioui, N; Mary, B; Rumpel, C				Fontaine, Sebastien; Barot, Sebastien; Barre, Pierre; Bdioui, Nadia; Mary, Bruno; Rumpel, Cornelia			Stability of organic carbon in deep soil layers controlled by fresh carbon supply	NATURE			English	Article							VERTICAL-DISTRIBUTION; CHEMICAL-COMPOSITION; ELEVATED CO2; CLIMATE; MATTER; DECOMPOSITION; TURNOVER; DROUGHT; INPUT; C-13	The world's soils store more carbon than is present in biomass and in the atmosphere(1). Little is known, however, about the factors controlling the stability of soil organic carbon stocks(2-4) and the response of the soil carbon pool to climate change remains uncertain(5,6). We investigated the stability of carbon in deep soil layers in one soil profile by combining physical and chemical characterization of organic carbon, soil incubations and radiocarbon dating. Here we show that the supply of fresh plant-derived carbon to the subsoil (0.6-0.8 m depth) stimulated the microbial mineralization of 2,567 +/- 226-year-old carbon. Our results support the previously suggested idea(7) that in the absence of fresh organic carbon, an essential source of energy for soil microbes, the stability of organic carbon in deep soil layers is maintained. We propose that a lack of supply of fresh carbon may prevent the decomposition of the organic carbon pool in deep soil layers in response to future changes in temperature. Any change in land use and agricultural practice that increases the distribution of fresh carbon along the soil profile(1,8,9) could however stimulate the loss of ancient buried carbon.	INRA, UR Agron 874, F-63100 Clermont Ferrand, France; IRD, UMR 137, F-93143 Bondy, France; CNRS INRA ENS Paris 6, UMR 7618, BIOEMCO, F-78820 Thiverval Grignon, France; INRA, UR Agron 1158, F-02007 Laon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); INRAE	Fontaine, S (corresponding author), INRA, UR Agron 874, 234 Ave Brezet, F-63100 Clermont Ferrand, France.	fontaine@clermont.inra.fr	Rumpel, Cornelia/A-2001-2015; barot, sébastien/A-8447-2012	Rumpel, Cornelia/0000-0003-2131-9451; barot, sébastien/0000-0002-5910-538X; Barre, Pierre/0000-0002-0822-0556				Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Boivin P., 2004, VOLCANOLOGIE CHAINE; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng WX, 2003, SOIL SCI SOC AM J, V67, P1418, DOI 10.2136/sssaj2003.1418; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Eusterhues K, 2003, ORG GEOCHEM, V34, P1591, DOI 10.1016/j.orggeochem.2003.08.007; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; HSIEH YP, 1993, SOIL SCI SOC AM J, V57, P1020, DOI 10.2136/sssaj1993.03615995005700040023x; HURD EA, 1974, AGR METEOROL, V14, P39, DOI 10.1016/0002-1571(74)90009-0; JENKINSON DS, 1992, SOIL BIOL BIOCHEM, V24, P295, DOI 10.1016/0038-0717(92)90189-5; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Klumpp K, 2007, AGR ECOSYST ENVIRON, V121, P59, DOI 10.1016/j.agee.2006.12.005; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Loiseau P, 1999, PLANT SOIL, V210, P233, DOI 10.1023/A:1004681028245; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Malosso E, 2004, SOIL BIOL BIOCHEM, V36, P165, DOI 10.1016/j.soilbio.2003.09.004; MARTEL YA, 1974, SOIL SCI SOC AM J, V38, P501, DOI 10.2136/sssaj1974.03615995003800030033x; MEHRA OP, 1960, CLAYS CLAY MINER, V32, P557; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; Schmidt MWI, 1997, EUR J SOIL SCI, V48, P319, DOI 10.1111/j.1365-2389.1997.tb00552.x; Schoening I, 2006, SOIL BIOL BIOCHEM, V38, P2411, DOI 10.1016/j.soilbio.2006.03.005; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wattel-Koekkoek EJW, 2003, EUR J SOIL SCI, V54, P269, DOI 10.1046/j.1365-2389.2003.00512.x	29	1386	1527	96	1442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2007	450	7167					277	U10		10.1038/nature06275	http://dx.doi.org/10.1038/nature06275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17994095				2022-12-24	WOS:000250746200056
J	Tavazoie, SF; Alarcon, C; Oskarsson, T; Padua, D; Wang, QQ; Bos, PD; Gerald, WL; Massague, J				Tavazoie, Sohail F.; Alarcon, Claudio; Oskarsson, Thordur; Padua, David; Wang, Qiongqing; Bos, Paula D.; Gerald, William L.; Massague, Joan			Endogenous human microRNAs that suppress breast cancer metastasis	NATURE			English	Article							EXPRESSION PROFILES; CELLS; BETA; DIFFERENTIATION; SIGNATURES; INVASION; TUMORS; GENES; SOX-4; CORE	A search for general regulators of cancer metastasis has yielded a set of microRNAs for which expression is specifically lost as human breast cancer cells develop metastatic potential. Here we show that restoring the expression of these microRNAs in malignant cells suppresses lung and bone metastasis by human cancer cells in vivo. Of these microRNAs, miR- 126 restoration reduces overall tumour growth and proliferation, whereas miR- 335 inhibits metastatic cell invasion. miR- 335 regulates a set of genes whose collective expression in a large cohort of human tumours is associated with risk of distal metastasis. miR- 335 suppresses metastasis and migration through targeting of the progenitor cell transcription factor SOX4 and extracellular matrix component tenascin C. Expression of miR- 126 and miR- 335 is lost in the majority of primary breast tumours from patients who relapse, and the loss of expression of either microRNA is associated with poor distal metastasis- free survival. miR- 335 and miR- 126 are thus identified as metastasis suppressor microRNAs in human breast cancer.	[Tavazoie, Sohail F.; Alarcon, Claudio; Oskarsson, Thordur; Padua, David; Wang, Qiongqing; Bos, Paula D.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Tavazoie, Sohail F.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Gerald, William L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	massaguj@mskcc.org	Vickers, Michael M/E-4095-2010; Oskarsson, Thordur/HBP-9601-2022	Oskarsson, Thordur/0000-0002-0983-6969; Padua, David/0000-0003-2549-9939; Massague, Joan/0000-0001-9324-8408	NCI NIH HHS [P01 CA094060, P30 CA008748, P01 CA094060-06A10002] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA094060, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoser M, 2007, J NEUROSCI, V27, P5495, DOI 10.1523/JNEUROSCI.1384-07.2007; Ilunga K, 2004, INT J EXP PATHOL, V85, P373, DOI 10.1111/j.0959-9673.2004.00406.x; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lyu MS, 1996, MAMM GENOME, V7, P501, DOI 10.1007/s003359900151; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	33	1506	1667	1	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					147	U3		10.1038/nature06487	http://dx.doi.org/10.1038/nature06487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18185580	Green Accepted			2022-12-24	WOS:000252214400033
J	Gennerich, A; Carter, AP; Reck-Peterson, SL; Vale, RD				Gennerich, Arne; Carter, Andrew P.; Reck-Peterson, Samara L.; Vale, Ronald D.			Force-induced bidirectional stepping of cytoplasmic dynein	CELL			English	Article							MOLECULAR MOTOR; MYOSIN-V; MICROTUBULE-BINDING; FLAGELLAR AXONEMES; HEAVY-CHAIN; IN-VITRO; TRANSPORT; KINESIN; ACTIN; SIZE	Cytoplasmic dynein is a minus-end-directed microtubule motor whose mechanism of movement remains poorly understood. Here, we use optical tweezers to examine the force-dependent stepping behavior of yeast cytoplasmic dynein. We find that dynein primarily advances in 8 nm increments but takes other sized steps (4-24 nm) as well. An opposing force induces more frequent backward stepping by dynein, and the motor walks backward toward the microtubule plus end at loads above its stall force of 7 pN. Remarkably, in the absence of ATP, dynein steps processively along microtubules under an external load, with less force required for minus-end-than for plus-end-directed movement. This nucleotide-independent walking reveals that force alone can drive repetitive microtubule detachment-attachment cycles of dynein's motor domains. These results suggest a model for how dynein's two motor domains coordinate their activities during normal processive motility and provide new clues for understanding dynein-based motility in living cells.	[Gennerich, Arne; Carter, Andrew P.; Reck-Peterson, Samara L.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019	Carter, Andrew/0000-0001-7292-5430; Reck-Peterson, Samara/0000-0002-1553-465X	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [P01 AR042895, P01-AR42895, P01 AR042895-140004] Funding Source: Medline; NIGMS NIH HHS [F32 GM067403, F32-GM67403-02] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067403] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; GEE MA, 1997, NATURE, V390, P639; Gennerich A, 2006, PHYS BIOL, V3, P45, DOI 10.1088/1478-3975/3/1/005; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; KAMIMURA S, 1992, J CELL BIOL, V116, P1443, DOI 10.1083/jcb.116.6.1443; KAMIMURA S, 1989, NATURE, V340, P476, DOI 10.1038/340476a0; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	42	288	290	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					952	965		10.1016/j.cell.2007.10.016	http://dx.doi.org/10.1016/j.cell.2007.10.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045537	Bronze, Green Accepted			2022-12-24	WOS:000251800900017
J	Miyanishi, M; Tada, K; Koike, M; Uchiyama, Y; Kitamura, T; Nagata, S				Miyanishi, Masanori; Tada, Kazutoshi; Koike, Masato; Uchiyama, Yasuo; Kitamura, Toshio; Nagata, Shigekazu			Identification of Tim4 as a phosphatidylserine receptor	NATURE			English	Article							APOPTOTIC CELLS; IMMUNOGLOBULIN-DOMAIN; DNA-DEGRADATION; GENE FAMILY; ANNEXIN-V; T-CELLS; B-CELLS; MACROPHAGES; EXPRESSION; CLEARANCE	In programmed cell death, a large number of cells undergo apoptosis, and are engulfed by macrophages to avoid the release of noxious materials from the dying cells(1,2). In definitive erythropoiesis, nuclei are expelled from erythroid precursor cells and are engulfed by macrophages. Phosphatidylserine is exposed on the surface of apoptotic cells(3) and on the nuclei expelled from erythroid precursor cells(4); it works as an 'eat me' signal for phagocytes(5,6). Phosphatidylserine is also expressed on the surface of exosomes involved in intercellular signalling(7). Here we established a library of hamster monoclonal antibodies against mouse peritoneal macrophages, and found an antibody that strongly inhibited the phosphatidylserine-dependent engulfment of apoptotic cells. The antigen recognized by the antibody was identified by expression cloning as a type I transmembrane protein called Tim4 (T-cell immunoglobulin- and mucin-domain-containing molecule; also known as Timd4)(8). Tim4 was expressed in Mac1(+) cells in various mouse tissues, including spleen, lymph nodes and fetal liver. Tim4 bound apoptotic cells by recognizing phosphatidylserine via its immunoglobulin domain. The expression of Tim4 in fibroblasts enhanced their ability to engulf apoptotic cells. When the anti-Tim4 monoclonal antibody was administered into mice, the engulfment of apoptotic cells by thymic macrophages was significantly blocked, and the mice developed autoantibodies. Among the other Tim family members, Tim1, but neither Tim2 nor Tim3, specifically bound phosphatidylserine. Tim1- or Tim4-expressing Ba/F3 B cells were bound by exosomes via phosphatidylserine, and exosomes stimulated the interaction between Tim1 and Tim4. These results indicate that Tim4 and Tim1 are phosphatidylserine receptors for the engulfment of apoptotic cells, and may also be involved in intercellular signalling in which exosomes are involved.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Osaka Univ, Sch Med, Dept Genet, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Neurosci, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Osaka University; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Koike, Masato/F-9584-2010; Nagata, Shigekazu/AAG-3203-2019; Kitamura, Toshio/AAA-2071-2021	Koike, Masato/0000-0002-3174-5684; Nagata, Shigekazu/0000-0001-9758-8426; 				Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hu B, 2000, J IMMUNOL, V165, P2124, DOI 10.4049/jimmunol.165.4.2124; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyasaka K, 2004, EUR J IMMUNOL, V34, P1414, DOI 10.1002/eji.200424930; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; TANAKA Y, 1983, J BIOL CHEM, V258, P1335; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	30	786	824	7	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					435	439		10.1038/nature06307	http://dx.doi.org/10.1038/nature06307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	17960135	Green Submitted, Bronze			2022-12-24	WOS:000250918600058
J	Kuhn, CD; Geiger, SR; Baumli, S; Gartmann, M; Gerber, J; Jennebach, S; Mielke, T; Tschochner, H; Beckmann, R; Cramer, P				Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Gerber, Jochen; Jennebach, Stefan; Mielke, Thorsten; Tschochner, Herbert; Beckmann, Roland; Cramer, Patrick			Functional architecture of RNA polymerase I	CELL			English	Article							INTRINSIC TRANSCRIPT CLEAVAGE; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; PREINITIATION COMPLEX; ELONGATION COMPLEX; III SUBUNITS; H ACTIVITY; YEAST; INITIATION; TERMINATION	Synthesis of ribosomal RNA (rRNA) by RNA polymerase (Pol) I is the first step in ribosome biogenesis and a regulatory switch in eukaryotic cell growth. Here we report the 12 angstrom cryoelectron microscopic structure for the complete 14-subunit yeast Pol I, a homology model for the core enzyme, and the crystal structure of the subcomplex A14/43. In the resulting hybrid structure of Pol I, A14/43, the clamp, and the dock domain contribute to a unique surface interacting with promoter-specific initiation factors. The Pol I-specific subunits A49 and A34.5 form a heterodimer near the enzyme funnel that acts as a built-in elongation factor and is related to the Pol II-associated factor TFIIF. In contrast to Pol II, Pol I has a strong intrinsic 3'-RNA cleavage activity, which requires the C-terminal domain of subunit A12.2 and, apparently, enables ribosomal RNA proofreading and 3'-end trimming.	[Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Jennebach, Stefan; Beckmann, Roland; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Gene Ctr Munich, D-81377 Munich, Germany; [Kuhn, Claus-D.; Geiger, Sebastian R.; Baumli, Sonja; Gartmann, Marco; Jennebach, Stefan; Beckmann, Roland; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Gerber, Jochen; Tschochner, Herbert] Univ Regensburg, Inst Biochem Genet & Mikrobiol, D-93053 Regensburg, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Munich; University of Munich; University of Regensburg; Max Planck Society	Cramer, P (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Kuhn, Claus D./U-3438-2019	Kuhn, Claus D./0000-0002-4244-3219				Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Bric A, 2004, J BIOL CHEM, V279, P31259, DOI 10.1074/jbc.M311828200; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GERBER J, 2007, IN RPESS NUCL ACIDS, DOI DOI 10.1093/NAR/GKM1093; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; HIGUCHI H, 1988, J MUSCLE RES CELL M, V9, P491, DOI 10.1007/BF01738754; Hsieh YJ, 1999, MOL CELL BIOL, V19, P7697; Hu P, 2002, MOL CELL BIOL, V22, P8044, DOI 10.1128/MCB.22.22.8044-8055.2002; HUET J, 1976, NATURE, V261, P431, DOI 10.1038/261431a0; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; HUET J, 1977, J BIOL CHEM, V252, P8848; IBORRA F, 1979, J BIOL CHEM, V254, P920; Imazawa Y, 2005, J BIOL CHEM, V280, P11467, DOI 10.1074/jbc.M411150200; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; KUHN A, 1989, GENE DEV, V3, P224, DOI 10.1101/gad.3.2.224; Labhart P, 1997, J BIOL CHEM, V272, P9055; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maniatis F.a.S., 1982, MOL CLONING LAB MANU; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Meka H, 2003, NUCLEIC ACIDS RES, V31, P4391, DOI 10.1093/nar/gkg652; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Peyroche E, 2002, P NATL ACAD SCI USA, V99, P14670, DOI 10.1073/pnas.232580799; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Siaut M, 2003, MOL CELL BIOL, V23, P195, DOI 10.1128/MCB.23.1.195-205.2003; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yamamoto K, 2004, MOL CELL BIOL, V24, P6338, DOI 10.1128/MCB.24.14.6338-6349.2004; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212	77	155	175	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1260	1272		10.1016/j.cell.2007.10.051	http://dx.doi.org/10.1016/j.cell.2007.10.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160037	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000252217200016
J	Mapelli, M; Massimiliano, L; Santaguida, S; Musacchio, A				Mapelli, Marina; Massimiliano, Lucia; Santaguida, Stefano; Musacchio, Andrea			The mad2 conformational dimer: Structure and implications for the spindle assembly checkpoint	CELL			English	Article							PROMOTING COMPLEX; PROTEIN; BINDING; ACTIVATION; ANAPHASE; MECHANISM; MODEL; OLIGOMERIZATION; UBIQUITINATION; IDENTIFICATION	The 25 kDa Mad2 protein is a key player in the spindle assembly checkpoint, a safeguard against chromosome segregation errors in mitosis. Mad2 combines three unusual properties. First, Mad2 adopts two conformations with distinct topologies, open (O) and closed (C) Mad2. Second, C-Mad2 forms topological links with its two best-characterized protein ligands, Mad1 and Cdc20. Third, O-Mad2 and C-Mad2 engage in a "conformational'' dimer that is essential for spindle checkpoint function in different organisms. The crystal structure of the O-Mad2-C-Mad2 conformational dimer, reported here, reveals an asymmetric interface that explains the selective dimerization of the O-Mad2 and C-Mad2 conformers. The structure also identifies several buried hydrophobic residues whose rearrangement correlates with the Mad2 topological change. The structure of the O-Mad2-C-Mad2 conformational dimer is consistent with a catalytic model in which a C-Mad2 template facilitates the binding of O-Mad2 to Cdc20, the target of Mad2 in the spindle checkpoint.	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; Italian Inst Technol Consortium Genom Technol Cog, Res Unit, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO); Istituto Italiano di Tecnologia - IIT	Mapelli, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	marina.mapelli@ifom-ieo-campus.it; andrea.musacchio@ifom-ieo-campus.it	Santaguida, Stefano/ABH-5433-2020; Massimiliano, Lucia/AAP-5179-2020; santaguida, stefano/G-2716-2010; Mapelli, Marina/AAC-7346-2022	Santaguida, Stefano/0000-0002-1501-6190; Mapelli, Marina/0000-0001-8502-0649; Musacchio, Andrea/0000-0003-2362-8784; Massimiliano, Lucia/0000-0001-9128-4317				Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	180	185	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					730	743		10.1016/j.cell.2007.08.049	http://dx.doi.org/10.1016/j.cell.2007.08.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022367	Green Submitted, Bronze			2022-12-24	WOS:000250966300020
J	Yu, JY; Vodyanik, MA; Smuga-Otto, K; Antosiewicz-Bourget, J; Frane, JL; Tian, S; Nie, J; Jonsdottir, GA; Ruotti, V; Stewart, R; Slukvin, II; Thomson, JA				Yu, Junying; Vodyanik, Maxim A.; Smuga-Otto, Kim; Antosiewicz-Bourget, Jessica; Frane, Jennifer L.; Tian, Shulan; Nie, Jeff; Jonsdottir, Gudrun A.; Ruotti, Victor; Stewart, Ron; Slukvin, Igor I.; Thomson, James A.			Induced pluripotent stem cell lines derived from human somatic cells	SCIENCE			English	Article							FIBROBLASTS; NANOG	Somatic cell nuclear transfer allows trans- acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG, and LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem ( ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations ( for example, mutation through viral integration) are eliminated.	Genome Ctr Wisconsin, Madison, WI 53706 USA; Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; WiCell Res Inst, Madison, WI 53707 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yu, JY (corresponding author), Genome Ctr Wisconsin, Madison, WI 53706 USA.	jyu@primate.wisc.edu; thomson@primate.wisc.edu	Wilson, Matthew H/K-3193-2013		NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069981] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000167] Funding Source: Medline; NIGMS NIH HHS [P20 GM069981] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	14	7274	8280	62	1875	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1917	1920		10.1126/science.1151526	http://dx.doi.org/10.1126/science.1151526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18029452				2022-12-24	WOS:000251786600057
J	Huang, CH; Mandelker, D; Schmidt-Kittler, O; Samuels, Y; Velculescu, VE; Kinzler, KW; Vogelstein, B; Gabelli, SB; Amzel, LM				Huang, Chuan-Hsiang; Mandelker, Diana; Schmidt-Kittler, Oleg; Samuels, Yardena; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Gabelli, Sandra B.; Amzel, L. Mario			The structure of a human p110 alpha/p85 alpha complex elucidates the effects of oncogenic PI3K alpha mutations	SCIENCE			English	Article							CANCER-SPECIFIC MUTATIONS; PROTEIN-KINASE B; MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR GENE; PHOSPHOINOSITIDE 3-KINASE; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; REGULATORY SUBUNIT	PIK3CA, one of the two most frequently mutated oncogenes in human tumors, codes for p110 alpha, the catalytic subunit of a phosphatidylinositol 3- kinase, isoform alpha ( PI3K alpha, p110 alpha/p85). Here, we report a 3.0 angstrom resolution structure of a complex between p110 alpha and a polypeptide containing the p110 alpha- binding domains of p85 alpha, a protein required for its enzymatic activity. The structure shows that many of the mutations occur at residues lying at the interfaces between p110 alpha and p85 alpha or between the kinase domain of p110 alpha and other domains within the catalytic subunit. Disruptions of these interactions are likely to affect the regulation of kinase activity by p85 or the catalytic activity of the enzyme, respectively. In addition to providing new insights about the structure of PI3K alpha, these results suggest specific mechanisms for the effect of oncogenic mutations in p110 alpha and p85 alpha.	Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; gabelli@jhmi.edu; mamzel@jhmi.edu	Gabelli, Sandra B/A-3705-2008; Velculescu, Victor/ABF-4846-2020	Gabelli, Sandra B/0000-0003-1205-5204; Velculescu, Victor/0000-0003-1195-438X; Huang, Chuan-Hsiang/0000-0001-9993-8004; Samuels, Yardena/0000-0002-3349-7266; Amzel, L. Mario/0000-0002-0129-9572	NCI NIH HHS [CA 43460] Funding Source: Medline; NIGMS NIH HHS [GM07309, GM066895, GM 07184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA043460, R01CA043460] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895, T32GM007184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Actor B, 2002, GENE CHROMOSOME CANC, V34, P416, DOI 10.1002/gcc.10087; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; END P, 1993, J BIOL CHEM, V268, P10066; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Philp AJ, 2001, CANCER RES, V61, P7426; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogt PK, 2007, TRENDS BIOCHEM SCI, V32, P342, DOI 10.1016/j.tibs.2007.05.005; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	58	419	444	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1744	1748		10.1126/science.1150799	http://dx.doi.org/10.1126/science.1150799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079394				2022-12-24	WOS:000251616800031
J	Dessaud, E; Yang, LL; Hill, K; Cox, B; Ulloa, F; Ribeiro, A; Mynett, A; Novitch, BG; Briscoe, J				Dessaud, Eric; Yang, Lin Lin; Hill, Katy; Cox, Barny; Ulloa, Fausto; Ribeiro, Ana; Mynett, Anita; Novitch, Bennett G.; Briscoe, James			Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism	NATURE			English	Article							PROGENITOR-CELL IDENTITY; VENTRAL NEURAL-TUBE; NEURONAL FATE; FLOOR PLATE; TRANSDUCTION; SPECIFICATION; INDUCTION; GENE; PATHWAY; PATTERN	Morphogens act in developing tissues to control the spatial arrangement of cellular differentiation(1,2). The activity of a morphogen has generally been viewed as a concentration-dependent response to a diffusible signal, but the duration of morphogen signalling can also affect cellular responses(3). One such example is the morphogen sonic hedgehog (SHH). In the vertebrate central nervous system and limbs, the pattern of cellular differentiation is controlled by both the amount and the time of SHH exposure(4-7). How these two parameters are interpreted at a cellular level has been unclear. Here we provide evidence that changing the concentration or duration of SHH has an equivalent effect on intracellular signalling. Chick neural cells convert different concentrations of SHH into time-limited periods of signal transduction, such that signal duration is proportional to SHH concentration. This depends on the gradual desensitization of cells to ongoing SHH exposure, mediated by the SHH-dependent upregulation of patched 1 (PTC1), a ligand-binding inhibitor of SHH signalling(8). Thus, in addition to its role in shaping the SHH gradient(8-10), PTC1 participates cell autonomously in gradient sensing. Together, the data reveal a novel strategy for morphogen interpretation, in which the temporal adaptation of cells to a morphogen integrates the concentration and duration of a signal to control differential gene expression.	Natl Inst Med Res, London NW7 1AA, England; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	MRC National Institute for Medical Research; University of Michigan System; University of Michigan	Briscoe, J (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	james.briscoe@nimr.mrc.ac.uk	Ulloa, Fausto/AAB-2787-2019	Dessaud, Eric/0000-0001-9723-6658; Novitch, Bennett/0000-0002-2696-3708; Briscoe, James/0000-0002-1020-5240; Ribeiro, Ana/0000-0003-0132-9740	MRC [MC_U117560541] Funding Source: UKRI; Medical Research Council [MC_U117560541] Funding Source: Medline; NINDS NIH HHS [R01 NS072804] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072804] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Bourillot PY, 2002, DEVELOPMENT, V129, P2167; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yang Y, 1997, DEVELOPMENT, V124, P4393	33	397	399	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					717	U7		10.1038/nature06347	http://dx.doi.org/10.1038/nature06347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046410	Green Published			2022-12-24	WOS:000251209700053
J	Krishnan, V; Han, MH; Graham, DL; Berton, O; Renthal, W; Russo, SJ; LaPlant, Q; Graham, A; Lutter, M; Lagace, DC; Ghose, S; Reister, R; Tannous, P; Green, TA; Neve, RL; Chakravarty, S; Kumar, A; Eisch, AJ; Self, DW; Lee, FS; Tamminga, CA; Cooper, DC; Gershenfeld, HK; Nestler, EJ				Krishnan, Vaishnav; Han, Ming-Hu; Graham, Danielle L.; Berton, Olivier; Renthal, William; Russo, Scott J.; LaPlant, Quincey; Graham, Ami; Lutter, Michael; Lagace, Diane C.; Ghose, Subroto; Reister, Robin; Tannous, Paul; Green, Thomas A.; Neve, Rachael L.; Chakravarty, Sumana; Kumar, Arvind; Eisch, Amelia J.; Self, David W.; Lee, Francis S.; Tamminga, Carol A.; Cooper, Donald C.; Gershenfeld, Howard K.; Nestler, Eric J.			Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions	CELL			English	Article							BDNF VAL66MET POLYMORPHISM; ACTIVITY-DEPENDENT SECRETION; DOPAMINE SYSTEM; STRESS; RESILIENCE; ASSOCIATION; DISORDERS; ALTERS; VULNERABILITY; TRAFFICKING	While stressful life events are an important cause of psychopathology, most individuals exposed to adversity maintain normal psychological functioning. The molecular mechanisms underlying such resilience are poorly understood. Here, we demonstrate that an inbred population of mice subjected to social defeat can be separated into susceptible and unsusceptible subpopulations that differ along several behavioral and physiological domains. By a combination of molecular and electrophysiological techniques, we identify signature adaptations within the mesolimbic dopamine circuit that are uniquely associated with vulnerability or insusceptibility. We show that molecular recapitulations of three prototypical adaptations associated with the unsusceptible phenotype are each sufficient to promote resistant behavior. Our results validate a multidisciplinary approach to examine the neurobiological mechanisms of variations in stress resistance, and illustrate the importance of plasticity within the brain's reward circuits in actively maintaining an emotional homeostasis.	Univ Texas, SW Med Ctr, Dept Psychait & Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Harvard Univ, McLean Hosp, Cambridge, MA 02478 USA; Harvard Univ, Dept Genet, Cambridge, MA 02478 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol & Psychiat, New York, NY 10021 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; McLean Hospital; Harvard University; Cornell University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychait & Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Kumar, Arvind/B-6094-2009; Russo, Scott/R-7107-2019; Gershenfeld, Howard K/HGF-0536-2022; Han, Ming-Hu/G-8836-2012; Ghose, Subroto/J-6732-2016; Graham, Danielle L/K-8459-2014	Russo, Scott/0000-0002-6470-1805; Tannous, Paul/0000-0001-7972-9651; Krishnan, Vaishnav/0000-0002-2847-0069; Renthal, William/0000-0003-0206-2101; Gershenfeld, Howard/0000-0002-4107-1513; Eisch, Amelia/0000-0001-6476-5385; Kumar, Arvind/0000-0003-2879-3826	NIDA NIH HHS [K01 DA017750] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA017750] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P917, DOI 10.1007/s11055-005-0146-6; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bonanno George A, 2003, Child Maltreat, V8, P302, DOI 10.1177/1077559503257066; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Curtis WJ, 2003, DEV PSYCHOPATHOL, V15, P773, DOI 10.1017/S0954579403000373; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; Grace AA, 2000, ADDICTION, V95, pS119; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Grimm JW, 2003, J NEUROSCI, V23, P742; Hines LM, 2006, J NEUROSCI, V26, P12609, DOI 10.1523/JNEUROSCI.1040-06.2006; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Horger BA, 1999, J NEUROSCI, V19, P4110; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Liu XQ, 2003, J PSYCHIATR RES, V37, P249, DOI 10.1016/S0022-3956(03)00004-9; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Malatynska E, 2005, NEUROSCI BIOBEHAV R, V29, P715, DOI 10.1016/j.neubiorev.2005.03.014; Martinez M, 1998, AGGRESSIVE BEHAV, V24, P241; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Strauss J, 2005, MOL PSYCHIATR, V10, P861, DOI 10.1038/sj.mp.4001685; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Weiss JM, 1998, ANN NY ACAD SCI, V863, P364, DOI 10.1111/j.1749-6632.1998.tb10707.x; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yehuda R, 2004, J CLIN PSYCHIAT, V65, P29; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P379, DOI 10.1196/annals.1364.028; Yoshida K, 2007, J PSYCHOPHARMACOL, V21, P650, DOI 10.1177/0269881106072192	50	1432	1466	3	156	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2007	131	2					391	404		10.1016/j.cell.2007.09.018	http://dx.doi.org/10.1016/j.cell.2007.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HM	17956738	Bronze			2022-12-24	WOS:000250507700027
J	Clem, RL; Celikel, T; Barth, AL				Clem, Roger L.; Celikel, Tansu; Barth, Alison L.			Ongoing in vivo experience triggers synaptic metaplasticity in the neocortex	SCIENCE			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; DEPENDENT PLASTICITY; VISUAL-CORTEX; LTP; ACTIVATION; SYNAPSES; NMDA; INTERNEURONS; INDUCTION	In vivo experience can occlude subsequent induction of long- term potentiation and enhance long- term depression of synaptic responses. Although a reduced capacity for synaptic strengthening may function to prevent excessive excitation, such an effect paradoxically implies that continued experience or training should not improve and may even degrade neural representations. In mice, we examined the effect of ongoing whisker stimulation on synaptic strengthening at layer 4-2/3 synapses in the barrel cortex. Although N- methyl- D- aspartate receptors were required to initiate strengthening, they subsequently suppressed further potentiation at these synapses in vitro and in vivo. Despite this transition, synaptic strengthening continued with additional sensory activity but instead required the activation of metabotropic glutamate receptors, suggesting a mechanism by which continued experience can result in increasing synaptic strength over time.	[Clem, Roger L.; Barth, Alison L.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Clem, Roger L.; Barth, Alison L.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Celikel, Tansu] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Max Planck Society	Barth, AL (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	barth@cmu.edu	Celikel, Tansu/P-4235-2018		NIDA NIH HHS [DA017188-01, R01 DA017188] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017188] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Glazewski S, 2007, J NEUROSCI, V27, P3910, DOI 10.1523/JNEUROSCI.0181-07.2007; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hardingham N, 2003, J NEUROSCI, V23, P4428; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Lee OK, 2002, NEUROREPORT, V13, P685, DOI 10.1097/00001756-200204160-00030; Lu YM, 1997, J NEUROSCI, V17, P5196; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	27	121	124	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					101	104		10.1126/science.1143808	http://dx.doi.org/10.1126/science.1143808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174444				2022-12-24	WOS:000252084000041
J	Diederichs, S; Haber, DA				Diederichs, Sven; Haber, Daniel A.			Dual role for argonautes in MicroRNA processing and Posttranscriptional regulation of MicroRNA expression	CELL			English	Article							RNA-INTERFERENCE; PASSENGER-STRAND; NUCLEAR EXPORT; COMPLEX; DICER; SIRNA; INITIATION; CLEAVAGE; GENES; IDENTIFICATION	MicroRNAs are small endogenous noncoding RNAs involved in posttranscriptional gene regulation. During microRNA biogenesis, Drosha and Dicer process the primary transcript (pri-miRNA) through a precursor hairpin (pre-miRNA) to the mature miRNA. The miRNA is incorporated into the RNA-Induced Silencing Complex (RISC) with Argonaute proteins, the effector molecules in RNA interference (RNAi). Here, we show that all Argonautes elevate mature miRNA expression posttranscriptionally, independent of RNase activity. Also, we identify a role for the RISC slicer Argonaute2 (Ago2) in cleaving the pre-miRNA to an additional processing intermediate, termed Ago2 cleaved precursor miRNA or ac-pre-miRNA. This endogenous, on-pathway intermediate results from cleavage of the pre-miRNA hairpin 12 nucleotides from its 3'-end. By analogy to siRNA processing, Ago2 cleavage may facilitate removal of the nicked passenger strand from RISC after maturation. The multiple roles of Argonautes in the RNAi effector phase and miRNA biogenesis and maturation suggest coordinate regulation of microRNA expression and function.	[Diederichs, Sven; Haber, Daniel A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Diederichs, S (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	sdiederichs@bics.bwh.harvard.edu; haber@helix.mgh.harvard.edu	Diederichs, Sven/J-6237-2012	Diederichs, Sven/0000-0001-7901-4752	PHS HHS [R01 95281] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; OCARROLL D, 2007, GENES DEV; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200	51	473	497	5	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1097	1108		10.1016/j.cell.2007.10.032	http://dx.doi.org/10.1016/j.cell.2007.10.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083100	Bronze			2022-12-24	WOS:000252217100018
J	Henzler-Wildman, KA; Lei, M; Thai, V; Kerns, SJ; Karplus, M; Kern, D				Henzler-Wildman, Katherine A.; Lei, Ming; Thai, Vu; Kerns, S. Jordan; Karplus, Martin; Kern, Dorothee			A hierarchy of timescales in protein dynamics is linked to enzyme catalysis	NATURE			English	Article							COLI ADENYLATE KINASE; N-15 NMR RELAXATION; MODEL-FREE APPROACH; TEMPERATURE-DEPENDENCE; GLOBULAR-PROTEINS; BACKBONE DYNAMICS; HYDRODYNAMIC CALCULATIONS; CONFORMATIONAL-CHANGE; DOMAIN FLEXIBILITY; ORDER PARAMETERS	The synergy between structure and dynamics is essential to the function of biological macromolecules. Thermally driven dynamics on different timescales have been experimentally observed or simulated, and a direct link between micro- to millisecond domain motions and enzymatic function has been established(1-4). However, very little is understood about the connection of these functionally relevant, collective movements with local atomic fluctuations, which are much faster. Here we show that pico- to nano-second timescale atomic fluctuations in hinge regions of adenylate kinase facilitate the large-scale, slower lid motions that produce a catalytically competent state. The fast, local mobilities differ between a mesophilic and hyperthermophilic adenylate kinase, but are strikingly similar at temperatures at which enzymatic activity and free energy of folding are matched. The connection between different timescales and the corresponding amplitudes of motions in adenylate kinase and their linkage to catalytic function is likely to be a general characteristic of protein energy landscapes.	Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02454 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Univ Strasbourg 1, Lab Chim Biophys, Inst Sci & Ingn Supramol, F-67000 Strasbourg, France	Brandeis University; Howard Hughes Medical Institute; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02454 USA.	dkern@brandeis.edu		Henzler-Wildman, Katherine/0000-0002-5295-2121	NIGMS NIH HHS [F32 GM070251, T32 GM007596] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070251, T32GM007596] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bae E, 2006, P NATL ACAD SCI USA, V103, P2132, DOI 10.1073/pnas.0507527103; Bernado P, 2002, J BIOMOL NMR, V23, P139, DOI 10.1023/A:1016359412284; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chang SL, 2005, J MAGN RESON, V174, P43, DOI 10.1016/j.jmr.2005.01.008; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clore GM, 2006, J MOL BIOL, V355, P879, DOI 10.1016/j.jmb.2005.11.042; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HENZLERWILDMAN KA, 2007, NATURE; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; MONNOT M, 1987, J BIOL CHEM, V262, P2502; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Prompers JJ, 2000, J PHYS CHEM B, V104, P11416, DOI 10.1021/jp0026033; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Shapiro YE, 2002, BIOCHEMISTRY-US, V41, P6271, DOI 10.1021/bi012132q; Spyracopoulos L, 2001, BIOCHEMISTRY-US, V40, P12541, DOI 10.1021/bi010903k; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; Tugarinov V, 2002, J MOL BIOL, V315, P155, DOI 10.1006/jmbi.2001.5231; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Vugmeyster L, 2003, J AM CHEM SOC, V125, P8400, DOI 10.1021/ja029480f; Wang TZ, 2003, J AM CHEM SOC, V125, P8639, DOI 10.1021/ja034077+; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang FL, 2002, J AM CHEM SOC, V124, P12654, DOI 10.1021/ja027847a; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; Zhuravleva AV, 2004, J MOL BIOL, V342, P1599, DOI 10.1016/j.jmb.2004.08.001	47	801	809	6	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					913	U27		10.1038/nature06407	http://dx.doi.org/10.1038/nature06407			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026087				2022-12-24	WOS:000251394900063
J	Yang, YG; Lindahl, T; Barnes, DE				Yang, Yun-Gui; Lindahl, Tomas; Barnes, Deborah E.			Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease	CELL			English	Article							AICARDI-GOUTIERES-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STALLED REPLICATION FORKS; DNA-DAMAGE-RESPONSE; SACCHAROMYCES-CEREVISIAE; MUTATIONS; EXCISION; RIBONUCLEOTIDES; IDENTIFICATION; ENDONUCLEASE	Trex1 is the major 3' DNA exonuclease in mammalian cells, and mutations in the human TREX1 gene can cause Aicardi-Goutieres syndrome, characterized by perturbed immunity. Similarly, Trex1(-/-) mice have an autoinflammatory phenotype; however, the mechanism of Trex1-deficient disease is unknown. We report that Trex1, ordinarily associated with the endoplasmic reticulum (ER), relocalizes to the S phase nucleus after gamma irradiation or hydroxyurea treatment. Notably, Trex1-deficient cells show defective G1/S transition and chronic ATM-dependent checkpoint activation, even in the absence of exogenous stress, correlating with persistent single-stranded DNA molecules produced in S phase, which accumulate in the ER. Our data indicate that Trex1 acts on a single-stranded DNA polynucleotide species generated from processing of aberrant replication intermediates to attenuate DNA damage checkpoint signaling and prevent pathological immune activation.	[Yang, Yun-Gui; Lindahl, Tomas; Barnes, Deborah E.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Barnes, DE (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, So Mimms, S Mimms EN6 3LD, Herts, England.	deborah.barnes@cancer.org.uk	Yang, Yungui/ABF-2507-2021					Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Alarcon-Riquelme ME, 2006, NAT GENET, V38, P866, DOI 10.1038/ng0806-866; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; BJURSELL G, 1979, NATURE, V280, P420, DOI 10.1038/280420a0; BLUMENTHAL AB, 1977, CELL, V12, P183, DOI 10.1016/0092-8674(77)90196-9; Bourdon JC, 2002, J CELL BIOL, V158, P235, DOI 10.1083/jcb.200203006; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Chi HB, 2007, NATURE, V448, P423, DOI 10.1038/448423a; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; HARPER JW, 1993, CELL, V75, P805; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Inamdar KV, 2002, RADIAT RES, V157, P306, DOI 10.1667/0033-7587(2002)157[0306:ROPDET]2.0.CO;2; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	56	407	422	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					873	886		10.1016/j.cell.2007.10.017	http://dx.doi.org/10.1016/j.cell.2007.10.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045533	Bronze			2022-12-24	WOS:000251800900011
J	Collison, LW; Workman, CJ; Kuo, TT; Boyd, K; Wang, Y; Vignali, KM; Cross, R; Sehy, D; Blumberg, RS; Vignali, DAA				Collison, Lauren W.; Workman, Creg J.; Kuo, Timothy T.; Boyd, Kelli; Wang, Yao; Vignali, Kate M.; Cross, Richard; Sehy, David; Blumberg, Richard S.; Vignali, Dario A. A.			The inhibitory cytokine IL-35 contributes to regulatory T-cell function	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; IN-VIVO; INTESTINAL INFLAMMATION; LEISHMANIA-MAJOR; TH1 RESPONSES; ACTIVATION; MICE; PROTEIN; GENE; INTERLEUKIN-12	Regulatory T (T-reg) cells are a critical sub-population of CD4(+) T cells that are essential for maintaining self tolerance and preventing autoimmunity(1,2), for limiting chronic inflammatory diseases, such as asthma and inflammatory bowel disease(3,4), and for regulating homeostatic lymphocyte expansion(5). However, they also suppress natural immune responses to parasites(6) and viruses(7) as well as anti-tumour immunity induced by therapeutic vaccines(8). Although the manipulation of T-reg function is an important goal of immunotherapy, the molecules that mediate their suppressive activity remain largely unknown. Here we demonstrate that Epstein-Barr-virus-induced gene 3 (Ebi3, which encodes IL-27 beta) and interleukin-12 alpha (Il12a, which encodes IL-2 alpha/p35) are highly expressed by mouse Foxp3(+) ( forkhead box P3) Treg cells but not by resting or activated effector CD4(+) T (T-eff) cells, and that an Ebi3-IL-12 alpha heterodimer is constitutively secreted by T-reg but not T-eff cells. Both Ebi3 and Il12a messenger RNA are markedly upregulated in T-reg cells co-cultured with T-eff cells, thereby boosting Ebi3 and IL-12 alpha production in trans. T-reg-cell restriction of this cytokine occurs because Ebi3 is a downstream target of Foxp3, a transcription factor that is required for T-reg-cell development and function. Ebi3(-/-) and Il12a(-/-) T-reg cells have significantly reduced regulatory activity in vitro and fail to control homeostatic proliferation and to cure inflammatory bowel disease in vivo. Because these phenotypic characteristics are distinct from those of other IL-12 family members, this novel Ebi3-IL-12 alpha heterodimeric cytokine has been designated interleukin-35 ( IL-35). Ectopic expression of IL-35 confers regulatory activity on naive T cells, whereas recombinant IL-35 suppresses T-cell proliferation. Taken together, these data identify IL-35 as a novel inhibitory cytokine that may be specifically produced by T-reg cells and is required for maximal suppressive activity.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; eBiosci, San Diego, CA 92121 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Vignali, DAA (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	dario.vignali@stjude.org						Annacker O, 2001, IMMUNOL REV, V182, P5, DOI 10.1034/j.1600-065X.2001.1820101.x; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2006, IMMUNOL REV, V212, P287, DOI 10.1111/j.0105-2896.2006.00409.x; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jooss K, 2001, P NATL ACAD SCI USA, V98, P8738, DOI 10.1073/pnas.151088898; Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0; Kretschmer K, 2006, IMMUNOL REV, V212, P163, DOI 10.1111/j.0105-2896.2006.00411.x; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2004, J IMMUNOL, V173, P6806, DOI 10.4049/jimmunol.173.11.6806; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nieuwenhuis EES, 2002, P NATL ACAD SCI USA, V99, P16951, DOI 10.1073/pnas.252648899; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schrader JW, 2002, TRENDS IMMUNOL, V23, P573, DOI 10.1016/S1471-4906(02)02336-0; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; SZYMCZAKWORKMAN AL, 2006, GENE TRANSFER DELIVE, P137; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vignali DAA, 1999, J IMMUNOL, V162, P1431; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Xystrakis E, 2006, EXPERT OPIN BIOL TH, V6, P121, DOI 10.1517/14712598.6.2.121; Zahn S, 2005, EUR J IMMUNOL, V35, P1106, DOI 10.1002/eji.200425926	43	1377	1515	6	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2007	450	7169					566	U19		10.1038/nature06306	http://dx.doi.org/10.1038/nature06306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033300				2022-12-24	WOS:000251158500051
J	Yang, MJ; Li, B; Tomchick, DR; Machius, M; Rizo, J; Yu, HT; Luo, XL				Yang, Maojun; Li, Bing; Tomchick, Diana R.; Machius, Mischa; Rizo, Josep; Yu, Hongtao; Luo, Xuelian			p31(comet) blocks Mad2 activation through structural mimicry	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; PROTEIN; CDC20; BINDING; MODEL; UBIQUITINATION; REFINEMENT; INITIATION; TEMPLATE	The status of spindle checkpoint signaling depends on the balance of two opposing dynamic processes that regulate the highly unusual two-state behavior of Mad2. In mitosis, a Mad1-Mad2 core complex recruits cytosolic Mad2 to kinetochores through Mad2 dimerization and converts Mad2 to a conformer amenable to Cdc20 binding, thereby facilitating checkpoint activation. p31(comet) inactivates the checkpoint through binding to Mad1- or Cdc20-bound Mad2, thereby preventing Mad2 activation and promoting the dissociation of the Mad2-Cdc20 complex. Here, we report the crystal structure of the Mad2-p31(comet) complex. The C-terminal region of Mad2 that undergoes rearrangement in different Mad2 conformers is a major structural determinant for p31(comet) binding, explaining the specificity of p31(comet) toward Mad1- or Cdc20-bound Mad2. p31(comet) adopts a fold strikingly similar to that of Mad2 and binds at the dimerization interface of Mad2. Thus, p31(comet) exploits the two-state behavior of Mad2 to block its activation by acting as an "anti-Mad2.''	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Luo, XL (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	xuelian.luo@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Yang, Maojun/0000-0002-6798-3094; Tomchick, Diana/0000-0002-7529-4643; Yu, Hongtao/0000-0002-8861-049X	NATIONAL CANCER INSTITUTE [K01CA100292] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA100292, K01 CA100292-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; *CONS TC, 1994, ACTA CRYSTALLOGR D, V50, P760; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	33	148	153	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 16	2007	131	4					744	755		10.1016/j.cell.2007.08.048	http://dx.doi.org/10.1016/j.cell.2007.08.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022368	Bronze, Green Accepted			2022-12-24	WOS:000250966300021
J	Scharlemann, JPW; Laurance, WF				Scharlemann, Jorn P. W.; Laurance, William F.			Environmental science - How green are biofuels?	SCIENCE			English	Editorial Material							ENERGY; ETHANOL; DEFORESTATION; CLIMATE		[Scharlemann, Jorn P. W.; Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Scharlemann, JPW (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.	jscharlemann@gmail.com; laurancew@si.edu	Scharlemann, Jorn/A-4737-2008; Laurance, William F/B-2709-2012	Scharlemann, Jorn/0000-0002-2834-6367; Laurance, William F/0000-0003-4430-9408				Adler PR, 2007, ECOL APPL, V17, P675, DOI 10.1890/05-2018; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Crutzen P.J., 2007, ATMOS CHEM PHYS DISC, V7, P11191, DOI DOI 10.5194/ACPD-7-11191-2007; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2007, SCIENCE, V318, P1721; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pimentel D, 2007, REV ENVIRON CONTAM T, V189, P25, DOI 10.1007/978-0-387-35368-5_2; Righelato R, 2007, SCIENCE, V317, P902, DOI 10.1126/science.1141361; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Ulgiati S, 2001, CRIT REV PLANT SCI, V20, P71, DOI 10.1080/20013591099191; Zah R, 2007, OKOBILANZ ENERGIEPRO	14	292	300	1	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					43	44		10.1126/science.1153103	http://dx.doi.org/10.1126/science.1153103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174426				2022-12-24	WOS:000252084000020
J	Kedde, M; Strasser, MJ; Boldajipour, B; Vrielink, JAFO; Le Sage, C; Nagel, R; Voorhoeve, PM; Van Duijse, J; Orom, UA; Lund, AH; Perrakis, A; Raz, E; Agami, R; Slanchev, K				Kedde, Martijn; Strasser, Markus J.; Boldajipour, Bijan; Vrielink, Joachim A. F. Oude; Le Sage, Carlos; Nagel, Remco; Voorhoeve, P. Mathijs; Van Duijse, Josyanne; Orom, Ulf Andersson; Lund, Anders H.; Perrakis, Anastassis; Raz, Erez; Agami, Reuven; Slanchev, Krasimir			RNA-binding protein Dnd1 inhibits microRNA access to target mRNA	CELL			English	Article							GERM-CELL TUMORS; EMBRYONIC-DEVELOPMENT; CHROMATOID BODY; DEAD-END; ZEBRAFISH; GENE; EXPRESSION; MIRNAS; IDENTIFICATION; REPRESSION	MicroRNAs (miRNAs) are inhibitors of gene expression capable of controlling processes in normal development and cancer. In mammals, miRNAs use a seed sequence of 6 -8 nucleotides (nt) to associate with 30 untranslated regions (3'UTRs) of mRNAs and inhibit their expression. Intriguingly, occasionally not only the miRNA-targeting site but also sequences in its vicinity are highly conserved throughout evolution. We therefore hypothesized that conserved regions in mRNAs may serve as docking platforms for modulators of miRNA activity. Here we demonstrate that the expression of dead end 1 (Dnd1), an evolutionary conserved RNA-binding protein (RBP), counteracts the function of several miRNAs in human cells and in primordial germ cells of zebrafish by binding mRNAs and prohibiting miRNAs from associating with their target sites. These effects of Dnd1 are mediated through uridine-rich regions present in the miRNA-targeted mRNAs. Thus, our data unravel a novel role of Dnd1 in protecting certain mRNAs from miRNA-mediated repression.	[Strasser, Markus J.; Boldajipour, Bijan; Raz, Erez; Slanchev, Krasimir] Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany; [Kedde, Martijn; Vrielink, Joachim A. F. Oude; Le Sage, Carlos; Nagel, Remco; Voorhoeve, P. Mathijs; Van Duijse, Josyanne; Agami, Reuven] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; [Strasser, Markus J.; Boldajipour, Bijan; Raz, Erez; Slanchev, Krasimir] Univ Munster, Ctr Mol Biol Inflammat, ZMBE, Inst Cell Biol, D-48149 Munster, Germany; [Perrakis, Anastassis] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Max Planck Society; Netherlands Cancer Institute; University of Munster; Netherlands Cancer Institute	Raz, E (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37070 Gottingen, Germany.	erezraz@uni-muenster.de; r.agami@nki.nl	Orom, Ulf A/G-1327-2010; Perrakis, Anastassis/E-8704-2013; Kedde, Martijn/F-9716-2016; Ørom, Ulf A/F-6727-2010; agami, reuven/GOG-8289-2022; Lund, Anders H./F-4786-2014	Perrakis, Anastassis/0000-0002-1151-6227; Lund, Anders H./0000-0002-7407-3398; Agami, Reuven/0000-0002-2848-2473; Boldajipour, Bijan/0000-0003-2065-555X; Orom, Ulf/0000-0002-0643-0592				Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kedde M, 2006, J BIOL CHEM, V281, P40503, DOI 10.1074/jbc.M607676200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Koprunner M, 2001, GENE DEV, V15, P2877; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; VOORHOEVE PM, 2006, BIOCHIM BIOPHYS ACTA, V1775, P274; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080; Westerfield M, 1995, ZEBRAFISH BOOK; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	43	547	581	3	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1273	1286		10.1016/j.cell.2007.11.034	http://dx.doi.org/10.1016/j.cell.2007.11.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18155131	Bronze, Green Submitted			2022-12-24	WOS:000252217200017
J	Schwarz, JK; Siegel, BA; Dehdashti, F; Grigsby, PW				Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Grigsby, Perry W.			Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL LUNG-CANCER; NON-HODGKINS-LYMPHOMA; FDG-PET; PROGNOSTIC VALUE; PREOPERATIVE CHEMOTHERAPY; F-18 FLUORODEOXYGLUCOSE; RADICAL RADIOTHERAPY; RADIATION-THERAPY; CLINICAL IMPACT; SURVEILLANCE	Context Retrospective studies have demonstrated that the use of positron emission tomography ( PET) with F-18 fluorodeoxyglucose (FDG) in the posttherapy evaluation of patients with cervical carcinoma is predictive of survival outcome. Objective To validate the association between the metabolic response on the 3-month posttherapy FDG-PET and long-term survival outcome. Design, Setting, and Patients A prospective cohort study designed to validate our previous finding that the results of a 3-month posttherapy FDG-PET are predictive of long-term clinical outcome. A total of 92 women were treated with external irradiation, brachytherapy, and concurrent chemotherapy from January 2003 through September 2006. Posttherapy whole-body FDG-PET was performed 2 to 4 months ( mean, 3 months) after completion of therapy. Main Outcome Measures The primary outcome end points were metabolic response, progression-free survival, and cause-specific survival. Results Posttherapy FDG-PET showed a complete metabolic response in 65 patients (70%), a partial metabolic response in 15 (16%),and progressive disease in 12 (13%). Their 3-year progression-free survival rates were 78%, 33%, and 0%, respectively ( P <. 001). Multivariate analysis demonstrated that the hazard ratio (HR) for risk of recurrence based on the posttherapy metabolic response showing progressive disease was 32.57 (95% confidence interval [Cl], 10.22-103.82). A partial metabolic response had an HR of 6.30 ( 95% Cl, 2.73-14.56). These were more predictive of survival outcome than the pretreatment lymph node status ( HR, 3.54; 95% Cl, 1.54-8.09). Conclusion In this single-site study population of women with cervical cancer, 3-month posttherapy FDG uptake, as detected by whole-body PET, was predictive of survival.	Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Nucl Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Grigsby, PW (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Nucl Med, 4921 Parkview Pl,Box 8224, St Louis, MO 63110 USA.	pgrigsby@wustl.edu						Bodurka-Bevers D, 2000, GYNECOL ONCOL, V78, P187, DOI 10.1006/gyno.2000.5860; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; Brun E, 2002, HEAD NECK-J SCI SPEC, V24, P127, DOI 10.1002/hed.10037.abs; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chien CR, 2005, EUR J GYNAECOL ONCOL, V26, P619; Chung HH, 2007, GYNECOL ONCOL, V104, P529, DOI 10.1016/j.ygyno.2006.09.009; Chung HH, 2006, GYNECOL ONCOL, V103, P165, DOI 10.1016/j.ygyno.2006.02.016; COX DR, 1972, J R STAT SOC B, V34, P187; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Greven KM, 2001, HEAD NECK-J SCI SPEC, V23, P942, DOI 10.1002/hed.1136; Grigsby PW, 2004, J CLIN ONCOL, V22, P2167, DOI 10.1200/JCO.2004.09.035; Grigsby PW, 2003, INT J RADIAT ONCOL, V55, P907, DOI 10.1016/S0360-3016(02)04287-6; Grigsby PW, 2001, J CLIN ONCOL, V19, P3745, DOI 10.1200/JCO.2001.19.17.3745; GRIGSBY PW, 1994, INT J RADIAT ONCOL, V28, P451, DOI 10.1016/0360-3016(94)90070-1; Hicks RJ, 2004, INT J RADIAT ONCOL, V60, P412, DOI 10.1016/j.ijrobp.2004.03.036; Hong JH, 2004, INT J RADIAT ONCOL, V60, P249, DOI 10.1016/j.ijrobp.2004.02.044; JACOBS AJ, 1986, CANCER, V57, P944, DOI 10.1002/1097-0142(19860301)57:5<944::AID-CNCR2820570512>3.0.CO;2-2; Jerusalem G, 1999, BLOOD, V94, P429, DOI 10.1182/blood.V94.2.429.414k26_429_433; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P901; Kostakoglu L, 2002, J NUCL MED, V43, P1018; Mac Manus MP, 2005, LUNG CANCER, V49, P95, DOI 10.1016/j.lungcan.2004.11.024; Mac Manus MP, 2003, J CLIN ONCOL, V21, P1285, DOI 10.1200/JCO.2003.07.054; Naumann R, 2001, BRIT J HAEMATOL, V115, P793, DOI 10.1046/j.1365-2141.2001.03147.x; (NCI) NCI, SURV EP END RES SEER; Ott K, 2003, J CLIN ONCOL, V21, P4604, DOI 10.1200/JCO.2003.06.574; Plummer M, 2002, VIRUS RES, V89, P285, DOI 10.1016/S0168-1702(02)00197-1; Porceddu SV, 2005, HEAD NECK-J SCI SPEC, V27, P175, DOI 10.1002/hed.20130; Schelling M, 2000, J CLIN ONCOL, V18, P1689, DOI 10.1200/JCO.2000.18.8.1689; SHIELD PW, 1992, CYTOPATHOLOGY, V3, P167, DOI 10.1111/j.1365-2303.1992.tb00043.x; Singh AK, 2005, INT J RADIAT ONCOL, V61, P450, DOI 10.1016/j.ijrobp.2004.06.207; Smith IC, 2000, J CLIN ONCOL, V18, P1676, DOI 10.1200/JCO.2000.18.8.1676; SOMMERS GM, 1989, GYNECOL ONCOL, V35, P150, DOI 10.1016/0090-8258(89)90033-4; Spaepen K, 2003, EUR J NUCL MED MOL I, V30, P682, DOI 10.1007/s00259-003-1120-6; Spaepen K, 2001, J CLIN ONCOL, V19, P414, DOI 10.1200/JCO.2001.19.2.414; Tewari D, 2005, GYNECOL ONCOL, V99, P84, DOI 10.1016/j.ygyno.2005.05.043; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Weber WA, 2001, J CLIN ONCOL, V19, P3058, DOI 10.1200/JCO.2001.19.12.3058; Weihrauch MR, 2001, BLOOD, V98, P2930, DOI 10.1182/blood.V98.10.2930; Wright JD, 2005, CANCER, V104, P2484, DOI 10.1002/cncr.21527; Yao M, 2004, INT J RADIAT ONCOL, V60, P1410, DOI 10.1016/j.ijrobp.2004.05.058; Yen TC, 2004, J NUCL MED, V45, P1632	44	222	227	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 21	2007	298	19					2289	2295		10.1001/jama.298.19.2289	http://dx.doi.org/10.1001/jama.298.19.2289			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	232XV	18029833	Bronze			2022-12-24	WOS:000251055900029
J	Roberts, SE; Williams, JG; Yeates, D; Goldacre, MJ				Roberts, Stephen E.; Williams, John G.; Yeates, David; Goldacre, Michael J.			Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; RESTORATIVE PROCTOCOLECTOMY; MEDICAL THERAPY; EPIDEMIOLOGY; POPULATION; SURGERY; CARDIFF; COPENHAGEN; EXPERIENCE; MANAGEMENT	Objective To compare mortality outcomes in the three years after elective colectommy, no colectomy, and emergency colectomy among people admitted to hospital for inflammatory bowel disease, to inform whether the threshold for elective colectomy in clinical practice is appropriate. Design Record linkage studies. Setting Oxford region (1968-99) and England (1998-2003). Participants 23 464 people with hospital stay for more than three days for inflammatory bowel disease, including 5480 who had colectomy. Main outcome measures Case fatality, relative survival, and standardised mortality ratios. Results In the Oxford region, three year mortality was lower after elective colectomy than after either no colectomy or emergency colectomy, although this was not significant. For England, mortality three years after elective colectomy for ulcerative colitis (3.7%) and Crohn's disease (3.3%) was significantly lower than that after either admission without colectomy (13.6% and 10.1%; both P<0.001) or emergency colectomy (13.2% and 9.9%; P<0.001 for colitis and P<0.01 for Crohn's disease). Three or more months after elective colectomy, mortality was similar to that in the general population. Adjustment for comorbidity did not affect the findings. Conclusions In England, the clinical threshold for elective colectomy in people with inflammatory bowel disease may be too high. Further research is now required to establish the threshold criteria and optimal timing of elective surgery for people with poorly controlled inflammatory bowel disease.	Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales; Univ Oxford, Dept Publ Hlth, Oxford OX1 2JD, England	Swansea University; University of Oxford	Roberts, SE (corresponding author), Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales.	stephen.e.roberts@swansea.ac.uk						ANDREWS HA, 1989, BRIT J SURG, V76, P1184, DOI 10.1002/bjs.1800761123; Armitage E, 1999, LANCET, V353, P1496, DOI 10.1016/S0140-6736(99)00333-5; BJOMSSON S, 1998, SCAND J GASTROENTERO, V33, P71; Caprilli R, 2000, AM J GASTROENTEROL, V95, P1258; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cosgrove M, 1996, ARCH DIS CHILD, V74, P460, DOI 10.1136/adc.74.5.460; FELLOWS IW, 1990, GUT, V31, P1262, DOI 10.1136/gut.31.11.1262; Fonager K, 1997, INT J EPIDEMIOL, V26, P1003, DOI 10.1093/ije/26.5.1003; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; KYLE J, 1992, GASTROENTEROLOGY, V103, P392, DOI 10.1016/0016-5085(92)90826-K; Lakatos L, 2004, WORLD J GASTROENTERO, V10, P404; Lapidus A, 1997, GUT, V41, P480, DOI 10.1136/gut.41.4.480; Logan RFA, 1998, GUT, V42, P309, DOI 10.1136/gut.42.3.309; MELVILLE DM, 1994, GUT, V35, P1076, DOI 10.1136/gut.35.8.1076; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; MILLER DS, 1974, LANCET, V2, P691; Molinie F, 2004, GUT, V53, P843, DOI 10.1136/gut.2003.025346; MUNKHOLM P, 1992, SCAND J GASTROENTERO, V27, P609, DOI 10.3109/00365529209000127; Oresland T, 2006, ALIMENT PHARM THERAP, V24, P74, DOI 10.1111/j.1365-2036.2006.03065.x; Pebody RG, 1998, BRIT MED J, V316, P1745; PRIMATESTA P, 1995, INT J EPIDEMIOL, V24, P922, DOI 10.1093/ije/24.5.922; Romanos J, 1997, BRIT J SURG, V84, P814, DOI 10.1002/bjs.1800840623; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; SCAMMELL BE, 1987, BRIT J SURG, V74, P671, DOI 10.1002/bjs.1800740805; Seagroatt V, 2003, J EPIDEMIOL COMMUN H, V57, P883, DOI 10.1136/jech.57.11.883; Smart NJ, 2006, BRIT MED J, V333, P501, DOI 10.1136/bmj.333.7566.501-b; SRIVASTAVA ED, 1992, GUT, V33, P256, DOI 10.1136/gut.33.2.256; THOMAS GAO, 1995, EUR J GASTROEN HEPAT, V7, P401; Travis S, 2006, ALIMENT PHARM THER, V24, P68, DOI 10.1111/j.1365-2036.2006.03064.x; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; TSIANOS EV, 1994, GUT, V35, P369, DOI 10.1136/gut.35.3.369; TYSK C, 1992, SCAND J GASTROENTERO, V27, P945, DOI 10.3109/00365529209000168; Yapp TR, 2000, EUR J GASTROEN HEPAT, V12, P907, DOI 10.1097/00042737-200012080-00010	33	118	121	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 17	2007	335	7628					1033	1036B		10.1136/bmj.39345.714039.55	http://dx.doi.org/10.1136/bmj.39345.714039.55			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237UV	17977817	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000251402800032
J	Groth, A; Corpet, A; Cook, AJL; Roche, D; Bartek, J; Lukas, J; Almouzni, G				Groth, Anja; Corpet, Armelle; Cook, Adam J. L.; Roche, Daniele; Bartek, Jiri; Lukas, Jiri; Almouzni, Genevieve			Regulation of replication fork progression through histone supply and demand	SCIENCE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; DNA-REPLICATION; STRUCTURAL BASIS; HUMAN ASF1; CHROMATIN; H3; ATR; COMPLEXES; HELICASE	DNA replication in eukaryotes requires nucleosome disruption ahead of the replication fork and reassembly behind. An unresolved issue concerns how histone dynamics are coordinated with fork progression to maintain chromosomal stability. Here, we characterize a complex in which the human histone chaperone Asf1 and MCM2-7, the putative replicative helicase, are connected through a histone H3-H4 bridge. Depletion of Asf1 by RNA interference impedes DNA unwinding at replication sites, and similar defects arise from overproduction of new histone H3-H4 that compromises Asf1 function. These data link Asf1 chaperone function, histone supply, and replicative unwinding of DNA in chromatin. We propose that Asf1, as a histone acceptor and donor, handles parental and new histones at the replication fork via an Asf1-( H3- H4)- MCM2- 7 intermediate and thus provides a means to fine- tune replication fork progression and histone supply and demand.	Inst Curie, Lab Nucl Dynam & Genome Plastic, CNRS, UMR218, F-75248 Paris 05, France; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Danish Cancer Society; Danish Cancer Society	Almouzni, G (corresponding author), Inst Curie, Lab Nucl Dynam & Genome Plastic, CNRS, UMR218, 26 Rue Ulm, F-75248 Paris 05, France.	Genevieve.Almouzni@curie.fr	Bartek, Jiri/G-5870-2014; Groth, Anja/AAH-5386-2019; Almouzni, Genevieve/ABG-1029-2021; Corpet, Armelle/GLT-6199-2022	Groth, Anja/0000-0003-0577-1771; Almouzni, Genevieve/0000-0001-5570-0723; Cook, Adam/0000-0002-5735-522X; Lukas, Jiri/0000-0001-9087-506X; Corpet, Armelle/0000-0002-2126-5783				Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Fujita M, 1997, J BIOL CHEM, V272, P10928; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147	25	325	330	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2007	318	5858					1928	1931		10.1126/science.1148992	http://dx.doi.org/10.1126/science.1148992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096807	Green Published			2022-12-24	WOS:000251786600060
J	Chambers, I; Silva, J; Colby, D; Nichols, J; Nijmeijer, B; Robertson, M; Vrana, J; Jones, K; Grotewold, L; Smith, A				Chambers, Ian; Silva, Jose; Colby, Douglas; Nichols, Jennifer; Nijmeijer, Bianca; Robertson, Morag; Vrana, Jan; Jones, Ken; Grotewold, Lars; Smith, Austin			Nanog safeguards pluripotency and mediates germline development	NATURE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; MOUSE EPIBLAST; ES CELLS; EXPRESSION; GENES; NETWORK; PROTEIN; CLONING	Nanog is a divergent homeodomain protein found in mammalian pluripotent cells and developing germ cells(1,2). Deletion of Nanog causes early embryonic lethality(2), whereas constitutive expression enables autonomous self- renewal of embryonic stem cells(1). Nanog is accordingly considered a core element of the pluripotent transcriptional network(3-7). However, here we report that Nanog fluctuates in mouse embryonic stem cells. Transient downregulation of Nanog appears to predispose cells towards differentiation but does not mark commitment. By genetic deletion we show that, although they are prone to differentiate, embryonic stem cells can self- renew indefinitely in the permanent absence of Nanog. Expanded Nanog null cells colonize embryonic germ layers and exhibit multilineage differentiation both in fetal and adult chimaeras. Although they are also recruited to the germ line, primordial germ cells lacking Nanog fail to mature on reaching the genital ridge. This defect is rescued by repair of the mutant allele. Thus Nanog is dispensible for expression of somatic pluripotency but is specifically required for formation of germ cells. Nanog therefore acts primarily in construction of inner cell mass and germ cell states rather than in the housekeeping machinery of pluripotency. We surmise that Nanog stabilizes embryonic stem cells in culture by resisting or reversing alternative gene expression states.	Univ Edinburgh, MRC Ctr Dev Stem Cell Biol, Inst Stem Cell Res, Sch Biol Sci, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England	University of Edinburgh; University of Cambridge; University of Cambridge; University of Cambridge	Chambers, I (corresponding author), Univ Edinburgh, MRC Ctr Dev Stem Cell Biol, Inst Stem Cell Res, Sch Biol Sci, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	ichambers@ed.ac.uk	Vrana, Jan/F-7306-2014; Chambers, Ian/H-5416-2011; Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019	Vrana, Jan/0000-0001-6171-8516; Chambers, Ian/0000-0003-2605-1597; Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682; Nijmeijer-Winter, Bianca/0000-0002-9429-8439; Nichols, Jennifer/0000-0002-8650-1388	Medical Research Council [G0300723B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [G15381/2] Funding Source: Medline; Medical Research Council [G9806702, G0300058] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0300058, G9806702] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASHFIELD R, 1994, EMBO J, V13, P5656, DOI 10.1002/j.1460-2075.1994.tb06904.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHAMBERS I, 2004, REND FIS ACC LINCEI, P83; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Vallier L, 2001, P NATL ACAD SCI USA, V98, P2467, DOI 10.1073/pnas.041617198; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	33	1107	1157	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1230	U8		10.1038/nature06403	http://dx.doi.org/10.1038/nature06403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097409				2022-12-24	WOS:000251786200050
J	Nagrath, S; Sequist, LV; Maheswaran, S; Bell, DW; Irimia, D; Ulkus, L; Smith, MR; Kwak, EL; Digumarthy, S; Muzikansky, A; Ryan, P; Balis, UJ; Tompkins, RG; Haber, DA; Toner, M				Nagrath, Sunitha; Sequist, Lecia V.; Maheswaran, Shyamala; Bell, Daphne W.; Irimia, Daniel; Ulkus, Lindsey; Smith, Matthew R.; Kwak, Eunice L.; Digumarthy, Subba; Muzikansky, Alona; Ryan, Paula; Balis, Ulysses J.; Tompkins, Ronald G.; Haber, Daniel A.; Toner, Mehmet			Isolation of rare circulating tumour cells in cancer patients by microchip technology	NATURE			English	Article							METASTATIC BREAST-CANCER; ON-A-CHIP; PERIPHERAL-BLOOD; CARCINOMA-CELLS; EXPRESSION; FLOW; MICROFLUIDICS; ENUMERATION; SEPARATION	Viable tumour- derived epithelial cells ( circulating tumour cells or CTCs) have been identified in peripheral blood from cancer patients and are probably the origin of intractable metastatic disease(1-4). Although extremely rare, CTCs represent a potential alternative to invasive biopsies as a source of tumour tissue for the detection, characterization and monitoring of non-haematologic cancers(5-8). The ability to identify, isolate, propagate and molecularly characterize CTC subpopulations could further the discovery of cancer stem cell biomarkers and expand the understanding of the biology of metastasis. Current strategies for isolating CTCs are limited to complex analytic approaches that generate very low yield and purity(9). Here we describe the development of a unique microfluidic platform ( the 'CTC-chip') capable of efficient and selective separation of viable CTCs from peripheral whole blood samples, mediated by the interaction of target CTCs with antibody ( EpCAM)- coated microposts under precisely controlled laminar flow conditions, and without requisite pre- labelling or processing of samples. The CTC- chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 ( 99%) samples, with a range of 5-1,281 CTCs per ml and approximately 50% purity. In addition, CTCs were isolated in 7/7 patients with early- stage prostate cancer. Given the high sensitivity and specificity of the CTC- chip, we tested its potential utility in monitoring response to anti- cancer therapy. In a small cohort of patients with metastatic cancer undergoing systemic treatment, temporal changes in CTC numbers correlated reasonably well with the clinical course of disease as measured by standard radiographic methods. Thus, the CTC- chip provides a new and effective tool for accurate identification and measurement of CTCs in patients with cancer. It has broad implications in advancing both cancer biology research and clinical cancer management, including the detection, diagnosis and monitoring of cancer(10).	Harvard Univ, Sch Med, Surg Serv, Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, BioMEMS Resource Ctr, Massachusetts Gen Hosp, Boston, MA 02114 USA; Shriners Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Toner, M (corresponding author), Harvard Univ, Sch Med, Surg Serv, Massachusetts Gen Hosp, Boston, MA 02114 USA.	mtoner@hms.harvard.edu	Irimia, Daniel/S-5404-2019; Irimia, Daniel/A-4095-2008	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Balis, Ulysses/0000-0002-4168-1477	NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bell DW, 2006, CLIN CANCER RES, V12, P3875, DOI 10.1158/1078-0432.CCR-06-0670; Braun S, 2004, NEW ENGL J MED, V351, P824, DOI 10.1056/NEJMe048163; Chang WC, 2005, LAB CHIP, V5, P64, DOI 10.1039/b400455h; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Davis JA, 2006, P NATL ACAD SCI USA, V103, P14779, DOI 10.1073/pnas.0605967103; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; DRUMMOND JE, 1984, INT J MULTIPHAS FLOW, V10, P515, DOI 10.1016/0301-9322(84)90079-X; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Kahn HJ, 2004, BREAST CANCER RES TR, V86, P237, DOI 10.1023/B:BREA.0000036897.92513.72; Kraeft SK, 2004, CLIN CANCER RES, V10, P3020, DOI 10.1158/1078-0432.CCR-03-0361; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Rao CG, 2005, INT J ONCOL, V27, P49; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Smerage JB, 2006, BRIT J CANCER, V94, P8, DOI 10.1038/sj.bjc.6602871; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Terstappen LWMM, 1998, VOX SANG, V74, P269, DOI 10.1111/j.1423-0410.1998.tb05431.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Zieglschmid V, 2005, CRIT REV CL LAB SCI, V42, P155, DOI 10.1080/10408360590913696	32	2751	3020	78	2152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1235	U10		10.1038/nature06385	http://dx.doi.org/10.1038/nature06385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097410	Green Accepted			2022-12-24	WOS:000251786200051
J	Lee, JS; Shukla, A; Schneider, J; Swanson, SK; Washburn, MP; Florens, L; Bhaumik, SR; Shilatifard, A				Lee, Jung-Shin; Shukla, Abhijit; Schneider, Jessica; Swanson, Selene K.; Washburn, Michael P.; Florens, Laurence; Bhaumik, Sukesh R.; Shilatifard, Ali			Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS	CELL			English	Article							SPECTRAL ABUNDANCE FACTORS; RNA-POLYMERASE-II; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; TRANSCRIPTIONAL REGULATION; COVALENT MODIFICATIONS; MAMMALIAN CHROMATIN; SHOTGUN PROTEOMICS; TRITHORAX FAMILY	COMPASS, the yeast homolog of the mammalian MLL complex, is a histone H3 lysine 4 (H3K4) methylase consisting of Set1 (KMT2) and seven other polypeptides, including Cps35, the only essential subunit. Histone H2B monoubiquitination by Rad6/Bre1 is required for both H3K4 methylation by COMPASS, and H3K79 methylation by Dot1. However, the molecular mechanism for such histone crosstalk is poorly understood. Here, we demonstrate that histone H2B monoubiquitination controls the binding of Cps35 with COMPASS complex. Cps 35 is required for COMPASS' catalytic activity in vivo, and the addition of exogenous purified Cps35 to COMPASS purified from a Delta rad6 background results in the generation of a methylation competent COMPASS. Cps35 associates with the chromatin of COMPASS-regulated genes in a H2BK123 monoubiquitination-dependent but Set1-independent manner. Cps35 is also required for proper H3K79 trimethylation. These findings offer insight into the molecular role of Cps35 in translating the H2B monoubiquitination signal into H3 methylation.	[Lee, Jung-Shin; Schneider, Jessica; Swanson, Selene K.; Washburn, Michael P.; Florens, Laurence; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shukla, Abhijit; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Stowers Institute for Medical Research; Southern Illinois University System; Southern Illinois University	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers-institute.org		Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069905] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berger SL, 2001, ONCOGENE, V20, P3007, DOI 10.1038/sj.onc.1204324; BERGER SL, 2007, IN PRESS NATURE; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; BREEN TR, 1991, MECH DEVELOP, V35, P113, DOI 10.1016/0925-4773(91)90062-B; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; PARVI R, 2006, CELL, V125, P703; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; STEWARD MM, 2006, NATURE SMB, V13, P853; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wood A, 2005, BIOCHEM CELL BIOL, V83, P460, DOI 10.1139/O05-116; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	59	300	311	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1084	1096		10.1016/j.cell.2007.09.046	http://dx.doi.org/10.1016/j.cell.2007.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083099	Bronze			2022-12-24	WOS:000252217100017
J	Downs, SH; Schindler, C; Liu, LJS; Keidel, D; Bayer-Oglesby, L; Brutsche, MH; Gerbase, MW; Keller, R; Kunzli, N; Leuenberger, P; Probst-Hensch, NM; Tschopp, JM; Zellweger, JP; Rochat, T; Schwartz, J; Ackermann-Liebrich, U				Downs, Sara H.; Schindler, Christian; Liu, L. -J. Sally; Keidel, Dirk; Bayer-Oglesby, Lucy; Brutsche, Martin H.; Gerbase, Margaret W.; Keller, Roland; Kuenzli, Nino; Leuenberger, Philippe; Probst-Hensch, Nicole M.; Tschopp, Jean-Marie; Zellweger, Jean-Pierre; Rochat, Thierry; Schwartz, Joel; Ackermann-Liebrich, Ursula		SAPALDIA Team	Reduced exposure to PM10 and attenuated age-related decline in lung function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PARTICULATE AIR-POLLUTION; LONG-TERM EXPOSURE; FOLLOW-UP; UNITED-STATES; SWISS COHORT; MORTALITY; POLLUTANTS; PARTICLES; FINE	Background Air pollution has been associated with impaired health, including reduced lung function in adults. Moving to cleaner areas has been shown to attenuate adverse effects of air pollution on lung function in children but not in adults. Methods We conducted a prospective study of 9651 adults ( 18 to 60 years of age) randomly selected from population registries in 1990 and assessed in 1991, with 8047 participants reassessed in 2002. There was complete information on lung volumes and flows ( e. g., forced vital capacity [ FVC], forced expiratory volume in 1 second [ FEV1], FEV1 as a percentage of FVC, and forced expiratory flow between 25 and 75% of the FVC [FEF25-75]), smoking habits, and spatially resolved concentrations of particulate matter that was less than 10 mu m in aerodynamic diameter (PM10) from a validated dispersion model assigned to residential addresses for 4742 participants at both the 1991 and the 2002 assessments and in the intervening years. Results Overall exposure to individual home outdoor PM10 declined over the 11-year follow-up period (median, -5.3 mu g per cubic meter; interquartile range, -7.5 to -4.2). In mixed-model regression analyses, with adjustment for confounders, PM10 concentrations at baseline, and clustering within areas, there were significant negative associations between the decrease in PM10 and the rate of decline in FEV1 (P = 0.045), FEV1 as a percentage of FVC (P = 0.02), and FEF25-75 (P = 0.001). The net effect of a decline of 10 mu g of PM10 per cubic meter over an 11-year period was to reduce the annual rate of decline in FEV1 by 9% and of FEF25-75 by 16%. Cumulative exposure in the interval between the two examinations showed similar associations. Conclusions Decreasing exposure to airborne particulates appears to attenuate the decline in lung function related to exposure to PM10. The effects are greater in tests reflecting small-airway function.	Univ Basel, Inst Social & Prevent Med, CH-4051 Basel, Switzerland; Univ Basel Hosp, Div Pneumol, CH-4031 Basel, Switzerland; Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; Hosp Aarau, Hirslanden Klin, Aarau, Switzerland; Univ Lausanne Hosp, Serv Pulmonol, Lausanne, Switzerland; CHU Vaudois, Lausanne, Switzerland; Univ Zurich, Inst Social & Prevent Med, Dept Mol Epidemiol & Canc Registry, CH-8006 Zurich, Switzerland; Inst Clin Pathol, Dept Mol Epidemiol & Canc Registry, Zurich, Switzerland; Ctr Valaisan Pneumol, Montana, Switzerland; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Inst Municipal Invest Med, Inst Catalana Recerca & Estud Avancats, E-08003 Barcelona, Spain; Inst Municipal Invest Med, Ctr Res Environm Epidemiol, E-08003 Barcelona, Spain; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	University of Basel; University of Basel; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Washington; University of Washington Seattle; ICREA; Harvard University; Harvard T.H. Chan School of Public Health	Ackermann-Liebrich, U (corresponding author), Univ Basel, Inst Social & Prevent Med, Steinengraben 49, CH-4051 Basel, Switzerland.	ackermann-liebrich@unibas.ch	Schindler, Christian/D-3472-2015; Downs, Sara H/D-8478-2011; Kuenzli, Nino/F-7195-2014	Downs, Sara H/0000-0003-1044-3182; Kuenzli, Nino/0000-0001-8360-080X; Brutsche, Martin/0000-0002-1612-3609; Gemperli, Armin/0000-0002-2363-0625; Keidel, Dirk/0000-0003-4706-5728; Bayer-Oglesby, Lucy/0000-0001-8750-2158	ICREA Funding Source: Custom	ICREA(ICREA)		Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; AckermannLiebrich U, 1997, AM J RESP CRIT CARE, V155, P122, DOI 10.1164/ajrccm.155.1.9001300; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Avol Edward, 2005, NEW ENGL J MED, V352, P1276; Avol EL, 2001, AM J RESP CRIT CARE, V164, P2067, DOI 10.1164/ajrccm.164.11.2102005; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dockery DW, 1996, AM J RESP CRIT CARE, V154, pS250, DOI 10.1164/ajrccm/154.6_Pt_2.S250; Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Evelson P, 2000, BBA-GEN SUBJECTS, V1523, P209, DOI 10.1016/S0304-4165(00)00124-0; Finkelstein MM, 2003, CAN MED ASSOC J, V169, P397; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Hole DJ, 1996, BRIT MED J, V313, P711; Jerrett M, 2005, SOC SCI MED, V60, P2845, DOI 10.1016/j.socscimed.2004.11.006; Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; KUNZLI N, 1995, EUR RESPIR J, V8, P371, DOI 10.1183/09031936.95.08030371; Kunzli N, 2005, SWISS MED WKLY, V135, P503; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Larson T, 2004, J AIR WASTE MANAGE, V54, P1175, DOI 10.1080/10473289.2004.10470976; Liu LJS, 2007, ENVIRON HEALTH PERSP, V115, P1638, DOI 10.1289/ehp.10177; Liu LJS, 2003, ENVIRON HEALTH PERSP, V111, P909, DOI 10.1289/ehp.6011; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Martin BW, 1997, SOZ PRAVENTIV MED, V42, P67, DOI 10.1007/BF01318136; MATHYS P, 2001, ICP INFORMATION NEWS, V27, P190; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; Nel A, 2005, SCIENCE, V309, P1326; Oglesby L, 2000, J AIR WASTE MANAGE, V50, P1251, DOI 10.1080/10473289.2000.10464156; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P1063, DOI 10.2307/3434960; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rojas-Bracho L, 2000, J EXPO ANAL ENV EPID, V10, P294, DOI 10.1038/sj.jea.7500092; Sarnat JA, 2001, ENVIRON HEALTH PERSP, V109, P1053, DOI 10.2307/3454961; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sekine K, 2004, OCCUP ENVIRON MED, V61, P350, DOI 10.1136/oem.2002.005934; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; *SWISS AG ENV FOR, 2003, MOD PM PM AMB CONC S; TASHKIN DP, 1994, AM J RESP CRIT CARE, V149, P1209, DOI 10.1164/ajrccm.149.5.8173761; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197	46	257	265	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2338	2347		10.1056/NEJMoa073625	http://dx.doi.org/10.1056/NEJMoa073625			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057336				2022-12-24	WOS:000251389200004
J	Nakata, M; Zanchetta, G; Chapman, BD; Jones, CD; Cross, JO; Pindak, R; Bellini, T; Clark, NA				Nakata, Michi; Zanchetta, Giuliano; Chapman, Brandon D.; Jones, Christopher D.; Cross, Julie O.; Pindak, Ronald; Bellini, Tommaso; Clark, Noel A.			End-to-end stacking and liquid crystal condensation of 6-to 20-base pair DNA duplexes	SCIENCE			English	Article							ORDERED PHASES; POLYDISPERSITY; BEHAVIOR; LENGTH	Short complementary B-form DNA oligomers, 6 to 20 base pairs in length, are found to exhibit nematic and columnar liquid crystal phases, even though such duplexes lack the shape anisotropy required for liquid crystal ordering. Structural study shows that these phases are produced by the end-to-end adhesion and consequent stacking of the duplex oligomers into polydisperse anisotropic rod-shaped aggregates, which can order into liquid crystals. Upon cooling mixed solutions of short DNA oligomers, in which only a small fraction of the DNA present is complementary, the duplex-forming oligomers phase-separate into liquid crystal droplets, leaving the unpaired single strands in isotropic solution. In a chemical environment where oligomer ligation is possible, such ordering and condensation would provide an autocatalytic link whereby complementarity promotes the extended polymerization of complementary oligomers.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; Univ Milan, Dipartimento Chim Biochim & Biotecnol Med, Milan, Italy; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Milan; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Bellini, T (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	tommaso.bellini@unimi.it; noel.clark@colorado.edu	Bellini, Tommaso/M-5510-2014; Zanchetta, Giuliano/C-5952-2008; Clark, Noel A./E-9011-2010; Clark, Noel A/AAP-9116-2020	Bellini, Tommaso/0000-0003-4898-4400; Zanchetta, Giuliano/0000-0002-6650-0353; Clark, Noel A./0000-0001-9301-5540; 				ALAM TM, 1990, J CHEM PHYS, V92, P6840, DOI 10.1063/1.458270; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Bates MA, 1998, J CHEM PHYS, V109, P6193, DOI 10.1063/1.477248; Bohle AM, 1996, PHYS REV LETT, V76, P1396, DOI 10.1103/PhysRevLett.76.1396; Bolhuis P, 1997, J CHEM PHYS, V106, P666, DOI 10.1063/1.473404; BRANDES R, 1986, BIOCHEMISTRY-US, V25, P5890, DOI 10.1021/bi00368a008; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, pCH3; FERRIS JP, 1992, SCIENCE, V257, P1387, DOI 10.1126/science.1529338; FLORY PJ, 1978, MACROMOLECULES, V11, P1138, DOI 10.1021/ma60066a015; FRANKLIN RE, 1953, NATURE, V171, P740, DOI 10.1038/171740a0; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HENTSCHKE R, 1991, PHYS REV A, V44, P1148, DOI 10.1103/PhysRevA.44.1148; Horowitz VR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041710; LIVOLANT F, 1989, NATURE, V339, P724, DOI 10.1038/339724a0; Livolant F, 1996, PROG POLYM SCI, V21, P1115, DOI 10.1016/S0079-6700(96)00016-0; Lu XJ, 2004, J CHEM PHYS, V120, P10328, DOI 10.1063/1.1729855; LUZZATI V, 1959, J MOL BIOL, V1, P127, DOI 10.1016/S0022-2836(59)80041-3; LYDON JE, 2001, CURR OPIN COLLOID IN, V8, P480; LYDON JE, 2003, LIQ CRYST TODAY, V12, P1, DOI DOI 10.1080/14645180310001603962; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; Merchant K, 1997, BIOPHYS J, V73, P3154, DOI 10.1016/S0006-3495(97)78341-3; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Podgornik R, 1998, CURR OPIN COLLOID IN, V3, P534, DOI 10.1016/S1359-0294(98)80029-0; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; RILL RL, 1991, PHYSICA A, V176, P87, DOI 10.1016/0378-4371(91)90435-F; ROBINSON C, 1961, TETRAHEDRON, V13, P219, DOI 10.1016/S0040-4020(01)92215-X; SELINGER JV, 1991, PHYS REV A, V43, P2922, DOI 10.1103/PhysRevA.43.2922; TAYLOR MP, 1990, LANGMUIR, V6, P911, DOI 10.1021/la00095a004; Teixeira PIC, 2000, J PHYS-CONDENS MAT, V12, pR411, DOI 10.1088/0953-8984/12/33/201; Tinland B, 1997, MACROMOLECULES, V30, P5763, DOI 10.1021/ma970381+; VANDERSCHOOT P, 1994, LANGMUIR, V10, P670, DOI 10.1021/la00015a014; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0	35	312	313	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1276	1279		10.1126/science.1143826	http://dx.doi.org/10.1126/science.1143826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033877				2022-12-24	WOS:000251086600036
J	Zhang, DY; Turberfield, AJ; Yurke, B; Winfree, E				Zhang, David Yu; Turberfield, Andrew J.; Yurke, Bernard; Winfree, Erik			Engineering entropy-driven reactions and networks catalyzed by DNA	SCIENCE			English	Article							LOGIC GATES; AMPLIFICATION; HAIRPINS; DESIGN	Artificial biochemical circuits are likely to play as large a role in biological engineering as electrical circuits have played in the engineering of electromechanical devices. Toward that end, nucleic acids provide a designable substrate for the regulation of biochemical reactions. However, it has been difficult to incorporate signal amplification components. We introduce a design strategy that allows a specified input oligonucleotide to catalyze the release of a specified output oligonucleotide, which in turn can serve as a catalyst for other reactions. This reaction, which is driven forward by the configurational entropy of the released molecule, provides an amplifying circuit element that is simple, fast, modular, composable, and robust. We have constructed and characterized several circuits that amplify nucleic acid signals, including a feedforward cascade with quadratic kinetics and a positive feedback circuit with exponential growth kinetics.	CALTECH, Pasadena, CA 91125 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Bell Labs, Alcatel Lucent, Murray Hill, NJ 07974 USA	California Institute of Technology; University of Oxford; Alcatel-Lucent; AT&T	Zhang, DY (corresponding author), CALTECH, MC 136-93,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dzhang@dna.caltech.edu; winfree@caltech.edu	Turberfield, Andrew J/O-2135-2017; Winfree, Erik/L-4002-2013	Turberfield, Andrew J/0000-0002-3876-0190; Winfree, Erik/0000-0002-5899-7523	Engineering and Physical Sciences Research Council [GR/A10274/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bois JS, 2005, NUCLEIC ACIDS RES, V33, P4090, DOI 10.1093/nar/gki721; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gesteland R.F., 2006, RNA WORLD NATURE MOD, V3rd; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; Green SJ, 2006, BIOPHYS J, V91, P2966, DOI 10.1529/biophysj.106.084681; Hagiya M, 2006, NAT COMP SER, P293, DOI 10.1007/3-540-30296-4_18; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Macdonald J, 2006, NANO LETT, V6, P2598, DOI 10.1021/nl0620864; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; MIR KU, 1999, DNA BASED COMPUTERS, V2, P243; Muller S, 2006, IEE P-NANOBIOTECHNOL, V153, P31, DOI 10.1049/ip-nbt:20050047; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paul N, 2004, CURR OPIN CHEM BIOL, V8, P634, DOI 10.1016/j.cbpa.2004.09.005; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sager J, 2006, LECT NOTES COMPUT SC, V3892, P275; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2005, J AM CHEM SOC, V127, P6914, DOI 10.1021/ja043003a; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; TUBERFIELD AJ, 2003, PHYS REV LETT, V90; YIN P, IN PRESS NATURE; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	768	797	39	515	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2007	318	5853					1121	1125		10.1126/science.1148532	http://dx.doi.org/10.1126/science.1148532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006742				2022-12-24	WOS:000250957900041
J	Rauch, A; Thiel, CT; Schindler, D; Wick, U; Crow, YJ; Ekici, AB; van Essen, AJ; Goecke, TO; Al-Gazali, L; Chrzanowska, KH; Zweier, C; Brunner, HG; Becker, K; Curry, CJ; Dallapiccola, B; Devriendt, K; Dorfler, A; Kinning, E; Megarbane, A; Meinecke, P; Semple, RK; Spranger, S; Toutain, A; Trembath, RC; Voss, E; Wilson, L; Hennekam, R; de Zegher, F; Dorr, HG; Reis, A				Rauch, Anita; Thiel, Christian T.; Schindler, Detlev; Wick, Ursula; Crow, Yanick J.; Ekici, Arif B.; van Essen, Anthonie J.; Goecke, Timm O.; Al-Gazali, Lihadh; Chrzanowska, Krystyna H.; Zweier, Christiane; Brunner, Han G.; Becker, Kristin; Curry, Cynthia J.; Dallapiccola, Bruno; Devriendt, Koenraad; Doerfler, Arnd; Kinning, Esther; Megarbane, Andre; Meinecke, Peter; Semple, Robert K.; Spranger, Stephanie; Toutain, Annick; Trembath, Richard C.; Voss, Egbert; Wilson, Louise; Hennekam, Raoul; de Zegher, Francis; Doerr, Helmuth-Guenther; Reis, Andre			Mutations in the pericentrin (PCNT) gene cause primordial dwarfism	SCIENCE			English	Article							II MOPD-II; CALMODULIN-BINDING PROTEIN; HOMO-FLORESIENSIS; CLINICAL REPORT; BRAIN; ANEUPLOIDY; HOMININ; STROKE; LB1	Fundamental processes influencing human growth can be revealed by studying extreme short stature. Using genetic linkage analysis, we find that biallelic loss- of- function mutations in the centrosomal pericentrin ( PCNT) gene on chromosome 21q22.3 cause microcephalic osteodysplastic primordial dwarfism type II ( MOPD II) in 25 patients. Adults with this rare inherited condition have an average height of 100 centimeters and a brain size comparable to that of a 3- month- old baby, but are of near- normal intelligence. Absence of PCNT results in disorganized mitotic spindles and missegregation of chromosomes. Mutations in related genes are known to cause primary microcephaly ( MCPH1, CDK5RAP2, ASPM, and CENPJ).	[Rauch, Anita; Thiel, Christian T.; Wick, Ursula; Ekici, Arif B.; Zweier, Christiane; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany; [Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [van Essen, Anthonie J.] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Goecke, Timm O.] Univ Dusseldorf, Inst Humangenet & Anthropol, Dusseldorf, Germany; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med, Al Ain, U Arab Emirates; [Chrzanowska, Krystyna H.] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Brunner, Han G.] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Nijmegen Med Ctr, Nijmegen, Netherlands; [Becker, Kristin] Glan Clwyd Gen Hosp, N Wales Clin Genet Serv, Rhyl, Wales; [Becker, Kristin] Univ Wales Hosp, Inst Med Genet, Cardiff, Wales; [Curry, Cynthia J.] Genet Med Cent Calif, Fresno, CA USA; [Curry, Cynthia J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dallapiccola, Bruno] San Giovanni Rotondo & CSS Mendel Inst, IRCCS, Rome, Italy; [Dallapiccola, Bruno] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; [Devriendt, Koenraad] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Doerfler, Arnd] Univ Erlangen Nurnberg, Dept Neuroradiol, Univ Hosp Erlangen, Erlangen, Germany; [Kinning, Esther] Leicester Royal Infirm, Dept Clin Genet, Leicester, Leics, England; [Megarbane, Andre] Univ St Joseph, Unite Genet Med, Fac Med, Beirut, Lebanon; [Meinecke, Peter] Altonaer Kinderkrankenhaus, Abt Med Genet, Hamburg, Germany; [Semple, Robert K.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; [Spranger, Stephanie] Praxis Humangenet, Bremen, Germany; [Toutain, Annick] Bretonneau Univ Hosp, Dept Genet, Tours, France; [Trembath, Richard C.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, England; [Voss, Egbert] Cnopfs Pediat Hosp, Nurnberg, Germany; [Wilson, Louise; Hennekam, Raoul] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Hennekam, Raoul] UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Hennekam, Raoul] Univ Amsterdam, Dept Paediat, Amsterdam, Netherlands; [de Zegher, Francis] Katholieke Univ Leuven, Dept Woman & Child, Louvain, Belgium; [Doerr, Helmuth-Guenther] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany	University of Erlangen Nuremberg; University of Wurzburg; Saint James's University Hospital; University of Leeds; University of Groningen; Heinrich Heine University Dusseldorf; United Arab Emirates University; Children's Memorial Health Institute; Radboud University Nijmegen; Cardiff University; University of California System; University of California San Francisco; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; KU Leuven; University of Erlangen Nuremberg; University of Leicester; Saint Joseph University Beirut; University of Hamburg; University Medical Center Hamburg-Eppendorf; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU Tours; University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Amsterdam; KU Leuven; University of Erlangen Nuremberg	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany.	Anita.Rauch@humgenet.uni-erlangen.de	O'Rahilly, Stephen/ABF-6509-2020; Crow, Yanick J/N-6120-2014; Reis, André/D-2309-2009; Thiel, Christian T/H-8964-2012; Rauch, Anita/C-5568-2014; Megarbane, Andre/ABD-5574-2021; Brunner, Han/C-9928-2013; Zweier, Christiane/F-2202-2015; Ekici, Arif B/C-3971-2013; Semple, Robert/AAB-2948-2019; Dallapiccola, Bruno/K-8692-2016	O'Rahilly, Stephen/0000-0003-2199-4449; Crow, Yanick J/0000-0001-7211-7564; Reis, André/0000-0002-6301-6363; Thiel, Christian T/0000-0003-3817-7277; Rauch, Anita/0000-0003-2930-3163; Zweier, Christiane/0000-0001-8002-2020; Ekici, Arif B/0000-0001-6099-7066; Semple, Robert Kenneth/0000-0001-6539-3069; Dallapiccola, Bruno/0000-0002-5031-1013; Trembath, Richard/0000-0003-0550-3400; Chrzanowska, Krystyna/0000-0003-3888-0624; Toutain, Annick/0000-0002-5999-5300	Wellcome Trust [062346/Z/00/Z, 080952/Z/06/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Brancati F, 2005, AM J MED GENET A, V139A, P212, DOI 10.1002/ajmg.a.31009; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Culotta E, 2007, SCIENCE, V317, P740, DOI 10.1126/science.317.5839.740; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Falk D, 2006, SCIENCE, V312, DOI 10.1126/science.1124972; Falk D, 2005, SCIENCE, V310, DOI 10.1126/science.1117062; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, P NATL ACAD SCI USA, V104, P2513, DOI 10.1073/pnas.0609185104; Flory MR, 2000, P NATL ACAD SCI USA, V97, P5919, DOI 10.1073/pnas.97.11.5919; Hall JG, 2006, AM J MED GENET A, V140A, P1356, DOI 10.1002/ajmg.a.31301; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Hall MN, 2004, CELL GROWTH CONTROL; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Martin RD, 2006, SCIENCE, V312, DOI 10.1126/science.1121144; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Stirling DA, 1996, J CELL SCI, V109, P1297; Stirling DA, 2000, BBA-MOL CELL RES, V1499, P85, DOI 10.1016/S0167-4889(00)00110-5; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; Weber J, 2005, SCIENCE, V310, DOI 10.1126/science.1114789; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	27	290	298	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					816	819		10.1126/science.1151174	http://dx.doi.org/10.1126/science.1151174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18174396				2022-12-24	WOS:000252963000063
J	Greenleaf, WJ; Frieda, KL; Foster, DAN; Woodside, MT; Block, SM				Greenleaf, William J.; Frieda, Kirsten L.; Foster, Daniel A. N.; Woodside, Michael T.; Block, Steven M.			Direct observation of hierarchical folding in single riboswitch aptamers	SCIENCE			English	Article							ADENINE-SENSING RIBOSWITCH; GENE-EXPRESSION; LIGAND-BINDING; NUCLEIC-ACID; INDUCED FIT; KINETICS; RNA; TRANSCRIPTION; EQUALITY; DOMAIN	Riboswitches regulate genes through structural changes in ligand- binding RNA aptamers. With the use of an optical- trapping assay based on in situ transcription by a molecule of RNA polymerase, single nascent RNAs containing pbuE adenine riboswitch aptamers were unfolded and refolded. Multiple folding states were characterized by means of both force- extension curves and folding trajectories under constant force by measuring the molecular contour length, kinetics, and energetics with and without adenine. Distinct folding steps correlated with the formation of key secondary or tertiary structures and with ligand binding. Adenine- induced stabilization of the weakest helix in the aptamer, the mechanical switch underlying regulatory action, was observed directly. These results provide an integrated view of hierarchical folding in an aptamer, demonstrating how complex folding can be resolved into constituent parts, and supply further insights into tertiary structure formation.	[Foster, Daniel A. N.; Woodside, Michael T.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada; [Greenleaf, William J.; Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Frieda, Kirsten L.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Woodside, Michael T.] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; Stanford University; Stanford University; Stanford University; National Research Council Canada	Woodside, MT (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada.	michael.woodside@nrc.ca; sblock@stanford.edu			NIGMS NIH HHS [R01 GM057035, R01 GM057035-12, GM066275, GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057035, R01GM057035, P01GM066275] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Li PTX, 2006, P NATL ACAD SCI USA, V103, P15847, DOI 10.1073/pnas.0607202103; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Noeske J, 2005, P NATL ACAD SCI USA, V102, P1372, DOI 10.1073/pnas.0406347102; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Saenger W., 1984, PRINCIPLES NUCL ACID; Seol Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118102; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	27	313	317	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2008	319	5863					630	633		10.1126/science.1151298	http://dx.doi.org/10.1126/science.1151298			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	257AQ	18174398	Green Accepted			2022-12-24	WOS:000252772000044
J	Gurley, KA; Rink, JC; Alvarado, AS				Gurley, Kyle A.; Rink, Jochen C.; Alvarado, Alejandro Sanchez			beta-catenin defines head versus tail identity during planarian regeneration and Homeostasis	SCIENCE			English	Article							WNT SIGNALING PATHWAY; CELL-FATE; C-ELEGANS; EMBRYOS; POLARITY; TRANSCRIPTION; ASYMMETRIES; ROLES	After amputation, freshwater planarians properly regenerate a head or tail from the resulting anterior or posterior wound. The mechanisms that differentiate anterior from posterior and direct the replacement of the appropriate missing body parts are unknown. We found that in the planarian Schmidtea mediterranea, RNA interference ( RNAi) of beta-catenin or dishevelled causes the inappropriate regeneration of a head instead of a tail at posterior amputations. Conversely, RNAi of the beta-catenin antagonist adenomatous polyposis coli results in the regeneration of a tail at anterior wounds. In addition, the silencing of beta-catenin is sufficient to transform the tail of uncut adult animals into a head. We suggest that beta-catenin functions as a molecular switch to specify and maintain anteroposterior identity during regeneration and homeostasis in planarians.	[Gurley, Kyle A.; Rink, Jochen C.; Alvarado, Alejandro Sanchez] Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Neurobiol & Anat, 401 MREB,20N 1900E, Salt Lake City, UT 84132 USA.	sanchez@neuro.utah.edu			NATIONAL CANCER INSTITUTE [T32CA093247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082016, R01GM057260] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA093247, T32 CA093247] Funding Source: Medline; NIGMS NIH HHS [F32GM082016, R01 GM057260-08, F32 GM082016, R01 GM057260, R0-1 GM57260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; BREMBECK FH, 2004, SCI STKE, pPE48; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Morgan TH, 1904, AM NAT, V38, P502; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sakai F, 2000, ZOOL SCI, V17, P375, DOI 10.2108/jsz.17.375; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014	25	338	347	0	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2008	319	5861					323	327		10.1126/science.1150029	http://dx.doi.org/10.1126/science.1150029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	252GY	18063757	Green Accepted			2022-12-24	WOS:000252436200036
J	Stevens, B; Allen, NJ; Vazquez, LE; Howell, GR; Christopherson, KS; Nouri, N; Micheva, KD; Mehalow, AK; Huberman, AD; Stafford, B; Sher, A; Litke, AM; Lambris, JD; Smith, SJ; John, SWM; Barres, BA				Stevens, Beth; Allen, Nicola J.; Vazquez, Luis E.; Howell, Gareth R.; Christopherson, Karen S.; Nouri, Navid; Micheva, Kristina D.; Mehalow, Adrienne K.; Huberman, Andrew D.; Stafford, Benjamin; Sher, Alexander; Litke, Alan M.; Lambris, John D.; Smith, Stephen J.; John, Simon W. M.; Barres, Ben A.			The classical complement cascade mediates CNS synapse elimination	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; VISUAL-CORTEX; DBA/2J MICE; EXPRESSION; PLASTICITY; GLAUCOMA; CELLS; C1Q; ACTIVATION	During development, the formation of mature neural circuits requires the selective elimination of inappropriate synaptic connections. Here we show that C1q, the initiating protein in the classical complement cascade, is expressed by postnatal neurons in response to immature astrocytes and is localized to synapses throughout the postnatal CNS and retina. Mice deficient in complement protein C1q or the downstream complement protein C3 exhibit large sustained defects in CNS synapse elimination, as shown by the failure of anatomical refinement of retinogeniculate connections and the retention of excess retinal innervation by lateral geniculate neurons. Neuronal C1q is normally downregulated in the adult CNS; however, in a mouse model of glaucoma, C1q becomes upregulated and synaptically relocalized in the adult retina early in the disease. These findings support a model in which unwanted synapses are tagged by complement for elimination and suggest that complement-mediated synapse elimination may become aberrantly reactivated in neurodegenerative disease.	[Stevens, Beth; Allen, Nicola J.; Vazquez, Luis E.; Christopherson, Karen S.; Nouri, Navid; Huberman, Andrew D.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Micheva, Kristina D.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; [Howell, Gareth R.; Mehalow, Adrienne K.; John, Simon W. M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Howell, Gareth R.; Mehalow, Adrienne K.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Stafford, Benjamin; Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Jackson Laboratory; University of California System; University of California Santa Cruz; University of Pennsylvania	Stevens, B (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	beths@stanfordmedalumni.org	Micheva, Kristina/ABH-6913-2020; Quill, Barry/O-2614-2014; Lambris, John/Q-5633-2018	Micheva, Kristina/0000-0003-1138-3732; Quill, Barry/0000-0002-0578-5703; Lambris, John/0000-0002-9370-5776; Smith, Stephen/0000-0002-2290-8701; Sher, Alexander/0000-0001-6655-6456; Mehalow, Adrienne/0000-0002-1744-827X	NIDA NIH HHS [R01 DA015043, DA15043] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cowell RM, 2003, J NEUROSCI, V23, P9459; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Fiske BK, 2000, NEUROSCIENCE, V96, P807, DOI 10.1016/S0306-4522(99)00601-6; Fonseca MI, 2004, NEUROBIOL DIS, V15, P40, DOI 10.1016/j.nbd.2003.09.004; Gasque P, 1998, J IMMUNOL, V160, P3543; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; JENNINGS C, 1994, NATURE, V372, P498, DOI 10.1038/372498a0; John SWM, 1999, J GLAUCOMA, V8, P400; JOHNSON SA, 1994, DEV BRAIN RES, V80, P163, DOI 10.1016/0165-3806(94)90101-5; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Maslinska D, 1998, FOLIA NEUROPATHOL, V36, P145; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mitchell DA, 2007, MOL IMMUNOL, V44, P2997, DOI 10.1016/j.molimm.2006.12.027; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Nilsson LG, 1996, BEHAV GENET, V26, P555, DOI 10.1007/BF02361228; PRASAD SS, 1994, BRAIN RES, V639, P73, DOI 10.1016/0006-8993(94)91766-3; Ritch R, 1996, GLAUCOMAS CLIN SCI; Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schiefer J, 1999, J NEUROCYTOL, V28, P439, DOI 10.1023/A:1007048903862; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007	47	1868	1911	6	139	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1164	1178		10.1016/j.cell.2007.10.036	http://dx.doi.org/10.1016/j.cell.2007.10.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083105	Bronze			2022-12-24	WOS:000252217100023
J	Morth, JP; Pedersen, BP; Toustrup-Jensen, MS; Sorensen, TLM; Petersen, J; Andersen, JP; Vilsen, B; Nissen, P				Morth, J. Preben; Pedersen, Bjorn P.; Toustrup-Jensen, Mads S.; Sorensen, Thomas L. -M.; Petersen, Janne; Andersen, Jens Peter; Vilsen, Bente; Nissen, Poul			Crystal structure of the sodium-potassium pump	NATURE			English	Article							TRANSMEMBRANE SEGMENT M1; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CATION-BINDING; ALPHA-SUBUNIT; K+-ATPASE; DENSITY-MODIFICATION; GAMMA-SUBUNIT; FXYD PROTEINS; ION-TRANSPORT	The Na+, K+-ATPase generates electrochemical gradients for sodium and potassium that are vital to animal cells, exchanging three sodium ions for two potassium ions across the plasma membrane during each cycle of ATP hydrolysis. Here we present the X- ray crystal structure at 3.5 angstrom resolution of the pig renal Na+, K 1- ATPase with two rubidium ions bound ( as potassium congeners) in an occluded state in the transmembrane part of the alpha-subunit. Several of the residues forming the cavity for rubidium/potassium occlusion in the Na+, K+-ATPase are homologous to those binding calcium in the Ca2+- ATPase of sarco( endo) plasmic reticulum. The beta- and gamma-subunits specific to the Na+, K+- ATPase are associated with transmembrane helices alpha M7/alpha M10 and alpha M9, respectively. The alpha-subunit corresponds to a fragment of the V- type ATPase c subunit. The carboxy terminus of the alpha-subunit is contained within a pocket between transmembrane helices and seems to be a novel regulatory element controlling sodium affinity, possibly influenced by the membrane potential.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Pedersen, Bjørn/AAT-2409-2021; Morth, Jens Preben/AAP-7834-2021; Pedersen, Bjørn/H-4128-2017; Morth, Jens Preben/G-4450-2013; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Andersen, Jens Peter/0000-0003-0654-4300; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Vilsen, Bente/0000-0002-4727-9382; Nissen, Poul/0000-0003-0948-6628				ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; GADSBY DC, 1993, SCIENCE, V260, P100, DOI 10.1126/science.7682009; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Hakansson KO, 2003, J MOL BIOL, V332, P1175, DOI 10.1016/j.jmb.2003.07.012; Hebert H, 2001, J MOL BIOL, V314, P479, DOI 10.1006/jmbi.2001.5137; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; POST RL, 1972, J BIOL CHEM, V247, P6530; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1987, J BIOL CHEM, V262, P10511; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	52	653	683	9	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1043	U6		10.1038/nature06419	http://dx.doi.org/10.1038/nature06419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075585				2022-12-24	WOS:000251579900078
J	Henzler-Wildman, KA; Thai, V; Lei, M; Ott, M; Wolf-Watz, M; Fenn, T; Pozharski, E; Wilson, MA; Petsko, GA; Karplus, M; Hubner, CG; Kern, D				Henzler-Wildman, Katherine A.; Thai, Vu; Lei, Ming; Ott, Maria; Wolf-Watz, Magnus; Fenn, Tim; Pozharski, Ed; Wilson, Mark A.; Petsko, Gregory A.; Karplus, Martin; Huebner, Christian G.; Kern, Dorothee			Intrinsic motions along an enzymatic reaction trajectory	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; MOLECULE FLUORESCENCE SPECTROSCOPY; SINGLE-MOLECULE; ADENYLATE KINASE; NORMAL-MODE; TRIOSEPHOSPHATE ISOMERASE; CONFORMATIONAL DYNAMICS; DIHYDROFOLATE-REDUCTASE; CHEMICAL-EXCHANGE; PROTEIN MOTION	The mechanisms by which enzymes achieve extraordinary rate acceleration and specificity have long been of key interest in biochemistry. It is generally recognized that substrate binding coupled to conformational changes of the substrate - enzyme complex aligns the reactive groups in an optimal environment for efficient chemistry. Although chemical mechanisms have been elucidated for many enzymes, the question of how enzymes achieve the catalytically competent state has only recently become approachable by experiment and computation. Here we show crystallographic evidence for conformational substates along the trajectory towards the catalytically competent 'closed' state in the ligand- free form of the enzyme adenylate kinase. Molecular dynamics simulations indicate that these partially closed conformations are sampled in nanoseconds, whereas nuclear magnetic resonance and single- molecule fluorescence resonance energy transfer reveal rare sampling of a fully closed conformation occurring on the microsecond- to- millisecond timescale. Thus, the larger- scale motions in substrate- free adenylate kinase are not random, but preferentially follow the pathways that create the configuration capable of proficient chemistry. Such preferred directionality, encoded in the fold, may contribute to catalysis in many enzymes.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Strasbourg, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France	Brandeis University; Brandeis University; Howard Hughes Medical Institute; Martin Luther University Halle Wittenberg; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	huebner@physik.uni-luebeck.de; dkern@brandeis.edu	Petsko, Gregory/AAO-7962-2020; Hübner, Christian/C-9512-2011; Pozharski, Edwin/AAM-7692-2020	Pozharski, Edwin/0000-0001-7012-5376; Henzler-Wildman, Katherine/0000-0002-5295-2121	NIGMS NIH HHS [F32 GM070251] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070251] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; BLATZ AL, 1986, BIOPHYS J, V49, P967, DOI 10.1016/S0006-3495(86)83725-0; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1983, J CHEM PHYS, V79, P6312, DOI 10.1063/1.445724; Bruice TC, 2006, CHEM REV, V106, P3119, DOI 10.1021/cr050283j; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cui Q, 2003, ADV PROTEIN CHEM, V66, P315; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FABER HR, 1990, NATURE, V348, P263, DOI 10.1038/348263a0; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; Gardberg A, 2003, STRUCTURE, V11, P1265, DOI 10.1016/j.str.2003.09.003; GERSTEIN M, 1993, J MOL BIOL, V229, P494, DOI 10.1006/jmbi.1993.1048; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Hubner CG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.093903; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; IMMIRZI A, 1976, CRYSTALLOGRAPHIC COM, P399; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaim G, 2002, FEBS LETT, V525, P156, DOI 10.1016/S0014-5793(02)03097-1; KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P2773, DOI 10.1073/pnas.88.7.2773; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P446; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; Lou HF, 2006, J PHYS CHEM B, V110, P12796, DOI 10.1021/jp061976m; Ma JP, 1997, J MOL BIOL, V274, P114, DOI 10.1006/jmbi.1997.1313; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NIE SM, 1994, SCIENCE, V266, P1018, DOI 10.1126/science.7973650; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Odintsov SG, 2005, J MOL BIOL, V354, P403, DOI 10.1016/j.jmb.2005.09.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vendruscolo M, 2006, SCIENCE, V313, P1586, DOI 10.1126/science.1132851; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Vosch T, 2003, J PHYS CHEM A, V107, P6920, DOI 10.1021/jp034906d; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P2764, DOI 10.1073/pnas.0400091101; Zondervan R, 2003, J PHYS CHEM A, V107, P6770, DOI 10.1021/jp034723r	84	675	685	5	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					838	U13		10.1038/nature06410	http://dx.doi.org/10.1038/nature06410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026086				2022-12-24	WOS:000251394900047
J	Livet, J; Weissman, TA; Kang, HN; Draft, RW; Lu, J; Bennis, RA; Sanes, JR; Lichtman, JW				Livet, Jean; Weissman, Tamily A.; Kang, Hyuno; Draft, Ryan W.; Lu, Ju; Bennis, Robyn A.; Sanes, Joshua R.; Lichtman, Jeff W.			Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system	NATURE			English	Article							CRE RECOMBINASE; SYNAPTIC COMPETITION; MONOMERIC RED; IN-VIVO; CELLS; MICE; NEURONS; CHROMOSOMES; ASTROCYTES; MICROSCOPY	Detailed analysis of neuronal network architecture requires the development of new methods. Here we present strategies to visualize synaptic circuits by genetically labelling neurons with multiple, distinct colours. In Brainbow transgenes, Cre/lox recombination is used to create a stochastic choice of expression between three or more fluorescent proteins (XFPs). Integration of tandem Brainbow copies in transgenic mice yielded combinatorial XFP expression, and thus many colours, thereby providing a way to distinguish adjacent neurons and visualize other cellular interactions. As a demonstration, we reconstructed hundreds of neighbouring axons and multiple synaptic contacts in one small volume of a cerebellar lobe exhibiting approximately 90 colours. The expression in some lines also allowed us to map glial territories and follow glial cells and neurons over time in vivo. The ability of the Brainbow system to label uniquely many individual cells within a population may facilitate the analysis of neuronal circuitry on a large scale.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu	livet, jean/C-2766-2012	livet, jean/0000-0003-3079-4908; Weissman, Tamily/0000-0001-9361-6071				Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eccles JC, 1967, CEREBELLUM NEURONAL; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Lam KP, 1998, P NATL ACAD SCI USA, V95, P13171, DOI 10.1073/pnas.95.22.13171; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Palay S.L., 1974, CEREBELLAR CORTEX; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wu HS, 1999, J COMP NEUROL, V411, P97, DOI 10.1002/(SICI)1096-9861(19990816)411:1<97::AID-CNE8>3.0.CO;2-O; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	41	1243	1283	8	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					56	+		10.1038/nature06293	http://dx.doi.org/10.1038/nature06293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972876				2022-12-24	WOS:000250585800035
J	Jones, DM; Head, IM; Gray, ND; Adams, JJ; Rowan, AK; Aitken, CM; Bennett, B; Huang, H; Brown, A; Bowler, BFJ; Oldenburg, T; Erdmann, M; Larter, SR				Jones, D. M.; Head, I. M.; Gray, N. D.; Adams, J. J.; Rowan, A. K.; Aitken, C. M.; Bennett, B.; Huang, H.; Brown, A.; Bowler, B. F. J.; Oldenburg, T.; Erdmann, M.; Larter, S. R.			Crude-oil biodegradation via methanogenesis in subsurface petroleum reservoirs	NATURE			English	Article							DEEP SUBSURFACE; AROMATIC-HYDROCARBONS; FIELD; DEGRADATION; MICROORGANISMS; ACCUMULATIONS; OXIDATION; BACTERIA; ORIGIN; WATERS	Biodegradation of crude oil in subsurface petroleum reservoirs has adversely affected the majority of the world's oil, making recovery and refining of that oil more costly(1). The prevalent occurrence of biodegradation in shallow subsurface petroleum reservoirs(2,3) has been attributed to aerobic bacterial hydrocarbon degradation stimulated by surface recharge of oxygen- bearing meteoric waters(2). This hypothesis is empirically supported by the likelihood of encountering biodegraded oils at higher levels of degradation in reservoirs near the surface(4,5). More recent findings, however, suggest that anaerobic degradation processes dominate subsurface sedimentary environments(6), despite slow reaction kinetics and uncertainty as to the actual degradation pathways occurring in oil reservoirs. Here we use laboratory experiments in microcosms monitoring the hydrocarbon composition of degraded oils and generated gases, together with the carbon isotopic compositions of gas and oil samples taken at wellheads and a Rayleigh isotope fractionation box model, to elucidate the probable mechanisms of hydrocarbon degradation in reservoirs. We find that crude- oil hydrocarbon degradation under methanogenic conditions in the laboratory mimics the characteristic sequential removal of compound classes seen in reservoir- degraded petroleum. The initial preferential removal of n-alkanes generates close to stoichiometric amounts of methane, principally by hydrogenotrophic methanogenesis. Our data imply a common methanogenic biodegradation mechanism in subsurface degraded oil reservoirs, resulting in consistent patterns of hydrocarbon alteration, and the common association of dry gas with severely degraded oils observed worldwide. Energy recovery from oilfields in the form of methane, based on accelerating natural methanogenic biodegradation, may offer a route to economic production of difficult- to- recover energy from oilfields.	[Jones, D. M.; Head, I. M.; Gray, N. D.; Rowan, A. K.; Aitken, C. M.; Brown, A.; Bowler, B. F. J.; Larter, S. R.] Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, J. J.; Bennett, B.; Huang, H.; Oldenburg, T.; Larter, S. R.] Univ Calgary, Dept Geol & Geophys, Petr Reservoir Grp, Calgary, AB T2A 1N4, Canada; [Erdmann, M.] Norsk Hydro Oil & Energy, R&D Ctr, N-5020 Bergen, Norway	Newcastle University - UK; University of Calgary	Larter, SR (corresponding author), Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	slarter@ucalgary.ca	Sherry, Angela/AAD-9302-2019; Abu Laban, Nidal/E-5809-2011; Sherry, Angela/A-3293-2012	Sherry, Angela/0000-0003-2642-5376; Sherry, Angela/0000-0003-2642-5376; Larter, Stephen/0000-0001-7195-1477; gray, neil/0000-0002-2395-4320; Head, Ian/0000-0002-5373-162X	Natural Environment Research Council [NE/E01657X/1] Funding Source: researchfish; NERC [NE/E01657X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams J, 2006, J GEOCHEM EXPLOR, V89, P1, DOI 10.1016/j.gexplo.2005.11.004; Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; Anderson RT, 2000, NATURE, V404, P722, DOI 10.1038/35008145; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; Bennett B, 1996, ANAL CHEM, V68, P3697, DOI 10.1021/ac960299x; Bennett B, 2000, ANAL CHEM, V72, P1039, DOI 10.1021/ac9910482; Boreham CJ, 2001, APPEA J, V41, P523, DOI [DOI 10.1071/AJ00026, 10.1071/AJ00026]; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; FEDORAK PM, 1981, CAN J MICROBIOL, V27, P432, DOI 10.1139/m81-066; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; HORSTAD I, 1992, ORG GEOCHEM, V19, P107, DOI 10.1016/0146-6380(92)90030-2; HORSTAD I, 1992, ORG GEOCHEM, V19, P1; Karlsson W., 1986, HABITAT HYDROCARBONS, P181; KREJCIGRAF K, 1932, AAPG BULL, V16, P1038; Larter S, 2006, AAPG BULL, V90, P921, DOI 10.1306/01270605130; Larter S, 2005, ORG GEOCHEM, V36, P299, DOI 10.1016/j.orggeochem.2004.07.015; Larter S, 2003, ORG GEOCHEM, V34, P601, DOI 10.1016/S0146-6380(02)00240-1; Larter SR, 2005, PETROLEUM GEOLOGY NW, P633; LOVLEY DR, 1989, NATURE, V339, P297, DOI 10.1038/339297a0; MAGOT M, 1994, RECHERCHE, V228, P936; Masterson WD, 2001, ORG GEOCHEM, V32, P411, DOI 10.1016/S0146-6380(00)00187-X; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pallasser RJ, 2000, ORG GEOCHEM, V31, P1363, DOI 10.1016/S0146-6380(00)00101-7; Palmer S.E., 1993, ORG GEOCHEM, P511, DOI 10.1007/978-1-4615-2890-6_23; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETERS KE, 1993, BIOMARKER GUIDE INTE, P252; RABUS R, 1995, ARCH MICROBIOL, V163, P96, DOI 10.1007/BF00381782; REUTER P, 1994, NATURE, V372, P455; Roadifer R. E., 1987, EXPLORATION HEAVY CR, P3; Townsend GT, 2003, ENVIRON SCI TECHNOL, V37, P5213, DOI 10.1021/es0264495; Volkman J.K., 1984, ORG GEOCHEM, V6, P619, DOI DOI 10.1016/0146-6380(84)90084-6; Wenger LM, 2002, SPE RESERV EVAL ENG, V5, P375, DOI 10.2118/80168-PA; WILLIAMS JA, 1986, ORG GEOCHEM, V10, P451, DOI 10.1016/0146-6380(86)90045-8; Winters J.C., 1969, AM CHEM SOC DIV PET, pE22; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	38	485	519	6	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2008	451	7175					176	U6		10.1038/nature06484	http://dx.doi.org/10.1038/nature06484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18075503				2022-12-24	WOS:000252214400039
J	Atsumi, S; Hanai, T; Liao, JC				Atsumi, Shota; Hanai, Taizo; Liao, James C.			Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; AMINO-ACIDS; CLOSTRIDIUM-ACETOBUTYLICUM; MOLECULAR CHARACTERIZATION; ISOLEUCINE BIOSYNTHESIS; DECARBOXYLASE; METABOLISM; GENE; 1,3-PROPANEDIOL	Global energy and environmental problems have stimulated increased efforts towards synthesizing biofuels from renewable resources(1-3). Compared to the traditional biofuel, ethanol, higher alcohols offer advantages as gasoline substitutes because of their higher energy density and lower hygroscopicity. In addition, branched- chain alcohols have higher octane numbers compared with their straight- chain counterparts. However, these alcohols cannot be synthesized economically using native organisms. Here we present a metabolic engineering approach using Escherichia coli to produce higher alcohols including isobutanol, 1-butanol, 2- methyl- 1- butanol, 3- methyl- 1- butanol and 2- phenylethanol from glucose, a renewable carbon source. This strategy uses the host's highly active amino acid biosynthetic pathway and diverts its 2- keto acid intermediates for alcohol synthesis. In particular, we have achieved high- yield, high- specificity production of isobutanol from glucose. The strategy enables the exploration of biofuels beyond those naturally accumulated to high quantities in microbial fermentation.	[Atsumi, Shota; Hanai, Taizo; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		Liao, James/0000-0002-4580-7276; Atsumi, Shota/0000-0002-5782-4196				Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Barbirato F, 1996, APPL ENVIRON MICROB, V62, P1448, DOI 10.1128/AEM.62.4.1448-1451.1996; BOGOSIAN G, 1989, J BIOL CHEM, V264, P531; CALHOUN DH, 1973, J BIOL CHEM, V248, P3511; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Dickinson JR, 1998, J BIOL CHEM, V273, P25751, DOI 10.1074/jbc.273.40.25751; Dickinson JR, 1997, J BIOL CHEM, V272, P26871, DOI 10.1074/jbc.272.43.26871; Dickinson JR, 2000, J BIOL CHEM, V275, P10937, DOI 10.1074/jbc.275.15.10937; Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FLINT DH, 1993, J BIOL CHEM, V268, P14732; GOLLOP N, 1990, J BACTERIOL, V172, P3444, DOI 10.1128/jb.172.6.3444-3449.1990; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; Ingram LO, 1999, BIOTECHNOL PROGR, V15, P855, DOI 10.1021/bp9901062; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Konig S, 1998, BBA-PROTEIN STRUCT M, V1385, P271, DOI 10.1016/S0167-4838(98)00074-0; LIN YL, 1983, APPL ENVIRON MICROB, V45, P966, DOI 10.1128/AEM.45.3.966-973.1983; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MIWA K, 1983, AGR BIOL CHEM TOKYO, V47, P2329, DOI 10.1080/00021369.1983.10865958; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; RUSSELL DW, 1983, J BIOL CHEM, V258, P2674; SENTHESHANMUGANATHAN S, 1958, BIOCHEM J, V69, P210, DOI 10.1042/bj0690210; SENTHESHANMUGANATHAN S, 1960, BIOCHEM J, V74, P568, DOI 10.1042/bj0740568; Vuralhan Z, 2003, APPL ENVIRON MICROB, V69, P4534, DOI 10.1128/AEM.69.8.4534-4541.2003; WOODS DR, 1995, TRENDS BIOTECHNOL, V13, P259, DOI 10.1016/S0167-7799(00)88960-X; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Zhu MM, 2002, BIOTECHNOL PROGR, V18, P694, DOI 10.1021/bp020281+	30	1383	1620	28	739	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					86	U13		10.1038/nature06450	http://dx.doi.org/10.1038/nature06450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172501				2022-12-24	WOS:000252079300039
J	Otto, SB; Rall, BC; Brose, U				Otto, Sonja B.; Rall, Bjoern C.; Brose, Ulrich			Allometric degree distributions facilitate food-web stability	NATURE			English	Article							PREY BODY-SIZE	In natural ecosystems, species are linked by feeding interactions that determine energy fluxes and create complex food webs. The stability of these food webs(1,2) enables many species to coexist and to form diverse ecosystems. Recent theory finds predator - prey body- mass ratios to be critically important for food- web stability(3-5). However, the mechanisms responsible for this stability are unclear. Here we use a bioenergetic consumer - resource model(6) to explore how and why only particular predator - prey body- mass ratios promote stability in tri- trophic ( three- species) food chains. We find that this 'persistence domain' of ratios is constrained by bottom- up energy availability when predators are much smaller than their prey and by enrichment- driven dynamics when predators are much larger. We also find that 97% of the tri- trophic food chains across five natural food webs(7) exhibit body- mass ratios within the predicted persistence domain. Further analyses of randomly rewired food webs show that body mass and allometric degree distributions in natural food webs mediate this consistency. The allometric degree distributions hold that the diversity of species' predators and prey decreases and increases, respectively, with increasing species' body masses. Our results demonstrate how simple relationships between species' body masses and feeding interactions may promote the stability of complex food webs.	Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany; Pacific Ecoinformat & Computat Ecol Lab, Berkeley, CA 94703 USA	Technical University of Darmstadt	Otto, SB (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	sonotto@bio.tu-darmstadt.de	Rall, Björn C./G-1508-2013; Brose, Ulrich/I-3488-2014; Brose, Ulrich/AAT-7547-2020	Rall, Björn C./0000-0002-3191-8389; Brose, Ulrich/0000-0001-9156-583X				Bascompte J, 2005, ECOLOGY, V86, P2868, DOI 10.1890/05-0101; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Brose U., 2005, ECOLOGY, V86, P2545, DOI [DOI 10.1890/05-0379, 10.1890/05-0379]; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; de Ruiter PC, 2005, SCIENCE, V309, P68, DOI 10.1126/science.1096112; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Fussmann GF, 2002, ECOL LETT, V5, P394, DOI 10.1046/j.1461-0248.2002.00329.x; GARD TC, 1980, MATH BIOSCI, V49, P61, DOI 10.1016/0025-5564(80)90110-8; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jonsson T, 1998, J THEOR BIOL, V193, P407, DOI 10.1006/jtbi.1998.0708; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Koelle K, 2005, ECOL LETT, V8, P167, DOI 10.1111/j.1461-0248.2004.00703.x; Loeuille N, 2005, P NATL ACAD SCI USA, V102, P5761, DOI 10.1073/pnas.0408424102; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; MURATORI S, 1992, SIAM J APPL MATH, V52, P1688, DOI 10.1137/0152097; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	30	217	219	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2007	450	7173					1226	U7		10.1038/nature06359	http://dx.doi.org/10.1038/nature06359			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097408				2022-12-24	WOS:000251786200049
J	Koebel, CM; Vermi, W; Swann, JB; Zerafa, N; Rodig, SJ; Old, LJ; Smyth, MJ; Schreiber, RD				Koebel, Catherine M.; Vermi, William; Swann, Jeremy B.; Zerafa, Nadeen; Rodig, Scott J.; Old, Lloyd J.; Smyth, Mark J.; Schreiber, Robert D.			Adaptive immunity maintains occult cancer in an equilibrium state	NATURE			English	Article							INTERFERON-GAMMA; MONOCLONAL-ANTIBODIES; TUMOR IMMUNOGENICITY; CELLS; IMMUNOSURVEILLANCE; NK; LYMPHOCYTES; ACTIVATION; EXPRESSION; LYMPHOMA	The capacity of immunity to control and shape cancer, that is, cancer immunoediting, is the result of three processes(1-8) that function either independently or in sequence(9): elimination ( cancer immunosurveillance, in which immunity functions as an extrinsic tumour suppressor in naive hosts); equilibrium ( expansion of transformed cells is held in check by immunity); and escape ( tumour cell variants with dampened immunogenicity or the capacity to attenuate immune responses grow into clinically apparent cancers). Extensive experimental support now exists for the elimination and escape processes because immunodeficient mice develop more carcinogen-induced and spontaneous cancers than wild-type mice, and tumour cells from immunodeficient mice are more immunogenic than those from immunocompetent mice. In contrast, the equilibrium process was inferred largely from clinical observations, including reports of transplantation of undetected ( occult) cancer from organ donor into immuno-suppressed recipients(10). Herein we use a mouse model of primary chemical carcinogenesis and demonstrate that equilibrium occurs, is mechanistically distinguishable from elimination and escape, and that neoplastic cells in equilibrium are transformed but proliferate poorly in vivo. We also show that tumour cells in equilibrium are unedited but become edited when they spontaneously escape immune control and grow into clinically apparent tumours. These results reveal that, in addition to destroying tumour cells and sculpting tumour immunogenicity, the immune system of a naive mouse can also restrain cancer growth for extended time periods.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ Brescia, Spedali Civili, Dept Pathol, I-25123 Brescia, Italy; Peter MacCallum Canc Ctr, Canc Immunol Program, Sir Donald & Lady Trescowthick Labs, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA	Washington University (WUSTL); Hospital Spedali Civili Brescia; University of Brescia; Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mark.smyth@petermac.org; schreiber@immunology.wustl.edu	Rodig, Scott/Y-3889-2019; Schreiber, Robert/Q-7550-2019; Smyth, Mark J/H-8709-2014; Schreiber, Robert D/A-1276-2013	Smyth, Mark J/0000-0001-7098-7240; Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; VERMI, WILLIAM/0000-0002-2291-2997				Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ho EL, 2002, J IMMUNOL, V169, P3667, DOI 10.4049/jimmunol.169.7.3667; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Mutter GL, 2001, CANCER RES, V61, P4311; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; Sakr WA, 2001, UROLOGY, V57, P115, DOI 10.1016/S0090-4295(00)00953-5; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; SIU H, 1986, J IMMUNOL, V137, P1376; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Smyth MJ, 2004, J EXP MED, V200, P1325, DOI 10.1084/jem.20041522; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	32	975	1011	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					903	U24		10.1038/nature06309	http://dx.doi.org/10.1038/nature06309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18026089				2022-12-24	WOS:000251394900061
J	Bechtluft, P; van Leeuwen, RGH; Tyreman, M; Tomkiewicz, D; Nouwen, N; Tepper, HL; Driessen, AJM; Tans, SJ				Bechtluft, Philipp; van Leeuwen, Ruud G. H.; Tyreman, Matthew; Tomkiewicz, Danuta; Nouwen, Nico; Tepper, Harald L.; Driessen, Arnold J. M.; Tans, Sander J.			Direct observation of chaperone-induced changes in a protein folding pathway	SCIENCE			English	Article							MALTOSE-BINDING PROTEIN; ATOMIC-FORCE MICROSCOPY; TERTIARY STRUCTURE; SUBSTRATE PROTEIN; SECB; EXPORT; MOLECULE; TRANSLOCATION; MEMBRANE; PEPTIDE	How chaperone interactions affect protein folding pathways is a central problem in biology. With the use of optical tweezers and all-atom molecular dynamics simulations, we studied the effect of chaperone SecB on the folding and unfolding pathways of maltose binding protein (MBP) at the single-molecule level. In the absence of SecB, we find that the MBP polypeptide first collapses into a molten globulelike compacted state and then folds into a stable core structure onto which several a helices are finally wrapped. Interactions with SecB completely prevent stable tertiary contacts in the core structure but have no detectable effect on the folding of the external a helices. It appears that SecB only binds to the extended or molten globulelike structure and retains MBP in this latter state. Thus during MBP translocation, no energy is required to disrupt stable tertiary interactions.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands	AMOLF; University of Groningen; University of Groningen	Tans, SJ (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	tans@amolf.nl	Institute, Zernike/W-7033-2019; Tans, Sander/AAS-2901-2020; van Leeuwen, R.G.H./L-4481-2015; Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104				Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; CHUN SY, 1993, J BIOL CHEM, V268, P20855; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; Crane JM, 2006, J MOL BIOL, V363, P63, DOI 10.1016/j.jmb.2006.07.021; de Cock H, 1998, MOL MICROBIOL, V27, P469, DOI 10.1046/j.1365-2958.1998.00695.x; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Duan XQ, 2001, J MOL BIOL, V306, P1115, DOI 10.1006/jmbi.2001.4456; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; LECKER SH, 1990, EMBO J, V9, P2309, DOI 10.1002/j.1460-2075.1990.tb07402.x; LIU G, 1988, J BIOL CHEM, V263, P14790; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Stan G, 2007, P NATL ACAD SCI USA, V104, P8803, DOI 10.1073/pnas.0700607104; TOPPING TB, 1994, PROTEIN SCI, V3, P730; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040	30	107	108	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2007	318	5855					1458	1461		10.1126/science.1144972	http://dx.doi.org/10.1126/science.1144972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048690				2022-12-24	WOS:000251246100048
J	Gimelbrant, A; Hutchinson, JN; Thompson, BR; Chess, A				Gimelbrant, Alexander; Hutchinson, John N.; Thompson, Benjamin R.; Chess, Andrew			Widespread monoallelic expression on human autosomes	SCIENCE			English	Article							X-LINKED GENE; ASYNCHRONOUS REPLICATION; INACTIVATION; INTERLEUKIN-2; DUPLICATION; CHROMOSOME; LOCUS; MOUSE; CELLS	Monoallelic expression with random choice between the maternal and paternal alleles defines an unusual class of genes comprising X-inactivated genes and a few autosomal gene families. Using a genome-wide approach, we assessed allele-specific transcription of about 4000 human genes in clonal cell lines and found that more than 300 were subject to random monoallelic expression. For a majority of monoallelic genes, we also observed some clonal lines displaying biallelic expression. Clonal cell lines reflect an independent choice to express the maternal, the paternal, or both alleles for each of these genes. This can lead to differences in expressed protein sequence and to differences in levels of gene expression. Unexpectedly widespread monoallelic expression suggests a mechanism that generates diversity in individual cells and their clonal descendants.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chess, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	chess@chgr.mgh.harvard.edu	Hutchinson, John/AAA-1976-2020	Hutchinson, John/0000-0002-7804-7576; Gimelbrant, Alexander/0000-0001-6986-0285; Edsall, Lee Elizabeth/0000-0002-0326-2829				Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 1999, P NATL ACAD SCI USA, V96, P7364, DOI 10.1073/pnas.96.13.7364; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ensminger AW, 2004, HUM MOL GENET, V13, P651, DOI 10.1093/hmg/ddh062; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rouhi A, 2006, J IMMUNOL, V176, P2991, DOI 10.4049/jimmunol.176.5.2991; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199	24	431	437	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1136	1140		10.1126/science.1148910	http://dx.doi.org/10.1126/science.1148910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006746				2022-12-24	WOS:000250957900046
J	Grieneisen, VA; Xu, J; Maree, AFM; Hogeweg, P; Scheres, B				Grieneisen, Veronica A.; Xu, Jian; Maree, Athanasius F. M.; Hogeweg, Paulien; Scheres, Ben			Auxin transport is sufficient to generate a maximum and gradient guiding root growth	NATURE			English	Article							BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; EFFLUX; PIN; PHYLLOTAXIS; PATTERN; MERISTEM; RECEPTOR; NETWORK; TISSUES	The plant growth regulator auxin controls cell identity, cell division and cell expansion. Auxin efflux facilitators (PINs) are associated with auxin maxima in distal regions of both shoots and roots. Here we model diffusion and PIN-facilitated auxin transport in and across cells within a structured root layout. In our model, the stable accumulation of auxin in a distal maximum emerges from the auxin flux pattern. We have experimentally tested model predictions of robustness and self-organization. Our model explains pattern formation and morphogenesis at timescales from seconds to weeks, and can be understood by conceptualizing the root as an 'auxin capacitor'. A robust auxin gradient associated with the maximum, in combination with separable roles of auxin in cell division and cell expansion, is able to explain the formation, maintenance and growth of sharply bounded meristematic and elongation zones. Directional permeability and diffusion can fully account for stable auxin maxima and gradients that can instruct morphogenesis.	Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Utrecht University	Scheres, B (corresponding author), Univ Utrecht, Dept Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	b.scheres@uu.nl	Xu, Jian/I-2921-2012; Hogeweg, paulien/D-1242-2011	Xu, Jian/0000-0001-6194-6316; Maree, Athanasius F. M./0000-0003-2689-2484; Grieneisen, Veronica/0000-0001-6780-8301; Scheres, Ben/0000-0001-5400-9578				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Beeckman T, 2001, J EXP BOT, V52, P403, DOI 10.1093/jexbot/52.suppl_1.403; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Berleth T, 2007, TRENDS PLANT SCI, V12, P151, DOI 10.1016/j.tplants.2007.03.005; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Feugier FG, 2005, J THEOR BIOL, V236, P366, DOI 10.1016/j.jtbi.2005.03.017; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; GOLDSMITH MHM, 1981, P NATL ACAD SCI-BIOL, V78, P976, DOI 10.1073/pnas.78.2.976; GUTKNECHT J, 1980, J MEMBRANE BIOL, V56, P65, DOI 10.1007/BF01869353; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kramer EM, 2004, TRENDS PLANT SCI, V9, P578, DOI 10.1016/j.tplants.2004.10.010; KRAMER EM, 2007, J EXP BOT; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Leyser O, 2005, CELL, V121, P819, DOI 10.1016/j.cell.2005.06.005; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SACHS T, 1981, ADV BOT RES, V9, P152; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Went FW, 1942, PLANT PHYSIOL, V17, P236, DOI 10.1104/pp.17.2.236; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790	38	597	620	0	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2007	449	7165					1008	1013		10.1038/nature06215	http://dx.doi.org/10.1038/nature06215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17960234	Green Published			2022-12-24	WOS:000250395000042
J	Nowacki, M; Vijayan, V; Zhou, Y; Schotanus, K; Doak, TG; Landweber, LF				Nowacki, Mariusz; Vijayan, Vikram; Zhou, Yi; Schotanus, Klaas; Doak, Thomas G.; Landweber, Laura F.			RNA-mediated epigenetic programming of a genome-rearrangement pathway	NATURE			English	Article							INTERNAL ELIMINATED SEGMENTS; NON-MENDELIAN INHERITANCE; DNA-POLYMERASE-ALPHA; DOUBLE-STRAND BREAKS; PARAMECIUM-TETRAURELIA; BINDING-PROTEIN; GENE; EVOLUTION; RECOMBINATION; INFORMATION	Genome- wide DNA rearrangements occur in many eukaryotes but are most exaggerated in ciliates, making them ideal model systems for epigenetic phenomena. During development of the somatic macronucleus, Oxytricha trifallax destroys 95% of its germ line, severely fragmenting its chromosomes, and then unscrambles hundreds of thousands of remaining fragments by permutation or inversion. Here we demonstrate that DNA or RNA templates can orchestrate these genome rearrangements in Oxytricha, supporting an epigenetic model for sequence- dependent comparison between germline and somatic genomes. A complete RNA cache of the maternal somatic genome may be available at a specific stage during development to provide a template for correct and precise DNA rearrangement. We show the existence of maternal RNA templates that could guide DNA assembly, and that disruption of specific RNA molecules disables rearrangement of the corresponding gene. Injection of artificial templates reprogrammes the DNA rearrangement pathway, suggesting that RNA molecules guide genome rearrangement.	[Nowacki, Mariusz; Zhou, Yi; Schotanus, Klaas; Doak, Thomas G.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Vijayan, Vikram] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Nowacki, Mariusz/E-4485-2011	Nowacki, Mariusz/0000-0003-4894-2905; Vijayan, Vikram/0000-0003-3948-7568; Doak, Thomas/0000-0001-5487-553X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059708-06S1, R01 GM059708-05A1, R01 GM059708, R01 GM059708-07, R01 GM059708-08, R01 GM059708-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Chang WJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-6; Chang WJ, 2004, PROTIST, V155, P245, DOI 10.1078/143446104774199628; DERR LK, 1993, NATURE, V361, P170, DOI 10.1038/361170a0; Duharcourt S, 1998, MOL CELL BIOL, V18, P7075, DOI 10.1128/MCB.18.12.7075; Galvani A, 2002, TRENDS GENET, V18, P11, DOI 10.1016/S0168-9525(01)02548-3; Herbert A, 1999, NAT GENET, V21, P265, DOI 10.1038/6780; Hoffman DC, 1997, NUCLEIC ACIDS RES, V25, P1883, DOI 10.1093/nar/25.10.1883; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; King ML, 2005, BIOL CELL, V97, P19; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Landweber LF, 2000, P NATL ACAD SCI USA, V97, P3298, DOI 10.1073/pnas.040574697; LAUGHLIN TJ, 1983, J PROTOZOOL, V30, P63, DOI 10.1111/j.1550-7408.1983.tb01035.x; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Lolle SJ, 2006, NATURE, V443, pE8, DOI 10.1038/nature05252; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Mayer KM, 1999, GENETICS, V151, P597; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MOLLENBECK M, UNPUB PLOS BIOL; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; NevoCaspi Y, 1997, CURR GENET, V32, P32, DOI 10.1007/s002940050245; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paschka AG, 2003, EUR J PROTISTOL, V39, P449, DOI 10.1078/0932-4739-00019; Peng P, 2006, NATURE, V443, pE8, DOI 10.1038/nature05251; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Prescott JD, 1998, CHROMOSOMA, V107, P293, DOI 10.1007/s004120050311; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; WILLIAMS K, 1993, EMBO J, V12, P4593, DOI 10.1002/j.1460-2075.1993.tb06148.x; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737	37	204	213	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2008	451	7175					153	U4		10.1038/nature06452	http://dx.doi.org/10.1038/nature06452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	249GA	18046331	Green Accepted			2022-12-24	WOS:000252214400034
J	Ahel, I; Ahel, D; Matsusaka, T; Clark, AJ; Pines, J; Boulton, SJ; West, SC				Ahel, Ivan; Ahel, Dragana; Matsusaka, Takahiro; Clark, Allison J.; Pines, Jonathon; Boulton, Simon J.; West, Stephen C.			Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins	NATURE			English	Article							VERTEBRATE SOMATIC-CELLS; DAMAGE CHECKPOINT; MAMMALIAN-CELLS; STRAND BREAKS; CHFR; ENTRY; POLY(ADP-RIBOSYL)ATION; POLYMERASE; RESPONSES; PROPHASE	Post- translational modification ( PTM) of proteins plays an important part in mediating protein interactions and/ or the recruitment of specific protein targets(1,2). PTM can be mediated by the addition of functional groups ( for example, acetylation or phosphorylation), peptides ( for example, ubiquitylation or sumoylation), or nucleotides ( for example, poly( ADP- ribosyl) ation). Poly( ADP- ribosyl) ation often involves the addition of long chains of ADP- ribose units, linked by glycosidic ribose - ribose bonds(3), and is critical for a wide range of processes, including DNA repair, regulation of chromosome structure, transcriptional regulation, mitosis and apoptosis(4). Here we identify a novel poly( ADP- ribose)- binding zinc finger ( PBZ) motif in a number of eukaryotic proteins involved in the DNA damage response and checkpoint regulation. The PBZ motif is also required for posttranslational poly( ADP- ribosyl) ation. We demonstrate interaction of poly( ADP- ribose) with this motif in two representative human proteins, APLF ( aprataxin PNK- like factor) and CHFR ( checkpoint protein with FHA and RING domains), and show that the actions of CHFR in the antephase checkpoint are abrogated by mutations in PBZ or by inhibition of poly( ADP- ribose) synthesis.	[Ahel, Dragana; Clark, Allison J.; Boulton, Simon J.] Canc Res UK London Res Inst, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Ahel, Ivan; West, Stephen C.] Canc Res UK London Res Inst, Clare Hall Labs, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [Matsusaka, Takahiro; Pines, Jonathon] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England	Cancer Research UK; Cancer Research UK	Boulton, SJ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk; stephen.west@cancer.org.uk		Ahel, Ivan/0000-0002-9446-3756; West, Stephen/0000-0001-8848-9418; Pines, Jonathon/0000-0002-5227-6004				Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MINAGA T, 1983, J BIOL CHEM, V258, P5726; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rieder CL, 1998, J CELL BIOL, V142, P1013, DOI 10.1083/jcb.142.4.1013; Rieder CL, 2000, COLD SPRING HARB SYM, V65, P369, DOI 10.1101/sqb.2000.65.369; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Walsh C., 2006, POSTRANSLATIONAL MOD; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	26	305	316	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					81	U12		10.1038/nature06420	http://dx.doi.org/10.1038/nature06420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18172500				2022-12-24	WOS:000252079300038
J	Tumer, EC; Brainard, MS				Tumer, Evren C.; Brainard, Michael S.			Performance variability enables adaptive plasticity of 'crystallized' adult birdsong	NATURE			English	Article							AUDITORY-FEEDBACK; ZEBRA FINCH; SENSORIMOTOR CONTROL; SONG; MODEL; MAINTENANCE; FOREBRAIN; CONTEXT; LESIONS; PERTURBATION	Significant trial- by- trial variation persists even in the most practiced skills. One prevalent view is that such variation is simply 'noise' that the nervous system is unable to control or that remains below threshold for behavioural relevance(1-3). An alternative hypothesis is that such variation enables trial- and- error learning, in which the motor system generates variation and differentially retains behaviours that give rise to better outcomes. Here we test the latter possibility for adult bengalese finch song. Adult bird-song is a complex, learned motor skill that is produced in a highly stereotyped fashion from one rendition to the next(4,5). Nevertheless, there is subtle trial- by- trial variation even in stable, 'crystallized' adult song(6-8). We used a computerized system to monitor small natural variations in the pitch of targeted song elements and deliver real- time auditory disruption to a subset of those variations. Birds rapidly shifted the pitch of their vocalizations in an adaptive fashion to avoid disruption. These vocal changes were precisely restricted to the targeted features of song. Hence, birds were able to learn effectively by associating small variations in their vocal behaviour with differential outcomes. Such a process could help to maintain stable, learned song despite changes to the vocal control system arising from ageing or injury. More generally, our results suggest that residual variability in well learned skills is not entirely noise but rather reflects meaningful motor exploration that can support continuous learning and optimization of performance.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tumer, EC (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, Dept Physiol, San Francisco, CA 94143 USA.	evren@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907	NIDCD NIH HHS [R01 DC006636] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Amir O, 2003, J ACOUST SOC AM, V113, P1102, DOI 10.1121/1.1536632; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Dent ML, 2000, J ACOUST SOC AM, V107, P2657, DOI 10.1121/1.428651; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya Kenji, 2000, P469; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HELD R, 1966, J EXP PSYCHOL, V72, P887, DOI 10.1037/h0023868; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; Okanoya K, 1997, J NEUROBIOL, V33, P343; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Sundberg J, 1996, VOCAL FOLD, P291; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Zevin JD, 2004, J NEUROSCI, V24, P5849, DOI 10.1523/JNEUROSCI.1891-04.2004	32	278	283	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1240	U11		10.1038/nature06390	http://dx.doi.org/10.1038/nature06390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097411				2022-12-24	WOS:000251786200052
J	Rothlin, CV; Ghosh, S; Zuniga, EI; Oldstone, MBA; Lemke, G				Rothlin, Carla V.; Ghosh, Sourav; Zuniga, Elina I.; Oldstone, Michael B. A.; Lemke, Greg			TAM receptors are pleiotropic inhibitors of the innate immune response	CELL			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TYRO-3 FAMILY RECEPTORS; TYROSINE KINASE; NEGATIVE REGULATION; CYTOKINE SIGNALING-1; APOPTOTIC CELLS; PROTEIN-S; SUPPRESSOR; MER; INFLAMMATION	The activation of Toll-like receptors (TLRs) in dendritic cells (DCs) triggers a rapid inflammatory response to pathogens. However, this response must be tightly regulated because unrestrained TLR signaling generates a chronic inflammatory milieu that often leads to autoimmunity. We have found that the TAM receptor tyrosine kinases-Tyro3, Axl, and Mer- broadly inhibit both TLR and TLR-induced cytokine-receptor cascades. Remarkably, TAM inhibition of inflammation is transduced through an essential stimulator of inflammation - the type I interferon receptor (IFNAR) - and its associated transcription factor STAT1. TLR induction of IFNAR-STAT1 signaling upregulates the TAM system, which in turn usurps the IFNAR-STAT1 cassette to induce the cytokine and TLR suppressors SOCS1 and SOCS3. These results illuminate a self-regulating cycle of inflammation, in which the obligatory, cytokine-dependent activation of TAM signaling hijacks a proinflammatory pathway to provide an intrinsic feedback inhibitor of both TLR- and cytokine-driven immune responses.	[Rothlin, Carla V.; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Ghosh, Sourav] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Zuniga, Elina I.; Oldstone, Michael B. A.] Scripps Res Inst, Mol & Integrat Neurosci Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Scripps Research Institute	Lemke, G (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	lemke@salk.edu		Rothlin, Carla V/0000-0002-5693-5572; Ghosh, Sourav/0000-0001-5990-8708	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927, R01AI009484, R37AI009484] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09484, AI05540, AI45927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Brouwer JLR, 2004, BLOOD, V104, P143, DOI 10.1182/blood-2003-11-4085; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hanada T, 2003, IMMUNITY, V19, P437, DOI 10.1016/S1074-7613(03)00240-1; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; LAI C, 1994, ONCOGENE, V9, P2567; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Meesters EW, 2007, BLOOD COAGUL FIBRIN, V18, P21, DOI 10.1097/01.mbc.0000256022.01900.c2; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Ruiz-Irastorza G, 2001, LANCET, V357, P1027, DOI 10.1016/S0140-6736(00)04239-2; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Smiley ST, 1997, P NATL ACAD SCI USA, V94, P11484, DOI 10.1073/pnas.94.21.11484; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Wormald S, 2007, CURR OPIN HEMATOL, V14, P9, DOI 10.1097/00062752-200701000-00004; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	43	705	742	4	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 14	2007	131	6					1124	1136		10.1016/j.cell.2007.10.034	http://dx.doi.org/10.1016/j.cell.2007.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083102	Bronze			2022-12-24	WOS:000252217100020
J	Hirayama, J; Sahar, S; Grimaldi, B; Tamaru, T; Takamatsu, K; Nakahata, Y; Sassone-Corsi, P				Hirayama, Jun; Sahar, Saurabh; Grimaldi, Benedetto; Tamaru, Teruya; Takamatsu, Ken; Nakahata, Yasukazu; Sassone-Corsi, Paolo			CLOCK-mediated acetylation of BMAL1 controls circadian function	NATURE			English	Article							MAMMALIAN CRY1; FEEDBACK LOOP; C-TERMINUS; IN-VIVO; MECHANISM; HISTONES; PROTEIN; GENETICS; RHYTHMS; TIME	Regulation of circadian physiology relies on the interplay of interconnected transcriptional - translational feedback loops(1,2). The CLOCK - BMAL1 complex activates clock- controlled genes, including cryptochromes ( Crys), the products of which act as repressors by interacting directly with CLOCK - BMAL1(3,4). We have demonstrated that CLOCK possesses intrinsic histone acetyltransferase activity and that this enzymatic function contributes to chromatin- remodelling events implicated in circadian control of gene expression(5). Here we show that CLOCK also acetylates a non- histone substrate: its own partner, BMAL1, is specifically acetylated on a unique, highly conserved Lys 537 residue. BMAL1 undergoes rhythmic acetylation in mouse liver, with a timing that parallels the downregulation of circadian transcription of clock- controlled genes. BMAL1 acetylation facilitates recruitment of CRY1 to CLOCK - BMAL1, thereby promoting transcriptional repression. Importantly, ectopic expression of a K537R- mutated BMAL1 is not able to rescue circadian rhythmicity in a cellular model of peripheral clock. These findings reveal that the enzymatic interplay between two clock core components(6,7) is crucial for the circadian machinery.	Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; Toho Univ, Fac Med, Dept Physiol, Tokyo 1438540, Japan	University of California System; University of California Irvine; Toho University	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA.	psc@uci.edu	Sassone-Corsi, Paolo/H-6182-2011	Nakahata, Yasukazu/0000-0003-3814-5822; Hirayama, Jun/0000-0002-8485-3320; Grimaldi, Benedetto/0000-0002-2589-9302				Belden WJ, 2006, TRENDS BIOCHEM SCI, V31, P610, DOI 10.1016/j.tibs.2006.09.009; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615	30	370	390	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1086	U13		10.1038/nature06394	http://dx.doi.org/10.1038/nature06394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075593				2022-12-24	WOS:000251579900088
J	Olesen, C; Picard, M; Winther, AML; Gyrup, C; Morth, JP; Oxvig, C; Moller, JV; Nissen, P				Olesen, Claus; Picard, Martin; Winther, Anne-Marie Lund; Gyrup, Claus; Morth, J. Preben; Oxvig, Claus; Moller, Jesper Vuust; Nissen, Poul			The structural basis of calcium transport by the calcium pump	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; PHOSPHOENZYME INTERMEDIATE; RECONSTITUTED PROTEOLIPOSOMES; CRYSTAL-STRUCTURES; A-DOMAIN; BINDING; PROTEIN; ATPASE; NA+,K+-ATPASE; HYDROLYSIS	The sarcoplasmic reticulum Ca2+-ATPase, a P-type ATPase, has a critical role in muscle function and metabolism. Here we present functional studies and three new crystal structures of the rabbit skeletal muscle Ca2+-ATPase, representing the phosphoenzyme intermediates associated with Ca2+ binding, Ca2+ translocation and dephosphorylation, that are based on complexes with a functional ATP analogue, beryllium fluoride and aluminium fluoride, respectively. The structures complete the cycle of nucleotide binding and cation transport of Ca2+-ATPase. Phosphorylation of the enzyme triggers the onset of a conformational change that leads to the opening of a luminal exit pathway defined by the transmembrane segments M1 through M6, which represent the canonical membrane domain of P-type pumps. Ca2+ release is promoted by translocation of the M4 helix, exposing Glu 309, Glu 771 and Asn 796 to the lumen. The mechanism explains how P-type ATPases are able to form the steep electrochemical gradients required for key functions in eukaryotic cells.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark	Danmarks Grundforskningsfond; Aarhus University; Aarhus University	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Ole Worms Alle,Blg 1185, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Picard, Martin/A-3236-2016	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Picard, Martin/0000-0002-6518-8900; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989; Oxvig, Claus/0000-0002-4715-9719; Nissen, Poul/0000-0003-0948-6628				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; Apell HJ, 2004, REV PHYSIOL BIOCH P, V150, P1, DOI 10.1007/s10254-003-0018-9; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 2002, METHOD ENZYMOL, V354, P177; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEMEIS L, 1981, SARCOPLASMIC RETICUL; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; FEHER JJ, 1983, BIOCHIM BIOPHYS ACTA, V727, P389, DOI 10.1016/0005-2736(83)90424-8; Fiske CH, 1925, J BIOL CHEM, V66, P375; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; HASSELBACH W, 1980, BASIC RES CARDIOL, V75, P2, DOI 10.1007/BF02001387; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LAUGER P, 1991, ELECTROGENIC PUMPS, pCH8; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LEVY D, 1990, J BIOL CHEM, V265, P19524; Mahaney JE, 2004, BIOCHEMISTRY-US, V43, P4400, DOI 10.1021/bi035068g; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MELTZER S, 1984, J BIOL CHEM, V259, P4244; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Reyes N, 2006, NATURE, V443, P470, DOI 10.1038/nature05129; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Sickmann A, 2001, PROTEOMICS, V1, P200, DOI 10.1002/1615-9861(200102)1:2<200::AID-PROT200>3.0.CO;2-V; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; TAYLOR JS, 1981, J BIOL CHEM, V256, P9793; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	63	354	362	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1036	U5		10.1038/nature06418	http://dx.doi.org/10.1038/nature06418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075584				2022-12-24	WOS:000251579900077
J	Jeoung, JH; Dobbek, H				Jeoung, Jae-Hun; Dobbek, Holger			Carbon dioxide activation at the Ni,Fe-cluster of anaerobic carbon monoxide dehydrogenase	SCIENCE			English	Article							CO DEHYDROGENASE; CLOSTRIDIUM-THERMOACETICUM; RHODOSPIRILLUM-RUBRUM; ACTIVE-SITE; CARBOXYDOTHERMUS-HYDROGENOFORMANS; CLUSTER; METALLOCLUSTERS; COORDINATION; CATALYSIS; SYNTHASE	Anaerobic CO dehydrogenases catalyze the reversible oxidation of CO to CO2 at a complex Ni-, Fe-, and S-containing metal center called cluster C. We report crystal structures of CO dehydrogenase II from Carboxydothermus hydrogenoformans in three different states. In a reduced state, exogenous CO2 supplied in solution is bound and reductively activated by cluster C. In the intermediate structure, CO2 acts as a bridging ligand between Ni and the asymmetrically coordinated Fe, where it completes the square-planar coordination of the Ni ion. It replaces a water/hydroxo ligand bound to the Fe ion in the other two states. The structures define the mechanism of CO oxidation and CO2 reduction at the Ni-Fe site of cluster C.	Univ Bayreuth, Lab Prot Kristallog, D-95440 Bayreuth, Germany; Univ Bayreuth, Forsch Zent Biomakromol, D-95440 Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Dobbek, H (corresponding author), Univ Bayreuth, Lab Prot Kristallog, POB 101251, D-95440 Bayreuth, Germany.	holger.dobbek@uni-bayreuth.de						Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Dobbek H, 2004, J AM CHEM SOC, V126, P5382, DOI 10.1021/ja037776v; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; ENSIGN SA, 1995, BIOCHEMISTRY-US, V34, P5372, DOI 10.1021/bi00016a008; Feng J, 2004, J AM CHEM SOC, V126, P9094, DOI 10.1021/ja048811g; Feng J, 2004, BIOCHEMISTRY-US, V43, P1552, DOI 10.1021/bi0357199; Fraser DM, 1999, BIOCHEMISTRY-US, V38, P15706, DOI 10.1021/bi990398f; GRAHAME DA, 1995, BIOCHEMISTRY-US, V34, P4617, DOI 10.1021/bi00014a015; Ha SW, 2007, J BIOL CHEM, V282, P10639, DOI 10.1074/jbc.M610641200; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Leitner W, 1996, COORDIN CHEM REV, V153, P257, DOI 10.1016/0010-8545(95)01226-5; LINDAHL PA, 1990, J BIOL CHEM, V265, P3880; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Lindahl PA, 2002, BIOCHEMISTRY-US, V41, P2097, DOI 10.1021/bi015932+; MACGREGOR SA, 1994, INORG CHEM, V33, P3616, DOI 10.1021/ic00094a030; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; Rees DC, 2002, ANNU REV BIOCHEM, V71, P221, DOI 10.1146/annurev.biochem.71.110601.135406; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Svetlitchnyi V, 2001, J BACTERIOL, V183, P5134, DOI 10.1128/JB.183.17.5134-5144.2001	22	375	379	8	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1461	1464		10.1126/science.1148481	http://dx.doi.org/10.1126/science.1148481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048691				2022-12-24	WOS:000251246100049
J	Galy, V; France-Lanord, C; Beyssac, O; Faure, P; Kudrass, H; Palhol, F				Galy, Valier; France-Lanord, Christian; Beyssac, Olivier; Faure, Pierre; Kudrass, Hermann; Palhol, Fabien			Efficient organic carbon burial in the Bengal fan sustained by the Himalayan erosional system	NATURE			English	Article							MATTER; BAY; TRANSPORT; SEDIMENTS; CONSTRAINTS; EVOLUTION; RIVERS; OCEAN; CYCLE; C-13	Continental erosion controls atmospheric carbon dioxide levels on geological timescales through silicate weathering, riverine transport and subsequent burial of organic carbon in oceanic sediments(1). The efficiency of organic carbon deposition in sedimentary basins is however limited by the organic carbon load capacity of the sediments and organic carbon oxidation in continental margins. At the global scale, previous studies have suggested that about 70 per cent of riverine organic carbon is returned to the atmosphere, such as in the Amazon basin(2-4). Here we present a comprehensive organic carbon budget for the Himalayan erosional system, including source rocks, river sediments and marine sediments buried in the Bengal fan. We show that organic carbon export is controlled by sediment properties, and that oxidative loss is negligible during transport and deposition to the ocean. Our results indicate that 70 to 85 per cent of the organic carbon is recent organic matter captured during transport, which serves as a net sink for atmospheric carbon dioxide. The amount of organic carbon deposited in the Bengal basin represents about 10 to 20 per cent of the total terrestrial organic carbon buried in oceanic sediments. High erosion rates in the Himalayas generate high sedimentation rates and low oxygen availability in the Bay of Bengal that sustain the observed extreme organic carbon burial efficiency. Active orogenic systems generate enhanced physical erosion and the resulting organic carbon burial buffers atmospheric carbon dioxide levels, thereby exerting a negative feedback on climate over geological timescales.	CNRS, ENS Paris, Geol Lab, INSU, F-75005 Paris 5, France; Nancy Univ, CNRS, G2R INSU, F-54506 Vandoeuvre Les Nancy, France; Fed Inst Geosci & Nat Resources, D-30655 Hannover, Germany; Nancy Univ, CRPG, CNRS, INSU, F-54501 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine	Galy, V (corresponding author), Woods Hole Oceanog Inst, 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	vgaly@whoi.edu	IMPMC, ROCKS @/U-8478-2017; Beyssac, Olivier/F-6811-2012; France-Lanord, Christian/F-8848-2010; Galy, valier/AAD-2248-2021; Beyssac, Olivier/A-8647-2008; galy, valier/I-6185-2012	France-Lanord, Christian/0000-0002-4873-5546; Galy, valier/0000-0003-0385-8443; galy, valier/0000-0003-0385-8443				Aucour AM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002324; BECK RA, 1995, GEOLOGY, V23, P387, DOI 10.1130/0091-7613(1995)023<0387:OCEAGW>2.3.CO;2; BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Berner U, 2003, DEEP-SEA RES PT II, V50, P925, DOI 10.1016/S0967-0645(02)00613-6; Beyssac O, 2003, SPECTROCHIM ACTA A, V59, P2267, DOI 10.1016/S1386-1425(03)00070-2; Beyssac O, 2002, CONTRIB MINERAL PETR, V143, P19, DOI 10.1007/s00410-001-0324-7; BROECKER WS, 1980, EARTH PLANET SC LETT, V49, P506, DOI 10.1016/0012-821X(80)90091-6; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Cai WJ, 1996, MAR CHEM, V52, P123, DOI 10.1016/0304-4203(95)00081-X; COCHRAN JR, 1989, P OCEAN DRILLING PRO, V116, P388; Curray JR, 2002, MAR PETROL GEOL, V19, P1191, DOI 10.1016/S0264-8172(03)00035-7; Drenzek NJ, 2007, MAR CHEM, V103, P146, DOI 10.1016/j.marchem.2006.06.017; FRANCELANORD C, 1994, GEOCHIM COSMOCHIM AC, V58, P4809, DOI 10.1016/0016-7037(94)90210-0; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Freeman KH, 2001, GEOCHIM COSMOCHIM AC, V65, P1439, DOI 10.1016/S0016-7037(00)00573-1; Galy A, 1999, GEOCHIM COSMOCHIM AC, V63, P1905, DOI 10.1016/S0016-7037(99)00081-2; Galy A, 2001, GEOLOGY, V29, P23, DOI 10.1130/0091-7613(2001)029<0023:HERITH>2.0.CO;2; Goni MA, 2006, ESTUAR COAST SHELF S, V69, P225, DOI 10.1016/j.ecss.2006.04.012; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Ittekkot V, 2003, DEEP-SEA RES PT II, V50, P853, DOI 10.1016/S0967-0645(02)00608-2; KUDRASS H, 1996, BENGAL FAN, P45; Mackenzie F.T., 1981, FLUX ORGANIC CARBON, P360; MEYERS PA, 1992, GEOPHYS MONOGR SER, V70, P295; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Pierson-Wickmann AC, 2001, PALEOCEANOGRAPHY, V16, P435, DOI 10.1029/2000PA000532; RSP, 1996, 24 RSP FAP WARPO; Schlunz B, 2000, INT J EARTH SCI, V88, P599, DOI 10.1007/s005310050290; Schwenk T, 2005, MAR PETROL GEOL, V22, P637, DOI 10.1016/j.marpetgeo.2005.01.007; SUBRAMANIAN V, 1991, BIOGEOCHEMISTRY MAJO, P157; Suckow A, 2001, RADIOCARBON, V43, P917; VONDERBORCH CC, 1974, INITIAL REPORT DEEP, V22; Wagai R, 2007, GEOCHIM COSMOCHIM AC, V71, P25, DOI 10.1016/j.gca.2006.08.047; Weber ME, 1997, GEOLOGY, V25, P315, DOI 10.1130/0091-7613(1997)025<0315:AGOTBF>2.3.CO;2	35	427	447	11	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2007	450	7168					407	U6		10.1038/nature06273	http://dx.doi.org/10.1038/nature06273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004382	Green Submitted			2022-12-24	WOS:000250918600052
J	Engstler, M; Pfohl, T; Herminghaus, S; Boshart, M; Wiegertjes, G; Heddergott, N; Overath, P				Engstler, Markus; Pfohl, Thomas; Herminghaus, Stephan; Boshart, Michael; Wiegertjes, Geert; Heddergott, Niko; Overath, Peter			Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes	CELL			English	Article							BLOOD-STREAM FORMS; ANTIGENIC VARIATION; DNA-MOLECULES; BRUCEI; GLYCOPROTEIN; ENDOCYTOSIS; MEMBRANE; MOVEMENT; MOTILITY; ANTIBODY	The unicellular parasite Trypanosoma brucei rapidly removes host-derived immunoglobulin (Ig) from its cell surface, which is dominated by a single type of glycosylphosphatidylinositol-anchored variant surface glycoprotein (VSG). We have determined the mechanism of antibody clearance and found that Ig-VSG immune complexes are passively sorted to the posterior cell pole, where they are endocytosed. The backward movement of immune complexes requires forward cellular motility but is independent of endocytosis and of actin function. We suggest that the hydrodynamic flow acting on swimming trypanosomes causes directional movement of Ig-VSG immune complexes in the plane of the plasmamembrane, that is, immunoglobulins attached to VSG function as molecular sails. Protein sorting by hydrodynamic forces helps to protect trypanosomes against complement-mediated immune destruction in culture and possibly in infected mammals but likewise may be of functional significance at the surface of other cell types such as epithelial cells lining blood vessels.	Tech Univ Darmstadt, Inst Mikrobiol & Genet, D-64287 Darmstadt, Germany; Max Planck Inst Dynam & Selbstorganisat, D-37073 Gottingen, Germany; Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Wageningen Inst Anim Sci, Cell Biol & Immunol Grp, NL-6709 PG Wageningen, Netherlands; Univ Tubingen, Immunol Abt, Interfak Inst Zellbiol, D-72076 Tubingen, Germany	Technical University of Darmstadt; Max Planck Society; University of Munich; Wageningen University & Research; Eberhard Karls University of Tubingen	Engstler, M (corresponding author), Tech Univ Darmstadt, Inst Mikrobiol & Genet, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	engstler@bio.tu-darmstadt.de	Engstler, Markus/E-6054-2010; Boshart, Michael/A-2700-2011; Wiegertjes, Geert F/E-3330-2012; Pfohl, Thomas/D-7296-2016; Herminghaus, Stephan/D-1904-2009	Boshart, Michael/0000-0002-5070-2663; Pfohl, Thomas/0000-0002-7879-5216; wiegertjes, geert/0000-0001-9265-3436				Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BALBER AE, 1979, INFECT IMMUN, V24, P617, DOI 10.1128/IAI.24.3.617-627.1979; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; BARRY JD, 1979, J CELL SCI, V37, P287; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; BENSIMON D, 1995, PHYS REV LETT, V74, P4754, DOI 10.1103/PhysRevLett.74.4754; Bocquet L, 1996, J PHYS-CONDENS MAT, V8, P9297, DOI 10.1088/0953-8984/8/47/019; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Chan TF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl593; Cottin-Bizonne C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056102; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; DELAUW MF, 1985, EMBO J, V4, P989, DOI 10.1002/j.1460-2075.1985.tb03728.x; Donelson JE, 1998, MOL BIOCHEM PARASIT, V91, P51, DOI 10.1016/S0166-6851(97)00209-0; Dukkipati VR, 2006, NANO LETT, V6, P2499, DOI 10.1021/nl0617484; Engstler M, 2005, J CELL SCI, V118, P2105, DOI 10.1242/jcs.02327; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Fache S, 2005, J CELL SCI, V118, P3445, DOI 10.1242/jcs.02461; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Kadau K, 2004, P NATL ACAD SCI USA, V101, P5851, DOI 10.1073/pnas.0401228101; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; LEVINE S, 1983, BIOPHYS J, V42, P127, DOI 10.1016/S0006-3495(83)84378-1; MANSFIELD JM, 1994, PARASITOL TODAY, V10, P267, DOI 10.1016/0169-4758(94)90143-0; MCCLOSKEY MA, 1984, J CELL BIOL, V99, P778, DOI 10.1083/jcb.99.3.778; MCLAUGHLIN S, 1981, BIOPHYS J, V34, P85, DOI 10.1016/S0006-3495(81)84838-2; MCLINTOCK LML, 1993, PARASITE IMMUNOL, V15, P475, DOI 10.1111/j.1365-3024.1993.tb00633.x; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Priezjev NV, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041608; QIAN T, 2003, PHYS REV E, V68; RICHARDSON S, 1973, J FLUID MECH, V59, P707, DOI 10.1017/S0022112073001801; ROSEN R, 1979, J THEOR BIOL, V80, P149, DOI 10.1016/0022-5193(79)90186-3; RUSSO DCW, 1993, EUR J CELL BIOL, V62, P432; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STEVENS DR, 1978, INFECT IMMUN, V19, P972, DOI 10.1128/IAI.19.3.972-982.1978; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; WEBSTER P, 1990, J CELL SCI, V96, P249	46	272	273	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 2	2007	131	3					505	515		10.1016/j.cell.2007.08.046	http://dx.doi.org/10.1016/j.cell.2007.08.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	226WF	17981118	Bronze			2022-12-24	WOS:000250618500018
J	Kolas, NK; Chapman, JR; Nakada, S; Ylanko, J; Chahwan, R; Sweeney, FD; Panier, S; Mendez, M; Wildenhain, J; Thomson, TM; Pelletier, L; Jackson, SP; Durocher, D				Kolas, Nadine K.; Chapman, J. Ross; Nakada, Shinichiro; Ylanko, Jarkko; Chahwan, Richard; Sweeney, Frederic D.; Panier, Stephanie; Mendez, Megan; Wildenhain, Jan; Thomson, Timothy M.; Pelletier, Laurence; Jackson, Stephen P.; Durocher, Daniel			Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; CELLULAR-RESPONSE; NUCLEAR FOCI; MDC1; ATM; CHECKPOINT; BRCA1; 53BP1; RECOGNITION	Cells respond to DNA double-strand breaks by recruiting factors such as the DNA-damage mediator protein MDC1, the p53-binding protein 1 (53BP1), and the breast cancer susceptibility protein BRCA1 to sites of damaged DNA. Here, we reveal that the ubiquitin ligase RNF8 mediates ubiquitin conjugation and 53BP1 and BRCA1 focal accumulation at sites of DNA lesions. Moreover, we establish that MDC1 recruits RNF8 through phosphodependent interactions between the RNF8 forkhead-associated domain and motifs in MDC1 that are phosphorylated by the DNA-damage activated protein kinase ataxia telangiectasia mutated ( ATM). We also show that depletion of the E2 enzyme UBC13 impairs 53BP1 recruitment to sites of damage, which suggests that it cooperates with RNF8. Finally, we reveal that RNF8 promotes the G(2)/M DNA damage checkpoint and resistance to ionizing radiation. These results demonstrate how the DNA-damage response is orchestrated by ATM- dependent phosphorylation of MDC1 and RNF8-mediated ubiquitination.	Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, Barcelona 08034, Spain	University of Cambridge; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Cambridge; University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk; durocher@mshri.on.ca	Thomson, Timothy/Z-6271-2019; Durocher, Daniel/A-7733-2010; Pelletier, Laurence/F-8858-2013; Chahwan, Richard/AAQ-9381-2021; Wildenhain, Jan/E-5597-2011; Jackson, Stephen Philip/R-4548-2019; Chapman, J Ross/C-7973-2012; OsakaU/AAY-3661-2020; 高, 雨莉/HGU-8187-2022; Wildenhain, Jan/Q-6596-2019; Dry, Kate/I-2328-2014; Panier, Stephanie/GVT-6365-2022	Thomson, Timothy/0000-0002-4670-9440; Durocher, Daniel/0000-0003-3863-8635; Chahwan, Richard/0000-0002-8672-7790; Wildenhain, Jan/0000-0002-5461-3828; Jackson, Stephen Philip/0000-0001-9317-7937; Wildenhain, Jan/0000-0002-5461-3828; Chapman, Ross/0000-0002-6477-4254; Nakada, Shinichiro/0000-0001-9297-1565	Cancer Research UK [A5290] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; KIM, 2007, SCIENCE, V316, P1202; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; PLANS V, 2007, IN PRESS ONCOGENE; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	27	694	712	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2007	318	5856					1637	1640		10.1126/science.1150034	http://dx.doi.org/10.1126/science.1150034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238BG	18006705	Green Accepted			2022-12-24	WOS:000251421700049
J	Zhao, Y; Tong, C; Jiang, J				Zhao, Yun; Tong, Chao; Jiang, Jin			Hedgehog regulates smoothened activity by inducing a conformational switch	NATURE			English	Review							PROTEIN-KINASE-A; SIGNAL-TRANSDUCTION; SONIC-HEDGEHOG; CUBITUS-INTERRUPTUS; ANIMAL DEVELOPMENT; PRIMARY CILIUM; DROSOPHILA; PHOSPHORYLATION; RECEPTOR; ENCODES	Hedgehog (HH) morphogen is essential for metazoan development. The seven-transmembrane protein smoothened (SMO) transduces the HH signal across the plasma membrane, but how SMO is activated remains poorly understood. In Drosophila melanogaster, HH induces phosphorylation at multiple Ser/Thr residues in the SMO carboxy-terminal cytoplasmic tail, leading to its cell surface accumulation and activation. Here we provide evidence that phosphorylation activates SMO by inducing a conformational switch. This occurs by antagonizing multiple Arg clusters in the SMO cytoplasmic tail. The Arg clusters inhibit SMO by blocking its cell surface expression and keeping it in an inactive conformation that is maintained by intramolecular electrostatic interactions. HH-induced phosphorylation disrupts the interaction, and induces a conformational switch and dimerization of SMO cytoplasmic tails, which is essential for pathway activation. Increasing the number of mutations in the Arg clusters progressively activates SMO. Hence, by employing multiple Arg clusters as inhibitory elements counteracted by differential phosphorylation, SMO acts as a rheostat to translate graded HH signals into distinct responses.	Univ Texas, SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, J (corresponding author), Univ Texas, SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA.	jin.jiang@utsouthwestern.edu		Tong, Chao/0000-0001-6521-5465	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM061269] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067045, R01 GM061269] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	37	218	230	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 8	2007	450	7167					252	U4		10.1038/nature06225	http://dx.doi.org/10.1038/nature06225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228RC	17960137	Bronze			2022-12-24	WOS:000250746200051
J	Folco, HD; Pidoux, AL; Urano, T; Allshire, RC				Folco, Hernan Diego; Pidoux, Alison L.; Urano, Takeshi; Allshire, Robin C.			Heterochromatin and RNAi are required to establish CENP-A chromatin at centromeres	SCIENCE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; LYSINE-9 METHYLATION; PROTEIN; RITS; PROPAGATION; DISTINCT; DOMAINS; COMPLEX; ACTS	Heterochromatin is defined by distinct posttranslational modifications on histones, such as methylation of histone H3 at lysine 9 ( H3K9), which allows heterochromatin protein 1 ( HP1)- related chromodomain proteins to bind. Heterochromatin is frequently found near CENP-A chromatin, which is the key determinant of kinetochore assembly. We have discovered that the RNA interference ( RNAi)- directed heterochromatin flanking the central kinetochore domain at fission yeast centromeres is required to promote CENP- A(Cnp1) and kinetochore assembly over the central domain. The H3K9 methyltransferase Clr4 ( Suv39); the ribonuclease Dicer, which cleaves heterochromatic double- stranded RNA to small interfering RNA ( siRNA); Chp1, a component of the RNAi effector complex ( RNA- induced initiation of transcriptional gene silencing; RITS); and Swi6 ( HP1) are required to establish CENP-A(Cnp1) chromatin on naive templates. Once assembled, CENP-A(Cnp1) chromatin is propagated by epigenetic means in the absence of heterochromatin. Thus, another, potentially conserved, role for centromeric RNAi- directed heterochromatin has been identified.	[Folco, Hernan Diego; Pidoux, Alison L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Urano, Takeshi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan	University of Edinburgh; Nagoya University	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, 6-34 Swann Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk		Allshire, Robin/0000-0002-8005-3625; Urano, Takeshi/0000-0003-3383-3554	Wellcome Trust [065061/Z, 065061] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	27	222	227	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					94	97		10.1126/science.1150944	http://dx.doi.org/10.1126/science.1150944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18174443	Green Accepted			2022-12-24	WOS:000252084000039
J	Lee, JA; Carvalho, CMB; Lupski, JR				Lee, Jennifer A.; Carvalho, Claudia M. B.; Lupski, James R.			A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders	CELL			English	Article							PELIZAEUS-MERZBACHER-DISEASE; PROTEOLIPID PROTEIN GENE; FAMILIAL PARKINSONS-DISEASE; SEVERE MENTAL-RETARDATION; GERM-CELL APOPTOSIS; COPY-NUMBER; LOCUS DUPLICATION; ESCHERICHIA-COLI; MAJOR CAUSE; MECP2 GENE	The prevailing mechanism for recurrent and some nonrecurrent rearrangements causing genomic disorders is nonallelic homologous recombination (NAHR) between region-specific low-copy repeats (LCRs). For other nonrecurrent rearrangements, nonhomologous end joining (NHEJ) is implicated. Pelizaeus-Merzbacher disease (PMD) is an X-linked dysmyelinating disorder caused most frequently (60%-70%) by nonrecurrent duplication of the dosage-sensitive proteolipid protein 1 (PLP1) gene but also by nonrecurrent deletion or point mutations. Many PLP1 duplication junctions are refractory to breakpoint sequence analysis, an observation inconsistent with a simple recombination mechanism. Our current analysis of junction sequences in PMD patients confirms the occurrence of simple tandem PLP1 duplications but also uncovers evidence for sequence complexity at some junctions. These data are consistent with a replication-based mechanism that we term FoSTeS, for replication Fork Stalling and Template Switching. We propose that complex duplication and deletion rearrangements associated with PMD, and potentially other nonrecurrent rearrangements, may be explained by this replication-based mechanism.	[Lee, Jennifer A.; Carvalho, Claudia M. B.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu			NICHD NIH HHS [HD024064, P01 HD39422] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Blanco-Rodriguez J, 2002, J ANDROL, V23, P484; Blanco-Rodriguez J, 2002, J ANDROL, V23, P182; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen JM, 2005, HUM MUTAT, V26, P362, DOI 10.1002/humu.20230; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; GORDON AJE, 1995, GENETICS, V140, P411; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kosynider B, 2007, DNA REPAIR, V6, P1850, DOI 10.1016/j.dnarep.2007.07.014; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lupski J.R., 2006, GENOMIC DISORDERS TH; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Ohno S., 1970, EVOLUTION GENE DUPLI; OHSHIMA A, 1992, P NATL ACAD SCI USA, V89, P1016, DOI 10.1073/pnas.89.3.1016; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vissers LELM, 2007, HUM GENET, V121, P697, DOI 10.1007/s00439-007-0359-6; Wojciechowska M, 2005, J BIOL CHEM, V280, P941, DOI 10.1074/jbc.M410427200; Wolf NI, 2005, BRAIN, V128, P743, DOI 10.1093/brain/awh409; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048	50	630	660	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2007	131	7					1235	1247		10.1016/j.cell.2007.11.037	http://dx.doi.org/10.1016/j.cell.2007.11.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160035	Bronze			2022-12-24	WOS:000252217200014
J	Berg, IA; Kockelkorn, D; Buckel, W; Fuchs, G				Berg, Ivan A.; Kockelkorn, Daniel; Buckel, Wolfgang; Fuchs, Georg			A 3-hydroxypropionate/4-hydroxybutyrate autotrophic carbon dioxide assimilation pathway in archaea	SCIENCE			English	Article							CO2 FIXATION PATHWAY; CHLOROFLEXUS-AURANTIACUS; GEN-NOV; CYCLE; CARBOXYLASE; COENZYME; METALLOSPHAERA; FERMENTATION; CATALYSIS	The assimilation of carbon dioxide (CO2) into organic material is quantitatively the most important biosynthetic process. We discovered that an autotrophic member of the archaeal order Sulfolobales, Metallosphaera sedula, fixed CO2 with acetyl- coenzyme A ( acetyl- CoA)/propionyl- CoA carboxylase as the key carboxylating enzyme. In this system, one acetyl-CoA and two bicarbonate molecules were reductively converted via 3- hydroxypropionate to succinyl- CoA. This intermediate was reduced to 4-hydroxybutyrate and converted into two acetyl- CoA molecules via 4-hydroxybutyryl-CoA dehydratase. The key genes of this pathway were found not only in Metallosphaera but also in Sulfolobus, Archaeoglobus, and Cenarchaeum species. Moreover, the Global Ocean Sampling database contains half as many 4-hydroxybutyryl-CoA dehydratase sequences as compared with those found for another key photosynthetic CO2-fixing enzyme, ribulose-1,5-bisphosphate carboxylase-oxygenase. This indicates the importance of this enzyme in global carbon cycling.	Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Univ Marburg, Fachbereich Biol, D-35032 Marburg, Germany	University of Freiburg; Philipps University Marburg	Fuchs, G (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020	Berg, Ivan/0000-0002-1864-4969				Alber B, 2006, J BACTERIOL, V188, P8551, DOI 10.1128/JB.00987-06; Burton NP, 1999, ARCH MICROBIOL, V172, P349, DOI 10.1007/s002030050771; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; HOLO H, 1989, ARCH MICROBIOL, V151, P252, DOI 10.1007/BF00413138; Hu YJ, 2006, J BACTERIOL, V188, P4350, DOI 10.1128/JB.00138-06; Huber H., 2001, BERGEYS MANUAL SYSTE, V1, P198; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Ishii M, 1996, ARCH MICROBIOL, V166, P368, DOI 10.1007/BF01682981; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; KANDLER O, 1981, ZBL BAKT MIK HYG I C, V2, P111, DOI 10.1016/S0721-9571(81)80034-8; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martins BM, 2004, P NATL ACAD SCI USA, V101, P15645, DOI 10.1073/pnas.0403952101; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Naser U, 2005, BIOORG CHEM, V33, P53, DOI 10.1016/j.bioorg.2004.09.001; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHERF U, 1994, ARCH MICROBIOL, V161, P239, DOI 10.1007/BF00248699; STETTER KO, 1988, SYST APPL MICROBIOL, V10, P172, DOI 10.1016/S0723-2020(88)80032-8; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; WACHTERSHAUSER G, 1990, P NATL ACAD SCI USA, V87, P200, DOI 10.1073/pnas.87.1.200; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	31	386	479	18	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2007	318	5857					1782	1786		10.1126/science.1149976	http://dx.doi.org/10.1126/science.1149976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079405				2022-12-24	WOS:000251616800044
J	Baker, JL; Olsen, LW; Sorensen, TIA				Baker, Jennifer L.; Olsen, Lina W.; Sorensen, Thorkild I. A.			Childhood body-mass index and the risk of coronary heart disease in adulthood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAUSE-SPECIFIC MORTALITY; OBESITY EPIDEMIC; FOLLOW-UP; OVERWEIGHT CHILDREN; METABOLIC SYNDROME; CAROTID-ARTERY; BIRTH COHORT; GROWTH; ASSOCIATION; ADOLESCENTS	Background: The worldwide epidemic of childhood obesity is progressing at an alarming rate. Risk factors for coronary heart disease (CHD) are already identifiable in overweight children. The severity of the long-term effects of excess childhood weight on CHD, however, remains unknown. Methods: We investigated the association between body-mass index (BMI) in childhood (7 through 13 years of age) and CHD in adulthood (25 years of age or older), with and without adjustment for birth weight. The subjects were a cohort of 276,835 Danish schoolchildren for whom measurements of height and weight were available. CHD events were ascertained by linkage to national registers. Cox regression analyses were performed. Results: In 5,063,622 person-years of follow-up, 10,235 men and 4318 women for whom childhood BMI data were available received a diagnosis of CHD or died of CHD as adults. The risk of any CHD event, a nonfatal event, and a fatal event among adults was positively associated with BMI at 7 to 13 years of age for boys and 10 to 13 years of age for girls. The associations were linear for each age, and the risk increased across the entire BMI distribution. Furthermore, the risk increased as the age of the child increased. Adjustment for birth weight strengthened the results. Conclusions: Higher BMI during childhood is associated with an increased risk of CHD in adulthood. The associations are stronger in boys than in girls and increase with the age of the child in both sexes. Our findings suggest that as children are becoming heavier worldwide, greater numbers of them are at risk of having CHD in adulthood.	Ctr Hlth & Soc, Inst Prevent Med, DK-1357 Copenhagen, Denmark		Baker, JL (corresponding author), Ctr Hlth & Soc, Inst Prevent Med, Oster Sogade 18,1st Fl, DK-1357 Copenhagen, Denmark.		Baker, Jennifer/F-1917-2010; Baker, Jennifer L./AAH-4693-2020	Baker, Jennifer/0000-0002-9649-6615; Baker, Jennifer L./0000-0002-9649-6615	NIDDK NIH HHS [F32 DK070491-02, F32DK070491, F32 DK070491] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070491] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Ahlgren M, 2004, NEW ENGL J MED, V351, P1619, DOI 10.1056/NEJMoa040576; Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; Barker D. J. P., 1994, MOTHERS BABIES DIS L; BARKER DJP, 1989, LANCET, V2, P577; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bua J, 2007, OBESITY, V15, P977, DOI 10.1038/oby.2007.603; DIPIETRO L, 1994, INT J OBESITY, V18, P585; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Juel K, 1999, DAN MED BULL, V46, P354; KUCZMARSKI RJ, 2000, DHHS PUBLICATION; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Meyer AA, 2006, PEDIATRICS, V117, P1560, DOI 10.1542/peds.2005-2140; MOSSBERG HO, 1989, LANCET, V2, P491; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Pearson Seija, 2005, Ugeskr Laeger, V167, P158; Pedersen CB, 2006, DAN MED BULL, V53, P441; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rossner S, 2002, INT J OBESITY, V26, pS2, DOI 10.1038/sj.ijo.0802209; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Sinha R, 2002, NEW ENGL J MED, V346, P1756; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; *STANB DENM, 2006, DANM STAT; Strand BH, 2007, AM J EPIDEMIOL, V165, P85, DOI 10.1093/aje/kwj352; Thomsen BL, 1999, INT J OBESITY, V23, P693, DOI 10.1038/sj.ijo.0800907; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	42	1078	1125	1	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2007	357	23					2329	2337		10.1056/NEJMoa072515	http://dx.doi.org/10.1056/NEJMoa072515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	237QA	18057335	Green Accepted			2022-12-24	WOS:000251389200003
J	Nguyen, MQ; Zhou, ZS; Marks, CA; Ryba, NJP; Belluscio, L				Nguyen, Minh Q.; Zhou, Zhishang; Marks, Carolyn A.; Ryba, Nicholas J. P.; Belluscio, Leonardo			Prominent roles for odorant receptor coding sequences in allelic exclusion	CELL			English	Article							OLFACTORY MARKER PROTEIN; MOLECULAR-CLONING; TOPOGRAPHIC MAP; AXON GUIDANCE; SENSORY MAP; EXPRESSION; MOUSE; BULB; NEURONS; SYSTEM	Mammalian odorant receptors (ORs) are crucial for establishing the functional organization of the olfactory system, but the mechanisms controlling their expression remain largely unexplained. Here, we utilized a transgenic approach to explore OR gene regulation. We determined that although olfactory sensory neurons (OSNs) are capable of supporting expression of multiple functional ORs, several levels of control ensure that each neuron normally expresses only a single odorant receptor. Surprisingly, this regulation extends beyond endogenous ORs even preventing expression of transgenes consisting of OR-coding sequences driven by synthetic promoters. Thus, part of the intrinsic feedback system must rely on elements present in the OR-coding sequence. Notably, by expressing the same transgenic ORs precociously in immature neurons, we have overcome this suppression and established a generic method to express any OR in similar to 90% of OSNs. These results provide important insights into the hierarchy of OR gene expression and the vital role of the OR-coding sequence in this regulation.	[Nguyen, Minh Q.; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; [Zhou, Zhishang; Marks, Carolyn A.; Belluscio, Leonardo] NIH, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Ryba, NJP (corresponding author), Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA.	nick.ryba@nih.gov		Marks, Carolyn/0000-0002-6665-8572; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003002] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DE000561-15, Z01 NS003002-05] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Ma MH, 1999, J NEUROSCI METH, V92, P31, DOI 10.1016/S0165-0270(99)00089-8; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Qasba P, 1998, J NEUROSCI, V18, P227; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Walters E, 1996, J NEUROSCI RES, V43, P146; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	40	102	105	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					1009	1017		10.1016/j.cell.2007.10.050	http://dx.doi.org/10.1016/j.cell.2007.10.050			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045541	Bronze, Green Accepted			2022-12-24	WOS:000251800900021
J	Warnecke, F; Luginbuhl, P; Ivanova, N; Ghassemian, M; Richardson, TH; Stege, JT; Cayouette, M; McHardy, AC; Djordjevic, G; Aboushadi, N; Sorek, R; Tringe, SG; Podar, M; Martin, HG; Kunin, V; Dalevi, D; Madejska, J; Kirton, E; Platt, D; Szeto, E; Salamov, A; Barry, K; Mikhailova, N; Kyrpides, NC; Matson, EG; Ottesen, EA; Zhang, XN; Hernandez, M; Murillo, C; Acosta, LG; Rigoutsos, I; Tamayo, G; Green, BD; Chang, C; Rubin, EM; Mathur, EJ; Robertson, DE; Hugenholtz, P; Leadbetter, JR				Warnecke, Falk; Luginbuehl, Peter; Ivanova, Natalia; Ghassemian, Majid; Richardson, Toby H.; Stege, Justin T.; Cayouette, Michelle; McHardy, Alice C.; Djordjevic, Gordana; Aboushadi, Nahla; Sorek, Rotem; Tringe, Susannah G.; Podar, Mircea; Martin, Hector Garcia; Kunin, Victor; Dalevi, Daniel; Madejska, Julita; Kirton, Edward; Platt, Darren; Szeto, Ernest; Salamov, Asaf; Barry, Kerrie; Mikhailova, Natalia; Kyrpides, Nikos C.; Matson, Eric G.; Ottesen, Elizabeth A.; Zhang, Xinning; Hernandez, Myriam; Murillo, Catalina; Acosta, Luis G.; Rigoutsos, Isidore; Tamayo, Giselle; Green, Brian D.; Chang, Cathy; Rubin, Edward M.; Mathur, Eric J.; Robertson, Dan E.; Hugenholtz, Philip; Leadbetter, Jared R.			Metagenomic and functional analysis of hindgut microbiota of a wood-feeding higher termite	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; NITROGEN-FIXATION; GUT; CELLULASES; LIGNOCELLULOSE; CLASSIFICATION; DEGRADATION; ISOPTERA; DATABASE	From the standpoints of both basic research and biotechnology, there is considerable interest in reaching a clearer understanding of the diversity of biological mechanisms employed during lignocellulose degradation. Globally, termites are an extremely successful group of wood-degrading organisms(1) and are therefore important both for their roles in carbon turnover in the environment and as potential sources of biochemical catalysts for efforts aimed at converting wood into biofuels. Only recently have data supported any direct role for the symbiotic bacteria in the gut of the termite in cellulose and xylan hydrolysis(2). Here we use a metagenomic analysis of the bacterial community resident in the hindgut paunch of a wood-feeding 'higher' Nasutitermes species ( which do not contain cellulose-fermenting protozoa) to show the presence of a large, diverse set of bacterial genes for cellulose and xylan hydrolysis. Many of these genes were expressed in vivo or had cellulase activity in vitro, and further analyses implicate spirochete and fibrobacter species in gut lignocellulose degradation. New insights into other important symbiotic functions including H-2 metabolism, CO2-reductive acetogenesis and N-2 fixation are also provided by this first system-wide gene analysis of a microbial community specialized towards plant lignocellulose degradation. Our results underscore how complex even a 1-mu l environment can be.	CALTECH, Dept Environm Sci & Engn, Pasadena, CA 91125 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Verenium Corp, San Diego, CA 92121 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Inst Nacl Biodiversidad, INBio, Santo Domingo De Heredia, Costa Rica	California Institute of Technology; United States Department of Energy (DOE); International Business Machines (IBM); United States Department of Energy (DOE); Oak Ridge National Laboratory; California Institute of Technology	Leadbetter, JR (corresponding author), CALTECH, Dept Environm Sci & Engn, Mailcode 138-78, Pasadena, CA 91125 USA.	jleadbetter@caltech.edu	Hugenholtz, Philip/AAD-9138-2019; Martin, Hector Garcia/B-5357-2009; Barry, Kerrie Whitelaw/AAA-5500-2020; Tamayo, Giselle/J-3609-2015; McHardy, Alice/ABF-2322-2020; Podar, Mircea/B-7299-2012; Tringe, Susannah Green/T-9431-2019; McHardy, Alice C/K-9377-2018; Rigoutsos, Isidore/C-5381-2012; Kyrpides, Nikos C./A-6305-2014	Hugenholtz, Philip/0000-0001-5386-7925; Martin, Hector Garcia/0000-0002-4556-9685; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Tamayo, Giselle/0000-0002-4912-8895; McHardy, Alice/0000-0003-2370-3430; Podar, Mircea/0000-0003-2776-0205; Tringe, Susannah Green/0000-0001-6479-8427; McHardy, Alice C/0000-0003-2370-3430; Kyrpides, Nikos C./0000-0002-6131-0462; Rigoutsos, Isidore/0000-0003-1529-8631; Kunin, Victor/0000-0002-8741-7866; Leadbetter, Jared/0000-0002-7033-0844; Ivanova, Natalia/0000-0002-5802-9485; Zhang, Xinning/0000-0003-2763-1526				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Austin JW, 2004, ANN ENTOMOL SOC AM, V97, P548, DOI 10.1603/0013-8746(2004)097[0548:PAOTST]2.0.CO;2; Bates PA, 2001, PROTEINS, P39; Beckwith TD, 1927, SCIENCE, V65, P165, DOI 10.1126/science.65.1676.165; Brennan Y, 2004, APPL ENVIRON MICROB, V70, P3609, DOI 10.1128/AEM.70.6.3609-3617.2004; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Brune A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P439, DOI 10.1007/0-387-30741-9_17; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860, DOI 10.1128/AEM.61.3.860-867.1995; Davies GJ, 2002, BIOCHEM SOC T, V30, P291, DOI 10.1042/BST0300291; DECAPRARIIS P, 1976, J INT ASS MATH GEOL, V8, P575; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efron B., 1994, INTRO BOOTSTRAP; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSTON D, 2002, HDB FOOD ENZYMOLOGY, P761; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Krebs C. J., 2014, ECOLOGICAL METHODOLO; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2002, PROTEINS, V48, P439, DOI 10.1002/prot.10163; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Markowitz VM, 2006, BIOINFORMATICS, V22, pE359, DOI 10.1093/bioinformatics/btl217; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; ODELSON DA, 1985, APPL ENVIRON MICROB, V49, P614, DOI 10.1128/AEM.49.3.614-621.1985; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; Ohkuma M, 2004, MOL PHYLOGENET EVOL, V31, P701, DOI 10.1016/j.ympev.2003.09.009; Pester M, 2007, ISME J, V1, P551, DOI 10.1038/ismej.2007.62; Pester M, 2006, ENVIRON MICROBIOL, V8, P1261, DOI 10.1111/j.1462-2920.2006.01020.x; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; POTRIKUS CJ, 1980, APPL ENVIRON MICROB, V40, P125, DOI 10.1128/AEM.40.1.125-132.1980; PRESTWICH GD, 1980, OECOLOGIA, V46, P397, DOI 10.1007/BF00346270; Qi M, 2005, J BACTERIOL, V187, P3739, DOI 10.1128/JB.187.11.3739-3751.2005; Ragsdale SW, 1997, BIOFACTORS, V6, P3, DOI 10.1002/biof.5520060102; Robertson DE, 2004, APPL ENVIRON MICROB, V70, P2429, DOI 10.1128/AEM.70.4.2429-2436.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sugimoto A, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P409; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Tokuda G, 2004, MOL ECOL, V13, P3219, DOI 10.1111/j.1365-294X.2004.02276.x; Tokuda G, 2007, BIOL LETTERS, V3, P336, DOI 10.1098/rsbl.2007.0073; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wei J, 2005, J PROTEOME RES, V4, P801, DOI 10.1021/pr0497632; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Xie G, 2007, APPL ENVIRON MICROB, V73, P3536, DOI 10.1128/AEM.00225-07	66	951	1017	21	506	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					560	U17		10.1038/nature06269	http://dx.doi.org/10.1038/nature06269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033299	Green Submitted			2022-12-24	WOS:000251158500050
J	Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Bianco, P; Brunello, E; Decostre, V; Stewart, A; Gore, DB; Irving, TC; Irving, M; Lombardi, V				Piazzesi, Gabriella; Reconditi, Massimo; Linari, Marco; Lucii, Leonardo; Bianco, Pasquale; Brunello, Elisabetta; Decostre, Valerie; Stewart, Alex; Gore, David B.; Irving, Thomas C.; Irving, Malcolm; Lombardi, Vincenzo			Skeletal muscle performance determined by modulation of number of myosin motors rather than motor force or stroke size	CELL			English	Article							X-RAY-DIFFRACTION; WORKING STROKE; ISOMETRIC CONTRACTION; POWER STROKE; ACTIN; HEADS; MECHANISM; FROG; GENERATION; STIFFNESS	Skeletal muscle can bear a high load at constant length, or shorten rapidly when the load is low. This force-velocity relationship is the primary determinant of muscle performance in vivo. Here we exploited the quasi-crystalline order of myosin II motors in muscle filaments to determine the molecular basis of this relationship by X-ray interference and mechanical measurements on intact single cells. We found that, during muscle shortening at a wide range of velocities, individual myosin motors maintain a force of about 6 pN while pulling an actin filament through a 6 nm stroke, then quickly detach when the motor reaches a critical conformation. Thus we show that the force-velocity relationship is primarily a result of a reduction in the number of motors attached to actin in each filament in proportion to the filament load. These results explain muscle performance and efficiency in terms of the molecular mechanism of the myosin motor.	Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; Univ Florence, Dipartimento Biol Anim & Genet, Lab Fisiol, I-50019 Sesto Fiorentino, Italy; Univ Roma La Sapienza, CRS SOFT INFM CNR, I-00185 Rome, Italy; Dexela Ltd, Spitfire Studios, London N1 9BE, England; BioCAT, Adv Photon Source, Argonne, IL 60439 USA	University of London; King's College London; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Sapienza University Rome; United States Department of Energy (DOE); Argonne National Laboratory	Irving, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	malcolm.irving@kcl.ac.uk		RECONDITI, MASSIMO/0000-0001-5065-924X; Brunello, Elisabetta/0000-0003-3167-4828; Bianco, Pasquale/0000-0002-0705-4349; LINARI, MARCO/0000-0001-6512-4897	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049033] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-08630] Funding Source: Medline; NIAMS NIH HHS [R01AR049033.03] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barclay CJ, 1998, J MUSCLE RES CELL M, V19, P855, DOI 10.1023/A:1005409708838; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; Cooke R, 1997, PHYSIOL REV, V77, P671, DOI 10.1152/physrev.1997.77.3.671; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; Decostre V, 2005, P NATL ACAD SCI USA, V102, P13927, DOI 10.1073/pnas.0506795102; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0; Holmes KC, 1997, CURR BIOL, V7, pR112, DOI 10.1016/S0960-9822(06)00051-0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1981, J PHYSIOL-LONDON, V317, pP12; Huxley AF, 1996, J MUSCLE RES CELL M, V17, P507, DOI 10.1007/BF00123366; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Huxley H, 2006, J MOL BIOL, V363, P743, DOI 10.1016/j.jmb.2006.08.075; Huxley H, 2006, J MOL BIOL, V363, P762, DOI 10.1016/j.jmb.2006.08.055; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; Irving TC, 2000, NUCL INSTRUM METH A, V448, P250, DOI 10.1016/S0168-9002(99)00732-9; Lan GH, 2005, BIOPHYS J, V88, P4107, DOI 10.1529/biophysj.104.056846; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LINARI M, 1995, J PHYSIOL-LONDON, V487, P699, DOI 10.1113/jphysiol.1995.sp020911; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 1999, J PHYSIOL-LONDON, V514, P305, DOI 10.1111/j.1469-7793.1999.305ae.x; Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Reconditi M, 2006, REP PROG PHYS, V69, P2709, DOI 10.1088/0034-4885/69/10/R01; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sleep J, 2006, P NATL ACAD SCI USA, V103, P1278, DOI 10.1073/pnas.0506272103; Smith DA, 2001, BIOPHYS J, V81, P2795, DOI 10.1016/S0006-3495(01)75922-X; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Takagi Y, 2006, BIOPHYS J, V90, P1295, DOI 10.1529/biophysj.105.068429; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5	53	222	224	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 16	2007	131	4					784	795		10.1016/j.cell.2007.09.045	http://dx.doi.org/10.1016/j.cell.2007.09.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	231RI	18022371	Bronze			2022-12-24	WOS:000250966300024
J	Basu, S; Andrews, JR; Poolman, EM; Gandhi, NR; Shah, NS; Moll, A; Moodley, P; Galvani, AP; Friedland, GH				Basu, Sanjay; Andrews, Jason R.; Poolman, Eric M.; Gandhi, Neel R.; Shah, N. Sarita; Moll, Anthony; Moodley, Prashini; Galvani, Alison P.; Friedland, Gerald H.			Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study	LANCET			English	Article							NEW-YORK-CITY; PERSONAL RESPIRATORY PROTECTION; MYCOBACTERIUM-TUBERCULOSIS; INFECTION-CONTROL; OUTBREAK; ASSAY; TB; VENTILATION; DISEASE; COMPLEX	Background Extensively drug-resistant (XDR) tuberculosis has spread among hospitalised patients in South Africa, but the epidemic-level effect of hospital-based infection control strategies remains unknown. We modelled the plausible effect of rapidly available infection control strategies on the overall course of the XDR tuberculosis epidemic in a rural area of South Africa. Methods We investigated the effect of administrative, environmental, and personal infection control measures on the epidemic trajectory of XDR tuberculosis in the rural community of Tugela Ferry. Assessments were done with a mathematical model incorporating over 2 years of longitudinal inpatient and community-based data. The model simulated inpatient airborne tuberculosis transmission, community tuberculosis transmission, and the effect of HIV and antiretroviral therapy. Findings If no new interventions are introduced, about 1300 cases of XDR tuberculosis are predicted to occur in the area of Tugela Ferry by the end of 2012, more than half of which are likely to be nosocomially transmitted. Mask use alone would avert fewer than 10% of cases in the overall epidemic, but could prevent a large proportion of cases of XDR tuberculosis in hospital staff. The combination of mask use with reduced hospitalisation time and a shift to outpatient therapy could prevent nearly a third of XDR tuberculosis cases. Supplementing this approach with improved ventilation, rapid drug resistance testing, HIV treatment, and tuberculosis isolation facilities could avert 48% of XDR tuberculosis cases (range 34-50%) by the end of 2012. However, involuntary detention could result in an unexpected rise in incidence due to restricted isolation capacity. Interpretation A synergistic combination of available nosocomial infection control strategies could prevent nearly half of XDR tuberculosis cases, even in a resource-limited setting. XDR tuberculosis transmission will probably continue in the community, indicating the need to develop and implement parallel community-based programmes.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, AIDS Program, New Haven, CT 06520 USA; Albany Med Coll, Div Gen Internal Med, Bronx, NY USA; Albany Med Coll, Div Infect Dis, Bronx, NY USA; Albany Med Coll, Div Epidemiol, Bronx, NY USA; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; Church Scotland Hosp & Philanjalo, Kwa Zulu, South Africa	Yale University; Yale University; Albany Medical College; Albany Medical College; Albany Medical College; University of Kwazulu Natal	Basu, S (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St, New Haven, CT 06520 USA.	sanjay.basu@yale.edu		Moodley, Pravi/0000-0002-9946-8783; Andrews, Jason/0000-0002-5967-251X	NIAID NIH HHS [R01 AI068932, R01 AI072706-01, R01 AI072706] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07205-32, T32 GM007205] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072706, R01AI068932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS J, 2007, THESIS YALE U; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 2006, M WHO GLOB TASK FORC; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Biscotto CR, 2005, INT J TUBERC LUNG D, V9, P545; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Cooksey RC, 1997, J CLIN MICROBIOL, V35, P1281, DOI 10.1128/JCM.35.5.1281-1283.1997; da Silva PA, 2006, CLIN MICROBIOL INFEC, V12, P293, DOI 10.1111/j.1469-0691.2005.01355.x; de Luna FFA, 2006, J CLIN MICROBIOL, V44, P3025, DOI 10.1128/JCM.00068-06; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; ESCOMBE AR, 2007, PLOS MED, V4, pE38; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Fennelly KP, 2005, INT J TUBERC LUNG D, V9, P476; Fennelly KP, 1997, CLIN CHEST MED, V18, P1, DOI 10.1016/S0272-5231(05)70352-X; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gammaitoni L, 1997, EMERG INFECT DIS, V3, P335, DOI 10.3201/eid0303.970310; GANDHI N, 2006, 16 INT C AIDS; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; MAKHAYE C, DEADLY TB UPWARD SPI; MOLL A, 2006, 16 INT AIDS C TOR; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Noakes CJ, 2006, EPIDEMIOL INFECT, V134, P1082, DOI 10.1017/S0950268806005875; RICH ML, 2003, PIH GUIDE MED MANAGE; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; *S AFR DEP HLTH, KZN OUTBR; *S AFR PRESS ASS, 2007, XDR TB FOUND ALL PRO; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SHAH NS, WORLDWIDE EMERGENCE; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; STROUD LA, 1995, INFECT CONT HOSP EP, V16, P141; VELLA V, 2007, KWAZULU NATAL EPIDEM, V15, P8; WEYER K, 2007, C RETR OPP INF LOS A; WEYER K, 2001, NATL SURVEY TUBERCUL; *WHO, 2007, GLOB MAP INF XDR TB; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; 2006, MMWR, V55, P11176	44	147	153	4	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2007	370	9597					1500	1507		10.1016/S0140-6736(07)61636-5	http://dx.doi.org/10.1016/S0140-6736(07)61636-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224ZN	17964351	Green Accepted			2022-12-24	WOS:000250487000027
J	Munch, J; Rucker, E; Standker, L; Adermann, K; Goffinet, C; Schindler, M; Wildum, S; Chinnadurai, R; Rajan, D; Specht, A; Gimenez-Gallego, G; Sanchez, PC; Fowler, DM; Koulov, A; Kelly, JW; Mothes, W; Grivel, JC; Margolis, L; Keppler, OT; Forssmann, WG; Kirchhoff, F				Muench, Jan; Ruecker, Elke; Staendker, Ludger; Adermann, Knut; Goffinet, Christine; Schindler, Michael; Wildum, Steffen; Chinnadurai, Raghavan; Rajan, Devi; Specht, Anke; Gimenez-Gallego, Guillermo; Cuevas Sanchez, Pedro; Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.; Mothes, Walther; Grivel, Jean-Charles; Margolis, Leonid; Keppler, Oliver T.; Forssmann, Wolf-Georg; Kirchhoff, Frank			Semen-derived amyloid fibrils drastically enhance HIV infection	CELL			English	Article							SEXUAL TRANSMISSION; ACID-PHOSPHATASE; VIRAL LOAD; VIRUS; PROTEIN; MEN; QUANTIFICATION; FUSION; CELLS; MODEL	Sexual intercourse is the major route of HIV transmission. To identify endogenous factors that affect the efficiency of sexual viral transmission, we screened a complex peptide/protein library derived from human semen. We show that naturally occurring fragments of the abundant semen marker prostatic acidic phosphatase (PAP) form amyloid fibrils. These fibrils, termed Semen-derived Enhancer of Virus Infection (SEVI), capture HIV virions and promote their attachment to target cells, thereby enhancing the infectious virus titer by several orders of magnitude. Physiological concentrations of SEVI amplified HIV infection of T cells, macrophages, ex vivo human tonsillar tissues, and transgenic rats in vivo, as well as trans-HIV infection of T cells by dendritic or epithelial cells. Amyloidogenic PAP fragments are abundant in seminal fluid and boost semen-mediated enhancement of HIV infection. Thus, they may play an important role in sexual transmission of HIV and could represent new targets for its prevention.	[Staendker, Ludger; Adermann, Knut; Forssmann, Wolf-Georg] IPF PharmaCeut GmbH, D-30625 Hannover, Germany; [Muench, Jan; Ruecker, Elke; Schindler, Michael; Wildum, Steffen; Chinnadurai, Raghavan; Rajan, Devi; Specht, Anke; Kirchhoff, Frank] Univ Clin Ulm, Inst Virol, D-89081 Ulm, Germany; [Staendker, Ludger; Adermann, Knut; Forssmann, Wolf-Georg] Hannover Med Sch, Ctr Pharmacol, D-30625 Hannover, Germany; [Adermann, Knut] VIRO Pharmaceut GmbH & Co KG, D-30625 Hannover, Germany; [Goffinet, Christine; Keppler, Oliver T.] Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany; [Gimenez-Gallego, Guillermo] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Cuevas Sanchez, Pedro] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Fowler, Douglas M.; Koulov, Atanas; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mothes, Walther] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; [Grivel, Jean-Charles; Margolis, Leonid] NICHHD, Bethesda, MD 20892 USA	Ulm University; Hannover Medical School; Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario Ramon y Cajal; Scripps Research Institute; Scripps Research Institute; Yale University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Forssmann, WG (corresponding author), IPF PharmaCeut GmbH, D-30625 Hannover, Germany.	wg.forssman@pharis.de; frank.kirchhoff@uniklinik-ulm.de	Goffinet, Christine/L-4878-2019; Kirchhoff, Frank/O-8367-2018; Schindler, Michael/C-1647-2015	Goffinet, Christine/0000-0002-3959-004X; Kirchhoff, Frank/0000-0002-7052-2360; Schindler, Michael/0000-0001-8989-5813; Jan, Munch/0000-0001-7316-7141; Koulov, Atanas/0000-0003-0262-7002; Wildum, Steffen/0000-0001-9779-5740; Grivel, Jean-Charles/0000-0003-0365-3181	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067057] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Collins KA, 2001, AM J FOREN MED PATH, V22, P228, DOI 10.1097/00000433-200109000-00004; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dittmar MT, 1999, AIDS RES HUM RETROV, V15, P707, DOI 10.1089/088922299310791; Evans DT, 2005, J VIROL, V79, P7707, DOI 10.1128/JVI.79.12.7707-7720.2005; Fowler Douglas M, 2006, PLoS Biol, V4, pe6; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; GRAVES HCB, 1985, NEW ENGL J MED, V312, P338, DOI 10.1056/NEJM198502073120603; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hsu M, 2003, J VIROL, V77, P989, DOI 10.1128/JVI.77.2.989-998.2003; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Keppler OT, 2002, J EXP MED, V195, P719, DOI 10.1084/jem.20011549; Kiessling Ann A, 2005, Methods Mol Biol, V304, P71; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maroun L, 2003, SCAND J UROL NEPHROL, V37, P519, DOI 10.1080/00365590310001764; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; RONNBERG L, 1981, INT J ANDROL, V4, P372, DOI 10.1111/j.1365-2605.1981.tb00721.x; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Rucker E, 2004, J VIROL, V78, P10197, DOI 10.1128/JVI.78.18.10197-10201.2004; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Sharkey DJ, 2007, MOL HUM REPROD, V13, P491, DOI 10.1093/molehr/gam028; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Tachet A, 1999, AIDS, V13, P823, DOI 10.1097/00002030-199905070-00012; TERMUSSI PA, 2003, EMBO J, V22, P355; TeviBenissan C, 1997, CLIN DIAGN LAB IMMUN, V4, P367; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	44	419	441	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1059	1071		10.1016/j.cell.2007.10.014	http://dx.doi.org/10.1016/j.cell.2007.10.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083097	Bronze			2022-12-24	WOS:000252217100015
J	Pedersen, BP; Buch-Pedersen, MJ; Morth, JP; Palmgren, MG; Nissen, P				Pedersen, Bjorn P.; Buch-Pedersen, Morten J.; Morth, J. Preben; Palmgren, Michael G.; Nissen, Poul			Crystal structure of the plasma membrane proton pump	NATURE			English	Article							H+-ATPASE; CALCIUM-PUMP; ANGSTROM RESOLUTION; ROTATION; BACTERIORHODOPSIN; SYNTHASE; BINDING; SECTOR; NMR	A prerequisite for life is the ability to maintain electrochemical imbalances across biomembranes. In all eukaryotes the plasma membrane potential and secondary transport systems are energized by the activity of P- type ATPase membrane proteins: H+-ATPase ( the proton pump) in plants and fungi(1-3), and Na+, K+-ATPase ( the sodium - potassium pump) in animals(4). The name P- type derives from the fact that these proteins exploit a phosphorylated reaction cycle intermediate of ATP hydrolysis(5). The plasma membrane proton pumps belong to the type III P- type ATPase subfamily, whereas Na+, K+-ATPase and Ca(2+-)ATPase are type II6. Electron microscopy has revealed the overall shape of proton pumps(7), however, an atomic structure has been lacking. Here we present the first structure of a P- type proton pump determined by X- ray crystallography. Ten transmembrane helices and three cytoplasmic domains define the functional unit of ATP- coupled proton transport across the plasma membrane, and the structure is locked in a functional state not previously observed in P- type ATPases. The transmembrane domain reveals a large cavity, which is likely to be filled with water, located near the middle of the membrane plane where it is lined by conserved hydrophilic and charged residues. Proton transport against a high membrane potential is readily explained by this structural arrangement.	Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus, Denmark; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Univ Copenhagen, Dept Plant Biol, Plant Physiol & Anat Lab, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen	Nissen, P (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	palmgren@life.ku.dk; pn@mb.au.dk	Morth, Jens Preben/G-4450-2013; Pedersen, Bjørn/H-4128-2017; Morth, Jens Preben/AAP-7834-2021; Palmgren, Michael/A-9808-2013; Nissen, Poul/D-5774-2014; Pedersen, Bjørn/AAT-2409-2021	Morth, Jens Preben/0000-0003-4077-0192; Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Palmgren, Michael/0000-0002-9982-6114; Pedersen, Bjørn/0000-0001-7860-7230; Nissen, Poul/0000-0003-0948-6628				Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; AMORY A, 1982, J BIOL CHEM, V257, P2509; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; BRISKIN DP, 1991, PLANT PHYSIOL, V95, P242, DOI 10.1104/pp.95.1.242; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutra MB, 1998, J BIOL CHEM, V273, P17411, DOI 10.1074/jbc.273.28.17411; ERASO P, 1994, J BIOL CHEM, V269, P10393; Fillingame RH, 2002, BBA-BIOMEMBRANES, V1565, P232, DOI 10.1016/S0005-2736(02)00572-2; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; MacLennan DH, 2002, J MOL CELL CARDIOL, V34, P897, DOI 10.1006/jmcc.2002.2031; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944	39	283	298	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1111	U19		10.1038/nature06417	http://dx.doi.org/10.1038/nature06417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075595				2022-12-24	WOS:000251579900093
J	Dunfield, PF; Yuryev, A; Senin, P; Smirnova, AV; Stott, MB; Hou, SB; Ly, B; Saw, JH; Zhou, ZM; Ren, Y; Wang, JM; Mountain, BW; Crowe, MA; Weatherby, TM; Bodelier, PLE; Liesack, W; Feng, L; Wang, L; Alam, M				Dunfield, Peter F.; Yuryev, Anton; Senin, Pavel; Smirnova, Angela V.; Stott, Matthew B.; Hou, Shaobin; Ly, Binh; Saw, Jimmy H.; Zhou, Zhemin; Ren, Yan; Wang, Jianmei; Mountain, Bruce W.; Crowe, Michelle A.; Weatherby, Tina M.; Bodelier, Paul L. E.; Liesack, Werner; Feng, Lu; Wang, Lei; Alam, Maqsudul			Methane oxidation by an extremely acidophilic bacterium of the phylum Verrucomicrobia	NATURE			English	Article							METHANOTROPHIC BACTERIA; MONOOXYGENASE OPERONS; IDENTIFICATION; METHYLOTROPHY; POPULATIONS; DIVERSITY; GENOME; KEY	Aerobic methanotrophic bacteria consume methane as it diffuses away from methanogenic zones of soil and sediment(1). They act as a biofilter to reduce methane emissions to the atmosphere, and they are therefore targets in strategies to combat global climate change. No cultured methanotroph grows optimally below pH 5, but some environments with active methane cycles are very acidic(2,3). Here we describe an extremely acidophilic methanotroph that grows optimally at pH 2.0-2.5. Unlike the known methanotrophs, it does not belong to the phylum Proteobacteria but rather to the Verrucomicrobia, a widespread and diverse bacterial phylum that primarily comprises uncultivated species with unknown genotypes. Analysis of its draft genome detected genes encoding particulate methane monooxygenase that were homologous to genes found in methanotrophic proteobacteria. However, known genetic modules for methanol and formaldehyde oxidation were incomplete or missing, suggesting that the bacterium uses some novel methylotrophic pathways. Phylogenetic analysis of its three pmoA genes ( encoding a subunit of particulate methane monooxygenase) placed them into a distinct cluster from proteobacterial homologues. This indicates an ancient divergence of Verrucomicrobia and Proteobacteria methanotrophs rather than a recent horizontal gene transfer of methanotrophic ability. The findings show that methanotrophy in the Bacteria is more taxonomically, ecologically and genetically diverse than previously thought, and that previous studies have failed to assess the full diversity of methanotrophs in acidic environments.	GNS Sci, Extremophile Res Grp, Taupo, New Zealand; Ariadne Genom Inc, Rockville, MD 20850 USA; Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; Coll Nat Sci, Honolulu, HI 96822 USA; Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300457, Peoples R China; Univ Hawaii Manoa, Biol Elect Microscopy Facil, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; Netherlands Inst Ecol, NIOO KNAW, Ctr Limnol, Dept Microbial Wetland Ecol, NL-3631 AC Nieuwersluis, Netherlands; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	GNS Science - New Zealand; University of Hawaii System; Nankai University; University of Hawaii System; University of Hawaii Manoa; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Max Planck Society	Dunfield, PF (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	p.dunfield@gns.cri.nz; wanglei@nankai.edu.cn; alam@hawaii.edu	Saw, Jimmy/J-1360-2019; Bodelier, Paul/AAF-8353-2020; feng, lu/M-5113-2015; Bodelier, Paul L/A-9591-2011; Saw, Jimmy HW/A-9972-2009; Zhou, Zhemin/AAX-5539-2020; Wang, Jianmei/HHZ-0585-2022; Dunfield, Peter F/C-3105-2009; Wang, Lei/C-5176-2009	Saw, Jimmy/0000-0001-8353-3854; Bodelier, Paul/0000-0002-5757-5572; Bodelier, Paul L/0000-0002-5757-5572; Saw, Jimmy HW/0000-0001-8353-3854; Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Liesack, Werner/0000-0002-9533-1552; Stott, Matthew/0000-0002-2082-9460; Smirnova, Angela/0000-0002-3410-8349; Senin, Pavel/0000-0001-5517-7768; Hou, Shaobin/0000-0003-3467-8242; Dunfield, Peter/0000-0002-9319-4697; Yuryev, Anton/0000-0003-1021-4849				Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Castaldi S, 2005, CHEMOSPHERE, V58, P131, DOI 10.1016/j.chemosphere.2004.08.023; Chistoserdova L, 2004, MOL BIOL EVOL, V21, P1234, DOI 10.1093/molbev/msh113; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Dedysh SN, 2002, MICROBIOLOGY+, V71, P638, DOI 10.1023/A:1021467520274; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; Dumont MG, 2005, METHOD ENZYMOL, V397, P413, DOI 10.1016/S0076-6879(05)97025-0; GIGGENBACH WF, 1994, GEOTHERMICS, V23, P599, DOI 10.1016/0375-6505(94)90022-1; Gilbert B, 2000, APPL ENVIRON MICROB, V66, P966, DOI 10.1128/AEM.66.3.966-975.2000; Holmes AJ, 1999, APPL ENVIRON MICROB, V65, P3312; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Kelly DP, 2005, TRENDS MICROBIOL, V13, P195, DOI 10.1016/j.tim.2005.03.003; Knief C, 2003, APPL ENVIRON MICROB, V69, P6703, DOI 10.1128/AEM.69.11.6703-6714.2003; Kvenvolden KA, 2005, MAR PETROL GEOL, V22, P579, DOI 10.1016/j.marpetgeo.2004.08.004; Lin JL, 2004, ENVIRON MICROBIOL, V6, P1049, DOI 10.1111/j.1462-2920.2004.00635.x; Morris SA, 2002, APPL ENVIRON MICROB, V68, P1446, DOI 10.1128/AEM.68.3.1446-1453.2002; Ricke P, 2004, APPL ENVIRON MICROB, V70, P3055, DOI 10.1128/AEM.70.5.3055-3063.2004; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Theisen AR, 2005, MOL MICROBIOL, V58, P682, DOI 10.1111/j.1365-2958.2005.04861.x; TROTSENKO YA, 1983, ACTA BIOTECHNOL, V3, P269, DOI 10.1002/abio.370030311; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Weatherby TM, 2000, ARTHROPOD STRUCT DEV, V29, P275, DOI 10.1016/S1467-8039(01)00011-1	29	382	424	12	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					879	U18		10.1038/nature06411	http://dx.doi.org/10.1038/nature06411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004300				2022-12-24	WOS:000251394900056
J	Mailand, N; Bekker-Jensen, S; Faustrup, H; Melander, F; Bartek, J; Lukas, C; Lukas, J				Mailand, Niels; Bekker-Jensen, Simon; Faustrup, Helene; Melander, Fredrik; Bartek, Jiri; Lukas, Claudia; Lukas, Jiri			RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins	CELL			English	Article							DAMAGE CHECKPOINT; H2A UBIQUITINATION; TUMOR-SUPPRESSOR; MDC1; CHROMATIN; SITES; BRCA1; 53BP1; ATM; BINDING	Accumulation of repair proteins on damaged chromosomes is required to restore genomic integrity. However, the mechanisms of protein retention at the most destructive chromosomal lesions, the DNA double-strand breaks (DSBs), are poorly understood. We show that RNF8, a RING-finger ubiquitin ligase, rapidly assembles at DSBs via interaction of its FHA domain with the phosphorylated adaptor protein MDC1. This is accompanied by an increase in DSB-associated ubiquitylations and followed by accumulation of 53BP1 and BRCA1 repair proteins. Knockdown of RNF8 or disruption of its FHA or RING domains impaired DSB-associated ubiquitylation and inhibited retention of 53BP1 and BRCA1 at the DSB sites. In addition, we show that RNF8 can ubiquitylate histone H2A and H2AX, and that its depletion sensitizes cells to ionizing radiation. These data suggest that MDC1-mediated and RNF8-executed histone ubiquitylation protects genome integrity by licensing the DSB-flanking chromatin to concentrate repair factors near the DNA lesions.	[Mailand, Niels; Bekker-Jensen, Simon; Faustrup, Helene; Melander, Fredrik; Bartek, Jiri; Lukas, Claudia; Lukas, Jiri] Ctr Genotoxic Stress Res, Inst Canc Biol, Danish Canc Soc, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Lukas, J (corresponding author), Ctr Genotoxic Stress Res, Inst Canc Biol, Danish Canc Soc, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Claudia/0000-0001-7169-6883; Kildegaard, Helene Faustrup/0000-0003-3727-5721; Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; Melander, Fredrik/0000-0002-3670-6633				Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Scott, 2001, APPL HRM RES, V6, P13; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; STRACKER TH, 2004, DNA REPAIR AMST, V3, P345; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	43	890	922	1	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 30	2007	131	5					887	900		10.1016/j.cell.2007.09.040	http://dx.doi.org/10.1016/j.cell.2007.09.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18001824	Bronze			2022-12-24	WOS:000251800900012
J	Ruban, AV; Berera, R; Ilioaia, C; van Stokkum, IHM; Kennis, JTM; Pascal, AA; van Amerongen, H; Robert, B; Horton, P; van Grondelle, R				Ruban, Alexander V.; Berera, Rudi; Ilioaia, Cristian; van Stokkum, Ivo H. M.; Kennis, John T. M.; Pascal, Andrew A.; van Amerongen, Herbert; Robert, Bruno; Horton, Peter; van Grondelle, Rienk			Identification of a mechanism of photoprotective energy dissipation in higher plants	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; PROTEINS; BINDING; PHOTOSYNTHESIS; XANTHOPHYLLS; AGGREGATION; INSIGHTS; LHCII; DYNAMICS	Under conditions of excess sunlight the efficient light-harvesting antenna(1) found in the chloroplast membranes of plants is rapidly and reversibly switched into a photoprotected quenched state in which potentially harmful absorbed energy is dissipated as heat(2,3), a process measured as the non-photochemical quenching of chlorophyll fluorescence or qE. Although the biological significance of qE is established(4-6), the molecular mechanisms involved are not(7-9). LHCII, the main light-harvesting complex, has an inbuilt capability to undergo transformation into a dissipative state by conformational change(10) and it was suggested that this provides a molecular basis for qE, but it is not known if such events occur in vivo or how energy is dissipated in this state. The transition into the dissipative state is associated with a twist in the configuration of the LHCII-bound carotenoid neoxanthin, identified using resonance Raman spectroscopy(11). Applying this technique to study isolated chloroplasts and whole leaves, we show here that the same change in neoxanthin configuration occurs in vivo, to an extent consistent with the magnitude of energy dissipation. Femtosecond transient absorption spectroscopy(12), performed on purified LHCII in the dissipative state, shows that energy is transferred from chlorophyll a to a low-lying carotenoid excited state, identified as one of the two luteins (lutein 1) in LHCII. Hence, it is experimentally demonstrated that a change in conformation of LHCII occurs in vivo, which opens a channel for energy dissipation by transfer to a bound carotenoid. We suggest that this is the principal mechanism of photoprotection.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; CEA, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; CNRS, F-91191 Gif Sur Yvette, France; Univ Wageningen & Res Ctr, Biophys Lab, NL-6700 ET Wageningen, Netherlands	University of Sheffield; University of London; Queen Mary University London; Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	bruno.robert@cea.fr; p.horton@sheffield.ac.uk; rienk@few.vu.nl	pascal, andrew a/B-6186-2014; Robert, Bruno/D-1264-2012; van Stokkum, Ivo HM/E-7175-2015; Horton, Peter/A-3958-2012; van Amerongen, Herbert/J-9483-2016	pascal, andrew a/0000-0002-1844-6065; Robert, Bruno/0000-0001-5999-4538; van Stokkum, Ivo HM/0000-0002-6143-2021; Horton, Peter/0000-0002-6095-1460; van Amerongen, Herbert/0000-0002-9783-2895; ILIOAIA, Cristian/0000-0001-7505-1900				BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Frank HA, 2000, BIOCHEMISTRY-US, V39, P2831, DOI 10.1021/bi9924664; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	30	705	718	16	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					575	U22		10.1038/nature06262	http://dx.doi.org/10.1038/nature06262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033302				2022-12-24	WOS:000251158500053
J	Vernooij, MW; Ikram, MA; Tanghe, HL; Vincent, AJPE; Hofman, A; Krestin, GP; Niessen, WJ; Breteler, MMB; van der Lugt, A				Vernooij, Meike W.; Ikram, M. Arfan; Tanghe, Herve L.; Vincent, Arnaud J. P. E.; Hofman, Albert; Krestin, Gabriel P.; Niessen, Wiro J.; Breteler, Monique M. B.; van der Lugt, Aad			Incidental findings on brain MRI in the general population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER LESIONS; UNRUPTURED INTRACRANIAL ANEURYSMS; CARDIOVASCULAR-HEALTH; NATURAL-HISTORY; ELDERLY-PEOPLE; ROTTERDAM SCAN; ASYMPTOMATIC MENINGIOMAS; CEREBRAL INFARCTION; RISK-FACTORS; STROKE	Background: Magnetic resonance imaging (MRI) of the brain is increasingly used both in research and in clinical medicine, and scanner hardware and MRI sequences are continually being improved. These advances are likely to result in the detection of unexpected, asymptomatic brain abnormalities, such as brain tumors, aneurysms, and subclinical vascular pathologic changes. We conducted a study to determine the prevalence of such incidental brain findings in the general population. Methods: The subjects were 2000 persons (mean age, 63.3 years; range, 45.7 to 96.7) from the population-based Rotterdam Study in whom high-resolution, structural brain MRI (1.5 T) was performed according to a standardized protocol. Two trained reviewers recorded all brain abnormalities, including asymptomatic brain infarcts. The volume of white-matter lesions was quantified in milliliters with the use of automated postprocessing techniques. Two experienced neuroradiologists reviewed all incidental findings. All diagnoses were based on MRI findings, and additional histologic confirmation was not obtained. Results: Asymptomatic brain infarcts were present in 145 persons (7.2%). Among findings other than infarcts, cerebral aneurysms (1.8%) and benign primary tumors (1.6%), mainly meningiomas, were the most frequent. The prevalence of asymptomatic brain infarcts and meningiomas increased with age, as did the volume of white-matter lesions, whereas aneurysms showed no age-related increase in prevalence. Conclusions: Incidental brain findings on MRI, including subclinical vascular pathologic changes, are common in the general population. The most frequent are brain infarcts, followed by cerebral aneurysms and benign primary tumors. Information on the natural course of these lesions is needed to inform clinical management.	Erasmus MC Univ Med Ctr, Dept Radiol, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Epidemiol & Biostat, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Neurosurg, NL-3015 CE Rotterdam, Netherlands; Erasmus MC Univ Med Ctr, Dept Med Informat, NL-3015 CE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Lugt, A (corresponding author), Erasmus MC Univ Med Ctr, Dept Radiol, Sgravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	a.vanderlugt@erasmusmc.nl	Ikram, M. Arfan/AAM-5225-2021; Vernooij, Meike Willemijn/E-4061-2016; Breteler, Monique M.B./J-5058-2014; Kennedy, Kristen M/B-4699-2008	Breteler, Monique M.B./0000-0002-0626-9305; Kennedy, Kristen M/0000-0001-5373-9026; Niessen, Wiro/0000-0002-5822-1995; Vernooij, Meike/0000-0003-4658-2176; Ikram, Mohammad Arfan/0000-0003-0372-8585				Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Howard G, 1998, STROKE, V29, P913, DOI 10.1161/01.STR.29.5.913; IKRAM MA, IN PRESS NEUROBIOL A; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Illes J, 2004, J MAGN RESON IMAGING, V20, P743, DOI 10.1002/jmri.20180; Illes J, 2002, BRAIN COGNITION, V50, P358, DOI 10.1016/S0278-2626(02)00532-8; INAGAWA T, 1990, SURG NEUROL, V34, P361, DOI 10.1016/0090-3019(90)90237-J; Jack CR, 1997, RADIOLOGY, V202, P17, DOI 10.1148/radiology.202.1.8988183; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P1217, DOI 10.1001/archneur.55.9.1217; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Longstreth WT, 2002, STROKE, V33, P2376, DOI 10.1161/01.STR.0000032241.58727.49; Lubman DI, 2002, ACTA PSYCHIAT SCAND, V106, P331, DOI 10.1034/j.1600-0447.2002.02217.x; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; MOSER FG, 1991, CLIN RADIOL, V43, P252, DOI 10.1016/S0009-9260(05)80249-1; Nakamura M, 2003, NEUROSURGERY, V53, P62, DOI 10.1227/01.NEU.0000068730.76856.58; NAKASU S, 1987, SURG NEUROL, V27, P319, DOI 10.1016/0090-3019(87)90005-X; Niiro M, 2000, J NEUROL NEUROSUR PS, V68, P25, DOI 10.1136/jnnp.68.1.25; OLIVERO WC, 1995, J NEUROSURG, V83, P222, DOI 10.3171/jns.1995.83.2.0222; Onizuka M, 2001, NEUROL MED-CHIR, V41, P431, DOI 10.2176/nmc.41.431; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Price TR, 1997, STROKE, V28, P1158, DOI 10.1161/01.STR.28.6.1158; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; STANECZEK W, 1992, CLIN NEUROPATHOL, V11, P135; Takanashi J, 2005, AM J NEURORADIOL, V26, P2144; Tsushima Y, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-18; VANROSSUM C, 1999, THESIS ERASMUS U ROT; Vermeer SE, 2002, STROKE, V33, P21, DOI 10.1161/hs0102.101629; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008; White PM, 2003, LANCET, V362, P90, DOI 10.1016/S0140-6736(03)13891-3; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Yue NC, 1997, RADIOLOGY, V202, P41, DOI 10.1148/radiology.202.1.8988190	45	998	1018	2	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2007	357	18					1821	1828		10.1056/NEJMoa070972	http://dx.doi.org/10.1056/NEJMoa070972			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	225OJ	17978290				2022-12-24	WOS:000250526900005
J	Contreras, M; Ceric, F; Torrealba, F				Contreras, Marco; Ceric, Francisco; Torrealba, Fernando			Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium	SCIENCE			English	Article							NEURAL SYSTEMS; CORTEX; RAT; ADDICTION; BRAIN; REINFORCEMENT; ATTENTION; AMYGDALA; STIMULI; NUCLEUS	Addiction profoundly alters motivational circuits so that drugs become powerful reinforcers of behavior. The interoceptive system continuously updates homeostatic and emotional information that are important elements in motivational decisions. We tested the idea that interoceptive information is essential in drug craving and in the behavioral signs of malaise. We inactivated the primary interoceptive cortex in amphetamine-experienced rats, which prevented the urge to seek amphetamine in a place preference task. Interoceptive insula inactivation also blunted the signs of malaise induced by acute lithium administration. Drug-seeking and malaise both induced Fos expression, a marker of neuronal activation, in the insula. We conclude that the insular cortex is a key structure in the perception of bodily needs that provides direction to motivated behaviors.	Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago 6513677, Chile	Pontificia Universidad Catolica de Chile	Torrealba, F (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago 6513677, Chile.	ftorrealba@bio.puc.cl		Ceric Garrido, Francisco/0000-0002-5526-3399; Torrealba, Fernando/0000-0002-0903-9230				Accarino AM, 1997, GASTROENTEROLOGY, V113, P415, DOI 10.1053/gast.1997.v113.pm9247458; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; BERMUDEZRATTONI F, 1991, BRAIN RES, V549, P165, DOI 10.1016/0006-8993(91)90616-4; BERNSTEIN IL, 1992, BRAIN RES, V575, P132, DOI 10.1016/0006-8993(92)90432-9; Camprodon JA, 2007, DRUG ALCOHOL DEPEN, V86, P91, DOI 10.1016/j.drugalcdep.2006.06.002; CECHETTO DF, 1987, J COMP NEUROL, V262, P27, DOI 10.1002/cne.902620104; CONTRERAS M, 2006, 36 ANN M SOC NEUR AT; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cunningham CL, 2003, PSYCHOPHARMACOLOGY, V170, P409, DOI 10.1007/s00213-003-1559-y; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Saper C. B., 2004, RAT NERVOUS SYSTEM, V3rd, P761; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; SHI CJ, 1998, J COMP NEUROL, V399, P110; Stehberg J, 2001, NEUROSCIENCE, V106, P745, DOI 10.1016/S0306-4522(01)00316-5; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Zangen A, 2002, J NEUROSCI, V22, P7225; ZITO KA, 1988, PHARMACOL BIOCHEM BE, V30, P693, DOI 10.1016/0091-3057(88)90086-X	29	230	248	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					655	658		10.1126/science.1145590	http://dx.doi.org/10.1126/science.1145590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962567				2022-12-24	WOS:000250409200050
J	Huber, D; Petreanu, L; Ghitani, N; Ranade, S; Hromadka, T; Mainen, Z; Svoboda, K				Huber, Daniel; Petreanu, Leopoldo; Ghitani, Nima; Ranade, Sachin; Hromadka, Tomas; Mainen, Zach; Svoboda, Karel			Sparse optical microstimulation in barrel cortex drives learned behaviour in freely moving mice	NATURE			English	Article							LIGHT-INDUCED ACTIVATION; ELECTRICAL-STIMULATION; NEURONS; CHANNELRHODOPSIN-2; PHOTOSTIMULATION; REPRESENTATION	Electrical microstimulation can establish causal links between the activity of groups of neurons and perceptual and cognitive functions(1-6). However, the number and identities of neurons microstimulated, as well as the number of action potentials evoked, are difficult to ascertain(7,8). To address these issues we introduced the light- gated algal channel channelrhodopsin- 2 (ChR2)(9) specifically into a small fraction of layer 2/3 neurons of the mouse primary somatosensory cortex. ChR2 photostimulation in vivo reliably generated stimulus- locked action potentials(10-13) at frequencies up to 50 Hz. Here we show that naive mice readily learned to detect brief trains of action potentials ( five light pulses, 1 ms, 20 Hz). After training, mice could detect a photostimulus firing a single action potential in approximately 300 neurons. Even fewer neurons ( approximately 60) were required for longer stimuli ( five action potentials, 250 ms). Our results show that perceptual decisions and learning can be driven by extremely brief epochs of cortical activity in a sparse subset of supragranular cortical pyramidal neurons.	[Huber, Daniel; Petreanu, Leopoldo; Ghitani, Nima; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Huber, Daniel; Petreanu, Leopoldo; Ranade, Sachin; Hromadka, Tomas; Mainen, Zach; Svoboda, Karel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679; Mainen, Zachary/0000-0001-7913-9109; Ranade, Sachin/0000-0002-5150-5776; Petreanu, Leopoldo/0000-0003-1434-4691	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Leal-Campanario R, 2006, P NATL ACAD SCI USA, V103, P10052, DOI 10.1073/pnas.0603584103; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Libet B, 1973, HDB SENSORY PHYSL, P743, DOI [10.1007/978-3-642-65438-1_20, DOI 10.1007/978-3-642-65438-1_20]; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	30	368	376	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2008	451	7174					61	U7		10.1038/nature06445	http://dx.doi.org/10.1038/nature06445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18094685	Green Accepted			2022-12-24	WOS:000252079300033
J	Hunt, T; Bergsten, J; Levkanicova, Z; Papadopoulou, A; John, OS; Wild, R; Hammond, PM; Ahrens, D; Balke, M; Caterino, MS; Gomez-Zurita, J; Ribera, I; Barraclough, TG; Bocakova, M; Bocak, L; Vogler, AP				Hunt, Toby; Bergsten, Johannes; Levkanicova, Zuzana; Papadopoulou, Anna; John, Oliver St.; Wild, Ruth; Hammond, Peter M.; Ahrens, Dirk; Balke, Michael; Caterino, Michael S.; Gomez-Zurita, Jesus; Ribera, Ignacio; Barraclough, Timothy G.; Bocakova, Milada; Bocak, Ladislav; Vogler, Alfried P.			A comprehensive phylogeny of beetles reveals the evolutionary origins of a superradiation	SCIENCE			English	Article							COLEOPTERA; DIVERSITY	Beetles represent almost one- fourth of all described species, and knowledge about their relationships and evolution adds to our understanding of biodiversity. We performed a comprehensive phylogenetic analysis of Coleoptera inferred from three genes and nearly 1900 species, representing more than 80% of the world's recognized beetle families. We defined basal relationships in the Polyphaga supergroup, which contains over 300,000 species, and established five families as the earliest branching lineages. By dating the phylogeny, we found that the success of beetles is explained neither by exceptional net diversification rates nor by a predominant role of herbivory and the Cretaceous rise of angiosperms. Instead, the pre- Cretaceous origin of more than 100 present- day lineages suggests that beetle species richness is due to high survival of lineages and sustained diversification in a variety of niches.	Nat Hist Museum, Dept Entomol, London SW7 5BD, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Palacky Univ, Dept Zool, Fac Sci, Olomouc 77146, Czech Republic; Zool Staatssammlung Munchen, D-81247 Munich, Germany; Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; IBMB CSIC, Barcelona 08034, Spain; CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Biol Evolut, E-28006 Madrid, Spain; Palacky Univ, Dept Biol, Pedagog Fac, Olomouc 77140, Czech Republic	Natural History Museum London; Imperial College London; Palacky University Olomouc; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Palacky University Olomouc	Vogler, AP (corresponding author), Nat Hist Museum, Dept Entomol, Cromwell Rd, London SW7 5BD, England.	a.vogler@imperial.ac.uk	Gomez-Zurita, Jesus/C-4248-2008; Ahrens, Dirk/AAR-1310-2021; Papadopoulou, Anna/K-5492-2014; Ribera, Ignacio/K-2909-2017; BOCAKOVA, Milada/D-5989-2018; Bocak, Ladislav/J-5989-2019	Gomez-Zurita, Jesus/0000-0001-7337-6541; Papadopoulou, Anna/0000-0002-4656-4894; Ribera, Ignacio/0000-0002-2791-7615; BOCAKOVA, Milada/0000-0002-2507-0887; Barraclough, Timothy/0000-0002-8084-2640; Hunt, Toby/0000-0001-8377-0841	Natural Environment Research Council [NE/E010962/1] Funding Source: researchfish; NERC [NE/E010962/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Beutel R.G., 2005, COLEOPTERA BEETLES, V1; Caterino MS, 2005, MOL PHYLOGENET EVOL, V34, P655, DOI 10.1016/j.ympev.2004.11.012; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; CROWSON RA, 1955, NATURAL CLASSIFICATI; Crowson RA, 1981, BIOL COLEOPTERA; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Erwin TL, 1985, TAXONOMY PHYLOGENY Z, P437; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; Ge SQ, 2007, SYST ENTOMOL, V32, P635, DOI 10.1111/j.1365-3113.2007.00392.x; GOULD SJ, 1996, DINOSAURS HAYSTACK, P377; Grimaldi David, 2005, pi; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; Lawrence J.F., 1995, P779; LAWRENCE JF, 1982, ANNU REV ECOL SYST, V13, P261, DOI 10.1146/annurev.es.13.110182.001401; Lawrence John F., 2001, Special Publication of the Japan Coleopterological Society, V1, P351; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; PAKALUK J, 1995, BIOL PHYLOGENY CLASS; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Slipinski Stanislaw A., 1991, P79; SLOWINSKI JB, 1989, AM NAT, V134, P907, DOI 10.1086/285021; Viviani VR, 2002, CELL MOL LIFE SCI, V59, P1833, DOI 10.1007/PL00012509; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]	24	684	732	13	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1913	1916		10.1126/science.1146954	http://dx.doi.org/10.1126/science.1146954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18096805				2022-12-24	WOS:000251786600056
J	Yeoh, S; O'Donnell, RA; Koussis, K; Dluzewski, AR; Ansell, KH; Osborne, SA; Hackett, F; Withers-Martinez, C; Mitchell, GH; Bannister, LH; Bryans, JS; Kettleborough, CA; Blackman, MJ				Yeoh, Sharon; O'Donnell, Rebecca A.; Koussis, Konstantinos; Dluzewski, Anton R.; Ansell, Keith H.; Osborne, Simon A.; Hackett, Fiona; Withers-Martinez, Chrislaine; Mitchell, Graham H.; Bannister, Lawrence H.; Bryans, Justin S.; Kettleborough, Catherine A.; Blackman, Michael J.			Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes	CELL			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; PARASITOPHOROUS VACUOLE ANTIGEN; DENSE GRANULES; EGRESS; SERA; CELL; PROTEOLYSIS; INHIBITION; DOMAIN; STAGE	The most virulent form of malaria is caused by waves of replication of blood stages of the protozoan pathogen Plasmodium falciparum. The parasite divides within an intraerythrocytic parasitophorous vacuole until rupture of the vacuole and host-cell membranes releases merozoites that invade fresh erythrocytes to repeat the cycle. Despite the importance of merozoite egress for disease progression, none of the molecular factors involved are known. We report that, just prior to egress, an essential serine protease called PfSUB1 is discharged from previously unrecognized parasite organelles (termed exonemes) into the parasitophorous vacuole space. There, PfSUB1 mediates the proteolytic maturation of at least two essential members of another enzyme family called SERA. Pharmacological blockade of PfSUB1 inhibits egress and ablates the invasive capacity of released merozoites. Our findings reveal the presence in the malarial parasitophorous vacuole of a regulated, PfSUB1-mediated proteolytic processing event required for release of viable parasites from the host erythrocyte.	[Yeoh, Sharon; O'Donnell, Rebecca A.; Koussis, Konstantinos; Dluzewski, Anton R.; Hackett, Fiona; Withers-Martinez, Chrislaine; Blackman, Michael J.] Natl Inst Med Res, Div Parasitol, London NE7 1AA, England; [Ansell, Keith H.; Osborne, Simon A.; Bryans, Justin S.; Kettleborough, Catherine A.] Med Res Council Technol, Drug Dicovery Grp, London NE7 1AA, England; [Mitchell, Graham H.; Bannister, Lawrence H.] Guys Kings & St Thomas Hosp Sch Biomed & Life Sci, London SE1 1UL, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, London NE7 1AA, England.	mblackm@nimr.mrc.ac.uk	Kousis, Konstantinos/K-7371-2019; Mitchell, Graham/AAA-5654-2020	Kousis, Konstantinos/0000-0002-6737-8724; Yeoh, Sharon/0000-0002-8530-1405; Mitchell, G.H./0000-0002-4922-8044	MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: Medline; Wellcome Trust [069515] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AIKAWA M, 1990, EXP PARASITOL, V71, P326, DOI 10.1016/0014-4894(90)90037-D; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; ANDERS RF, 1987, MOL STRATEGIES PARAS, P333; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Blackman MJ, 2002, BIOCHEMISTRY-US, V41, P12244, DOI 10.1021/bi0263661; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; DEBRABANT A, 1989, MOL BIOCHEM PARASIT, V33, P151, DOI 10.1016/0166-6851(89)90029-7; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Gelhaus C, 2005, BIOL CHEM, V386, P499, DOI 10.1515/BC.2005.059; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Kim K, 2004, ACTA TROP, V91, P69, DOI 10.1016/j.actaropia.2003.11.016; KNAPP B, 1991, MOL BIOCHEM PARASIT, V44, P1, DOI 10.1016/0166-6851(91)90215-R; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Li J, 2002, MOL BIOCHEM PARASIT, V120, P177, DOI 10.1016/S0166-6851(01)00452-2; Ling IT, 2003, MOL BIOCHEM PARASIT, V127, P47, DOI 10.1016/S0166-6851(02)00302-X; MCCOUBRIE JE, 2007, IN PRESS INFECT 0924, DOI DOI 10.1128/IAI.00405.07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Pang XL, 1999, INFECT IMMUN, V67, P1821; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200	33	240	244	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 14	2007	131	6					1072	1083		10.1016/j.cell.2007.10.049	http://dx.doi.org/10.1016/j.cell.2007.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GU	18083098	Bronze, Green Accepted			2022-12-24	WOS:000252217100016
J	Decaestecker, E; Gaba, S; Raeymaekers, JAM; Stoks, R; Van Kerckhoven, L; Ebert, D; De Meester, L				Decaestecker, Ellen; Gaba, Sabrina; Raeymaekers, Joost A. M.; Stoks, Robby; Van Kerckhoven, Liesbeth; Ebert, Dieter; De Meester, Luc			Host-parasite 'Red Queen' dynamics archived in pond sediment	NATURE			English	Article							NATURAL-POPULATIONS; MEDIATED SELECTION; DAPHNIA CRUSTACEA; GENETIC-VARIATION; LOCAL ADAPTATION; RAPID EVOLUTION; VIRULENCE; ECOLOGY; BANKS; SEX	Antagonistic interactions between hosts and parasites are a key structuring force in natural populations, driving coevolution(1,2). However, direct empirical evidence of long-term host-parasite coevolution, in particular `Red Queen' dynamics-in which antagonistic biotic interactions such as host-parasite interactions can lead to reciprocal evolutionary dynamics-is rare(3-5), and current data, although consistent with theories of antagonistic coevolution, do not reveal the temporal dynamics of the process(6). Dormant stages of both the water flea Daphnia and its microparasites are conserved in lake sediments, providing an archive of past gene pools. Here we use this fact to reconstruct rapid coevolutionary dynamics in a natural setting and show that the parasite rapidly adapts to its host over a period of only a few years. A coevolutionary model based on negative frequency-dependent selection, and designed to mimic essential aspects of our host parasite system, corroborated these experimental results. In line with the idea of continuing host-parasite coevolution, temporal variation in parasite infectivity changed little over time. In contrast, from the moment the parasite was first found in the sediments, we observed a steady increase in virulence over time, associated with higher fitness of the parasite.	Katholieke Univ Leuven, Lab Aquat Ecol & Evolut Biol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Anim Biodivers & Systemat, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Interdisciplinary Res Ctr, B-8500 Kortrijk, Belgium; Univ Basel, Inst Zool, CH-4053 Basel, Switzerland; INRA, UR1282, F-37380 Nouzilly, France	KU Leuven; KU Leuven; KU Leuven; University of Basel; INRAE	Decaestecker, E (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolut Biol, Charles Beriotstr 32, B-3000 Louvain, Belgium.	ellen.decaestecker@kuleuven-kortrijk.be	Ebert, Dieter/B-5502-2009; Stoks, Robby/AAK-1227-2020; Raeymaekers, Joost/J-9538-2014; Gaba, Sabrina/H-5240-2018; Decaestecker, Ellen/ABB-1242-2020; Decaestecker, Ellen/AAB-3420-2021; Ebert, Dieter/P-6134-2019; Gaba, Sabrina/N-8428-2013; De Meester, Luc/F-3832-2015; Decaestecker, Ellen/AAQ-6099-2020; Decaestecker, Ellen/M-8949-2016	Ebert, Dieter/0000-0003-2653-3772; Raeymaekers, Joost/0000-0003-2732-7495; Gaba, Sabrina/0000-0002-7145-6713; Decaestecker, Ellen/0000-0001-6328-5283; Ebert, Dieter/0000-0003-2653-3772; Gaba, Sabrina/0000-0002-7145-6713; De Meester, Luc/0000-0001-5433-6843; Decaestecker, Ellen/0000-0001-6328-5283; Stoks, Robby/0000-0003-4130-0459				Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Decaestecker E, 2003, EVOLUTION, V57, P784, DOI 10.1111/j.0014-3820.2003.tb00290.x; Decaestecker E, 2004, LIMNOL OCEANOGR, V49, P1355, DOI 10.4319/lo.2004.49.4_part_2.1355; Decaestecker E, 2002, P NATL ACAD SCI USA, V99, P5481, DOI 10.1073/pnas.082543099; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duncan AB, 2007, EVOLUTION, V61, P796, DOI 10.1111/j.1558-5646.2007.00072.x; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Fenner F., 1999, BIOL CONTROL VERTEBR; Haag CR, 2004, P ROY SOC B-BIOL SCI, V271, P2149, DOI 10.1098/rspb.2004.2841; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Harvell D, 2004, AM NAT, V164, pS1, DOI 10.1086/424611; Kerfoot WC, 2004, LIMNOL OCEANOGR, V49, P1300, DOI 10.4319/lo.2004.49.4_part_2.1300; Kosman J, 2003, J BACTERIOL, V185, P6095, DOI 10.1128/JB.185.20.6095-6103.2003; Little TJ, 1999, J ANIM ECOL, V68, P134, DOI 10.1046/j.1365-2656.1999.00271.x; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; Little TJ, 2006, EVOLUTION, V60, P31, DOI 10.1111/j.0014-3820.2006.tb01079.x; Little TJ, 2001, EVOLUTION, V55, P1146, DOI 10.1111/j.0014-3820.2001.tb00634.x; Little TJ, 2002, J EVOLUTION BIOL, V15, P1, DOI 10.1046/j.1420-9101.2002.00366.x; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Mitchell SE, 2004, ECOL LETT, V7, P848, DOI 10.1111/j.1461-0248.2004.00639.x; *R DEV COR TEAM, 2005, R PROJ STAT COMP; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; VAVREK MC, 1991, J ECOL, V79, P645, DOI 10.2307/2260659; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	31	454	458	12	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					870	U16		10.1038/nature06291	http://dx.doi.org/10.1038/nature06291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004303	Green Published			2022-12-24	WOS:000251394900054
J	Li, CY; Krishnamurthy, PC; Penmatsa, H; Marrs, KL; Wang, XQ; Zaccolo, M; Jalink, K; Li, M; Nelson, DJ; Schuetz, JD; Naren, AP				Li, Chunying; Krishnamurthy, Partha C.; Penmatsa, Himabindu; Marrs, Kevin L.; Wang, Xue Qing; Zaccolo, Manuela; Jalink, Kees; Li, Min; Nelson, Deborah J.; Schuetz, John D.; Naren, Anjaparavanda P.			Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BETA(2) ADRENERGIC-RECEPTOR; CYSTIC-FIBROSIS; CYCLIC-NUCLEOTIDES; RESISTANCE; COMPLEX; MRP4; GLUTATHIONE; EXPRESSION; SECRETION	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel localized at apical cell membranes and exists in macromolecular complexes with a variety of signaling and transporter molecules. Here, we report that the multidrug resistance protein 4 (MRP4), a cAMP transporter, functionally and physically associates with CFTR. Adenosine-stimulated CFTR-mediated chloride currents are potentiated by MRP4 inhibition, and this potentiation is directly coupled to attenuated cAMP efflux through the apical cAMP transporter. CFTR single-channel recordings and FRET-based intracellular cAMP dynamics suggest that a compartmentalized coupling of cAMP transporter and CFTR occurs via the PDZ scaffolding protein, PDZK1, forming a macromolecular complex at apical surfaces of gut epithelia. Disrupting this complex abrogates the functional coupling of cAMP transporter activity to CFTR function. Mrp4 knockout mice are more prone to CFTR-mediated secretory diarrhea. Our findings have important implications for disorders such as inflammatory bowel disease and secretory diarrhea.	[Li, Chunying; Penmatsa, Himabindu; Marrs, Kevin L.; Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Krishnamurthy, Partha C.; Schuetz, John D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Wang, Xue Qing; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Zaccolo, Manuela] Vet Inst Mol Med, Dulbecco Telethon Inst, I-35124 Padua, Italy; [Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Netherlands Cancer Institute; Johns Hopkins University	Naren, AP (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	anaren@utmem.edu	Zaccolo, Manuela/B-3802-2011; Schuetz, John D/N-2692-2018; Zaccolo, Manuela/AAP-6706-2020	Zaccolo, Manuela/0000-0002-0934-3662; Jalink, Kees/0000-0001-7019-3440	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI070942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK058545, R01DK074996, R01DK093045] Funding Source: NIH RePORTER; NIAID NIH HHS [R03 AI070942-01A1, R03 AI070942] Funding Source: Medline; NIDDK NIH HHS [R01 DK074996, R01 DK074996-01, R01 DK058545-01A2, R01 DK058545, R01 DK058545-04, R01 DK080834, R01 DK058545-05, R01 DK074996-02, R01 DK058545-03, R01 DK058545-02, R01 DK093045] Funding Source: Medline; Telethon [TCR05005] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon)		Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lai LQ, 2002, BIOCHEM J, V361, P497, DOI 10.1042/0264-6021:3610497; LAMPRECHT G, 2006, LIVER PHYSL, V291, pG766; LAMPRECHT G, 2006, BIOCHEM J, V291, pG766; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Lohi H, 2002, AM J PHYSIOL-GASTR L, V283, pG567, DOI 10.1152/ajpgi.00356.2001; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Reddy MM, 1996, AM J PHYSIOL-CELL PH, V270, pC474, DOI 10.1152/ajpcell.1996.270.2.C474; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Stelzner M, 2001, BMC Gastroenterol, V1, P10, DOI 10.1186/1471-230X-1-10; Umar S, 2000, AM J PHYSIOL-GASTR L, V278, pG753, DOI 10.1152/ajpgi.2000.278.5.G753; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200	29	155	158	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					940	951		10.1016/j.cell.2007.09.037	http://dx.doi.org/10.1016/j.cell.2007.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18045536	Green Accepted, Bronze			2022-12-24	WOS:000251800900016
J	Sun, J; Pang, ZP; Qin, D; Fahim, AT; Adachi, R; Sudhof, TC				Sun, Jianyuan; Pang, Zhiping P.; Qin, Dengkui; Fahim, Abigail T.; Adachi, Roberto; Suedhof, Thomas C.			A dual-Ca2+-sensor model for neurotransmitter release in a central synapse	NATURE			English	Article							SHORT-TERM DEPRESSION; CALCIUM-CHANNEL TYPES; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; ASYNCHRONOUS RELEASE; DETERMINES FAST; CA2+ CHANNELS; CALYX; MODULATION; SENSOR	Ca2+-triggered synchronous neurotransmitter release is well described, but asynchronous release-in fact, its very existence-remains enigmatic. Here we report a quantitative description of asynchronous neurotransmitter release in calyx-of-Held synapses. We show that deletion of synaptotagmin 2 (Syt2) in mice selectively abolishes synchronous release, allowing us to study pure asynchronous release in isolation. Using photolysis experiments of caged Ca2+, we demonstrate that asynchronous release displays a Ca2+ cooperativity of similar to 2 with a Ca2+ affinity of similar to 44 mu M, in contrast to synchronous release, which exhibits a Ca2+ cooperativity of similar to 5 with a Ca2+ affinity of similar to 38 mu M. Our results reveal that release triggered in wild-type synapses at low Ca2+ concentrations is physiologically asynchronous, and that asynchronous release completely empties the readily releasable pool of vesicles during sustained elevations of Ca2+. We propose a dual-Ca2+-sensor model of release that quantitatively describes the contributions of synchronous and asynchronous release under conditions of different presynaptic Ca2+ dynamics.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu	Pang, Zhiping/AAF-5757-2020	Adachi, Roberto/0000-0002-0146-0768; Fahim, Abigail/0000-0001-9737-054X; Pang, Zhiping/0000-0002-6183-1233	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Atluri PP, 1998, J NEUROSCI, V18, P8214; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Chuhma N, 2002, J NEUROPHYSIOL, V87, P222, DOI 10.1152/jn.00235.2001; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Ravin R, 1997, J PHYSIOL-LONDON, V501, P251, DOI 10.1111/j.1469-7793.1997.tb00001.x; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2006, P NATL ACAD SCI USA, V103, P2880, DOI 10.1073/pnas.0511300103; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Wu LG, 1999, J NEUROSCI, V19, P726; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	43	260	265	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					676	U4		10.1038/nature06308	http://dx.doi.org/10.1038/nature06308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046404	Green Accepted			2022-12-24	WOS:000251209700046
J	Lin, RC; Ding, L; Casola, C; Ripoll, DR; Feschotte, C; Wang, HY				Lin, Rongcheng; Ding, Lei; Casola, Claudio; Ripoll, Daniel R.; Feschotte, Cedric; Wang, Haiyang			Transposase-derived transcription factors regulate light signaling in Arabidopsis	SCIENCE			English	Article							PHYTOCHROME-A PHOTORECEPTOR; NUCLEAR ACCUMULATION; FHY1; FAR1; EVOLUTION; FHL	Plants use light to optimize growth and development. The photoreceptor phytochrome A ( phyA) mediates various far-red light-induced responses. We show that Arabidopsis FHY3 and FAR1, which encode two proteins related to Mutator-like transposases, act together to modulate phyA signaling by directly activating the transcription of FHY1 and FHL, whose products are essential for light-induced phyA nuclear accumulation and subsequent light responses. FHY3 and FAR1 have separable DNA binding and transcriptional activation domains that are highly conserved in Mutator-like transposases. Further, expression of FHY3 and FAR1 is negatively regulated by phyA signaling. We propose that FHY3 and FAR1 represent transcription factors that have been co-opted from an ancient Mutator-like transposase(s) to modulate phyA-signaling homeostasis in higher plants.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Univ Texas, Dept Biol, Arlington, TX 76019 USA; Cornell Univ, Computat Biol Serv Unit, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; University of Texas System; University of Texas Arlington; Cornell University	Wang, HY (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.	hw75@cornell.edu	Feschotte, Cedric/C-4048-2011; Lin, Rongcheng/I-8105-2014	Lin, Rongcheng/0000-0001-8346-3390; Casola, Claudio/0000-0003-4853-1866	NIGMS NIH HHS [R01 GM077582, R01 GM077582-01A1, R01 GM77582-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077582] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen T, 2006, PLANT CELL, V18, P2506, DOI 10.1105/tpc.105.037358; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Desnos T, 2001, GENE DEV, V15, P2980, DOI 10.1101/gad.205401; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Hiltbrunner A, 2006, PLANT CELL PHYSIOL, V47, P1023, DOI 10.1093/pcp/pcj087; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Lin RC, 2004, PLANT PHYSIOL, V136, P4010, DOI 10.1104/pp.104.052191; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Mathews S, 2005, J HERED, V96, P197, DOI 10.1093/jhered/esi032; Miller WJ, 1999, GENETICA, V107, P197, DOI 10.1023/A:1004070603792; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Neff MM, 2000, GENE DEV, V14, P257; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Zhou QQ, 2005, PLANT J, V43, P356, DOI 10.1111/j.1365-313X.2005.02453.x	21	316	343	7	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1302	1305		10.1126/science.1146281	http://dx.doi.org/10.1126/science.1146281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	18033885	Green Accepted			2022-12-24	WOS:000251086600044
J	Chamero, P; Marton, TF; Logan, DW; Flanagan, K; Cruz, JR; Saghatelian, A; Cravatt, BF; Stowers, L				Chamero, Pablo; Marton, Tobias F.; Logan, Darren W.; Flanagan, Kelly; Cruz, Jason R.; Saghatelian, Alan; Cravatt, Benjamin F.; Stowers, Lisa			Identification of protein pheromones that promote aggressive behaviour	NATURE			English	Article							MAJOR URINARY PROTEINS; MUTANT MICE; VOMERONASAL NEURONS; HOUSE MOUSE; SIGNALS; SYSTEM; GENES; TRP2	Mice use pheromones, compounds emitted and detected by members of the same species, as cues to regulate social behaviours such as pup suckling, aggression and mating(1). Neurons that detect pheromones are thought to reside in at least two separate organs within the nasal cavity: the vomeronasal organ (VNO) and the main olfactory epithelium (MOE)(2). Each pheromone ligand is thought to activate a dedicated subset of these sensory neurons. However, the nature of the pheromone cues and the identity of the responding neurons that regulate specific social behaviours are largely unknown. Here we show, by direct activation of sensory neurons and analysis of behaviour, that at least two chemically distinct ligands are sufficient to promote male-male aggression and stimulate VNO neurons. We have purified and analysed one of these classes of ligand and found its specific aggression-promoting activity to be dependent on the presence of the protein component of the major urinary protein (MUP) complex, which is known to comprise specialized lipocalin proteins bound to small organic molecules(1,3,4). Using calcium imaging of dissociated vomeronasal neurons (VNs), we have determined that the MUP protein activates a sensory neuron subfamily characterized by the expression of the G-protein G alpha(o) subunit ( also known as Gnao) and Vmn2r putative pheromone receptors (V2Rs). Genomic analysis indicates species-specific co-expansions of MUPs and V2Rs, as would be expected among pheromone-signalling components. Finally, we show that the aggressive behaviour induced by the MUPs occurs exclusively through VNO neuronal circuits. Our results substantiate the idea of MUP proteins as pheromone ligands that mediate male-male aggression through the accessory olfactory neural pathway.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92030 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92030 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Scripps Research Institute; Scripps Research Institute; Harvard University	Stowers, L (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92030 USA.	stowers@scripps.edu	Logan, Darren/D-5629-2009; Stowers, Lisa/K-6137-2015	Logan, Darren/0000-0003-1545-5510; Chamero, Pablo/0000-0002-4305-1073; Stowers, Lisa/0000-0002-4403-1269				BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; Cavaggioni A, 2000, BBA-PROTEIN STRUCT M, V1482, P218, DOI 10.1016/S0167-4838(00)00149-7; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Flower DR, 1996, BIOCHEM J, V318, P1; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; MUGFORD RA, 1970, NATURE, V226, P967, DOI 10.1038/226967a0; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Robertson DHL, 1997, RAPID COMMUN MASS SP, V11, P786, DOI 10.1002/(SICI)1097-0231(19970422)11:7<786::AID-RCM876>3.0.CO;2-8; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Xia J, 2006, EUR J NEUROSCI, V24, P3333, DOI 10.1111/j.1460-9568.2006.05244.x	24	389	399	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					899	U23		10.1038/nature05997	http://dx.doi.org/10.1038/nature05997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064011				2022-12-24	WOS:000251394900060
J	Rawashdeh, O; de Borsetti, NH; Roman, G; Cahill, GM				Rawashdeh, Oliver; de Borsetti, Nancy Hernandez; Roman, Gregg; Cahill, Gregory M.			Melatonin suppresses nighttime memory formation in zebrafish	SCIENCE			English	Article							LONG-TERM POTENTIATION; CIRCADIAN-RHYTHMS; MODULATION; PINEALECTOMY; RECEPTORS	Memory processes are modulated by the biological clock, although the mechanisms are unknown. Here, we report that in the diurnal zebrafish both learning and memory formation of an operant conditioning paradigm occur better during the day than during the night. Melatonin treatment during the day mimics the nighttime suppression of memory formation. Training in constant light improves nighttime memory formation while reducing endogenous melatonin concentrations. Treatment with melatonin receptor antagonists at night dramatically improves memory. Pinealectomy also significantly improves nighttime memory formation. We adduce that melatonin is both sufficient and necessary for poor memory formation during the night.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Roman, G (corresponding author), Univ Houston, Dept Biol & Biochem, 369 Sci & Res 2, Houston, TX 77204 USA.	gwroman@central.uh.edu	Rawashdeh, Oliver/N-7400-2016; Roman, Gregg/W-1586-2019	Rawashdeh, Oliver/0000-0002-7147-4778; Roman, Gregg/0000-0003-1519-4699	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060939] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60939] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BOLLIET V, 1995, J NEUROENDOCRINOL, V7, P535, DOI 10.1111/j.1365-2826.1995.tb00790.x; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; DUBOCOVICH ML, 1988, J PHARMACOL EXP THER, V246, P902; FEKETE M, 1985, PHYSIOL BEHAV, V34, P883, DOI 10.1016/0031-9384(85)90008-3; FOA A, 1992, J PINEAL RES, V12, P109, DOI 10.1111/j.1600-079X.1992.tb00036.x; Hogan MV, 2001, J PINEAL RES, V30, P87, DOI 10.1034/j.1600-079X.2001.300204.x; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; KEZUKA H, 1992, ZOOL SCI, V9, P1047; Lyon LC, 2005, P NATL ACAD SCI USA, V102, P12589, DOI 10.1073/pnas.0503847102; MELKE J, 2007, MOL PSYCHIAT, V1; MORGAN PJ, 1994, NEUROCHEM INT, V24, P101, DOI 10.1016/0197-0186(94)90100-7; Okimoto DK, 1999, GEN COMP ENDOCR, V114, P293, DOI 10.1006/gcen.1999.7258; Ozcan M, 2006, BRAIN RES, V1111, P90, DOI 10.1016/j.brainres.2006.06.117; Wan Q, 1999, NAT NEUROSCI, V2, P401, DOI 10.1038/8062; Wang LM, 2005, EUR J NEUROSCI, V22, P2231, DOI 10.1111/j.1460-9568.2005.04408.x; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1	18	111	116	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1144	1146		10.1126/science.1148564	http://dx.doi.org/10.1126/science.1148564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006748				2022-12-24	WOS:000250957900048
J	Froemke, RC; Merzenich, MM; Schreiner, CE				Froemke, Robert C.; Merzenich, Michael M.; Schreiner, Christoph E.			A synaptic memory trace for cortical receptive field plasticity	NATURE			English	Article							PRIMARY AUDITORY-CORTEX; BASAL FOREBRAIN NEURONS; NUCLEUS BASALIS; ACETYLCHOLINE; MODULATION; MECHANISMS; ATTENTION; RAT	Receptive fields of sensory cortical neurons are plastic, changing in response to alterations of neural activity or sensory experience(1-12). In this way, cortical representations of the sensory environment can incorporate new information about the world, depending on the relevance or value of particular stimuli(1,6,9). Neuromodulation is required for cortical plasticity, but it is uncertain how subcortical neuromodulatory systems, such as the cholinergic nucleus basalis, interact with and refine cortical circuits(13-24). Here we determine the dynamics of synaptic receptive field plasticity in the adult primary auditory cortex ( also known as AI) using in vivo whole-cell recording. Pairing sensory stimulation with nucleus basalis activation shifted the preferred stimuli of cortical neurons by inducing a rapid reduction of synaptic inhibition within seconds, which was followed by a large increase in excitation, both specific to the paired stimulus. Although nucleus basalis was stimulated only for a few minutes, reorganization of synaptic tuning curves progressed for hours thereafter: inhibition slowly increased in an activity-dependent manner to rebalance the persistent enhancement of excitation, leading to a retuned receptive field with new preference for the paired stimulus. This restricted period of disinhibition may be a fundamental mechanism for receptive field plasticity, and could serve as a memory trace(9,25) for stimuli or episodes that have acquired new behavioural significance.	Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, Dept Otolaryngol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Froemke, RC (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	rfroemke@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328; Froemke, Robert/0000-0002-1230-6811	NIDCD NIH HHS [R01 DC002260-12, R01 DC002260] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gritti I, 2003, J COMP NEUROL, V458, P11, DOI 10.1002/cne.10505; Hromadka T, 2007, HEARING RES, V229, P180, DOI 10.1016/j.heares.2007.01.002; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; METHERATE R, 1992, J NEUROSCI, V12, P4701; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; RICHARDSON RT, 1988, TRENDS NEUROSCI, V11, P264, DOI 10.1016/0166-2236(88)90107-5; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; WOODY CD, 1987, BRAIN RES, V424, P193, DOI 10.1016/0006-8993(87)91210-8; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zhang YF, 2006, CEREB CORTEX, V16, P1258, DOI 10.1093/cercor/bhj067	30	406	408	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 15	2007	450	7168					425	429		10.1038/nature06289	http://dx.doi.org/10.1038/nature06289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231AM	18004384	Green Submitted			2022-12-24	WOS:000250918600056
J	Amanna, IJ; Carlson, NE; Slifka, MK				Amanna, Ian J.; Carlson, Nichole E.; Slifka, Mark K.			Duration of humoral immunity to common viral and vaccine antigens	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEMORY B-CELLS; SERUM ANTIBODY-LEVELS; IMMUNOLOGICAL MEMORY; PLASMA-CELLS; SMALLPOX VACCINATION; RHEUMATOID-ARTHRITIS; BONE-MARROW; IMMUNIZATION; TETANUS; MAINTENANCE	Background Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. Methods We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels. Results Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested. Conclusions These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.	Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Dept Publ Hlth & Preventat Med, Div Biostat, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	slifkam@ohsu.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Amanna, Ian/0000-0001-7545-4013	NCRR NIH HHS [RR000334, RR024140, P51 RR000163, UL1 RR024140, M01 RR000334, RR000163] Funding Source: Medline; NIA NIH HHS [P01 AG023664] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG023664] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; BOJLEN K, 1955, Dan Med Bull, V2, P70; Cambridge G, 2003, ARTHRITIS RHEUM-US, V48, P2146, DOI 10.1002/art.11181; *CDCP, 2006, EP PREV VACC PREV DI; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; GOTTLIEB S, 1964, AM J PUBLIC HEALTH N, V54, P961, DOI 10.2105/AJPH.54.6.961; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; HERRMANN KL, 1982, JAMA-J AM MED ASSOC, V247, P193, DOI 10.1001/jama.247.2.193; Hopkins RJ, 2004, CLIN INFECT DIS, V39, P759, DOI 10.1086/422998; IPSEN J, 1946, J IMMUNOL, V54, P325; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; MACK TM, 1972, AM J TROP MED HYG, V21, P214, DOI 10.4269/ajtmh.1972.21.214; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Nanan R, 2001, VACCINE, V20, P498, DOI 10.1016/S0264-410X(01)00328-0; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Parker AA, 2006, NEW ENGL J MED, V355, P1184; Parker AA, 2006, NEW ENGL J MED, V355, P447, DOI 10.1056/NEJMoa060775; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9; Simonsen O, 1996, APMIS, V104, P921, DOI 10.1111/j.1699-0463.1996.tb04959.x; SIMONSEN O, 1987, VACCINE, V5, P115, DOI 10.1016/0264-410X(87)90057-0; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Slifka MK, 1996, ANN NY ACAD SCI, V797, P166, DOI 10.1111/j.1749-6632.1996.tb52958.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slifka MK, 1996, TRENDS MICROBIOL, V4, P394, DOI 10.1016/0966-842X(96)10059-7; SLIFKA MK, 1996, THESIS U CALIFORNIA; Traggiai E, 2003, VACCINE, V21, pS35, DOI 10.1016/S0264-410X(03)00198-1; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wolters K. L., 1942, ZEITSCHR HYG U INJEKTIONSKRANKH, V124, P326, DOI 10.1007/BF02178438; Zinkernagel RM, 1996, ANNU REV IMMUNOL, V14, P333, DOI 10.1146/annurev.immunol.14.1.333	41	785	799	3	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1903	1915		10.1056/NEJMoa066092	http://dx.doi.org/10.1056/NEJMoa066092			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989383				2022-12-24	WOS:000250732500005
J	Raizen, DM; Zimmerman, JE; Maycock, MH; Ta, UD; You, YJ; Sundaram, MV; Pack, AI				Raizen, David M.; Zimmerman, John E.; Maycock, Matthew H.; Ta, Uyen D.; You, Young-Jai; Sundaram, Meera V.; Pack, Allan I.			Lethargus is a Caenorhabditis elegans sleep-like state	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; C-ELEGANS; DROSOPHILA-MELANOGASTER; NEMATODE; BEHAVIOR; REST	There are fundamental similarities between sleep in mammals and quiescence in the arthropod Drosophila melanogaster, suggesting that sleep- like states are evolutionarily ancient(1-3). The nematode Caenorhabditis elegans also has a quiescent behavioural state during a period called lethargus, which occurs before each of the four moults(4). Like sleep, lethargus maintains a constant temporal relationship with the expression of the C. elegans Period homologue LIN-42 ( ref. 5). Here we show that quiescence associated with lethargus has the additional sleep- like properties of reversibility, reduced responsiveness and homeostasis. We identify the cGMP-dependent protein kinase ( PKG) gene egl- 4 as a regulator of sleep-like behaviour, and show that egl- 4 functions in sensory neurons to promote the C. elegans sleep- like state. Conserved effects on sleep- like behaviour of homologous genes in C. elegans and Drosophila suggest a common genetic regulation of sleep- like states in arthropods and nematodes. Our results indicate that C. elegans is a suitable model system for the study of sleep regulation. The association of this C. elegans sleep- like state with developmental changes that occur with larval moults suggests that sleep may have evolved to allow for developmental changes.	[Raizen, David M.; Zimmerman, John E.; Maycock, Matthew H.; Ta, Uyen D.; Pack, Allan I.] Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; [Raizen, David M.; Ta, Uyen D.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Sundaram, Meera V.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Pack, Allan I.] Univ Penn, Sch Med, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA; [You, Young-Jai] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas	Raizen, DM (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, 3400 Spruce St, Philadelphia, PA 19104 USA.	raizen@mail.med.upenn.edu	PhD/K-3106-2019; Raizen, David/ABB-1478-2020	you, young/0000-0002-5716-5418; Pack, Allan/0000-0002-2879-0484; Sundaram, Meera/0000-0002-2940-8750				AVERY L, 1993, GENETICS, V133, P897; Barger AJ, 1998, J NEUROSCI, V18, P2871; Borbely A A, 1982, Hum Neurobiol, V1, P195; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Charlie NK, 2006, GENETICS, V173, P111, DOI 10.1534/genetics.105.054007; Ewer John, 2002, P1; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; KALDERON D, 1989, J BIOL CHEM, V264, P10738; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; RANKIN CH, 1991, J COMP PHYSIOL A, V169, P59; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; TRACHSEL L, 1991, PHYSIOL BEHAV, V49, P575, DOI 10.1016/0031-9384(91)90283-T; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995	30	307	319	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2008	451	7178					569	U6		10.1038/nature06535	http://dx.doi.org/10.1038/nature06535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256OQ	18185515				2022-12-24	WOS:000252739900041
J	Becker, CG; Fonseca, CR; Haddad, CFB; Batista, RF; Prado, PI				Becker, Carlos Guilherme; Fonseca, Carlos Roberto; Baptista Haddad, Celio Fernando; Batista, Romulo Fernandes; Prado, Paulo Inacio			Habitat split and the global decline of amphibians	SCIENCE			English	Article							ECOLOGICAL TRAITS; BIODIVERSITY; CONSERVATION; POPULATIONS; EXTINCTIONS; LANDSCAPE; DISEASE; BRAZIL	The worldwide decline in amphibians has been attributed to several causes, especially habitat loss and disease. We identified a further factor, namely "habitat split"- defined as human- induced disconnection between habitats used by different life history stages of a species- which forces forest- associated amphibians with aquatic larvae to make risky breeding migrations between suitable aquatic and terrestrial habitats. In the Brazilian Atlantic Forest, we found that habitat split negatively affects the richness of species with aquatic larvae but not the richness of species with terrestrial development ( the latter can complete their life cycle inside forest remnants). This mechanism helps to explain why species with aquatic larvae have the highest incidence of population decline. These findings reinforce the need for the conservation and restoration of riparian vegetation.	Univ Vale Rio dos Sinos, Lab Interacao Anim Planta, BR-93022970 Sao Leopoldo, RS, Brazil; Univ Estadual Campinas, Dept Zool, BR-13083970 Campinas, SP, Brazil; Univ Estadual Paulista, Dept Zool, BR-13506900 Rio Claro, SP, Brazil; Secretaria Estadual Meio Ambiente & Desenvolvimen, BR-69050030 Manaus, Amazonas, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508900 Sao Paulo, Brazil	Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo	Fonseca, CR (corresponding author), Univ Vale Rio dos Sinos, Lab Interacao Anim Planta, BR-93022970 Sao Leopoldo, RS, Brazil.	cfonseca@unisinos.br	Fonseca, Carlos Roberto/A-9273-2013; Fonseca, Carlos Roberto/V-5869-2017; Haddad, Célio F. B./C-4267-2012; Becker, C. Guilherme/B-9887-2014; Prado, Paulo Inácio/AAN-6512-2021; Prado, Paulo I/G-3353-2012	Fonseca, Carlos Roberto/0000-0003-0292-0399; Haddad, Célio F. B./0000-0002-7044-5764; Prado, Paulo Inácio/0000-0002-7174-5005; 				Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Amezaga JM, 2002, ACTA OECOL, V23, P213, DOI 10.1016/S1146-609X(02)01152-9; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Bustarnante MR, 2005, BIOTROPICA, V37, P180, DOI 10.1111/j.1744-7429.2005.00025.x; CAROLSFELD J, 2004, MIGRATORY FISHES S A; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; *IUCN, CONS INT NATURESERVE; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; MAC ARTHUR ROBERT H., 1967; Mazerolle MJ, 2005, CAN J ZOOL, V83, P455, DOI 10.1139/Z05-032; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mendelson JR, 2006, SCIENCE, V314, P1541; Mittermeier R, 2005, HOTSPOTS REVISITED E; Pounds JA, 2006, SCIENCE, V314, P1541, DOI 10.1126/science.314.5805.1541; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Silvano DL, 2005, CONSERV BIOL, V19, P653, DOI 10.1111/j.1523-1739.2005.00681.x; VIANA V.M., 1997, TROPICAL FOREST REMN, P347; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070	29	408	444	4	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2007	318	5857					1775	1777		10.1126/science.1149374	http://dx.doi.org/10.1126/science.1149374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240VR	18079402				2022-12-24	WOS:000251616800041
J	Cunningham, JT; Rodgers, JT; Arlow, DH; Vazquez, F; Mootha, VK; Puigserver, P				Cunningham, John T.; Rodgers, Joseph T.; Arlow, Daniel H.; Vazquez, Francisca; Mootha, Vamsi K.; Puigserver, Pere			mTOR controls mitochondrial oxidative function through a YY1-PGC-1 alpha transcriptional complex	NATURE			English	Article							INSULIN-RESISTANCE; AMINO-ACID; ERR-ALPHA; METABOLISM; GENES; CELL; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; SIROLIMUS	Transcriptional complexes that contain peroxisome-proliferator-activated receptor coactivator (PGC)-1 alpha control mitochondrial oxidative function to maintain energy homeostasis in response to nutrient and hormonal signals(1,2). An important component in the energy and nutrient pathways is mammalian target of rapamycin (mTOR), a kinase that regulates cell growth, size and survival(3-5). However, it is unknown whether and how mTOR controls mitochondrial oxidative activities. Here we show that mTOR is necessary for the maintenance of mitochondrial oxidative function. In skeletal muscle tissues and cells, the mTOR inhibitor rapamycin decreased the gene expression of the mitochondrial transcriptional regulators PGC-1 alpha, oestrogen-related receptor a and nuclear respiratory factors, resulting in a decrease in mitochondrial gene expression and oxygen consumption. Using computational genomics, we identified the transcription factor yin-yang 1 (YY1) as a common target of mTOR and PGC-1 alpha. Knockdown of YY1 caused a significant decrease in mitochondrial gene expression and in respiration, and YY1 was required for rapamycin-dependent repression of those genes. Moreover, mTOR and raptor interacted with YY1, and inhibition of mTOR resulted in a failure of YY1 to interact with and be coactivated by PGC-1 alpha. We have therefore identified a mechanism by which a nutrient sensor (mTOR) balances energy metabolism by means of the transcriptional control of mitochondrial oxidative function. These results have important implications for our understanding of how these pathways might be altered in metabolic diseases and cancer.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Puigserver, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	vamsi@hms.harvard.edu; pere_puigserver@dfci.harvard.edu	Cunningham, John T./AAS-5008-2021; Vazquez, Francisca/ABC-4620-2020	Cunningham, John T./0000-0001-6490-4533; Rodgers, Joseph/0000-0002-6598-5520				Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ribes D, 2005, TRANSPL P, V37, P2813, DOI 10.1016/j.transproceed.2005.05.029; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	30	1025	1061	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					736	U12		10.1038/nature06322	http://dx.doi.org/10.1038/nature06322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046414				2022-12-24	WOS:000251209700057
J	Miller, SE; Collins, BM; Mccoy, AJ; Robinson, MS; Owen, DJ				Miller, Sharon E.; Collins, Brett M.; Mccoy, Airlie J.; Robinson, Margaret S.; Owen, David J.			A SNARE-adaptor interaction is a new mode of cargo recognition in clathrin-coated vesicles	NATURE			English	Article							HOMOLOGY ENTH DOMAINS; TRANS-GOLGI NETWORK; MEMBRANE; PROTEINS; COMPLEX; FUSION; SIGNAL; EPSIN; LOCALIZATION; REFINEMENT	Soluble NSF attachment protein receptors (SNAREs) are type II transmembrane proteins that have critical roles in providing the specificity and energy for transport-vesicle fusion and must therefore be correctly partitioned between vesicle and organelle membranes(1-3). Like all other cargo, SNAREs need to be sorted into the forming vesicles by direct interaction with components of the vesicles' coats. Here we characterize the molecular details governing the sorting of a SNARE into clathrin-coated vesicles, namely the direct recognition of the three-helical bundle H-abc domain of the mouse SNARE Vti1b by the human clathrin adaptor epsinR (EPNR, also known as CLINT1). Structures of each domain and of their complex show that this interaction ( dissociation constant 22 mu M) is mediated by surface patches composed of approximately 15 residues each, the topographies of which are dependent on each domain's overall fold. Disruption of the interface with point mutations abolishes the interaction in vitro and causes Vti1b to become relocalized to late endosomes and lysosomes. This new class of highly specific, surface-surface interaction between the clathrin coat component and the cargo is distinct from the widely observed binding of short, linear cargo motifs by the assembly polypeptide (AP) complex and GGA adaptors(4) and is therefore not vulnerable to competition from standard motif-containing cargoes for incorporation into clathrin-coated vesicles. We propose that conceptually similar but mechanistically different interactions will direct the post-Golgi trafficking of many SNAREs.	Univ Cambridge, CIMR, Cambridge CB2 0XY, England; Univ Queensland, IMB, St Lucia, Qld 4075, Australia	University of Cambridge; University of Queensland	Owen, DJ (corresponding author), Univ Cambridge, CIMR, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	msr12@mole.bio.cam.ac.uk; djo30@cam.ac.uk	Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; KRISSINEL E, 2005, DETECTION PROTEIN AS; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	38	96	98	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					570	U21		10.1038/nature06353	http://dx.doi.org/10.1038/nature06353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	18033301				2022-12-24	WOS:000251158500052
J	Yapici, N; Kim, YJ; Ribeiro, C; Dickson, BJ				Yapici, Nilay; Kim, Young-Joon; Ribeiro, Carlos; Dickson, Barry J.			A receptor that mediates the post-mating switch in Drosophila reproductive behaviour	NATURE			English	Article							MELANOGASTER SEX-PEPTIDE; MALE COURTSHIP BEHAVIOR; FUNCTIONAL EXPRESSION; HELICOVERPA-ARMIGERA; FMRFAMIDE RECEPTOR; MOLECULAR-CLONING; SEMINAL PEPTIDES; NEURAL CIRCUITRY; FEMALE; IDENTIFICATION	Mating in many species induces a dramatic switch in female reproductive behaviour. In most insects, this switch is triggered by factors present in the male's seminal fluid. How these factors exert such profound effects in females is unknown. Here we identify a receptor for the Drosophila melanogaster sex peptide (SP, also known as Acp70A), the primary trigger of post- mating responses in this species. Females that lack the sex peptide receptor (SPR, also known as CG16752), either entirely or only in the nervous system, fail to respond to SP and continue to show virgin behaviours even after mating. SPR is expressed in the female's reproductive tract and central nervous system. The behavioural functions of SPR map to the subset of neurons that also express the fruitless gene, a key determinant of sex- specific reproductive behaviour. SPR is highly conserved across insects, opening up the prospect of new strategies to control the reproductive and host- seeking behaviours of agricultural pests and human disease vectors.	[Yapici, Nilay; Kim, Young-Joon; Ribeiro, Carlos; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Ribeiro, Carlos/0000-0002-9542-7335; Kim, Young-Joon/0000-0002-7990-754X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 1996, J INSECT PHYSIOL, V42, P1007, DOI 10.1016/S0022-1910(96)00070-4; Cheng CC, 1998, APPL ACOUST, V54, P291, DOI 10.1016/S0003-682X(97)00093-5; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fan YL, 1999, J INSECT PHYSIOL, V45, P127, DOI 10.1016/S0022-1910(98)00106-1; Fan YL, 2000, INSECT BIOCHEM MOLEC, V30, P805, DOI 10.1016/S0965-1748(00)00052-7; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harshman LG, 1999, J INSECT PHYSIOL, V45, P571, DOI 10.1016/S0022-1910(99)00038-4; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Kvitsiani D, 2006, CURR BIOL, V16, pR355, DOI 10.1016/j.cub.2006.04.025; Le Poul E, 2002, J BIOMOL SCREEN, V7, P57, DOI 10.1089/108705702753520341; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ottiger M, 2000, J NEUROBIOL, V44, P57; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Peng J, 2005, CURR BIOL, V15, P207, DOI 10.1016/j.cub.2005.01.034; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; Schlote, 1984, DROS INFORM SERV, V60, P210; SCHMIDT T, 1993, J INSECT PHYSIOL, V39, P361, DOI 10.1016/0022-1910(93)90023-K; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Vernon WI, 2002, BIOTECHNIQUES, V33, P730, DOI 10.2144/02334bm02	45	340	355	7	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2008	451	7174					33	U1		10.1038/nature06483	http://dx.doi.org/10.1038/nature06483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247KZ	18066048				2022-12-24	WOS:000252079300026
J	Vasudevan, S; Tong, YC; Steitz, JA				Vasudevan, Shobha; Tong, Yingchun; Steitz, Joan A.			Switching from repression to activation: MicroRNAs can up-regulate translation	SCIENCE			English	Article							MESSENGER-RNA DEGRADATION; SIRNAS; MIRNAS	AU- rich elements ( AREs) and microRNA target sites are conserved sequences in messenger RNA ( mRNA) 3' untranslated regions ( 3' UTRs) that control gene expression posttranscriptionally. Upon cell cycle arrest, the ARE in tumor necrosis factor-alpha ( TNF alpha) mRNA is transformed into a translation activation signal, recruiting Argonaute ( AGO) and fragile X mental retardation- related protein 1 ( FXR1), factors associated with micro- ribonucleoproteins ( microRNPs). We show that human microRNA miR369-3 directs association of these proteins with the AREs to activate translation. Furthermore, we document that two well- studied microRNAs- Let- 7 and the synthetic microRNA miRcxcr4- likewise induce translation up-regulation of target mRNAs on cell cycle arrest, yet they repress translation in proliferating cells. Thus, activation is a common function of microRNPs on cell cycle arrest. We propose that translation regulation by microRNPs oscillates between repression and activation during the cell cycle.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Mol Biophys & Biochem,Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu	Huang, H/E-9490-2010					Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Khabar KSA, 2005, GENOMICS, V85, P165, DOI 10.1016/j.ygeno.2004.10.004; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	13	2040	2204	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2007	318	5858					1931	1934		10.1126/science.1149460	http://dx.doi.org/10.1126/science.1149460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HE	18048652				2022-12-24	WOS:000251786600061
J	Pol, A; Heijmans, K; Harhangi, HR; Tedesco, D; Jetten, MSM; den Camp, HJMO				Pol, Arjan; Heijmans, Klaas; Harhangi, Harry R.; Tedesco, Dario; Jetten, Mike S. M.; den Camp, Huub J. M. Op			Methanotrophy below pH1 by a new Verrucomicrobia species	NATURE			English	Article							MOSBY MUD VOLCANO; PMOA-LIKE GENE; SP NOV.; METHANE MONOOXYGENASE; METHYLOCYSTIS STRAIN; ACTIVATED-SLUDGE; BACTERIA; DIVERSITY; ENVIRONMENT; SEQUENCE	Mud volcanoes, mudpots and fumaroles are remarkable geological features characterized by the emission of gas, water and/or semi-liquid mud matrices(1) with significant methane fluxes to the atmosphere ( 10(-1) to 10(3) ty(-1))(2-4). Environmental conditions in these areas vary from ambient temperature and neutral pH to high temperatures and low pH. Although there are strong indications for biological methane consumption in mud volcanoes(4,5), no methanotrophic bacteria are known that would thrive in the hostile conditions of fumaroles ( temperatures up to 70 degrees C and pH down to 1.8)(2). The first step in aerobic methane oxidation is performed by a soluble or membrane-bound methane mono-oxygenase. Here we report that pmoA ( encoding the beta-subunit of membrane-bound methane mono-oxygenase) clone libraries, made by using DNA extracted from the Solfatara volcano mudpot and surrounding bare soil near the fumaroles, showed clusters of novel and distant pmoA genes. After methanotrophic enrichment at 50 degrees C and pH 2.0 the most distant cluster, sharing less than 50% identity with any other described pmoA gene, was represented in the culture. Finally we isolated an acidiphilic methanotrophic bacterium Acidimethylosilex fumarolicum SolV belonging to the Planctomycetes/Verrucomicrobia/Chlamydiae superphylum(6), 'outside' the subphyla of the Alpha- and Gammaproteobacteria containing the established methanotrophs. This bacterium grows under oxygen limitation on methane as the sole source of energy, down to pH 0.8-far below the pH optimum of any previously described methanotroph. A. fumarolicum SolV has three different pmoA genes, with two that are very similar to sequences retrieved from the mudpot. Highly homologous environmental 16S rRNA gene sequences from Yellowstone Park show that this new type of methanotrophic bacteria may be a common inhabitant of extreme environments. This is the first time that a representative of the widely distributed Verrucomicrobia phylum, of which most members remain uncultivated(6), is coupled to a geochemically relevant reaction.	Radboud Univ Nijmegen, Dept Microbiol, IWWR, NL-6525 ED Nijmegen, Netherlands; Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy	Radboud University Nijmegen; Universita della Campania Vanvitelli	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, IWWR, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.jetten@science.ru.nl; h.opdencamp@science.ru.nl	Jetten, Mike/B-8834-2011; Camp, Huub J.M. Op den/F-5114-2011	Jetten, Mike/0000-0002-4691-7039; Camp, Huub J.M. Op den/0000-0003-1990-9030				Alain K, 2006, ENVIRON MICROBIOL, V8, P574, DOI 10.1111/j.1462-2920.2005.00922.x; Castaldi S, 2005, CHEMOSPHERE, V58, P131, DOI 10.1016/j.chemosphere.2004.08.023; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dedysh SN, 2004, INT J SYST EVOL MICR, V54, P151, DOI 10.1099/ijs.0.02805-0; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Dedysh SN, 2000, INT J SYST EVOL MICR, V50, P955, DOI 10.1099/00207713-50-3-955; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; Dimitrov LI, 2002, EARTH-SCI REV, V59, P49, DOI 10.1016/S0012-8252(02)00069-7; Dunfield PF, 2002, FEMS MICROBIOL ECOL, V41, P17, DOI 10.1111/j.1574-6941.2002.tb00962.x; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Houghton J, 2005, REP PROG PHYS, V68, P1343, DOI 10.1088/0034-4885/68/6/R02; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Stoecker K, 2006, P NATL ACAD SCI USA, V103, P2363, DOI 10.1073/pnas.0506361103; Trotsenko YA, 2002, ARCH MICROBIOL, V177, P123, DOI 10.1007/s00203-001-0368-0; Visser JM, 1997, ANTON LEEUW INT J G, V72, P127, DOI 10.1023/A:1000252126252; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Ward N, 2004, PLOS BIOL, V2, P1616, DOI 10.1371/journal.pbio.0020303; Yimga MT, 2003, APPL ENVIRON MICROB, V69, P5593, DOI 10.1128/AEM.69.9.5593-5602.2003; [No title captured]	30	273	303	7	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					874	U17		10.1038/nature06222	http://dx.doi.org/10.1038/nature06222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18004305				2022-12-24	WOS:000251394900055
J	Nishimura, Y; Onoe, H; Morichika, Y; Perfiliev, S; Tsukada, H; Isa, T				Nishimura, Yukio; Onoe, Hirotaka; Morichika, Yosuke; Perfiliev, Sergei; Tsukada, Hideo; Isa, Tadashi			Time-dependent central compensatory mechanisms of finger dexterity after spinal cord injury	SCIENCE			English	Article							PRIMARY MOTOR CORTEX; DISYNAPTIC PYRAMIDAL EXCITATION; VENTRAL PREMOTOR CORTEX; PROPRIOSPINAL NEURONS; BRAIN-INJURY; FORELIMB MOTONEURONS; CORTICAL PLASTICITY; FUNCTIONAL RECOVERY; SUPPLEMENTARY MOTOR; MACAQUE MONKEY	Transection of the direct cortico-motoneuronal pathway at the mid-cervical segment of the spinal cord in the macaque monkey results in a transient impairment of finger movements. Finger dexterity recovers within a few months. Combined brain imaging and reversible pharmacological inactivation of motor cortical regions suggest that the recovery involves the bilateral primary motor cortex during the early recovery stage and more extensive regions of the contralesional primary motor cortex and bilateral premotor cortex during the late recovery stage. These changes in the activation pattern of frontal motor-related areas represent an adaptive strategy for functional compensation after spinal cord injury.	Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan; RIKEN, Mol Imaging Res Program, Funct Probe Res Lab, Kobe, Hyogo 6500047, Japan; Univ Gothenburg, Dept Physiol, SE-40530 Gothenburg, Sweden; Cent Res Inst Hamamatsu Photon, Hamamatsu, Shizuoka 4348601, Japan; Grad Univ Adv Studies SOKENDAI, Hayama 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); RIKEN; University of Gothenburg; Hamamatsu Photonics; Graduate University for Advanced Studies - Japan	Isa, T (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	tisa@nips.ac.jp						Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; Buford JA, 2004, EXP BRAIN RES, V159, P284, DOI 10.1007/s00221-004-1956-4; Cerri G, 2003, J NEUROPHYSIOL, V90, P832, DOI 10.1152/jn.01026.2002; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Davidson AG, 2006, EXP BRAIN RES, V173, P25, DOI 10.1007/s00221-006-0374-1; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; ILLERT M, 1978, EXP BRAIN RES, V33, P101; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Jankowska E, 2006, J PHYSIOL-LONDON, V575, P527, DOI 10.1113/jphysiol.2006.112425; Jankowska E, 2005, J NEUROSCI, V25, P7401, DOI 10.1523/JNEUROSCI.1838-05.2005; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Lacroix S, 2004, J COMP NEUROL, V473, P147, DOI 10.1002/cne.20051; MARTINO AM, 1987, BRAIN RES, V404, P307, DOI 10.1016/0006-8993(87)91384-9; Nair DG, 2007, NEUROIMAGE, V34, P253, DOI 10.1016/j.neuroimage.2006.09.010; Nishimura Y, 2007, NEUROSCI RES, V59, P243, DOI 10.1016/j.neures.2007.07.003; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Schmidlin E, 2004, BRAIN RES, V1017, P172, DOI 10.1016/j.brainres.2004.05.036; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119	27	169	178	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2007	318	5853					1150	1155		10.1126/science.1147243	http://dx.doi.org/10.1126/science.1147243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OC	18006750				2022-12-24	WOS:000250957900050
J	Miller, SP; McQuillen, PS; Hamrick, S; Xu, D; Glidden, DV; Charlton, N; Karl, T; Azakie, A; Ferriero, DM; Barkovich, AJ; Vigneron, DB				Miller, Steven P.; McQuillen, Patrick S.; Hamrick, Shannon; Xu, Duan; Glidden, David V.; Charlton, Natalie; Karl, Tom; Azakie, Anthony; Ferriero, Donna M.; Barkovich, A. James; Vigneron, Daniel B.			Abnormal brain development in newborns with congenital heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHITE-MATTER DEVELOPMENT; CEREBRAL-BLOOD-FLOW; CIRCULATORY ARREST; PREMATURE NEWBORNS; MR SPECTROSCOPY; WATER DIFFUSION; ARTERIAL SWITCH; YOUNG-CHILDREN; INJURY; TRANSPOSITION	Background Congenital heart disease in newborns is associated with global impairment in development. We characterized brain metabolism and microstructure, as measures of brain maturation, in newborns with congenital heart disease before they underwent heart surgery. Methods We studied 41 term newborns with congenital heart disease - 29 who had transposition of the great arteries and 12 who had single-ventricle physiology - with the use of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and diffusion tensor imaging (DTI) before cardiac surgery. We calculated the ratio of N-acetylaspartate to choline (which increases with brain maturation), the ratio of lactate to choline (which decreases with maturation), average diffusivity (which decreases with maturation), and fractional anisotropy of white-matter tracts (which increases with maturation). We compared these findings with those in 16 control newborns of a similar gestational age. Results As compared with control newborns, those with congenital heart disease had a decrease of 10% in the ratio of N-acetylaspartate to choline (P=0.003), an increase of 28% in the ratio of lactate to choline (P=0.08), an increase of 4% in average diffusivity (P<0.001), and a decrease of 12% in white-matter fractional anisotropy (P<0.001). Preoperative brain injury, as seen on MRI, was not significantly associated with findings on MRS or DTI. White-matter injury was observed in 13 newborns with congenital heart disease (32%) and in no control newborns. Conclusions Term newborns with congenital heart disease have widespread brain abnormalities before they undergo cardiac surgery. The imaging findings in such newborns are similar to those in premature newborns and may reflect abnormal brain development in utero.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; Emory University	Miller, SP (corresponding author), British Columbia Childrens Hosp, Div Neurol, K3-180,4480 Oak St, Vancouver, BC V6H 3V4, Canada.	smiller6@cw.bc.ca	McQuillen, Patrick/AAF-7119-2020; Glidden, David/AAD-4730-2020; Xu, Duan/B-3197-2013; Xu, Duan/GMW-4195-2022	Xu, Duan/0000-0003-0550-4235; Glidden, David/0000-0001-5888-1419; McQuillen, Patrick/0000-0002-8837-364X; Miller, Steven/0000-0001-9102-9105	NCRR NIH HHS [5-M01-RR-01271] Funding Source: Medline; NINDS NIH HHS [P50 NS35902, R01 NS40117] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, R01NS040117] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Bartha AL, 2007, AM J NEURORADIOL, V28, P1015, DOI 10.3174/ajnr.A0521; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Bland JM, 1996, BRIT MED J, V312, P700; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Donofrio MT, 2003, PEDIATR CARDIOL, V24, P436, DOI 10.1007/s00246-002-0404-0; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; DUMOULIN CL, 2002, MAGN RESON ENG, V15, P117; Galli KK, 2004, J THORAC CARDIOV SUR, V127, P692, DOI 10.1016/j.jtcvs.2003.09.053; GILLES FH, 1973, J NEUROPATH EXP NEUR, V32, P179; GLAUSER TA, 1990, PEDIATRICS, V85, P984; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506; Jouannic JM, 2002, ULTRASOUND OBST GYN, V20, P122, DOI 10.1046/j.1469-0705.2002.00756.x; Karl TR, 2004, J THORAC CARDIOV SUR, V127, P213, DOI 10.1016/j.jtcvs.2003.06.001; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kinney HC, 2005, ACTA NEUROPATHOL, V110, P563, DOI 10.1007/s00401-005-1077-6; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; Limperopoulos C, 2002, J PEDIATR-US, V141, P51, DOI 10.1067/mpd.2002.125227; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; Mahle WT, 2002, CIRCULATION, V106, pI109, DOI 10.1161/01.cir.0000032908.33237.b1; Marshall AC, 2005, J PEDIATR-US, V147, P535, DOI 10.1016/j.jpeds.2005.04.055; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McQuillen PS, 2007, STROKE, V38, P736, DOI 10.1161/01.STR.0000247941.41234.90; McQuillen PS, 2006, CIRCULATION, V113, P280, DOI 10.1161/CIRCULATIONAHA.105.566752; McQuillen PS, 2003, J NEUROSCI, V23, P3308; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2005, J PEDIATR-US, V146, P453, DOI 10.1016/j.jpeds.2004.12.026; Miller SP, 2004, ANN THORAC SURG, V77, P1698, DOI 10.1016/j.athoracsur.2003.10.084; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Miller SP, 2002, PEDIATR RES, V52, P71, DOI 10.1203/00006450-200207000-00014; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Partridge SC, 2006, ANN NEUROL, V59, P640, DOI 10.1002/ana.20772; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Prayer D, 2001, AM J NEURORADIOL, V22, P1572; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Rudolph AM, 2001, CONGENITAL DIS HEART, V2nd; Star-Lack J, 1998, J MAGN RESON, V133, P243, DOI 10.1006/jmre.1998.1458; Vigneron DB, 2006, NEUROIMAG CLIN N AM, V16, P75, DOI 10.1016/j.nic.2005.11.008; Vigneron DB, 2001, AM J NEURORADIOL, V22, P1424; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	50	540	555	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2007	357	19					1928	1938		10.1056/NEJMoa067393	http://dx.doi.org/10.1056/NEJMoa067393			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228LX	17989385				2022-12-24	WOS:000250732500007
J	Cherezov, V; Rosenbaum, DM; Hanson, MA; Rasmussen, SGF; Thian, FS; Kobilka, TS; Choi, HJ; Kuhn, P; Weis, WI; Kobilka, BK; Stevens, RC				Cherezov, Vadim; Rosenbaum, Daniel M.; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Kuhn, Peter; Weis, William I.; Kobilka, Brian K.; Stevens, Raymond C.			High-resolution crystal structure of an engineered human beta(2)-adrenergic G protein-coupled receptor	SCIENCE			English	Article							BETA-ADRENERGIC-RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; MOLECULAR-MECHANISM; LIGAND-BINDING; ACTIVATION; RHODOPSIN; CRYSTALLIZATION; MEMBRANE; AGONIST; MODELS	Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors constitute the largest family of eukaryotic signal transduction proteins that communicate across the membrane. We report the crystal structure of a human beta(2)-adrenergic receptor-T4 lysozyme fusion protein bound to the partial inverse agonist carazolol at 2.4 angstrom resolution. The structure provides a high-resolution view of a human G protein-coupled receptor bound to a diffusible ligand. Ligand-binding site accessibility is enabled by the second extracellular loop, which is held out of the binding cavity by a pair of closely spaced disulfide bridges and a short helical segment within the loop. Cholesterol, a necessary component for crystallization, mediates an intriguing parallel association of receptor molecules in the crystal lattice. Although the location of carazolol in the beta(2)-adrenergic receptor is very similar to that of retinal in rhodopsin, structural differences in the ligand-binding site and other regions highlight the challenges in using rhodopsin as a template model for this large receptor family.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Stanford University; Scripps Research Institute; Stanford University; Scripps Research Institute	Stevens, RC (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	kobilka@stanford.edu; stevens@scripps.edu	Weis, William I/G-1437-2011; soler, martha maricel m gomez/L-6025-2014; Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015	Weis, William I/0000-0002-5583-6150; soler, martha maricel m gomez/0000-0002-4412-8108; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Kobilka, Brian/0000-0001-5958-3990; Choi, Hee-Jung/0000-0002-1167-1526; Rasmussen, Soren/0000-0002-1853-1841	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, R01GM089857, R21GM075811, F32GM082028, R01GM075915, P50GM073197, U54GM074961, P50GM062411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER; NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NIGMS NIH HHS [P50 GM073197-04, U54 GM074961-030001, R01 GM056169, R01 GM089857, Y1-GM-1104, F32 GM082028, P50 GM073197, U54 GM074961, GM075915, R21 GM075811, P50 GM062411] Funding Source: Medline; NINDS NIH HHS [R01 NS028471, NS028471, R37 NS028471] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BAI TR, 1992, LUNG, V170, P125; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARNES PJ, 1993, LIFE SCI, V52, P2101, DOI 10.1016/0024-3205(93)90725-I; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2006, J MOL BIOL, V364, P716, DOI 10.1016/j.jmb.2006.09.022; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; DeLano W.L., PYMOL MOL GRAPHICS S; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Fano A, 2006, J CHEM INF MODEL, V46, P1223, DOI 10.1021/ci050490k; Freddolino PL, 2004, P NATL ACAD SCI USA, V101, P2736, DOI 10.1073/pnas.0308751101; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Furse KE, 2003, J MED CHEM, V46, P4450, DOI 10.1021/jm0301437; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gouldson PR, 2004, PROTEINS, V56, P67, DOI 10.1002/prot.20108; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hein L, 1997, TRENDS CARDIOVAS MED, V7, P137, DOI 10.1016/S1050-1738(97)00034-0; Hobrath JV, 2006, J MED CHEM, V49, P4470, DOI 10.1021/jm0501634; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Landau EM, 2003, FEBS LETT, V555, P51, DOI 10.1016/S0014-5793(03)01082-2; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; NODA K, 1994, J BIOL CHEM, V269, P6743; Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8; Nowak M, 2006, J MED CHEM, V49, P205, DOI 10.1021/jm050826h; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rohrer DK, 1998, J MOL MED-JMM, V76, P764, DOI 10.1007/s001090050278; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schertler GFX, 2005, CURR OPIN STRUC BIOL, V15, P408, DOI 10.1016/j.sbi.2005.07.010; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Smiley R M, 1996, J Matern Fetal Med, V5, P106; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiang Y, 2005, RECEPTORS, P267; Yao ZP, 2005, ANAL BIOCHEM, V343, P344, DOI 10.1016/j.ab.2005.05.002; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013	67	2659	2750	8	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1258	1265		10.1126/science.1150577	http://dx.doi.org/10.1126/science.1150577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962520	Green Accepted			2022-12-24	WOS:000251086600033
J	Frank, MJ; Samanta, J; Moustafa, AA; Sherman, SJ				Frank, Michael J.; Samanta, Johan; Moustafa, Ahmed A.; Sherman, Scott J.			Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism	SCIENCE			English	Article							HIGH-FREQUENCY STIMULATION; OPTIMAL DECISION-MAKING; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; COGNITIVE CONTROL; REACTION-TIME; SELECTION; CHOICE; DOPAMINE; DISEASE	Deep brain stimulation (DBS) of the subthalamic nucleus markedly improves the motor symptoms of Parkinson's disease, but causes cognitive side effects such as impulsivity. We showed that DBS selectively interferes with the normal ability to slow down when faced with decision conflict. While on DBS, patients actually sped up their decisions under high-conflict conditions. This form of impulsivity was not affected by dopaminergic medication status. Instead, medication impaired patients' ability to learn from negative decision outcomes. These findings implicate independent mechanisms leading to impulsivity in treated Parkinson's patients and were predicted by a single neurocomputational model of the basal ganglia.	Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; Univ Arizona, Program Neurosci, Tucson, AZ 85721 USA; Banner Good Samaritan Med Ctr, Phoenix, AZ 85004 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; Banner Research; Banner Health; University of Arizona	Frank, MJ (corresponding author), Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA.	mfrank@u.arizona.edu	Moustafa, Ahmed/AAM-2836-2021; Frank, Michael J/B-2979-2008	Moustafa, Ahmed/0000-0001-5971-273X				Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 2007, EUR J NEUROSCI, V25, P1187, DOI 10.1111/j.1460-9568.2007.05373.x; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; Benazzouz A, 2000, NEUROLOGY, V55, pS13; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Cools R, 2006, NEUROPSYCHOLOGIA, V44, P1663, DOI 10.1016/j.neuropsychologia.2006.03.030; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Drapier S, 2005, J NEUROL, V252, P583, DOI 10.1007/s00415-005-0704-4; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; LIU Y, 2006, NEUROSCI BIOBEHAV RE; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Orieux G, 2002, J NEUROSCI, V22, P8762; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Saint-Cyr JA, 2006, NEUROLOGY, V66, P1799, DOI 10.1212/01.wnl.0000227468.17113.07; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Simen P, 2006, NEURAL NETWORKS, V19, P1013, DOI 10.1016/j.neunet.2006.05.038; Thobois S, 2007, J CEREBR BLOOD F MET, V27, P1173, DOI 10.1038/sj.jcbfm.9600425; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Winstanley CA, 2005, EUR J NEUROSCI, V21, P3107, DOI 10.1111/j.1460-9568.2005.04143.x	35	759	778	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2007	318	5854					1309	1312		10.1126/science.1146157	http://dx.doi.org/10.1126/science.1146157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962524				2022-12-24	WOS:000251086600046
J	Kobayakawa, K; Kobayakawa, R; Matsumoto, H; Oka, Y; Imai, T; Ikawa, M; Okabe, M; Ikeda, T; Itohara, S; Kikusui, T; Mori, K; Sakano, H				Kobayakawa, Ko; Kobayakawa, Reiko; Matsumoto, Hideyuki; Oka, Yuichiro; Imai, Takeshi; Ikawa, Masahito; Okabe, Masaru; Ikeda, Toshio; Itohara, Shigeyoshi; Kikusui, Takefumi; Mori, Kensaku; Sakano, Hitoshi			Innate versus learned odour processing in the mouse olfactory bulb	NATURE			English	Article							PREDATOR ODOR; C-ELEGANS; EXPRESSION; MICE; BEHAVIOR; NEURONS; RECEPTORS; ACCURACY; FAMILY; SPEED	The mammalian olfactory system mediates various responses, including aversive behaviours to spoiled foods and fear responses to predator odours. In the olfactory bulb, each glomerulus represents a single species of odorant receptor. Because a single odorant can interact with several different receptor species, the odour information received in the olfactory epithelium is converted to a topographical map of multiple glomeruli activated in distinct areas in the olfactory bulb. To study how the odour map is interpreted in the brain, we generated mutant mice in which olfactory sensory neurons in a specific area of the olfactory epithelium are ablated by targeted expression of the diphtheria toxin gene. Here we show that, in dorsal-zone-depleted mice, the dorsal domain of the olfactory bulb was devoid of glomerular structures, although second-order neurons were present in the vacant areas. The mutant mice lacked innate responses to aversive odorants, even though they were capable of detecting them and could be conditioned for aversion with the remaining glomeruli. These results indicate that, in mice, aversive information is received in the olfactory bulb by separate sets of glomeruli, those dedicated for innate and those for learned responses.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo 1130033, Japan; Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; RIKEN, Brain Sci Inst, Lab Behav Genet, Saitama 3510198, Japan; Univ Tokyo, Lab Vet Ethol, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo; Osaka University; RIKEN; University of Tokyo	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	ikawa, masahito/A-5315-2009; Imai, Takeshi/L-2201-2013; Itohara, Shigeyoshi/I-8769-2012; Oka, Yoshitaka/G-4952-2014; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Imai, Takeshi/0000-0002-8449-0080; Itohara, Shigeyoshi/0000-0002-2410-9989; Oka, Yoshitaka/0000-0002-3482-3051; Kobayakawa, Reiko/0000-0001-6613-5969; Mori, Kensaku/0000-0001-7853-9370; Kobayakawa, Ko/0000-0001-6406-5610; Okabe, Masaru/0000-0002-0803-9044				Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Day HEW, 2004, BRAIN RES, V1025, P139, DOI 10.1016/j.brainres.2004.07.079; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; Fendt M, 2003, J NEUROSCI, V23, P23; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Hebb ALO, 2004, EUR J NEUROSCI, V20, P2415, DOI 10.1111/j.1460-9568.2004.03704.x; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; HORDER TJ, 1971, J PHYSIOL-LONDON, V6, pP53; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Inaki K, 2002, EUR J NEUROSCI, V15, P1563, DOI 10.1046/j.1460-9568.2002.01991.x; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAY E, 1992, PHYSIOL BEHAV, V52, P105, DOI 10.1016/0031-9384(92)90439-9; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; NYBY J, 1985, J COMP PSYCHOL, V99, P479, DOI 10.1037/0735-7036.99.4.479; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schellinck HM, 2001, CHEM SENSES, V26, P663, DOI 10.1093/chemse/26.6.663; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Wallace KJ, 2001, J NEUROSCI, V21, P3619, DOI 10.1523/JNEUROSCI.21-10-03619.2001; WOOD RW, 1995, TOXICOL APPL PHARM, V130, P67, DOI 10.1006/taap.1995.1009; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	44	445	453	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2007	450	7169					503	U5		10.1038/nature06281	http://dx.doi.org/10.1038/nature06281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	234JW	17989651				2022-12-24	WOS:000251158500037
J	Lin, JH; Li, H; Yasumura, D; Cohen, HR; Zhang, C; Panning, B; Shokat, KM; LaVail, MM; Walter, P				Lin, Jonathan H.; Li, Han; Yasumura, Douglas; Cohen, Hannah R.; Zhang, Chao; Panning, Barbara; Shokat, Kevan M.; LaVail, Matthew M.; Walter, Peter			IRE1 signaling affects cell fate during the unfolded protein response	SCIENCE			English	Article							ER STRESS; RETINITIS-PIGMENTOSA; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; RHODOPSIN; ATF6; TRANSLATION; PROTEOLYSIS; DEATH	Endoplasmic reticulum (ER) stress activates a set of signaling pathways, collectively termed the unfolded protein response (UPR). The three UPR branches (IRE1, PERK, and ATF6) promote cell survival by reducing misfolded protein levels. UPR signaling also promotes apoptotic cell death if ER stress is not alleviated. How the UPR integrates its cytoprotective and proapoptotic outputs to select between life or death cell fates is unknown. We found that IRE1 and ATF6 activities were attenuated by persistent ER stress in human cells. By contrast, PERK signaling, including translational inhibition and proapoptotic transcription regulator Chop induction, was maintained. When IRE1 activity was sustained artificially, cell survival was enhanced, suggesting a causal link between the duration of UPR branch signaling and life or death cell fate after ER stress. Key findings from our studies in cell culture were recapitulated in photoreceptors expressing mutant rhodopsin in animal models of retinitis pigmentosa.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lin, JH (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	Jonathan.Lin@ucsf.edu	Longo, Kenneth A/A-5631-2010	Lin, Jonathan/0000-0002-7438-6941	NATIONAL EYE INSTITUTE [R01EY020846, K08EY018313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186] Funding Source: NIH RePORTER; NEI NIH HHS [K08 EY018313-01, K08 EY018313, R01 EY020846] Funding Source: Medline; NIGMS NIH HHS [R01 GM085186] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cohen HR, 2007, CHROMOSOMA, V116, P373, DOI 10.1007/s00412-007-0100-1; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	29	1011	1081	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2007	318	5852					944	949		10.1126/science.1146361	http://dx.doi.org/10.1126/science.1146361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991856	Green Accepted			2022-12-24	WOS:000250788500034
J	Mumby, PJ; Hastings, A; Edwards, HJ				Mumby, Peter J.; Hastings, Alan; Edwards, Helen J.			Thresholds and the resilience of Caribbean coral reefs	NATURE			English	Article							CLIMATE-CHANGE; STABLE STATES; MORTALITY; DYNAMICS	The deteriorating health of the world's coral reefs threatens global biodiversity, ecosystem function, and the livelihoods of millions of people living in tropical coastal regions(1). Reefs in the Caribbean are among the most heavily affected(2,3), having experienced mass disease-induced mortality of the herbivorous urchin Diadema antillarum(4) in 1983 and two framework-building species of coral(5). Declining reef health is characterized by increases in macroalgae. A critical question is whether the observed macroalgal bloom on Caribbean reefs is easily reversible. To answer this question, we must resolve whether algal-dominated reefs are an alternative stable state of the ecosystem or simply the readily reversible result of a phase change along a gradient of some environmental or ecological parameter(6). Here, using a fully parameterized simulation model in combination with a simple analytical model, we show that Caribbean reefs became susceptible to alternative stable states once the urchin mortality event of 1983 confined the majority of grazing to parrotfishes. We reveal dramatic hysteresis in a natural system(7,8) and define critical thresholds of grazing and coral cover beyond which resilience is lost. Most grazing thresholds lie near the upper level observed for parrotfishes in nature, suggesting that reefs are highly sensitive to parrotfish exploitation. Ecosystem thresholds can be combined with stochastic models of disturbance to identify targets for the restoration of ecosystem processes. We illustrate this principle by estimating the relationship between current reef state (coral cover and grazing) and the probability that the reef will withstand moderate hurricane intensity for two decades without becoming entrained in a shift towards a stable macroalgal-dominated state. Such targets may help reef managers face the challenge of addressing global disturbance at local scales.	Univ Exeter, Sch Biosci, Marine Spatial Ecol Lab, Exeter EX4 4PS, Devon, England; Univ Calif Davis, Davis, CA 95616 USA	University of Exeter; University of California System; University of California Davis	Mumby, PJ (corresponding author), Univ Exeter, Sch Biosci, Marine Spatial Ecol Lab, Prince Wales Rd, Exeter EX4 4PS, Devon, England.	p.j.mumby@ex.ac.uk	Hastings, Alan/A-7423-2008; Mumby, Peter/F-9914-2010; Edwards, Helen/D-1633-2009; Edwards, Helen/GPX-3511-2022; Hastings, Alan/O-6864-2019	Mumby, Peter/0000-0002-6297-9053; Edwards, Helen/0000-0003-1174-8009; Hastings, Alan/0000-0002-0717-8026	NERC [NE/E00606X/1] Funding Source: UKRI; Natural Environment Research Council [NE/E00606X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; BYTHELL JC, 1993, CORAL REEFS, V12, P143, DOI 10.1007/BF00334474; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Done TJ, 1999, AM ZOOL, V39, P66; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Hildebrand F. B, 1987, INTRO NUMERICAL ANAL; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; KNOWLTON N, 1992, AM ZOOL, V32, P674; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Ludwig D., 1997, CONSERV ECOL, V1, P1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; Meesters EH, 1997, J SEA RES, V37, P131, DOI 10.1016/S1385-1101(96)00004-4; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2005, CORAL REEFS, V24, P681, DOI 10.1007/s00338-005-0058-5; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Petraitis PS, 2004, J EXP MAR BIOL ECOL, V300, P343, DOI 10.1016/j.jembe.2003.12.026; VANSTEVENINCK EDD, 1987, MAR ECOL PROG SER, V38, P241	26	588	604	10	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					98	101		10.1038/nature06252	http://dx.doi.org/10.1038/nature06252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972885				2022-12-24	WOS:000250585800044
J	Kay, S; Hahn, S; Marois, E; Hause, G; Bonas, U				Kay, Sabine; Hahn, Simone; Marois, Eric; Hause, Gerd; Bonas, Ulla			A bacterial effector acts as a plant transcription factor and induces a cell size regulator	SCIENCE			English	Article							CAMPESTRIS PV VESICATORIA; AVIRULENCE GENE AVRBS3; PROTEIN AVRBS3; NUCLEAR IMPORT; III SECRETION; HOST-PLANT; XANTHOMONAS; EXPRESSION; RESISTANCE; PEPPER	Pathogenicity of many Gram-negative bacteria relies on the injection of effector proteins by type III secretion into eukaryotic cells, where they modulate host signaling pathways to the pathogen's benefit. One such effector protein injected by Xanthomonas into plants is AvrBs3, which localizes to the plant cell nucleus and causes hypertrophy of plant mesophyll cells. We show that AvrBs3 induces the expression of a master regulator of cell size, upa20, which encodes a transcription factor containing a basic helix-loop-helix domain. AvrBs3 binds to a conserved element in the upa20 promoter via its central repeat region and induces gene expression through its activation domain. Thus, AvrBs3 and likely other members of this family provoke developmental reprogramming of host cells by mimicking eukaryotic transcription factors.	Univ Halle Wittenberg, Dept Genet, Inst Biol, D-06120 Halle, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Bonas, U (corresponding author), Univ Halle Wittenberg, Dept Genet, Inst Biol, Weinbergweg 10, D-06120 Halle, Germany.	ulla.bonas@genetik.uni-halle.de	Marois, Eric/AAZ-5549-2021; Marois, Eric/H-9246-2016	Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747				Bai JF, 2000, MOL PLANT MICROBE IN, V13, P1322, DOI 10.1094/MPMI.2000.13.12.1322; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; BONAS U, 1993, MOL GEN GENET, V238, P261, DOI 10.1007/BF00279555; Chalupowicz L, 2006, PLANTA, V224, P429, DOI 10.1007/s00425-006-0229-9; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Jordan T, 2006, THEOR APPL GENET, V113, P895, DOI 10.1007/s00122-006-0349-4; Kitagawa N, 2005, BIOINFORMATICS, V21, P1758, DOI 10.1093/bioinformatics/bti253; KNOOP V, 1991, J BACTERIOL, V173, P7142, DOI 10.1128/jb.173.22.7142-7150.1991; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; LEYNS F, 1984, BOT REV, V50, P308, DOI 10.1007/BF02862635; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Wichmann G, 2004, GENETICS, V166, P693, DOI 10.1534/genetics.166.2.693; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yang YN, 1996, MOL PLANT MICROBE IN, V9, P105, DOI 10.1094/MPMI-9-0105	29	399	537	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					648	651		10.1126/science.1144956	http://dx.doi.org/10.1126/science.1144956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17962565				2022-12-24	WOS:000250409200048
J	Bonneau, R; Facciotti, MT; Reiss, DJ; Schmid, AK; Pan, M; Kaur, A; Thorsson, V; Shannon, P; Johnson, MH; Bare, JC; Longabaugh, W; Vuthoori, M; Whitehead, K; Madar, A; Suzuki, L; Mori, T; Chang, DE; DiRuggiero, J; Johnson, CH; Hood, L; Baliga, NS				Bonneau, Richard; Facciotti, Marc T.; Reiss, David J.; Schmid, Amy K.; Pan, Min; Kaur, Amardeep; Thorsson, Vesteinn; Shannon, Paul; Johnson, Michael H.; Bare, J. Christopher; Longabaugh, William; Vuthoori, Madhavi; Whitehead, Kenia; Madar, Aviv; Suzuki, Lena; Mori, Tetsuya; Chang, Dong-Eun; DiRuggiero, Jocelyne; Johnson, Carl H.; Hood, Leroy; Baliga, Nitin S.			A predictive model for transcriptional control of physiology in a free living cell	CELL			English	Article							SYSTEMS-BIOLOGY; REGULATORY NETWORK; ESCHERICHIA-COLI; GENOME-SCALE; DE-NOVO; DATABASE; GENES; RADIATION; NRC-1; EXPRESSION	The environment significantly influences the dynamic expression and assembly of all components encoded in the genome of an organism into functional biological networks. We have constructed a model for this process in Halobacterium salinarum NRC-1 through the data-driven discovery of regulatory and functional interrelationships among similar to 80% of its genes and key abiotic factors in its hypersaline environment. Using relative changes in 72 transcription factors and 9 environmental factors (EFs) this model accurately predicts dynamic transcriptional responses of all these genes in 147 newly collected experiments representing completely novel genetic backgrounds and environments-suggesting a remarkable degree of network completeness. Using this model we have constructed and tested hypotheses critical to this organism's interaction with its changing hypersaline environment. This study supports the claim that the high degree of connectivity within biological and EF networks will enable the construction of similar models for any organism from relatively modest numbers of experiments.	[Facciotti, Marc T.; Reiss, David J.; Schmid, Amy K.; Pan, Min; Kaur, Amardeep; Thorsson, Vesteinn; Shannon, Paul; Johnson, Michael H.; Bare, J. Christopher; Longabaugh, William; Vuthoori, Madhavi; Whitehead, Kenia; Hood, Leroy; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98103 USA; [Bonneau, Richard; Madar, Aviv] NYU, Ctr Genome & Syst Biol, New York, NY 10003 USA; [DiRuggiero, Jocelyne] Univ Maryland, College Pk, MD 20742 USA; [Suzuki, Lena; Mori, Tetsuya; Chang, Dong-Eun; Johnson, Carl H.] Vanderbilt Univ, Nashville, TN 37240 USA; [Bonneau, Richard] NYU, Dept Comp Sci, Courant Inst Math Sci, New York, NY 10003 USA; [Baliga, Nitin S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Baliga, Nitin S.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); New York University; University System of Maryland; University of Maryland College Park; Vanderbilt University; New York University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Baliga, NS (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	nbaliga@systemsbiology.org	Bonneau, Richard/GZL-2900-2022; Madar, Aviv/D-1023-2013; Bonneau, Richard/ABD-6737-2021; Madar, Aviv/AAO-1540-2020; Facciotti, Marc/AAF-9227-2020	Facciotti, Marc/0000-0003-4453-3274; baliga, nitin/0000-0001-9157-5974; Bare, J. Christopher/0000-0003-1006-1491; Mori, Tetsuya/0000-0001-6036-5261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067152, R37GM067152, P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067152, P50GM076547, R37 GM067152, R01GM067152] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 1999, J BACTERIOL, V181, P2513, DOI 10.1128/JB.181.8.2513-2518.1999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Facciotti MT, 2007, P NATL ACAD SCI USA, V104, P4630, DOI 10.1073/pnas.0611663104; Facciotti MT, 2004, CURR GENOMICS, V5, P527, DOI 10.2174/1389202043348850; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Hayete B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100118; Hofacker A, 2004, MICROBIOL-SGM, V150, P1829, DOI 10.1099/mic.0.27078-0; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; LANYI JK, 1980, J SUPRAMOL STR CELL, V13, P83, DOI 10.1002/jss.400130108; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; PEEL JL, 1962, J BIOL CHEM, V237, pP263; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thorsson V, 2005, STAT APPL GENET MOL, V4; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091	41	230	238	2	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 28	2007	131	7					1354	1365		10.1016/j.cell.2007.10.053	http://dx.doi.org/10.1016/j.cell.2007.10.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	249GV	18160043	Bronze			2022-12-24	WOS:000252217200023
J	Sanjuan, MA; Dillon, CP; Tait, SWG; Moshiach, S; Dorsey, F; Connell, S; Komatsu, M; Tanaka, K; Cleveland, JL; Withoff, S; Green, DR				Sanjuan, Miguel A.; Dillon, Christopher P.; Tait, Stephen W. G.; Moshiach, Simon; Dorsey, Frank; Connell, Samuel; Komatsu, Masaaki; Tanaka, Keiji; Cleveland, John L.; Withoff, Sebo; Green, Douglas R.			Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis	NATURE			English	Article							PHAGOSOME MATURATION; LEGIONELLA-PNEUMOPHILA; CLASS-I; INNATE; IMMUNITY; DEFENSE; SYSTEM; ROLES	Phagocytosis and autophagy are two ancient, highly conserved processes involved, respectively, in the removal of extracellular organisms and the destruction of organisms in the cytosol(1-3). Autophagy, for either metabolic regulation or defence, involves the formation of a double membrane called the autophagosome, which then fuses with lysosomes to degrade the contents(4), a process that has similarities with phagosome maturation. Toll-like-receptor ( TLR) engagement activates a variety of defence mechanisms within phagocytes(5), including facilitation of phagosome maturation(6), and also engages autophagy(7). Therefore we speculated that TLR signalling might link these processes to enhance the function of conventional phagosomes. Here we show that a particle that engages TLRs on a murine macrophage while it is phagocytosed triggers the autophagosome marker LC3 to be rapidly recruited to the phagosome in a manner that depends on the autophagy pathway proteins ATG5 and ATG7; this process is preceded by recruitment of beclin 1 and phosphoinositide-3-OH kinase activity. Translocation of beclin 1 and LC3 to the phagosome was not associated with observable double- membrane structures characteristic of conventional autophagosomes, but was associated with phagosome fusion with lysosomes, leading to rapid acidification and enhanced killing of the ingested organism.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Tokyo Metropolitan Institute of Medical Science; Scripps Research Institute	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Sanjuán, Miguel Ángel/I-6896-2019; Dillon, Christopher/P-4457-2014; Green, Douglas R/N-8083-2018; Komatsu, Masaaki/B-8321-2011	Sanjuán, Miguel Ángel/0000-0001-6694-0634; Dillon, Christopher/0000-0002-9458-0266; Green, Douglas R/0000-0002-7332-1417; Komatsu, Masaaki/0000-0001-7672-7722; Tait, Stephen/0000-0001-7697-132X				Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Blander JM, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217b; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Gillooly DJ, 2001, J CELL BIOL, V155, P15, DOI 10.1083/jcb.200109001; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kuo CC, 2006, J IMMUNOL, V176, P5943, DOI 10.4049/jimmunol.176.10.5943; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tilney LG, 2001, J CELL SCI, V114, P4637; Vasselon T, 2002, J LEUKOCYTE BIOL, V71, P503; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	30	967	996	3	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2007	450	7173					1253	1257		10.1038/nature06421	http://dx.doi.org/10.1038/nature06421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243HA	18097414				2022-12-24	WOS:000251786200055
J	Whitehouse, I; Rando, OJ; Delrow, J; Tsukiyama, T				Whitehouse, Iestyn; Rando, Oliver J.; Delrow, Jeff; Tsukiyama, Toshio			Chromatin remodelling at promoters suppresses antisense transcription	NATURE			English	Article							RNA-QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; IN-VIVO; NUCLEOSOME POSITIONS; POLY(A) POLYMERASE; NUCLEAR EXOSOME; DNA-REPLICATION; BUDDING YEAST; COMPLEX; GENOME	Chromatin allows the eukaryotic cell to package its DNA efficiently. To understand how chromatin structure is controlled across the Saccharomyces cerevisiae genome, we have investigated the role of the ATP- dependent chromatin remodelling complex Isw2 in positioning nucleosomes. We find that Isw2 functions adjacent to promoter regions where it repositions nucleosomes at the interface between genic and intergenic sequences. Nucleosome repositioning by Isw2 is directional and results in increased nucleosome occupancy of the intergenic region. Loss of Isw2 activity leads to inappropriate transcription, resulting in the generation of both coding and noncoding transcripts. Here we show that Isw2 repositions nucleosomes to enforce directionality on transcription by preventing transcription initiation from cryptic sites. Our analyses reveal how chromatin is organized on a global scale and advance our understanding of how transcription is regulated.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	Fred Hutchinson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Tsukiyama, T (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	ttsukiya@fhcrc.org		Rando, Oliver/0000-0003-1516-9397; Whitehouse, Iestyn/0000-0003-0385-3116				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; BEHE MJ, 1995, NUCLEIC ACIDS RES, V23, P689, DOI 10.1093/nar/23.4.689; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; KUNKEL GR, 1981, NUCLEIC ACIDS RES, V9, P6869, DOI 10.1093/nar/9.24.6869; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li JW, 2006, EMBO J, V25, P5735, DOI 10.1038/sj.emboj.7601454; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	48	325	329	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2007	450	7172					1031	U3		10.1038/nature06391	http://dx.doi.org/10.1038/nature06391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240HY	18075583				2022-12-24	WOS:000251579900076
J	Shojaei, F; Wu, XM; Zhong, CL; Yu, LL; Liang, XH; Yao, J; Blanchard, D; Bais, C; Peale, FV; van Bruggen, N; Ho, C; Ross, J; Tan, M; Carano, RAD; Meng, YG; Ferrara, N				Shojaei, Farbod; Wu, Xiumin; Zhong, Cuiling; Yu, Lanlan; Liang, Xiao-Huan; Yao, Jenny; Blanchard, Dominique; Bais, Carlos; Peale, Franklin V.; van Bruggen, Nicholas; Ho, Calvin; Ross, Jed; Tan, Martha; Carano, Richard A. D.; Meng, Y. Gloria; Ferrara, Napoleone			Bv8 regulates myeloid-cell-dependent tumour angiogenesis	NATURE			English	Article							COLONY-STIMULATING-FACTOR; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; HEMATOPOIETIC STEM-CELLS; GLAND-DERIVED VEGF; MICROCOMPUTED TOMOGRAPHY; PROGENITOR CELLS; IDENTIFICATION; NEOVASCULARIZATION; NEUTROPHILS	Bone- marrow- derived cells facilitate tumour angiogenesis, but the molecular mechanisms of this facilitation are incompletely understood. We have previously shown that the related EG- VEGF and Bv8 proteins, also known as prokineticin 1 ( Prok1) and prokineticin 2 ( Prok2), promote both tissue- specific angiogenesis and haematopoietic cell mobilization. Unlike EG- VEGF, Bv8 is expressed in the bone marrow. Here we show that implantation of tumour cells in mice resulted in upregulation of Bv8 in CD11b(+) Gr1(+) myeloid cells. We identified granulocyte colony- stimulating factor as a major positive regulator of Bv8 expression. Anti- Bv8 antibodies reduced CD11b(+) Gr1(+) cell mobilization elicited by granulocyte colony- stimulating factor. Adenoviral delivery of Bv8 into tumours was shown to promote angiogenesis. Anti- Bv8 antibodies inhibited growth of several tumours in mice and suppressed angiogenesis. Anti- Bv8 treatment also reduced CD11b(+) Gr1(+) cells, both in peripheral blood and in tumours. The effects of anti- Bv8 antibodies were additive to those of anti- Vegf antibodies or cytotoxic chemotherapy. Thus, Bv8 modulates mobilization of CD11b(+) Gr1(+) cells from the bone marrow during tumour development and also promotes angiogenesis locally.	Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	nf@gene.com						Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Garcia-Sanz A, 1998, HYPERTENSION, V31, P440, DOI 10.1161/01.HYP.31.1.440; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686; Kavgaci H, 2002, J EXP CLIN CANC RES, V21, P475; Kwon HM, 1998, J CLIN INVEST, V101, P1551, DOI 10.1172/JCI1568; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2002, NAT MED, V8, P913, DOI 10.1038/nm0902-913; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Maehara N, 2003, EUR RADIOL, V13, P1559, DOI 10.1007/s00330-002-1729-z; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; NEBEN S, 1993, BLOOD, V81, P1960; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031	45	485	508	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2007	450	7171					825	U6		10.1038/nature06348	http://dx.doi.org/10.1038/nature06348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	18064003				2022-12-24	WOS:000251394900045
J	Takahashi, K; Tanabe, K; Ohnuki, M; Narita, M; Ichisaka, T; Tomoda, K; Yamanaka, S				Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya			Induction of pluripotent stem cells from adult human fibroblasts by defined factors	CELL			English	Article							SELF-RENEWAL; HUMAN BLASTOCYSTS; MOUSE EMBRYOS; ES CELLS; LINES; DIFFERENTIATION; ACTIVATION; STAT3; GENERATION; MAINTAIN	Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.	[Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Narita, Megumi; Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agncy, CREST, Kawagoe, Saitama 3320012, Japan; [Tomoda, Kiichiro; Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Yamanaka, Shinya] Kyoto Univ, Inst Integrat Cell Mat Sci, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes; Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Wilson, Matthew H/K-3193-2013	Takahashi, Kazutoshi/0000-0002-5329-8395; 				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS PM, 2007, J BIOL CHEM, DOI DOI 10.1074/JBC.M701847200; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Sumi T, 2007, ONCOGENE, V26, P5564, DOI 10.1038/sj.onc.1210353; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	30	13437	14885	70	3345	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 30	2007	131	5					861	872		10.1016/j.cell.2007.11.019	http://dx.doi.org/10.1016/j.cell.2007.11.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	243MG	18035408	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000251800900010
J	Gu, LC; Geders, TW; Wang, B; Gerwick, WH; Hakansson, K; Smith, JL; Sherman, DH				Gu, Liangcai; Geders, Todd W.; Wang, Bo; Gerwick, William H.; Hakansson, Kristina; Smith, Janet L.; Sherman, David H.			GNAT-like strategy for polyketide chain initiation	SCIENCE			English	Article							CYANOBACTERIUM LYNGBYA-MAJUSCULA; FATTY-ACID SYNTHASE; GENE-CLUSTER; SACCHAROPOLYSPORA-ERYTHRAEA; BACTERIAL SYMBIONT; PEPTIDE SYNTHETASE; CURACIN-A; BIOSYNTHESIS; MECHANISM; ACETYLTRANSFERASES	An unexpected biochemical strategy for chain initiation is described for the loading module of the polyketide synthase of curacin A, an anticancer lead derived from the marine cyanobacterium Lyngbya majuscula. A central GCN5-related N-acetyltransferase (GNAT) domain bears bifunctional decarboxylase/S-acetyltransferase activity, both unprecedented for the GNAT superfamily. A CurA loading tridomain, consisting of an adaptor domain, the GNAT domain, and an acyl carrier protein, was assessed biochemically, revealing that a domain showing homology to GNAT (GNAT(L)) catalyzes (i) decarboxylation of malonyl-coenzyme A (malonyl-CoA) to acetyl-CoA and (ii) direct S-acetyl transfer from acetyl-CoA to load an adjacent acyl carrier protein domain (ACP(L)). Moreover, the N-terminal adapter domain was shown to facilitate acetyl- group transfer. Crystal structures of GNAT(L) were solved at 1.95 angstroms (ligand-free form) and 2.75 angstroms (acyl-CoA complex), showing distinct substrate tunnels for acyl-CoA and holo-ACP(L) binding. Modeling and site-directed mutagenesis experiments demonstrated that histidine-389 and threonine-355, at the convergence of the CoA and ACP tunnels, participate in malonyl-CoA decarboxylation but not in acetyl-group transfer. Decarboxylation precedes acetyl- group transfer, leading to acetyl-ACP(L) as the key curacin A starter unit.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Diego; Scripps Institution of Oceanography	Sherman, DH (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu; davidhs@umich.edu	Gu, Liangcai/U-6908-2019; Gu, Liangcai/E-4600-2010; Hakansson, Kristina/G-9428-2016	Hakansson, Kristina/0000-0003-1926-0542	NIDDK NIH HHS [DK42303] Funding Source: Medline; NIGMS NIH HHS [GM076477] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042303, R01DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; HSIEH YJ, 1994, J BACTERIOL, V176, P714, DOI 10.1128/jb.176.3.714-724.1994; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lau J, 2000, BIOCHEMISTRY-US, V39, P10514, DOI 10.1021/bi000602v; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Minas W, 1998, BIOTECHNOL PROGR, V14, P561, DOI 10.1021/bp980055t; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rossi JV, 1997, J APPL PHYCOL, V9, P195, DOI 10.1023/A:1007973009869; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Van Wagoner RM, 2006, STRUCTURE, V14, P1425, DOI 10.1016/j.str.2006.07.005; Verdier-Pinard P, 1998, MOL PHARMACOL, V53, P62, DOI 10.1124/mol.53.1.62; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111	23	83	83	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2007	318	5852					970	974		10.1126/science.1148790	http://dx.doi.org/10.1126/science.1148790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	229FM	17991863				2022-12-24	WOS:000250788500042
J	Condamin, S; Benichou, O; Tejedor, V; Voituriez, R; Klafter, J				Condamin, S.; Benichou, O.; Tejedor, V.; Voituriez, R.; Klafter, J.			First-passage times in complex scale-invariant media	NATURE			English	Article							RANDOM-WALKS; DETERMINISTIC FRACTALS; ANOMALOUS DIFFUSION; DISORDERED MEDIA; NETWORKS; PROTEIN; MECHANISMS; MODELS; DNA	How long does it take a random walker to reach a given target point? This quantity, known as a first-passage time (FPT), has led to a growing number of theoretical investigations over the past decade(1). The importance of FPTs originates from the crucial role played by first encounter properties in various real situations, including transport in disordered media(2,3), neuron firing dynamics(4), spreading of diseases(5) or target search processes(6-9). Most methods of determining FPT properties in confining domains have been limited to effectively one-dimensional geometries, or to higher spatial dimensions only in homogeneous media(1). Here we develop a general theory that allows accurate evaluation of the mean FPT in complex media. Our analytical approach provides a universal scaling dependence of the mean FPT on both the volume of the confining domain and the source-target distance. The analysis is applicable to a broad range of stochastic processes characterized by length-scale-invariant properties. Our theoretical predictions are confirmed by numerical simulations for several representative models of disordered media(10), fractals(3), anomalous diffusion(11) and scale-free networks(12).	Univ Paris 06, Lab Phys Theor Mat Condensee, UMR 7600, F-75005 Paris, France; Tel Aviv Univ, Sch Chem, IL-69978 Tel Aviv, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University	Benichou, O (corresponding author), Univ Paris 06, Lab Phys Theor Mat Condensee, UMR 7600, Case 121,4 Pl Jussieu, F-75005 Paris, France.	benichou@lptmc.jussieu.fr	voituriez, raphael/V-3418-2017; Tejedor, Vincent/C-6168-2009	Tejedor, Vincent/0000-0002-2980-434X; voituriez, raphael/0000-0001-8746-5713				Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARTON G, 1989, ELEMENTS GREEN FUNCT; ben Avraham D., 2000, DIFFUSION REACTIONS; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bollt EM, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/026; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Condamin S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260601; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Eliazar I, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/6/065140; Gallos LK, 2007, P NATL ACAD SCI USA, V104, P7746, DOI 10.1073/pnas.0700250104; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HAVLIN S, 1987, ADV PHYS, V36, P695, DOI 10.1080/00018738700101072; Holcman D, 2007, J STAT PHYS, V127, P471, DOI 10.1007/s10955-007-9282-4; Hughes BD, 1995, RANDOM WALKS RANDOM, V1, DOI [10.1079/PNS19950063, DOI 10.1079/PNS19950063]; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; MONTROLL EW, 1969, J MATH PHYS, V10, P753, DOI 10.1063/1.1664902; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Redner S., 2002, GUIDE 1 PASSAGE PROC; Rice S. A., 1985, DIFFUSION LTD REACTI; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; VANDENBROECK C, 1989, PHYS REV A, V40, P7334, DOI 10.1103/PhysRevA.40.7334; Yuste SB, 1995, J PHYS A-MATH GEN, V28, P7027, DOI 10.1088/0305-4470/28/24/004	30	468	471	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					77	80		10.1038/nature06201	http://dx.doi.org/10.1038/nature06201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972880	Green Submitted			2022-12-24	WOS:000250585800039
J	Huang, B; Wang, WQ; Bates, M; Zhuang, XW				Huang, Bo; Wang, Wenqin; Bates, Mark; Zhuang, Xiaowei			Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopy	SCIENCE			English	Article							FLUORESCENCE NANOSCOPY; AXIAL RESOLUTION; LOCALIZATION; TRACKING; PROBES; ENDOCYTOSIS; PRECISION; MOLECULES; EMITTERS; CELLS	Recent advances in far- field fluorescence microscopy have led to substantial improvements in image resolution, achieving a near- molecular resolution of 20 to 30 nanometers in the two lateral dimensions. Three- dimensional ( 3D) nanoscale- resolution imaging, however, remains a challenge. We demonstrated 3D stochastic optical reconstruction microscopy ( STORM) by using optical astigmatism to determine both axial and lateral positions of individual fluorophores with nanometer accuracy. Iterative, stochastic activation of photoswitchable probes enables high- precision 3D localization of each probe, and thus the construction of a 3D image, without scanning the sample. Using this approach, we achieved an image resolution of 20 to 30 nanometers in the lateral dimensions and 50 to 60 nanometers in the axial dimension. This development allowed us to resolve the 3D morphology of nanoscopic cellular structures.	[Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Wang, Wenqin; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Bates, Mark] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Wang, Wenqin/E-9418-2012; Huang, Bo/D-4854-2009	Bates, Mark/0000-0003-0668-5277	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM068518, GM 068518, R01 GM068518-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bock H, 2007, APPL PHYS B-LASERS O, V88, P161, DOI 10.1007/s00340-007-2729-0; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Egner A, 2005, TRENDS CELL BIOL, V15, P207, DOI 10.1016/j.tcb.2005.02.003; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gustafsson MGL, 1999, J MICROSC-OXFORD, V195, P10, DOI 10.1046/j.1365-2818.1999.00576.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nagorni M, 1998, J STRUCT BIOL, V123, P236, DOI 10.1006/jsbi.1998.4037; Prabhat P, 2006, PROC SPIE, V6090, DOI 10.1117/12.644343; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Speidel M, 2003, OPT LETT, V28, P69, DOI 10.1364/OL.28.000069; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Toprak E, 2007, NANO LETT, V7, P2043, DOI 10.1021/nl0709120; Torok P, 1997, OPT COMMUN, V137, P127, DOI 10.1016/S0030-4018(96)00771-7; van Oijen AM, 1998, CHEM PHYS LETT, V292, P183, DOI 10.1016/S0009-2614(98)00673-3; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	31	1855	1949	42	1201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2008	319	5864					810	813		10.1126/science.1153529	http://dx.doi.org/10.1126/science.1153529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259TE	18174397	Green Submitted, Green Accepted			2022-12-24	WOS:000252963000061
J	Vavylonis, D; Wu, JQ; Hao, S; O'Shaughnessy, B; Pollard, TD				Vavylonis, Dimitrios; Wu, Jian-Qiu; Hao, Steven; O'Shaughnessy, Ben; Pollard, Thomas D.			Assembly mechanism of the contractile ring for cytokinesis by fission yeast	SCIENCE			English	Article							F-ACTIN; SCHIZOSACCHAROMYCES-POMBE; MYOSIN-II; PROFILIN; DYNAMICS; FORMINS; CDC12P; SITE	Animals and fungi assemble a contractile ring of actin filaments and the motor protein myosin to separate into individual daughter cells during cytokinesis. We used fluorescence microscopy of live fission yeast cells to observe that membrane- bound nodes containing myosin were broadly distributed around the cell equator and assembled into a contractile ring through stochastic motions, after a meshwork of dynamic actin filaments appeared. Analysis of node motions and numerical simulations supported a mechanism whereby transient connections are established when myosins in one node capture and exert force on actin filaments growing from other nodes.	[Vavylonis, Dimitrios; Wu, Jian-Qiu; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Vavylonis, Dimitrios; O'Shaughnessy, Ben] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Hao, Steven; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Columbia University; Lehigh University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Wu, Jian-qiu/G-6835-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026132, R01GM026132, R01GM026338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-26132, R01 GM026132, GM-26338, R01 GM026338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai R, 2002, J CELL SCI, V115, P887; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Daga RR, 2005, P NATL ACAD SCI USA, V102, P8228, DOI 10.1073/pnas.0409021102; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Howard J., 2001, MECH MOTOR PROTEINS; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Motegi F, 2000, J CELL SCI, V113, P1813; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230	20	271	272	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2008	319	5859					97	100		10.1126/science.1151086	http://dx.doi.org/10.1126/science.1151086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247MM	18079366				2022-12-24	WOS:000252084000040
J	Buist, M; Harrison, J; Abaloz, E; Van Dyke, S				Buist, Michael; Harrison, Julia; Abaloz, Ellie; Van Dyke, Susan			Quality improvement report - Six year audit of cardiac arrests and medical emergency team calls in an Australian outer metropolitan teaching hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE; ANTECEDENTS; RESPONSES; SURVIVAL	Problem In-hospitai cardiac arrest often represents failure of optimal clinical care. The use of medical emergency teams to prevent such events is controversial. In-hospitat cardiac arrests have been reduced in several single centre historical control studies, but the only randomised prospective study showed no such benefit. In our hospital an important problem was failure to call the medical emergency team or cardiac arrest team when, before in-hospital cardiac arrest, patients had fulfilled the criteria for calling the team. Design Single centre, prospective audit of cardiac arrests and data on use of the medical emergency team during 2000 to 2005. Setting 400 bed general outer suburban metropolitan teaching hospital. Strategies for change Three initiatives in the hospital to improve use of the medical emergency team: orientation programme for first year doctors, professional development course for medical registrars, and the evolving role of liaison intensive care unit nurses. Key measures for improvement Incidence of cardiac arrests. Effects of the change Incidence of cardiac arrests reduced 24% per year, from 2.4/1000 admissions in 2000 to 0.66/ 1000 admissions in 2005. Lessons learnt Medical emergency teams can be efficacious when supported with a multidisciplinary, multifaceted education system for clinical staff.	Dandenong Hosp, Intens Care Unit, Dandenong, Vic 3175, Australia		Buist, M (corresponding author), Dandenong Hosp, Intens Care Unit, POB 478, Dandenong, Vic 3175, Australia.	mbuist@patientrack.com						BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; Bellomo R, 2003, MED J AUSTRALIA, V179, P283, DOI 10.5694/j.1326-5377.2003.tb05548.x; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist MD, 2002, BRIT MED J, V324, P387, DOI 10.1136/bmj.324.7334.387; BULST M, 2004, CRIT CARE RESUSC, V6, P83; DeVita MA, 2004, QUAL SAF HEALTH CARE, V13, P251, DOI 10.1136/qshc.2003.006585; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Esmonde L, 2006, INTENS CARE MED, V32, P1713, DOI 10.1007/s00134-006-0380-6; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; PEATFIELD RC, 1977, LANCET, V1, P1223; Russell S, 2000, Prof Nurse, V15, P497; Russell S, 1999, HEART LUNG, V28, P365, DOI 10.1053/hl.1999.v28.a101055; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68	17	141	148	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2007	335	7631					1210	1212		10.1136/bmj.39385.534236.47	http://dx.doi.org/10.1136/bmj.39385.534236.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	242ER	18048504	Green Published			2022-12-24	WOS:000251707800037
J	Rezza, G; Nicoletti, L; Angelini, R; Romi, R; Finarelli, AC; Panning, M; Cordioli, P; Fortuna, C; Boros, S; Magurano, F; Silvi, G; Angelini, P; Dottori, M; Ciufolini, MG; Majori, GC; Cassone, A				Rezza, G.; Nicoletti, L.; Angelini, R.; Romi, R.; Finarelli, A. C.; Panning, M.; Cordioli, P.; Fortuna, C.; Boros, S.; Magurano, F.; Silvi, G.; Angelini, P.; Dottori, M.; Ciufolini, M. G.; Majori, G. C.; Cassone, A.		CHIKV Study Grp	Infection with chikungunya virus in Italy: an outbreak in a temperate region	LANCET			English	Article							AEDES-ALBOPICTUS; TRAVELERS	Background Chikungunya virus (CHIKV), which is transmitted by Aedes spp mosquitoes, has recently caused several outbreaks on islands in the Indian Ocean and on the Indian subcontinent. We report on an outbreak in Italy. Methods After reports of a large number of cases of febrile illness of unknown origin in two contiguous villages in northeastern Italy, an outbreak investigation was done to identify the primary source of infection and modes of transmission. An active surveillance system was also implemented. The clinical case definition was presentation with fever and joint pain. Blood samples were gathered and analysed by PCR and serological assays to identify the causal agent. Locally captured mosquitoes were also tested by PCR. Phylogenetic analysis of the CHIKV E1 region was done. Findings Analysis of samples from human beings and from mosquitoes showed that the outbreak was caused by CHIKV. We identified 205 cases of infection with CHIKV between July 4 and Sept 27, 2007. The presumed index case was a man from India who developed symptoms while visiting relatives in one of the villages. Phylogenetic analysis showed a high similarity between the strains found in Italy and those identified during an earlier outbreak on islands in the Indian Ocean. The disease was fairly mild in nearly all cases, with only one reported death. Interpretation This outbreak of CHIKV disease in a non-tropical area was to some extent unexpected and emphasises the need for preparedness and response to emerging infectious threats in the era of globalisation.	Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; Local Hlth Unit, Ravenna, Italy; Reg Hlth Author, Emilia Romagna, Italy; Bernhard Nocht Inst Trop Med, Hamburg, Germany; Ist Zooprofilatt, Brescia, Italy	Istituto Superiore di Sanita (ISS); Bernhard Nocht Institut fur Tropenmedizin	Cassone, A (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	cassone@iss.it	Nicoletti, Loredana/B-9973-2016; VENTURI, GIULIETTA/O-8123-2015; MAGURANO, FABIO/B-9975-2016; dottori, michele/AAB-3815-2019; Cassone, Antonio/J-4666-2019; FORTUNA, CLAUDIA/O-9446-2015; Panning, Marcus/I-7889-2016; rezza, giovanni/D-4393-2016	Nicoletti, Loredana/0000-0002-5887-6940; VENTURI, GIULIETTA/0000-0002-9078-8350; MAGURANO, FABIO/0000-0002-0394-7043; FORTUNA, CLAUDIA/0000-0001-8878-4505; rezza, giovanni/0000-0003-0268-6790; Dottori, Michele/0000-0002-9975-0367; Boros, Stefano/0000-0003-2521-0883				Angelini R, 2007, Euro Surveill, V12; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Peragallo MS, 2003, EMERG INFECT DIS, V9, P876; Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Romi R., 1995, Parassitologia (Rome), V37, P99; Romi R, 1999, J AM MOSQUITO CONTR, V15, P425; ROSS R. W., 1956, JOUR HYG, V54, P177; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Staikowsky F, 2008, EPIDEMIOL INFECT, V136, P196, DOI 10.1017/S0950268807008424; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; WHO, 2006, WKLY EPIDEMIOL REC, V81, P105; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	26	1028	1086	1	156	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2007	370	9602					1840	1846		10.1016/S0140-6736(07)61779-6	http://dx.doi.org/10.1016/S0140-6736(07)61779-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	240LI	18061059				2022-12-24	WOS:000251588700030
J	Rosenbaum, DM; Cherezov, V; Hanson, MA; Rasmussen, SGF; Thian, FS; Kobilka, TS; Choi, HJ; Yao, XJ; Weis, WI; Stevens, RC; Kobilka, BK				Rosenbaum, Daniel M.; Cherezov, Vadim; Hanson, Michael A.; Rasmussen, Soren G. F.; Thian, Foon Sun; Kobilka, Tong Sun; Choi, Hee-Jung; Yao, Xiao-Jie; Weis, William I.; Stevens, Raymond C.; Kobilka, Brian K.			GPCR engineering yields high-resolution structural insights into beta(2)-adrenergic receptor function	SCIENCE			English	Article							BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED-RECEPTORS; INDUCED CONFORMATIONAL-CHANGES; LIGAND-BINDING SPECIFICITY; RESONANCE ENERGY-TRANSFER; CONSERVED ASPARTIC-ACID; CONSTITUTIVE ACTIVATION; BETA-2-ADRENERGIC RECEPTORS; IDENTIFICATION; AGONISTS	The beta(2)-adrenergic receptor (beta(2)AR) is a well-studied prototype for heterotrimeric guanine nucleotide-binding protein ( G protein)-coupled receptors (GPCRs) that respond to diffusible hormones and neurotransmitters. To overcome the structural flexibility of the b2AR and to facilitate its crystallization, we engineered a b2AR fusion protein in which T4 lysozyme (T4L) replaces most of the third intracellular loop of the GPCR ("beta(2)AR-T4L") and showed that this protein retains near-native pharmacologic properties. Analysis of adrenergic receptor ligand-binding mutants within the context of the reported high-resolution structure of beta(2)AR-T4L provides insights into inverse-agonist binding and the structural changes required to accommodate catecholamine agonists. Amino acids known to regulate receptor function are linked through packing interactions and a network of hydrogen bonds, suggesting a conformational pathway from the ligand-binding pocket to regions that interact with G proteins.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Scripps Research Institute; Stanford University	Stevens, RC (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	stevens@scripps.edu; kobilka@stanford.edu	Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015; Weis, William I/G-1437-2011	Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990	NIGMS NIH HHS [R21 GM075811, R01 GM056169, P50 GM62411, P50 GM073197, F32 GM082028] Funding Source: Medline; NINDS NIH HHS [NS028471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, F32GM082028, R01GM056169, P50GM062411, R21GM075811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494; Gabilondo AM, 1997, P NATL ACAD SCI USA, V94, P12285, DOI 10.1073/pnas.94.23.12285; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; GREEN SA, 1993, J BIOL CHEM, V268, P23116; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; KHORANA HG, 1992, J BIOL CHEM, V267, P1; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; MORO O, 1994, J BIOL CHEM, V269, P6651; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Sugimoto Y, 2002, J PHARMACOL EXP THER, V301, P51, DOI 10.1124/jpet.301.1.51; SURYANARAYANA S, 1993, MOL PHARMACOL, V44, P111; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tao YX, 2000, MOL ENDOCRINOL, V14, P1272, DOI 10.1210/me.14.8.1272; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	45	1124	1172	1	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2007	318	5854					1266	1273		10.1126/science.1150609	http://dx.doi.org/10.1126/science.1150609			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233JG	17962519				2022-12-24	WOS:000251086600034
J	Coresh, J; Selvin, E; Stevens, LA; Manzi, J; Kusek, JW; Eggers, P; Van Lente, F; Levey, AS				Coresh, Josef; Selvin, Elizabeth; Stevens, Lesley A.; Manzi, Jane; Kusek, John W.; Eggers, Paul; Van Lente, Frederick; Levey, Andrew S.			Prevalence of chronic kidney disease in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; SERUM CREATININE; RISK-FACTOR; CARDIOVASCULAR OUTCOMES; HYPERTENSION; AWARENESS; EQUATION; HEALTH; TRENDS	Context The prevalence and incidence of kidney failure treated by dialysis and transplantation in the United States have increased from 1988 to 2004. Whether there have been changes in the prevalence of earlier stages of chronic kidney disease (CKD) during this period is uncertain. Objective To update the estimated prevalence of CKD in the United States. Design, Setting, and Participants Cross-sectional analysis of the most recent National Health and Nutrition Examination Surveys (NHANES 1988-1994 and NHANES 1999-2004), a nationally representative sample of noninstitutionalized adults aged 20 years or older in 1988-1994 (n = 15 488) and 1999-2004 (n = 13 233). Main Outcome Measures Chronic kidney disease prevalence was determined based on persistent albuminuria and decreased estimated glomerular filtration rate (GFR). Persistence of microalbuminuria (> 30 mg/g) was estimated from repeat visit data in NHANES 1988-1994. The GFR was estimated using the abbreviated Modification of Diet in Renal Disease Study equation reexpressed to standard serum creatinine. Results The prevalence of both albuminuria and decreased GFR increased from 1988-1994 to 1999-2004. The prevalence of CKD stages 1 to 4 increased from 10.0% (95% confidence interval [CI], 9.2%-10.9%) in 1988-1994 to 13.1% (95% CI, 12.0%-14.1%) in 1999-2004 with a prevalence ratio of 1.3 (95% CI, 1.2-1.4). The prevalence estimates of CKD stages in 1988-1994 and 1999-2004, respectively, were 1.7% (95% CI, 1.3%-2.2%) and 1.8% (95% CI, 1.4%-2.3%) for stage 1; 2.7% (95% CI, 2.2%3.2%) and 3.2% (95% CI, 2.6%-3.9%) for stage 2; 5.4% (95% CI, 4.9%-6.0%) and 7.7% (95% CI, 7.0%-8.4%) for stage 3; and 0.21% (95% CI, 0.15%-0.27%) and 0.35% (0.25%-0.45%) for stage 4. A higher prevalence of diagnosed diabetes and hypertension and higher body mass index explained the entire increase in prevalence of albuminuria but only part of the increase in the prevalence of decreased GFR. Estimation of GFR from serum creatinine has limited precision and a change in mean serum creatinine accounted for some of the increased prevalence of CKD. Conclusions The prevalence of CKD in the United States in 1999-2004 is higher than it was in 1988-1994. This increase is partly explained by the increasing prevalence of diabetes and hypertension and raises concerns about future increased incidence of kidney failure and other complications of CKD.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA; NIDDKD, Bethesda, MD 20892 USA; Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Tufts Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cleveland Clinic Foundation	Coresh, J (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument,Ste 2-600, Baltimore, MD 21287 USA.	coresh@jhu.edu			NIDDK NIH HHS [UO1 DK 053869, K01 DK076595, UO1 DK 35073, K01 DK076595-01, UO1 DK 067651] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK053869, U01DK035073, U01DK067651, K01DK076595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], NAT HLTH NUTR EX SUR; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Go AS, 2006, CURR OPIN NEPHROL HY, V15, P296, DOI 10.1097/01.mnh.0000222698.30207.aa; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; KANNEL WB, 1986, CORONARY HEART DISEA, P60; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; *NAT CTR HLTH STAT, SURV OP MAN BROCH CO; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; National Center for Health Statistics, NAT HLTH NUTR EX SUR; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; *US BUR CENS, PCT 16 GROUP QUART P; *US DEP HHS, HLTH STAT PLAN OP 3; US Renal Data Systems, 2007, USRDS 2006 ANN DAT R	33	3614	3803	7	225	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2007	298	17					2038	2047		10.1001/jama.298.17.2038	http://dx.doi.org/10.1001/jama.298.17.2038			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228GP	17986697	Bronze			2022-12-24	WOS:000250718200024
J	Raberg, L; Sim, D; Read, AF				Raberg, Lars; Sim, Derek; Read, Andrew F.			Disentangling genetic variation for resistance and tolerance to infectious diseases in animals	SCIENCE			English	Article							PLASMODIUM-CHABAUDI; NATURAL ENEMIES; MORNING GLORY; MALARIA; VIRULENCE; EVOLUTION; ALPHA(+)-THALASSEMIA; COEVOLUTION; PATHOGENS; PARASITES	Hosts can in principle employ two different strategies to defend themselves against parasites: resistance and tolerance. Animals typically exhibit considerable genetic variation for resistance (the ability to limit parasite burden). However, little is known about whether animals can evolve tolerance (the ability to limit the damage caused by a given parasite burden). Using rodent malaria in laboratory mice as a model system and the statistical framework developed by plant-pathogen biologists, we demonstrated genetic variation for tolerance, as measured by the extent to which anemia and weight loss increased with increasing parasite burden. Moreover, resistance and tolerance were negatively genetically correlated. These results mean that animals, like plants, can evolve two conceptually different types of defense, a finding that has important implications for the understanding of the epidemiology and evolution of infectious diseases.	Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	University of Edinburgh; University of Edinburgh; Lund University	Raberg, L (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	lars.raberg@zooekol.lu.se			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2004, EVOLUTION, V58, P1685, DOI 10.1111/j.0014-3820.2004.tb00454.x; Fortin A, 2002, GENES IMMUN, V3, P177, DOI 10.1038/sj.gene.6363841; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Koskela T, 2002, EVOLUTION, V56, P899; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; MALO D, 1994, TRENDS GENET, V10, P365, DOI 10.1016/0168-9525(94)90133-3; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; Miller MR, 2006, EVOLUTION, V60, P945, DOI 10.1111/j.0014-3820.2006.tb01173.x; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Simms EL, 2000, EVOL ECOL, V14, P563, DOI 10.1023/A:1010956716539; Smith JA, 1999, P ROY SOC B-BIOL SCI, V266, P1283, DOI 10.1098/rspb.1999.0776; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	27	507	524	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					812	814		10.1126/science.1148526	http://dx.doi.org/10.1126/science.1148526			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17975068	Green Submitted			2022-12-24	WOS:000250583900045
J	Tritsch, NX; Yi, EY; Gale, JE; Glowatzki, E; Bergles, DE				Tritsch, Nicolas X.; Yi, Eunyoung; Gale, Jonathan E.; Glowatzki, Elisabeth; Bergles, Dwight E.			The origin of spontaneous activity in the developing auditory system	NATURE			English	Article							INNER HAIR-CELLS; MAMMALIAN COCHLEA; BRAIN-STEM; CALCIUM CURRENTS; HEARING; NERVE; RAT; EAR; ORGANIZATION; ASTROCYTES	Spontaneous activity in the developing auditory system is required for neuronal survival as well as the refinement and maintenance of tonotopic maps in the brain. However, the mechanisms responsible for initiating auditory nerve firing in the absence of sound have not been determined. Here we show that supporting cells in the developing rat cochlea spontaneously release ATP, which causes nearby inner hair cells to depolarize and release glutamate, triggering discrete bursts of action potentials in primary auditory neurons. This endogenous, ATP-mediated signalling synchronizes the output of neighbouring inner hair cells, which may help refine tonotopic maps in the brain. Spontaneous ATP-dependent signalling rapidly subsides after the onset of hearing, thereby preventing this experience-independent activity from interfering with accurate encoding of sound. These data indicate that supporting cells in the organ of Corti initiate electrical activity in auditory nerves before hearing, pointing to an essential role for peripheral, non-sensory cells in the development of central auditory pathways.	Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; UCL, UCL Ear Inst, London WC1X 8EE, England; UCL, Dept Physiol, London WC1X 8EE, England	Johns Hopkins University; Johns Hopkins University; University of London; University College London; University of London; University College London	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dbergles@jhmi.edu	Tritsch, Nicolas/U-5266-2019; Bergles, Dwight/U-8343-2019; Gale, Jonathan/AAG-6874-2019; Yi, Eunyoung/J-3173-2015	Bergles, Dwight/0000-0002-7133-7378; Yi, Eunyoung/0000-0002-9592-0736; Gale, Jonathan/0000-0003-4678-4878; Glowatzki, Elisabeth/0000-0003-3135-658X; Tritsch, Nicolas/0000-0003-3181-7681	NIDCD NIH HHS [R01 DC006476] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CHARLES A, 2002, INTERCELLULAR CALCIU; Erazo-Fischer E, 2007, J NEUROSCI, V27, P1725, DOI 10.1523/JNEUROSCI.4116-06.2007; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Friauf E, 1999, CELL TISSUE RES, V297, P187, DOI 10.1007/s004410051346; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; Gabriele ML, 2000, J NEUROSCI, V20, P6939, DOI 10.1523/JNEUROSCI.20-18-06939.2000; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; GEALDOR M, 1993, HEARING RES, V69, P236, DOI 10.1016/0378-5955(93)90113-F; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; GUMMER AW, 1994, NEUROREPORT, V5, P685, DOI 10.1097/00001756-199402000-00006; HINOJOSA R, 1977, ACTA OTO-LARYNGOL, V84, P238, DOI 10.3109/00016487709123963; Housley GD, 2000, CLIN EXP PHARMACOL P, V27, P575, DOI 10.1046/j.1440-1681.2000.03314.x; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Jones TA, 2001, J NEUROSCI, V21, P8129, DOI 10.1523/JNEUROSCI.21-20-08129.2001; Jones TA, 2000, J NEUROPHYSIOL, V83, P1452, DOI 10.1152/jn.2000.83.3.1452; Jones TA, 2007, J NEUROPHYSIOL, V98, P1898, DOI 10.1152/jn.00472.2007; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOTAK VC, 1995, J NEUROPHYSIOL, V74, P1611, DOI 10.1152/jn.1995.74.4.1611; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lagostena L, 2001, CELL CALCIUM, V29, P191, DOI 10.1054/ceca.2000.0183; Leake PA, 2006, J COMP NEUROL, V497, P13, DOI 10.1002/cne.20968; Leao RN, 2006, J PHYSIOL-LONDON, V571, P563, DOI 10.1113/jphysiol.2005.098780; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; PUEL JL, 1987, DEV BRAIN RES, V37, P179, DOI 10.1016/0165-3806(87)90239-2; RETZIUS G, 1884, GEHORORGAN WIRBELTHI, V2; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; RUBSAMEN R, 1998, DEV AUDITORY SYSTEM, P193; Salih SG, 2002, NEUROPHARMACOLOGY, V42, P386, DOI 10.1016/S0028-3908(01)00184-8; Sugasawa M, 1996, J PHYSIOL-LONDON, V491, P707, DOI 10.1113/jphysiol.1996.sp021251; Wada T., 1923, American Anatomical Memoir, Vno. 10, P1; WALSH EJ, 1987, HEARING RES, V28, P97, DOI 10.1016/0378-5955(87)90157-2; Zhao HB, 2005, EUR J NEUROSCI, V21, P1859, DOI 10.1111/j.1460-9568.2005.04031.x	46	385	394	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2007	450	7166					50	+		10.1038/nature06233	http://dx.doi.org/10.1038/nature06233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17972875				2022-12-24	WOS:000250585800034
J	Sharif, J; Muto, M; Takebayashi, SI; Suetake, I; Iwamatsu, A; Endo, TA; Shinga, J; Mizutani-Koseki, Y; Toyoda, T; Okamura, K; Tajima, S; Mitsuya, K; Okano, M; Koseki, H				Sharif, Jafar; Muto, Masahiro; Takebayashi, Shin-ichiro; Suetake, Isao; Iwamatsu, Akihiro; Endo, Takaho A.; Shinga, Jun; Mizutani-Koseki, Yoko; Toyoda, Tetsuro; Okamura, Kunihiro; Tajima, Shoji; Mitsuya, Kohzoh; Okano, Masaki; Koseki, Haruhiko			The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA	NATURE			English	Article							EMBRYONIC STEM-CELLS; CYTOSINE-5 METHYLTRANSFERASE; MAMMALIAN-CELLS; BINDING-PROTEIN; REPLICATION; TRANSCRIPTION; MAINTENANCE; TARGET; DOMAIN; MARK	DNA methyltransferase (cytosine-5) 1 (Dnmt1) is the principal enzyme responsible for maintenance of CpG methylation and is essential for the regulation of gene expression, silencing of parasitic DNA elements, genomic imprinting and embryogenesis(1-4). Dnmt1 is needed in S phase to methylate newly replicated CpGs occurring opposite methylated ones on the mother strand of the DNA, which is essential for the epigenetic inheritance of methylation patterns in the genome. Despite an intrinsic affinity of Dnmt1 for such hemi-methylated DNA(5), the molecular mechanisms that ensure the correct loading of Dnmt1 onto newly replicated DNA in vivo are not understood. The Np95 ( also known as Uhrf1 and ICBP90) protein binds methylated CpG through its SET and RING finger-associated ( SRA) domain(6). Here we show that localization of mouse Np95 to replicating heterochromatin is dependent on the presence of hemi-methylated DNA. Np95 forms complexes with Dnmt1 and mediates the loading of Dnmt1 to replicating heterochromatic regions. By using Np95-deficient embryonic stem cells and embryos, we show that Np95 is essential in vivo to maintain global and local DNA methylation and to repress transcription of retrotransposons and imprinted genes. The link between hemimethylated DNA, Np95 and Dnmt1 thus establishes key steps of the mechanism for epigenetic inheritance of DNA methylation.	RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; TUBERO, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Aoba Ku, Sendai, Miyagi 9808574, Japan; Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138565, Japan; RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Prot Res Network Inc, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	RIKEN; RIKEN; Tohoku University; University of Tokyo; RIKEN; Osaka University	Koseki, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, 1-7-22 Suehiro, Yokohama, Kanagawa 2300045, Japan.	koseki@rcai.riken.jp	Suetake, Isao/G-3144-2013; Endo, Takaho/B-5763-2017; Suetake, Isao/D-4326-2009; Koseki, Haruhiko/I-3825-2014; Mitsuya, Kohzoh/F-4437-2010	Endo, Takaho/0000-0002-2801-2463; Suetake, Isao/0000-0002-1246-8474; Koseki, Haruhiko/0000-0001-8424-5854; Mitsuya, Kohzoh/0000-0002-0950-5406				Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koberna K, 1999, CHROMOSOMA, V108, P325, DOI 10.1007/s004120050384; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lin IG, 2002, MOL CELL BIOL, V22, P704, DOI 10.1128/MCB.22.3.704-723.2002; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007	30	867	895	9	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2007	450	7171					908	U25		10.1038/nature06397	http://dx.doi.org/10.1038/nature06397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RU	17994007				2022-12-24	WOS:000251394900062
J	Sutton, T; Baumann, U; Hayes, J; Collins, NC; Shi, BJ; Schnurbusch, T; Hay, A; Mayo, G; Pallotta, M; Tester, M; Langridge, P				Sutton, Tim; Baumann, Ute; Hayes, Julie; Collins, Nicholas C.; Shi, Bu-Jun; Schnurbusch, Thorsten; Hay, Alison; Mayo, Gwenda; Pallotta, Margaret; Tester, Mark; Langridge, Peter			Boron-toxicity tolerance in barley arising from efflux transporter amplification	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; FOLIAR ANALYSIS; BORIC-ACID; WHEAT	Both limiting and toxic soil concentrations of the essential micronutrient boron represent major limitations to crop production worldwide. We identified Bot1, a BOR1 ortholog, as the gene responsible for the superior boron-toxicity tolerance of the Algerian barley landrace Sahara 3771 (Sahara). Bot1 was located at the tolerance locus by high-resolution mapping. Compared to intolerant genotypes, Sahara contains about four times as many Bot1 gene copies, produces substantially more Bot1 transcript, and encodes a Bot1 protein with a higher capacity to provide tolerance in yeast. Bot1 transcript levels identified in barley tissues are consistent with a role in limiting the net entry of boron into the root and in the disposal of boron from leaves via hydathode guttation.	Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia	University of Adelaide	Sutton, T (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Private Mail Bag 1, Glen Osmond, SA 5064, Australia.	tim.sutton@acpfg.com.au	Tester, Mark/J-2368-2017; Schnurbusch, Thorsten/B-2249-2009; Sutton, Tim/ABC-8454-2020; Sutton, Tim/F-4824-2010; Hayes, Julie/B-9078-2009; Langridge, Peter/G-5864-2010	Tester, Mark/0000-0002-5085-8801; Schnurbusch, Thorsten/0000-0002-5267-0677; Langridge, Peter/0000-0001-9494-400X; Sutton, Timothy/0000-0002-9059-0774; Pallotta, Margaret/0000-0002-1642-5623; Hayes, Julie/0000-0001-8716-5024				Avci Muzaffer, 2005, Turkish Journal of Agriculture and Forestry, V29, P377; CARTWRIGHT B, 1984, AUST J SOIL RES, V22, P261, DOI 10.1071/SR9840261; Dixon J, 2006, J AGR SCI-CAMBRIDGE, V144, P489, DOI 10.1017/S0021859606006459; Dordas C, 2000, J MEMBRANE BIOL, V175, P95, DOI 10.1007/s002320001058; EGLINTON JK, 2004, CZECH J GENET PLANT, V40, P166; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Goldberg S, 1997, PLANT SOIL, V193, P35, DOI 10.1023/A:1004203723343; Gupta U.C., 1993, BORON ITS ROLE CROP; Hayes JE, 2004, PLANT PHYSIOL, V136, P3376, DOI 10.1104/pp.103.037028; Jefferies SP, 1999, THEOR APPL GENET, V98, P1293, DOI 10.1007/s001220051195; Matoh T, 1997, PLANT SOIL, V193, P59, DOI 10.1023/A:1004207824251; Miwa K, 2007, PLANT CELL PHYSIOL, V48, pS89; Nable R. O., 1991, Current Topics in Plant Biochemistry and Physiology, V10, P257; NABLE RO, 1992, PLANT SOIL, V140, P311, DOI 10.1007/BF00010608; NABLE RO, 1990, PLANT SOIL, V128, P225, DOI 10.1007/BF00011113; NABLE RO, 1990, ANN BOT-LONDON, V66, P83, DOI 10.1093/oxfordjournals.aob.a088003; NABLE RO, 1988, PLANT SOIL, V112, P45, DOI 10.1007/BF02181751; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; NABLE RO, 1990, ASPECTS PLANT MINERA, P243; OERTLI J. J., 1962, SOIL SCI, V94, P214, DOI 10.1097/00010694-196210000-00004; OERTLI JJ, 1969, AGROCHIMICA, V13, P212; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; YAU SK, 1996, BARLEY NEWSL, V40	26	294	302	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2007	318	5855					1446	1449		10.1126/science.1146853	http://dx.doi.org/10.1126/science.1146853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235PF	18048688				2022-12-24	WOS:000251246100044
J	Alber, F; Dokudovskaya, S; Veenhoff, LM; Zhang, WH; Kipper, J; Devos, D; Suprapto, A; Karni-Schmidt, O; Williams, R; Chait, BT; Sali, A; Rout, MP				Alber, Frank; Dokudovskaya, Svetlana; Veenhoff, Liesbeth M.; Zhang, Wenzhu; Kipper, Julia; Devos, Damien; Suprapto, Adisetyantari; Karni-Schmidt, Orit; Williams, Rosemary; Chait, Brian T.; Sali, Andrej; Rout, Michael P.			The molecular architecture of the nuclear pore complex	NATURE			English	Article							FG-REPEAT DOMAINS; TERMINAL DOMAIN; TRANSPORT; NUCLEOPORINS; COMPONENTS; DYNAMICS; HOMOLOG; REGIONS; BINDING; IMPORT	Nuclear pore complexes (NPCs) are proteinaceous assemblies of approximately 50 MDa that selectively transport cargoes across the nuclear envelope. To determine the molecular architecture of the yeast NPC, we collected a diverse set of biophysical and proteomic data, and developed a method for using these data to localize the NPC's 456 constituent proteins (see the accompanying paper). Our structure reveals that half of the NPC is made up of a core scaffold, which is structurally analogous to vesicle-coating complexes. This scaffold forms an interlaced network that coats the entire curved surface of the nuclear envelope membrane within which the NPC is embedded. The selective barrier for transport is formed by large numbers of proteins with disordered regions that line the inner face of the scaffold. The NPC consists of only a few structural modules that resemble each other in terms of the configuration of their homologous constituents, the most striking of these being a 16-fold repetition of 'columns'. These findings provide clues to the evolutionary origins of the NPC.	Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Rockefeller University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University	Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA.	chait@rockefeller.edu; sali@salilab.org; rout@rockefeller.edu	devos, damien/ABH-5348-2020; Rout, Michael/Y-7090-2018; Li, Chia Cheng/D-9906-2015	Rout, Michael/0000-0003-2010-706X; Veenhoff, Liesbeth/0000-0002-0158-4728; Devos, Damien/0000-0002-9453-4753; Svetlana, Dokudovskaya/0000-0001-6032-622X	NCRR NIH HHS [U54 RR022220] Funding Source: Medline; NIGMS NIH HHS [R01 GM062427] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062427] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; Antonin W, 2005, NAT CELL BIOL, V7, P10, DOI 10.1038/ncb0105-10; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; SCANNELL DR, IN PRESS YEAST; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	56	768	783	3	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2007	450	7170					695	701		10.1038/nature06405	http://dx.doi.org/10.1038/nature06405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235BY	18046406				2022-12-24	WOS:000251209700048
